"gene","baseMean","log2FoldChange","lfcSE","stat","pvalue","padj","start","end","saccver","spid","gene_uni","evalue","protein_names","gene_ontology_biological_process","gene_ontology_i_ds"
"g12054",692.03156298201,9.88125652279459,1.0335000617294,9.56096365031646,1.16665283159023e-21,7.55909369172257e-17,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55150",890.459662735156,7.80882790144769,0.882448230523991,8.84904930548829,8.82679729739635e-19,2.85957338645101e-14,0,9464,"sp|Q4R4T8|LGMN_MACFA","Q4R4T8","LGMN",5.67e-32,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]","GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185"
"g30042",106.357388665719,6.13838391129803,0.706329654955132,8.6905368735905,3.60730707084253e-18,7.79094156803668e-14,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30043",259.785564119009,7.07725116928767,0.823771527620517,8.59127917388754,8.60063762288346e-18,1.39315278374872e-13,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67692",117.758847249438,5.26668563025739,0.625662524458602,8.41777383872361,3.83705607148045e-17,4.97228748078866e-13,0,11389,"sp|P22985|XDH_RAT","P22985","XDH",2.67e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g103777",185.271687396029,5.18619120470841,0.635648246456526,8.15890114323332,3.38086204718871e-16,3.65093657705831e-12,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11730",150.517103123504,7.28324043266323,0.909620149504559,8.00690314152582,1.17633065191001e-15,1.0888284561315e-11,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96133",48.9270740972731,5.21015861702623,0.653291740577208,7.97524029987407,1.52084626387788e-15,1.23175239969299e-11,1193,6945,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.5e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68732",132.822608110026,5.1550976591774,0.659583073326229,7.81569125657003,5.46622093156956e-15,3.93525392021318e-11,0,11159,"sp|P22985|XDH_RAT","P22985","XDH",2.61e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g29611",90.6421545311478,4.47646869159581,0.588755228598543,7.60327632631217,2.88726074189504e-14,1.87074285249605e-10,0,35434,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",9.38e-173,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g91194",44.3106861664398,6.12486699043851,0.814423075252601,7.52049785492488,5.45680488785503e-14,3.2142069008981e-10,0,6917,"sp|P22985|XDH_RAT","P22985","XDH",3.83e-12,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g87617",96.9535585393511,5.69537172279101,0.759157994861735,7.50222188442908,6.27450419626989e-14,3.28654670789764e-10,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104526",59.419723259272,5.47776810997285,0.730787187017399,7.49570902074728,6.59409306602092e-14,3.28654670789764e-10,0,5017,"sp|Q6AUV1|XDH_ORYSJ","Q6AUV1","XDH",8.48e-10,"Xanthine dehydrogenase (EC 1.17.1.4)",NA,"GO:0004854; GO:0005506; GO:0016491; GO:0051537; GO:0071949"
"g36661",70.1855268069926,6.3783777955615,0.878536665421009,7.260229477736,3.86434164771043e-13,1.77040033124194e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157582",113.620928107725,5.44490803573143,0.750787248344925,7.25226493621791,4.0985916640114e-13,1.77040033124194e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58444",36.8953435484053,5.34377581423728,0.738590158328939,7.23510292410012,4.65176219949877e-13,1.88376017620077e-09,0,8264,"sp|Q5VYJ5|MALR1_HUMAN","Q5VYJ5","MALR1",6.67e-11,"MAM and LDL-receptor class A domain-containing protein 1","cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]","GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858"
"g11904",104.163753200365,3.80861728315323,0.528091801839861,7.21203637300199,5.51212445494518e-13,2.10086517534861e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94663",89.9847512842749,4.30969604629733,0.598573693896671,7.19994227985785,6.02380540184184e-13,2.1683356855641e-09,0,5641,"sp|P08793|XDH_CALVI","P08793","XDH",3.5e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g94664",91.8128422798398,4.16359686089416,0.584229741584753,7.12664310721359,1.02846302902331e-12,3.5072213178688e-09,0,5641,"sp|P08793|XDH_CALVI","P08793","XDH",3.5e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g58468",67.1429379754093,3.14103822327889,0.441884444122491,7.10827969859058,1.17498259783697e-12,3.80653237308254e-09,0,13937,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.03e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g23420",75.9457938886204,3.72593622276808,0.526085985184681,7.08237118588153,1.41708467484839e-12,4.37224606368818e-09,0,32832,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g99479",45.4885327919426,4.39449669493127,0.632023960383,6.9530539511006,3.57461901955721e-12,1.05277404606441e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72496",62.1756072857837,5.78682022419137,0.838506679171639,6.90134064275812,5.15140380411717e-12,1.45119524643549e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139790",33.5016146491814,5.46617638638496,0.79605073181975,6.86661812858262,6.57417405410494e-12,1.77483524786509e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87706",35.7015069703596,6.24935799521614,0.913657488633641,6.83993517588516,7.92290238911626e-12,2.05339445799204e-08,0,6628,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",9.78e-17,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g98008",32.028287641542,4.74059416754438,0.694858163212656,6.82239112745884,8.95374837892206e-12,2.23130853352114e-08,0,6726,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",5.55e-08,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g113541",94.2927012979224,5.21517880177713,0.767363020651977,6.79623419609944,1.07389157231693e-11,2.35958128221304e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122771",36.4520715506102,4.61066233594646,0.677957077855759,6.80081746550836,1.04027160682639e-11,2.35958128221304e-08,0,4239,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",1.85e-128,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g146361",102.741640210692,4.42493269166351,0.651323536345135,6.79375524565529,1.09251676055116e-11,2.35958128221304e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154026",445.915959831858,1.18229136565644,0.173946429217376,6.79687057087542,1.06916067135139e-11,2.35958128221304e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32791",31.1467463182319,5.79055648155842,0.858985446698492,6.74115784361004,1.57129390878161e-11,3.23567178657406e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57002",335.972847688843,4.66810028276922,0.692729490808758,6.73870586528551,1.59803523791721e-11,3.23567178657406e-08,4396,14144,"sp|P81182|BGBP_PENVA","P81182","BGBP",0,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g125331",20.2461823690416,4.72388263923838,0.702068597479444,6.7285200565842,1.71397375691067e-11,3.36525762519736e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57249",48.4943919743002,4.07279452570236,0.606059738692743,6.72012058495633,1.81574235204838e-11,3.46021747694915e-08,2725,13679,"sp|Q9R0J8|LGMN_RAT","Q9R0J8","LGMN",1.05e-07,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]","GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028"
"g37881",32.3631429995884,3.39576136591528,0.50762707183292,6.68948043620683,2.23964322431236e-11,4.14609152665345e-08,0,21764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.78e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g78509",27.4883430167498,4.0348369808357,0.60549620697029,6.66368663319088,2.67042549112999e-11,4.80624663463293e-08,0,9359,"sp|P21328|RTJK_DROME","P21328","RTJK",1.01e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31622",49.1638614374158,4.20114693139449,0.633478501812321,6.63186977833567,3.31460950324397e-11,5.80441874442397e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104041",27.8895075981641,6.72539669820607,1.02084359827636,6.58807745825269,4.45558198079359e-11,7.59711903372523e-08,1831,6054,"sp|P08793|XDH_CALVI","P08793","XDH",1.88e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g21471",61.0053093902623,4.59488752809823,0.700111357759283,6.56308096872509,5.27072080796277e-11,8.75655931564953e-08,24355,27804,"sp|O19015|BGAL_FELCA","O19015","BGAL",7.75e-11,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"g79937",27.4512061013853,5.32391369854249,0.812654555954317,6.55126296842145,5.70524896944792e-11,9.2055045385858e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80595",24.8015168578398,-2.33320688831482,0.356314984778234,-6.54815819707099,5.82509971882793e-11,9.2055045385858e-08,6653,8964,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.73e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g52273",54.1451037892613,5.36075554779325,0.820539335080219,6.5332097056251,6.43749058888564e-11,9.93105542203969e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29384",117.586839712528,2.61933158132633,0.401226730075214,6.52830777459744,6.65169071031195e-11,1.0022860376587e-07,0,36208,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",1.16e-172,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g146797",24.6995771305146,4.21734968886774,0.648236013880055,6.50588612567905,7.72367197002563e-11,1.13736335898607e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97681",17.7514648400563,6.48665244139388,1.00817613045826,6.4340468350956,1.24250546097793e-10,1.78901458518096e-07,710,2179,"sp|Q16563|SYPL1_HUMAN","Q16563","SYPL1",8.19e-29,"Synaptophysin-like protein 1 (Pantophysin)","chemical synaptic transmission [GO:0007268]","GO:0005887; GO:0007268; GO:0016021; GO:0030141; GO:0030285; GO:0030672; GO:0042470; GO:0070062"
"g149788",73.5817583186908,3.14877423358106,0.491417433962964,6.40753464562344,1.47891487999866e-10,2.08311590912508e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140341",25.670013432466,2.61410760965608,0.40869743758208,6.39619280493062,1.5929883712735e-10,2.19605309659412e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72502",31.854518760883,5.94378714329313,0.932539152219952,6.37376685916476,1.84440906680318e-10,2.48968326386205e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83832",45.1182538579225,4.25011258412807,0.671285578640187,6.33130327741803,2.43098976428481e-10,3.2145126489246e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73940",201.06366827752,3.53455472482803,0.558611799695816,6.32739001709724,2.49342569223084e-10,3.23113061753425e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59432",46.7230762700507,4.75364309822419,0.759944664271652,6.25524899603077,3.9688218277003e-10,5.04219358200364e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95701",21.251491886555,3.21434733290841,0.514657343349496,6.24560666323884,4.22158325994729e-10,5.26017392618778e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74523",6197.79050672389,-0.382741438732953,0.0615680915347533,-6.21655518616988,5.08187705951974e-10,6.21264264749929e-07,0,6289,"sp|Q9NL83|ORCKA_PROCL","Q9NL83","ORCKA",9.52e-50,"Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]","neuropeptide signaling pathway [GO:0007218]","GO:0005184; GO:0005576; GO:0007218"
"g99049",118.898887922721,3.39677901733142,0.548436978733124,6.19356306932092,5.88191367629161e-10,7.05753394125856e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80405",595.334279098409,-1.89916807426401,0.306881205600894,-6.18860992332624,6.0697074971127e-10,7.15044650655314e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43367",23.8939341201334,2.65957686523265,0.430958819861477,6.17130162479914,6.77300722441622e-10,7.78196810144577e-07,0,13135,"sp|P05187|PPB1_HUMAN","P05187","PPB1",3.39e-15,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)","dephosphorylation [GO:0016311]","GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0016311; GO:0031225"
"g53690",61.542630953118,-1.09596632179382,0.177680356074392,-6.16819071059806,6.90758028798342e-10,7.78196810144577e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73734",199.853103035935,3.41669049255673,0.554040866813706,6.16685644906693,6.96609432938519e-10,7.78196810144577e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148164",40.0161165263616,6.2292067720484,1.0120914178356,6.15478667467588,7.51786199970876e-10,8.2560141109683e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124730",1005.67590303041,1.04818685609136,0.171493898473831,6.11209416439566,9.83321300929095e-10,1.06187228418498e-06,0,4064,"sp|Q6GMC7|AK1A1_XENLA","Q6GMC7","AK1A1",6.14e-11,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0005829; GO:0006629; GO:0008106; GO:0016324; GO:0046185; GO:0110095"
"g56507",34.8586381608233,3.09105437698905,0.507685342483796,6.08852397011581,1.13956394370084e-09,1.21042240334768e-06,625,5588,"sp|P04323|POL3_DROME","P04323","POL3",4.37e-82,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g152513",26.1936401984225,3.92794976414248,0.64801103519212,6.06154764475258,1.34817938308141e-09,1.40891268980636e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9144",111.555535211302,-0.616211405097422,0.10213761155512,-6.03314876581852,1.60795259044071e-09,1.65371543162579e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32185",28.3690628414639,2.95630672622123,0.490267878956202,6.02998249143981,1.63977443273936e-09,1.66009226282002e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99050",42.480315125773,3.25224505668531,0.542200274610694,5.99823572391301,1.99472822327523e-09,1.98837578108726e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114167",61.6869753623178,2.89235290177573,0.484548109094855,5.96917591357172,2.38454906483947e-09,2.34094072057794e-06,0,5044,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",1.68e-27,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g18128",285.365939868482,1.04069848623922,0.175243222926383,5.93859476481095,2.87475465381199e-09,2.7800593773797e-06,9862,56101,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.99e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g162225",28.2996865803044,5.3432132953798,0.909737069106947,5.87335998149996,4.27049740965962e-09,4.06909321564817e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9738",121.907529586421,3.02829043454043,0.516300616879305,5.86536280518981,4.48151691111736e-09,4.19119833081179e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74991",4367.71226167938,0.837942976642239,0.142962081769671,5.86129529081891,4.59270417309952e-09,4.19119833081179e-06,0,654,"sp|P52174|NDKA1_BOVIN","P52174","NDKA1",3.6e-15,"Nucleoside diphosphate kinase A 1 (NDK A 1) (NDP kinase A 1) (EC 2.7.4.6) (Nucleoside diphosphate kinase NBR-A) (NDK NBR-A)","cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; nervous system development [GO:0007399]; UTP biosynthetic process [GO:0006228]","GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0030154; GO:0046872"
"g145502",58.5053404397319,2.46158755551379,0.419947442036092,5.86165626721982,4.58272916457701e-09,4.19119833081179e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46895",61.3271172938925,2.8374814430866,0.488582035338598,5.8075844747754,6.33805758181589e-09,5.70363562359162e-06,0,6164,"sp|Q9NTJ4|MA2C1_HUMAN","Q9NTJ4","MA2C1",3.49e-09,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g147186",25.5354249571954,5.66820388742832,0.979224262461806,5.7884634855536,7.10331855399969e-09,6.30473039820961e-06,0,2234,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.98e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g117059",34.6446306841816,2.60954353762699,0.451469127277469,5.78011513957452,7.46495186517918e-09,6.53617062433182e-06,0,4763,"sp|Q8S8Q4|GUN14_ARATH","Q8S8Q4","GUN14",2.83e-09,"Endoglucanase 14 (EC 3.2.1.4) (Endo-1,4-beta glucanase 14)","cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]","GO:0005576; GO:0008810; GO:0030245; GO:0071555"
"g52187",62.2881199494972,5.26047011259944,0.915221765086494,5.74775460251679,9.04363623903244e-09,7.81285763780838e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69228",20.1897766490498,7.813314677628,1.36298237402729,5.73251336665602,9.89532338171047e-09,8.43615378777851e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89158",141.03197587309,0.515353439043946,0.0899427191128837,5.72979607606865,1.00551440459342e-08,8.46107724893782e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93508",2043.35521844549,0.883623014339416,0.154292502922357,5.72693421652555,1.02261799192491e-08,8.49467789112705e-06,0,3733,"sp|P54985|PPIA_BLAGE","P54985","PPIA",1.09e-17,"Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)","protein folding [GO:0006457]","GO:0003755; GO:0005737; GO:0006457"
"g72805",10377.523026437,0.522189446534159,0.0917280885545356,5.69279764533302,1.24974470692059e-08,1.02499631386717e-05,0,5886,"sp|Q01768|NDKB_MOUSE","Q01768","NDKB",4.29e-33,"Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18) (nm23-M2)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; CTP biosynthetic process [GO:0006241]; dTMP biosynthetic process [GO:0006231]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]","GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006165; GO:0006183; GO:0006228; GO:0006231; GO:0006241; GO:0007189; GO:0007229; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0042802; GO:0042981; GO:0043066; GO:0043209; GO:0045618; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0071944; GO:1901363"
"g61350",24.1398550817952,3.68041366807832,0.646784932657489,5.69032066494862,1.26801022163204e-08,1.02697732862756e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11892",30.301969824922,2.0346262979977,0.358579777009268,5.67412450018092,1.39399726414366e-08,1.11507734241556e-05,1015,30236,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g160502",122.616405134112,1.66511805837336,0.29369412297641,5.6695654700149,1.4316013810168e-08,1.13119205219783e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11932",72.5876365163577,1.8002166207222,0.317971868042106,5.66155940714798,1.50003558003202e-08,1.17098560647006e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4920",108.603254986274,2.94419767180347,0.521634858330971,5.64417355317042,1.65976581819245e-08,1.280252460216e-05,14296,26864,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",2.51e-64,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g137728",150.641230168128,0.655792207355589,0.116338883567136,5.63691336247999,1.73125155283583e-08,1.31968213956343e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146559",41.3576375925708,2.89801448001075,0.514947366864383,5.62778774393457,1.8253550585033e-08,1.37523523611168e-05,0,2024,"sp|Q9NTJ4|MA2C1_HUMAN","Q9NTJ4","MA2C1",5.66e-13,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g108640",23.2345077288521,3.77819956169207,0.671705718414157,5.62478397625093,1.85740264965041e-08,1.38329528596321e-05,0,5474,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.96e-07,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g120970",48.7087280323703,2.57912095999155,0.459641963409882,5.61115208206445,2.0098403257591e-08,1.47981345712397e-05,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g12048",677.306171194611,0.924978767052658,0.166004890335313,5.57199709709935,2.51835618683684e-08,1.82811795891281e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91416",57.2703165533203,1.19317508338226,0.214193308777142,5.57055255457909,2.53932703073099e-08,1.82811795891281e-05,0,7513,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",8.97e-40,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g13459",5046.84702808212,0.768844770795326,0.138452227202038,5.55314122663681,2.80581206253702e-08,1.95480624696732e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56502",95.0585987562763,0.680096367924642,0.122464430981815,5.55341957229714,2.80134586968429e-08,1.95480624696732e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153882",34.72799407135,3.05704946210068,0.550330865117383,5.55493005366622,2.77722947974549e-08,1.95480624696732e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38625",43.3036367642699,1.91579719608498,0.34522351409562,5.5494400522044,2.86585997063058e-08,1.96728670683956e-05,615,25586,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.44e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g120971",47.1194364841266,2.69421409677204,0.485591898997878,5.54830939793709,2.88445105412249e-08,1.96728670683956e-05,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g104479",60.3501771098582,3.72233654499157,0.67366097600616,5.52553387767786,3.28485182382103e-08,2.21703546063371e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21054",105.141325383012,1.57506931068512,0.285601320793575,5.51492306236057,3.4893257085119e-08,2.330761655996e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4154",2105.44667885651,0.466434591001941,0.0847331961900463,5.50474444461867,3.6970416223126e-08,2.41962038216667e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149135",530.089756278356,1.03258839270508,0.187526131021691,5.50637069660252,3.66306786066814e-08,2.41962038216667e-05,0,2065,"sp|Q28FD1|AK1A1_XENTR","Q28FD1","AK1A1",9.99e-10,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0004032; GO:0005829; GO:0006629; GO:0016324; GO:0046185; GO:0110095"
"g4102",590.874712243702,-0.827174298328148,0.150430800554887,-5.49870302675375,3.82594854325405e-08,2.4789468396306e-05,32745,48476,"sp|Q9V5M3|LOLA6_DROME","Q9V5M3","LOLA6",9.9e-07,"Longitudinals lacking protein, isoforms N/O/W/X/Y","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813"
"g88412",20.9378262112898,3.34439771923073,0.611172195118563,5.47210384559779,4.44724091240189e-08,2.85297109343818e-05,0,4914,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.7e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11930",48.6255644914053,1.72578256491289,0.315482368344952,5.47029798833605,4.49279539376458e-08,2.85393815635479e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123344",42.4179143323602,0.883212465296319,0.162439832128143,5.43716681878609,5.41344502016119e-08,3.39905301762112e-05,0,4187,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",4.45e-28,"PiggyBac transposable element-derived protein 4",NA,NA
"g132823",53.2723599107722,1.20951817375214,0.22251069070645,5.43577555717454,5.45585964274838e-08,3.39905301762112e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67159",228.546250121063,0.939649149089742,0.172936505277217,5.43349218017032,5.52617065523668e-08,3.41006833585476e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74524",5224.65580778237,-0.376755026679342,0.0693999723523122,-5.42874894483715,5.67504465149619e-08,3.43647820658311e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86262",54.0712795764267,0.867750226343944,0.159826656313116,5.42932103042896,5.65688480957449e-08,3.43647820658311e-05,0,3664,"sp|A7YWE4|AL4A1_BOVIN","A7YWE4","AL4A1",5.9e-17,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133; GO:0016620"
"g88738",104.291166525753,0.912310996500109,0.168273477265648,5.42159710088996,5.90688965035476e-08,3.54375093625404e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58981",156.604377896696,0.513519176864754,0.094847358672125,5.41416423244767,6.15756308795845e-08,3.66024757025772e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67578",17.2544412363584,7.97401478114846,1.47691781991694,5.39909172576501,6.69791244770616e-08,3.94525310203841e-05,7247,11467,"sp|Q86UW6|N4BP2_HUMAN","Q86UW6","N4BP2",3.99e-07,"NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)",NA,"GO:0004519; GO:0005524; GO:0005829; GO:0043130; GO:0046404"
"g141887",14391.2550100875,0.661923170031063,0.122760230657946,5.39200005151033,6.96777480369672e-08,4.06723453023353e-05,0,2014,"sp|Q56FH2|RS4_LYSTE","Q56FH2","RS4",2.58e-42,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g101476",2186.78188448475,0.570435819170835,0.106165289336654,5.37309155125045,7.73980060204892e-08,4.47754375364782e-05,0,6329,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.31e-16,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g118276",1618.98836273445,0.809457664648394,0.151265650162905,5.35123250901081,8.73571937269502e-08,5.00896871960202e-05,1125,4644,"sp|Q4U3L0|G3P_GLOMM","Q4U3L0","G3P",9.78e-06,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0015630; GO:0050661; GO:0051287"
"g4918",39.9820217136645,2.30260902867001,0.43050935111178,5.34856913728721,8.86523104773434e-08,5.0386396076829e-05,0,7370,"sp|O04847|DV4H_CATRO","O04847","DV4H",5.87e-07,"Deacetoxyvindoline 4-hydroxylase (EC 1.14.11.20)","alkaloid metabolic process [GO:0009820]","GO:0005634; GO:0005737; GO:0009820; GO:0031418; GO:0046872; GO:0050590"
"g97904",130.621948238928,1.5386107775905,0.287784737962488,5.34639462983285,8.97234741218865e-08,5.05517657285164e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146918",123.810105753028,0.451457901222331,0.0845155452572483,5.34171435382904,9.20716580572515e-08,5.1427577073306e-05,0,2257,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.23e-11,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g20154",533.62469464498,2.06516301366399,0.388644665720368,5.31375622983564,1.07388255721444e-07,5.86723353543112e-05,0,49874,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.73e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g32795",17.9924027406243,4.79526912832629,0.902532028815259,5.31312903611961,1.07758676202106e-07,5.86723353543112e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111234",28.453001860754,8.11521300891868,1.52688401586745,5.31488503683648,1.0672468505263e-07,5.86723353543112e-05,0,2734,"sp|Q6DCX5|PCFT_XENLA","Q6DCX5","PCFT",2.11e-13,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)",NA,"GO:0005542; GO:0016021; GO:0022857"
"g70399",35.8913006085421,1.40682103016961,0.266274291450109,5.28335282579542,1.2684076868786e-07,6.73638846360042e-05,0,10825,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.45e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113851",83.8346835590263,2.84272996103915,0.537962848694019,5.28424958701198,1.26221070765541e-07,6.73638846360042e-05,0,5074,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.83e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g135902",20.0950624628229,5.7982665119437,1.09737542851036,5.28375828481471,1.26560216561063e-07,6.73638846360042e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119911",19.9095773315836,6.9775912970014,1.32305862041674,5.27383381909681,1.33602895100244e-07,7.03783120506513e-05,0,4496,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.18e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g13396",2438.51737596901,0.60219195291266,0.114350605791345,5.26618944206973,1.39284555124769e-07,7.20075870206479e-05,0,2024,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.17e-28,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g72727",3805.9999764661,1.28376262455758,0.243819874615255,5.2652091080899,1.40029879224633e-07,7.20075870206479e-05,0,7809,"sp|A4II20|EGR1_XENTR","A4II20","EGR1",4.51e-59,"Early growth response protein 1 (EGR-1)","circadian regulation of gene expression [GO:0032922]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841"
"g132561",500.343857628726,6.15149756072856,1.16772706905651,5.26792409265532,1.37975134112281e-07,7.20075870206479e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15417",601.4547612243,-0.425086805109174,0.0808020481847633,-5.26084195461436,1.43397252405404e-07,7.31041098339833e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97799",26.2079530784369,1.54178217711127,0.293140300390014,5.25953673056887,1.44418780713192e-07,7.31041098339833e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5581",52.5806090466652,2.12082221050892,0.404267680897607,5.24608399513905,1.55366091392804e-07,7.80359314698754e-05,71535,112204,"sp|P21328|RTJK_DROME","P21328","RTJK",9.87e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42649",18.3547889031172,2.13950231100951,0.408009596259615,5.24375487886357,1.57341201528398e-07,7.84200651586884e-05,0,19781,"sp|Q9ULJ7|ANR50_HUMAN","Q9ULJ7","ANR50",6.72e-50,"Ankyrin repeat domain-containing protein 50","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456"
"g31717",74.4367643487444,0.806791875996453,0.153920803525913,5.24160384766069,1.59186845430204e-07,7.87342998164825e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50107",387.582964718102,0.38950644382478,0.0743809456386655,5.2366428052281,1.63523727182375e-07,8.02666125403607e-05,10341,17303,"sp|P21328|RTJK_DROME","P21328","RTJK",2.78e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g108740",406.283727741543,0.754339249454155,0.144325135913377,5.22666578264581,1.72594069050565e-07,8.40818610225058e-05,0,5572,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.83e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g90986",29.6523764834271,2.96209842832269,0.56884572888524,5.20720869984816,1.91702445028176e-07,9.2068059924583e-05,0,3881,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.91e-54,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g146509",337.034861177162,1.81176581803304,0.347942363716107,5.20708602046313,1.91829180464228e-07,9.2068059924583e-05,0,1792,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",7.49e-22,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g43487",79.6959112641429,2.52698061322845,0.48547319283476,5.20519083344846,1.93797346127819e-07,9.23287606445574e-05,0,21467,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g57554",100.718981849394,0.800009611924469,0.153783252769122,5.20218942907613,1.96954319597822e-07,9.31478921876037e-05,0,2304,"sp|Q55E60|PEPD_DICDI","Q55E60","PEPD",1.58e-07,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)",NA,"GO:0008233; GO:0030145; GO:0070006; GO:0102009"
"g7372",49.300939014903,2.28761628534965,0.440507970912593,5.19313255696698,2.06784841631359e-07,9.70884800276858e-05,67786,78254,"sp|P21328|RTJK_DROME","P21328","RTJK",6.07e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g106542",118.134365027691,0.608186637622535,0.117258634099119,5.18671091723985,2.14040585719718e-07,9.97721702916378e-05,0,5374,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.27e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g61918",177.093255496821,0.533818394930969,0.103076748934108,5.17884392407656,2.23265158922347e-07,0.000103328710300397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90822",118.321081206812,0.878840649601706,0.170440133615183,5.15630110679177,2.51875751734277e-07,0.000114928067479711,322,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",1.99e-10,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g140128",23.5879910157443,1.25760708845994,0.243882984772338,5.15660036567909,2.51473717901647e-07,0.000114928067479711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159612",510.421753594533,0.728945102508992,0.141674137831909,5.14522349431098,2.67202503438871e-07,0.00012106889374346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87015",1063.59628337367,0.995144191485339,0.193498930269063,5.14289247026625,2.70540485270925e-07,0.000121730067098327,0,7301,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.15e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g16072",995.752539347937,0.915590202439585,0.178076387482976,5.1415587174752,2.72468470776435e-07,0.000121752066393224,9950,60394,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.45e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61264",1528.05796027795,0.73820823123112,0.143684066478037,5.13771811534828,2.7809460438467e-07,0.000123414956862301,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128841",983.840194195327,0.767953896667558,0.149714009831142,5.12947250249799,2.90555207479535e-07,0.000128067643253207,0,1454,"sp|A0A1L5YRA2|TPIS_SCYPA","A0A1L5YRA2","TPIS",3.89e-12,"Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Allergen Scy p 8) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase) (allergen Scy p 8.0101)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]","GO:0004807; GO:0005737; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019863; GO:0042803"
"g18404",340.564919077667,0.519108328335892,0.101318007933907,5.12355442948034,2.99829040974128e-07,0.000131262317917815,48225,55293,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g110234",5579.14917513621,0.564310119247972,0.110402861634035,5.11137221350796,3.19827129836476e-07,0.000139077578681173,0,2975,"sp|Q5UAP0|RS4_BOMMO","Q5UAP0","RS4",2.78e-20,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g106217",42.7870283008066,0.80417702422481,0.157654130149476,5.10089411208162,3.38052661727072e-07,0.000146022974075215,0,5831,"sp|B3NQ53|KAD2_DROER","B3NQ53","KAD2",6.4e-22,"Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]","GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034"
"g37680",51.6873747129225,1.03314540984703,0.202610673924483,5.09916575388375,3.41153714316899e-07,0.000146386573587648,0,13964,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.63e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g99315",19.1718690554016,2.80807218990032,0.551275254357801,5.09377514717496,3.51003028798617e-07,0.000149621968716768,835,2860,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",6.89e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g84847",48.7273260995282,2.30107862064378,0.452003510743723,5.09084236283387,3.56476298399445e-07,0.000150961887596048,0,8386,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.29e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g147750",2513.12152767691,0.694370385686274,0.136482976398072,5.0875970323291,3.62628861521424e-07,0.000152570206652971,798,2185,"sp|A2Q0R8|RS3A_SOLSE","A2Q0R8","RS3A",7.59e-14,"40S ribosomal protein S3a","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0022627"
"g79278",2286.63144230807,0.551205567091384,0.108721599318304,5.06988096705258,3.98064582316412e-07,0.000166398699884047,2216,7571,"sp|P60060|SC61G_MOUSE","P60060","SC61G",4.72e-14,"Protein transport protein Sec61 subunit gamma","posttranslational protein targeting to membrane, translocation [GO:0031204]","GO:0008320; GO:0016020; GO:0016021; GO:0031204; GO:0043022; GO:0071261"
"g86828",43.2033264858173,2.81147448186556,0.555691662637981,5.05941454748289,4.20545689176065e-07,0.000174669338710159,0,8116,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g78945",226.041041161525,0.465591209975197,0.0920802616084412,5.05636280612517,4.27328029178724e-07,0.000175806664225519,0,9290,"sp|P21328|RTJK_DROME","P21328","RTJK",1.16e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g103134",45.8603514236137,6.65168438021006,1.31566812326358,5.05574640184353,4.28710708681988e-07,0.000175806664225519,0,4523,"sp|F6R2G2|NLRC4_XENTR","F6R2G2","NLRC4",1.39e-06,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"g139279",35.7747698020795,1.73852924407146,0.343954489339943,5.05453278835738,4.31445635863202e-07,0.000175815453361537,0,2774,"sp|Q71R50|DHR11_CHICK","Q71R50","DHR11",2.51e-10,"Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)","estrogen biosynthetic process [GO:0006703]","GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0044594; GO:0072555; GO:0072582; GO:0102176"
"g68623",3330.84297032461,0.364039034922977,0.0720507389835907,5.05253714338566,4.35979536985386e-07,0.000176552638374338,3875,11232,"sp|Q08473|SQD_DROME","Q08473","SQD",4.68e-45,"RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0010468; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0045451; GO:0048477; GO:0071011; GO:0071013"
"g105330",862.917013168831,0.791198080696859,0.156778276764769,5.04660528884354,4.49729103426459e-07,0.000180989427318699,0,5919,"sp|Q04820|MDHC_ECHGR","Q04820","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37)","malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]","GO:0005737; GO:0006099; GO:0006108; GO:0030060"
"g32261",9030.64699092201,0.460917993195049,0.0913779417280456,5.04408377425276,4.55699627523911e-07,0.000182129879371242,24369,27074,"sp|P60868|RS20_RAT","P60868","RS20",2.12e-43,"40S ribosomal protein S20","positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0045202; GO:0097371; GO:1901798; GO:1990948"
"g100350",272.831140348337,-0.824308038025984,0.163454474376789,-5.04304358243398,4.58184839990623e-07,0.000182129879371242,0,6294,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.55e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g69555",1123.43151096336,0.701288832176394,0.139095252409198,5.04178841498703,4.61201077642983e-07,0.000182210984290987,6266,11014,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.07e-07,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10279",853.40227218515,-0.926629341495742,0.184023132864539,-5.0353959693635,4.76862053598951e-07,0.000187256503265678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11996",102.94817297833,0.73447755248646,0.146125386906163,5.02635146456871,4.99899344638287e-07,0.000192991598778451,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89536",42213.6200850853,0.926539562725777,0.184385264960523,5.02501955849969,5.03381232441131e-07,0.000192991598778451,3932,7064,"sp|H6VGI3|KARG0_SCYPA","H6VGI3","KARG0",0,"Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)","phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]","GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314"
"g107086",17.8541040098135,-2.44653505008542,0.486868863076952,-5.02503905183753,5.03330104445607e-07,0.000192991598778451,0,5739,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.76e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147306",6578.63845907559,0.44372794231198,0.0882630847284755,5.02733326936197,4.97347579543734e-07,0.000192991598778451,0,2223,"sp|B0WN96|RS3A_CULQU","B0WN96","RS3A",4.22e-32,"40S ribosomal protein S3a","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0022627"
"g18751",27.7541551795686,1.59883911401523,0.318365498068232,5.02202381764548,5.11298409871982e-07,0.000194873869828443,436,32054,"sp|O02467|ASPG_SPOFR","O02467","ASPG",2.52e-75,"N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] (Fragment)",NA,"GO:0003948; GO:0005764; GO:0008233"
"g49628",57.8528504561871,0.907360334275139,0.180987054606348,5.0133990867395,5.34768193581636e-07,0.000202627108577397,15998,17522,"sp|P09488|GSTM1_HUMAN","P09488","GSTM1",2.16e-07,"Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4)","cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0005737; GO:0005829; GO:0006693; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042803; GO:0043295; GO:0045171; GO:0051122; GO:0070458; GO:1901687"
"g24981",823.764714340518,0.65004585884649,0.12975246200596,5.00989228872306,5.44605074569855e-07,0.000202796532164394,0,7124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.37e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g41649",626.711693967805,0.591381851587001,0.118032882479223,5.01031440701365,5.43411823096896e-07,0.000202796532164394,14645,18044,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.86e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g51876",20.3229875238934,1.48675349326071,0.296672623629001,5.01142800125685,5.40275979650336e-07,0.000202796532164394,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55151",67.2422039443832,7.81225785738891,1.56773995578497,4.98313373245458,6.25626789765635e-07,0.000231635637653056,7525,13689,"sp|O89017|LGMN_MOUSE","O89017","LGMN",7.42e-10,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]","GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028"
"g111963",90.4005335256274,1.18036224551105,0.237120250729275,4.97790569080789,6.42759590178059e-07,0.000236626830263676,2926,5252,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.29e-13,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g31547",171.460734165409,0.840245187379901,0.168988672947102,4.97219827060789,6.61979514273445e-07,0.000242325642193895,0,8497,"sp|O16852|PCNA_SARCR","O16852","PCNA",1.45e-21,"Proliferating cell nuclear antigen (PCNA) (Cyclin)","DNA replication [GO:0006260]; regulation of DNA replication [GO:0006275]","GO:0003677; GO:0005634; GO:0006260; GO:0006275; GO:0030337"
"g6770",73.8390884065304,1.40988026495491,0.284079399590243,4.96297960002917,6.94198759976548e-07,0.000252692248624497,0,4854,"sp|P21328|RTJK_DROME","P21328","RTJK",5.56e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g122495",973.988737292293,0.729054137019632,0.146953436950106,4.96112341535204,7.0086641445821e-07,0.000253694064759725,455,4140,"sp|O88989|MDHC_RAT","O88989","MDHC",2.06e-21,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NAD metabolic process [GO:0019674]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0016615; GO:0019674; GO:0030060; GO:0051287"
"g62055",115.264863704864,0.765297684777376,0.154401349976778,4.95654788570487,7.17566882416846e-07,0.000257014472703478,0,12822,"sp|P21328|RTJK_DROME","P21328","RTJK",4.66e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g161420",25.21102923438,2.11636314064748,0.426992766503277,4.95643792277506,7.17972922373242e-07,0.000257014472703478,0,1100,"sp|Q6UWP2|DHR11_HUMAN","Q6UWP2","DHR11",7.22e-11,"Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)","estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]","GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0044594; GO:0072555; GO:0072582; GO:0102176"
"g86267",56.6883496247424,0.894967258357077,0.180616775740349,4.95506164744997,7.23073602600684e-07,0.000257418175457726,0,5514,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",1.2e-29,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g53749",71.105844119441,-1.45705507615352,0.294302275316593,-4.95087941330427,7.38788724171109e-07,0.00026157561642196,11533,14844,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.25e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g161980",104.333787645796,0.927928467571764,0.187531912477915,4.94810965936821,7.49376891820164e-07,0.000263882483433173,0,1065,"sp|Q5JJ64|Y1782_THEKO","Q5JJ64","Y1782",4.03e-06,"Uncharacterized serpin-like protein TK1782",NA,"GO:0004867; GO:0005615"
"g85374",172.533145947374,0.926075070115756,0.187215386444169,4.94657564052263,7.55303860196771e-07,0.000264531908182321,0,5524,"sp|Q8BQ86|CHST8_MOUSE","Q8BQ86","CHST8",4.87e-10,"Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)","carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446"
"g38786",18184.695729553,0.532243810104745,0.107893800319346,4.93303422930139,8.09619601838974e-07,0.0002797385639059,0,3768,"sp|Q5E973|RL18_BOVIN","Q5E973","RL18",4.42e-23,"60S ribosomal protein L18","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g60891",1428.91638567219,-0.254111685894449,0.0515174185283209,-4.93253919069635,8.11674872506431e-07,0.0002797385639059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107851",12494.379426057,0.541875864335851,0.109812461106709,4.93455714292105,8.03328244252336e-07,0.0002797385639059,0,5660,"sp|P0CX36|RS4B_YEAST","P0CX36","RS4B",1.87e-10,"40S ribosomal protein S4-B (RP5) (S7) (Small ribosomal subunit protein eS4-B) (YS6)","cytoplasmic translation [GO:0002181]; translation [GO:0006412]","GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0019843; GO:0022627; GO:0030686"
"g69957",3046.64690965719,0.548779145223823,0.111305421911191,4.9303900546883,8.20655932685046e-07,0.000281337353684985,0,10923,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.44e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g149368",1624.34011161315,0.720618366818747,0.146310576155576,4.92526504750071,8.42460826412535e-07,0.000287292443819723,55,2046,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.01e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g129095",2051.20181024683,0.768762179770198,0.156296691823867,4.91860813430731,8.71617624011564e-07,0.000295679166034457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45295",26.6911383323589,2.75275592979918,0.559898266423981,4.91652876044924,8.80922610919704e-07,0.00029727926421521,7505,12128,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.46e-72,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g54624",106.2073451346,0.984050329708509,0.200290073982256,4.91312579871376,8.96357229325959e-07,0.000300920590464854,0,13844,"sp|P49717|MCM4_MOUSE","P49717","MCM4",3.56e-45,"DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)","DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006268; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g53066",1865.5670874751,0.486121776765559,0.0990321873164301,4.90872503110823,9.16704008457053e-07,0.000304594886256194,7615,15941,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.31e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68509",158.836634224027,1.91942753017849,0.39095889206108,4.90953798252175,9.12912174360112e-07,0.000304594886256194,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106062",26.8099721602594,3.25329960425206,0.664611459780114,4.89503988590327,9.82857920868182e-07,0.000324909761565368,0,5846,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.21e-11,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g67656",83.416632869446,-0.59848883463391,0.122333197018567,-4.89228475360677,9.96720963217197e-07,0.000326164350352181,5245,11449,"sp|Q9UJU3|ZN112_HUMAN","Q9UJU3","ZN112",2.66e-75,"Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g111224",542.968574214224,0.589687640468858,0.120531150959597,4.89240860785046,9.96093743680319e-07,0.000326164350352181,0,5322,"sp|Q5ZIK9|COPE_CHICK","Q5ZIK9","COPE",6.62e-26,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g89400",177.392243874212,0.839019978285375,0.171730901151378,4.88566689314577,1.03079347050351e-06,0.000335249946753329,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107963",309.096523274625,1.39254354750943,0.285071269885673,4.88489614568281,1.03483384548741e-06,0.000335249946753329,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89787",643.183139982189,0.629191446739227,0.128830458866818,4.88387181318411,1.04022714825173e-06,0.000335320585157585,2730,7723,"sp|P36967|SUCA_DICDI","P36967","SUCA",9.87e-23,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (p36)","succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099; GO:0006104; GO:0009361; GO:0016020"
"g138002",48.7254777693841,2.75660939194204,0.565794659053146,4.87210218024187,1.10417033189973e-06,0.000354170833241482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50362",55.5063154354754,2.00065147371761,0.410821531601716,4.86987978920541,1.11666161382971e-06,0.000355929350485112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63508",6165.06712237363,0.564238442536951,0.115879630291839,4.86917710313657,1.12063938232468e-06,0.000355929350485112,8325,12381,"sp|Q95V31|RS16_SPOFR","Q95V31","RS16",5.61e-21,"40S ribosomal protein S16","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g28394",472.805644709826,-0.53332552200064,0.109621467067831,-4.86515585191566,1.14366650656379e-06,0.000361471141267256,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20234",984.676666205862,1.97194092984116,0.405868045072078,4.85857646046258,1.18232749467974e-06,0.000364793073156116,0,49764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.71e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g26334",176.849184536521,0.576824806445458,0.11869033606993,4.85991383582911,1.17436853580139e-06,0.000364793073156116,0,3300,"sp|T1SH39|TXD17_EPICO","T1SH39","TXD17",4.52e-09,"Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14)",NA,"GO:0004601; GO:0005829; GO:0047134"
"g39158",905.353096094255,-0.428078747428064,0.0880994836149041,-4.85903809946559,1.17957435147627e-06,0.000364793073156116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118685",172.358289544511,0.761746705393212,0.156783090612505,4.85860243229861,1.18217243869819e-06,0.000364793073156116,0,4608,"sp|Q8VHP7|ILEUB_MOUSE","Q8VHP7","ILEUB",3.32e-10,"Leukocyte elastase inhibitor B (Serine protease inhibitor EIB) (Serpin B1b)","negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of protein catabolic process [GO:0042176]; type B pancreatic cell proliferation [GO:0044342]","GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0030414; GO:0032691; GO:0036464; GO:0042176; GO:0044342"
"g145649",34.732989570026,0.908066231810027,0.186863093798669,4.85952690469954,1.17666591672741e-06,0.000364793073156116,0,2373,"sp|M1RIR6|GSTM_TYRPU","M1RIR6","GSTM",7.86e-09,"Glutathione S-transferase (EC 2.5.1.18) (GST class-mu) (allergen Tyr p 8)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0043295"
"g78785",407.235590057294,0.868616934782286,0.178953059075821,4.85388145510417,1.21068124635219e-06,0.000371770947843117,6121,7924,"sp|P28765|SODM_PALVU","P28765","SODM",7.93e-19,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g152645",449.758690315792,0.766980147478764,0.158087017958885,4.85163271077857,1.22449231416845e-06,0.000374238351471303,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140389",5881.65279736169,0.600803584392447,0.123913025074957,4.84859105028716,1.24341457104225e-06,0.000375170142878735,0,2813,"sp|Q90YX1|RLA0_ICTPU","Q90YX1","RLA0",2.17e-19,"60S acidic ribosomal protein P0 (60S ribosomal protein L10E)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254"
"g142014",3410.75402346725,0.527282396552181,0.108754968411988,4.84835225692603,1.24491196146078e-06,0.000375170142878735,0,2684,"sp|P35979|RL12_MOUSE","P35979","RL12",1.78e-13,"60S ribosomal protein L12","cytoplasmic translation [GO:0002181]; translation [GO:0006412]","GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0015934; GO:0022625; GO:0022626; GO:0070180"
"g153068",55.4015084890075,1.70936637465245,0.352509401789336,4.84913697613658,1.23999776483859e-06,0.000375170142878735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59290",350.816536939874,-0.371547215168382,0.0766518809230469,-4.84720284348129,1.25214383849568e-06,0.000375602572813197,2975,7076,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.69e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87960",98.434263493637,0.507644404750293,0.104788040768226,4.8444879876428,1.26938597298209e-06,0.000377281308933158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156417",229.453297227622,1.17357382697397,0.242230347784321,4.84486703548353,1.26696498336006e-06,0.000377281308933158,0,1340,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",3.51e-19,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g88739",33.5886396393539,1.07731537428919,0.222482552373511,4.84224656179133,1.28379324141974e-06,0.000379821075302783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33909",392.299816485621,-1.25790917673807,0.259888864594747,-4.84018112395686,1.29720845879555e-06,0.000380316867288417,10185,30381,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.56e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g96464",616.296374495609,0.545820237052354,0.11275998723289,4.84054894335025,1.29480960926026e-06,0.000380316867288417,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119744",1142.03250905203,0.677728996889159,0.140153671152972,4.83561358981063,1.32735549897787e-06,0.000387402454257986,0,4512,"sp|Q7YRU4|MDHC_FELCA","Q7YRU4","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g17414",975.119192837446,0.800432876147688,0.165741320441004,4.82941051765425,1.36937834177255e-06,0.00039433835954875,36066,42324,"sp|P28765|SODM_PALVU","P28765","SODM",1.42e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g100573",313.463889005763,1.14678453530796,0.237426867173205,4.83005377176365,1.36496184032004e-06,0.00039433835954875,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158896",46.4069759165672,-0.698524186716878,0.144626544364079,-4.8298477280798,1.36637501687502e-06,0.00039433835954875,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87299",64.9430016799495,0.606520920332312,0.125647228725385,4.82717308200983,1.38484757991162e-06,0.00039702844798767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41593",1647.48987703658,0.541398204157883,0.112206381906494,4.82502149128248,1.39988171723229e-06,0.00039957064363274,0,18081,"sp|P30104|GSTT1_DROER","P30104","GSTT1",6.13e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g122571",102.529206137668,1.63075067319654,0.338233556062767,4.82137459150835,1.42572341291538e-06,0.000403392563725005,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138192",3862.10191487773,3.53932907425315,0.734066980966006,4.82153422783779,1.42458270285908e-06,0.000403392563725005,0,2014,"sp|P81580|CUPC1_CANPG","P81580","CUPC1",8.2e-29,"Cuticle protein CP1158 (CPCP1158)",NA,"GO:0042302"
"g127726",236.649336122588,0.694175834887034,0.144070527910515,4.81830562402189,1.44782478692052e-06,0.000407864832256267,3460,3811,"sp|P11217|PYGM_HUMAN","P11217","PYGM",2.02e-15,"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)","glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]","GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499"
"g41645",705.536939396888,0.543751908413555,0.112990567448419,4.81236549822428,1.49154252185038e-06,0.000416752568380382,0,9889,"sp|P30104|GSTT1_DROER","P30104","GSTT1",2.76e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g142393",4998.67682558659,0.456910108864363,0.0949468522266598,4.81227232024096,1.49223829525178e-06,0.000416752568380382,1734,2650,"sp|Q27389|RL13A_CAEEL","Q27389","RL13A",1.72e-07,"60S ribosomal protein L13a","negative regulation of translation [GO:0017148]; translation [GO:0006412]","GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625"
"g22016",134.816948623314,1.00824457850494,0.209868077670678,4.80418265462486,1.55384933861947e-06,0.000432096824880564,0,13202,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.21e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17388",2848.5491563898,-0.605508411837412,0.126080886203983,-4.8025393068524,1.56666052620351e-06,0.000433797587497027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9960",210.116418737879,-0.599583920327006,0.124889156083039,-4.80092859245796,1.57931581142322e-06,0.00043395159085063,0,1254,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.31e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g115372",45.8993016638438,-1.49228895243033,0.310862326379211,-4.80048183970011,1.58284329289064e-06,0.00043395159085063,1916,4925,"sp|Q7M3K2|PELET_DROME","Q7M3K2","PELET",9.73e-47,"Transposable element P transposase (P-element transposase) (EC 2.7.7.-) (THAP domain-containing protein) (DmTHAP)","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003693; GO:0004803; GO:0006313; GO:0015074; GO:0016740; GO:0046872"
"g155268",497.055676032997,1.24583917663029,0.259554283984573,4.79991760299488,1.58730923142314e-06,0.00043395159085063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27896",3327.17206744676,-0.430783538227696,0.0898272927023614,-4.79568653655273,1.62118626653003e-06,0.000439532885068787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30674",14857.7376772183,0.448895456195013,0.093604257502225,4.7956734893639,1.62129179898199e-06,0.000439532885068787,23345,34333,"sp|P62083|RS7_RAT","P62083","RS7",1.01e-22,"40S ribosomal protein S7 (S8)","cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005815; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059"
"g161149",64.1628565239604,3.80358638696329,0.793548868973459,4.79313440630775,1.64195539526021e-06,0.000443280066354562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132776",7884.9713952647,0.48769745503378,0.101809516633432,4.79029339457279,1.66537622467538e-06,0.000447737434545195,0,3405,"sp|A7S3J7|RS3A_NEMVE","A7S3J7","RS3A",3.91e-15,"40S ribosomal protein S3a","translation [GO:0006412]","GO:0003735; GO:0005829; GO:0006412; GO:0022627"
"g21999",96.9839152864293,1.18327643526828,0.247185106342115,4.78700538547242,1.69288293093791e-06,0.000453251916298596,4205,13200,"sp|P21328|RTJK_DROME","P21328","RTJK",2.32e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g50245",46.659553248428,0.839317801384089,0.175511950363802,4.78211198522007,1.73462992919072e-06,0.000460622446729732,0,17231,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.36e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g145637",1000.8885467558,0.643293383757618,0.134513236570772,4.78237978772566,1.73231986359218e-06,0.000460622446729732,0,1489,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.75e-15,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g135769",66.161449898108,0.788867787120383,0.165103975747235,4.77800600227881,1.7704209742988e-06,0.000468207698725477,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11934",26.8422198285114,1.45158607406003,0.304061612132205,4.77398664001323,1.80614368734645e-06,0.000475421890516822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69215",57.40863243448,0.854296242916055,0.178999173612468,4.77262674276698,1.81838604211405e-06,0.000475421890516822,4345,11096,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",7.13e-20,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g84518",21.6898653181079,-1.54056700120075,0.322802195741514,-4.77247993205836,1.8197124511625e-06,0.000475421890516822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139265",27.9820781488664,1.48033240420071,0.311062998899768,4.75894725324665,1.94605277676534e-06,0.00050638794202794,0,2902,"sp|Q9H0J4|QRIC2_HUMAN","Q9H0J4","QRIC2",1.22e-12,"Glutamine-rich protein 2","cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]","GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059"
"g28406",6184.29821517226,0.471943054667513,0.0992565034349932,4.75478218892333,1.98660479578671e-06,0.000514872338133633,12842,17484,"sp|Q9M5L0|RL35_EUPES","Q9M5L0","RL35",1.05e-07,"60S ribosomal protein L35","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]","GO:0000463; GO:0003735; GO:0006412; GO:0022625"
"g6771",87.9603423054767,1.41710602795884,0.298805518351834,4.74256980184094,2.11024082912263e-06,0.000533890394093486,4925,24051,"sp|P21328|RTJK_DROME","P21328","RTJK",6.35e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g24053",27.9900431458603,2.5064337579784,0.528455383834708,4.74294298941682,2.10635562270432e-06,0.000533890394093486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33074",19.1810959068131,1.9198476832089,0.404794599211832,4.74277000470609,2.10815568863174e-06,0.000533890394093486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37758",26.1456717191257,2.27744705228171,0.479899065349568,4.74567928283581,2.07807756734248e-06,0.000533890394093486,25127,26435,"sp|O18345|AMY2_DROAN","O18345","AMY2",7.4e-08,"Alpha-amylase 2 (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005975; GO:0046872"
"g110298",1599.88839878691,-0.379464717325783,0.0800244696582624,-4.74185857083782,2.11766442797873e-06,0.000533890394093486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129274",281.748708906163,-1.0378730236863,0.218798580326554,-4.74350894844604,2.10047660549814e-06,0.000533890394093486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155721",260.38965042894,0.740382692922759,0.156103496691283,4.74289627468739,2.10684158712341e-06,0.000533890394093486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134259",3434.15239066458,0.341478598901059,0.0720908571188839,4.73678095320648,2.17139641781469e-06,0.000545315070152974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52339",160.603333392439,1.01238146333366,0.213788399747301,4.73543683628437,2.18583774906482e-06,0.000546822336969717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127756",1961.6909602994,4.20206306810261,0.888358469888529,4.73014352936815,2.24361157919376e-06,0.000559116634810388,0,574,"sp|P10787|HCYB_PANIN","P10787","HCYB",6.39e-53,"Hemocyanin B chain",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g898",14173.6539536557,0.580912290311612,0.122893131883995,4.72697116108949,2.27893616765152e-06,0.000559776370488458,56472,61074,"sp|Q9VMU4|RL37A_DROME","Q9VMU4","RL37A",1.71e-16,"60S ribosomal protein L37a","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0022625; GO:0022626; GO:0046872"
"g1754",18159.5028805669,0.530402197064365,0.112275561813364,4.72411082605897,2.3112435705998e-06,0.000559776370488458,69535,71911,"sp|Q9V3G1|RL8_DROME","Q9V3G1","RL8",1.4e-42,"60S ribosomal protein L8","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626"
"g5778",53.1628603933642,1.75670729836691,0.371802976343065,4.72483387746198,2.30303543994763e-06,0.000559776370488458,107866,116500,"sp|O76082|S22A5_HUMAN","O76082","S22A5",5.74e-07,"Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)","(R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1901235; GO:1902270; GO:1902603; GO:1990961"
"g36307",521.270058765084,0.431474533131049,0.0912973529991644,4.72603551972638,2.28945618688157e-06,0.000559776370488458,1984,21084,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.78e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g40306",26.7467958537919,0.947505120324225,0.20053198315485,4.72495761233542,2.30163360059308e-06,0.000559776370488458,17975,21117,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.3e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g42492",5159.61186806565,0.512519869418321,0.108496360073104,4.72384390658809,2.31428075200677e-06,0.000559776370488458,17587,21054,"sp|P62985|RL40_CHICK","P62985","RL40",8.06e-19,"Ubiquitin-60S ribosomal protein L40 (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52)] (Fragment)","modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]","GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0016567; GO:0019941; GO:0031386; GO:0031625"
"g53974",12817.4072691161,-0.596813929454231,0.126279192215986,-4.72614623978155,2.28820886167297e-06,0.000559776370488458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54384",1343.49755644635,0.620468212833324,0.131350832374348,4.72374785616125,2.31537461285797e-06,0.000559776370488458,10665,12684,"sp|Q9VWG3|RS10B_DROME","Q9VWG3","RS10B",4.93e-07,"40S ribosomal protein S10b","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0022626; GO:0022627"
"g72400",24.8438711179839,-1.49021284834626,0.316022246888216,-4.71553146343328,2.41080633697677e-06,0.000576396217681681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93160",20.2071952227642,7.20313798884236,1.52720847502557,4.7165387742638,2.39890666638733e-06,0.000576396217681681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162427",10125.9731808363,0.480132890602518,0.101815005516403,4.7157380011649,2.40836183450232e-06,0.000576396217681681,0,628,"sp|Q7KF90|RL31_SPOFR","Q7KF90","RL31",9.93e-34,"60S ribosomal protein L31","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g98243",44.1854688400477,2.7791173571897,0.589566795699519,4.71382950576837,2.43104095472676e-06,0.000579097193307394,0,6698,"sp|P21842|CMA1_CANLF","P21842","CMA1",8.1e-07,"Chymase (EC 3.4.21.39) (Alpha-chymase) (Mast cell protease I)",NA,"GO:0004252; GO:0005615"
"g11933",24.9520946823488,1.62590562760474,0.345333933999656,4.70821273998043,2.49898218493958e-06,0.000586654176481123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26893",106.464987198686,0.723999716749748,0.153747286533894,4.70902435465187,2.48905332282995e-06,0.000586654176481123,0,4706,"sp|Q8BTV1|TUSC3_MOUSE","Q8BTV1","TUSC3",2.1e-15,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)","cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062"
"g54068",10389.0636334611,2.90440395432927,0.616842348572675,4.70850284687786,2.49542881329421e-06,0.000586654176481123,2285,4174,"sp|P81580|CUPC1_CANPG","P81580","CUPC1",3.28e-28,"Cuticle protein CP1158 (CPCP1158)",NA,"GO:0042302"
"g114788",22.3617195253975,3.46739544023269,0.73625143957701,4.70952619423708,2.48293304274763e-06,0.000586654176481123,1445,4748,"sp|Q9V774|C6A21_DROME","Q9V774","C6A21",7.41e-30,"Probable cytochrome P450 6a21 (EC 1.14.-.-) (CYPVIA21)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g9739",39.5443840507402,2.42406982639073,0.515333213043014,4.70388821259305,2.55253042873283e-06,0.000596391846052591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28258",387.104559413999,2.31280020899991,0.491731321511523,4.70338192387387,2.55887106944609e-06,0.000596391846052591,34446,37594,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",2.62e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g51992",25147.2703859385,0.505529304965704,0.107564624533795,4.69977287753073,2.60450991355571e-06,0.000604853085408656,11136,16394,"sp|A2I3Z2|RSSA_MACHI","A2I3Z2","RSSA",4.49e-24,"40S ribosomal protein SA","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003735; GO:0006412; GO:0022627"
"g148185",2003.17303627812,4.18622739322264,0.891359920564715,4.69645010577825,2.64721860324195e-06,0.000612575839142342,1497,2147,"sp|P10787|HCYB_PANIN","P10787","HCYB",1.19e-27,"Hemocyanin B chain",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g99113",93.6876471069136,-1.00477094603477,0.214108094143896,-4.69282093258696,2.69463339649269e-06,0.000618448059650019,2181,6074,"sp|Q8SWR3|SPR_DROME","Q8SWR3","SPR",2.49e-92,"Sex peptide receptor","G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity, post-mating [GO:0045434]; regulation of oviposition [GO:0046662]","GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0045434; GO:0046662"
"g109782",64.1047420051681,1.8486571407728,0.393975004754208,4.6923208794074,2.70123008474612e-06,0.000618448059650019,3445,5306,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",6.19e-19,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g143206",129.195418921353,0.910074539444239,0.193926633115172,4.69288062616832,2.69384695408843e-06,0.000618448059650019,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120604",13390.7143756051,0.499738390434058,0.106606890381581,4.68767439557924,2.763271983336e-06,0.000630424935268624,0,3248,"sp|Q95307|RL13A_PIG","Q95307","RL13A",4.45e-20,"60S ribosomal protein L13a (Fragment)","negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]","GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194"
"g20745",47.3309409369723,-0.92187821300914,0.196718762560552,-4.68627496945228,2.78222413221249e-06,0.000632521572626119,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45242",22606.0553609928,0.503142881437487,0.107409519588024,4.68434160554225,2.80861259867737e-06,0.000636288238133227,4598,16874,"sp|P30742|RS26_CRICR","P30742","RS26",3.81e-24,"40S ribosomal protein S26","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556"
"g99309",81.2973779623384,2.72306903570351,0.581559939135175,4.68235318917072,2.83600292125855e-06,0.000640254833718136,0,5224,"sp|O46108|LIP3_DROME","O46108","LIP3",9.99e-15,"Lipase 3 (DmLip3) (EC 3.1.1.-)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0016042"
"g90811",101.262859603515,0.882394823730373,0.188541258042281,4.68011528560233,2.86713647380248e-06,0.000645036019260708,3478,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",9.77e-11,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g32986",187.91731698968,0.847513707726957,0.181139384832284,4.67879312117387,2.88568415946042e-06,0.00064696240049799,0,12444,"sp|P20700|LMNB1_HUMAN","P20700","LMNB1",5.2e-14,"Lamin-B1","nuclear envelope organization [GO:0006998]","GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0016020; GO:0016363; GO:0031965; GO:0043274; GO:1990837"
"g1127",698.139470082102,0.633650626828901,0.135559764942521,4.67432668607516,2.94919565108879e-06,0.000658921495934469,142465,168465,"sp|P50137|TKT_RAT","P50137","TKT",1.77e-27,"Transketolase (TK) (EC 2.2.1.1)","glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]","GO:0000287; GO:0004802; GO:0005509; GO:0005777; GO:0005789; GO:0006098; GO:0009052; GO:0030246; GO:0030976; GO:0040008; GO:0042803; GO:0043231; GO:0046166; GO:0046390; GO:0048029"
"g99007",60.8621346818399,1.13598350218508,0.243173208305976,4.67149942256678,2.99008940045036e-06,0.000665762414169692,0,6618,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.06e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g41311",23.440726688713,-0.741243834969275,0.158784358041254,-4.66824216259823,3.03787709334954e-06,0.000674086200374647,13517,14374,"sp|B3LYS5|FOXO_DROAN","B3LYS5","FOXO",3.37e-34,"Forkhead box protein O","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]","GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627"
"g2450",927.184622203478,-0.38349840714401,0.0821993053006434,-4.66547017327418,3.07912159629728e-06,0.000678590223091461,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14457",268.652794151233,-0.489851314892766,0.104983306197103,-4.6659924576302,3.07130966677458e-06,0.000678590223091461,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10033",191.97463717477,-0.481311559116551,0.103265532540243,-4.66091199335056,3.14811321500472e-06,0.000684482213220807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52676",38707.5735754978,0.421343857676632,0.0903816613503714,4.6618290854741,3.13411422857697e-06,0.000684482213220807,4833,13924,"sp|O42248|GBLP_DANRE","O42248","GBLP",2.77e-49,"Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)","angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]","GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0015935; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543"
"g54395",1064.54388407264,-0.405840687129724,0.0870655166531269,-4.66132520348569,3.14179834579296e-06,0.000684482213220807,3045,15432,"sp|P21328|RTJK_DROME","P21328","RTJK",8.4e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g125773",49.7966391092462,0.765132798587962,0.16410123286325,4.66256581524631,3.1229116606857e-06,0.000684482213220807,0,3973,"sp|O88342|WDR1_MOUSE","O88342","WDR1",1.4e-22,"WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1)","actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]","GO:0002102; GO:0002446; GO:0003779; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0015629; GO:0030036; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043209; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:1990266"
"g41173",17302.6018483274,0.452124970247728,0.0970804701533687,4.65721858921219,3.20510088018428e-06,0.000687642719635033,14045,17209,"sp|Q4GXH6|RL17_BIPLU","Q4GXH6","RL17",6.98e-20,"60S ribosomal protein L17","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0015934"
"g41532",2604.91993302647,-0.594237920477134,0.127592694428188,-4.65730364218921,3.203777488758e-06,0.000687642719635033,6976,22863,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.48e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g45313",162.503926655983,0.858172769814009,0.18425621818644,4.65749692607749,3.20077201477461e-06,0.000687642719635033,56,6564,"sp|O18835|BGLR_CANLF","O18835","BGLR",1.2e-10,"Beta-glucuronidase (EC 3.2.1.31)","carbohydrate metabolic process [GO:0005975]","GO:0004566; GO:0005764; GO:0005975"
"g124926",813.491230324461,0.433982946462779,0.0931515363835037,4.65889198731061,3.17915952463777e-06,0.000687642719635033,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79035",7180.15949756356,0.630513871688458,0.135446501438138,4.65507683841086,3.23859905711606e-06,0.000692536464381918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54626",118.442730282577,0.887366678502181,0.190656654879519,4.65426543365576,3.25137737490737e-06,0.000692981888988071,0,15347,"sp|P49717|MCM4_MOUSE","P49717","MCM4",4.01e-45,"DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)","DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006268; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g85149",20.5035700627813,1.4552307550823,0.312868563812409,4.65125270928413,3.29924734132495e-06,0.000700879124545796,2645,5040,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",4.01e-18,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g24983",836.306662398907,0.612886676976598,0.131867866056517,4.6477333356856,3.35602370925147e-06,0.000705996247381593,0,7334,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.45e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g70253",60.2713052086641,-0.885892708005932,0.190577003547573,-4.64847642430683,3.34395832888327e-06,0.000705996247381593,345,10859,"sp|P21329|RTJK_DROFU","P21329","RTJK",7.99e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g105743",92.0160949581307,0.55970809780311,0.120422392599662,4.64787391879708,3.35373789222964e-06,0.000705996247381593,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g582",150.011776773892,0.451416807581965,0.0971858928971454,4.64487997306061,3.40274227286759e-06,0.000713507702543398,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62328",57.0282114999406,0.714138661190098,0.153895669236448,4.64040778231961,3.47722324117674e-06,0.000726773307953433,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35231",88.7942263407044,0.475314201657592,0.102582021316036,4.63350395673369,3.59527884617924e-06,0.00074494970057385,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78234",21550.6381324594,0.467422473823622,0.100869913401085,4.63391370194827,3.58816622490137e-06,0.00074494970057385,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87674",25.0008613467884,0.849051767296337,0.18324957246689,4.63330831208214,3.59867973823739e-06,0.00074494970057385,6605,7902,"sp|B0WGM1|EFGM_CULQU","B0WGM1","EFGM",2.26e-22,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"g140691",300.066685439481,-0.798533610459189,0.17265279023757,-4.62508372648023,3.74447113414966e-06,0.000772660885971206,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26052",1232.95484104517,-0.320280935177406,0.0692914969811885,-4.62222565727447,3.7964470825211e-06,0.00078089903434219,0,17875,"sp|Q9VTW2|INP5E_DROME","Q9VTW2","INP5E",1.14e-09,"Inositol polyphosphate 5-phosphatase E (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV)","phosphatidylinositol dephosphorylation [GO:0046856]; protein localization to cilium [GO:0061512]; sensory perception of sound [GO:0007605]","GO:0004439; GO:0005737; GO:0007605; GO:0016020; GO:0046856; GO:0061512; GO:0097546"
"g54409",1322.91547259798,0.63829526905782,0.138146258972622,4.62043108372786,3.82943533122445e-06,0.000785191782962106,10658,12884,"sp|Q9VWG3|RS10B_DROME","Q9VWG3","RS10B",5.52e-07,"40S ribosomal protein S10b","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0022626; GO:0022627"
"g28257",100.464804782037,1.7866964725106,0.38698819070689,4.61692763607835,3.8946299945807e-06,0.000786120751522952,30686,36144,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",5.24e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g66650",72.472074356588,0.775305881360945,0.167923481154471,4.61701887092103,3.89291882039596e-06,0.000786120751522952,0,10741,"sp|Q28F67|AATM_XENTR","Q28F67","AATM",2.41e-16,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0006103; GO:0006531; GO:0006536; GO:0009058; GO:0016212; GO:0030170"
"g77489",276.508145300828,0.589042007684016,0.12753607900081,4.61863036953077,3.86281253845023e-06,0.000786120751522952,0,8684,"sp|Q66HF1|NDUS1_RAT","Q66HF1","NDUS1",5.91e-20,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2)","apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0032981; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g86967",41.7503065615537,-0.525034780772527,0.11368767825071,-4.61822062734619,3.87044618130736e-06,0.000786120751522952,0,6407,"sp|P21414|POL_GALV","P21414","POL",6.22e-09,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g99360",239.763078734937,-0.373797346159343,0.0809397413760305,-4.61821769880326,3.87050079311366e-06,0.000786120751522952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66174",28.7591242861383,2.61415137767165,0.56632660854208,4.61597837403645,3.91247690486152e-06,0.000787270546884139,0,11792,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.17e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g89290",354.627077532519,1.57418579767451,0.34113299210766,4.61458092325971,3.93889284028653e-06,0.000790132147989737,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42491",1623.82710094929,0.367899728100473,0.0797507175951736,4.61312122566704,3.96666792606195e-06,0.000793247885596703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145081",56.5595724365949,-1.63055318183582,0.353515794874571,-4.61239131455032,3.98062696068094e-06,0.000793590038964308,0,2252,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.94e-16,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g124773",77.623250950022,1.01004490021977,0.219066722503417,4.61067244115094,4.01368542519348e-06,0.000797726134216445,0,4061,"sp|Q8JG30|ST1B1_CHICK","Q8JG30","ST1B1",8.03e-08,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006805; GO:0008146; GO:0042403; GO:0051923"
"g116231",140.56663510262,1.3785635624633,0.299202378024058,4.60746191780754,4.07613826608107e-06,0.00080766124365196,20,4288,"sp|Q64581|CP3AI_RAT","Q64581","CP3AI",3.78e-14,"Cytochrome P450 3A18 (EC 1.14.14.1) (CYPIIIA18) (Cytochrome P450(6)beta-2)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0008390; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"g81009",19.0106004177967,2.02973116612168,0.440604622310965,4.60669512606512,4.09119150848967e-06,0.000808172473809668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59682",28.2531337673756,1.3220996410623,0.287459871764127,4.59924939418028,4.24015928086391e-06,0.000835053617887585,0,13531,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.62e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g8962",356.330564017778,0.563767354725266,0.12266487985472,4.59599646934779,4.3068599051763e-06,0.000838001122630895,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15980",10830.7329603821,0.583400873578949,0.126905729508927,4.59712004994944,4.28370823558371e-06,0.000838001122630895,0,18120,"sp|P56649|G3P_PANVR","P56649","G3P",3.66e-177,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287"
"g17623",3282.35522605402,0.379719116430796,0.0825893849319504,4.59767458909721,4.27232581020993e-06,0.000838001122630895,945,51358,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.7e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g81843",185.831344817111,0.699953475008278,0.15228371174003,4.59637782012562,4.29898866571577e-06,0.000838001122630895,0,8826,"sp|P21328|RTJK_DROME","P21328","RTJK",2.72e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g129039",47.9260336103347,0.704735842103996,0.153419118883252,4.59353336946408,4.3580329348464e-06,0.000840191035558755,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137348",1634.74099127308,0.409328347201915,0.0891109723997816,4.59346740562465,4.35941136837365e-06,0.000840191035558755,52,2611,"sp|P84589|UBIQ_LUMTE","P84589","UBIQ",9.58e-13,"Ubiquitin (Fragment)",NA,"GO:0005634; GO:0005737"
"g137784",6005.95505566262,0.489916184619043,0.106633914737249,4.59437493058582,4.34048360438919e-06,0.000840191035558755,0,2042,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.37e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g161524",14074.1178683664,0.619058462161004,0.134784142778266,4.59296212002787,4.36998408752952e-06,0.000840191035558755,394,1093,"sp|Q90YS3|RS2_ICTPU","Q90YS3","RS2",1.62e-43,"40S ribosomal protein S2","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935"
"g17753",7771.10808913155,0.374692386567137,0.0816107396334712,4.59121419864529,4.40674783481393e-06,0.000844752699589051,16955,19622,"sp|P46782|RS5_HUMAN","P46782","RS5",3.65e-18,"40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]","cytoplasmic translation [GO:0002181]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]; translational initiation [GO:0006413]","GO:0000028; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006450; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0070062; GO:1990904"
"g52040",2545.36804046774,0.618167825101203,0.134682092706037,4.58982937286581,4.43608484946042e-06,0.000846876206114893,2702,5834,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.18e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g109772",65.016699159182,2.40705930525546,0.524475628632706,4.5894588305859,4.44396632474285e-06,0.000846876206114893,1325,5466,"sp|Q2KHZ8|GLCM_BOVIN","Q2KHZ8","GLCM",2.49e-08,"Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)","autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]","GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295"
"g19173",77.2386292879505,0.69074547495536,0.15070353181095,4.58347237556362,4.57317324857038e-06,0.000863679756952174,48075,53406,"sp|Q5RBL1|GARS_PONAB","Q5RBL1","GARS",7.56e-18,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062"
"g76257",20.6230799621064,2.54127276858418,0.554442394153833,4.58347484856846,4.57311913754416e-06,0.000863679756952174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122706",268.395916866178,-0.656216069656197,0.143160032683459,-4.58379379604612,4.5661454882929e-06,0.000863679756952174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135453",20.2645985449418,2.48411352590091,0.542038295634161,4.58291147675203,4.585461954093e-06,0.000863679756952174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37260",121.323002862076,0.379801045078627,0.0829923320860534,4.57633898858051,4.73183580863984e-06,0.000886097796384975,0,21904,"sp|P98194|AT2C1_HUMAN","P98194","AT2C1",8.26e-25,"Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1)","actin cytoskeleton reorganization [GO:0031532]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629]","GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0015662; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0030173; GO:0031532; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0034220; GO:0042998; GO:0043123; GO:0046872; GO:0070588; GO:0098629; GO:0140613"
"g84416",117.219636606227,0.457034178327869,0.0998675704771588,4.57640229099595,4.73040490909274e-06,0.000886097796384975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137005",6296.20323795249,3.9100269456039,0.854887157763663,4.57373456846902,4.79106734568157e-06,0.000892033409565361,0,3073,"sp|C0HLU7|HCY_SCYOL","C0HLU7","HCY",0,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g144190",83.9404255041981,1.04762574161491,0.229046691031718,4.5738523307016,4.78837385422402e-06,0.000892033409565361,1052,2499,"sp|P21328|RTJK_DROME","P21328","RTJK",4.03e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g76149",975.678057426221,-0.491801219602179,0.107557837881332,-4.57243497349566,4.82088859197482e-06,0.000895013852549639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76702",743.16684225993,0.500373930517921,0.109476130437515,4.57062127167087,4.86280415576047e-06,0.000896428056717566,0,9573,"sp|P18258|TBA1_PARLI","P18258","TBA1",1.32e-28,"Tubulin alpha-1 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g114579",177.995806575189,0.59069910486987,0.129254592567677,4.57004345559778,4.87623093080979e-06,0.000896428056717566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121187",42.1606301244115,0.615742631040205,0.134744168038227,4.56971637440754,4.88384708257529e-06,0.000896428056717566,0,4384,"sp|P28339|DPOD1_BOVIN","P28339","DPOD1",3.18e-26,"DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)","base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]","GO:0000166; GO:0000731; GO:0003682; GO:0003684; GO:0003887; GO:0006261; GO:0006287; GO:0006297; GO:0008296; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897"
"g131016",121.838781402185,-0.435154983275461,0.0952195057006211,-4.5700193471244,4.87679191295168e-06,0.000896428056717566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140520",6392.75527236097,0.596718940546457,0.130662038743506,4.5668883348578,4.9501753629529e-06,0.000906035910428835,0,2804,"sp|Q9VXX8|RL371_DROME","Q9VXX8","RL371",7.92e-18,"Probable 60S ribosomal protein L37-A","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0019843; GO:0022625; GO:0022626; GO:0046872"
"g6796",11316.9346034618,0.389089068064208,0.0852311647551137,4.56510325984795,4.99248536302942e-06,0.000908646359906643,6945,16006,"sp|P21328|RTJK_DROME","P21328","RTJK",1.5e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g88604",22.9789909362303,0.826588325413634,0.181057105341454,4.56534596559897,4.98671245525181e-06,0.000908646359906643,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48697",1980.06637987997,0.75367605342028,0.165128815193364,4.56417041772953,5.01473322422162e-06,0.000910138963016783,0,7584,"sp|Q8VEM8|MPCP_MOUSE","Q8VEM8","MPCP",3.54e-53,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)","mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877; GO:1990547"
"g31899",93.6557434952833,-0.550735623813955,0.120781278939226,-4.55977638795388,5.12081191977329e-06,0.000920145118419364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33854",42.4749316174072,0.542484433087398,0.11897798465342,4.55953624250437,5.12667090193987e-06,0.000920145118419364,22867,30457,"sp|O94761|RECQ4_HUMAN","O94761","RECQ4",0,"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]","GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0032508; GO:0043138; GO:0061820; GO:0061821; GO:1990814"
"g42273",131.926509333505,-0.598115558235885,0.131160814189738,-4.56016960500601,5.11123219421282e-06,0.000920145118419364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138964",361.949318768605,0.675181273818367,0.148067868656227,4.55994457099909,5.116712468641e-06,0.000920145118419364,0,2924,"sp|P20000|ALDH2_BOVIN","P20000","ALDH2",2.21e-34,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)","aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:1903179; GO:1905627"
"g38317",2420.4068181205,-0.433828411690621,0.0951965441327558,-4.55718656220995,5.18433724487394e-06,0.000927924759964413,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25955",33.8354732573476,1.07654871445243,0.236464351587048,4.55268926257636,5.29644755400218e-06,0.000942782215292482,0,11821,"sp|Q5ZLY5|PKHF2_CHICK","Q5ZLY5","PKHF2",4.47e-08,"Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2)","protein transport [GO:0015031]","GO:0005783; GO:0015031; GO:0031901; GO:0035091; GO:0046872"
"g124006",27.1880720240221,1.02191389209264,0.224442810152011,4.55311485095253,5.28573969313726e-06,0.000942782215292482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59895",267.633884223374,0.542809729841811,0.119296127282798,4.5501035298074,5.36195272312435e-06,0.000951827404902454,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2943",41.2427213660297,0.88795302665196,0.195176180093047,4.54949485243867,5.37748493799472e-06,0.000951976452424842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118985",32.929643683645,1.78521825366264,0.392469587138067,4.54867921532636,5.39836589492734e-06,0.000953068995722145,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90955",96.2547456560859,1.22286995834069,0.268943875848385,4.54693364733863,5.44331496321024e-06,0.000958393223943698,807,7570,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.84e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g70278",1012.33872771907,0.656858597319147,0.144505601091414,4.5455580431351,5.47898953530531e-06,0.000962060078485196,0,374,"sp|Q6DIY9|MDHC_XENTR","Q6DIY9","MDHC",1.88e-20,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g74148",362.511619846657,0.442112071199395,0.0972790966786082,4.54477977586542,5.49927194948457e-06,0.000963011695737713,5858,10082,"sp|Q9N4G9|RUXG_CAEEL","Q9N4G9","RUXG",1.68e-11,"Probable small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0003723; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034719; GO:0043186; GO:0071004; GO:0071011; GO:0071013; GO:0097526; GO:1990904"
"g87964",23.6567761401522,2.02933176311311,0.446598555280041,4.54397296883463,5.52037400963111e-06,0.000964101329396303,5318,7664,"sp|Q9Y4A0|JERKL_HUMAN","Q9Y4A0","JERKL",4.13e-41,"Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)","central nervous system development [GO:0007417]","GO:0003677; GO:0005634; GO:0007417"
"g117607",62.2056102382746,0.863248661832515,0.190112012112095,4.54073707516976,5.60579042815251e-06,0.000976387040890553,0,4711,"sp|Q9XYU1|MCM3_DROME","Q9XYU1","MCM3",6.08e-13,"DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g128281",1681.82567143424,-0.945316541287697,0.208291393023528,-4.53843304596325,5.66737840685096e-06,0.000984467691997571,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67644",96.4040252674735,0.795965930633261,0.17541618550892,4.53758544756855,5.69019772543342e-06,0.000985788719850287,0,11114,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.01e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g25965",4788.56518220747,0.392604582243042,0.0866551208640105,4.5306564497113,5.8800691509626e-06,0.00101596618799552,9715,20282,"sp|Q9UBQ5|EIF3K_HUMAN","Q9UBQ5","EIF3K",6.89e-30,"Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)","formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022"
"g142592",6807.78262329321,0.382124432439438,0.0843990158672034,4.52759346199827,5.96592169468207e-06,0.00102805841586047,0,2284,"sp|Q6F444|RL24_PLUXY","Q6F444","RL24",1.02e-11,"60S ribosomal protein L24",NA,"GO:0005840"
"g83160",581.862837493783,-0.394913197370181,0.0872550169865569,-4.5259655090208,6.01203854897389e-06,0.00102828616118215,0,8437,"sp|P18729|ZG57_XENLA","P18729","ZG57",3.67e-22,"Gastrula zinc finger protein XlCGF57.1 (Fragment)",NA,"GO:0003677; GO:0005634; GO:0046872"
"g122758",220.908845882624,1.41703935784851,0.313097389014434,4.52587408125329,6.01463861846384e-06,0.00102828616118215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146547",328.483897855192,-0.84389301737679,0.186459988963631,-4.52586649858373,6.01485430660776e-06,0.00102828616118215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134338",37.9778888170174,1.90419461481245,0.420958733612819,4.52347097890089,6.0833664124677e-06,0.00103726199990268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45411",678.156492353779,0.673046912245993,0.148878179001066,4.5207895257852,6.16094200725869e-06,0.00104773206161762,16400,20038,"sp|Q21217|GABT_CAEEL","Q21217","GABT",3.96e-20,"Probable 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (L-AIBAT)","gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0003867; GO:0005739; GO:0005759; GO:0009450; GO:0030170; GO:0034386; GO:0042135; GO:0047298"
"g32960",829.012834324846,0.452303935936603,0.100069317668162,4.51990626573951,6.18670171790278e-06,0.00104935854557088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44922",127.011972852789,-0.743923971792346,0.164642325759227,-4.51842482400462,6.23013856660276e-06,0.00105396701865768,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71757",65.960205406428,1.06197380504068,0.235203747167108,4.51512281514023,6.3280081862177e-06,0.00106773602710834,3557,10529,"sp|Q91Z53|GRHPR_MOUSE","Q91Z53","GRHPR",2.56e-06,"Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)","dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487]","GO:0005737; GO:0005829; GO:0008465; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0070402; GO:1902494"
"g83536",1545.56765673448,-0.37678976681722,0.0834883564304926,-4.5130816191227,6.38924197093453e-06,0.00106971099489085,2875,8577,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.26e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g105613",7362.78458272659,0.467326820832493,0.103546063018958,4.51322635749976,6.38488135943931e-06,0.00106971099489085,0,5892,"sp|P29693|EF1D_XENLA","P29693","EF1D",2.12e-18,"Elongation factor 1-delta (EF-1-delta) (P36)",NA,"GO:0003746; GO:0005853"
"g119843",25.400425320493,1.78800205468218,0.396161755100859,4.51331313954568,6.38226819536276e-06,0.00106971099489085,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82694",614.767608440159,-0.222978736877714,0.0494136111758818,-4.51249628536655,6.40690571793157e-06,0.00106990371696376,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5315",502.444974366632,-1.24944109637042,0.277050391705999,-4.50979725629232,6.48896111482207e-06,0.00108082071340017,76195,96875,"sp|Q6C5V7|YNG2_YARLI","Q6C5V7","YNG2",3.53e-12,"Chromatin modification-related protein YNG2 (ING1 homolog 2)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006281; GO:0006325; GO:0006355; GO:0035064; GO:0046872; GO:0051321"
"g124943",48.994026957011,0.770248447085837,0.170833497549083,4.50876706346501,6.52054519675131e-06,0.00108329662803361,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23624",124.088567773731,0.582094628312064,0.129127942963954,4.50789050728202,6.54753478383541e-06,0.00108499851981854,3255,11850,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",2.53e-41,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g64613",5839.27873196163,0.636531661818865,0.141277177819927,4.50555193444051,6.62006450107799e-06,0.00109421897759782,8105,12153,"sp|Q26365|ADT_DROME","Q26365","ADT",1.7e-16,"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)","action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171"
"g107418",75.674787451173,1.75899152110399,0.390548410649318,4.50390136828244,6.67171803680531e-06,0.00109715895116428,4125,5244,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",7.31e-20,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g153063",10621.4011505845,-1.35391180686091,0.300577690601579,-4.50436559064372,6.65715162141135e-06,0.00109715895116428,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40691",128.442864530369,-0.412328147494858,0.0915709946657447,-4.50282481914662,6.70561553595509e-06,0.00109994163904086,9266,23144,"sp|P21328|RTJK_DROME","P21328","RTJK",2.31e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g113228",744.326989715858,0.536650406556088,0.119238075817093,4.50066308835183,6.77418057971872e-06,0.00110838253106494,0,5132,"sp|Q2T9X2|TCPD_BOVIN","Q2T9X2","TCPD",1.86e-31,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0016887; GO:0042470; GO:0051082"
"g23245",482.946183063251,-0.428581556847878,0.0953057833345073,-4.49691028028832,6.89480648399957e-06,0.00112351705625331,10183,45565,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.33e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g72490",375.578133683195,0.723964291830932,0.160998725724483,4.49670821041063,6.90135953557975e-06,0.00112351705625331,6215,10388,"sp|P17917|PCNA_DROME","P17917","PCNA",2.58e-30,"Proliferating cell nuclear antigen (PCNA) (Cyclin) (Mutagen-sensitive 209 protein)","cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; eggshell chorion gene amplification [GO:0007307]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]; mitotic spindle organization [GO:0007052]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; response to hydrogen peroxide [GO:0042542]; response to methyl methanesulfonate [GO:0072702]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]","GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006260; GO:0006261; GO:0006272; GO:0006289; GO:0006298; GO:0006974; GO:0007052; GO:0007307; GO:0009411; GO:0019985; GO:0030337; GO:0042542; GO:0043626; GO:0045739; GO:0045740; GO:0072702"
"g17338",2635.54057863851,0.699117523690204,0.155565228719735,4.49404747734295,6.98820372318854e-06,0.00113189467716695,18597,55264,"sp|P28765|SODM_PALVU","P28765","SODM",8.59e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g113888",1236.18050058126,0.556218319062698,0.123782053427792,4.49352958413448,7.00522842813187e-06,0.00113189467716695,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160597",1912.04989520398,0.816374682716107,0.181656050263856,4.49406822140148,6.98752262866436e-06,0.00113189467716695,0,1156,"sp|P80021|ATPA_PIG","P80021","ATPA",2.2e-30,"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha) (ATP synthase subunit alpha heart isoform, mitochondrial) (ATP synthase subunit alpha liver isoform, mitochondrial)","ATP synthesis coupled proton transport [GO:0015986]","GO:0005524; GO:0005754; GO:0005886; GO:0015986; GO:0043531; GO:0045261; GO:0046933"
"g69532",419.456089469188,-0.679197516846277,0.151214911911944,-4.49160409022219,7.06887377950404e-06,0.00113539039445871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79481",974.333520203473,-1.11507599244102,0.24822254498336,-4.49224300925516,7.04769386292361e-06,0.00113539039445871,6838,9084,"sp|Q9V7U0|RESIL_DROME","Q9V7U0","RESIL",6.83e-06,"Pro-resilin","chitin-based cuticle development [GO:0040003]","GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129"
"g138612",992.386693904444,0.512058893576133,0.114011636518409,4.49128623369469,7.07943326225549e-06,0.00113539039445871,0,1603,"sp|Q6NUH0|RL31_XENLA","Q6NUH0","RL31",4.46e-14,"60S ribosomal protein L31","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g5316",591.630766012311,-0.475996289395364,0.106030118027831,-4.48925548937352,7.14725336689324e-06,0.00113781815086269,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9369",756.86602943185,0.52730856933745,0.117456018136649,4.48941295391078,7.14197243096047e-06,0.00113781815086269,39575,54000,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.5e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g120898",67.4341035799295,-0.605090097000199,0.134763884259095,-4.49000190464131,7.12225367358546e-06,0.00113781815086269,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34956",57.7911939834343,-0.860790519696627,0.191815018733112,-4.48760751573012,7.20274649158145e-06,0.00114384204271823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67990",121.662532497891,0.482582656455518,0.10759760595229,4.48506871676586,7.28904399046385e-06,0.00115190006652225,5635,11196,"sp|Q24134|NELFD_DROME","Q24134","NELFD",4.65e-15,"Negative elongation factor D","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]","GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244"
"g80551",1936.87150364521,-0.312802519710081,0.0697415613150928,-4.48516657516223,7.28569939655568e-06,0.00115190006652225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55888",35806.2999617531,-1.32466808319131,0.29542153585845,-4.48399294703423,7.32590845883977e-06,0.00115490897025208,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38983",22.7413683911722,0.905627934740739,0.202036034067378,4.48250698901918,7.37712259121199e-06,0.00116015996129223,20490,25260,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.9e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28338",298.179394589455,-0.51419336050844,0.114797413692395,-4.47913715100102,7.49453700770781e-06,0.00116928308512927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48245",244.085698112564,0.490561841373734,0.10951085938619,4.47957256589293,7.47926604055488e-06,0.00116928308512927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53850",836.767176825547,0.604563856634334,0.134960551463192,4.47955976824249,7.47971445785725e-06,0.00116928308512927,8572,13184,"sp|Q5ZJF4|PRDX6_CHICK","Q5ZJF4","PRDX6",5.72e-15,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0008379; GO:0016042; GO:0045454; GO:0047184"
"g143676",55.1721668343828,1.14189163093879,0.25495633408985,4.47877333589355,7.50731967054741e-06,0.00116928308512927,0,2544,"sp|Q9I7S8|PUR6_DROME","Q9I7S8","PUR6",1.08e-21,"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) (Protein adenosine-5) [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0043727"
"g46997",1236.92007822689,-0.564919984718658,0.126207466150799,-4.47612175371354,7.6011148101453e-06,0.00118105283427756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81367",4303.86680812759,0.434633974134618,0.0971296737543028,4.47478054167111,7.6489835585983e-06,0.00118564734859392,8092,8904,"sp|P79781|RS27A_CHICK","P79781","RS27A",7.37e-20,"Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a]","modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]","GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0016567; GO:0019941; GO:0022627; GO:0031386; GO:0031625; GO:0046872"
"g2494",292.76457326429,0.537291117066476,0.120200450214684,4.46995927308796,7.82344930034465e-06,0.0012040492886395,3115,6079,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.59e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g91666",266.569874785954,0.496830501066182,0.111143762808739,4.47016088452167,7.81607804772391e-06,0.0012040492886395,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141953",51.5807032190586,1.75120994606226,0.39168820502754,4.47092846704213,7.78807465880873e-06,0.0012040492886395,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16396",250.241952108256,-0.371327074800224,0.0832113713740715,-4.46245589597299,8.10256091629344e-06,0.00123526877517506,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36749",444.340796283331,0.369383420276436,0.0827530070283737,4.463685774582,8.05616853590461e-06,0.00123526877517506,4133,25164,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.07e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g54121",77.7319306737607,0.644762267880651,0.144467877070153,4.46301476118152,8.08144833398971e-06,0.00123526877517506,2470,13014,"sp|Q7ZUC7|PGES2_DANRE","Q7ZUC7","PGES2",8.6e-15,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2)","prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004362; GO:0005739; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220; GO:0097573"
"g120709",64.2782117251314,2.63831681286991,0.591168958803411,4.46288116718805,8.08649040532033e-06,0.00123526877517506,0,4428,"sp|Q93789|LIPL1_CAEEL","Q93789","LIPL1",1.85e-07,"Lipase lipl-1 (EC 3.1.1.-) (Lipase-like 1)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0005764; GO:0016042; GO:0016788; GO:0043202"
"g2017",146.210437264727,0.963970149697987,0.216160141450931,4.45951849969903,8.21439833281714e-06,0.00124611807904888,134126,164284,"sp|Q6NX31|MCM7_XENTR","Q6NX31","MCM7",5.16e-55,"DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0000785; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0006271; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162"
"g52344",159.910864735436,0.927598557350155,0.208024896271561,4.45907472603301,8.23142218809009e-06,0.00124611807904888,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73930",67.41262032636,0.583857566572822,0.130932842679854,4.45921401095997,8.22607537146013e-06,0.00124611807904888,6926,10120,"sp|Q29RY4|RNZ1_BOVIN","Q29RY4","RNZ1",8.84e-08,"Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1)",NA,"GO:0005634; GO:0005654; GO:0005829; GO:0042781; GO:0046872"
"g50646",63.6879618685926,2.62420131198098,0.588751034911131,4.45723430851733,8.30238411381497e-06,0.00125101482299166,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57810",15100.5907290744,0.367067372405222,0.0823478283907796,4.45752340502913,8.29119869052266e-06,0.00125101482299166,0,12718,"sp|Q5REY2|RL27A_PONAB","Q5REY2","RL27A",3.32e-14,"60S ribosomal protein L27a","translation [GO:0006412]","GO:0003735; GO:0005783; GO:0006412; GO:0022625"
"g16082",2000.17006730504,-0.711203667309892,0.159602508654347,-4.45609328641665,8.34667232670601e-06,0.00125360461218051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101379",445.495315044169,0.38788229912124,0.0870511892091596,4.45579552266963,8.35826698041422e-06,0.00125360461218051,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15143",84.9414867718319,1.31696037302374,0.295603118732859,4.45516400053241,8.38290885667569e-06,0.00125439679803831,1587,8924,"sp|Q9H3S4|TPK1_HUMAN","Q9H3S4","TPK1",5.25e-10,"Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1)","thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0042802"
"g52037",9086.25274324529,0.471918072291015,0.105979625673546,4.45291318299883,8.4713013272885e-06,0.00125799622862232,2704,16254,"sp|Q7ZWJ4|RL18A_DANRE","Q7ZWJ4","RL18A",3.07e-27,"60S ribosomal protein L18a","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0022625"
"g99546",188.135484309047,0.492285846105719,0.110559149264128,4.4526920601536,8.48003299845192e-06,0.00125799622862232,1685,6556,"sp|P21328|RTJK_DROME","P21328","RTJK",1.15e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g108729",60.8957186768118,0.617485445887368,0.138680500434268,4.45257584125926,8.48462568345273e-06,0.00125799622862232,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117619",292.47966445576,1.08593983983287,0.243885295623609,4.45266631207162,8.48105029442229e-06,0.00125799622862232,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88674",51.1719094936337,0.663951928069937,0.14916077217842,4.45125027427281,8.53717730365187e-06,0.00126289801149661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66053",12098.0230624331,0.44093225184833,0.099090934582497,4.44977387392827,8.59607482327567e-06,0.00126871406839294,0,2103,"sp|Q93572|RLA0_CAEEL","Q93572","RLA0",5.47e-32,"60S acidic ribosomal protein P0","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0022625; GO:0070180"
"g49136",1771.22574499569,-0.60056047719969,0.135004790263636,-4.44843828153742,8.64968951279143e-06,0.00127372575591431,2965,12620,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.09e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18162",937.132196732746,-0.437010658363729,0.098291213350185,-4.44608061563731,8.74511420347853e-06,0.00128094849387989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70400",35.1193202365015,1.34817781092112,0.303250043409591,4.44576296103006,8.7580476716434e-06,0.00128094849387989,0,10825,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.16e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g160760",110.393971706697,0.736428515936572,0.165633706373931,4.44612713232431,8.74322178579844e-06,0.00128094849387989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83979",31.3368692947873,0.80512368544379,0.181127295471291,4.4450709836354,8.78628519079754e-06,0.00128218418100753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34238",71.9494992250049,0.855464436845962,0.192475194157158,4.44454383117788,8.80785506220972e-06,0.00128244348999046,15775,25633,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.86e-54,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g6950",281.311635842184,-0.54377650638535,0.122444507401338,-4.441003667098,8.95402688142017e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7375",33.5112634251205,2.28015285045916,0.513414627604278,4.44115287696209,8.94781955898336e-06,0.00128574685273767,67802,79504,"sp|P21328|RTJK_DROME","P21328","RTJK",7.29e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g26313",110.707619024378,0.523530494670852,0.117895456035709,4.44063335666034,8.96945005536753e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33475",1350.00290561951,-0.525060802175032,0.118230533048579,-4.44099158344565,8.95452975698053e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34469",193.561553715244,1.29431965684095,0.29145216513837,4.44093340746485,8.95695119734374e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54053",27.1236465000327,0.732400355084449,0.164864433207432,4.4424400147177,8.89444342994915e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160499",238.851990872353,0.823172798149009,0.185292533185041,4.44255785162673,8.88957209949774e-06,0.00128574685273767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24453",91.3990102800859,0.948624896063482,0.213733035995694,4.43836345487833,9.06454603915646e-06,0.00129174962526585,25700,31294,"sp|P21328|RTJK_DROME","P21328","RTJK",1.15e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g35388",33.7425543322409,-0.66890543313588,0.150718135788459,-4.43812172726662,9.07472962144578e-06,0.00129174962526585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52638",1579.94247079622,0.561925080036101,0.126602379635496,4.4385033018649,9.05865950505729e-06,0.00129174962526585,0,8885,"sp|Q5RF02|TCPE_PONAB","Q5RF02","TCPE",3.95e-17,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","protein folding [GO:0006457]","GO:0005524; GO:0005815; GO:0005832; GO:0006457; GO:0016887; GO:0031681; GO:0051082"
"g142948",77.9559602866173,0.594309867744038,0.133921911719436,4.43773434917137,9.09107201582314e-06,0.00129174962526585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70142",81.1698035769516,0.628232232475156,0.141582714541001,4.43720996953499,9.11323892228744e-06,0.00129206584133867,0,3400,"sp|P51570|GALK1_HUMAN","P51570","GALK1",3.5e-11,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0061623; GO:0070062"
"g54969",55.3330917905,1.67601746835237,0.377943785235933,4.43456813903186,9.22570378427843e-06,0.00129638440652633,0,15203,"sp|Q9VA27|CP4C3_DROME","Q9VA27","CP4C3",6.86e-19,"Cytochrome P450 4c3 (EC 1.14.-.-) (CYPIVC3)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g64976",253.685507361741,0.546117564832949,0.123143681030954,4.43479974173969,9.21579148259543e-06,0.00129638440652633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99137",63.3953055578869,0.560362044256809,0.126374249754956,4.43414734681607,9.24373922823709e-06,0.00129638440652633,0,6574,"sp|Q9VCD0|GATB_DROME","Q9VCD0","GATB",1.3e-11,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)","glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]","GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681"
"g105245",564.572205488292,4.01283107299091,0.904929735606603,4.43441177264551,9.23240182627995e-06,0.00129638440652633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144949",4663.74435562686,3.60040712337183,0.811662161526128,4.43584448559505,9.17120411106521e-06,0.00129638440652633,0,1984,"sp|C0HLU8|HCY_SCYSE","C0HLU8","HCY",4.95e-84,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g11302",154.907079233931,0.859620765973201,0.194018374630057,4.43061523225456,9.39646189905456e-06,0.00131495670804631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149317",5078.36092196843,0.611358721761073,0.138014181005914,4.42968046692881,9.43728120396743e-06,0.00131782276088074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1133",217.740435106065,0.690853859695387,0.156093398620671,4.42590055569396,9.60407635216081e-06,0.00133822993351732,167475,172420,"sp|Q9D4D4|TKTL2_MOUSE","Q9D4D4","TKTL2",3.33e-09,"Transketolase-like protein 2 (EC 2.2.1.1)",NA,"GO:0004802; GO:0005737; GO:0030976; GO:0046872"
"g10282",2812.01397761198,-0.97751472556141,0.220919893396447,-4.4247474074561,9.65551911889427e-06,0.00133963608194971,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56253",748.727394455911,-0.501554817591509,0.113351027420255,-4.42479286695802,9.65348616388089e-06,0.00133963608194971,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3883",2743.14242597482,-0.435047790514069,0.0983836364541897,-4.42195273719772,9.78128554682833e-06,0.00133987068591046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22796",38.1969921724778,-0.785265666109854,0.177511551365952,-4.42374403280932,9.70049443704912e-06,0.00133987068591046,0,11234,"sp|P21328|RTJK_DROME","P21328","RTJK",1.52e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g35387",165.469465083884,-1.00765507413153,0.22783935008455,-4.42265602389401,9.7494895333794e-06,0.00133987068591046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124341",25.3251117532348,-1.62792843609169,0.368100021594933,-4.42251654601396,9.75578755301331e-06,0.00133987068591046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126296",8403.1584961451,0.386917069435069,0.0874979378595512,4.42201357997872,9.77853089907224e-06,0.00133987068591046,0,3927,"sp|P49149|RL3_TOXCA","P49149","RL3",1.12e-26,"60S ribosomal protein L3","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412"
"g137534",6787.16579936351,2.74225858156401,0.619848178420824,4.4240810524771,9.68536557653788e-06,0.00133987068591046,0,2044,"sp|P81580|CUPC1_CANPG","P81580","CUPC1",6.34e-29,"Cuticle protein CP1158 (CPCP1158)",NA,"GO:0042302"
"g56894",852.272312552449,0.578663278640132,0.130893565461192,4.42086879214622,9.83048540543527e-06,0.00134376928454508,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110286",228.132964628213,-0.699378898250802,0.158318236939509,-4.41755107794703,9.98254849993483e-06,0.00136168266306585,0,2120,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.71e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g116176",20799.7272444114,0.522094995030821,0.118234768574875,4.41574844120571,1.00661093083249e-05,0.00137019626137457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88056",10945.1561113737,0.407456657355499,0.0922919160717539,4.41486832973231,1.01071489728969e-05,0.00137289832998094,0,7381,"sp|Q90YV8|RL10A_ICTPU","Q90YV8","RL10A",3.63e-22,"60S ribosomal protein L10a","hemoglobin biosynthetic process [GO:0042541]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934; GO:0042541"
"g54638",50.5717228967093,0.844662980547915,0.191443481394591,4.4120749079304,1.02384676009083e-05,0.00138204381513677,12851,15024,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.03e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g140934",17.3933725240951,0.974903581699315,0.22093246299411,4.41267692618494,1.02100297408924e-05,0.00138204381513677,0,2084,"sp|Q6P1B1|XPP1_MOUSE","Q6P1B1","XPP1",1.73e-16,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]","GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006"
"g153549",238.868131778827,0.801405285359203,0.181625251253275,4.41241115885175,1.02225746226696e-05,0.00138204381513677,0,1674,"sp|Q5E947|PRDX1_BOVIN","Q5E947","PRDX1",4.82e-28,"Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1)","cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; leukocyte activation [GO:0045321]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005829; GO:0006979; GO:0008283; GO:0019430; GO:0032872; GO:0034101; GO:0042267; GO:0042802; GO:0045321; GO:0045454; GO:0051920; GO:1901222"
"g34468",68.8511692088235,1.3330342516063,0.302311424112002,4.4094736264827,1.03622176475757e-05,0.00138459339106356,0,9068,"sp|Q960A1|GAD3_CAEEL","Q960A1","GAD3",3.53e-08,"Probable aldehyde oxidase gad-3 (EC 1.2.3.1)","endoplasmic reticulum unfolded protein response [GO:0030968]","GO:0004031; GO:0005506; GO:0016491; GO:0030968; GO:0051537; GO:0071949; GO:0102797; GO:0102798"
"g39394",2668.23377779996,0.402981597079597,0.0914257428791699,4.40774758168698,1.044511725366e-05,0.00138459339106356,10211,21884,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.75e-38,"PiggyBac transposable element-derived protein 4",NA,NA
"g39532",206.476701291794,0.512779650442089,0.116296610895975,4.40923984363362,1.03734090209711e-05,0.00138459339106356,4106,6684,"sp|A0A1L8EXB5|AR1AB_XENLA","A0A1L8EXB5","AR1AB",1.81e-14,"Actin-related protein 2/3 complex subunit 1A-B","Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030833; GO:0034314; GO:0035861"
"g57450",307.295126139923,-1.07738586298414,0.244475289956731,-4.40693152741459,1.04845313814767e-05,0.00138459339106356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59526",187.818948872776,-0.557733850342377,0.126517553459632,-4.40835152981624,1.04160386661477e-05,0.00138459339106356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117047",32.9199579138024,1.11934273292496,0.253982562917604,4.40716370473075,1.04733031531239e-05,0.00138459339106356,0,4764,"sp|Q01415|GALK2_HUMAN","Q01415","GALK2",5.23e-19,"N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)","carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]","GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858"
"g125421",98.9661054294018,0.603332931911268,0.136906066153862,4.40691160633606,1.04854953115474e-05,0.00138459339106356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137020",6653.33505505756,3.71959964255918,0.844053786431427,4.40682774291584,1.04895541762025e-05,0.00138459339106356,0,3072,"sp|C0HLU7|HCY_SCYOL","C0HLU7","HCY",0,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g137095",851.348028303874,1.67023130172938,0.378779133228049,4.40951244461452,1.03603605088855e-05,0.00138459339106356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145272",24.4848522543761,1.10608583611767,0.250846794925876,4.40940788756942,1.03653634565175e-05,0.00138459339106356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153835",18.4270477649458,1.58778938803404,0.36030696165194,4.40676855299804,1.04924197831896e-05,0.00138459339106356,0,1570,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.9e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g28357",3488.57534385355,-0.353448515850845,0.0802400610861681,-4.40488841940542,1.05838341293559e-05,0.00138537043382497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31688",4361.21905868374,-0.463050657843671,0.105119553619505,-4.40499071675808,1.05788408073065e-05,0.00138537043382497,10490,33018,"sp|O94967|WDR47_HUMAN","O94967","WDR47",1.01e-22,"WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)",NA,"GO:0005737; GO:0005874"
"g57806",459.850837248462,0.548533853899584,0.124514745675876,4.40537264018089,1.05602182919314e-05,0.00138537043382497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93938",101.557126528718,0.511589128531783,0.116116673171979,4.40581972042959,1.05384585114561e-05,0.00138537043382497,0,7209,"sp|Q28HW9|CNEP1_XENTR","Q28HW9","CNEP1",9.22e-23,"CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]; nuclear envelope organization [GO:0006998]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]","GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0006470; GO:0006998; GO:0007399; GO:0010867; GO:0016021; GO:0030154; GO:0031965; GO:0048471; GO:0071595"
"g116968",361.930137560352,-0.412834417645976,0.0937330225541525,-4.40436472010138,1.06094321287428e-05,0.00138592124176941,744,4772,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.59e-41,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18681",3345.14790636736,0.548623906496108,0.124582497415518,4.40369970001717,1.06420229813364e-05,0.00138718890144022,5005,17790,"sp|O96647|RL10_BOMMA","O96647","RL10",1.1e-12,"60S ribosomal protein L10 (QM protein homolog)","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g49031",118.934084485423,0.873046802312304,0.198290888025188,4.40285890595943,1.06833648977308e-05,0.00138718890144022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143303",75.0311234711109,1.58348626912155,0.359619275340746,4.40322968678797,1.06651147053179e-05,0.00138718890144022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133372",401.912963958413,0.553855780720985,0.125809852311653,4.40232438512832,1.07097270208405e-05,0.00138783068572264,0,3359,"sp|O96347|SODM_CHAFE","O96347","SODM",2.14e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g65912",35.2173247274741,0.667192226974258,0.151618538400345,4.40046602489038,1.08018640098055e-05,0.00139446721172862,6578,11850,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.59e-69,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g154793",39.4739444766161,1.73081625942748,0.393329478865406,4.40042344250469,1.08039840767948e-05,0.00139446721172862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6955",836.335619660089,-0.345362876287104,0.078556132811946,-4.39638337485199,1.10069456866171e-05,0.00139862956385004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74149",13002.5547461743,3.46185839645699,0.78713134934374,4.3980695208535,1.09217997562086e-05,0.00139862956385004,2868,5744,"sp|P10787|HCYB_PANIN","P10787","HCYB",0,"Hemocyanin B chain",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g89100",8168.72585265144,0.43816614861718,0.0996637369641374,4.39644510595511,1.10038172833094e-05,0.00139862956385004,0,7670,"sp|Q962T1|RL32_SPOFR","Q962T1","RL32",5.5e-25,"60S ribosomal protein L32","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g94493",508.976908733475,0.41554592687713,0.0944935278575254,4.39761258044761,1.0944811716928e-05,0.00139862956385004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107138",4929.51200144992,0.39927013239003,0.0907657725665326,4.39890633991309,1.08797764533413e-05,0.00139862956385004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121141",54.9603176888836,2.26303991688447,0.514627436857724,4.39743347284866,1.09538443715522e-05,0.00139862956385004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127278",19.3613401341034,1.51794112237028,0.345190486872,4.39740137720871,1.09554637527769e-05,0.00139862956385004,0,3849,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",3.44e-06,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g134850",273.065911400495,0.568450461941139,0.129307451863374,4.39611525669658,1.10205432106497e-05,0.00139862956385004,0,3243,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.66e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g161641",815.625348645357,0.522363994984376,0.118829304782334,4.39591896915681,1.1030508035241e-05,0.00139862956385004,0,1086,"sp|B4MQL8|EIF3B_DROWI","B4MQL8","EIF3B",3.15e-10,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","formation of cytoplasmic translation initiation complex [GO:0001732]; ovarian follicle cell development [GO:0030707]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0030707; GO:0031369; GO:0033290"
"g44085",1082.43601246966,0.794795282816353,0.180822235534984,4.39545103767164,1.10542979717347e-05,0.00139890845406759,8835,14029,"sp|Q9V3P0|PRDX1_DROME","Q9V3P0","PRDX1",1.41e-37,"Peroxiredoxin 1 (EC 1.11.1.24) (Cytosolic thioredoxin peroxidase) (DPx-4783) (DmTPx-1) (Thioredoxin peroxidase) (Thioredoxin-dependent peroxiredoxin 1)","cell adhesion [GO:0007155]; cell redox homeostasis [GO:0045454]; determination of adult lifespan [GO:0008340]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0005829; GO:0006979; GO:0007155; GO:0007281; GO:0008340; GO:0008354; GO:0008379; GO:0019430; GO:0042594; GO:0042744; GO:0045321; GO:0045454"
"g8055",222.145450875607,0.369962460159559,0.0841799374176515,4.3949006320119,1.10823436463522e-05,0.00139972376584425,51255,60352,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.43e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g119664",73.2259053993407,3.34301454173039,0.760793874641766,4.39411337703594,1.11225759671872e-05,0.00140098647166124,1189,4520,"sp|Q6ZNB7|ALKMO_HUMAN","Q6ZNB7","ALKMO",1.07e-06,"Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)","ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432]","GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0016021; GO:0019432; GO:0046485; GO:0050479"
"g156597",50.5747603814252,1.74220068175378,0.39650806532801,4.39385937915928,1.1135586142107e-05,0.00140098647166124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28697",696.644937828642,0.511912445596893,0.116549860032522,4.392218450147,1.12199879108332e-05,0.00140886952850119,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23016",583.587590584449,0.679307959690141,0.154687087523918,4.39149750999808,1.1257262512955e-05,0.00141081588008103,0,1130,"sp|P23004|QCR2_BOVIN","P23004","QCR2",7.35e-11,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",NA,"GO:0004222; GO:0005739; GO:0005743; GO:0046872; GO:0070469"
"g18004",469.834512439127,1.13566256309704,0.258639852535869,4.39090322687044,1.12880774551697e-05,0.00141120288069391,41025,51234,"sp|F4KHQ8|NCER3_ARATH","F4KHQ8","NCER3",6.14e-19,"Neutral ceramidase 3 (AtNCER3) (N-CDase 3) (NCDase 3) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3)","cellular response to oxidative stress [GO:0034599]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512]","GO:0005576; GO:0005783; GO:0005794; GO:0017040; GO:0034599; GO:0042759; GO:0046512; GO:0046514; GO:0102121"
"g149722",37.1097561604788,1.16441125048214,0.265205588154183,4.39059847338203,1.13039108403707e-05,0.00141120288069391,0,1184,"sp|Q561P5|MCM5_XENTR","Q561P5","MCM5",3.71e-62,"DNA replication licensing factor mcm5 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"g117194",152.847084127477,0.984672954450425,0.224294172912093,4.39009601393588,1.13300622891369e-05,0.00141174754980778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17",784.536420866979,-0.375962589476244,0.0856947698040927,-4.3872291195336,1.14803836263053e-05,0.00142773223857812,215115,231557,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.13e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g2498",343.691862498383,0.472166042044928,0.107651322088727,4.38606821433894,1.15417938915268e-05,0.00143261963910669,13655,15709,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51991",12393.5751270112,0.501701480593267,0.114433220468445,4.38422932204039,1.16397109024802e-05,0.00144201106788605,8796,11084,"sp|Q803F6|RSSA_DANRE","Q803F6","RSSA",6.04e-12,"40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40)","cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0002181; GO:0003735; GO:0005055; GO:0005634; GO:0005886; GO:0006412; GO:0022627; GO:0043236"
"g140674",20.8795957833897,6.38469946870133,1.45653266327283,4.38349213148088,1.16791869194776e-05,0.00144414037800327,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1752",5312.82263603329,0.424977415964889,0.0970122548982782,4.38065702534692,1.18321988460236e-05,0.00145749745214906,62785,65394,"sp|Q95V39|RL8_SPOFR","Q95V39","RL8",6.04e-19,"60S ribosomal protein L8","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843"
"g78101",1016.14386400256,0.663857690372012,0.151539004861919,4.38077108251381,1.18260063644199e-05,0.00145749745214906,0,5954,"sp|Q24407|ATP5J_DROME","Q24407","ATP5J",2.74e-09,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)","ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0015078; GO:0015986; GO:1902600"
"g5151",101.524231337314,2.08667418321515,0.476401359794158,4.38007604368878,1.18637900232738e-05,0.00145861583866789,109046,124074,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.57e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g14151",469.957141469197,0.866721994770216,0.197968091392087,4.37808936114672,1.19724263357395e-05,0.00146468932434517,33745,56447,"sp|Q9GMB0|RPN1_PIG","Q9GMB0","RPN1",9.43e-29,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0016021; GO:0018279; GO:0042470"
"g119855",9342.90849291,0.356755129916678,0.081489395682678,4.37793318907276,1.19810063109123e-05,0.00146468932434517,0,3264,"sp|Q7ZV82|RL27_DANRE","Q7ZV82","RL27",5.14e-16,"60S ribosomal protein L27","erythrocyte differentiation [GO:0030218]; translation [GO:0006412]","GO:0003735; GO:0006412; GO:0015934; GO:0022625; GO:0030218; GO:0098556"
"g124774",83.5529914287311,1.00354250263932,0.229189020002277,4.37866745374343,1.19407173691779e-05,0.00146468932434517,0,4061,"sp|Q8JG30|ST1B1_CHICK","Q8JG30","ST1B1",9.45e-08,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006805; GO:0008146; GO:0042403; GO:0051923"
"g34236",113.699621461809,0.994950368829434,0.227593725786401,4.37160719343909,1.23335271615972e-05,0.00150211696500257,4555,15733,"sp|Q498J7|MC6ZA_XENLA","Q498J7","MC6ZA",6.99e-37,"Zygotic DNA replication licensing factor mcm6-A (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-A) (zMCM6-A) (zMCM6a)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0046872"
"g135363",3759.62015817152,0.995586434333727,0.227722398436732,4.37193021489422,1.23152892597214e-05,0.00150211696500257,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95074",60.0298198343119,1.79891818768125,0.411667018132769,4.36983802064285,1.24338733009813e-05,0.00150584664072987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97015",90.0050865422764,0.863230494172667,0.197530294042466,4.37011699069857,1.24179987583478e-05,0.00150584664072987,156,6838,"sp|P31335|PUR9_CHICK","P31335","PUR9",1.28e-21,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803"
"g147199",54.862040361873,1.13888909707341,0.260578180066241,4.37062342205282,1.23892301433975e-05,0.00150584664072987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4622",30.1182676964593,0.734833940848603,0.168221691970971,4.3682472351747,1.25247662354675e-05,0.00151402458711688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144112",263.492084529082,1.46830274159234,0.336508710649736,4.36334244886952,1.28090197600839e-05,0.00154550245310077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2880",1443.67751054293,0.526891268482845,0.120793727677481,4.36190917039703,1.28932398280437e-05,0.00154702164477488,2345,14234,"sp|Q15427|SF3B4_HUMAN","Q15427","SF3B4",2.01e-41,"Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)","mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005689; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935"
"g18548",138.834798071464,-0.564799912492278,0.129472371276336,-4.36231998320949,1.2869046426581e-05,0.00154702164477488,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104894",3504.93274826158,0.41150050439183,0.0943360354581772,4.36207121057428,1.28836918534523e-05,0.00154702164477488,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37171",172.510018153605,-0.901375663250829,0.206720780181877,-4.36035343160848,1.29852536172238e-05,0.00155518213977963,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39480",1043.78035213659,0.557289773821377,0.127895763202047,4.35737478606686,1.31631758180514e-05,0.00157249461836226,2525,12299,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.44e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g130343",1241.54101365114,0.405787441930216,0.093131977113472,4.35712259641825,1.31783460832297e-05,0.00157249461836226,0,3067,"sp|Q19162|RL112_CAEEL","Q19162","RL112",3.6e-10,"60S ribosomal protein L11-2","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625"
"g56916",252.847761002535,0.479474222888324,0.110092039123411,4.355212481357,1.32937903190255e-05,0.00158335396349379,6795,14455,"sp|Q6BCY4|NB5R2_HUMAN","Q6BCY4","NB5R2",4.06e-08,"NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)","bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]","GO:0004128; GO:0005634; GO:0005789; GO:0015701; GO:0016020; GO:0016126; GO:0071949"
"g4131",1318.02598546034,-0.430528616989938,0.0988825095116182,-4.35394104696901,1.33711678716062e-05,0.00158964785303666,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9788",152.606510971448,-0.805567318168814,0.185051949994986,-4.35319551180435,1.34167396332641e-05,0.00159214434259722,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34069",3795.65551809899,0.313947202496026,0.0721323492140542,4.35237734410094,1.34669216592857e-05,0.00159252746695655,0,3398,"sp|Q9NB33|RL44_OCHTR","Q9NB33","RL44",3.49e-15,"60S ribosomal protein L44","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g52043",5773.65627972563,0.434434138953687,0.0998345824683536,4.35153959893003,1.3518489959371e-05,0.00159252746695655,13226,16375,"sp|Q7ZWJ4|RL18A_DANRE","Q7ZWJ4","RL18A",1.28e-27,"60S ribosomal protein L18a","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0022625"
"g62001",383.224409431669,0.34267217337493,0.0787448496144661,4.35167728496084,1.351000163277e-05,0.00159252746695655,4893,12474,"sp|Q9VAH9|INT11_DROME","Q9VAH9","INT11",2.3e-35,"Integrator complex subunit 11 (EC 3.1.27.-)","snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0004521; GO:0005634; GO:0005737; GO:0016180; GO:0032039; GO:0034472"
"g84361",2379.52899886804,0.75727713543367,0.17399686482235,4.35224586492893,1.34750025672589e-05,0.00159252746695655,0,8458,"sp|Q24751|ATPB_DROVI","Q24751","ATPB",2.5e-16,"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (Fragment)",NA,"GO:0005524; GO:0005743; GO:0045261; GO:0046933; GO:0046961"
"g90406",81.4474458919506,-0.71891840463182,0.165225118630256,-4.35114473266397,1.35428616408108e-05,0.00159252746695655,0,5384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.3e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g89746",35.8735345871314,2.85205854457189,0.655576061771911,4.35046169450309,1.35851186696776e-05,0.00159460252529786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93046",3435.62637613554,0.505203149654314,0.116182745208904,4.34834922127143,1.37166069897677e-05,0.0016071249849693,0,7319,"sp|P56252|ENO_HOMGA","P56252","ENO",6.7e-40,"Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"g56736",182.37289090459,0.702168093263115,0.161517387159346,4.34732201660981,1.37809818958398e-05,0.00160884893689576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62251",3956.94315732488,0.442160538095239,0.101705374990336,4.34746480348018,1.37720162305662e-05,0.00160884893689576,6350,12314,"sp|P48855|RS14_PROCL","P48855","RS14",7.96e-15,"40S ribosomal protein S14","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g113999",10451.43296111,0.429625193574693,0.0988507904308011,4.34619886904643,1.3851699323237e-05,0.00161419632059441,0,2980,"sp|Q9FY65|RS153_ARATH","Q9FY65","RS153",3.35e-22,"40S ribosomal protein S15-3","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003723; GO:0003735; GO:0006412; GO:0022627"
"g121373",96.1771725893549,-0.719263764032083,0.165531084719703,-4.34518848982368,1.39156120761002e-05,0.00161873295017372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134670",20.9592227168676,0.828050414347269,0.190626576232935,4.3438351079413,1.40016626973407e-05,0.00162582389094766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127988",620.308551500476,0.545026064142372,0.125495584669479,4.34298995919118,1.40556560471431e-05,0.00162626450404026,0,3790,"sp|Q90YV8|RL10A_ICTPU","Q90YV8","RL10A",1.36e-19,"60S ribosomal protein L10a","hemoglobin biosynthetic process [GO:0042541]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934; GO:0042541"
"g134946",17.29756473871,-0.70194063903145,0.161624414962243,-4.34303591567789,1.40527149630624e-05,0.00162626450404026,0,3235,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.13e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17476",120.208900047595,0.752799285590399,0.173454207374806,4.34004626917883,1.42452718211118e-05,0.00164526541373493,162,12244,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.42e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g44466",245.816667976063,-0.399435223771691,0.0920524845885052,-4.33921176117357,1.42994683457343e-05,0.00164611443986405,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55280",5371.47827725571,0.476895589987234,0.10990528120967,4.33915081002747,1.43034344704437e-05,0.00164611443986405,4125,8400,"sp|B4LYI3|EI3D1_DROVI","B4LYI3","EI3D1",1.95e-119,"Eukaryotic translation initiation factor 3 subunit D-1 (eIF3d-1) (Eukaryotic translation initiation factor 3 subunit 7-1) (Eukaryotic translation initiation factor 3 subunit p66)","cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0002191; GO:0003743; GO:0005634; GO:0005852; GO:0006446; GO:0016282; GO:0033290; GO:0098808"
"g89281",130.531244517911,0.845464701666888,0.194968376923443,4.33641965434667,1.4482232926609e-05,0.00166373637945706,3322,4884,"sp|Q91924|SNAI2_XENLA","Q91924","SNAI2",1.38e-68,"Zinc finger protein SNAI2 (Protein slug-alpha) (Protein snail homolog 2) (Snail protein homolog Slug) (xSlu)","neural crest cell fate specification [GO:0014036]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]","GO:0001755; GO:0003677; GO:0005634; GO:0014029; GO:0014036; GO:0046872"
"g39995",1655.34865183177,-0.368634950870661,0.085073722152038,-4.33312357265692,1.47008538275967e-05,0.00168586269389641,13315,24277,"sp|Q9V477|TOLL8_DROME","Q9V477","TOLL8",0,"Toll-like receptor Tollo (Toll-like receptor 8)","axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]","GO:0003401; GO:0007165; GO:0016021; GO:0016324; GO:0045087; GO:0048935; GO:0050135; GO:0060026; GO:0060049; GO:0061809"
"g13520",62.4203420443246,0.552927856117155,0.127660502701277,4.33123671313589,1.48274172143533e-05,0.00169716020020089,24115,26890,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.49e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g36757",686.712366236666,-0.556379032719754,0.128468023908402,-4.33087562019679,1.48517561081275e-05,0.00169716020020089,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27602",27.7549017730298,1.003213474879,0.231754489524338,4.32877687477828,1.4993974598865e-05,0.00170727142823281,37225,38620,"sp|Q5RFP3|ERAP2_PONAB","Q5RFP3","ERAP2",4.26e-19,"Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-)","adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]","GO:0002250; GO:0005789; GO:0008270; GO:0016021; GO:0019885; GO:0070006"
"g27724",45.1668666627764,1.32576308309759,0.306256366451005,4.32893232052919,1.49833966696346e-05,0.00170727142823281,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87925",8858.4436656286,0.499050790326736,0.11529668645023,4.32840531407779,1.50192877948652e-05,0.00170727142823281,0,4118,"sp|P62279|RS13_PIG","P62279","RS13",8.28e-26,"40S ribosomal protein S13 (Fragment)","translation [GO:0006412]","GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0070181"
"g135294",617.177572146458,0.530839401860861,0.122682807259807,4.32692578298028,1.51204880708465e-05,0.00171576494496385,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79462",33.1433004894686,0.681904393159303,0.157659156204483,4.32518103975437,1.52406643658356e-05,0.0017263782626846,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g422",244.713598151964,0.294251559707518,0.0680573021921948,4.32358542330326,1.53513657194872e-05,0.00172647717008387,103189,109414,"sp|P49754|VPS41_HUMAN","P49754","VPS41",1.34e-42,"Vacuolar protein sorting-associated protein 41 homolog (S53)","cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192]","GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042802; GO:0046872; GO:0048193; GO:1902501; GO:1902774"
"g9750",168.887506564416,0.31411506283306,0.0726544090467053,4.32341363661955,1.53633296143319e-05,0.00172647717008387,0,7024,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.56e-21,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g59054",5262.68576020179,0.554187398231995,0.128158444587276,4.32423629997001,1.53061166619832e-05,0.00172647717008387,0,3122,"sp|P48162|R23A1_CAEEL","P48162","R23A1",6.16e-12,"60S ribosomal protein L23a 1","ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]","GO:0000027; GO:0003735; GO:0006412; GO:0019843; GO:0022625"
"g106503",29.1124569516284,0.628068193677189,0.14527687819412,4.32324951832982,1.53747677548253e-05,0.00172647717008387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139469",28.0318971653827,1.26599718579221,0.292752977261688,4.32445537406286,1.52909152168362e-05,0.00172647717008387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95481",28.3353404317721,-3.92392320197487,0.908251753404635,-4.32030347011808,1.55814772180845e-05,0.00174666203008884,0,5595,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.47e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g87049",13765.1453094183,0.428905667612406,0.0992903326759698,4.31971226254346,1.56232772616937e-05,0.00174832297688588,99,8086,"sp|Q90Z10|RL13_DANRE","Q90Z10","RL13",2.51e-18,"60S ribosomal protein L13","regulation of cell cycle [GO:0051726]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0022625; GO:0051726"
"g34770",531.839632047623,-0.600583044033559,0.139094713184331,-4.31779921956959,1.57592686382259e-05,0.00176050050495961,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123576",1701.21203799924,0.660493711848231,0.153059205587238,4.31528250335635,1.59398924203301e-05,0.00177455919173616,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126403",37.9605857541755,1.74046977808786,0.403308069608321,4.31548463629342,1.59253128411374e-05,0.00177455919173616,165,1294,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",3.17e-19,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g54787",355.434141523842,0.45755286579232,0.106054531135493,4.3143169923382,1.60097091521753e-05,0.00177622788543989,0,9644,"sp|Q99805|TM9S2_HUMAN","Q99805","TM9S2",4.84e-32,"Transmembrane 9 superfamily member 2 (p76)","ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908]","GO:0005768; GO:0005794; GO:0005856; GO:0005887; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0070062; GO:0072657"
"g109903",4444.06835057774,0.392873524190832,0.0910572268500058,4.3145781810157,1.59907937213304e-05,0.00177622788543989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30011",797.489234909729,-0.416654124456854,0.0966683397910199,-4.31014047988812,1.63150871094193e-05,0.00180701442577881,11905,33279,"sp|P21328|RTJK_DROME","P21328","RTJK",9.03e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g50644",177.961591973664,2.14645895158028,0.498161900963281,4.3087577501004,1.6417407033992e-05,0.00180906981964872,5890,9804,"sp|G5ECR8|GLCM3_CAEEL","G5ECR8","GLCM3",5.06e-09,"Putative glucosylceramidase 3 (EC 3.2.1.45)","glucosylceramide catabolic process [GO:0006680]","GO:0004348; GO:0006680"
"g54968",50.6347490903736,1.71386377470187,0.397705539891209,4.30937868044455,1.63713836932588e-05,0.00180906981964872,0,15203,"sp|Q9VA27|CP4C3_DROME","Q9VA27","CP4C3",6.86e-19,"Cytochrome P450 4c3 (EC 1.14.-.-) (CYPIVC3)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g118611",133.652607492608,0.569282909131284,0.132113976260264,4.30902865272786,1.63973125948437e-05,0.00180906981964872,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100589",6414.47308359373,0.436348720762381,0.101279459581001,4.30836343882147,1.64466973657508e-05,0.00180922047948912,1255,5090,"sp|O16797|RL3_DROME","O16797","RL3",3.41e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g20604",1492.84559389253,-0.412390643917342,0.0957648421221002,-4.30628438139692,1.66019598859722e-05,0.00181767502230751,28204,49544,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.4e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g26714",2377.48824211568,-0.277808344855433,0.0645246428167278,-4.30546118084689,1.66638211419545e-05,0.00181767502230751,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41432",88.8897152634051,1.11336971016434,0.258579762376972,4.30571093394855,1.66450297073554e-05,0.00181767502230751,5026,13654,"sp|Q3SZP5|ACOX1_BOVIN","Q3SZP5","ACOX1",6.44e-08,"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0009062; GO:0016401; GO:0019395; GO:0033540; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493"
"g112412",138.032038234567,1.1315317423767,0.262763926426145,4.30626744609382,1.66032303194811e-05,0.00181767502230751,0,5212,"sp|P05186|PPBT_HUMAN","P05186","PPBT",1.02e-06,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)","bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]","GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0010259; GO:0016020; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031225; GO:0031966; GO:0032496; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071407; GO:0071529; GO:0120162; GO:1904383"
"g140688",300.685891161982,-0.76500936852541,0.177675420314824,-4.30565672601132,1.66491065981907e-05,0.00181767502230751,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88041",228.814664304503,0.761326680649825,0.176913539421798,4.30338278877947,1.68209855745647e-05,0.00183173465266012,0,7324,"sp|Q6NVG7|GT252_MOUSE","Q6NVG7","GT252",1.35e-103,"Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)",NA,"GO:0005788; GO:0050211"
"g93161",17.9288287445208,1.70656108389706,0.396665337064772,4.30226925429179,1.69057692827559e-05,0.00183479984780168,0,6524,"sp|Q9Y4A0|JERKL_HUMAN","Q9Y4A0","JERKL",3.41e-58,"Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)","central nervous system development [GO:0007417]","GO:0003677; GO:0005634; GO:0007417"
"g102257",27.7705527592355,0.786963440734635,0.182907306988419,4.30252598265231,1.68861861249021e-05,0.00183479984780168,0,1560,"sp|Q28452|QOR_LAMGU","Q28452","QOR",2.6e-10,"Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)","xenobiotic catabolic process [GO:0042178]","GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0070402"
"g10784",817.511849353482,-0.519029153620073,0.120718296391236,-4.29950694414995,1.711785125997e-05,0.00185471059646695,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5563",141.016574042167,-0.499212411974889,0.116177704518599,-4.29697259076907,1.73146595013418e-05,0.00187091186491034,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36469",48.0167276606954,1.47777419319686,0.343980359209328,4.29610050002175,1.73828799820355e-05,0.00187091186491034,1283,11884,"sp|Q2QEI3|IOD1_XENLA","Q2QEI3","IOD1",1.72e-11,"Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)","hormone biosynthetic process [GO:0042446]","GO:0004800; GO:0005789; GO:0016021; GO:0042446"
"g46806",25.4470861765088,1.71501534912008,0.399138877904183,4.2967885216428,1.73290372828926e-05,0.00187091186491034,10125,15435,"sp|Q0II68|ACMSD_BOVIN","Q0II68","ACMSD",9.13e-24,"2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase)","negative regulation of quinolinate biosynthetic process [GO:1904985]; secondary metabolic process [GO:0019748]","GO:0001760; GO:0005737; GO:0005829; GO:0008270; GO:0016787; GO:0016831; GO:0019748; GO:1904985"
"g85988",2628.00440233575,0.319777274769857,0.0744304463693386,4.29632348545995,1.73654123129923e-05,0.00187091186491034,1975,4788,"sp|Q567C6|ZN367_DANRE","Q567C6","ZN367",5.46e-20,"Zinc finger protein 367","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872"
"g53969",68.2755019254735,1.54412925721284,0.359630574743672,4.29365400401071,1.75756301825026e-05,0.00188852040864825,0,6657,"sp|Q9Z110|P5CS_MOUSE","Q9Z110","P5CS",2.78e-146,"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]","cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266]","GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0008652; GO:0009266; GO:0019240; GO:0031966; GO:0042802; GO:0055129"
"g30021",8943.30272261322,-0.326424586582223,0.0760556330358707,-4.29191860684756,1.77135883575545e-05,0.00189773078555588,11170,27854,"sp|Q0IIE2|SHC1_BOVIN","Q0IIE2","SHC1",2.79e-08,"SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1)","angiogenesis [GO:0001525]; cellular response to growth factor stimulus [GO:0071363]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; regulation of growth [GO:0040008]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0005737; GO:0005886; GO:0007169; GO:0007173; GO:0008286; GO:0019901; GO:0030971; GO:0035556; GO:0035924; GO:0040008; GO:0071363"
"g157842",75.3049413815321,1.08838774460996,0.253594716238829,4.29183920214229,1.77199253817744e-05,0.00189773078555588,0,1264,"sp|Q3LSM4|AGT_AEDAE","Q3LSM4","AGT",2.1e-21,"Alanine--glyoxylate aminotransferase (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]","GO:0005777; GO:0008453; GO:0009436; GO:0030170"
"g61708",228.859734381647,0.338577051289481,0.0789736829730448,4.28721364565262,1.80928263681704e-05,0.00193446947008723,3798,7954,"sp|P59470|RPC2_MOUSE","P59470","RPC2",0,"DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003677; GO:0003899; GO:0005666; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607"
"g149995",311.077266839848,0.358075948114445,0.083539325906686,4.28631598625081,1.81660544462075e-05,0.00193909911982392,0,1987,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.08e-12,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g134553",34.638706101994,1.69901664457167,0.396911564928244,4.28059244098577,1.86396441292935e-05,0.0019863790494561,1720,2854,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",5.12e-19,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g129027",457.360729987796,0.558597529342932,0.130513277434312,4.28000537818136,1.86888797127792e-05,0.00198835563748786,0,3614,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.42e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68955",107.088793739061,0.910469118837164,0.212748008512677,4.27956588267153,1.87258202325383e-05,0.00198901978742107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117162",3475.7372276656,0.61808831226031,0.144455171902375,4.27875516065304,1.87941456776779e-05,0.00199300995236298,95,4282,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.12e-52,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g71918",30.4680453947783,0.553438577532233,0.129360069429201,4.27827984303249,1.88343145083263e-05,0.00199400611100978,0,9204,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g116762",145.023021845289,0.710204839625193,0.166041397686721,4.27727572472724,1.89194410092395e-05,0.00199975096461934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145097",26.4162808521991,1.02194638210595,0.238955479673894,4.27672294228457,1.8966460725485e-05,0.00200145584655757,0,2314,"sp|Q28BS0|MCM3Z_XENTR","Q28BS0","MCM3Z",6.86e-09,"Zygotic DNA replication licensing factor mcm3 (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 3) (zMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0042555; GO:0071162; GO:1902975"
"g36986",83.0175849866939,0.633164442455471,0.148223640646627,4.27168324629786,1.94003013295399e-05,0.00203398660848685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90512",54.8685913668329,0.918610150408148,0.21500198070059,4.27256598946126,1.93236340969972e-05,0.00203398660848685,0,7626,"sp|Q6PCI7|MCM5B_XENLA","Q6PCI7","MCM5B",5.69e-57,"DNA replication licensing factor mcm5-B (xMCM5-B) (EC 3.6.4.12) (CDC46 homolog B) (xCDC46-B)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000785; GO:0003678; GO:0003688; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"g92973",28.4367547791862,0.853727957746803,0.199841001551017,4.27203602424328,1.93696274809768e-05,0.00203398660848685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102589",220.860020885005,0.592240298610582,0.138622838488751,4.27231403617986,1.93454870447162e-05,0.00203398660848685,0,4634,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.87e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g161081",48.7853824627042,0.555326229212702,0.130020177823452,4.27107729360862,1.94530965886638e-05,0.00203622695843182,0,454,"sp|Q8VE22|RT23_MOUSE","Q8VE22","RT23",9.92e-06,"28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0031965; GO:0032543"
"g110840",30.6080986387996,1.67010173481747,0.391174500278019,4.26945451104425,1.95951606321378e-05,0.00204778910135178,0,5355,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.17e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g11801",989.508938075336,0.425416506668287,0.0996645108470732,4.26848537210054,1.9680473083029e-05,0.00205009146699147,42670,60244,"sp|P84104|SRSF3_MOUSE","P84104","SRSF3",2.45e-06,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Protein X16) (Splicing factor, arginine/serine-rich 3)","cellular response to leukemia inhibitory factor [GO:1990830]; insulin receptor signaling pathway [GO:0008286]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]","GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0008286; GO:0008380; GO:0016607; GO:0043274; GO:0048024; GO:1990825; GO:1990830"
"g82945",534.414250173978,-0.40799397371372,0.0955800030568667,-4.26861226893849,1.96692823740553e-05,0.00205009146699147,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17629",121.668672134931,2.37574581762418,0.556728047600186,4.26733631952798,1.97820815035993e-05,0.00205407116484409,0,6370,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.14e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g103355",77.4542905785473,-0.689360464536149,0.161533107087303,-4.26761099917166,1.97577467930127e-05,0.00205407116484409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115718",107.230220058794,1.38854058383552,0.325439782653065,4.26665901911499,1.98422076392389e-05,0.00205701785531073,406,4834,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",7.61e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g584",650.874442613254,0.29409902831029,0.0689452054663489,4.26569224532712,1.99283328235959e-05,0.00205946369985866,204136,213662,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.14e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g63839",406.464956119249,0.570736456031555,0.133797278215377,4.26568061506323,1.99293710711246e-05,0.00205946369985866,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74589",67.6348919542598,0.715454546283402,0.167742433307202,4.26519713692911,1.99725773479281e-05,0.00206026240740804,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77824",974.674280293415,0.519108765609231,0.121716999461547,4.26488303117616,2.00006953569006e-05,0.00206026240740804,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14626",799.096927498412,-0.35721154040542,0.083763488797027,-4.26452557714022,2.00327396594491e-05,0.00206028777897569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18702",6962.07867511652,0.418086292648661,0.0980586277688809,4.26363597126883,2.0112701585096e-05,0.00206446023254897,0,8650,"sp|O61231|RL10_DROME","O61231","RL10",2.41e-23,"60S ribosomal protein L10 (QM protein homolog) (dQM)","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025"
"g140642",3441.39804588223,0.399233948335131,0.0936428997713976,4.26336592854073,2.01370343551148e-05,0.00206446023254897,0,1987,"sp|P61486|RL36A_TAKRU","P61486","RL36A",3.36e-07,"60S ribosomal protein L36a (60S ribosomal protein L44)","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412"
"g83535",329.100167001448,-0.417171218209289,0.097861924631374,-4.26285523997907,2.01831276790353e-05,0.00206591689053355,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1797",2184.48677446529,-0.483362897577745,0.113405760442313,-4.26224290276348,2.02385279806635e-05,0.00206832010008065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28380",2129.94436911082,-0.386682320622194,0.0907460211149044,-4.26114903850792,2.03378542819925e-05,0.00207519778345376,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48755",64.4570288082513,0.480834411167087,0.112874444759052,4.25990499615306,2.04513813303129e-05,0.00208350055115561,10778,16204,"sp|O75564|JERKY_HUMAN","O75564","JERKY",8.96e-55,"Jerky protein homolog","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g85079",105.769068762502,0.452158573129475,0.10617329787307,4.25868445444757,2.05633500195615e-05,0.00209161874068673,0,6785,"sp|P21328|RTJK_DROME","P21328","RTJK",4.85e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g138878",401.185876433361,0.522378946610538,0.122719491504656,4.25669093153566,2.07474857547814e-05,0.00210704050863566,0,1864,"sp|Q8AVT9|AR1AA_XENLA","Q8AVT9","AR1AA",8.05e-09,"Actin-related protein 2/3 complex subunit 1A-A","Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030833; GO:0034314; GO:0035861"
"g56805",111.638212185687,0.382821613181315,0.0899432147526189,4.2562589544329,2.07875926060097e-05,0.00210780983993926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3592",4901.81039949749,0.383163286254876,0.0900626896093661,4.25440643530403,2.09604280383679e-05,0.00211903072754386,0,14341,"sp|Q6XIM8|RS15A_DROYA","Q6XIM8","RS15A",3.47e-25,"40S ribosomal protein S15a","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g5492",17.616718869325,0.858809734544126,0.201894626668996,4.25375230987268,2.10217824882431e-05,0.00211903072754386,56483,69214,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.42e-12,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g32118",749.190158187812,-0.365624524059578,0.0859472175171708,-4.25405888197058,2.09930059462479e-05,0.00211903072754386,0,25448,"sp|Q9ESJ0|XPO4_MOUSE","Q9ESJ0","XPO4",1.94e-08,"Exportin-4 (Exp4)","positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]","GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827"
"g92931",24.2282480051198,3.00598077663518,0.706678575521393,4.25367469845444,2.10290734772383e-05,0.00211903072754386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125523",38.4069168205534,1.94531982792731,0.457406579707883,4.25293363547516,2.1098811923572e-05,0.00212275670957142,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30356",274.183084142152,1.78441115096348,0.419627861721657,4.25236575960988,2.11524013766986e-05,0.00212299609281529,0,6918,"sp|P29981|CP4C1_BLADI","P29981","CP4C1",1.84e-21,"Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g56664",253.17453468346,0.421067051125158,0.0990310751838371,4.25186791462687,2.11994887109949e-05,0.00212299609281529,9128,14551,"sp|Q6BCY4|NB5R2_HUMAN","Q6BCY4","NB5R2",2.79e-08,"NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2)","bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]","GO:0004128; GO:0005634; GO:0005789; GO:0015701; GO:0016020; GO:0016126; GO:0071949"
"g125524",59.6164537567082,1.8532810073179,0.435840071913137,4.25220425277293,2.11676661463151e-05,0.00212299609281529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48015",179.677212841847,-0.466741838622895,0.109797644960018,-4.25092759314516,2.12886988717699e-05,0.00212863991666449,5055,10822,"sp|P21328|RTJK_DROME","P21328","RTJK",1.42e-32,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g83889",17.630539917795,-1.04080356375056,0.244917695567542,-4.24960540861995,2.14147418689357e-05,0.00213794355918944,0,7879,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.75e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g127561",3568.83711126523,0.404607687079407,0.0952311058343747,4.24869252052054,2.15021811276749e-05,0.00214337049508529,0,3825,"sp|P02594|CALM_ELEEL","P02594","CALM",1.14e-29,"Calmodulin (CaM)",NA,"GO:0005509"
"g10785",725.735471269315,-0.438722107206899,0.103292288486815,-4.2473849077601,2.16280206063279e-05,0.00214600970772711,57578,64764,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.96e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g145652",193.615763894432,0.643496399979718,0.15148371171121,4.24795770258447,2.15728110543785e-05,0.00214600970772711,0,2373,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.05e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g149131",64.2272768930683,0.506213875089556,0.119178933072688,4.24751138509364,2.16158183708593e-05,0.00214600970772711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70143",36.4051398625755,0.697329342336198,0.164231598068755,4.24601203749026,2.17608944614e-05,0.00215260096921755,3413,7124,"sp|P51570|GALK1_HUMAN","P51570","GALK1",3.93e-13,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0061623; GO:0070062"
"g81131",4569.39712274154,0.457344108253865,0.107710208852266,4.24606091778312,2.17561502493965e-05,0.00215260096921755,3525,8939,"sp|P62250|RS16_RAT","P62250","RS16",7.38e-19,"40S ribosomal protein S16","cellular response to leukemia inhibitory factor [GO:1990830]; liver regeneration [GO:0097421]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0000462; GO:0003723; GO:0003735; GO:0006364; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0042274; GO:0097421; GO:1990830"
"g26845",226.575270646592,-0.339694397960161,0.0800318901663792,-4.24448800664293,2.19093084628758e-05,0.00216397838907792,0,24299,"sp|P21328|RTJK_DROME","P21328","RTJK",5.8e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31559",1591.01691363125,-0.450284997707476,0.106122684248724,-4.24306076401278,2.20491702198286e-05,0.00216557955412919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34724",22.6769584600052,1.22073338387686,0.287642080750971,4.24393183601575,2.19637093438471e-05,0.00216557955412919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85684",2680.35783928357,-0.402549840168592,0.0948734436172278,-4.24301917186333,2.2053258732595e-05,0.00216557955412919,1745,8145,"sp|P48613|TIPE_DROME","P48613","TIPE",2.29e-16,"Protein tipE (Temperature-induced paralytic E)","cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]","GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433"
"g117301",101.555401442596,-0.582353742803539,0.137251808041884,-4.24295862554922,2.20592117315955e-05,0.00216557955412919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50008",5463.6337423423,0.355007393325506,0.0836986407828191,4.2414953218497,2.22035518662949e-05,0.00217645194564727,0,5816,"sp|Q90YS9|RL39_ICTPU","Q90YS9","RL39",3.74e-08,"60S ribosomal protein L39","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g144785",234.55253116914,0.698752127261865,0.164761922579065,4.24098066060472,2.22545313449386e-05,0.00217815385110666,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65981",1859.21270617558,0.463405990704997,0.109298957864714,4.23980246251373,2.23716568578402e-05,0.00218631487600308,3735,11502,"sp|P55884|EIF3B_HUMAN","P55884","EIF3B",3.6e-09,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)","formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]","GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525"
"g58902",2065.11167531456,-0.412643288683201,0.0973392375598269,-4.23922869161145,2.2428908034017e-05,0.00218860879254226,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31803",8082.42656173814,0.546349182481203,0.128918611005556,4.23793879114673,2.2558124544256e-05,0.00219790761443004,23519,32887,"sp|Q7PQV7|ADT2_ANOGA","Q7PQV7","ADT2",5.54e-70,"ADP,ATP carrier protein 2 (ADP/ATP translocase 2) (Adenine nucleotide translocator 2) (ANT 2)","mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]","GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544"
"g32048",166.670131237749,-0.468491405221988,0.110627942363677,-4.23483791899406,2.28716611942074e-05,0.00221893752706285,19315,22150,"sp|B2RRL2|JERKL_MOUSE","B2RRL2","JERKL",2.83e-32,"Jerky protein homolog-like",NA,"GO:0003677; GO:0005634"
"g59056",2893.03598807103,0.507531451087741,0.119832670901889,4.23533454831591,2.2821168416333e-05,0.00221893752706285,5747,13674,"sp|P62752|RL23A_RAT","P62752","RL23A",1.32e-12,"60S ribosomal protein L23a","ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]","GO:0000027; GO:0003735; GO:0005634; GO:0006412; GO:0022625; GO:0022626; GO:0070180; GO:1904841"
"g69936",30.9951801422885,1.85348207589166,0.4376799759345,4.23478837919017,2.28767037809329e-05,0.00221893752706285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17239",3575.66544833347,-0.26977294321753,0.0637169690081036,-4.23392618037465,2.29646354084829e-05,0.00222413695369482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27250",529.318157174646,2.78629331584541,0.658358925215172,4.23217975655873,2.31437315565721e-05,0.00222949565108324,0,3365,"sp|P82120|CUO7_BLACR","P82120","CUO7",2.64e-06,"Cuticle protein 7 (BcNCP15.0)",NA,"GO:0042302"
"g82025",93.0024074260068,0.458122748367543,0.108235302010563,4.23265551864799,2.30948107659068e-05,0.00222949565108324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147477",32.2615098038194,2.01350255815354,0.475668092977989,4.23299899210754,2.30595538901745e-05,0.00222949565108324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151184",63.3502919733222,0.558205115465128,0.131899616309288,4.2320450285178,2.31576030308679e-05,0.00222949565108324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139651",437.134672481337,-0.557164374269364,0.131734081721774,-4.22946261883931,2.34250196703742e-05,0.00225189510311952,0,2474,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.32e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g1604",94.5460746681421,0.499426891689672,0.1181758272028,4.22613408774885,2.37740359716413e-05,0.00225902089614109,59355,75340,"sp|Q32PW3|TAF2_DANRE","Q32PW3","TAF2",3.31e-29,"Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)","transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000976; GO:0003682; GO:0005669; GO:0006367"
"g27472",101.441029403552,-0.478554918401668,0.113209385991403,-4.22716645100443,2.36652606700321e-05,0.00225902089614109,28472,32684,"sp|P17141|ZFP37_MOUSE","P17141","ZFP37",2.36e-59,"Zinc finger protein 37 (Zfp-37) (Male germ cell-specific zinc finger protein)","germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007281; GO:0007283; GO:0008270"
"g31845",699.606949134171,-0.518819891998717,0.122765763356138,-4.22609592296221,2.37780663214888e-05,0.00225902089614109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33079",3457.56765878827,-0.268882883087486,0.0636043302213374,-4.22743046191663,2.36375192031899e-05,0.00225902089614109,10625,31391,"sp|O43639|NCK2_HUMAN","O43639","NCK2",3.97e-19,"Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta)","actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]","GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0007176; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441"
"g42575",526.698506192688,0.764576143662349,0.180870977699395,4.227190859404,2.36626946102774e-05,0.00225902089614109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134948",41610.459480615,3.2221667364992,0.762431109825792,4.22617426672874,2.37697936175173e-05,0.00225902089614109,0,1813,"sp|C0HLU7|HCY_SCYOL","C0HLU7","HCY",6.04e-161,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g136252",4838.33218593465,0.428213086655967,0.101324730980761,4.22614580380455,2.37727988410133e-05,0.00225902089614109,0,1652,"sp|Q6QMZ4|RL6_CHILA","Q6QMZ4","RL6",1.01e-09,"60S ribosomal protein L6","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g156872",1675.13017251721,0.451378271556155,0.106765720430018,4.22774528882633,2.36044785945832e-05,0.00225902089614109,0,800,"sp|O00148|DX39A_HUMAN","O00148","DX39A",1.15e-39,"ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)","mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]","GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0042802"
"g23337",2254.35353523753,-0.456042417214092,0.107970204552124,-4.22378024665063,2.40238308430422e-05,0.00226745132645749,7078,17624,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.67e-16,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35076",1384.53521389077,0.610529769461515,0.144527980657708,4.22430152751847,2.39682970122215e-05,0.00226745132645749,0,22254,"sp|P80147|GABT_PIG","P80147","GABT",1.12e-23,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)","behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537"
"g60892",1931.26624924602,-0.282818725796066,0.0669461690492506,-4.22456922946559,2.39398252992485e-05,0.00226745132645749,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95748",6646.04220157021,0.413005886039422,0.0977849966800354,4.22361200656199,2.40417801502677e-05,0.00226745132645749,1426,6990,"sp|P62864|RS30_RAT","P62864","RS30",1.2e-08,"40S ribosomal protein S30","antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0050830; GO:0061844"
"g121668",679.584831591646,0.446290039128698,0.105661141066287,4.22378591244549,2.40232265890368e-05,0.00226745132645749,0,4339,"sp|Q963B6|RL10A_SPOFR","Q963B6","RL10A",2.65e-21,"60S ribosomal protein L10a","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g113454",75.1214082005772,0.573071158980428,0.135738785301068,4.22186744716596,2.42286585185068e-05,0.00228175504562443,0,4566,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.91e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62681",61.0888874103478,1.79405676744233,0.425354335680309,4.21779353576572,2.46704551689905e-05,0.00231998955263339,3126,4344,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",1.01e-08,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g94978",3443.80676448905,0.365641303334395,0.0866976427628641,4.21743073608702,2.47101685739254e-05,0.00232035645276862,0,2966,"sp|Q7ZUB2|RS17_COTJA","Q7ZUB2","RS17",7.91e-26,"40S ribosomal protein S17","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g114648",81.5033731165511,-1.38854276988923,0.329278116152899,-4.21693001075256,2.47650797372361e-05,0.00232214733923985,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92576",1224.90632404715,-0.340632200369886,0.0807844818869345,-4.21655486813213,2.48062951341999e-05,0.00232265069455233,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162655",267.150193928351,0.485244435535022,0.115105007565249,4.21566746572651,2.49040503289454e-05,0.00232843886430499,0,1019,"sp|P46471|PRS7_MOUSE","P46471","PRS7",3.17e-34,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0043197; GO:0140296"
"g83400",467.978063383597,-0.346340143517036,0.0821748055167505,-4.21467554853462,2.50137524634076e-05,0.00233133375975053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84552",24.158139749852,1.05253120235964,0.249722922978758,4.21479610203494,2.50003952236941e-05,0.00233133375975053,0,642,"sp|Q9XYU1|MCM3_DROME","Q9XYU1","MCM3",8.09e-06,"DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g98071",463.766694761765,0.472081311336478,0.112032912151939,4.21377345521682,2.51139194230075e-05,0.00233133375975053,2707,6718,"sp|Q9YHT1|SDHA_CHICK","Q9YHT1","SDHA",4.81e-32,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0050660"
"g123180",237.631074779506,-0.933376410109742,0.22150654532493,-4.2137644679554,2.51149192706908e-05,0.00233133375975053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142735",619.486041106536,0.538035648975701,0.127669173251299,4.21429570877422,2.50558828372994e-05,0.00233133375975053,0,2625,"sp|O16797|RL3_DROME","O16797","RL3",1.2e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g4494",1800.15891907594,-0.490280203274608,0.11639103407874,-4.21235370194348,2.52723396804136e-05,0.00233626140792682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6952",157.667854390996,-0.552009034340225,0.13105635327029,-4.21199751531131,2.53122329320239e-05,0.00233626140792682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77585",73.5637994336238,0.737097008398785,0.174981206119671,4.2124352937348,2.52632097425518e-05,0.00233626140792682,0,9495,"sp|Q92072|DNMT1_CHICK","Q92072","DNMT1",2.87e-67,"DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT)","positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]","GO:0003677; GO:0003886; GO:0005634; GO:0007265; GO:0008270; GO:0090309; GO:1990841"
"g137384",692.346932630537,-1.19326980600837,0.283301410224883,-4.21201505866547,2.53102666575092e-05,0.00233626140792682,0,3046,"sp|Q9I7U4|TITIN_DROME","Q9I7U4","TITIN",2.32e-13,"Titin (D-Titin) (Kettin)","cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]","GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301"
"g55782",111.192595418061,0.452316185434806,0.107413046217756,4.2109985831501,2.54244341201655e-05,0.00234283877666125,0,3886,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.16e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g84127",53.8413903447116,1.8547052240611,0.440472232660471,4.21071996493082,2.54558131089704e-05,0.00234283877666125,0,6481,"sp|O97396|AMY_PHACE","O97396","AMY",1.28e-17,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]; digestion [GO:0007586]","GO:0004556; GO:0005576; GO:0005975; GO:0007586; GO:0046872"
"g89778",554.135781075811,-0.418962558190377,0.0995285305413858,-4.20947195654782,2.55968209189074e-05,0.0023524749188635,3778,6474,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.57e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g41895",46.3087673063491,0.816616252286997,0.194031548074122,4.20867771448713,2.5686945879409e-05,0.00235741400051635,0,15346,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.03e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6944",31.1677962847225,0.92740235982028,0.22045340571257,4.20679533991613,2.59017512532012e-05,0.00236510059297922,0,16576,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.16e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g53091",515.949625812543,0.895722125563849,0.212884679728454,4.20754620156974,2.5815863367586e-05,0.00236510059297922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104480",50.8667156432715,3.04939600903591,0.724896361243231,4.20666480351212,2.59167104627852e-05,0.00236510059297922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132349",756.393346414094,0.475702744145529,0.113072484916527,4.20706013931423,2.58714309966265e-05,0.00236510059297922,0,3278,"sp|O16797|RL3_DROME","O16797","RL3",1.66e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g13239",530.02820154036,-0.413378253333241,0.0982848502737312,-4.20592036495909,2.6002178799273e-05,0.00236956282832812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31293",91.4322300680998,0.71878535077506,0.170916010169794,4.20548870793902,2.60518596752488e-05,0.0023707558201382,26275,30840,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.18e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g96285",812.743981488419,0.283174177451609,0.067356874107632,4.20408727695877,2.62137782174664e-05,0.00238214492572834,0,2323,"sp|Q8MQI6|ELOF1_DROME","Q8MQI6","ELOF1",1.96e-15,"Transcription elongation factor 1 homolog","transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000993; GO:0006368; GO:0008023; GO:0046872"
"g118609",1474.88901669199,0.59952987218786,0.142628292092651,4.20344283305592,2.62885568120058e-05,0.00238559448392197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43291",940.151928736359,-0.541272010026253,0.128826985295012,-4.20154215971714,2.65102863483344e-05,0.00240235102568899,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29210",33.8226794160352,0.96388595641535,0.229477173760985,4.20035657846866,2.66494938362387e-05,0.00241097958957996,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89864",35.8412100412125,0.786342310689686,0.187219982598315,4.20009819345408,2.66799247716394e-05,0.00241097958957996,874,6384,"sp|P05895|POL_SIVVT","P05895","POL",2.36e-11,"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Nucleocapsid protein p7 (NC); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0030430; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0075713; GO:0075732"
"g70234",17.6391820700496,0.763910115725288,0.181942952827962,4.19862437017614,2.685413504148e-05,0.00242334257902871,0,10864,"sp|P51570|GALK1_HUMAN","P51570","GALK1",2.76e-17,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0061623; GO:0070062"
"g56921",99.6543905236166,0.404025436971074,0.0962443691604332,4.197912464859,2.69386712838064e-05,0.00242759016480065,4895,8660,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.08e-45,"PiggyBac transposable element-derived protein 4",NA,NA
"g11168",7923.15231179786,0.283526488490415,0.0675584354244866,4.19675924566558,2.70761492028559e-05,0.00243565707953351,38145,68787,"sp|P47826|RLA0_CHICK","P47826","RLA0",2.85e-31,"60S acidic ribosomal protein P0 (60S ribosomal protein L10E)","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0070180"
"g29785",8334.45280386174,0.331845927250609,0.0790811520686212,4.19627077464244,2.71345818714952e-05,0.00243565707953351,0,22214,"sp|Q6QMZ4|RL6_CHILA","Q6QMZ4","RL6",2.16e-10,"60S ribosomal protein L6","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g148801",452.553605603663,0.747359615011452,0.17810316466339,4.19621749239516,2.71409629346256e-05,0.00243565707953351,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39346",167.583407296384,0.61231117156096,0.145947392683024,4.19542384625402,2.72361787935622e-05,0.0024408212068759,0,7173,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.38e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g5019",1796.70560858437,0.338626243788529,0.0807422105594028,4.19391841568913,2.74176626620356e-05,0.00244101216654713,4411,11874,"sp|G4WAW9|SELM_ERISI","G4WAW9","SELM",9.44e-11,"Selenoprotein M",NA,"GO:0005783"
"g17402",2564.08788281677,-0.587736360440559,0.140180242519161,-4.19271895866652,2.75630829905907e-05,0.00244101216654713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17633",154.975901676516,2.07705452125577,0.495446077658784,4.19229178495233,2.76150497442478e-05,0.00244101216654713,43915,53258,"sp|Q04519|ASM_MOUSE","Q04519","ASM",3.3e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g23020",922.966215835621,0.64321905146647,0.153407779291309,4.19287114667797,2.75445914115888e-05,0.00244101216654713,11545,35730,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.56e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g24867",42.4644021194618,-3.17481386989517,0.757026515930404,-4.1937948051836,2.74326152267826e-05,0.00244101216654713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39943",35.2320989455795,1.5179896870579,0.362081001309807,4.19240358253169,2.76014402957597e-05,0.00244101216654713,8795,24330,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.86e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g41347",364.950114531961,0.475801394092818,0.11346327994036,4.19343944880595,2.74756441652224e-05,0.00244101216654713,5510,11304,"sp|Q28104|COPE_BOVIN","Q28104","COPE",4.17e-11,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g48344",309.67613931517,1.76717581095514,0.421501761113875,4.19257040892342,2.75811438853748e-05,0.00244101216654713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64675",775.3311237336,0.468850042863499,0.111815758605067,4.1930587308313,2.75218152595737e-05,0.00244101216654713,0,5904,"sp|Q963B6|RL10A_SPOFR","Q963B6","RL10A",1.38e-20,"60S ribosomal protein L10a","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g134025",76.4632780376016,0.418013502359483,0.0997054273146047,4.19248493906463,2.75915405346366e-05,0.00244101216654713,0,2564,"sp|Q9VBX1|NEMF_DROME","Q9VBX1","NEMF",5.23e-20,"Ribosome quality control complex subunit NEMF homolog (Protein Caliban)","CAT tailing [GO:0140708]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0006611; GO:0032473; GO:0043023; GO:0072344; GO:0140708; GO:1902167; GO:1902231; GO:1990112; GO:1990116"
"g10664",191.777589686333,-0.338430222712842,0.0807603216754852,-4.19055070227107,2.78278220118598e-05,0.00244315456858324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19623",386.704962780986,-0.385116839110354,0.0918777854272015,-4.19162082890535,2.76968613430882e-05,0.00244315456858324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54362",25.6765796350003,1.44211521710985,0.344120318313635,4.19072963833391,2.78058831411643e-05,0.00244315456858324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77565",113.121143924671,0.542410841150217,0.129416526019805,4.19120229720284,2.77480107676124e-05,0.00244315456858324,6386,8664,"sp|Q94511|NDUS1_DROME","Q94511","NDUS1",8.86e-10,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]","GO:0005747; GO:0008137; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593"
"g157659",458.770892701726,0.499929165185458,0.119294400972199,4.19071776304038,2.78073386294363e-05,0.00244315456858324,0,1363,"sp|Q3SZ71|MPPB_BOVIN","Q3SZ71","MPPB",9.72e-23,"Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)","protein processing involved in protein targeting to mitochondrion [GO:0006627]","GO:0004222; GO:0006627; GO:0017087; GO:0046872"
"g43715",23158.7475849041,0.364457285718131,0.0869959238823195,4.18936048326973,2.79741709229671e-05,0.00245267991422437,5858,17584,"sp|Q9XYC2|RL15_FAXLI","Q9XYC2","RL15",1.24e-35,"60S ribosomal protein L15","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g18974",7249.80140283183,0.298827195028791,0.0713472269773775,4.18835051744256,2.8098929589438e-05,0.00246028911471413,20858,35994,"sp|P36241|RL19_DROME","P36241","RL19",3.62e-20,"60S ribosomal protein L19","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g43493",1497.76209005079,-0.325363212037459,0.0776965239090763,-4.18761606913345,2.81899862433412e-05,0.0024649308753911,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5108",126.885146706163,-0.410539572025725,0.09808175800043,-4.18568733264269,2.84304479024942e-05,0.0024729760450022,43095,53844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.01e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g15628",328.603956288939,-0.728334189619256,0.174019942329359,-4.18534898857037,2.84728308547473e-05,0.0024729760450022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53189",57.315618784333,0.721498760731755,0.172367733517013,4.18581103324968,2.84149674203802e-05,0.0024729760450022,13235,15899,"sp|Q75Q39|TOM70_RAT","Q75Q39","TOM70",1.48e-15,"Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70)","activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein import [GO:1904591]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068]","GO:0002218; GO:0002230; GO:0005739; GO:0005742; GO:0006626; GO:0031307; GO:0032728; GO:0042981; GO:0061052; GO:0097068; GO:0098586; GO:1904591"
"g95498",172.911951559946,0.835139473506573,0.199526090842356,4.18561537481537,2.8439456735293e-05,0.0024729760450022,0,5243,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.13e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g127088",43.5888556112035,-0.64330968181882,0.153682293563358,-4.18597137576949,2.83949133201733e-05,0.0024729760450022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46537",87.9882512179209,0.675145047125675,0.161394958702809,4.18318547587896,2.87452684109834e-05,0.00249329608588065,2672,8909,"sp|Q2TA32|TYSY_BOVIN","Q2TA32","TYSY",1.07e-39,"Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)","dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]","GO:0004799; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006231; GO:0006235; GO:0032259"
"g47247",19.4346519504187,-0.874887520279896,0.209203736787453,-4.18198801663262,2.889712039594e-05,0.00250081271667124,6145,9360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.04e-09,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g86304",294.782647160825,2.51340964375777,0.60102189687585,4.18189363286535,2.8909121738255e-05,0.00250081271667124,830,7134,"sp|A1YG61|EHF_PANPA","A1YG61","EHF",3.57e-07,"ETS homologous factor (ETS domain-containing transcription factor)","epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; transcription by RNA polymerase II [GO:0006366]","GO:0000978; GO:0001228; GO:0005654; GO:0005794; GO:0006366; GO:0030855; GO:0050673"
"g93638",33.2030312720437,1.31095768906509,0.313516405021222,4.18146440846166,2.89637594428435e-05,0.00250219848744021,0,7243,"sp|O23887|ALDO1_MAIZE","O23887","ALDO1",2.95e-08,"Indole-3-acetaldehyde oxidase (IAA oxidase) (EC 1.2.3.7) (Aldehyde oxidase) (ZmAO-1)","abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]","GO:0005506; GO:0005737; GO:0009688; GO:0009851; GO:0016491; GO:0043546; GO:0050302; GO:0051537; GO:0071949"
"g6640",29.0021373196554,-0.656743393227917,0.157104542195358,-4.18029538834889,2.9113066902681e-05,0.00251174826075288,58695,64524,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.38e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g80175",80413.8357804255,0.394874254282993,0.0944780887868356,4.17953262342045,2.92108814853158e-05,0.00251237671026038,3897,8114,"sp|O42820|EF1A_SCHCO","O42820","EF1A",6.32e-101,"Elongation factor 1-alpha (EF-1-alpha)",NA,"GO:0003746; GO:0003924; GO:0005525; GO:0005737"
"g131580",92.0236968507816,0.674706525654198,0.161420027612984,4.17981916885712,2.91740992202989e-05,0.00251237671026038,0,3502,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.85e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g150273",28.8415203281093,0.628126072192129,0.150293418133919,4.17933186955957,2.92366774117007e-05,0.00251237671026038,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7636",3689.17225671937,0.363779503091404,0.0870606101844732,4.17846259428449,2.93486252747637e-05,0.00251650136201444,75090,91444,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.23e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g11873",1987.96262695622,-0.270794551066559,0.0648088716737723,-4.1783562045279,2.93623544161085e-05,0.00251650136201444,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99078",235.756017264357,0.509961480123996,0.122088075705912,4.17699662457127,2.95383407171101e-05,0.0025282400397407,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86924",412.323304320487,1.67711558439794,0.401541943609931,4.17668841596069,2.95783749188658e-05,0.0025283267099183,0,3784,"sp|P04040|CATA_HUMAN","P04040","CATA",1.91e-27,"Catalase (EC 1.11.1.6)","aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]","GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009410; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034774; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813"
"g136999",240.363930794152,0.677967505473348,0.16237027546844,4.17544100062283,2.97409330598024e-05,0.00253887256356229,475,3073,"sp|P08991|H2AV_STRPU","P08991","H2AV",9.56e-19,"Histone H2A.V (H2A.F/Z) (Fragment)",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g31326",950.075552443305,-0.526258187275326,0.126108170531336,-4.17306971513442,3.00522935474861e-05,0.00255870992880718,23954,27754,"sp|O88623|UBP2_MOUSE","O88623","UBP2",3.05e-07,"Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)","cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000122; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0006511; GO:0007049; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0048642; GO:0048643; GO:0050821; GO:0051926"
"g89993",76.897819392884,-0.998857588801483,0.239354907473637,-4.1731234982575,3.00451973717912e-05,0.00255870992880718,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29538",189.997107650701,0.43767713152672,0.104926735259691,4.17126417250551,3.0291444296573e-05,0.00257568707389482,11486,14414,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.83e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g46611",141.79120921529,0.52039885868088,0.124787704347353,4.17027351695102,3.0423427559551e-05,0.00258235276948252,12009,19052,"sp|Q9NII1|ADAR_DROME","Q9NII1","ADAR",2.45e-08,"Double-stranded RNA-specific editase Adar (EC 3.5.-.-) (Adenosine deaminase that act on RNA) (Pre-mRNA adenosine deaminase) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dADAR) (dsRNA adenosine deaminase)","adenosine to inosine editing [GO:0006382]; adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; male courtship behavior [GO:0008049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene silencing by miRNA [GO:0060964]; regulation of membrane potential [GO:0042391]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; RNA modification [GO:0009451]; RNA processing [GO:0006396]","GO:0001666; GO:0003725; GO:0003726; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006979; GO:0007626; GO:0008049; GO:0008251; GO:0008344; GO:0009408; GO:0009451; GO:0016556; GO:0030534; GO:0042391; GO:0042752; GO:0045475; GO:0046872; GO:0060964"
"g55425",37.2169181425913,1.45523743990092,0.348971280097054,4.17007794881057,3.04495472641279e-05,0.00258235276948252,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55422",220.969272743995,1.3066208756813,0.313375523720702,4.16950519992058,3.05261651576829e-05,0.00258347688372121,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103776",76.0612389188878,-0.454155424012659,0.108933121629262,-4.16912154191552,3.05775903707246e-05,0.00258347688372121,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152185",22.9134690391855,1.23303138611749,0.29575681233965,4.16907180045432,3.05842637022614e-05,0.00258347688372121,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159718",6094.58529605535,0.601970716201157,0.144399436749539,4.16878853374806,3.06222932523249e-05,0.00258347688372121,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72797",37.5858898368601,0.829783512149789,0.199077784338355,4.1681371676283,3.07099119857652e-05,0.00258749977541441,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31517",2030.43953786224,-0.413295462439675,0.0991752233028064,-4.16732575612945,3.0819392538023e-05,0.00259335181911185,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110721",167.315652589261,-0.798137917758695,0.1916789644379,-4.16393066447975,3.12815143977332e-05,0.00262882381630652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33247",1892.75502485328,-0.387416621678563,0.0931031548258889,-4.1611546075218,3.1664261862224e-05,0.00265754212284855,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2273",1006.0685566079,-0.44679197021164,0.107430052116989,-4.15891048554175,3.19769172471247e-05,0.00267903197447379,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20172",1204.8981391545,-0.445327648843604,0.107090352760993,-4.15842918957879,3.20443532513881e-05,0.00267903197447379,38565,47621,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.07e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g57084",2522.33104305475,-0.305016212325376,0.0733471876079964,-4.15852634944278,3.20307289787162e-05,0.00267903197447379,2585,8331,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.31e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g128648",847.339624950405,3.42781109890882,0.824484489933454,4.1575204151936,3.21720532970328e-05,0.00268624207380754,1802,3740,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.72e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55374",12618.9525257031,0.518725531457151,0.124786094793205,4.15691774245185,3.22570067309978e-05,0.00268986903104445,0,4632,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.75e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g39847",253.67902954966,-0.659371956655282,0.158644667213859,-4.15628188602409,3.23468688053842e-05,0.00269043731772434,14766,24314,"sp|Q4R649|BBS5_MACFA","Q4R649","BBS5",1.92e-08,"Bardet-Biedl syndrome 5 protein homolog","cell projection organization [GO:0030030]; protein transport [GO:0015031]","GO:0005737; GO:0005815; GO:0015031; GO:0030030; GO:0034464; GO:0060170"
"g101688",1098.83775947473,-0.356918218665969,0.0858723574540428,-4.15638081040206,3.23328727645205e-05,0.00269043731772434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95284",68.8950003400927,1.66254937720283,0.400077188302116,4.15557153922849,3.24475394398726e-05,0.00269535054221495,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85062",285.229905265192,-0.442653097343,0.106534283002429,-4.15502958172544,3.25245459790157e-05,0.00269828797390316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3206",806.805254449173,-0.5008345560085,0.12057364346709,-4.15376479972757,3.27049343338268e-05,0.00270978364487422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34504",2152.84637776036,-0.52104947313346,0.125481240462457,-4.15240932599287,3.28993124639387e-05,0.00272240760214046,15586,24204,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.28e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g62138",384.823577979607,0.472583798143801,0.113847059350415,4.15104088625789,3.30966628986889e-05,0.0027352449989729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137725",5371.56204814685,0.442213990711919,0.106569764263504,4.14952584129307,3.33164676977548e-05,0.00274990304654857,0,2540,"sp|Q962U2|RL11_SPOFR","Q962U2","RL11",3.68e-18,"60S ribosomal protein L11","translation [GO:0006412]","GO:0003735; GO:0005634; GO:0005737; GO:0005840; GO:0006412; GO:0019843"
"g152826",29.5094346167097,-0.930657563655093,0.224326431627963,-4.14867546771552,3.34404479194267e-05,0.00275662460819772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122831",90.0994411326698,1.064134896962,0.256546327845359,4.14792488319476,3.35502434033255e-05,0.00276216127170479,602,3684,"sp|Q5RB59|PUR6_PONAB","Q5RB59","PUR6",1.68e-17,"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) [Includes: Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC); Phosphoribosylaminoimidazole succinocarboxamide synthetase (EC 6.3.2.6) (SAICAR synthetase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0004638; GO:0004639; GO:0005524; GO:0006189; GO:0043727"
"g29360",30.8042292527181,1.10558390468777,0.266562861243552,4.14755416238435,3.36045986797616e-05,0.00276312533281446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1940",501.397765511988,0.333611647212573,0.0804834182180556,4.14509789219826,3.39668569924504e-05,0.0027789208308066,128075,133860,"sp|Q24562|U2AF2_DROME","Q24562","U2AF2",5.94e-20,"Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)","mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701"
"g98295",293.437074320075,0.496203964602942,0.11971572875953,4.14485188992713,3.40033418134663e-05,0.0027789208308066,2805,5880,"sp|Q8BMF3|MAON_MOUSE","Q8BMF3","MAON",1.06e-22,"NADP-dependent malic enzyme, mitochondrial (NADP-ME) (EC 1.1.1.40) (Malic enzyme 3)","malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]","GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0046872; GO:0051287; GO:0070401"
"g104176",1999.30479072269,-0.334209642679747,0.080633492390905,-4.14479929828073,3.40111465564124e-05,0.0027789208308066,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115345",82.4195849038556,0.511097930036509,0.123299756615702,4.14516576565099,3.39567971654075e-05,0.0027789208308066,0,2394,"sp|Q6DCD7|ZCHC4_XENLA","Q6DCD7","ZCHC4",5.87e-09,"rRNA N6-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4)","positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]","GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0031167; GO:0045727; GO:1904047"
"g146867",124.219912953838,0.362201972733374,0.087366828286593,4.14576080918525,3.38687241843358e-05,0.0027789208308066,0,2263,"sp|O75400|PR40A_HUMAN","O75400","PR40A",9.12e-08,"Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)","cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]","GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004"
"g16516",2909.97120777438,1.03605131656115,0.25012049538008,4.14220879815057,3.43976967725781e-05,0.00280366941854205,45525,52721,"sp|P07837|ACT2_BOMMO","P07837","ACT2",0,"Actin, muscle-type A2",NA,"GO:0005524; GO:0005737; GO:0005856"
"g104706",83.1720216324155,0.686755910257758,0.165795385253075,4.14218953808319,3.44005862939041e-05,0.00280366941854205,1036,5024,"sp|Q6WIT9|HPRT_CANLF","Q6WIT9","HPRT",1.15e-15,"Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)","GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]","GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0006164; GO:0006166; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657"
"g23999",281.876020389304,0.511876161443873,0.123624574007158,4.14056966873136,3.46444364592843e-05,0.00281999619535981,33015,35277,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",1.06e-22,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g64058",465.315667049904,-0.424939333131383,0.102648450409469,-4.13975399956143,3.47678453566968e-05,0.00282649059497673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77564",186.369672805209,0.569297458403355,0.137550492100692,4.1388253121378,3.49088619117749e-05,0.00283439835820756,0,8214,"sp|Q66HF1|NDUS1_RAT","Q66HF1","NDUS1",3.36e-20,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2)","apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0032981; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g81370",1111.46232683445,0.393481974810641,0.0950990184859775,4.13760290142911,3.50953070651894e-05,0.00284241278834352,4394,8904,"sp|P09623|DLDH_PIG","P09623","DLDH",1.98e-45,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]","GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077"
"g93372",115.144158727819,0.469866667160135,0.1135555704726,4.13776854102908,3.50699880241091e-05,0.00284241278834352,0,5894,"sp|Q0VD19|ASM_BOVIN","Q0VD19","ASM",1.05e-14,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005811; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0043065; GO:0043407; GO:0045121; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g35081",268.589377663364,-0.428165852468166,0.103489735855556,-4.13727843566796,3.51449539860724e-05,0.00284288015433157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46359",762.721953961385,-0.538580687927278,0.130232175853146,-4.13554242182515,3.54117187406234e-05,0.00286088714758256,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61626",23.9525766283453,0.577908078523794,0.139772613512041,4.1346302684253,3.55526543508687e-05,0.0028651282753182,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114308",201.254473032951,1.72305146253837,0.416722687872665,4.1347675868919,3.55314034533707e-05,0.0028651282753182,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73724",23.5777080869692,0.592302447824434,0.143276904780903,4.13397015192486,3.56549801098642e-05,0.00286980512578687,5085,9751,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.75e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g26926",759.654034192827,-0.381495584667107,0.0922956771392866,-4.13340685600452,3.57425186292956e-05,0.00287328164956322,16545,19896,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.35e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g34192",19.9383490338744,1.6159187558109,0.391117816103294,4.13153962637216,3.60341556206882e-05,0.00289313636323575,26015,28500,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.15e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g4988",76.7759824202175,-0.651446880778987,0.157692025177208,-4.13113396220841,3.60978131631511e-05,0.00289466040628719,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75204",767.371211158464,-0.441133255994356,0.106838815352891,-4.12896057053124,3.64406882102734e-05,0.00291854327714245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5792",3182.66432015551,-0.429095361389445,0.103973560626181,-4.12696611335823,3.67580533931303e-05,0.00294032660926061,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10189",1067.99049554983,0.592037487988918,0.143511558286899,4.12536450064429,3.70148057210392e-05,0.00295721369554043,52465,63959,"sp|P91929|NDUAA_DROME","P91929","NDUAA",2.05e-24,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120"
"g107455",1281.16438216569,0.427211726567284,0.103579327157593,4.12448833460073,3.7155982249698e-05,0.00296483689397128,0,2834,"sp|Q9NJH0|EF1G_DROME","Q9NJH0","EF1G",4.68e-13,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]; translational elongation [GO:0006414]","GO:0003746; GO:0005634; GO:0005737; GO:0005853; GO:0006414; GO:0006749"
"g5946",747.188047463745,0.513071173087283,0.124433351626389,4.12326089734992,3.73546189929528e-05,0.00297336342556559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38948",47.2988626493614,1.82588848336175,0.4428030946898,4.12347724137034,3.73195349102178e-05,0.00297336342556559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154269",217.785728307473,0.627812930710488,0.152290545825648,4.12246818938614,3.7483438623085e-05,0.00297995636650987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145109",29.0178373792654,0.632662837819377,0.153497587874694,4.12164677360172,3.76173682987032e-05,0.00298693890217877,0,2420,"sp|Q5ZL98|RPC1_CHICK","Q5ZL98","RPC1",5.84e-39,"DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)","transcription, DNA-templated [GO:0006351]","GO:0003677; GO:0003899; GO:0005666; GO:0006351; GO:0046872"
"g105052",131.441862039678,0.796055258606731,0.193182302248689,4.1207463071951,3.77647088912297e-05,0.00299496791088059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30359",266.977513847552,1.7012713067563,0.412944961054894,4.11985002168398,3.79119093013135e-05,0.00300296618503668,0,6923,"sp|P29981|CP4C1_BLADI","P29981","CP4C1",1.84e-21,"Cytochrome P450 4C1 (EC 1.14.14.1) (CYPIVC1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g149694",102.484607890128,0.581508207989535,0.141159072580339,4.11952414648074,3.79655639255244e-05,0.00300354430210806,0,814,"sp|P10768|ESTD_HUMAN","P10768","ESTD",3.01e-28,"S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56)","formaldehyde catabolic process [GO:0046294]","GO:0005788; GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0047374; GO:0052689; GO:0070062"
"g97855",478.837851880185,0.50492600326656,0.122584549295024,4.11900199633932,3.80516850867124e-05,0.00300668638027238,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120271",2966.64847590506,0.418896158171879,0.101754738354788,4.11672384937314,3.84296069670968e-05,0.00303284960319014,2662,4404,"sp|Q8WQI5|RS8_SPOFR","Q8WQI5","RS8",1.37e-08,"40S ribosomal protein S8","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g45248",189.959314687925,0.543735709293581,0.132167667540939,4.11398430047318,3.88887895336966e-05,0.00306272286309991,10798,12764,"sp|P51688|SPHM_HUMAN","P51688","SPHM",0,"N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)","glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]","GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062"
"g48896",400.564349337321,0.322920057498325,0.0784973438330915,4.11377050139363,3.8924843144335e-05,0.00306272286309991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92290",15334.0106097446,0.351414336203898,0.0854269925061998,4.11362177099228,3.89499427282936e-05,0.00306272286309991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19171",42.959134594431,0.74187367040255,0.180378164953049,4.11287957495107,3.90754247076039e-05,0.00306515011268738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23338",1058.37346485092,-0.543205438149465,0.132070143556419,-4.11300710002949,3.90538369683344e-05,0.00306515011268738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105825",605.945514890284,0.326332891856501,0.0793520203206117,4.11247111967654,3.91446452173273e-05,0.00306686698617447,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26322",965.381206027401,-0.460405318097721,0.11197018825256,-4.11185624747927,3.92490665022859e-05,0.003067629391897,13075,37190,"sp|Q0IHQ9|PXYP1_XENTR","Q0IHQ9","PXYP1",2.18e-37,"2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2)","chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]","GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650"
"g42194",63.8416463395587,0.7015929959458,0.170619859787518,4.1120242205071,3.92205140987643e-05,0.003067629391897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9361",31.8087900882391,0.825186631606225,0.200734373627246,4.11083870039398,3.94224534481995e-05,0.00307321825515305,65279,75904,"sp|P07850|SUOX_CHICK","P07850","SUOX",1.91e-15,"Sulfite oxidase (EC 1.8.3.1)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"g15758",1443.36373721102,-0.481333279942599,0.117106852097083,-4.11020594715986,3.95306389989035e-05,0.00307321825515305,30055,41361,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.59e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28644",102.569030012963,-0.66227783731659,0.161115976061146,-4.11056590108263,3.94690610508374e-05,0.00307321825515305,6188,17364,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g94492",503.916987125882,0.398226522105274,0.0968687830386949,4.11098921255364,3.93967608989181e-05,0.00307321825515305,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108565",56.4129649016751,0.780897737282085,0.189997241933382,4.11004775298731,3.95577303844188e-05,0.00307321825515305,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6170",368.75763591104,0.549300901959576,0.133729347534508,4.10755688326252,3.99866317618254e-05,0.00309932913783123,53242,65274,"sp|Q495T6|MMEL1_HUMAN","Q495T6","MMEL1",7.98e-08,"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]","protein processing [GO:0016485]; proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016020; GO:0016021; GO:0016485"
"g13286",103.612130780124,-0.666325381986294,0.162220045099232,-4.10754035716544,3.99894920628294e-05,0.00309932913783123,7915,12318,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.73e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g94421",41.9922768489467,1.28822718131713,0.313647185162509,4.10724929876118,4.00398996546418e-05,0.00309952833730371,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146500",698.07852127712,0.525286169622783,0.127974026958692,4.10463108887194,4.04960589740925e-05,0.00313109922327969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79785",93.9027902185715,0.545754716766731,0.13297151033977,4.10429809642844,4.0554427044512e-05,0.00313187484087612,0,9159,"sp|Q0P563|FUCM_BOVIN","Q0P563","FUCM",2e-10,"Fucose mutarotase (EC 5.1.3.29)","fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]","GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806"
"g84488",29.8835419007797,0.533464080962571,0.130052364522788,4.10191758465949,4.09740226747424e-05,0.00316051172757689,0,1434,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.01e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g152444",38.5899888089795,0.738235068431304,0.180009943222564,4.10107939158978,4.11227430598462e-05,0.00316821152327778,0,1772,"sp|O00462|MANBA_HUMAN","O00462","MANBA",8.53e-07,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]","GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0006516; GO:0009313; GO:0035577; GO:0043202"
"g83000",23.7199279440556,1.83894754673563,0.448634777939782,4.09898571657871,4.14964640566049e-05,0.00319320712068837,1613,7057,"sp|A9ZSY2|TRET1_APILI","A9ZSY2","TRET1",4.52e-25,"Facilitated trehalose transporter Tret1 (AmTRET1)","trehalose transport [GO:0015771]","GO:0005886; GO:0015574; GO:0015771; GO:0016021; GO:0051119"
"g69124",1553.71459797146,0.645898236708496,0.15759494283453,4.09847057964714,4.15889087574286e-05,0.00319652451378419,8635,11120,"sp|P04636|MDHM_RAT","P04636","MDHM",1.14e-22,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)","aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005737; GO:0005739; GO:0005759; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0016615; GO:0030060; GO:0042803; GO:0043621; GO:0046554"
"g79296",81.3858706741283,0.629342398124289,0.15356846619824,4.0981225749294,4.1651471042694e-05,0.00319754000387355,5880,9235,"sp|Q10039|GARS_CAEEL","Q10039","GARS",8.35e-20,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]","GO:0004820; GO:0005524; GO:0005576; GO:0005737; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070150"
"g17579",296.072511596577,2.12226995424209,0.517917979447889,4.09769507616722,4.17284465333673e-05,0.00319797365368559,34425,50323,"sp|P21328|RTJK_DROME","P21328","RTJK",1.79e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g34228",2421.9250586106,-0.35683197927168,0.0870884813279276,-4.09734988864998,4.17906995226891e-05,0.00319797365368559,0,18360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",5.58e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g118325",98.8839430243192,0.600131543323757,0.146471089416262,4.0972696094191,4.18051901389301e-05,0.00319797365368559,0,4639,"sp|P12955|PEPD_HUMAN","P12955","PEPD",1.03e-18,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009"
"g4151",1189.95108417766,-0.256419559495092,0.0626013524653142,-4.09607060226323,4.20221822540216e-05,0.00320700030009991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90178",125.71325516524,-0.662507828744954,0.161741108473844,-4.09610045953216,4.2016765840339e-05,0.00320700030009991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76120",125.558094048469,0.623356099221481,0.152238987905981,4.09458909176703,4.22917769061766e-05,0.00322377776597871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113123",81.3938024051767,0.804264139744059,0.196446955288465,4.09405245585542,4.23898342723141e-05,0.00322745538426093,0,2414,"sp|Q640T1|ALLC_XENTR","Q640T1","ALLC",4.1e-16,"Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)","allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]","GO:0000256; GO:0004037; GO:0006144"
"g31868",1496.17845747246,-0.442652285762878,0.108151076917828,-4.09290687044382,4.25998847713614e-05,0.00323964123707843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38835",90.6174422815925,0.929540813165589,0.227126174952231,4.09261862205484,4.26528922549025e-05,0.00323986969269859,0,24324,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.93e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g98066",253.254760315141,-0.81172588212349,0.198475162129702,-4.08981090335644,4.31725017507922e-05,0.00327441359663261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143434",110.530495825215,2.63625069913523,0.644620546255176,4.08961630908312,4.3208735899262e-05,0.00327441359663261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40786",17.7496220726067,1.03446581768463,0.2529956642544,4.08886777065246,4.33483855245507e-05,0.00328115881225726,0,23489,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.56e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g33907",104.650997061793,-0.820995067195011,0.20080303096346,-4.08855913805607,4.34060895360125e-05,0.00328169283466378,0,8050,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.21e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g86270",64.0253869799972,0.694017047987543,0.169764762743556,4.08811014000541,4.34901673346296e-05,0.00328421726353457,3724,8087,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",8.73e-30,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g17237",757.890790027012,-0.402275132288979,0.0984153921866697,-4.08752252417958,4.36004356191799e-05,0.00328488723845758,21936,26784,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.67e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36216",6990.61884567133,-0.310020289943912,0.0758424533377402,-4.08768804673731,4.35693478973298e-05,0.00328488723845758,0,15819,"sp|Q9V427|INX2_DROME","Q9V427","INX2",5.59e-31,"Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)","cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]","GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098"
"g6954",1816.29299456902,-0.407256689864093,0.0996521072338985,-4.08678452637435,4.3739299359073e-05,0.00328964508827097,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60993",52.8980535627716,1.4859183812716,0.363603267372662,4.08664749359543,4.37651299691259e-05,0.00328964508827097,8394,13121,"sp|P21328|RTJK_DROME","P21328","RTJK",1.03e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g5929",501.95322447007,1.42760874460133,0.349523635665439,4.08444121921364,4.41830087266511e-05,0.00330953720742879,17162,21644,"sp|Q1QBB9|DHMA_PSYCK","Q1QBB9","DHMA",8.38e-54,"Haloalkane dehalogenase (EC 3.8.1.5)",NA,"GO:0018786"
"g34754",33.1581268031419,1.05657787939326,0.258680143828568,4.08449548448326,4.41726853852165e-05,0.00330953720742879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104267",9716.17985520116,0.341258633979184,0.0835480695963862,4.08457832272817,4.41569307767701e-05,0.00330953720742879,0,1844,"sp|P48855|RS14_PROCL","P48855","RS14",1.79e-46,"40S ribosomal protein S14","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g90739",83.8723217870998,-0.741866776697154,0.181690514290466,-4.08313433199459,4.44323212351818e-05,0.00332436881038237,0,5344,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.25e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g57",881.239447039904,-0.453404464220611,0.111106290263968,-4.08081723495048,4.48776330253014e-05,0.00333841156901074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3891",191.072199407508,-0.460387571311793,0.112806460250486,-4.08121636198411,4.48006261488976e-05,0.00333841156901074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20818",365.861813119543,-0.36030943670085,0.0882920954215952,-4.08087989055385,4.48655360608478e-05,0.00333841156901074,0,11004,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.17e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g65139",78.5141440766334,2.32428689706399,0.569486154489601,4.08137560279603,4.47699374923787e-05,0.00333841156901074,0,12032,"sp|P81182|BGBP_PENVA","P81182","BGBP",6.61e-175,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g157387",158.171345888123,0.966221303458348,0.236731837959981,4.08150129608543,4.47457281463867e-05,0.00333841156901074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68107",31.4820634289185,0.979691982364271,0.240168798909158,4.07918092114386,4.5194654890084e-05,0.00335813907602432,0,5075,"sp|Q80XN0|BDH_MOUSE","Q80XN0","BDH",3.7e-13,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH)","lipid metabolic process [GO:0006629]","GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0006629; GO:0099617"
"g109202",75.1577370821066,1.1430423067024,0.280279706907823,4.07822000141565,4.53818135446939e-05,0.00336818309851243,0,1424,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",1.18e-16,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g37184",62.9388191141094,0.650230928065925,0.159451819859534,4.07791474966377,4.5441421204106e-05,0.00336874828841836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46972",291.47358184529,0.333465007130343,0.0817993304837063,4.07662269554598,4.5694548742304e-05,0.00338364216761155,5585,12597,"sp|Q8CC12|CDAN1_MOUSE","Q8CC12","CDAN1",8.24e-63,"Codanin-1","chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; nuclear envelope organization [GO:0006998]; protein localization [GO:0008104]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497"
"g151260",41.9738997224973,0.53801693965963,0.132012222411745,4.0755085387591,4.59138973826714e-05,0.00339600359944684,0,1813,"sp|A2RRV9|NARFL_DANRE","A2RRV9","NARFL",8.56e-14,"Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)","iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]","GO:0002040; GO:0016226; GO:0046872; GO:0051539; GO:0097361"
"g82061",303.11619478377,0.996204855983696,0.244536097917012,4.07385602563175,4.62410740744869e-05,0.00341630320696491,0,8384,"sp|P15144|AMPN_HUMAN","P15144","AMPN",4.12e-11,"Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g2449",2946.84110320516,-0.3782424234872,0.0928629437919817,-4.07312549055611,4.63864143965215e-05,0.00342254045023161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24355",1980.73624895806,-0.351384768035532,0.0862738276885197,-4.07290110396121,4.6431143113509e-05,0.00342254045023161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95397",75.7199917886507,-0.855140828544797,0.210035986303477,-4.07140149454779,4.67311235457144e-05,0.00342904834416475,215,4252,"sp|Q8N8E2|ZN513_HUMAN","Q8N8E2","ZN513",5.65e-23,"Zinc finger protein 513","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]","GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041"
"g101950",62.8026642857564,0.806281307569388,0.198018502732085,4.07174731878602,4.66617825989967e-05,0.00342904834416475,0,6276,"sp|Q58D68|ENPP6_PIG","Q58D68","ENPP6",6.1e-10,"Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6)","choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]","GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0016042; GO:0019695; GO:0031225; GO:0046872; GO:0047390"
"g142790",70.6683199576875,0.51543172875828,0.126581507435828,4.07193546039562,4.6624099461236e-05,0.00342904834416475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148175",23.1839138841889,1.56860202093192,0.385270001778181,4.07143565211973,4.67242702914501e-05,0.00342904834416475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28904",13315.1280305821,0.328181454152059,0.0806152939468241,4.07095773127783,4.68202453104979e-05,0.00343170153213019,536,3625,"sp|Q6QN05|RL21_CHILA","Q6QN05","RL21",1.26e-17,"60S ribosomal protein L21","translation [GO:0006412]","GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412"
"g90854",30.4856423623714,0.762813203986891,0.187428347210304,4.06989239002879,4.70348580138253e-05,0.00344353622066642,0,7524,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.1e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g78161",22.1213315922856,1.3454569693742,0.330643957941906,4.0692017411992,4.71744870360748e-05,0.00344509833873091,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113526",203.94923468537,0.390974948948499,0.0960839337345918,4.06909806616027,4.71954809975082e-05,0.00344509833873091,917,5103,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147484",838.343984507988,0.537796771776675,0.132169330696228,4.06899822329223,4.72157073263015e-05,0.00344509833873091,0,1394,"sp|Q9XTL9|PYG_DROME","Q9XTL9","PYG",8.37e-35,"Glycogen phosphorylase (EC 2.4.1.1)","defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]","GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499"
"g97654",3890.98179704131,0.72642134908358,0.17855982524489,4.06822390247813,4.73728497577249e-05,0.0034526761016336,0,6767,"sp|Q5R546|ATPA_PONAB","Q5R546","ATPA",1.58e-51,"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)","lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]","GO:0001937; GO:0005524; GO:0005753; GO:0005886; GO:0006629; GO:0008180; GO:0042288; GO:0042776; GO:0043532; GO:0043536; GO:0045261; GO:0046933"
"g69382",2609.25885039776,0.455152292241248,0.111893703408147,4.06772033079483,4.74753117160898e-05,0.00345625603597821,0,7284,"sp|P56252|ENO_HOMGA","P56252","ENO",9.82e-102,"Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"g85941",2341.68846778123,-0.376618839763372,0.092616550360429,-4.06643130517939,4.77385485201518e-05,0.00347151938750415,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55226",21853.2514802617,0.358018673007687,0.0880525811714943,4.06596454350835,4.7834208504477e-05,0.00347457608927195,0,15099,"sp|Q8WQI5|RS8_SPOFR","Q8WQI5","RS8",1.06e-24,"40S ribosomal protein S8","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g36143",1166.45630243425,0.823548003352322,0.202604993257286,4.06479618351018,4.80744542629373e-05,0.00348811659021108,16485,17771,"sp|O16808|ACT_MAYDE","O16808","ACT",0,"Actin",NA,"GO:0005524; GO:0005737; GO:0005856"
"g129732",27.2516951790657,1.30250026706666,0.320483219667041,4.06417617877111,4.82024078168811e-05,0.0034934883777172,0,3650,"sp|A8Y9I2|NINAB_GALME","A8Y9I2","NINAB",4.79e-07,"Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B)","retinol metabolic process [GO:0042572]","GO:0004497; GO:0016702; GO:0042572; GO:0046872"
"g82215",27.7961594869865,0.784531305546538,0.193054809924784,4.06377497588482,4.82853781020792e-05,0.00349559162387488,5425,8777,"sp|Q1LW01|HE12_DANRE","Q1LW01","HE12",4.13e-13,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188"
"g155444",430.434076570191,0.485960125359426,0.119591704437781,4.0634935980217,4.83436488748597e-05,0.00349590406422855,0,1523,"sp|Q94511|NDUS1_DROME","Q94511","NDUS1",8.92e-07,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]","GO:0005747; GO:0008137; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593"
"g15759",653.612789220249,-0.302798576343876,0.0745366317270465,-4.06241292808516,4.85680660057225e-05,0.00349695256489367,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46697",2169.04996219422,0.371389984184192,0.0914216776231319,4.06238425983797,4.85740328184264e-05,0.00349695256489367,0,4169,"sp|Q5REU2|RL23_PONAB","Q5REU2","RL23",8.02e-17,"60S ribosomal protein L23","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g74146",228.845659295576,0.429657686193293,0.105759208038872,4.0626030977404,4.85285029847442e-05,0.00349695256489367,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146477",2449.09038087012,0.46532684785158,0.114533016286092,4.06281841638783,4.84837448316355e-05,0.00349695256489367,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g313",11288.6926416692,-0.4617144908844,0.113687226460513,-4.06126972448192,4.88065440071455e-05,0.00349913725257713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33954",761.303947591167,-0.278196906657531,0.0684898119207744,-4.06187283707736,4.86805937012484e-05,0.00349913725257713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56552",411.452167392077,-0.432476898652493,0.106498896964237,-4.06085800867704,4.88927015478326e-05,0.00349913725257713,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58721",57.874006897594,1.56894410997935,0.386366549176771,4.06076590564657,4.89119951761608e-05,0.00349913725257713,0,13191,"sp|Q54IT3|AOFA_DICDI","Q54IT3","AOFA",1.19e-07,"Probable flavin-containing monoamine oxidase A (EC 1.4.3.4)",NA,"GO:0097621"
"g68073",150.244445926553,0.40408340325788,0.0995110791419585,4.0606875811429,4.89284081742608e-05,0.00349913725257713,0,4675,"sp|P51400|RED1_RAT","P51400","RED1",7.65e-19,"Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049"
"g83525",173.013960253329,0.822140103591036,0.202436228435416,4.06123009673305,4.88148304278148e-05,0.00349913725257713,0,3232,"sp|O35567|PUR9_RAT","O35567","PUR9",3.73e-08,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]","GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006177; GO:0006189; GO:0009116; GO:0009235; GO:0009259; GO:0010035; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0044208; GO:0046452; GO:0046654; GO:0097294; GO:0098761"
"g84692",75.3204297791251,0.791594967652051,0.194984300449052,4.05978822822655,4.91172432558231e-05,0.00350785926140456,6803,8408,"sp|Q94529|GS1_DROME","Q94529","GS1",3.06e-19,"Probable pseudouridine-5'-phosphatase (EC 3.1.3.96) (GS1-like protein) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase)","nucleotide metabolic process [GO:0009117]; wound healing [GO:0042060]","GO:0009117; GO:0016791; GO:0042060; GO:0046872; GO:1990738"
"g116214",347.04094826446,0.478561894116245,0.117884249428992,4.05959147582738,4.91586469117858e-05,0.00350785926140456,0,4847,"sp|Q9YGD2|SUCA_COLLI","Q9YGD2","SUCA",7.12e-24,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (Fragment)","tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099"
"g104728",55.9452904969693,1.7291487251202,0.425999513385356,4.05903920260121,4.92750415545889e-05,0.00351229677386851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91791",493.994116561261,0.742443488805814,0.18294502300019,4.05828743865333,4.94338998674978e-05,0.00351974799353273,0,7468,"sp|P21328|RTJK_DROME","P21328","RTJK",2.9e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g84145",26.8119430049765,0.847955982240939,0.208979434447514,4.05760492405729,4.95785451668408e-05,0.00352617198352922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113501",4121.95063614232,0.366746207633361,0.0903999508009462,4.0569292835226,4.97221287355238e-05,0.00353250645522017,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14056",56.7699537331948,0.825275698354891,0.203437439972147,4.05665593544571,4.97803311492177e-05,0.00353276779425111,45586,51004,"sp|P21328|RTJK_DROME","P21328","RTJK",2.78e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g2015",29.8306656618831,1.01216031434764,0.249526348100729,4.05632640421225,4.98505821694313e-05,0.00353388268107655,124414,131004,"sp|Q6NX31|MCM7_XENTR","Q6NX31","MCM7",1.16e-11,"DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0000785; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0006271; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162"
"g89230",24.8714470666029,1.95006755584997,0.480946599092084,4.05464465188286,5.02105720403055e-05,0.00355551212481695,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17631",310.046806700805,2.21493294978893,0.546413675521712,4.05358256759244,5.04391859597958e-05,0.00356655769331457,10075,44675,"sp|P21328|RTJK_DROME","P21328","RTJK",3.95e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g20895",374.708200810354,-0.399457604017621,0.0985629023263214,-4.05281900785652,5.06041516228446e-05,0.00356655769331457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34766",127.252212268025,-0.30558897212708,0.0753957498611649,-4.05313260614554,5.05363375066999e-05,0.00356655769331457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98056",36.6515720672554,0.59279531789687,0.146253954777161,4.05319171573911,5.0523564994006e-05,0.00356655769331457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129367",95.4264917581156,-0.42316811987779,0.104417757694933,-4.05264515556941,5.06417834928063e-05,0.00356655769331457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83011",1053.96604796262,-0.462898576051716,0.11422980724281,-4.05234489337592,5.0706840381242e-05,0.00356726200740696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13041",4678.38436020652,-0.29554939203832,0.0729508028036615,-4.05135215350209,5.09224986359933e-05,0.00357467113122634,5320,53294,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.95e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g55020",1274.22868441479,0.955424635446888,0.235826469190123,4.05138845833554,5.09145966498798e-05,0.00357467113122634,6045,13768,"sp|P29413|CALR_DROME","P29413","CALR",7.44e-26,"Calreticulin","olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030433; GO:0042048; GO:0045169; GO:0051082"
"g102360",129.727437292326,0.577813410797975,0.142688151919225,4.04948415846798,5.13306522087709e-05,0.0035994231045053,0,5664,"sp|Q9GZM7|TINAL_HUMAN","Q9GZM7","TINAL",7.55e-07,"Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP)","endosomal transport [GO:0016197]","GO:0005201; GO:0005576; GO:0005615; GO:0005764; GO:0016197; GO:0043236; GO:0062023; GO:0070062"
"g154457",56.1293225554336,0.499306767100642,0.123309565598593,4.04921357622834,5.13900303953065e-05,0.00359969106962496,0,1319,"sp|Q9VFR0|BCCIP_DROME","Q9VFR0","BCCIP",3.75e-10,"Protein BCCIP homolog","regulation of protein kinase activity [GO:0045859]","GO:0005634; GO:0019887; GO:0045859"
"g2359",1799.41092708802,-0.413991547240878,0.1022633234425,-4.04828958520651,5.15932875903316e-05,0.00360934383394728,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90552",195.664341565373,0.719714639217164,0.177802641757858,4.04782871672579,5.16949528174814e-05,0.00360934383394728,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108546",68.6965666975864,0.730432620853897,0.18044252032232,4.04800719669147,5.16555585459752e-05,0.00360934383394728,0,5314,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.95e-47,"PiggyBac transposable element-derived protein 4",NA,NA
"g102327",167.756758373203,0.330070975006308,0.0815483387077019,4.0475499591647,5.17565374233933e-05,0.00360975385282446,0,6240,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.84e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73858",1652.66222943767,0.6913045274282,0.170839386326486,4.04651727153287,5.19852907168937e-05,0.0036172056510525,2095,10133,"sp|Q5T750|XP32_HUMAN","Q5T750","XP32",5.52e-06,"Skin-specific protein 32","epidermis development [GO:0008544]","GO:0008544"
"g146637",226.830628660359,0.450445455390664,0.11131794522645,4.04647655393151,5.19943297820743e-05,0.0036172056510525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151421",22.1956583948762,0.687195537740765,0.16983256064734,4.04631205654219,5.20308623891613e-05,0.0036172056510525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51206",123.19710233297,-0.500312385662923,0.123657690595589,-4.04594638031167,5.21121612099259e-05,0.00361897455656455,2470,6444,"sp|P21328|RTJK_DROME","P21328","RTJK",9.99e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g96771",244.832861282947,0.589977647780554,0.145902758234375,4.04363601428856,5.26286020129583e-05,0.00364702140131081,0,1084,"sp|Q9W141|ATPK_DROME","Q9W141","ATPK",2.11e-08,"Putative ATP synthase subunit f, mitochondrial","mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0042776; GO:1902600"
"g107685",98.5404970121654,0.447433836717183,0.110646996348233,4.04379559756867,5.25927746796826e-05,0.00364702140131081,0,5677,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.2e-52,"PiggyBac transposable element-derived protein 4",NA,NA
"g132293",10190.1757735035,0.401457937268074,0.0992942298461001,4.04311446788306,5.27458534525616e-05,0.00365124154140152,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128634",99.6259533513754,1.3942867779398,0.344924223471139,4.0422988096006,5.29297220510727e-05,0.00366005921115812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54790",250.851353961131,0.420255116468415,0.10398248954036,4.04159506399679,5.3088850806252e-05,0.00366714915809114,0,6254,"sp|Q99805|TM9S2_HUMAN","Q99805","TM9S2",2.83e-32,"Transmembrane 9 superfamily member 2 (p76)","ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908]","GO:0005768; GO:0005794; GO:0005856; GO:0005887; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0070062; GO:0072657"
"g114140",125.251465956667,0.471957505255077,0.11680863373246,4.04043340097665,5.33525145702507e-05,0.00368143714222604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15197",799.878873133594,0.604199042691715,0.149559558068836,4.03985576377291,5.34840828576355e-05,0.00368658955382423,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148980",227.803645017519,-0.752310536128433,0.186235643150649,-4.03956258534182,5.35509775934861e-05,0.00368727788651939,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28822",1830.19475171619,-0.362746796042935,0.0898297301594711,-4.03815969834224,5.38721740838363e-05,0.00369869675506565,0,33835,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.97e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52207",36.7498887067721,0.660544604557093,0.163558701883969,4.03857817987387,5.37761705546735e-05,0.00369869675506565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73485",4138.68717382911,-0.606037739621383,0.150080277649929,-4.03809047471914,5.38880702665716e-05,0.00369869675506565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4934",807.003298542349,-0.375796862209454,0.0930779622067084,-4.03744187453181,5.40372277728597e-05,0.00370500962866339,6485,13828,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",1.01e-33,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g107880",88.5507434961923,0.547360866378971,0.1356344793917,4.03555842757535,5.44725812605983e-05,0.00373091116027267,0,4966,"sp|O88554|PARP2_MOUSE","O88554","PARP2",2.89e-19,"Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)","base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003677; GO:0003682; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0016570; GO:0018312; GO:0030592; GO:0031491; GO:0061051; GO:0070212; GO:0070213; GO:0090734; GO:0097191; GO:0140294; GO:1901215; GO:1990404"
"g4919",252.433704213085,1.34020095794575,0.332248851932702,4.03372637753224,5.48992411849171e-05,0.00374529323659833,7465,14223,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.52e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g54671",2952.89145605765,-0.318721959985771,0.0790254579775321,-4.03315549371934,5.50328380708575e-05,0.00374529323659833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54833",641.77572275386,0.828555607822328,0.205383936760073,4.03417921037435,5.4793488887748e-05,0.00374529323659833,0,5505,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.47e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g64376",54.2391333952984,0.591941731181592,0.146761375094915,4.03336184877503,5.49845118419293e-05,0.00374529323659833,10477,11614,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.52e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g104459",321.79796500165,0.50629152125922,0.125539576500887,4.03292360362266,5.50871923584061e-05,0.00374529323659833,0,4484,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",6.41e-20,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g130704",223.300118667995,0.50731662415918,0.12577044720292,4.03367114804535,5.49121524225608e-05,0.00374529323659833,0,3576,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",2.25e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g132874",10467.9548611882,3.17575124943967,0.787449322028841,4.03295953224957,5.50787674764376e-05,0.00374529323659833,0,3398,"sp|C0HLU8|HCY_SCYSE","C0HLU8","HCY",4.83e-79,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g66998",19.9323427683049,0.989729193307859,0.24546214834788,4.03210515335819,5.5279441256483e-05,0.00375185480020924,4985,6995,"sp|A6QPT7|ERAP2_BOVIN","A6QPT7","ERAP2",3.55e-09,"Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-)","adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0002250; GO:0005737; GO:0005789; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0070006"
"g87511",76.2174304022111,0.427694013894606,0.106074381777348,4.03201985935063,5.52995128208267e-05,0.00375185480020924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143740",137.931537642634,0.932043320165557,0.231191745139338,4.03147318086041,5.54283223732208e-05,0.00375666034678671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112547",356.433240352211,2.81901418253021,0.69933137544924,4.03101345298474,5.55368644020344e-05,0.00376008365224766,926,4814,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.02e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g102303",479.632570098293,-0.786458325180781,0.195122461485834,-4.03058837609979,5.56374044457549e-05,0.00376295860778058,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70533",83.018107011343,0.607950030926788,0.150853234365788,4.03007620938796,5.57587721819774e-05,0.00376723475076836,3452,10794,"sp|Q07598|SCP2_CHICK","Q07598","SCP2",6.18e-13,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X) (Fragment)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032385; GO:0033814; GO:0050632; GO:0050633; GO:0120019; GO:0120020"
"g24916",1366.69461722352,-0.592787767377327,0.14711459635145,-4.02942863644328,5.59125860682288e-05,0.00377369186366536,0,11300,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.1e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5120",125.021617343909,0.98684546707191,0.244952836887876,4.0287162198641,5.60822661439076e-05,0.00377983048001771,13311,40384,"sp|A7NF38|ARLY_ROSCS","A7NF38","ARLY",1.77e-21,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","arginine biosynthetic process via ornithine [GO:0042450]","GO:0004056; GO:0005737; GO:0042450"
"g81992",6965.69150785336,0.483433493444875,0.120001646249845,4.02855717861038,5.61202123960465e-05,0.00377983048001771,0,1274,"sp|Q4R6V2|TCPE_MACFA","Q4R6V2","TCPE",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]","GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g60018",55.2213918183596,0.876238488756019,0.217539369177627,4.02795361625116,5.62644400163981e-05,0.00378560941015834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g574",431.302659285318,0.339901748379647,0.0844118632501222,4.02670590711259,5.65637072310008e-05,0.00379785728768729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105703",4493.73600131517,0.422599858255968,0.104946371978341,4.02681722378343,5.65369464181146e-05,0.00379785728768729,0,5883,"sp|P62832|RL23_RAT","P62832","RL23",1.57e-15,"60S ribosomal protein L23","cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412]","GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005840; GO:0006412; GO:0008284; GO:0010628; GO:0014069; GO:0022625; GO:0022626; GO:0031625; GO:0032986; GO:0032991; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1904667; GO:1990948; GO:2000059"
"g78298",157.430913239595,-1.29388464147791,0.321375316098712,-4.02608593959496,5.67129686397548e-05,0.00380393724334952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38108",663.878455332526,-0.294433017742659,0.0731430219473362,-4.02544234437912,5.6868313213651e-05,0.00381008219574972,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89777",1097.30101190178,-0.350584555629912,0.0870970028895189,-4.02521951386344,5.69221916794365e-05,0.00381008219574972,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56419",38.5785474534152,2.01697921520585,0.50154451241009,4.0215358064902,5.7819916492997e-05,0.00386617734709056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72022",68.0448546102451,0.577497692162199,0.143645100951539,4.02030900000568,5.81218558247605e-05,0.00388236021077702,1755,7957,"sp|B4QBN2|TRE11_DROSI","B4QBN2","TRE11",7.46e-09,"Facilitated trehalose transporter Tret1-1","trehalose transport [GO:0015771]","GO:0005886; GO:0015574; GO:0015771; GO:0016021; GO:0051119"
"g23027",230.912458006078,0.548194115367118,0.136391365467015,4.01927287325014,5.83780280014392e-05,0.00389293301287501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60499",130.995303006387,0.806064868891957,0.200554409478005,4.01918297877344,5.84003038679258e-05,0.00389293301287501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64694",644.140703284288,0.498137014581857,0.12394822327115,4.01891210245208,5.84674757503569e-05,0.00389340509382618,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5869",1267.67192507452,-0.302659645380507,0.0753216576040524,-4.01822868757768,5.86372742293227e-05,0.00389380146745538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8833",356.619818693372,0.242708277056258,0.0604162924164024,4.01726533272613,5.88774187286075e-05,0.00389380146745538,37776,76514,"sp|Q3UQU0|BRD9_MOUSE","Q3UQU0","BRD9",7.16e-12,"Bromodomain-containing protein 9","chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0070577; GO:0140288; GO:1902459"
"g11553",21.9272788862201,1.1428292334863,0.284485489587375,4.01717934768444,5.88988982419484e-05,0.00389380146745538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16597",535.249919081323,0.321076892305291,0.0799067508012151,4.0181447635637,5.86581578143305e-05,0.00389380146745538,50266,59470,"sp|Q9VCA9|SPCS3_DROME","Q9VCA9","SPCS3",6.71e-17,"Signal peptidase complex subunit 3 (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit)","protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]","GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047"
"g18960",7275.35680162087,0.289459520075413,0.0720337455618557,4.01838774060211,5.85977149169705e-05,0.00389380146745538,20913,36634,"sp|P36241|RL19_DROME","P36241","RL19",3.77e-20,"60S ribosomal protein L19","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g31756",118.745242197782,0.670383749050913,0.166850340827811,4.01787461580762,5.87254290064448e-05,0.00389380146745538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89948",52.4526356845984,0.671515478952011,0.167170146900475,4.01695811963245,5.89541962800569e-05,0.00389380146745538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95807",34.0871274664426,-0.507557858633012,0.12633157416481,-4.01766432492054,5.87778454287282e-05,0.00389380146745538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5677",44.63713544887,0.569165852852184,0.141727485893983,4.01591723201766,5.92150364675793e-05,0.00389804258017161,72715,92199,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.93e-32,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g19818",27.2797143933714,0.888767297517809,0.221314560531618,4.01585551073959,5.92305377225967e-05,0.00389804258017161,40730,48984,"sp|Q561P5|MCM5_XENTR","Q561P5","MCM5",5.57e-16,"DNA replication licensing factor mcm5 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"g27566",455.232744211799,-0.425353021850935,0.105921401677083,-4.01574200412949,5.92590548588433e-05,0.00389804258017161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74604",307.21085940037,0.467242463478493,0.116350394500607,4.01582191004996,5.9238978127188e-05,0.00389804258017161,0,3414,"sp|Q55E60|PEPD_DICDI","Q55E60","PEPD",1.74e-22,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)",NA,"GO:0008233; GO:0030145; GO:0070006; GO:0102009"
"g93469",23.7072775048467,0.649968191725159,0.16188103115976,4.01509792140938,5.942111906877e-05,0.0039009916224529,1515,7266,"sp|Q09582|METH_CAEEL","Q09582","METH",1.92e-13,"Probable methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)","methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]","GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558"
"g127077",28.4809351387197,1.63384813784062,0.406927379822377,4.01508529250058,5.94243009485748e-05,0.0039009916224529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4682",118.561033928232,0.489957039073358,0.122051081736435,4.01436048007673,5.96071895488958e-05,0.00390903707737005,36905,53678,"sp|P21328|RTJK_DROME","P21328","RTJK",1.51e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g7121",206.700380372111,-0.444128117415983,0.110643260255626,-4.01405486777853,5.96844629394075e-05,0.00390981881876282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39873",539.063572090544,-0.482383325527168,0.120180120630366,-4.01383625675347,5.97397964375039e-05,0.00390981881876282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53609",218.774834148431,0.447325307625287,0.11145348078163,4.01356067561255,5.98096190831311e-05,0.00391043859662292,3834,9714,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",5.08e-14,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g108433",13650.7760830874,0.461555834958555,0.115011348993096,4.013132956003,5.99181413712713e-05,0.00391358481236772,0,808,"sp|Q90YT5|RL34_ICTPU","Q90YT5","RL34",2.03e-16,"60S ribosomal protein L34","translation [GO:0006412]","GO:0003735; GO:0005783; GO:0005829; GO:0005840; GO:0006412"
"g135221",16974.4783839672,0.361409919676948,0.0900741767049855,4.01235884576167,6.0115025182692e-05,0.00391854409120942,0,3060,"sp|Q4R7Y2|RL10_MACFA","Q4R7Y2","RL10",6.46e-32,"60S ribosomal protein L10 (Ribosomal protein L10)","embryonic brain development [GO:1990403]; regulation of translation [GO:0006417]; translation [GO:0006412]","GO:0003735; GO:0006412; GO:0006417; GO:0022625; GO:0045182; GO:1990403"
"g138924",1111.86476342974,-0.412830333284129,0.102883747332666,-4.01259036521362,6.0056077422811e-05,0.00391854409120942,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49350",2760.09466880682,-0.704117730160616,0.175545031524566,-4.01103764683925,6.0452468818839e-05,0.0039365797107327,0,10729,"sp|P18444|MYCN_CHICK","P18444","MYCN",5.79e-09,"N-myc proto-oncogene protein",NA,"GO:0003677; GO:0003700; GO:0005634; GO:0046983"
"g4714",1517.47892886586,0.269114527877628,0.0671064861280147,4.01026105530627,6.06516519604987e-05,0.00393767784115891,48571,57994,"sp|Q94613|RS19_MYAAR","Q94613","RS19",3.68e-17,"40S ribosomal protein S19","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g70901",59.8508691403938,0.559414791484748,0.139488965413419,4.01045910568444,6.06007963018798e-05,0.00393767784115891,0,4710,"sp|Q54UQ2|PGM2_DICDI","Q54UQ2","PGM2",6.29e-18,"Probable phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2)","glucose metabolic process [GO:0006006]","GO:0000287; GO:0004614; GO:0005737; GO:0006006"
"g93729",77.0132583833838,0.574052002210999,0.143142061994664,4.01036560610954,6.0624800222818e-05,0.00393767784115891,0,7120,"sp|Q90988|SMC2_CHICK","Q90988","SMC2",8.75e-19,"Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII)","cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]","GO:0000785; GO:0000793; GO:0000796; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0016887; GO:0051301"
"g18525",156.127377008492,0.435498238463494,0.108642279795329,4.00855209669687,6.10921626353757e-05,0.00396230680043433,43695,54810,"sp|Q99707|METH_HUMAN","Q99707","METH",1.71e-108,"Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)","axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]","GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732"
"g27170",2051.93012920013,0.533117538565723,0.13301932737934,4.00782013462897,6.12817623313988e-05,0.00397062922673832,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14148",531.490377008034,0.641674069640447,0.16014227359177,4.00689995994552,6.15209050944783e-05,0.00398214186192461,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11173",7904.95864042628,0.274937092482146,0.0686273957394843,4.00622942950992,6.16957244131609e-05,0.00398947212764664,38085,68725,"sp|P47826|RLA0_CHICK","P47826","RLA0",2.85e-31,"60S acidic ribosomal protein P0 (60S ribosomal protein L10E)","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0005634; GO:0022625; GO:0070180"
"g84413",8331.1350968089,0.308194174000006,0.0769441942646853,4.00542467102624,6.19061603705027e-05,0.0039911301978965,6374,8451,"sp|Q5R938|RS15A_PONAB","Q5R938","RS15A",7.19e-19,"40S ribosomal protein S15a","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g84553",187.257478277527,0.839580739555552,0.209605679707868,4.0055247583257,6.18799516319572e-05,0.0039911301978965,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121439",137.777422523508,1.24880349190169,0.311761194105572,4.00564122640232,6.18494666674362e-05,0.0039911301978965,0,2089,"sp|P36624|DHSO_SCHPO","P36624","DHSO",2.12e-07,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase) (Protein tms1)","sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0005829; GO:0006062; GO:0008270; GO:0046526"
"g53296",113.495565874247,0.659716002574616,0.164795270204263,4.0032459776115,6.24792813512745e-05,0.00402007951995345,11465,15846,"sp|P90893|YM9I_CAEEL","P90893","YM9I",6.34e-19,"Putative serine protease F56F10.1 (EC 3.4.-.-)","innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0006508; GO:0008236; GO:0008239; GO:0045087; GO:0045121"
"g153403",52.0122838115784,0.738861182090143,0.184557188215129,4.00342673853964,6.24315404610517e-05,0.00402007951995345,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112623",22.8851699360515,0.751711644294045,0.187788301139139,4.00297377277552,6.25512387667738e-05,0.00402071667997577,0,5191,"sp|Q9CZW5|TOM70_MOUSE","Q9CZW5","TOM70",9.55e-08,"Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70)","activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein import [GO:1904591]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068]","GO:0002218; GO:0002230; GO:0005739; GO:0005742; GO:0006626; GO:0031307; GO:0032728; GO:0042981; GO:0061052; GO:0097068; GO:0098586; GO:1904591"
"g144968",63.9176311517007,0.766056211585754,0.191417741252855,4.00201259596843,6.28059542151808e-05,0.0040330883959011,0,2432,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.04e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g79459",27.0568506384625,1.874076783721,0.468327402187292,4.00163811677098,6.29054581487275e-05,0.00403547856418862,0,9213,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.07e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29962",3745.09627099716,0.350340864939557,0.0875959987377378,3.99950762578182,6.34744026308254e-05,0.00405917132497997,8955,35418,"sp|P29775|ETS4_DROME","P29775","ETS4",4.28e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g99004",1802.8966176997,1.28623410923272,0.321589005433151,3.99962090588353,6.34440291373194e-05,0.00405917132497997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117068",133.507055330636,0.801661573329451,0.200449588521151,3.99931763015249,6.35253765611979e-05,0.00405917132497997,0,4762,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.74e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g147380",137.666551104544,0.511402742181634,0.127866468306188,3.99950627366225,6.34747652541754e-05,0.00405917132497997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14466",44.3696314091927,0.52603235946453,0.131578109506492,3.9978713893786,6.39146605419845e-05,0.00407953532390795,16236,32724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.8e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55445",20.5339477679012,1.47187103750717,0.368182548639797,3.9976664916488,6.39699950471575e-05,0.00407953532390795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87449",88.9072924398304,0.722954198273922,0.180867462308393,3.99714901202753,6.41099470982037e-05,0.00408444031694583,0,8034,"sp|P09010|LAML1_XENLA","P09010","LAML1",3.52e-07,"Lamin-L(I)",NA,"GO:0005637; GO:0005882"
"g29989",3451.23164388931,0.354424810210594,0.0886938037551811,3.99604927519967,6.44083332640797e-05,0.00409941958465571,9085,35022,"sp|P29775|ETS4_DROME","P29775","ETS4",4.19e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g134231",1138.09071542629,0.504274871988068,0.126208819755444,3.99555968406334,6.45415940471321e-05,0.00410386997359748,0,3292,"sp|P54385|DHE3_DROME","P54385","DHE3",2.69e-12,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g2446",523.975679314582,-0.538156420820552,0.134741190385068,-3.99400078982967,6.49676466819484e-05,0.00412691052104263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95442",284.72560835292,0.321619412081119,0.080532583659541,3.99365570389241,6.50623193599327e-05,0.00412887645277975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15788",202.216080546028,0.527412971573821,0.132108085120573,3.99228382647783,6.54399802896329e-05,0.00413814612496912,22859,27134,"sp|Q6XUZ5|IDHC_SHEEP","Q6XUZ5","IDHC",9.23e-35,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287"
"g28423",555.165914084335,0.316662065420496,0.0793151798096144,3.99245221634246,6.53935131843723e-05,0.00413814612496912,33210,36774,"sp|Q5R1W5|SRSF2_PANTR","Q5R1W5","SRSF2",4.56e-08,"Serine/arginine-rich splicing factor 2 (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)","mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000381; GO:0003723; GO:0006397; GO:0008380; GO:0016607"
"g51591",22.0844617586459,1.10861624005054,0.277695751414121,3.99219733973274,6.54638584120715e-05,0.00413814612496912,0,16589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.41e-46,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g143783",165.229919882137,0.579571832487114,0.145151470689246,3.99287606067676,6.52766917194604e-05,0.00413814612496912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18111",766.031791016159,0.262652015400694,0.0658019318504242,3.99155477680708,6.56415219813659e-05,0.00414533248902402,2566,16454,"sp|A2AKG8|FOCAD_MOUSE","A2AKG8","FOCAD",9.63e-27,"Focadhesin","regulation of posttranscriptional gene silencing [GO:0060147]","GO:0005925; GO:0016021; GO:0060147"
"g155933",204.820194467088,0.530483028839793,0.132990896441212,3.98886723103104,6.63895647805074e-05,0.0041884898450082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3349",661.998234714338,-0.466092473151492,0.11687035492813,-3.98811549291622,6.66002406137642e-05,0.00419702493570534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38027",14475.0210186357,0.395110994031683,0.0990780109306889,3.98787773715086,6.66670036389095e-05,0.00419702493570534,187,8981,"sp|P41105|RL28_MOUSE","P41105","RL28",5.23e-07,"60S ribosomal protein L28","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0044297"
"g107642",41.5215804682798,-0.642235518004919,0.16106011119331,-3.98755168642648,6.67586633242828e-05,0.00419702493570534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153671",70.4598844781815,0.495455014894953,0.124253231735932,3.98746179856243,6.67839536479589e-05,0.00419702493570534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5190",2930.72813585346,0.407688095958602,0.102296057983848,3.98537445131046,6.73737935677558e-05,0.00422226416413065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87028",69.8042118618379,-0.665391627964175,0.16695944446753,-3.98534883777467,6.7381061931244e-05,0.00422226416413065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138999",663.649954383671,0.356540474394058,0.0894550534445531,3.98569405153899,6.72831628427195e-05,0.00422226416413065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3028",568.957900002147,-0.599160269204269,0.150376741647866,-3.9843945455828,6.76523912269937e-05,0.00423517042006822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37197",840.607700585124,-0.633603564544955,0.159034175721396,-3.98407173597034,6.77444079051764e-05,0.00423683727934372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108456",2261.62222055394,0.520147263264454,0.13056531047052,3.98380903311906,6.78193785793224e-05,0.00423743586913214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9194",113.057702713198,0.73516435302122,0.184659420152552,3.98119062874714,6.85709273558443e-05,0.00427614638707144,17526,19564,"sp|Q9YH58|FTCD_CHICK","Q9YH58","FTCD",2.68e-17,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005794; GO:0005814; GO:0005829; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0035999"
"g57793",3625.69538543175,-0.376066672217424,0.0944592394877579,-3.98125873399778,6.85512799903161e-05,0.00427614638707144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5934",22372.0664460755,0.360096531818629,0.0904822405030243,3.97974817839079,6.89883066804466e-05,0.00428425879525284,56695,64640,"sp|B4PEU8|RS9_DROYA","B4PEU8","RS9",2.82e-26,"40S ribosomal protein S9","translation [GO:0006412]","GO:0000228; GO:0003735; GO:0005730; GO:0006412; GO:0015935; GO:0019843; GO:0022626"
"g42132",215.029177236643,-0.353152313303826,0.0887372975432203,-3.97975060184609,6.89876034315138e-05,0.00428425879525284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43979",1928.08860363169,0.417704647392326,0.104958595088023,3.97970882748593,6.89997266486344e-05,0.00428425879525284,11206,17974,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.61e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g99034",20.9118268048035,1.72371937313743,0.433118236694066,3.97978941338132,6.89763418533148e-05,0.00428425879525284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111756",158.039538277121,1.11724899732538,0.280744118781028,3.97959893933452,6.90316265992309e-05,0.00428425879525284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154438",55.9231976024885,1.36057147494046,0.341909474113223,3.97933247819247,6.91090368128778e-05,0.00428495868154717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37542",62.4574341349654,0.873556528011199,0.219589301228641,3.97813792895872,6.94570784365794e-05,0.0042947086480684,17028,26464,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.89e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g72549",42.0490140222529,0.682755008448683,0.171623511767828,3.97821371568432,6.94349481822498e-05,0.0042947086480684,0,5100,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.66e-44,"PiggyBac transposable element-derived protein 4",NA,NA
"g120550",30.6148878963406,1.36667408760622,0.343548562614251,3.97811033527964,6.94651376410365e-05,0.0042947086480684,1905,4443,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.48e-58,"PiggyBac transposable element-derived protein 4",NA,NA
"g52019",552.861701572003,1.0103609947116,0.254000635735919,3.97778923577996,6.95589852968667e-05,0.00429641118621533,1429,16384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.44e-53,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g111171",176.583312776548,-0.391567593986835,0.0984588146649875,-3.97696839352748,6.9799438184043e-05,0.00430715714119876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88193",198.030619216967,0.511329971760794,0.128581835634601,3.97668900305541,6.98814604766684e-05,0.00430811557437181,4037,7564,"sp|Q84WW2|6PGL3_ARATH","Q84WW2","6PGL3",1.02e-10,"6-phosphogluconolactonase 3, chloroplastic (6PGL3) (EC 3.1.1.31) (Protein EMBRYO DEFECTIVE 2024)","carbohydrate metabolic process [GO:0005975]; cellular response to redox state [GO:0071461]; defense response to bacterium [GO:0042742]; defense response to oomycetes [GO:0002229]; nitrate assimilation [GO:0042128]; pentose-phosphate shunt, oxidative branch [GO:0009051]","GO:0002229; GO:0005737; GO:0005777; GO:0005975; GO:0009051; GO:0009507; GO:0009536; GO:0009570; GO:0017057; GO:0042128; GO:0042742; GO:0071461"
"g24462",103.036388787576,2.20965744013276,0.555714452454898,3.97624612851345,7.00116646035104e-05,0.00431203971925404,0,41444,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g24529",98.6078310962858,2.17040727587735,0.545878284960977,3.97599123407612,7.00867070247955e-05,0.00431256221107082,0,41334,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g77309",232.803924426866,-1.21716154377858,0.306148494766025,-3.97572277697724,7.01658246464659e-05,0.00431333422800614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92124",19.8205497328598,-1.85385374978386,0.466326696730715,-3.9754398853437,7.02492877298827e-05,0.0043143716586562,0,1050,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.99e-10,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51046",4539.5624062634,-0.651436344958837,0.16387572786311,-3.97518505915043,7.03245509114126e-05,0.00431490400303329,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143634",23.2539068468388,-0.905376893153102,0.227784590549041,-3.97470650218624,7.04660994007452e-05,0.00431949856052269,265,1840,"sp|P0DPW5|TX11A_CORWE","P0DPW5","TX11A",1.47e-06,"U-scoloptoxin(01)-Cw1a (U-SLPTX(01)-Cw1a)",NA,"GO:0005576; GO:0008061; GO:0090729"
"g99410",140.299030959715,1.40825909386443,0.354352669155189,3.97417380041713,7.06239799260583e-05,0.0043250846232033,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23362",1216.25088050315,-0.356939537909363,0.0898248075055133,-3.97373006212626,7.07557491416056e-05,0.00432906256291978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54019",164.806159530141,-0.362169582351212,0.0911509186983769,-3.97329601854754,7.08848644724374e-05,0.00433287077713456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30841",230.615862611389,-0.297971770606381,0.0750069977221534,-3.97258628735082,7.1096469156559e-05,0.00434162459908829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61720",2107.02846723272,1.11375169801839,0.280383386759917,3.97224568434242,7.11982312036574e-05,0.00434162459908829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76888",93.7642793631302,0.538365992429113,0.135535418862679,3.97214246244054,7.12290980326711e-05,0.00434162459908829,5271,9414,"sp|P37227|MDHM_SCHMA","P37227","MDHM",3.72e-19,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37) (Fragment)","tricarboxylic acid cycle [GO:0006099]","GO:0005759; GO:0006099; GO:0030060"
"g16210",311.18574353043,-0.320360589820048,0.0806841329081365,-3.9705525519472,7.17061369001982e-05,0.00434897332154624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73894",81.9730108738619,-0.335865347115094,0.0845811006975151,-3.97092665318035,7.15936199414804e-05,0.00434897332154624,0,10126,"sp|P21329|RTJK_DROFU","P21329","RTJK",7.16e-43,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g83518",733.52928426251,0.303000443691191,0.0763131181379231,3.97048962333801,7.17250801180685e-05,0.00434897332154624,0,8581,"sp|Q5R8D7|PRS7_PONAB","Q5R8D7","PRS7",2.15e-24,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0006511; GO:0016887; GO:0022624; GO:0036402"
"g97485",28.2509883040409,-0.875733622757694,0.220565650223753,-3.97039893505314,7.17523880779241e-05,0.00434897332154624,0,6785,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.6e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g137281",51.3428275035483,0.602318001258577,0.15169166666864,3.97067297423991,7.16698997170962e-05,0.00434897332154624,0,1474,"sp|Q5ZI74|DHX30_CHICK","Q5ZI74","DHX30",9.83e-62,"ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)","central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254]","GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645"
"g145065",1995.46167836962,1.43610316966537,0.361604999430381,3.97146934342058,7.14306939538767e-05,0.00434897332154624,0,425,"sp|P81585|CUPC6_CANPG","P81585","CUPC6",9.99e-06,"Cuticle protein CP434 (CPCP434)",NA,"GO:0042302"
"g83208",462.555611743733,0.979897643303084,0.246826141905421,3.9699913296808,7.1875247257215e-05,0.00435234850050162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44816",1238.89839163216,0.494296338102038,0.124535243647724,3.96912812488863,7.21360890683145e-05,0.0043599940475777,17845,20471,"sp|P11217|PYGM_HUMAN","P11217","PYGM",1.73e-35,"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)","glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]","GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499"
"g46426",34.9709342763886,1.55712693856291,0.39229300761136,3.9692956753018,7.20853890298228e-05,0.0043599940475777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17577",116.948285817288,2.3407651461841,0.589920676898876,3.96793202518202,7.24990047861679e-05,0.00437308128494289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26910",104.976381936036,0.707803299202573,0.178386994619136,3.96779653535711,7.25402232789213e-05,0.00437308128494289,0,4807,"sp|Q8BTV1|TUSC3_MOUSE","Q8BTV1","TUSC3",2.15e-15,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)","cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062"
"g39361",204.110364192069,-0.414545435886109,0.104481774897653,-3.96763393704008,7.25897179342934e-05,0.00437308128494289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87009",244.255297098508,0.72563188983262,0.182892787311722,3.96752600525385,7.26225898260391e-05,0.00437308128494289,0,2227,"sp|P61166|TM258_MOUSE","P61166","TM258",4.59e-19,"Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)","protein N-linked glycosylation [GO:0006487]","GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0032991; GO:0034998; GO:0043227"
"g8169",154.717190040744,0.411104601459407,0.103666109864995,3.96566054224269,7.3192967956505e-05,0.00440098050855141,5737,15834,"sp|Q5ZLS8|INT10_CHICK","Q5ZLS8","INT10",4.83e-07,"Integrator complex subunit 10 (Int10)","snRNA processing [GO:0016180]","GO:0016180; GO:0032039"
"g77100",41.0632873427945,-0.678941755355184,0.171213622395802,-3.96546574889728,7.32527710654308e-05,0.00440098050855141,0,9576,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.48e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g139749",59.3661243439847,0.669964626493032,0.168954913739905,3.96534561595764,7.32896758712664e-05,0.00440098050855141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87527",246.432687641056,0.54614359846964,0.13774981384805,3.96475017434205,7.34728551025994e-05,0.00440789509320622,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47849",568.174486041162,-0.232407389735889,0.0586310109160813,-3.96389873046082,7.3735542252775e-05,0.00441956243217766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46931",131.6305916973,0.461921798342424,0.116543411695503,3.96351704160938,7.3853588876696e-05,0.00442254675054322,9976,13744,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.57e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g10915",457.772854245651,0.595283531477305,0.150232952473385,3.96240319901031,7.41990946475372e-05,0.00443698887256889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97521",288.100886629838,0.544509756875479,0.137428523676033,3.96213058476186,7.42838901324313e-05,0.00443698887256889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122258",69.6263869644896,0.547596636992416,0.138209447713935,3.96207817953102,7.43002010516144e-05,0.00443698887256889,0,3548,"sp|Q1RMG8|RPAC2_BOVIN","Q1RMG8","RPAC2",5.83e-07,"DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (DNA-directed RNA polymerase I subunit D)","transcription, DNA-templated [GO:0006351]","GO:0003677; GO:0003899; GO:0005666; GO:0005736; GO:0006351; GO:0046983"
"g68935",454.806023031114,0.536429897775742,0.135421549494954,3.96118564420747,7.45785197356495e-05,0.00444950831420989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146181",45.1151337544519,2.70054393677947,0.681987667541115,3.95981344723753,7.50083348350167e-05,0.00447103499444824,1014,2326,"sp|O61866|LIPL5_CAEEL","O61866","LIPL5",4.16e-17,"Lipase lipl-5 (EC 3.1.1.-) (Lipase-like 5)","defense response to Gram-negative bacterium [GO:0050829]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; triglyceride catabolic process [GO:0019433]","GO:0005576; GO:0005764; GO:0006629; GO:0016788; GO:0019433; GO:0043202; GO:0050829; GO:0055088"
"g35652",272.748768509971,0.384845933955767,0.0971980360802841,3.95940030761414,7.51382012475029e-05,0.00447465944249031,10178,20854,"sp|Q3KPW1|RNP1B_XENLA","Q3KPW1","RNP1B",1.94e-09,"RNA-binding protein with serine-rich domain 1-B","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607"
"g10302",171.39730278878,0.725252566525662,0.183225796258295,3.95824486145645,7.55025343065559e-05,0.00449222746127151,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147694",57.994682801263,0.588966668003172,0.148818496053987,3.9576173904453,7.57010865468148e-05,0.00449990871617227,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34741",468.679028501229,-0.51603938488701,0.130411043612522,-3.95702212475402,7.58899042765262e-05,0.00450699777065899,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83162",228.370580561551,0.538724168412941,0.136171850622309,3.9562080264824,7.61488566058903e-05,0.00451710931007735,0,4510,"sp|Q18515|C1GLT_CAEEL","Q18515","C1GLT",6.95e-19,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)","O-glycan processing, core 1 [GO:0016267]","GO:0016021; GO:0016263; GO:0016267; GO:0046872"
"g90928",26.8913191479339,1.82507824048545,0.461376212866665,3.95572677911958,7.63023268083534e-05,0.00451710931007735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104075",2227.53533486429,0.513705038081153,0.129867403760781,3.9556118256388,7.63390288230935e-05,0.00451710931007735,1213,5714,"sp|Q08747|UAF30_YEAST","Q08747","UAF30",3.04e-07,"Upstream activation factor subunit UAF30 (Upstream activation factor 30 KDa subunit) (p30)","chromatin organization [GO:0006325]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription initiation from RNA polymerase I promoter [GO:0006361]","GO:0000500; GO:0001165; GO:0001181; GO:0005634; GO:0005730; GO:0006325; GO:0006361; GO:0042790; GO:0045943"
"g160767",67.3141635922331,0.839158585708425,0.212120815737739,3.95604072514006,7.62021760215705e-05,0.00451710931007735,0,1145,"sp|Q28F67|AATM_XENTR","Q28F67","AATM",3.86e-15,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0006103; GO:0006531; GO:0006536; GO:0009058; GO:0016212; GO:0030170"
"g27601",206.080007111038,0.965003277835083,0.243973841473985,3.95535550862728,7.64209250934303e-05,0.00451782937917758,28915,37178,"sp|P37898|AAP1_YEAST","P37898","AAP1",9.3e-09,"Alanine/arginine aminopeptidase (EC 3.4.11.-)","glycogen metabolic process [GO:0005977]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0005634; GO:0005737; GO:0005977; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006"
"g3280",376.748619641245,-0.560966997184908,0.141833221206001,-3.95511709044633,7.64971770490862e-05,0.00451821476074881,109415,118301,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.09e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g1700",429.12306282908,0.428336899859252,0.108348709066147,3.95331798182988,7.70748999518891e-05,0.00454467317983993,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8261",909.391721404955,0.751275456625149,0.190038257809405,3.95328532941311,7.70854231883704e-05,0.00454467317983993,6445,16804,"sp|Q24319|OST48_DROME","Q24319","OST48",1.99e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0012505; GO:0016021; GO:0018279"
"g2210",1000.9054049504,0.632052761104397,0.159892421348019,3.95298761364481,7.71814338489289e-05,0.0045461969485215,67066,76844,"sp|P35434|ATPD_RAT","P35434","ATPD",5.22e-21,"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)","aerobic respiration [GO:0009060]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to resveratrol [GO:1904638]","GO:0000275; GO:0005743; GO:0005753; GO:0006754; GO:0009060; GO:0015986; GO:0033615; GO:0042776; GO:0044877; GO:0045259; GO:0045261; GO:0046034; GO:0046933; GO:1904638"
"g11262",2734.14850964717,-0.5069142807755,0.128259198225623,-3.95226453765741,7.74150903551407e-05,0.00454755752437047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38431",5553.59823264587,0.479048092156997,0.121201071736776,3.95250706361238,7.73366454965917e-05,0.00454755752437047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153730",343.440830969341,0.589926045623631,0.14925462311174,3.95248089020319,7.73451076492026e-05,0.00454755752437047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21036",359.123589139983,0.559573343315945,0.141620481747919,3.95121762339414,7.77545781953479e-05,0.00455923292761193,226,9284,"sp|Q5R4E3|G6PI_PONAB","Q5R4E3","G6PI",2.32e-35,"Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]","GO:0004347; GO:0005125; GO:0005615; GO:0005737; GO:0006094; GO:0006096; GO:0051156"
"g118003",1235.1519477468,0.379902664125055,0.0961480521735826,3.95122579747316,7.77519221043954e-05,0.00455923292761193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g571",4509.22195287225,0.322266892973333,0.0815955112540025,3.94956644085645,7.82928770950273e-05,0.00458611875342124,107645,124308,"sp|P81021|VIGLN_CHICK","P81021","VIGLN",3.62e-14,"Vigilin",NA,"GO:0003729; GO:0005634; GO:0005737; GO:0005844"
"g87843",6381.49746397041,-0.536707128700022,0.135906555101294,-3.94908934524903,7.84490690243212e-05,0.00458611875342124,4016,7980,"sp|Q0V9R3|DI3L2_XENTR","Q0V9R3","DI3L2",0,"DIS3-like exonuclease 2 (EC 3.1.13.-)","cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]","GO:0000175; GO:0000178; GO:0000291; GO:0000932; GO:0003723; GO:0005737; GO:0006402; GO:0007049; GO:0010587; GO:0019827; GO:0034427; GO:0046872; GO:0051301; GO:1990074"
"g116112",108.347203023785,0.382439104200533,0.0968458807627521,3.9489454914186,7.84962217761819e-05,0.00458611875342124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154151",157.683778684732,1.48515305382741,0.376085118775561,3.94898117389673,7.8484523190118e-05,0.00458611875342124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16882",3652.20527427643,-0.446553392918712,0.113090682396089,-3.94863116445529,7.85993458729044e-05,0.0045880066821109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92129",238.529842333736,-0.337091185644409,0.0853977011431179,-3.94730983541909,7.90342487816638e-05,0.00460924039721903,0,7363,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.19e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g57552",617.07179780098,0.910119570382537,0.230594577554487,3.94683855984205,7.91899143187589e-05,0.00461001987282601,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58663",45.6590374582804,-0.420902886573654,0.106638896407113,-3.94699214596879,7.91391519638347e-05,0.00461001987282601,0,13872,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.56e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g72940",118.157086851224,0.759849123946021,0.192540274189082,3.94644251518943,7.93209546593793e-05,0.00461350324528291,0,5322,"sp|P55861|MCM2_XENLA","P55861","MCM2",5.72e-39,"DNA replication licensing factor mcm2 (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0007049; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162; GO:1905775"
"g31851",2743.61298582295,-0.298670098109652,0.0756885803632708,-3.94603910756645,7.94546419307452e-05,0.0046171341835146,0,22596,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.38e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52742",325.410716196162,0.301444622978963,0.0764334470105078,3.9438836630974,8.01725624108176e-05,0.00465467816871335,0,14219,"sp|O65781|GALE2_CYATE","O65781","GALE2",8.09e-21,"UDP-glucose 4-epimerase GEPI48 (EC 5.1.3.2) (Galactowaldenase) (UDP-galactose 4-epimerase)","galactose metabolic process [GO:0006012]","GO:0003978; GO:0006012"
"g13457",251.337620180496,0.304446791778608,0.0772089730299606,3.94315297602092,8.04173231537297e-05,0.00466470870107396,7971,12944,"sp|O08609|MLX_MOUSE","O08609","MLX",9.02e-18,"Max-like protein X (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006913; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837"
"g31823",492.116208548303,0.373594345289161,0.0947580958187933,3.94261136276512,8.05992048399223e-05,0.00467107717280241,28585,32259,"sp|P38040|GBG1_DROME","P38040","GBG1",3.12e-20,"Guanine nucleotide-binding protein subunit gamma-1","apical protein localization [GO:0045176]; asymmetric neuroblast division [GO:0055059]; cell adhesion involved in heart morphogenesis [GO:0061343]; convergent extension involved in gastrulation [GO:0060027]; dorsal closure [GO:0007391]; embryonic heart tube development [GO:0035050]; establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO:0003380]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; mesectoderm development [GO:0048383]; proboscis extension reflex [GO:0007637]; regulation of gastrulation [GO:0010470]; regulation of myosin II filament organization [GO:0043519]","GO:0003015; GO:0003380; GO:0005834; GO:0007186; GO:0007391; GO:0007637; GO:0010470; GO:0031681; GO:0035050; GO:0043519; GO:0045176; GO:0048383; GO:0055059; GO:0060027; GO:0061343"
"g121929",183.761620321043,0.565734924149107,0.143510343029619,3.94211951700473,8.07647107019524e-05,0.00467648605943843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58629",141.937418737699,0.669076100780289,0.16978988125233,3.9406123371154,8.12738787814595e-05,0.00468940250868422,3285,12584,"sp|B8A4W9|LOX3B_DANRE","B8A4W9","LOX3B",1.6e-13,"Lysyl oxidase homolog 3B (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3B)","collagen fibril organization [GO:0030199]; embryonic viscerocranium morphogenesis [GO:0048703]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]","GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0048703; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046"
"g61578",416.114927651994,-0.662997276171424,0.168230237497823,-3.94101135463239,8.11387848481743e-05,0.00468940250868422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76163",1118.66837550252,-0.977687853459466,0.248105928721839,-3.94060657274977,8.12758319590853e-05,0.00468940250868422,7367,9604,"sp|Q9V7U0|RESIL_DROME","Q9V7U0","RESIL",6.45e-06,"Pro-resilin","chitin-based cuticle development [GO:0040003]","GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129"
"g111150",54.6141416764036,0.634761566618043,0.161082372689041,3.9406022895094,8.12772833061037e-05,0.00468940250868422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124594",45.0052319224702,0.980181913025304,0.248762356260091,3.94023407625422,8.14021414880153e-05,0.00469242789451332,2445,4076,"sp|Q9DCG6|PBLD1_MOUSE","Q9DCG6","PBLD1",2.3e-12,"Phenazine biosynthesis-like domain-containing protein 1 (EC 5.1.-.-)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392"
"g129628",21.4884134539815,-0.599921099809978,0.152271492972607,-3.93981229249457,8.15453877773869e-05,0.00469650694245354,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9846",444.233042186355,0.56557448997958,0.143567350938175,3.9394366914462,8.1673150010326e-05,0.00469968775188193,75725,82443,"sp|Q16P20|CISY2_AEDAE","Q16P20","CISY2",3.61e-27,"Probable citrate synthase 2, mitochondrial (EC 2.3.3.16)","carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]","GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101"
"g6015",207.778462348306,0.382927674833507,0.0972340778448243,3.93820441681589,8.2093643164598e-05,0.00470462347644746,82075,86310,"sp|Q6GMK8|GMPAA_DANRE","Q6GMK8","GMPAA",1.04e-22,"Mannose-1-phosphate guanyltransferase alpha-A (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-A) (GTP-mannose-1-phosphate guanylyltransferase subunit alpha-A)","GDP-mannose biosynthetic process [GO:0009298]","GO:0004475; GO:0005525; GO:0005737; GO:0009298"
"g13761",1888.46237757968,-0.394386421368752,0.100150117117442,-3.93795267264912,8.21797979934448e-05,0.00470462347644746,0,21203,"sp|Q96JN8|NEUL4_HUMAN","Q96JN8","NEUL4",2.64e-08,"Neuralized-like protein 4",NA,"GO:0005737; GO:0005814; GO:0061630"
"g22910",47.5378330901766,0.568932942320385,0.144474847714002,3.93793765020349,8.21849418512153e-05,0.00470462347644746,36326,43294,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.77e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g62842",82.3544019977607,2.13975290362021,0.543372799628504,3.93790948881345,8.21945854542701e-05,0.00470462347644746,0,7094,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.93e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g73123",41.7550788071278,-0.749948914132171,0.190408083752423,-3.93864010052897,8.19447400809971e-05,0.00470462347644746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140484",185.854107562473,1.34928954062216,0.342599225266837,3.93839051904234,8.20300079757181e-05,0.00470462347644746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83435",3005.6185891257,0.307676757705582,0.0781488759883562,3.93705928350683,8.24862343232123e-05,0.00471714967387811,3883,7804,"sp|Q90YW0|RL9_ICTPU","Q90YW0","RL9",4.33e-08,"60S ribosomal protein L9","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g39141",98.0138619756198,1.0321625934802,0.262193200490266,3.93664897316251,8.26273341491008e-05,0.00472105190610466,9137,23419,"sp|P22105|TENX_HUMAN","P22105","TENX",5.54e-11,"Tenascin-X (TN-X) (Hexabrachion-like protein)","actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641]","GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0043506; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0098609; GO:0098633; GO:1904028; GO:1905935"
"g6693",1917.58220315932,-0.514302262054708,0.130676327739358,-3.93569570672752,8.29560299053333e-05,0.00473398921303797,100205,105707,"sp|P21329|RTJK_DROFU","P21329","RTJK",7.55e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g28545",4520.50516188356,0.336591219817619,0.0855254318986042,3.93556878165396,8.29998880436333e-05,0.00473398921303797,4391,37325,"sp|P35270|SPRE_HUMAN","P35270","SPRE",3.62e-22,"Sepiapterin reductase (SPR) (EC 1.1.1.153)","nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004033; GO:0004757; GO:0005654; GO:0005829; GO:0006729; GO:0006809; GO:0050661; GO:0070062"
"g58878",1218.36340081809,-0.486124367218188,0.123538209072563,-3.93501225950793,8.31924494963613e-05,0.00474079892719238,30,13090,"sp|Q96MY1|NOL4L_HUMAN","Q96MY1","NOL4L",1.62e-26,"Nucleolar protein 4-like",NA,"GO:0005654; GO:0005829"
"g15640",338.797853599693,-0.675541032617211,0.171777581114376,-3.93264958229567,8.40146671151267e-05,0.0047834466839986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33176",1920.62033446508,0.318808205805872,0.0810793494842824,3.93205184592255,8.42238947625688e-05,0.00478694632750098,3955,8552,"sp|P62282|RS11_RAT","P62282","RS11",2.08e-10,"40S ribosomal protein S11","osteoblast differentiation [GO:0001649]; translation [GO:0006412]","GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627"
"g94747",55.9367410374658,0.523338547287112,0.133093645240242,3.93210770012689,8.42043230936095e-05,0.00478694632750098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70843",10890.2381885074,-1.04366977165106,0.265463303681071,-3.93150298809258,8.44164468546922e-05,0.00479368522441374,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33476",826.072483189925,-0.439144311974119,0.111707614692715,-3.93119406570552,8.45250069001897e-05,0.00479385900113204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109781",17.595345768901,-1.34830647427652,0.342986856605374,-3.93107330007058,8.45674816460716e-05,0.00479385900113204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7179",16176.3218161559,0.322275213549049,0.0819895746684377,3.93068527129597,8.47040926549467e-05,0.00479601886379174,1455,18689,"sp|P82013|VDAC2_MELGA","P82013","VDAC2",7.11e-36,"Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2)",NA,"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930"
"g42673",42.316964650357,0.757103100340316,0.19262040070334,3.93054472722415,8.47536246051509e-05,0.00479601886379174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119755",381.943765842678,0.766760737109643,0.195128418065146,3.92951854328901,8.51161130207336e-05,0.00481232836906841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4100",214.083785345147,-0.845146065864528,0.215111591779156,-3.92887272542801,8.53449918024307e-05,0.00482106194756312,2035,12790,"sp|P42284|LOLA2_DROME","P42284","LOLA2",1.31e-18,"Longitudinals lacking protein, isoforms H/M/V","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0048813"
"g465",828.436918342738,-0.312299401791882,0.0795134674479562,-3.92762901449733,8.57874041159248e-05,0.00482326093521683,98665,103086,"sp|P21328|RTJK_DROME","P21328","RTJK",1.51e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g8469",542.527064290122,0.762002260015778,0.193997391927657,3.92789950650436,8.56910008117902e-05,0.00482326093521683,0,6564,"sp|Q5M9I5|QCR6_RAT","Q5M9I5","QCR6",3.39e-08,"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)","mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]","GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0044877"
"g16211",619.350271085978,-0.303334666936948,0.0772254760169712,-3.92790931933248,8.56875054464258e-05,0.00482326093521683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94613",148.079453666354,0.638328673114926,0.162491739354185,3.92837614793177,8.55213749579543e-05,0.00482326093521683,0,6420,"sp|Q9GZR2|REXO4_HUMAN","Q9GZR2","REXO4",3.01e-19,"RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2)","DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]","GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0006364; GO:0008408; GO:0016607"
"g106693",29.090757766424,0.658427236353256,0.16766284054185,3.92709102521084,8.59794480912357e-05,0.00482326093521683,0,5779,"sp|Q04451|GARS_BOMMO","Q04451","GARS",1.67e-08,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]","GO:0004820; GO:0005524; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983"
"g137538",38.7524617706633,2.27761484655064,0.579942249044565,3.92731319420672,8.59000920890757e-05,0.00482326093521683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152586",132.526031846561,0.854076501790942,0.217477217739133,3.92719987256513,8.59405605187415e-05,0.00482326093521683,0,1747,"sp|Q7N4H8|FUMC_PHOLL","Q7N4H8","FUMC",4.82e-13,"Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent fumarase)","fumarate metabolic process [GO:0006106]; tricarboxylic acid cycle [GO:0006099]","GO:0004333; GO:0006099; GO:0006106; GO:0045239"
"g162389",735.795816087965,-0.6884851959031,0.175284634886406,-3.92781259092833,8.5721966340796e-05,0.00482326093521683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61803",204.414719223462,0.669698317275677,0.1705533167074,3.92662148238727,8.61473909080436e-05,0.00482735709452356,3173,10464,"sp|Q8NDH3|PEPL1_HUMAN","Q8NDH3","PEPL1",3.51e-09,"Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)",NA,"GO:0005634; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g70844",9286.75555066132,-1.0959099195513,0.279108153704745,-3.92647045600328,8.6201474825425e-05,0.00482735709452356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147603",1149.04926086445,0.426707243272198,0.108770569751952,3.92300274095548,8.74521560078243e-05,0.00488894524953836,0,2100,"sp|A7MB16|EIF3B_BOVIN","A7MB16","EIF3B",8.4e-20,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta)","formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]","GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0071541; GO:0075522; GO:0075525"
"g151736",22.7651314650204,6.96550865310422,1.77554904922834,3.92301674579558,8.7447070656109e-05,0.00488894524953836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102341",35.0934134968669,0.505650226581179,0.12893049100912,3.92188242380472,8.78598650822328e-05,0.00490750365368371,44,6238,"sp|O55028|BCKD_MOUSE","O55028","BCKD",4.26e-06,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)","branched-chain amino acid catabolic process [GO:0009083]; isoleucine catabolic process [GO:0006550]; leucine catabolic process [GO:0006552]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; regulation of glucose metabolic process [GO:0010906]; spermatogenesis [GO:0007283]; valine catabolic process [GO:0006574]","GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005947; GO:0006468; GO:0006550; GO:0006552; GO:0006574; GO:0007283; GO:0009083; GO:0010906; GO:0016310; GO:0047323"
"g66025",96.7032990261579,-0.485664816701855,0.12389664543959,-3.91991901781279,8.8578728227268e-05,0.00494339495092969,0,4974,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-11,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27676",2577.84259680219,-0.419609244889376,0.107078167584695,-3.9187189541461,8.90208405709934e-05,0.0049528685636562,9505,35294,"sp|C9J069|AJM1_HUMAN","C9J069","AJM1",1.42e-22,"Apical junction component 1 homolog","cell-cell junction organization [GO:0045216]","GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216"
"g46929",152.283068181442,0.483568702543701,0.123407257452961,3.91847864156631,8.91096236591641e-05,0.0049528685636562,4255,4772,"sp|P51400|RED1_RAT","P51400","RED1",1.77e-11,"Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; brain development [GO:0007420]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0007420; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049"
"g49302",1024.72918577731,-0.522883805684398,0.133443969062693,-3.91837719873831,8.91471266474921e-05,0.0049528685636562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60990",26.0897165252381,1.63014423748425,0.41595919704087,3.91900034686354,8.89169867068892e-05,0.0049528685636562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101642",286.57941304447,3.83078108263035,0.977531968890266,3.91882946496288,8.89800405871047e-05,0.0049528685636562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158585",46.6493098670545,0.570205615429279,0.145526883768889,3.91821497624331,8.92071306126709e-05,0.0049528685636562,0,1295,"sp|Q5PRA2|DHTK1_DANRE","Q5PRA2","DHTK1",9.24e-18,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g6780",1598.70812944099,-0.438203346812849,0.111845967077886,-3.91791817140532,8.931701358947e-05,0.00495472368279326,0,55600,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g10523",100.501068186344,0.42308554137186,0.108001477389789,3.91740512812523,8.95072538668381e-05,0.00496102951222758,46835,78080,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.24e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g135862",190.902495702175,0.538865486259923,0.137565488528673,3.91715605435158,8.95997502442355e-05,0.00496191163895278,0,3162,"sp|P48758|CBR1_MOUSE","P48758","CBR1",3.66e-13,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0006805; GO:0016491; GO:0016655; GO:0032355; GO:0032570; GO:0035003; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:1905344; GO:2000379"
"g12794",24.7107742752652,0.657591170581679,0.16790304333424,3.91649345671853,8.98462532096649e-05,0.00496379472054284,45524,47074,"sp|P28340|DPOD1_HUMAN","P28340","DPOD1",1.05e-20,"DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125)","base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; response to UV [GO:0009411]","GO:0000109; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006287; GO:0006297; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897"
"g54410",2563.42915099911,0.761928012258968,0.194545725938431,3.91644693597689,8.98635841402119e-05,0.00496379472054284,12931,15429,"sp|Q07254|RS10_XENLA","Q07254","RS10",4.99e-16,"40S ribosomal protein S10",NA,"GO:0005737; GO:0005840"
"g95860",242.30743684515,0.41849917530068,0.106851475467879,3.91664385978914,8.97902433500339e-05,0.00496379472054284,0,6976,"sp|Q7ZVF3|SDHA_DANRE","Q7ZVF3","SDHA",1.57e-18,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0050660"
"g82079",31.4523426780422,1.77021004676018,0.452035754728609,3.91608413326281,8.99988517803361e-05,0.00496703203015615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46181",41.4293126055524,-0.585037304871851,0.149433630152684,-3.9150310694727,9.03925670622886e-05,0.00498451540226967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67859",1402.52917669636,-0.35894675958088,0.0917145601871578,-3.91373800243269,9.08782393067779e-05,0.00500278144384372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107373",45.2678821004159,-1.09283316305653,0.279217224153862,-3.91391743961443,9.08106962403994e-05,0.00500278144384372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63143",35.5945301861913,1.03963308085554,0.265653047957475,3.91349953952705,9.09680740489421e-05,0.00500347574011299,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11675",19.2740891826572,0.76158521167783,0.194614860824808,3.91329422866328,9.10454868073602e-05,0.00500348619737853,66946,68244,"sp|E2RDZ6|SIR5_CANLF","E2RDZ6","SIR5",1.65e-28,"NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)","peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]","GO:0005634; GO:0005739; GO:0005829; GO:0008270; GO:0010566; GO:0016740; GO:0034979; GO:0036046; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0061698; GO:0070403"
"g4567",854.289204462698,0.461733690258363,0.118053260830262,3.91123198979017,9.182651609292e-05,0.00502889425892026,0,23243,"sp|Q96HR9|REEP6_HUMAN","Q96HR9","REEP6",1.82e-13,"Receptor expression-enhancing protein 6 (Polyposis locus protein 1-like 1)","detection of light stimulus involved in visual perception [GO:0050908]; endoplasmic reticulum organization [GO:0007029]; regulation of intracellular transport [GO:0032386]","GO:0001917; GO:0005634; GO:0005783; GO:0005789; GO:0007029; GO:0016021; GO:0030665; GO:0032386; GO:0050908"
"g11823",1292.1767120971,-0.373777582536278,0.0955696349540435,-3.91104959976059,9.18958962011573e-05,0.00502889425892026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38810",4833.23237246921,-0.286000261455013,0.0731124872482332,-3.9117840497476,9.16168170712568e-05,0.00502889425892026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64525",161.460179703754,0.529966196086507,0.13549381295885,3.9113682352969,9.17747213784341e-05,0.00502889425892026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138091",40.5101837491974,-0.551658061291853,0.141038540966394,-3.91139937716243,9.17628864480642e-05,0.00502889425892026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113463",232.160109170287,0.473023813072577,0.1209620954022,3.91051272301268,9.2100408476607e-05,0.00503583271428253,0,3911,"sp|P40313|CTRL_HUMAN","P40313","CTRL",1.53e-06,"Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-)","protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0030163"
"g55710",59.6009600459509,0.645537054334914,0.165091659532154,3.91017363423612,9.22297988594764e-05,0.00503865544477407,7605,10694,"sp|B4Q5D5|EFGM_DROSI","B4Q5D5","EFGM",2.36e-18,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005739; GO:0070125"
"g133260",368.533873695305,-0.324046684449041,0.0829213618940887,-3.90787942994629,9.31097480709357e-05,0.00507389395017673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143930",952.704685649479,0.703835068029491,0.180103146976389,3.90795541247129,9.30804782195311e-05,0.00507389395017673,2295,2521,"sp|Q68HB4|PROF_BOMMO","Q68HB4","PROF",1.65e-09,"Profilin",NA,"GO:0003779; GO:0005737; GO:0005856"
"g152626",79.5397925264734,-0.470693076676299,0.120444541664533,-3.90796519436548,9.30767106873059e-05,0.00507389395017673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32047",2572.28304380251,-0.299486242174183,0.0766700620637682,-3.90616929362981,9.37708277305361e-05,0.00510232262589407,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46807",53.4011785745071,1.4261716084569,0.365111837679154,3.9061226212834,9.3788931635205e-05,0.00510232262589407,15065,18248,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.02e-31,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g7387",13420.2759000912,0.386517929929595,0.0989769663962852,3.90513009241008,9.41747096046986e-05,0.00511043715194073,91230,93064,"sp|Q9BMX5|RS6_APLCA","Q9BMX5","RS6",2.64e-29,"40S ribosomal protein S6","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g95551",50.1653760282141,0.532810459043407,0.136436315946403,3.90519529457767,9.41493207874526e-05,0.00511043715194073,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144983",18.6055117720721,1.30622012811302,0.334463931548383,3.90541402197225,9.40641985851137e-05,0.00511043715194073,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34740",9939.29593328874,-0.319564510538348,0.0818430291433053,-3.90460267518689,9.43803163382956e-05,0.00511730864979681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34287",9437.03492161547,-0.605012077687702,0.154966063687414,-3.90415851891346,9.4553793609274e-05,0.00511875575592135,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86473",404.345678192101,2.7758023996902,0.710991314465523,3.90412983002032,9.45650091805883e-05,0.00511875575592135,0,8160,"sp|P28622|GUN4_BACS5","P28622","GUN4",1.59e-10,"Endoglucanase 4 (EC 3.2.1.4) (Cellulase 4) (EG-IV) (Endo-1,4-beta-glucanase 4)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"g29967",657.49861856566,0.44612465356925,0.114284203246958,3.90364233108591,9.47557830710089e-05,0.00511940318872005,0,3974,"sp|P16290|PGAM2_RAT","P16290","PGAM2",7.44e-08,"Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to inorganic substance [GO:0010035]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]","GO:0004082; GO:0004619; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0006941; GO:0007219; GO:0007283; GO:0010035; GO:0016787; GO:0042802; GO:0046538; GO:0046689"
"g112723",29920.087846558,0.348449471961091,0.0892660512504086,3.90349373675803,9.48140050077023e-05,0.00511940318872005,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142290",510.304687088751,0.316456026571314,0.0810676401336133,3.90360476818791,9.47704977023247e-05,0.00511940318872005,0,2480,"sp|P33731|SRP72_CANLF","P33731","SRP72",9.85e-12,"Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"g21235",3364.19561891301,-0.692335046371212,0.177396715021863,-3.90275009481369,9.51058852447261e-05,0.00512235712606944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32486",141.08597763677,1.32198724890705,0.338728574394941,3.90279223200601,9.50893237015912e-05,0.00512235712606944,0,20981,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.84e-09,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g118514",685.342636614132,-0.295009605916366,0.0755857289084021,-3.90298023419039,9.50154647618142e-05,0.00512235712606944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82743",134.621837391032,0.433829760423787,0.11117247870656,3.90231256396542,9.52780128107865e-05,0.00512736568442632,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6376",94.1734820936743,0.456592197362985,0.117061474550252,3.90044802628025,9.60148377217578e-05,0.00515844890589209,32035,39627,"sp|Q9VZU4|NDUS3_DROME","Q9VZU4","NDUS3",7.57e-26,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase (Ubiquinone) 30 kDa subunit)","reactive oxygen species metabolic process [GO:0072593]","GO:0005739; GO:0005747; GO:0008137; GO:0072593"
"g46650",3010.88414917954,-0.46457760203871,0.119106251672117,-3.90053079092463,9.5982017130945e-05,0.00515844890589209,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52654",66.1670904238608,0.453609738048577,0.116322439621671,3.89958927549923,9.63560041362741e-05,0.00517248929246198,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68560",197.64845441702,1.27199715074369,0.326209126875407,3.89933035573684,9.64590927303493e-05,0.00517373675105755,0,8567,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.82e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g58862",189.557978445063,0.643929853619813,0.165154043642086,3.89896510808604,9.66046927260904e-05,0.00517589952147076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83060",30.5042479740861,1.01981334639132,0.261569169638971,3.89882855001189,9.66591826428723e-05,0.00517589952147076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22684",186.940255185985,0.384787735463867,0.0987002982755942,3.89854683508099,9.67716852940753e-05,0.00517764476074238,14995,46652,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.67e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g2956",1293.31839182918,-0.679400850101582,0.174298850724,-3.89790780191319,9.70273411975717e-05,0.00518704003152992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67424",26.2046100473355,0.622031247716339,0.159591812844186,3.89763883642105,9.71351359129338e-05,0.00518852173223967,0,514,"sp|Q9W256|DPOE4_DROME","Q9W256","DPOE4",7.59e-08,"DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4) (Mesoderm-expressed 4)","DNA-dependent DNA replication [GO:0006261]","GO:0005634; GO:0006261; GO:0008622; GO:0046982"
"g138378",222.097527029799,2.92721150913738,0.751292368772933,3.89623484918171,9.76996572656935e-05,0.00521437717727849,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101743",261.447976061439,0.595355799635089,0.152871763636428,3.89447851894358,9.84102118141076e-05,0.005247977657672,1989,3824,"sp|E2RQ08|RPN1_CANLF","E2RQ08","RPN1",7.71e-07,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1)","protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0016021; GO:0018279"
"g102761",105.562485571577,0.592145043857792,0.152070664434393,3.89388082218354,9.86531312913318e-05,0.00525660553927571,0,3175,"sp|Q7SF72|PPIL1_NEUCR","Q7SF72","PPIL1",9.51e-24,"Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase)","protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","GO:0000413; GO:0003755; GO:0005634; GO:0006457"
"g4941",290.502409709903,-0.480500583786933,0.123417140237224,-3.89330511842478,9.88876473892467e-05,0.00525828301815147,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37049",4504.01936888201,0.950470182746934,0.244135600271221,3.89320599572948,9.89280786369922e-05,0.00525828301815147,14135,22831,"sp|P22844|H10B_XENLA","P22844","H10B",1.36e-13,"Histone H1.0-B (H1-SA) (H1D) (Histone H1(0)-2) (Histone H5A) (XlH5A)","chromosome condensation [GO:0030261]; nucleosome assembly [GO:0006334]","GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0030261"
"g114662",855.713257541751,-0.426290172996471,0.109490572535642,-3.89339614474754,9.88505323192403e-05,0.00525828301815147,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6683",4206.62799184195,-0.612302337186882,0.157352673211771,-3.89127381625619,9.97193209749921e-05,0.00527585774781193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17510",1946.41733501649,-0.333506789113579,0.0856882076349028,-3.89209668773296,9.93816211871015e-05,0.00527585774781193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25686",694.077280360749,0.50408583037595,0.129530311118883,3.8916437860888,9.95673545398231e-05,0.00527585774781193,0,15832,"sp|P13697|MAOX_RAT","P13697","MAOX",2.21e-23,"NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1)","malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to hormone [GO:0009725]","GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0006090; GO:0006108; GO:0008948; GO:0009725; GO:0030145; GO:0042802; GO:0050661; GO:0051287; GO:1902031"
"g74703",3144.48858154011,-0.426235608498928,0.109543754936604,-3.89100783285731,9.98287098732492e-05,0.00527585774781193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85508",378.348778759156,0.384384733967358,0.0987811815542666,3.89127491612552,9.97188688754025e-05,0.00527585774781193,0,3294,"sp|Q08163|CAP1_RAT","Q08163","CAP1",6.55e-13,"Adenylyl cyclase-associated protein 1 (CAP 1)","actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]","GO:0000902; GO:0001667; GO:0003779; GO:0005737; GO:0005886; GO:0006898; GO:0008179; GO:0019933; GO:0030036; GO:0030864; GO:0045761"
"g142371",5794.13449675533,0.415688032770184,0.106830901518526,3.89108419812498,9.9797292143863e-05,0.00527585774781193,0,2583,"sp|Q90YP3|RS28_ICTPU","Q90YP3","RS28",3.04e-20,"40S ribosomal protein S28","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556"
"g153086",22.6134398239093,-0.691542965678142,0.177703022157473,-3.89156558668611,9.9599456992085e-05,0.00527585774781193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31638",36.4126586950028,1.473211640887,0.378690075007364,3.89028321077163,0.00010012729444204,0.00528732501123316,0,2914,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.89e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g54991",69.3684135974873,-0.471851784083989,0.121309801572014,-3.88964269967816,0.000100391922348469,0.00528836896319053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80480",44.7265174856916,-0.757751632805799,0.19479880400514,-3.88991932817926,0.000100277552068123,0.00528836896319053,0,3704,"sp|Q29444|MANBA_BOVIN","Q29444","MANBA",1.39e-09,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]","GO:0004567; GO:0005764; GO:0005975; GO:0006516"
"g95547",428.655998911019,0.447508128331096,0.115045590932236,3.88983293236057,0.000100313258650646,0.00528836896319053,0,7018,"sp|Q01205|ODO2_RAT","Q01205","ODO2",6.73e-38,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)","2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; NADH metabolic process [GO:0006734]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]","GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0016746; GO:0031072; GO:0033512; GO:0043231; GO:0045252; GO:0051087; GO:0106077"
"g32544",6455.81898479077,-0.357795038407824,0.0920005508343419,-3.88905321938862,0.000100636050094901,0.00529371777567656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92052",7586.20771874247,2.44344916151781,0.628297059464835,3.88900301968477,0.000100656865705146,0.00529371777567656,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117226",226.625478114502,0.427084754953488,0.109839973710759,3.88824524009928,0.000100971577729242,0.00530596223504522,0,4747,"sp|P53451|TCPD_TAKRU","P53451","TCPD",9.3e-34,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]; response to hypoxia [GO:0001666]","GO:0001666; GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g4957",1807.76382920782,-0.637619479318655,0.164031793811341,-3.88717006930989,0.000101419699051221,0.00531956348077371,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20027",850.024198873535,-0.649998338124119,0.167239100100993,-3.88664096931637,0.000101640911660177,0.00531956348077371,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63846",450.881808111365,-0.421044495595423,0.108312939841486,-3.88729634900144,0.000101366969705486,0.00531956348077371,0,12200,"sp|P62291|ASPM_MACFA","P62291","ASPM",2.05e-60,"Abnormal spindle-like microcephaly-associated protein homolog","cell division [GO:0051301]; spindle organization [GO:0007051]","GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0051301"
"g65103",17.9518434386953,1.41233102951095,0.363347131486866,3.88700200750588,0.000101489915093032,0.00531956348077371,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74862",41.7317646903473,1.54892764951567,0.398508505260581,3.88681202300272,0.000101569345668964,0.00531956348077371,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18680",3188.09950710595,0.293536487660696,0.0755346951660801,3.8861146790265,0.000101861401305849,0.0053268004639305,0,4910,"sp|O61231|RL10_DROME","O61231","RL10",1.06e-23,"60S ribosomal protein L10 (QM protein homolog) (dQM)","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025"
"g2942",1818.05750392619,0.492984224574706,0.126881568773679,3.8853887868777,0.000102166255136887,0.00533843400732608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3519",3489.10173620044,-0.361519930199347,0.0930618522428319,-3.8847274311284,0.000102444755070709,0.00534867285680614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150970",42.0058133983473,1.53344097584867,0.394913336237412,3.88298098630634,0.000103183639432415,0.00538291268095369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57338",5808.41606999449,0.62497669110555,0.160970019271245,3.88256579663088,0.000103360036035733,0.00538777700310799,0,684,"sp|P02553|TBA_LYTPI","P02553","TBA",5.16e-92,"Tubulin alpha chain (Fragment)","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g68559",203.604752211475,1.32152638604602,0.340482806640965,3.881330746429,0.000103886440850549,0.00541086347430034,0,8568,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.82e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g69846",3856.72397149116,0.292126418722878,0.0753228767981448,3.87832264433736,0.000105179164019646,0.00547379403560237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160816",33.09626100099,1.5727731957152,0.405581820749938,3.87781975239196,0.00010539675591991,0.00548071589592193,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58167",788.660494552978,0.369789677880049,0.095369749507919,3.87743157330348,0.000105565004146013,0.00548290073221049,0,7964,"sp|Q80X41|VRK1_MOUSE","Q80X41","VRK1",1.71e-21,"Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0006974; GO:0007049; GO:0007165; GO:0016572; GO:0018105; GO:0019901; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166; GO:0106310; GO:0120187"
"g153210",19.2137132578513,-0.941838744265659,0.242908948478644,-3.87733243326135,0.000105608014967646,0.00548290073221049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62168",14291.496767651,0.329232501842226,0.0849432313532792,3.87591214269854,0.000106226010776073,0.00551056998896247,0,11500,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121789",373.852925203367,0.315353942423407,0.0813717055287179,3.87547416358517,0.000106417271310395,0.00551607540801153,0,1714,"sp|Q9NDJ2|DOM_DROME","Q9NDJ2","DOM",3.63e-14,"Helicase domino (EC 3.6.4.-)","cell cycle [GO:0007049]; chromatin organization [GO:0006325]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]","GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043486; GO:0048477; GO:0048813; GO:0070983; GO:0140658"
"g1963",672.127260154702,-0.435113869176887,0.112298345345672,-3.87462404577325,0.000106789436014291,0.00551770967119138,127990,139924,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.43e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65367",949.608051747198,0.656600045544844,0.169451962491834,3.87484474000404,0.000106692702606698,0.00551770967119138,1352,3254,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g140440",5393.37757044276,-0.34198471863474,0.0882496116187669,-3.87519800214072,0.000106538034888186,0.00551770967119138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144208",83.4663041845433,0.915942600425088,0.236388164454246,3.87473967886566,0.000106738742075711,0.00551770967119138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19638",6986.55045463164,-0.331735315573793,0.0856314852404888,-3.8739876418369,0.000107068844483606,0.00551959157783149,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89998",10818.9615828806,0.447041913663348,0.115396655004767,3.87395902979059,0.000107081422581671,0.00551959157783149,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108045",18.4584593352261,0.843886154283374,0.217830152915194,3.87405574017072,0.000107038913486258,0.00551959157783149,0,5584,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.55e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g141629",26.5090011005501,1.80786098777833,0.466825688280317,3.87266817821892,0.000107650344485835,0.00554450617668576,2107,2716,"sp|P81589|CUC11_CANPG","P81589","CUC11",9.4e-09,"Cuticle protein CP575 (CPCP575)",NA,"GO:0042302"
"g80783",67.02250814811,-0.32400898771967,0.0836747460669608,-3.87224345396139,0.000107838157555954,0.00554536328771663,0,7384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.95e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113078",7081.49481645058,-0.434608626239225,0.112232354225718,-3.87240051442878,0.000107768669419471,0.00554536328771663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101167",169.25368365514,0.717233713263342,0.185258449382495,3.87153037097111,0.000108154178313812,0.0055572035491569,4115,6364,"sp|Q17CS8|KAT_AEDAE","Q17CS8","KAT",5.19e-10,"Kynurenine aminotransferase (EC 2.6.1.-) (EC 2.6.1.63) (EC 2.6.1.7) (AeKAT)","biosynthetic process [GO:0009058]; L-kynurenine catabolic process [GO:0097053]","GO:0005739; GO:0009058; GO:0016212; GO:0030170; GO:0047315; GO:0097053"
"g18450",60.0363678500926,-0.77262554728659,0.199596837992718,-3.87093079758498,0.000108420570443953,0.00556527676627862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24611",68.6998657514415,0.545091219774108,0.140824804081986,3.87070462002393,0.000108521222486749,0.00556527676627862,6265,11173,"sp|P36871|PGM1_HUMAN","P36871","PGM1",4.03e-15,"Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)","carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0006006; GO:0006094; GO:0006096; GO:0070062; GO:1904724; GO:1904813"
"g120176",410.499675654228,0.468404097431335,0.121015970408381,3.870597375294,0.000108568978633127,0.00556527676627862,0,3381,"sp|Q5ZIA5|COPB_CHICK","Q5ZIA5","COPB",1.18e-21,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126"
"g26482",73.7752217048844,0.831907614023613,0.214987405480709,3.86956441547578,0.000109029972643194,0.00558263843687311,6955,20911,"sp|O35567|PUR9_RAT","O35567","PUR9",1.64e-20,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cobalamin metabolic process [GO:0009235]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; ribonucleotide metabolic process [GO:0009259]; tetrahydrofolate biosynthetic process [GO:0046654]","GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006177; GO:0006189; GO:0009116; GO:0009235; GO:0009259; GO:0010035; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0044208; GO:0046452; GO:0046654; GO:0097294; GO:0098761"
"g43453",41.0069227615573,0.809481604940595,0.20920188743961,3.8693800273397,0.000109112456226316,0.00558263843687311,0,5784,"sp|P04323|POL3_DROME","P04323","POL3",1.17e-23,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g155199",176.57686765126,0.4440982634037,0.114776018601241,3.86926004940632,0.000109166158373871,0.00558263843687311,0,1370,"sp|Q9CR62|M2OM_MOUSE","Q9CR62","M2OM",1.06e-26,"Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11)","malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]","GO:0005739; GO:0005743; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015139; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0035435; GO:0071422; GO:0071423"
"g123940",192.648710494383,0.479820725293527,0.124035724809605,3.86840747720105,0.000109548488679407,0.00559777226104482,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g149656",39.1100944309248,0.527034206159131,0.136249279812798,3.86816140887685,0.000109659071078195,0.00559900724378999,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146448",192.752535712339,0.425395965307576,0.109993190140121,3.86747547521499,0.00010996788390965,0.00561035362374643,0,864,"sp|Q9U1M2|TM120_DROME","Q9U1M2","TM120",3.74e-20,"Transmembrane protein 120 homolog","defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]","GO:0016020; GO:0016021; GO:0045089; GO:0050829"
"g9787",507.748700167132,-0.440131610032875,0.113809093242642,-3.86727982354197,0.000110056118132936,0.00561043749975397,66435,70064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.9e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g98203",69.5822792871028,1.26051394456952,0.325964328609319,3.86703032797275,0.000110168731557144,0.00561176306901105,0,4671,"sp|Q8BX37|ACP7_MOUSE","Q8BX37","ACP7",2.55e-08,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)",NA,"GO:0003993; GO:0005576; GO:0046872"
"g22621",8110.31351419202,-0.333247371720675,0.086185427884672,-3.86663244471683,0.000110348546849166,0.00561650698821524,0,35555,"sp|P42325|NCAH_DROME","P42325","NCAH",5.24e-18,"Neurocalcin homolog (DrosNCa)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"g113282",66.7527580612647,0.990914591763383,0.256308474686744,3.8661015519462,0.000110588904318207,0.00562432250980345,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111757",43.4230333406941,1.53618306981452,0.397376059623957,3.86581685687919,0.000110718001098191,0.00562647172169028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113889",154.62826255319,-0.715924611067932,0.185210157424293,-3.86547164056365,0.000110874732337802,0.00563002079338807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54003",90.9306118364487,-0.681995702912506,0.176504022079205,-3.86391026605877,0.000111586227817848,0.00566171218402647,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17203",1431.48523366198,-0.680105382097971,0.176048597623756,-3.86316841643615,0.000111925785108456,0.00566890997289075,50851,57414,"sp|P04323|POL3_DROME","P04323","POL3",5.32e-37,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g21018",38.1699035358208,0.508858873796074,0.131752505367901,3.86223299796202,0.000112355331630471,0.00566890997289075,1805,16342,"sp|Q91821|MELK_XENLA","Q91821","MELK",3.58e-17,"Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]","GO:0004674; GO:0004712; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351; GO:0106310"
"g22702",33.506726825976,0.880645972703948,0.228006274255433,3.86237604899139,0.000112289541670835,0.00566890997289075,10755,14167,"sp|B2RRL2|JERKL_MOUSE","B2RRL2","JERKL",2.63e-30,"Jerky protein homolog-like",NA,"GO:0003677; GO:0005634"
"g34084",465.937129550079,0.667370639593362,0.172764797254207,3.86288555423354,0.00011205551247794,0.00566890997289075,19832,28904,"sp|O88844|IDHC_MOUSE","O88844","IDHC",6.77e-32,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004448; GO:0004450; GO:0005737; GO:0005739; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0014070; GO:0042802; GO:0042803; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0071071"
"g43516",161.082729870996,0.528055712400853,0.136714154066043,3.86248019459464,0.000112241667391903,0.00566890997289075,13602,17634,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.09e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g116616",43.4513278184262,0.556744178807048,0.144156748933306,3.86207501852463,0.000112428029496467,0.00566890997289075,1864,4806,"sp|P0C6T1|CTF8_RAT","P0C6T1","CTF8",1.95e-12,"Chromosome transmission fidelity protein 8 homolog","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005634; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"g125769",73.9968814648254,0.50016620114892,0.129505875313735,3.86211204655571,0.000112410986217632,0.00566890997289075,0,3953,"sp|Q498P2|RT35_DANRE","Q498P2","RT35",8.96e-18,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005763; GO:0032543"
"g155404",23.6576951622263,0.622442764093518,0.161120926496847,3.8632024878885,0.000111910168689354,0.00566890997289075,0,1430,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.31e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g91102",1373.98318891481,0.433253698083332,0.112205862546053,3.86123940632346,0.000112813294242202,0.00567949632776612,7047,7551,"sp|P29522|EF1B2_BOMMO","P29522","EF1B2",9.46e-17,"Elongation factor 1-beta'",NA,"GO:0003746; GO:0005853"
"g158012",661.051644446209,-0.781076820868169,0.202283940687032,-3.86128932536779,0.00011279024379303,0.00567949632776612,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36985",501.073894102892,0.541036162750073,0.140137261442686,3.86075878164172,0.000113035453329885,0.0056862625214311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125355",727.67961077249,0.568713704208024,0.147316572662688,3.86048693591462,0.000113161291191523,0.00568817652457127,0,4009,"sp|O13082|COX6A_CYPCA","O13082","COX6A",5.8e-07,"Cytochrome c oxidase subunit 6A, mitochondrial (Cytochrome c oxidase polypeptide VIa)","oxidative phosphorylation [GO:0006119]","GO:0004129; GO:0005751; GO:0006119; GO:0016021"
"g5291",777.162839790452,-0.47479019938028,0.123012798964128,-3.85968129640506,0.000113534999658802,0.00570253738983933,94026,98654,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.86e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g97236",200.502762960658,-0.395563527789289,0.102504034349167,-3.85900448017344,0.000113849850881302,0.00571392206673292,788,5583,"sp|Q2EI21|RESTA_XENLA","Q2EI21","RESTA",4.86e-16,"RE1-silencing transcription factor A (Neural-restrictive silencer factor A)","negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; response to hypoxia [GO:0001666]","GO:0000381; GO:0001666; GO:0005634; GO:0005737; GO:0045666; GO:0045667; GO:0045892; GO:0046872"
"g11080",1132.42850275305,-0.439319558628287,0.113888167773005,-3.85746445147762,0.000114569335415433,0.00573670088838652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61718",1505.19675798253,1.08781396247238,0.28199483184196,3.85756701768927,0.000114521284621013,0.00573670088838652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104638",50.455826701774,-0.629540193976816,0.16319259703165,-3.85765166697311,0.000114481641967016,0.00573670088838652,0,5986,"sp|Q03650|CRAM_TRYBB","Q03650","CRAM",3.83e-09,"Cysteine-rich, acidic integral membrane protein","endocytosis [GO:0006897]","GO:0005886; GO:0006897; GO:0016021; GO:0020016"
"g1789",2018.44808281184,0.82104842133639,0.212876324391696,3.85692689726099,0.000114821482977856,0.00573982784475181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7501",78.5403857504721,0.439779930408352,0.114056019573185,3.85582393681699,0.000115340482056192,0.00573982784475181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104316",85.2781133960429,2.47165345252695,0.640950013266273,3.85623434178811,0.000115147107682752,0.00573982784475181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124091",308.226053361453,0.374488493073742,0.0971214479217143,3.85587839851401,0.000115314803212192,0.00573982784475181,0,4124,"sp|Q9Y113|NELFB_DROME","Q9Y113","NELFB",2.13e-17,"Negative elongation factor B","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0003723; GO:0005634; GO:0005694; GO:0017053; GO:0032021; GO:0034244; GO:0045944"
"g131253",55.7823955864676,1.42694156450848,0.370061517869734,3.85595771406519,0.000115277415349806,0.00573982784475181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134940",99.7287567501288,-0.502932445756534,0.130433295158533,-3.85585938885661,0.000115323765706748,0.00573982784475181,0,3236,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.88e-41,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g144556",58.4870417259804,0.809085519535059,0.209798203568763,3.85649402984461,0.000115024906011076,0.00573982784475181,0,1950,"sp|Q0IG34|HKT_AEDAE","Q0IG34","HKT",6.48e-11,"3-hydroxykynurenine transaminase (EC 2.6.1.63) (3-hydroxykynurenine transaminase and alanine--glyoxylate aminotransferase) (Ae-HKT/AGT) (Alanine--glyoxylate aminotransferase) (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]; L-kynurenine catabolic process [GO:0097053]","GO:0005777; GO:0008453; GO:0009436; GO:0036137; GO:0047315; GO:0097053"
"g155130",50.8174806564539,0.682790125352737,0.177019975599617,3.8571360268237,0.000114723325600773,0.00573982784475181,0,654,"sp|Q6P286|DHTK1_XENLA","Q6P286","DHTK1",2.19e-18,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g100360",31.3187115361261,1.62603717594016,0.421765826681812,3.855308024201,0.000115584003978227,0.00574312451668807,0,6458,"sp|O75093|SLIT1_HUMAN","O75093","SLIT1",5.08e-07,"Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)","axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]","GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0022028; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048843; GO:0048846; GO:0048853; GO:0050919; GO:0051964"
"g105381",2967.09035430279,-0.59404807977886,0.154080978500118,-3.85542774690003,0.000115527449103813,0.00574312451668807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45291",1036.22438768198,0.760433013660465,0.197260198514165,3.85497439112563,0.000115741744109073,0.00574655542226754,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114187",25.5007328053502,1.46436065692486,0.37999314879149,3.85365015548842,0.000116369840776112,0.00577331630429295,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137707",212.445492565727,0.29760407682283,0.0772342347902384,3.85326633494974,0.00011655249025199,0.00577795371147449,0,2664,"sp|Q14746|COG2_HUMAN","Q14746","COG2",6.7e-11,"Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"g104552",672.201103110767,-0.291493891206279,0.0756569120357134,-3.8528388664433,0.000116756228786133,0.00578362869399074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99346",78.5985605468336,0.527640772947153,0.136961158980476,3.85248472541305,0.000116925272571458,0.00578757768198815,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64959",370.171617497212,0.506142672887141,0.131388852253413,3.85224974726874,0.000117037563132083,0.00578871360917333,0,11564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73023",50.9828916581738,0.656037384430762,0.170337227067058,3.85140345259052,0.000117442830849614,0.00580432748988486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11263",1368.84159242864,-0.397310196099128,0.103180753357011,-3.85062313631705,0.000117817675583213,0.0058095590974605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27855",999.856214442259,-0.289777855869431,0.075253820809718,-3.85067299907794,0.000117793689036811,0.0058095590974605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75217",19.4688535131665,0.909911929779552,0.236288207116192,3.85085629488108,0.000117705553923024,0.0058095590974605,0,3744,"sp|Q10469|MGAT2_HUMAN","Q10469","MGAT2",3.78e-07,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]","GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0042803"
"g34229",1129.630722082,-0.513629110247614,0.133419301427016,-3.84973616826036,0.00011824512316747,0.00581735479528464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59943",121.168803008399,-0.308674694611806,0.080176151456192,-3.84995648962353,0.000118138809611986,0.00581735479528464,0,2061,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.23e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g142178",652.368036371723,0.536421247133538,0.139335123687779,3.84986378836931,0.000118183530554053,0.00581735479528464,0,1754,"sp|P54357|MLC2_DROME","P54357","MLC2",9.62e-17,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"g161562",18.4568766771586,1.72454786619912,0.448024701591798,3.8492249647663,0.000118492146179618,0.0058250846945493,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104011",184.011453710433,1.56985945657603,0.407941952467947,3.84824224887578,0.000118968380188874,0.00583963504361947,0,2914,"sp|P50903|LIPP_CAVPO","P50903","LIPP",4.31e-17,"Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0005576; GO:0016042; GO:0046872; GO:0047376"
"g113371",4844.84457554086,0.27128364947506,0.0704946890912338,3.84828492716617,0.000118947660425959,0.00583963504361947,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65826",790.866398315516,0.445375547701664,0.115740526714172,3.84805184791966,0.000119060858878737,0.00583975036285393,0,11597,"sp|Q9TC96|NDUS2_NEPOL","Q9TC96","NDUS2",7.58e-28,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 (EC 7.1.1.2) (NADH dehydrogenase subunit 7)",NA,"GO:0005739; GO:0008137; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0070469"
"g37753",181.966107568988,1.87035447051748,0.486303900965301,3.84606100589543,0.00012003188909389,0.00587847784585064,5136,15554,"sp|P29957|AMY_PSEHA","P29957","AMY",2.78e-06,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g53127",413.417537388332,0.320310948383473,0.083281999023524,3.84610062365335,0.00012001249298331,0.00587847784585064,6808,15923,"sp|Q9VEX9|SAP18_DROME","Q9VEX9","SAP18",4.66e-11,"Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Bicoid-interacting protein 1) (dSAP18)","heterochromatin assembly [GO:0031507]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]","GO:0000398; GO:0003714; GO:0005634; GO:0005737; GO:0008134; GO:0031507; GO:0045892; GO:0071011; GO:0071013"
"g76872",430.029791050695,-0.468690396791299,0.121877799704894,-3.84557645384271,0.000120269355952554,0.00588565889745756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98004",688.733095170524,-0.346260945333816,0.0900458484033072,-3.84538489529184,0.000120363356128,0.00588581353479357,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5684",1704.15402020347,-0.369977259259022,0.0962253714177808,-3.84490341588494,0.000120599930051623,0.00589293459112732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80973",103.544608587859,0.909409787476293,0.236586639540224,3.84387634586474,0.000121106044659215,0.00591320569073438,0,7681,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.17e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g58313",135.437791807927,0.623255391864149,0.162166117014693,3.84331451808567,0.000121383746089601,0.00592230200330085,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30003",69.2235377072863,0.472161886167771,0.122859211338953,3.84311343872407,0.000121483281829194,0.00592269847972835,25595,30580,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.28e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g24755",162.509541031832,0.270121065042034,0.0703041673342009,3.84217714659752,0.000121947767419285,0.00593216887226272,0,11610,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.76e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g60596",460.902927787817,0.52235357255543,0.135965840292363,3.84180005383874,0.000122135312079985,0.00593216887226272,0,4147,"sp|P50143|TCPG_XENLA","P50143","TCPG",2.18e-13,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g69534",72.8652585831005,0.381779960957822,0.0993691380077781,3.84203756429827,0.000122017156107361,0.00593216887226272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69601",582.578191336455,-0.544976127896376,0.141846936533497,-3.84200139400036,0.000122035143037128,0.00593216887226272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104425",158.845505573931,0.440069036635285,0.114547563290655,3.84180181571078,0.00012213443519232,0.00593216887226272,0,3214,"sp|Q5U526|I4A3A_XENLA","Q5U526","I4A3A",9.42e-11,"Eukaryotic initiation factor 4A-III-A (eIF-4A-III-A) (eIF4A-III-A) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48-A) (ATP-dependent RNA helicase eIF4A-3-A) (DEAD box protein 48-A) (Eukaryotic translation initiation factor 4A isoform 3 A)","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","GO:0000184; GO:0000381; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0016887; GO:0051028"
"g127385",1470.40691636627,0.5437933447281,0.141562115199069,3.84137623235851,0.000122346421510716,0.00593797130257965,1895,3840,"sp|Q24407|ATP5J_DROME","Q24407","ATP5J",2.51e-09,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)","ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0015078; GO:0015986; GO:1902600"
"g22200",428.915323381155,-0.498760582140377,0.129848641386473,-3.84109203465516,0.000122488175668351,0.00593854832180429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31016",3301.38189419812,-0.319057383809526,0.0830678466597127,-3.84092517910744,0.000122571473193417,0.00593854832180429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124349",272.054924610547,0.520796310011431,0.135595738561817,3.84080145537911,0.000122633272955013,0.00593854832180429,0,3302,"sp|Q9QXN5|MIOX_MOUSE","Q9QXN5","MIOX",9.48e-20,"Inositol oxygenase (EC 1.13.99.1) (Aldehyde reductase-like 6) (Myo-inositol oxygenase) (MI oxygenase) (Renal-specific oxidoreductase)","inositol catabolic process [GO:0019310]","GO:0004033; GO:0005737; GO:0008199; GO:0016234; GO:0016491; GO:0016651; GO:0016701; GO:0019310; GO:0050113; GO:0050661"
"g73030",75.2768369990089,1.45514981231933,0.378917886930276,3.84027743875573,0.000122895344062418,0.00594679464364172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2356",178.470874715859,-1.28946537434187,0.335801829180871,-3.8399593518811,0.000123054683041278,0.00594742241094857,34675,73810,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.44e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g65174",28.0893624668627,1.06874715934127,0.278327899917941,3.83988511269034,0.000123091899635486,0.00594742241094857,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86758",20.2654689349736,1.01027843513975,0.263163535500342,3.83897576546442,0.000123548623219758,0.00596504168724127,0,8126,"sp|P49736|MCM2_HUMAN","P49736","MCM2",1.89e-15,"DNA replication licensing factor MCM2 (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)","apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0000781; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0016887; GO:0019899; GO:0030174; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775"
"g43977",252.748231721862,0.487125921323887,0.126961009185141,3.83681513285339,0.000124640225841792,0.00601326444748118,6135,8800,"sp|K7IM66|EIF3D_NASVI","K7IM66","EIF3D",1.04e-11,"Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7)","cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0098808"
"g12309",329.393503875172,-0.621114836127907,0.161904133952548,-3.83631239650711,0.000124895520699222,0.00602109782192311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86925",114.294457466147,1.62322895735894,0.423148097981349,3.83607764067154,0.000125014900954839,0.00602150054412676,2405,7874,"sp|O62839|CATA_PIG","O62839","CATA",3.74e-27,"Catalase (EC 1.11.1.6)","hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]","GO:0004096; GO:0005737; GO:0005739; GO:0005777; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781"
"g122171",37.6272775176278,-1.26670513086117,0.330221078368564,-3.83593057450859,0.000125089743219092,0.00602150054412676,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28665",3931.59821685209,0.331841847649822,0.0865161018996612,3.83560794307032,0.00012525407898636,0.00602493507035131,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124562",22.8265390845758,2.33075795871811,0.607701821321794,3.8353644450967,0.000125378242009924,0.00602643355678712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2181",79.7517584083962,2.59369958569236,0.676363511647196,3.83477159992818,0.000125681027325436,0.00603650912045734,76215,80323,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.57e-17,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121355",26.0953803980562,1.51629103524762,0.395453005389476,3.8343141020113,0.000125915157424398,0.00604327466296224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48652",180.635376879855,-0.353502567246684,0.092228195942625,-3.83291208977565,0.000126635217148309,0.00607333502937854,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88022",73.3613807443239,0.364772740757092,0.095198607709328,3.83170247479732,0.000127259580564155,0.00609876479548322,0,7958,"sp|P21328|RTJK_DROME","P21328","RTJK",2.29e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g23849",31.37889568456,0.4986650017752,0.130185511109993,3.83041858900783,0.000127925453587985,0.00611710251979803,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88617",217.875922702572,1.42409283783578,0.371776197136514,3.8305110676918,0.000127877381019869,0.00611710251979803,2775,7875,"sp|C4N147|FABP1_DORPE","C4N147","FABP1",8.72e-08,"Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)",NA,"GO:0005737; GO:0008289; GO:0016020"
"g152401",552.317476088354,0.627293891058679,0.163762258200301,3.83051563866092,0.000127875005365564,0.00611710251979803,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2139",1505.35389208581,-0.394508755129187,0.103018696527485,-3.82948696136854,0.000128410686252592,0.00612674049658629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22818",2766.09930509617,-0.378312285491839,0.0987854976807304,-3.8296338468074,0.000128334066841759,0.00612674049658629,30855,39686,"sp|Q99816|TS101_HUMAN","Q99816","TS101",6.64e-13,"Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)","autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]","GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007049; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016236; GO:0019076; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397"
"g44071",30413.2901175598,0.276697312448736,0.0722482520651983,3.82981324169668,0.000128240548069091,0.00612674049658629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83754",8358.02816857663,1.18377285586649,0.30916149263045,3.82897897727998,0.000128675996963177,0.0061340994694777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146216",68.0116203794163,2.10829328781641,0.550636531772905,3.82882930238619,0.000128754267876,0.0061340994694777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20777",35.6486344456051,0.543093054435504,0.141851768084802,3.82859559502163,0.000128876572420904,0.00613541495728701,1846,16803,"sp|Q91821|MELK_XENLA","Q91821","MELK",3.7e-17,"Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]","GO:0004674; GO:0004712; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0007049; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351; GO:0106310"
"g7163",343.080411627796,0.351786885490218,0.0918959004376559,3.82810205694515,0.00012913521231142,0.00614292703785787,14875,26275,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.32e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104783",1393.37122563892,-0.989742785464545,0.258558030386914,-3.82793287829221,0.000129223983340797,0.00614292703785787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18893",797.994813679272,-0.3442547886188,0.0899588256127205,-3.82680394362687,0.000129817829246389,0.00616132309264462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53782",1071.61888057949,-0.363137429480756,0.0948968242613694,-3.82665523643432,0.000129896244108971,0.00616132309264462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60274",40.8896089724638,-0.45342948257238,0.118485930572368,-3.8268634966363,0.000129786438831174,0.00616132309264462,0,5284,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.12e-28,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g309",20.245427477936,-0.890589333150892,0.232762977059636,-3.82616404207064,0.000130155573388036,0.00616910758341696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49217",621.082569928535,-0.232845167121971,0.0608642623543949,-3.82564674432726,0.000130429211549274,0.00617755840929246,7415,12494,"sp|P21328|RTJK_DROME","P21328","RTJK",5.12e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g10524",227.889468024002,0.693766037291075,0.181406889212241,3.82436433535547,0.000131109915012252,0.00619844798395921,4159,13604,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",5.16e-30,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g31325",1673.70810614273,-0.534392234131735,0.139748122333335,-3.82396718617138,0.000131321400022332,0.00619844798395921,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57820",542.050098933445,-0.428584314216907,0.112098613368564,-3.82327935500668,0.000131688436099014,0.00619844798395921,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59367",81.304499888993,0.373709236314444,0.0977230439635001,3.82416696366954,0.000131214976812533,0.00619844798395921,0,13634,"sp|Q80W14|PR40B_MOUSE","Q80W14","PR40B",6.2e-10,"Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C)","mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0005685; GO:0016607; GO:0045292; GO:0071004"
"g65016",252.127729304324,0.50299393097571,0.131529498241132,3.8241910575343,0.000131202147294559,0.00619844798395921,777,11544,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.53e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68633",318.9481055226,-0.595147390895527,0.15563880054023,-3.82390116622423,0.000131356587299131,0.00619844798395921,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101782",214.428892243505,0.487506264977259,0.127512649616538,3.82319923900342,0.000131731249886744,0.00619844798395921,3716,6294,"sp|Q68FU3|ETFB_RAT","Q68FU3","ETFB",9.98e-13,"Electron transfer flavoprotein subunit beta (Beta-ETF)","cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0000166; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251"
"g109499",576.540823528687,0.36089864056154,0.0943935233392546,3.82334113395104,0.000131655430542845,0.00619844798395921,152,3654,"sp|Q66HV4|COPB_DANRE","Q66HV4","COPB",4.6e-11,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; notochord development [GO:0030903]; somite development [GO:0061053]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006891; GO:0030126; GO:0030903; GO:0061053"
"g128089",298.544804442316,0.212240067606613,0.05551323682296,3.82323351606174,0.000131712930709119,0.00619844798395921,0,3751,"sp|Q2TL32|UBR4_RAT","Q2TL32","UBR4",2.94e-24,"E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Zinc finger UBR1-type protein 1)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016021; GO:0061630"
"g32490",158.919179260982,1.36013857867285,0.355792279242424,3.82284455854115,0.000131920947834084,0.0062005334065028,20565,29125,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",2.93e-12,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g105771",2394.4622877414,0.503608942854741,0.131739666717733,3.82275859201754,0.00013196696506671,0.0062005334065028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13723",1408.55461219558,-0.389793813618452,0.101990821572797,-3.82185188438973,0.000132453240779297,0.00621887161580652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57411",33.6211906442488,0.903176795910865,0.236352958980051,3.82130521999134,0.000132747237279534,0.0062191552748032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89183",93.5736950921259,0.558261872408611,0.146085616185921,3.82147049780807,0.000132658285968451,0.0062191552748032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109762",384.826311918499,0.597992322687714,0.156475199035433,3.82164283141318,0.00013256559709521,0.0062191552748032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16216",1332.2933448426,-0.352105620733308,0.0921731706556127,-3.82004457727599,0.000133427557396501,0.00624454590009887,37781,60592,"sp|Q16832|DDR2_HUMAN","Q16832","DDR2",6.17e-16,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)","biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of kinase activity [GO:0033673]; negative regulation of necrotic cell death [GO:0060547]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001503; GO:0003416; GO:0004712; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0033673; GO:0033674; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0060547; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901216; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491"
"g106940",1616.44440588267,-0.520862898062876,0.136353541245876,-3.81994404621765,0.000133481951316299,0.00624454590009887,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115939",81.5358913405877,-0.359163443499255,0.09403262411442,-3.81956206031453,0.000133688821408033,0.00624971125937279,0,4266,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.57e-27,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g119460",154.456753585801,1.62123867963313,0.424514365251727,3.81904315221882,0.000133970327663033,0.00625835576082978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144170",51.753938096763,0.566407556569326,0.148323150151144,3.81874006850681,0.000134135008035242,0.00626153427638865,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5623",6788.24806854304,0.545169792071557,0.142814605805889,3.81732518880135,0.000134906308707685,0.00628510371789652,104065,115004,"sp|O01666|ATPG_DROME","O01666","ATPG",1.21e-24,"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)","ATP synthesis coupled proton transport [GO:0015986]","GO:0000275; GO:0005739; GO:0005756; GO:0015986; GO:0046933"
"g6558",4000.00105226926,-0.511776232087309,0.134071806104545,-3.81718011382827,0.000134985629928997,0.00628510371789652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12088",42.3787824724712,-0.563454599867628,0.147608091946334,-3.81723381447463,0.000134956263432124,0.00628510371789652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125713",32.1026750127055,1.60315818109063,0.419993452965075,3.81710278999026,0.000135027925475159,0.00628510371789652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115772",133.930137371424,0.473500239695764,0.124060874184265,3.8166766340247,0.000135261253638217,0.00629144465684208,0,3974,"sp|Q9ESJ4|SPN90_MOUSE","Q9ESJ4","SPN90",2.33e-09,"NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (VIP54) (90 kDa N-WASP-interacting protein) (90 kDa SH3 protein interacting with Nck) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-binding protein) (N-WASP-binding protein)","endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976]","GO:0006897; GO:0008180; GO:0010976; GO:0017124; GO:0071933"
"g78291",76.272139083743,-0.39514954038165,0.103570703788241,-3.81526364047469,0.000136037614024942,0.00631848396094484,0,7944,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.02e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g134631",23373.0729152091,0.277799113803805,0.072809605763287,3.81541845875342,0.000135952345762851,0.00631848396094484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122127",28.9143637718271,0.92724178953385,0.243049929366795,3.81502595762749,0.000136168619124397,0.00632003820840048,1926,4114,"sp|Q9VPP5|RNH2A_DROME","Q9VPP5","RNH2A",2.81e-57,"Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)","DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]","GO:0003723; GO:0004523; GO:0006298; GO:0032299; GO:0043137; GO:0046872"
"g24821",57.0118921777192,-2.72944254645527,0.715617931590299,-3.81410586007774,0.000136676876296918,0.00633455282253664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138965",60.7715832823018,0.589896852417299,0.154656299649273,3.8142439315764,0.000136600492504977,0.00633455282253664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23336",491.401777851687,-0.443258575195815,0.116258297075237,-3.81270486792832,0.000137454210782807,0.00636112805587157,3736,7014,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.38e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g103217",48.9417290079006,0.646369683936955,0.16953771799553,3.81254207959788,0.000137544802776165,0.00636112805587157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134034",93.365043090294,0.615451886777559,0.16142779480784,3.81255215379842,0.00013753919483352,0.00636112805587157,0,3309,"sp|Q3T0V9|DEOC_BOVIN","Q3T0V9","DEOC",1.12e-14,"Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase)","carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]","GO:0004139; GO:0005654; GO:0005737; GO:0009264; GO:0016052; GO:0046121; GO:0046386"
"g107895",115.153823968348,-0.491353271868383,0.12890264078018,-3.81181695653773,0.000137949018725182,0.00637527159077084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82605",601.430732585646,0.321603885702267,0.0843764805289275,3.81153472728705,0.000138106648217774,0.00637800716890538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29100",853.263129068687,-0.458507542750218,0.120309630139681,-3.81106269064151,0.000138370667396945,0.00638564861299877,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116989",27.7508166802264,1.01346672651881,0.265987928057237,3.81019820681758,0.0001388554229417,0.00640345866096908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24124",593.086511297913,-0.444362159887704,0.116634274933496,-3.80987630043636,0.000139036338937044,0.00640375297920756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36658",3161.46900163041,-0.372839745233209,0.0978624347238536,-3.80983516591715,0.000139059473118161,0.00640375297920756,9187,24294,"sp|Q12959|DLG1_HUMAN","Q12959","DLG1",7.16e-15,"Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg)","actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex localization [GO:0031503]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]","GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0004385; GO:0004721; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007015; GO:0007163; GO:0007268; GO:0008022; GO:0008092; GO:0008284; GO:0008360; GO:0009898; GO:0014704; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0019902; GO:0030054; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031503; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0033268; GO:0035748; GO:0042110; GO:0042130; GO:0042383; GO:0042391; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045296; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070062; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099645; GO:1902305; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764; GO:2000134"
"g3418",104.726538400642,1.22627361811156,0.321914610885273,3.80931332920638,0.00013935327064038,0.00640880626567755,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97861",10877.8594925792,0.469127241897063,0.123153494649168,3.8092889140782,0.000139367030826473,0.00640880626567755,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70033",23.2788135451698,1.02365144417344,0.268796418490481,3.80827784061301,0.000139937989582617,0.00642594058045817,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151013",104.98865082959,-0.765124413063589,0.200907654107581,-3.80833879357272,0.000139903506797282,0.00642594058045817,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38947",45.7841910382859,2.02302099351131,0.531348117126938,3.80733633620463,0.000140471642704846,0.00644131574364831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105523",1294.05307621615,0.41634223754534,0.109348946640331,3.80746454663862,0.000140398859312324,0.00644131574364831,0,1344,"sp|Q6DRI1|EI3EA_DANRE","Q6DRI1","EI3EA",1.53e-24,"Eukaryotic translation initiation factor 3 subunit E-A (eIF3e-A) (Eukaryotic translation initiation factor 3 subunit 6-A)","formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540"
"g65622",100980.73306261,0.324804120939207,0.0853221896141414,3.80679542341907,0.000140779103271468,0.0064472610282062,1085,11816,"sp|Q9YIC0|EF1A_ORYLA","Q9YIC0","EF1A",4.09e-128,"Elongation factor 1-alpha (EF-1-alpha)","translation [GO:0006412]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006414"
"g77014",574.796908714573,0.311561157350668,0.0818442213354609,3.80675815918206,0.000140800307979439,0.0064472610282062,0,2217,"sp|P48602|VATA1_DROME","P48602","VATA1",2.57e-51,"V-type proton ATPase catalytic subunit A isoform 1 (V-ATPase subunit A 1) (EC 7.1.2.2) (V-ATPase 69 kDa subunit 1) (Vacuolar proton pump subunit alpha 1)","cellular response to hypoxia [GO:0071456]; proton transmembrane transport [GO:1902600]; vacuolar acidification [GO:0007035]","GO:0000221; GO:0005524; GO:0007035; GO:0033176; GO:0046933; GO:0046961; GO:0071456; GO:1902600"
"g35854",29.5430012070817,0.488795783913576,0.128432444211361,3.80585907957312,0.000141312829812383,0.00645957233821604,6035,25134,"sp|P0CV25|RLR78_PLAVT","P0CV25","RLR78",1.27e-08,"Secreted RxLR effector protein 78",NA,"GO:0005576; GO:0043657"
"g77074",103.840464904783,-0.622111644653455,0.163465723787965,-3.80576202911143,0.000141368258540126,0.00645957233821604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136191",30.192221075654,0.911457354270784,0.239482124465428,3.80595151435766,0.000141260056282857,0.00645957233821604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139221",79.0382046694676,0.506025624433271,0.13298611430437,3.80510120985346,0.000141746219016974,0.00647227820209077,425,2905,"sp|Q1ZXF7|GMDS_DICDI","Q1ZXF7","GMDS",5.05e-26,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; spore germination [GO:0009847]","GO:0005737; GO:0008446; GO:0009847; GO:0019673; GO:0042351"
"g98731",2058.23259184708,0.687741850151902,0.180753367624948,3.80486327413232,0.00014188254099664,0.00647394047802485,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64715",1329.70843001509,-0.362698016899998,0.0953394459678737,-3.80428072785545,0.000142216824247163,0.0064846268074922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68312",298.43102111194,-0.43041776453606,0.113175262757689,-3.80310815321536,0.000142891934595581,0.00650625236700738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103418",388.354749953564,0.704780106702057,0.185308935798759,3.80327102772546,0.000142797979361255,0.00650625236700738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17909",339.850069486014,-0.276505583828177,0.0727131876589613,-3.80268824308791,0.000143134431120154,0.00651271713171919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79838",26.2537237265119,1.09578225631004,0.288202308973683,3.80212865126666,0.000143458195727009,0.00652242484780484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162091",113.127084355792,0.838486440507998,0.22053989407624,3.8019717204459,0.000143549115382367,0.00652242484780484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62198",4367.73080360425,1.36932521378974,0.360180979454956,3.80176992094883,0.000143666109972579,0.00652316626731136,0,7673,"sp|P81580|CUPC1_CANPG","P81580","CUPC1",5.68e-32,"Cuticle protein CP1158 (CPCP1158)",NA,"GO:0042302"
"g73849",98.2149382444602,0.648461393072454,0.1705826926214,3.80144892255676,0.000143852395948943,0.00652564443076554,0,10134,"sp|P79274|ACADL_PIG","P79274","ACADL",4.42e-20,"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)","carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]","GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0033539; GO:0042758; GO:0050660"
"g86219",470.050677181601,0.335546903143507,0.0882709478220479,3.80132887912296,0.000143922119543222,0.00652564443076554,2298,7014,"sp|Q6PA72|LST8_XENLA","Q6PA72","LST8",4.04e-30,"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)","TOR signaling [GO:0031929]","GO:0005737; GO:0031929; GO:0031931; GO:0031932"
"g52266",1150.27341137973,-0.497567081608581,0.130907079210323,-3.80091806042942,0.000144160972038514,0.0065296651785513,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104222",188.091864446315,-0.572975024782921,0.150749983266061,-3.80082977370332,0.000144212351187735,0.0065296651785513,1949,4644,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g19471",1008.29689151863,-0.348720162031799,0.0917785648256583,-3.79958177265274,0.000144940482372004,0.00655347430169521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129485",19.7705213643393,0.730951120725662,0.192374452310586,3.79962677968046,0.000144914163499994,0.00655347430169521,0,3670,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.82e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g894",159.730217977053,0.646158467866881,0.170088983396724,3.79894367620359,0.000145314108251958,0.00655664137602308,34718,46784,"sp|Q6PAY8|HSDL2_XENLA","Q6PAY8","HSDL2",5.93e-19,"Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-)",NA,"GO:0005777; GO:0016491"
"g16066",123.48907363892,0.619450800929314,0.163055851138359,3.79900995030032,0.000145275260483391,0.00655664137602308,26295,37559,"sp|Q3UDW8|HGNAT_MOUSE","Q3UDW8","HGNAT",3.64e-19,"Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259"
"g161408",71.6655839099923,0.573086303849165,0.150840625621838,3.79928352515527,0.000145115003082532,0.00655664137602308,0,1079,"sp|P00349|6PGD_SHEEP","P00349","6PGD",6.28e-11,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)","D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098]","GO:0004616; GO:0005737; GO:0006098; GO:0019521; GO:0050661"
"g43508",136.22819956252,0.950288631647037,0.250166765593815,3.79862060970153,0.000145503619672744,0.00656062354172311,0,16314,"sp|Q9W3Z3|AGT_DROME","Q9W3Z3","AGT",7.06e-18,"Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]","GO:0004760; GO:0005777; GO:0008453; GO:0009436; GO:0019265"
"g109268",95.0334961758391,0.509343102128096,0.134099210222089,3.79825579348711,0.00014571790133315,0.00656571625944282,0,5518,"sp|Q9XYZ5|DDB1_DROME","Q9XYZ5","DDB1",7.27e-24,"DNA damage-binding protein 1 (D-DDB1) (Damage-specific DNA-binding protein 1) (Protein piccolo)","cellular response to DNA damage stimulus [GO:0006974]; defense response to fungus [GO:0050832]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc development [GO:0035220]","GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0006511; GO:0006974; GO:0007307; GO:0016567; GO:0035220; GO:0035861; GO:0043161; GO:0045732; GO:0045879; GO:0050832"
"g51680",741.738634650602,-0.423068837382934,0.111390801952424,-3.79805899560388,0.000145833617618559,0.00656636385431502,7138,16542,"sp|Q9UR07|TF211_SCHPO","Q9UR07","TF211",1.18e-07,"Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872"
"g19639",1890.05905444209,-0.544710579673075,0.143425445268806,-3.79786570404007,0.000145947356429103,0.00656692157299368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21623",94.1342645421097,0.615360739187827,0.162048444045255,3.79738752083283,0.000146229093439423,0.00657195768893649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79369",1704.34081033499,-0.383382005109569,0.100960900209954,-3.7973314848848,0.000146262142321646,0.00657195768893649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70144",33.3055981082982,0.605757945363087,0.159537006979834,3.79697448780431,0.000146472857256545,0.00657231013865882,7184,10880,"sp|P51570|GALK1_HUMAN","P51570","GALK1",5.58e-18,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0061623; GO:0070062"
"g82374",133.052808027409,1.23119876805723,0.324252134558221,3.79704136638817,0.000146433360912026,0.00657231013865882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9784",3324.42079019684,-0.699171037540631,0.184170065672267,-3.79633375808648,0.000146851760395401,0.00658019786396902,26694,38910,"sp|Q92797|SYMPK_HUMAN","Q92797","SYMPK",2.58e-08,"Symplekin","cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]","GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006378; GO:0007155; GO:0016604; GO:0032091; GO:0035307; GO:0097165"
"g75591",163.048957047002,0.578855862327115,0.152475274203594,3.79639167957285,0.000146817469928175,0.00658019786396902,2604,8154,"sp|Q178M1|FEN1_AEDAE","Q178M1","FEN1",1.58e-27,"Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1)","base-excision repair [GO:0006284]; DNA replication, removal of RNA primer [GO:0043137]","GO:0000287; GO:0003677; GO:0005654; GO:0005730; GO:0005739; GO:0006284; GO:0008409; GO:0017108; GO:0043137"
"g33767",239.457234445406,-0.365814693300254,0.0963694674941738,-3.79596051334796,0.000147072908316991,0.00658393314468781,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41024",45.2181513979322,0.947887125437236,0.249716686597535,3.79585016264826,0.00014713835126492,0.00658393314468781,0,17758,"sp|P04323|POL3_DROME","P04323","POL3",8.46e-89,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g9864",1411.1399099377,-0.453325570237342,0.119441463921875,-3.79537855073391,0.000147418347542923,0.00659190958754216,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33790",942.255617672978,-0.325261641752768,0.0857090701978113,-3.79495006773593,0.000147673173049011,0.00659875027680315,5531,10744,"sp|O75564|JERKY_HUMAN","O75564","JERKY",1.27e-15,"Jerky protein homolog","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g110883",43.9715588043451,-0.396955832293621,0.104606440514433,-3.79475518277339,0.000147789211333187,0.00659938412812625,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132828",211.898956665622,0.390774769103461,0.102984137522903,3.79451416987936,0.000147932833818835,0.00660124800387312,0,2878,"sp|Q6ZW76|ANKS3_HUMAN","Q6ZW76","ANKS3",1.6e-09,"Ankyrin repeat and SAM domain-containing protein 3",NA,"GO:0005737; GO:0005929"
"g13526",171.503865090568,0.409438397365333,0.107970914096675,3.79211754194032,0.000149368181725304,0.00666071066657098,42555,54528,"sp|P19826|VINC_CAEEL","P19826","VINC",9.6e-21,"Vinculin (P107B)","cell adhesion [GO:0007155]; positive regulation of ovulation [GO:0060279]","GO:0005200; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0055120; GO:0060279; GO:0097433"
"g22791",677.91183175092,-0.41594392764674,0.109693704140125,-3.79186691622159,0.000149519037175443,0.00666285211534282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69180",49.3684321132606,0.680064993163705,0.179359698157505,3.79162654793557,0.000149663853265169,0.00666472168014439,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52514",385.508634687019,0.782551585513862,0.206399847528882,3.79143490115396,0.000149779410428461,0.0066652866345407,715,16145,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.53e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g117590",536.28834500811,0.533886915398535,0.140821419525675,3.7912337284826,0.000149900801776313,0.00666611026046167,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22402",39.852094322866,1.14260682245591,0.301422934768605,3.79070963307108,0.000150217485857598,0.0066756114960023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38981",1525.71843439295,-0.297113870517947,0.0784016710112265,-3.78963696418413,0.000150867609691897,0.00669531851696374,7215,23857,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.2e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g93349",84.9266904789191,2.41638047735295,0.637625554961144,3.78965438030506,0.000150857032996494,0.00669531851696374,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69723",800.475558161384,0.400197811248256,0.105616284903786,3.78916766115023,0.000151152877322054,0.0067033869817439,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43897",44.0332324461966,0.554562701970816,0.146370716926461,3.78875442858859,0.000151404482639548,0.00670995256064585,10528,20888,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.01e-06,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11677",3475.24967751437,-0.869024592293317,0.229435701023192,-3.78766071896316,0.000152072314745697,0.0067261078638428,0,75131,"sp|Q9GSR1|DPOZ_DROME","Q9GSR1","DPOZ",3.71e-15,"DNA polymerase zeta catalytic subunit (EC 2.7.7.7)","DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in double-strand break repair via homologous recombination [GO:0043150]; double-strand break repair via homologous recombination [GO:0000724]; translesion synthesis [GO:0019985]","GO:0000166; GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0016035; GO:0019985; GO:0043150; GO:0046872; GO:0051536; GO:0071897"
"g12888",725.024460583609,-0.605225717079423,0.159787522145548,-3.78769073424978,0.000152053950106592,0.0067261078638428,64364,69574,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.36e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18717",1948.83620457767,-0.324813551290677,0.0857560152004133,-3.78764743827686,0.000152080441105207,0.0067261078638428,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13522",61.1397287272389,0.523640068372197,0.138312753641908,3.78591311780188,0.000153145179191667,0.00676857816873511,30075,34130,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.4e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g8979",17.3278584451065,-0.608851226165342,0.160870026877443,-3.78474000398587,0.000153869354120861,0.00679494549639788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20586",353.269525169634,-0.473628108086338,0.125151508068991,-3.78443788168534,0.000154056378531762,0.00679494549639788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41090",488.408749398562,0.43071947604318,0.113812556643244,3.78446358421864,0.000154040459429144,0.00679494549639788,18673,21934,"sp|P53596|SUCA_CAEEL","P53596","SUCA",1.35e-32,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)","tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099; GO:0009361"
"g84812",83.3275922331336,0.557030919926726,0.147240884481751,3.78312668989546,0.000154870534905635,0.00682620854975566,0,3104,"sp|O75330|HMMR_HUMAN","O75330","HMMR",6.51e-10,"Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168)",NA,"GO:0005540; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0009986; GO:0015630; GO:0016020"
"g16777",1285.9765967163,0.89517226768548,0.236678124669363,3.78223491898978,0.000155426572885248,0.00684328422819697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34083",947.884914782637,0.646494353740051,0.170932273088956,3.7821667146707,0.000155469176977543,0.00684328422819697,7441,12924,"sp|Q9Z2K9|IDHC_MICME","Q9Z2K9","IDHC",1.25e-17,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287"
"g23351",753.109404549396,0.582549010468053,0.154042370246032,3.78174530512366,0.000155732655946609,0.00685022809012125,34755,40214,"sp|O18373|SPS1_DROME","O18373","SPS1",1.26e-30,"Inactive selenide, water dikinase-like protein (Protein patufet) (dSelD)","cell cycle [GO:0007049]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of reactive oxygen species metabolic process [GO:2000378]","GO:0005524; GO:0005737; GO:0007049; GO:0010637; GO:0016301; GO:2000378"
"g18619",6627.45676928234,-0.488288601796452,0.129142467774132,-3.78100721019566,0.000156195149894989,0.00686236095558476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38584",409.02729647006,0.521737173824723,0.13799102141265,3.78095015518808,0.000156230954620286,0.00686236095558476,0,5901,"sp|Q8UWA5|CAH2_TRIHK","Q8UWA5","CAH2",3.57e-09,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)",NA,"GO:0004089; GO:0005737; GO:0005886; GO:0008270"
"g121908",55.4195047738966,0.621168156080271,0.164302824622549,3.78062980662245,0.000156432132042021,0.00686236095558476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128345",370.777579938121,0.466053709008261,0.123268979894048,3.78078661321641,0.000156333627780042,0.00686236095558476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87800",111.526350854663,0.65604686668471,0.173540278285258,3.78037233296542,0.000156594001016064,0.00686481401071301,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147124",3873.36307670906,0.323415213171165,0.0855720194271229,3.77945051824563,0.000157174822499824,0.00688561749440914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78627",80.9295816934641,0.831155319962257,0.219926700312048,3.77923789509393,0.000157309080589924,0.00688684274233983,0,9339,"sp|P21328|RTJK_DROME","P21328","RTJK",7.44e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g44889",4224.92430096451,-0.399980704385755,0.105861640238695,-3.7783346591257,0.000157880621091064,0.006902536492816,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153663",27.0784825459454,1.0541709995585,0.279003833369507,3.77833876627198,0.000157878017795355,0.006902536492816,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14339",201.792446251925,0.394982910140515,0.104554837886559,3.77775833356527,0.000158246323223363,0.00690920082251441,57155,64115,"sp|P47245|NRDC_RAT","P47245","NRDC",1.38e-17,"Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase)","negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548]","GO:0004222; GO:0005739; GO:0008233; GO:0046872; GO:0051044; GO:0052548; GO:0120163"
"g87030",367.897693242228,0.445516902869042,0.117927334821748,3.77789342515422,0.000158160530625211,0.00690920082251441,7025,8089,"sp|B2RYZ5|ENY2_XENTR","B2RYZ5","ENY2",1.03e-10,"Transcription and mRNA export factor ENY2 (Enhancer of yellow 2 transcription factor homolog)","chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000124; GO:0003682; GO:0003713; GO:0005643; GO:0006325; GO:0006357; GO:0006368; GO:0015031; GO:0016578; GO:0016973; GO:0045893; GO:0070390; GO:0071819"
"g9489",404.163556707641,-0.659105191009964,0.17450498248698,-3.77699926739422,0.000158729198261129,0.0069256167965881,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1884",2441.27352290501,-0.545474907481888,0.144438151774412,-3.7765292672384,0.000159028880559844,0.00692935995838195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151277",86.677099155597,-0.283603979044009,0.0750944430568216,-3.77663069994958,0.000158964159840949,0.00692935995838195,0,1870,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.11e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g106831",71.0701564672494,-0.317229593725907,0.0840041974175897,-3.7763540808436,0.000159140719366103,0.00692957300395692,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29418",391.007258428897,-0.453218373431818,0.120035664487048,-3.7756976259395,0.000159560458136132,0.00694318385763225,9356,19894,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.25e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20610",5461.22789007423,0.389868272697624,0.103277222295105,3.77496861392739,0.00016002781089554,0.00695660835494578,44892,49414,"sp|C4N147|FABP1_DORPE","C4N147","FABP1",7.94e-10,"Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)",NA,"GO:0005737; GO:0008289; GO:0016020"
"g112771",521.872082999579,1.03904143681198,0.275251399893318,3.77488157086465,0.000160083698196165,0.00695660835494578,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42886",5102.65593707019,-0.288071989700716,0.0763184136785725,-3.77460662264259,0.000160260353476808,0.00695961734773645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98690",275.950379523391,0.707048368179082,0.187346362307872,3.77401706373763,0.000160639765904037,0.00696675525583686,0,5752,"sp|P46561|ATPB_CAEEL","P46561","ATPB",1.28e-23,"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2)","dauer larval development [GO:0040024]; defecation [GO:0030421]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; embryonic morphogenesis [GO:0048598]; gonad development [GO:0008406]; inductive cell migration [GO:0040039]; mating behavior [GO:0007617]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of gene expression [GO:0010629]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]","GO:0002119; GO:0005524; GO:0005739; GO:0005753; GO:0005929; GO:0007617; GO:0008340; GO:0008406; GO:0010629; GO:0019904; GO:0030421; GO:0040024; GO:0040039; GO:0042776; GO:0043050; GO:0045261; GO:0046933; GO:0046961; GO:0048598; GO:0050829; GO:0097730"
"g127089",18480.1454477239,0.391869841647602,0.103829447011719,3.77416862870679,0.000160542145170422,0.00696675525583686,0,2244,"sp|Q90YW2|RL7A_ICTPU","Q90YW2","RL7A",4.15e-12,"60S ribosomal protein L7a","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254; GO:1990904"
"g67553",136.865338078802,0.435617295588938,0.115437799547807,3.77361052701401,0.000160901886058208,0.00697345545375884,9925,11473,"sp|Q27HV0|OGT1_PIG","Q27HV0","OGT1",6.16e-31,"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)","apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]","GO:0000123; GO:0005547; GO:0005634; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016262; GO:0016485; GO:0016757; GO:0031397; GO:0031966; GO:0032922; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0048015; GO:0061087; GO:0080182; GO:0097363"
"g50501",2095.88588379264,-0.367550462657108,0.0974243160322672,-3.77267685959812,0.000161505405364765,0.0069949329744647,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65980",2635.49960883459,0.400128060999054,0.106083051297794,3.77183778279361,0.000162049598336265,0.00700445605403712,1999,5244,"sp|Q1HDZ5|EIF3B_BOMMO","Q1HDZ5","EIF3B",7.6e-24,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290"
"g85549",1375.45631778471,0.526028898639409,0.139457172507454,3.77197450071127,0.000161960810845213,0.00700445605403712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87381",409.930415636955,-0.543510813828423,0.144087135391952,-3.77209812902408,0.000161880563430887,0.00700445605403712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63366",64.5123836142217,0.632118723389087,0.167617959133442,3.77118732776035,0.000162472645153221,0.00701806006494178,10375,12469,"sp|Q08BY0|NDUF7_DANRE","Q08BY0","NDUF7",1.22e-20,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)","chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]","GO:0005739; GO:0019918; GO:0032981; GO:0035243; GO:0043009"
"g11642",234.442730933422,0.413425312893609,0.109637337521673,3.77084415071538,0.000162696261225543,0.00702303721091712,4055,7603,"sp|Q9VFS6|INT5_DROME","Q9VFS6","INT5",3.87e-31,"Integrator complex subunit 5 (Protein oocyte maintenance defects)","positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; snRNA 3'-end processing [GO:0034472]","GO:0003677; GO:0005634; GO:0005737; GO:0010628; GO:0016021; GO:0031965; GO:0032039; GO:0034472; GO:0045666"
"g34688",930.634450827101,1.41151196066624,0.374354970918736,3.77051747757517,0.000162909392264691,0.00702755542809994,795,6515,"sp|C6KSS5|LRR2_PLAF7","C6KSS5","LRR2",1.21e-06,"Protein PFF0380w",NA,NA
"g10280",2790.5757993107,-0.901895906106516,0.239235345308873,-3.76991077527483,0.000163305919637967,0.00703061823993541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18045",1451.20214843549,-0.321220945744113,0.0852059076604243,-3.76993749100464,0.000163288439723707,0.00703061823993541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32867",93.271412379374,0.773012616947463,0.205043805909468,3.76998765468082,0.000163255622738925,0.00703061823993541,27081,31680,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.98e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g5389",2731.14373120733,-0.309359116574808,0.0820678677495682,-3.76955226275433,0.000163540662267025,0.00703604922328508,56377,62664,"sp|Q8SX83|SPEN_DROME","Q8SX83","SPEN",1.26e-10,"Protein split ends","axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; wing disc pattern formation [GO:0035222]","GO:0003729; GO:0005634; GO:0006355; GO:0006357; GO:0007173; GO:0007379; GO:0007400; GO:0007403; GO:0007411; GO:0007422; GO:0008586; GO:0035222; GO:0035321; GO:0048106; GO:0048749; GO:0050832; GO:0090263"
"g66425",92.8149101999825,0.59202652523347,0.157105366310494,3.76834056745982,0.000164336393850293,0.00706559254594694,4170,11726,"sp|P21328|RTJK_DROME","P21328","RTJK",1.39e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g56",3064.96422059575,-0.394308424281839,0.104672157134528,-3.76708033039828,0.000165167866921581,0.00709663236170426,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81533",434.943483059612,0.387241794179176,0.102809848110845,3.76658268925432,0.000165497286902204,0.00710607402932705,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26437",284.948558139859,-0.626806106244299,0.166427168418052,-3.76624869726684,0.000165718723742514,0.00710616364490318,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68439",118.289987556109,-0.497581645573708,0.132112108397951,-3.76635912943634,0.000165645476336758,0.00710616364490318,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12176",529.220029709453,0.355590623485844,0.0944579866407712,3.76453740050774,0.000166857693975568,0.00713140538638455,0,40370,"sp|P21328|RTJK_DROME","P21328","RTJK",3.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27803",902.8863206612,-0.417649389920861,0.110937289153703,-3.76473405026338,0.000166726438301521,0.00713140538638455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40887",659.452882570878,0.628176200762145,0.1668610721328,3.76466597471097,0.000166771864953921,0.00713140538638455,0,23388,"sp|Q24251|ATP5H_DROME","Q24251","ATP5H",1.25e-07,"ATP synthase subunit d, mitochondrial (ATPase subunit d)","ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; determination of adult lifespan [GO:0008340]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of TOR signaling [GO:0032007]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]","GO:0000274; GO:0005739; GO:0006979; GO:0008340; GO:0015078; GO:0015986; GO:0032007; GO:0046034; GO:0051881; GO:0070373; GO:1902600"
"g84922",56.3899943415531,1.35650471274968,0.360327801227575,3.76464071916823,0.000166788720877816,0.00713140538638455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153635",205.887117238243,0.46989754360416,0.124818251944712,3.76465409732144,0.000166779791900272,0.00713140538638455,0,1667,"sp|A7RKF6|RTCB_NEMVE","A7RKF6","RTCB",1.27e-26,"RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]","GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0046872; GO:0072669"
"g131071",211.775381176399,0.491350042825252,0.130535841394938,3.76410062994628,0.000167149568276422,0.00713917071676611,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115117",134.200589204804,0.567915044842094,0.150903565176614,3.76343026871113,0.000167598475266891,0.00715362846374684,0,4114,"sp|Q9XYN7|PSB3_DROME","Q9XYN7","PSB3",1.24e-13,"Proteasome subunit beta type-3 (20S proteasome subunit beta-3)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0004298; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161"
"g147708",64.0231122263073,0.91767766068269,0.243875250969294,3.76289786288414,0.000167955808302561,0.00716416108449495,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5191",15934.132467729,0.422507677966159,0.112303776161729,3.76218585346325,0.00016843480549204,0.00717300849162925,55696,65294,"sp|Q90YU6|RL22_ICTPU","Q90YU6","RL22",5.72e-06,"60S ribosomal protein L22","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g10190",143.605978823976,0.586383627297988,0.155863976599091,3.76214979299719,0.000168459098964814,0.00717300849162925,59085,66634,"sp|P91929|NDUAA_DROME","P91929","NDUAA",1.41e-12,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120"
"g10850",7071.23903667792,-0.313591888352437,0.083355631661839,-3.76209599879983,0.000168495345550595,0.00717300849162925,54915,69355,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.73e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147409",21.704352874355,1.51347672277536,0.402351683566365,3.76157671159769,0.000168845619232971,0.00718320039853048,0,2214,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.12e-13,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g138659",89.3839570943792,0.946889255719812,0.251750679273338,3.76121827537049,0.000169087793892903,0.00718878309035619,0,2949,"sp|Q940M2|AGT21_ARATH","Q940M2","AGT21",1.21e-17,"Alanine--glyoxylate aminotransferase 2 homolog 1, mitochondrial (EC 2.6.1.44) (Beta-alanine-pyruvate aminotransferase 1)","photorespiration [GO:0009853]","GO:0000325; GO:0005739; GO:0005886; GO:0008270; GO:0008453; GO:0009853; GO:0030170"
"g115826",766.723746793687,0.593294844578395,0.157774338439082,3.76040140905089,0.000169640924645069,0.00720757011837899,0,4691,"sp|Q9VU02|SMD1_DROME","Q9VU02","SMD1",1.01e-21,"Probable small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0030532; GO:0034715; GO:0034719; GO:0071011; GO:0071013; GO:0097526"
"g8877",244.483954132018,0.690768123036206,0.183708093937436,3.76013984049856,0.000169818401956455,0.00721038251504887,31760,52114,"sp|Q3TDQ1|STT3B_MOUSE","Q3TDQ1","STT3B",1.55e-26,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (B6dom1 antigen) (Source of immunodominant MHC-associated peptides)","co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872"
"g3207",561.388971685805,-0.376657717580308,0.100191294013405,-3.75938569602578,0.000170331075953042,0.00722526765231478,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26504",379.426240391989,1.03621941532382,0.275641863741156,3.75929621596554,0.000170392001801691,0.00722526765231478,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63035",119.091638981803,-0.585942370149984,0.155877192413849,-3.75900002480366,0.00017059382089973,0.00722909446537356,0,12556,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.5e-65,"PiggyBac transposable element-derived protein 4",NA,NA
"g156447",100.552833125281,0.710478904573943,0.18904403131706,3.75827207885948,0.000171090785364483,0.00724541520007906,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2402",1008.22816669326,-0.419350193613419,0.111587348624227,-3.75804424770044,0.000171246603945564,0.00724727707997709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80264",52.065270528984,0.510603034528588,0.135884724140818,3.75761909778356,0.000171537730025333,0.00725485910021633,0,9077,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.46e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84667",498.686804898673,0.525339264363349,0.13981385239437,3.75741927832399,0.000171674719347254,0.00725591656273101,0,7441,"sp|A0A1L5YRA2|TPIS_SCYPA","A0A1L5YRA2","TPIS",5.18e-29,"Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Allergen Scy p 8) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase) (allergen Scy p 8.0101)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]","GO:0004807; GO:0005737; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019863; GO:0042803"
"g85186",146.236457012397,1.18734468333189,0.316037922005668,3.75696902383316,0.000171983775520487,0.00726424039589236,0,4414,"sp|Q6NS09|TM45B_XENLA","Q6NS09","TM45B",5.25e-11,"Transmembrane protein 45B",NA,"GO:0016021"
"g152212",95.6152173124441,0.795859896678915,0.211850398908546,3.75670709509725,0.000172163804948721,0.00726710711012539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132987",935.230328007783,0.423685140003235,0.112800233074767,3.75606617516831,0.000172605071186773,0.00728098982903945,0,2865,"sp|Q6MJP3|GPMA_BDEBA","Q6MJP3","GPMA",3.52e-25,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]","GO:0006094; GO:0006096; GO:0046538"
"g104153",46.4636229379696,0.443088736119129,0.117982006855161,3.75556195329921,0.000172952969700602,0.00728617800117757,0,6039,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.12e-09,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121389",526.982362229945,0.472931746868971,0.125924727690167,3.75567019714031,0.000172878229033427,0.00728617800117757,1905,4313,"sp|Q9XTL9|PYG_DROME","Q9XTL9","PYG",4.66e-35,"Glycogen phosphorylase (EC 2.4.1.1)","defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]","GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499"
"g29301",312.701110740765,0.308658872060739,0.0822010203298366,3.75492750360308,0.000173391658669857,0.00729043850758991,3315,28380,"sp|Q96BP3|PPWD1_HUMAN","Q96BP3","PPWD1",1.78e-23,"Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8) (Spliceosome-associated cyclophilin)","mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]","GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013"
"g57439",951.716739800236,0.285008387972846,0.0758976630521394,3.7551668458758,0.0001732260431517,0.00729043850758991,0,9665,"sp|Q9BUQ8|DDX23_HUMAN","Q9BUQ8","DDX23",0,"Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0016887; GO:0046540; GO:0062176; GO:0070062; GO:0071013"
"g140041",28.5948103820524,1.32819936606477,0.353706754335795,3.7550862396137,0.000173281802919043,0.00729043850758991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132641",294.159477679628,0.438648436827573,0.116858079101597,3.75368515553135,0.000174253710360287,0.00732193298013884,0,2214,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.24e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g24866",17.5237624210471,-3.06925303035703,0.81778008465613,-3.75315208568283,0.000174624836080615,0.00732802267109541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54652",43.6072780311823,0.545516484861141,0.145348386947015,3.75316504241634,0.000174615806734625,0.00732802267109541,0,15335,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.92e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g92203",19.9546849253646,0.850122577015474,0.226536535041019,3.75269524124019,0.000174943484694913,0.00733322611456399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125456",727.894431042786,-0.354062620181221,0.0943500290614378,-3.7526498264316,0.00017497519134962,0.00733322611456399,163,3998,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.44e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g3202",95.7562576289732,-0.367003873523253,0.0978172290053539,-3.75193488156535,0.000175475047660838,0.00734942130774964,128995,138399,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.12e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g23949",687.910177717155,-0.423890186633694,0.112988847221293,-3.75161086300393,0.000175702028349841,0.00734942641889687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38387",588.341825756715,0.390737607118322,0.104151415817953,3.75163029757843,0.000175688406309315,0.00734942641889687,2174,5474,"sp|Q9NQP4|PFD4_HUMAN","Q9NQP4","PFD4",5.23e-23,"Prefoldin subunit 4 (Protein C-1)","negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]","GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907"
"g15100",345.57306160835,0.516396204612585,0.137672038487117,3.75091565642,0.000176189964819483,0.00736033294039249,36305,43009,"sp|Q27640|ALDH_ENCBU","Q27640","ALDH",4.29e-16,"Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g61996",2953.21342976496,-0.406995825173448,0.108502512514571,-3.75102673423155,0.000176111918503928,0.00736033294039249,505,12064,"sp|Q13231|CHIT1_HUMAN","Q13231","CHIT1",3.71e-08,"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724"
"g61165",294.425299446252,-0.395650558687614,0.10549076616812,-3.75057052915008,0.000176432668278405,0.00736097995863663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150064",220.677189866146,0.889844921932787,0.237246038874132,3.75072614976253,0.000176323192477325,0.00736097995863663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126815",79.2884730520202,3.99714745335897,1.06605684658649,3.74946933285764,0.000177209164868582,0.00738861867395755,1415,3887,"sp|P81182|BGBP_PENVA","P81182","BGBP",2.67e-122,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g35977",240.669107237595,-0.401986278589914,0.10722015482631,-3.74916711546546,0.000177422831499963,0.00739029422809871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94097",21.5880741526707,-0.766069468935665,0.204334783192864,-3.74908988555609,0.000177477471623811,0.00739029422809871,1399,3164,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.53e-16,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g51698",19.5759838520448,1.01304871881336,0.270252604944029,3.74852526962014,0.000177877418093935,0.00740159806458676,82,16380,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.94e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g57054",53.0626029505583,0.551557457186182,0.147158021183634,3.7480624756289,0.000178205870707566,0.00740159806458676,0,14404,"sp|Q08824|PARP1_ONCMA","Q08824","PARP1",3.44e-23,"Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (Fragment)","ATP generation from poly-ADP-D-ribose [GO:1990966]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003677; GO:0003950; GO:0005694; GO:0005730; GO:0006281; GO:0006471; GO:0018312; GO:0018424; GO:0030592; GO:0046872; GO:0070212; GO:0070213; GO:1905168; GO:1990404; GO:1990966"
"g93954",972.034039582793,0.643567662767657,0.171703211631474,3.74813992500585,0.000178150863889192,0.00740159806458676,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138479",337.83854066622,0.462298630644612,0.123338454569726,3.74821163648732,0.000178099946527762,0.00740159806458676,0,2693,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.25e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g43824",96.8704168673779,0.400791526220424,0.106951775367028,3.74740414401746,0.000178674082365517,0.0074115427776626,0,13687,"sp|Q9D3U0|PUS10_MOUSE","Q9D3U0","PUS10",5.54e-15,"tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)","primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]","GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029"
"g54642",54.0533734412247,0.4856451843528,0.129592386820684,3.74748236580274,0.000178618389800902,0.0074115427776626,7901,15339,"sp|Q6P3K3|FBX9_DANRE","Q6P3K3","FBX9",4.43e-13,"F-box only protein 9","protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006"
"g87840",134.052141608464,0.862988991332531,0.230311774986275,3.74704676469086,0.000178928738068908,0.00741735747005679,0,1974,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",1.1e-16,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g5067",327.657059340756,-0.383230321422439,0.102285679066605,-3.74666644362691,0.000179200116046391,0.0074230942592348,95255,107896,"sp|Q8TF32|ZN431_HUMAN","Q8TF32","ZN431",3.5e-79,"Zinc finger protein 431","cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872"
"g89323",488.3456687807,0.380347539372453,0.101519900585956,3.74653183442013,0.000179296259097471,0.0074230942592348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g464",418.647591232329,-0.341932637543988,0.0912760541755794,-3.74613737011729,0.000179578279998097,0.00743002266661346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15116",142.343074677894,1.01489667108065,0.270958583041713,3.74557860351822,0.000179978482198405,0.00744182884306398,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30484",23.4542690966537,1.08755750727495,0.290381087808142,3.74527664829712,0.000180195098730524,0.00744603382145845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114580",29.548316725159,0.762895462384024,0.203742202242638,3.74441551130132,0.000180814208042935,0.00746685467286545,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23550",374.234458267331,-0.426229428581531,0.11384151997299,-3.74405953717641,0.000181070717291688,0.00746705241559639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73630",212.537420057668,2.55858843184665,0.683396587835907,3.74392918751448,0.000181164730716551,0.00746705241559639,3116,8914,"sp|P00688|AMYP_MOUSE","P00688","AMYP",2.2e-23,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]","GO:0004556; GO:0005509; GO:0005615; GO:0016052; GO:0016160; GO:0031404"
"g77890",398.682017341989,-0.409507588596556,0.109374990154613,-3.74406971847653,0.000181063376059706,0.00746705241559639,0,6131,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.75e-30,"PiggyBac transposable element-derived protein 4",NA,NA
"g136299",292211.913049045,0.768290882877927,0.205232310809769,3.74351816167026,0.00018146147970833,0.0074697799585399,295,2386,"sp|P49871|ACT_MANSE","P49871","ACT",0,"Actin, muscle",NA,"GO:0005524; GO:0005737; GO:0005856"
"g159410",36.8648448293442,1.27222542626879,0.339837928331786,3.74362400487184,0.000181385020263048,0.0074697799585399,465,1239,"sp|P48987|ATO_DROME","P48987","ATO",1.68e-10,"Protein atonal","antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; insect visual primordium development [GO:0001748]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; R8 cell fate commitment [GO:0007460]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]","GO:0000978; GO:0001746; GO:0001748; GO:0005634; GO:0006357; GO:0007399; GO:0007420; GO:0007423; GO:0007438; GO:0007455; GO:0007460; GO:0007605; GO:0008038; GO:0010608; GO:0016360; GO:0030182; GO:0045165; GO:0045433; GO:0045944; GO:0046982; GO:0048800; GO:0048801"
"g124459",515.222414474683,0.428517115211103,0.114484992330157,3.74299815625899,0.000181837563687917,0.00748050873906742,0,4088,"sp|P50991|TCPD_HUMAN","P50991","TCPD",2.84e-14,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]","GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0042995; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874"
"g89176",41.015446358725,-1.42907605782148,0.381820246576636,-3.74279800674386,0.000181982513214129,0.00748172143317452,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22677",219.555757387924,0.403701299624828,0.107910007028838,3.74109232999071,0.0001832221899337,0.00752509263510451,38695,43923,"sp|Q92665|RT31_HUMAN","Q92665","RT31",2.97e-18,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)","mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543"
"g37427",27.6375998587692,0.603628785446393,0.161360624930094,3.74086792058412,0.00018338587919729,0.00752509263510451,8916,13280,"sp|O70579|PM34_MOUSE","O70579","PM34",4.13e-07,"Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17)","ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; FAD transmembrane transport [GO:0035350]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; NAD transport [GO:0043132]","GO:0005347; GO:0005739; GO:0005777; GO:0005778; GO:0005779; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015866; GO:0015867; GO:0015908; GO:0035349; GO:0035350; GO:0043132; GO:0044610; GO:0051087; GO:0051724; GO:0080121; GO:0080122"
"g134094",26.1635609519318,2.67826652666293,0.715935079741151,3.74093490101263,0.000183337007780046,0.00752509263510451,314,3224,"sp|O42563|CP3AR_ONCMY","O42563","CP3AR",7.86e-14,"Cytochrome P450 3A27 (EC 1.14.14.1) (CYPIIIA27)","progesterone metabolic process [GO:0042448]","GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0020037; GO:0042448; GO:0050649; GO:0070330"
"g15714",198.606049447369,0.371582410976593,0.0993457198018682,3.74029612667424,0.000183803580167651,0.00753745909481179,59275,62016,"sp|Q9VE51|CPSF3_DROME","Q9VE51","CPSF3",6.24e-30,"Cleavage and polyadenylation specificity factor 73 (EC 3.1.27.-)","mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]","GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0006398; GO:0008409; GO:0046872"
"g119583",57.4663848626886,1.28629365895935,0.343923730206858,3.74005497726397,0.000183980010146823,0.00753992207301902,0,3627,"sp|Q5WN23|GCP2_CAEBR","Q5WN23","GCP2",9.1e-07,"Glutamate carboxypeptidase 2 homolog (EC 3.4.17.21) (Glutamate carboxypeptidase II homolog)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0006508; GO:0016021; GO:0046872"
"g66351",457.757847758263,0.566398023000052,0.151473439368833,3.73925636969853,0.000184565425535436,0.00755913250108566,318,2717,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.9e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g15429",4157.61096953291,-0.333578640035811,0.0892199299929593,-3.73883548285831,0.000184874658774831,0.0075670143815525,5482,62314,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.25e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g63894",520.924004261278,0.489356026367184,0.130896121045125,3.73850670638655,0.000185116555604268,0.00757213193640616,3526,12284,"sp|Q5XGB9|AMPL_XENTR","Q5XGB9","AMPL",2.27e-20,"Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)",NA,"GO:0004180; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g62901",263.965527818297,0.355014570544602,0.0949711399248369,3.73813108725,0.000185393280985463,0.00757388830699314,8280,12586,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.23e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g119163",20.7481657229458,0.781883084385887,0.209156606333267,3.73826625939821,0.000185293652470975,0.00757388830699314,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13817",480.169049375048,0.545730329381871,0.146010856105602,3.73760105198736,0.000185784429076834,0.00758508538952444,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7949",327.551160933461,-0.550291727107412,0.147305003300098,-3.73573004839711,0.000187171377654672,0.00763021063998515,0,23731,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.74e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g22199",397.147992915463,-0.37765986349234,0.101096955716296,-3.73562053195896,0.000187252861407944,0.00763021063998515,36085,38734,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.94e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g49229",251.925923675545,-0.560331566972839,0.150002738018654,-3.7354755944732,0.000187360750825188,0.00763021063998515,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50537",1721.42953686061,-0.292228809166655,0.0782207793982053,-3.73594857293585,0.000187008887959044,0.00763021063998515,0,16652,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.05e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g158287",55.8284580747682,0.640850485228257,0.171619518975079,3.73413519077231,0.000188361301049742,0.00766613930836427,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2182",78.778873128381,2.38552302053401,0.639030314698062,3.73303576632536,0.000189185717997937,0.00769485889908371,80375,82558,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.52e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g53929",270.393875230832,0.407686708534806,0.109217002299159,3.73281357254342,0.000189352744175468,0.00769682079884638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25977",1571.07980516863,-0.482228833465029,0.129223771466824,-3.73173471096866,0.000190165711636588,0.00772017979578287,13510,41062,"sp|O75325|LRRN2_HUMAN","O75325","LRRN2",1.26e-23,"Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5)","cell adhesion [GO:0007155]; signal transduction [GO:0007165]","GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023"
"g90145",2507.42421234754,0.193445402340452,0.0518377387097561,3.73174847428374,0.00019015531977464,0.00772017979578287,0,7034,"sp|P30153|2AAA_HUMAN","P30153","2AAA",1.55e-31,"Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)","apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]","GO:0000159; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0043005; GO:0043025; GO:0043409; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0098978; GO:1903538; GO:1990405; GO:2001241"
"g58118",1067.6903451549,0.853643911619515,0.228765443126388,3.73152474409299,0.000190324311353094,0.00772178027896119,0,7760,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.79e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g8553",126.456208780817,0.419223808756974,0.112406437770614,3.72953557706791,0.000191833020457025,0.00773557392836938,31825,66096,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.14e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g17438",96.9909634056895,-0.343183365399801,0.0920027750720545,-3.73014145639659,0.000191372297324656,0.00773557392836938,28145,57559,"sp|Q6GNY1|MIB1_XENLA","Q6GNY1","MIB1",6.37e-37,"E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase mib1)","Notch signaling pathway [GO:0007219]","GO:0004842; GO:0005737; GO:0005815; GO:0007219; GO:0008270"
"g18520",47.0167749790165,0.470554454362511,0.126146536384113,3.73022096246609,0.000191311916512992,0.00773557392836938,31595,39660,"sp|Q9Z2Q4|METH_RAT","Q9Z2Q4","METH",1.14e-31,"Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)","cellular response to methionine [GO:0061431]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; protein methylation [GO:0006479]; tetrahydrofolate metabolic process [GO:0046653]","GO:0005542; GO:0005829; GO:0006479; GO:0006555; GO:0008168; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0016597; GO:0031419; GO:0046653; GO:0050667; GO:0061431"
"g19386",709.10337176742,0.476870775324501,0.127855355170092,3.72976771047328,0.000191656378385052,0.00773557392836938,17705,20644,"sp|P91917|OLA1_CAEEL","P91917","OLA1",2.15e-23,"Obg-like ATPase 1",NA,"GO:0005524; GO:0005525; GO:0005737; GO:0005783; GO:0016887; GO:0043022; GO:0043023; GO:0046872"
"g28388",1622.27671100519,-0.30433604733734,0.0815795605832392,-3.73054286100025,0.000191067633910269,0.00773557392836938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41209",187.603632741726,1.43176671480911,0.38378732379218,3.73062533869517,0.000191005090369953,0.00773557392836938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46996",1466.51248437063,-0.364476069460274,0.0977277980120267,-3.72950252512003,0.000191858183799015,0.00773557392836938,0,4212,"sp|P17133|RU17_DROME","P17133","RU17",1.19e-08,"U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)","mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatogenesis [GO:0007283]","GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0007283; GO:0016607; GO:0017069; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013"
"g83867",272.659856893583,0.456823996564645,0.122469230114858,3.73011242200356,0.000191394351931988,0.00773557392836938,1796,6184,"sp|P26640|SYVC_HUMAN","P26640","SYVC",2.47e-18,"Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)","tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]","GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438"
"g124067",79.5806481022023,0.482536082038233,0.129347563987142,3.73053861367038,0.000191070855217817,0.00773557392836938,0,4127,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.8e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g130115",87.9495772852417,0.532932465756174,0.142879166692929,3.72995222530611,0.000191516080752948,0.00773557392836938,0,1694,"sp|P23685|NAC1_CANLF","P23685","NAC1",3.59e-11,"Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)","calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]","GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0015491; GO:0016020; GO:0030001; GO:0030424; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070588; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:1905060"
"g828",2148.74325006687,-0.259574632715101,0.0696451221125096,-3.72710428012123,0.000193692333702356,0.00780466876714973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59268",70.8517247967267,-0.497902965248864,0.133596750991313,-3.72690923659694,0.000193842222998142,0.00780585404270888,1762,13388,"sp|P0CT39|TF26_SCHPO","P0CT39","TF26",1.46e-64,"Transposon Tf2-6 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g78621",197.788590921626,0.411460984099177,0.110413314036529,3.72655225223157,0.000194116844820672,0.00781205759407812,2455,7480,"sp|Q2TBL4|RPC3_BOVIN","Q2TBL4","RPC3",9.16e-47,"DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"g9901",53.7163332706285,0.43593549217279,0.117022434563637,3.72523007061289,0.000195137164005913,0.00784824473459662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4945",293.699518345044,-0.471236223492304,0.126513756410992,-3.72478248105644,0.000195483706275088,0.00785243383799241,113952,121054,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.51e-25,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g41511",32.4536603407052,1.49841617404167,0.402268752809383,3.72491316707291,0.000195382464050922,0.00785243383799241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29242",94.1516203284313,1.73078356032194,0.464754753477684,3.7240793071416,0.000196029300597205,0.00786882160933936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92703",103.148191259538,0.360932338891389,0.0969220679251725,3.72394385115722,0.000196134565448167,0.00786882160933936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3890",129.392494905603,-0.453267957000271,0.121730096693569,-3.72354881259385,0.000196441859166315,0.00787627313178405,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130071",106.943544929319,-0.654648056029324,0.175835687742407,-3.72306705444436,0.000196817222816682,0.00788644299193646,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15386",285.772720920522,0.230567877087555,0.0619379434802427,3.72256268342365,0.000197210927438731,0.0078973347475511,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28608",465.402902875038,-0.494555062883694,0.13286276530995,-3.7222999365546,0.000197416316826121,0.00790067660044152,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31294",40.7597762791546,0.832692786068041,0.223770265861765,3.72119496243723,0.000198282277703842,0.00791577548938078,30895,33579,"sp|P28474|ADHX_MOUSE","P28474","ADHX",1.03e-09,"Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 2) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase B2) (ADH-B2) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)","ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]","GO:0001523; GO:0003016; GO:0004022; GO:0004024; GO:0005504; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006068; GO:0006069; GO:0008270; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0106321; GO:0106322"
"g71414",65.7014614878093,0.549592833500859,0.147679865369177,3.72151499547324,0.000198031103492004,0.00791577548938078,0,7100,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",5.41e-63,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g112270",40.0365250407511,0.761924162191991,0.204750494857558,3.72123233558996,0.000198252930389977,0.00791577548938078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162839",38.3186326574154,-0.666632820799684,0.17913441898588,-3.72141113122559,0.000198112587355075,0.00791577548938078,0,1007,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.81e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g12015",155.840883907846,1.00520117826096,0.270189318280742,3.72035869018514,0.000198940030009624,0.00791764211573316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58128",788.014373101143,0.344680609940866,0.0926379554305764,3.72072773345232,0.000198649514490749,0.00791764211573316,0,7964,"sp|Q80X41|VRK1_MOUSE","Q80X41","VRK1",1.71e-21,"Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0006974; GO:0007049; GO:0007165; GO:0016572; GO:0018105; GO:0019901; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166; GO:0106310; GO:0120187"
"g70052",307.561259851328,0.423563358633746,0.113834219877716,3.7208790035962,0.000198530547941407,0.00791764211573316,425,10902,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.04e-52,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g144034",42.8022556417279,0.823990437235228,0.221465073148211,3.72063380253098,0.000198723420258668,0.00791764211573316,1618,2214,"sp|P84239|H3_URECA","P84239","H3",1.23e-94,"Histone H3",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g151741",20.4914942368001,2.08056915104782,0.559218174882002,3.72049630090586,0.000198831654471946,0.00791764211573316,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80998",63.2908031421745,0.668070540696563,0.179583682300227,3.72010715082502,0.000199138273682978,0.00792066676902468,0,8000,"sp|Q55F21|AATM_DICDI","Q55F21","AATM",2.53e-13,"Aspartate aminotransferase, mitochondrial (EC 2.6.1.1) (EC 2.6.1.7) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0016212; GO:0030170"
"g29175",67.3313500682917,0.541642071082248,0.145620838814826,3.71953681554471,0.000199588455125005,0.00792210776471978,0,31231,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.66e-07,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g33181",12210.7121133838,0.326159589189809,0.087732364301499,3.71766555918791,0.00020107221371519,0.00792210776471978,19796,30084,"sp|P62282|RS11_RAT","P62282","RS11",4.18e-23,"40S ribosomal protein S11","osteoblast differentiation [GO:0001649]; translation [GO:0006412]","GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627"
"g34124",25.6735623149796,-0.808785076485186,0.21742940395507,-3.71975943351395,0.000199412622943215,0.00792210776471978,15937,20004,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.33e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34717",3587.06728694691,-0.395918649908281,0.106478870627673,-3.71828370806728,0.000200580928042883,0.00792210776471978,10483,27114,"sp|Q8WVB3|HEXD_HUMAN","Q8WVB3","HEXD",7.1e-91,"Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)","carbohydrate metabolic process [GO:0005975]","GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561"
"g35413",20.160590384477,1.09150516223947,0.293532865268218,3.71851091100855,0.000200400637746291,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38125",1343.33204199611,-0.479495982884837,0.128982893257134,-3.71751610447237,0.000201191165302694,0.00792210776471978,0,17289,"sp|Q15375|EPHA7_HUMAN","Q15375","EPHA7",2.22e-14,"Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11)","apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006915; GO:0007169; GO:0007411; GO:0007420; GO:0008046; GO:0016310; GO:0019838; GO:0022407; GO:0030425; GO:0031290; GO:0031594; GO:0031952; GO:0033674; GO:0043005; GO:0043025; GO:0043235; GO:0043281; GO:0043525; GO:0045499; GO:0046875; GO:0048013; GO:0048671; GO:0048755; GO:0050730; GO:0050919; GO:0051964; GO:0070372; GO:0072178; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0099175"
"g39531",612.551600675368,0.365369517642018,0.0982844621019018,3.71746977933502,0.000201228049078642,0.00792210776471978,0,4899,"sp|A0A1L8EXB5|AR1AB_XENLA","A0A1L8EXB5","AR1AB",9.19e-26,"Actin-related protein 2/3 complex subunit 1A-B","Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030833; GO:0034314; GO:0035861"
"g61291",4303.95982336368,1.62307835745115,0.436385648660431,3.719366946263,0.000199722722346537,0.00792210776471978,6547,10634,"sp|P02515|HSP22_DROME","P02515","HSP22",2.06e-07,"Heat shock protein 22","chaperone-mediated protein folding [GO:0061077]; determination of adult lifespan [GO:0008340]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]","GO:0005759; GO:0006979; GO:0008340; GO:0009408; GO:0042802; GO:0051082; GO:0061077"
"g72123",23.3339487322587,0.561587973037874,0.151069857290195,3.71740586183981,0.000201278950205801,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85285",71.750692424078,0.679828526304229,0.182801410470736,3.71894573763729,0.000200056018129284,0.00792210776471978,5286,8325,"sp|A0A0R4IC37|CPSF1_DANRE","A0A0R4IC37","CPSF1",3.97e-29,"Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"g90814",274.974220076247,0.326589752162972,0.0878462296404347,3.71774353321416,0.000201010180116192,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94098",38.0291045600707,-0.803009295093743,0.215958551402983,-3.71834914559744,0.000200528986373149,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121790",60.6371223775787,0.484749001133378,0.130372838069021,3.71817480015849,0.000200667402769311,0.00792210776471978,2365,4328,"sp|Q7TT47|SPG7_RAT","Q7TT47","SPG7",7.79e-15,"Paraplegin (EC 3.4.24.-)","anterograde axonal transport [GO:0008089]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; regulation of mitochondrial membrane permeability [GO:0046902]","GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0007005; GO:0008089; GO:0008270; GO:0016887; GO:0034982; GO:0046902; GO:0065003; GO:1902686; GO:1904115"
"g137887",301.131583220104,-0.816456276411231,0.219574938852084,-3.71834910067416,0.000200529022027095,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141588",1772.03515100623,-0.263589226296636,0.0708961021281046,-3.71796499926537,0.000200834086970817,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143857",28.1324272116582,0.799795804825367,0.215025329082641,3.71954228944806,0.000199584129880642,0.00792210776471978,0,2527,"sp|Q642M9|DHDH_DANRE","Q642M9","DHDH",4.79e-09,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)",NA,"GO:0000166; GO:0047115; GO:0047837"
"g143902",248.968320912746,1.20854291780665,0.325114419781488,3.71728488271583,0.000201375325860718,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146288",9337.24350036606,0.987340911915442,0.265603546787157,3.71734837075295,0.000201324743952204,0.00792210776471978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2183",205.997430920547,2.3957572904449,0.64467708915389,3.71621286183635,0.000202231226478541,0.00795095136967481,82573,86314,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.47e-26,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g6744",320.783115292958,-0.314829236789796,0.0847334291253101,-3.71552573806736,0.000202781621524499,0.00795462494393349,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50451",1785.65368781364,0.614859183080015,0.165470356128323,3.7158267950012,0.000202540298035437,0.00795462494393349,13735,14784,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",7.59e-33,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g60496",18.2043233302138,0.910406958348882,0.245014813459411,3.71572210469511,0.000202624185867777,0.00795462494393349,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148724",869.176876418405,-0.375284916032041,0.101005682435202,-3.7154831984111,0.000202815742555185,0.00795462494393349,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4117",10009.8506216406,-0.489939378401524,0.131880769392103,-3.71501759248046,0.000203189557518882,0.00795700197818756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27224",20.6698248265619,1.57845089515753,0.424891685112786,3.71494889277142,0.000203244768322202,0.00795700197818756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148584",124.380957523256,2.69983099759956,0.726708344837056,3.71515067465603,0.000203082645560714,0.00795700197818756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22433",468.52047832039,0.325388769080165,0.0876146946686238,3.7138606749798,0.000204121200823486,0.00798648850540827,0,15620,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.4e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g27277",1257.18710146022,-0.308950044695646,0.0831996825438911,-3.71335605196165,0.000204528819522111,0.00799760760609301,0,35824,"sp|P21328|RTJK_DROME","P21328","RTJK",8.05e-32,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g138966",60.6791848633566,0.499213631105451,0.134476731824938,3.71226772342539,0.000205410541550621,0.00802724078328671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123064",143.223612090606,0.629351540443997,0.169549631920601,3.71190154360652,0.000205708008271367,0.00803401987940125,0,4214,"sp|B5DFC9|NID2_RAT","B5DFC9","NID2",4.27e-14,"Nidogen-2 (NID-2)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005604; GO:0005615; GO:0007160; GO:0009986; GO:0031012"
"g63887",247.677442200353,1.89966069440952,0.511834211862716,3.71147658828059,0.000206053728620684,0.00804267424007227,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33496",49.8435576172621,0.672146425797558,0.18114499686977,3.71054369379455,0.000206814595458515,0.00806751239225982,0,6844,"sp|Q8K3X3|GMDS_CRIGR","Q8K3X3","GMDS",5.83e-12,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]","GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401"
"g17420",381.26865721674,-0.289387956878323,0.0780003056240303,-3.71008747418508,0.000207187647325652,0.0080723446982387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103388",417.010728721726,-0.249200071560643,0.0671660218354178,-3.71021038243529,0.000207087082802482,0.0080723446982387,0,4108,"sp|P11346|KRAF1_DROME","P11346","KRAF1",2.39e-22,"Raf homolog serine/threonine-protein kinase Raf (D-Raf) (dRAF-1) (EC 2.7.11.1) (Protein pole-hole)","border follicle cell migration [GO:0007298]; cellular response to starvation [GO:0009267]; compound eye photoreceptor development [GO:0042051]; dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal appendage formation [GO:0046843]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell migration, open tracheal system [GO:0007427]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gastrulation [GO:0007369]; hemocyte differentiation [GO:0042386]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; instar larval development [GO:0002168]; lamellocyte differentiation [GO:0035171]; MAPK cascade [GO:0000165]; metamorphosis [GO:0007552]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of macroautophagy [GO:0016242]; photoreceptor cell development [GO:0042461]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of photoreceptor cell differentiation [GO:0046534]; protein autophosphorylation [GO:0046777]; R7 cell fate commitment [GO:0007465]; Ras protein signal transduction [GO:0007265]; regulation of cellular pH [GO:0030641]; regulation of multicellular organism growth [GO:0040014]; sevenless signaling pathway [GO:0045500]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]; terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472]","GO:0000165; GO:0002168; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0007265; GO:0007283; GO:0007298; GO:0007362; GO:0007369; GO:0007427; GO:0007430; GO:0007465; GO:0007472; GO:0007474; GO:0007476; GO:0007552; GO:0008069; GO:0008284; GO:0008293; GO:0008543; GO:0009267; GO:0016242; GO:0019900; GO:0030641; GO:0035171; GO:0035309; GO:0040014; GO:0042051; GO:0042386; GO:0042461; GO:0045500; GO:0046530; GO:0046534; GO:0046777; GO:0046843; GO:0046872; GO:0048010; GO:0070371; GO:0070374; GO:0106310; GO:2001234"
"g64714",49.8620252671839,0.895494821579657,0.241389500547336,3.70975050509312,0.000207463593476968,0.00807819091844428,0,12131,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.33e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g131915",67.4079355317742,1.27451951661427,0.343573311832302,3.70959988078575,0.000207587052292836,0.00807819091844428,0,3329,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.71e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g97746",761.420803700668,-0.397425559013818,0.107164471150666,-3.70855708749839,0.000208443669496384,0.00810665706943529,3269,6324,"sp|A4WFX9|TATD_ENT38","A4WFX9","TATD",5.62e-07,"3'-5' ssDNA/RNA exonuclease TatD (EC 3.1.11.-) (EC 3.1.13.-) (DNase TatD)",NA,"GO:0000175; GO:0000287; GO:0005737; GO:0008310"
"g63121",74.5297709397018,-0.346981078892713,0.0935728669842234,-3.70813773346514,0.000208789088876249,0.00811416089777419,465,12300,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.3e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g92301",201.165886962179,0.476938318563552,0.128628752902874,3.7078670810381,0.000209012309020807,0.00811416089777419,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158599",2271.8611276863,1.16773118255018,0.314922805164443,3.70799181069287,0.000208909410611902,0.00811416089777419,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20349",340.156056420665,-0.42793730994626,0.115421327859025,-3.70761035143297,0.000209224253463654,0.00811752518243746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57534",67.6970705803886,0.534330882972632,0.144130768141799,3.70726452000134,0.00020951007547653,0.00812375004210101,0,5091,"sp|Q3ULW8|PARP3_MOUSE","Q3ULW8","PARP3",7.61e-10,"Protein mono-ADP-ribosyltransferase PARP3 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly [ADP-ribose] polymerase 3) (PARP-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3)","DNA ADP-ribosylation [GO:0030592]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]","GO:0000723; GO:0003950; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045171; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034"
"g4000",139.078470014759,0.639881277870448,0.172630502824785,3.70665245944345,0.000210016828996453,0.00812880549651565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98445",317.095614695906,0.435241918194281,0.117421413257848,3.70666564230941,0.000210005902166594,0.00812880549651565,0,6675,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.05e-22,"PiggyBac transposable element-derived protein 4",NA,NA
"g135888",38.4016412314926,0.503466426334953,0.135820335895032,3.70685599484935,0.000209848184914095,0.00812880549651565,0,3112,"sp|F1N9S8|CARME_CHICK","F1N9S8","CARME",5.62e-14,"Carnosine N-methyltransferase (EC 2.1.1.22)","carnosine metabolic process [GO:0035498]; methylation [GO:0032259]","GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803"
"g1298",1500.64500850127,-0.361761083986243,0.09761201139849,-3.70611238108181,0.000210464940907068,0.0081364289476084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74412",41.568929791576,1.81506249520877,0.489732213312877,3.7062346438893,0.000210363418882114,0.0081364289476084,0,3094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.39e-16,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85092",19.8859233533752,1.14879447366603,0.309987474488063,3.70593836271364,0.000210609517984288,0.00813716308810733,1755,5070,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.03e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g101166",265.239145718343,0.561143746684952,0.151466370034942,3.70474149842966,0.000211606420516961,0.0081708073924645,0,4064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.14e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g59427",227.861719190918,-0.263573653308159,0.0711586521108966,-3.70402818897406,0.00021220266214809,0.00818895002296675,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18786",43.4359541662157,0.786583928304541,0.212373085629256,3.70378349014383,0.000212407564373041,0.00819197816572764,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2960",72.396515891194,-0.517515299643397,0.139739737711865,-3.7034225776957,0.000212710118950302,0.00819876664910584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19345",15201.580292833,0.574008396684886,0.155025685960466,3.70266638801563,0.000213345349023009,0.00821347902510267,0,13159,"sp|Q9BKS0|AT5G_CAEEL","Q9BKS0","AT5G",9.11e-12,"ATP synthase c subunit (ATP synthase lipid-binding protein, mitochondrial) (ATPase protein 9) (ATPase subunit c)","ATP synthesis coupled proton transport [GO:0015986]","GO:0000276; GO:0008289; GO:0015078; GO:0015986; GO:0016021; GO:0045263"
"g41433",50.7436147476057,0.956502732618149,0.258325112136876,3.70270905800029,0.000213309457128949,0.00821347902510267,20036,22854,"sp|Q7KML2|ACOX1_DROME","Q7KML2","ACOX1",4.82e-15,"Probable peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid beta-oxidation [GO:0140493]","GO:0003997; GO:0005504; GO:0005634; GO:0005777; GO:0006091; GO:0006629; GO:0006635; GO:0006693; GO:0009062; GO:0019395; GO:0033540; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493"
"g64610",194.040873264467,0.484680805796217,0.130921536329238,3.70207086920637,0.000213846862438117,0.00822301469314715,0,5846,"sp|Q8CJ27|ASPM_MOUSE","Q8CJ27","ASPM",9.19e-09,"Abnormal spindle-like microcephaly-associated protein homolog (Calmodulin-binding protein Sha1) (Calmodulin-binding protein 1) (Spindle and hydroxyurea checkpoint abnormal protein)","brain development [GO:0007420]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuronal stem cell population maintenance [GO:0097150]; neuron migration [GO:0001764]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051]","GO:0000922; GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0007051; GO:0007283; GO:0007420; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431"
"g68472",34.8126019201355,0.791994642030413,0.213929816317291,3.70212369488395,0.000213802330832519,0.00822301469314715,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138702",437.607000760769,-0.429972577913274,0.116157346743876,-3.70163911251651,0.00021421115637111,0.00823213728039937,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122905",46.1679333129837,-0.449165988361897,0.121388017122769,-3.70024981879076,0.000215387328827796,0.00827243105912233,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39777",14369.7726227182,-0.375423026202256,0.101486389917519,-3.69924505647873,0.000216241733721637,0.00830032621624765,7981,22684,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.91e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g143684",81.7905248419706,-0.38576541892879,0.104300055386719,-3.69861183197329,0.000216781833203717,0.00831613103538689,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50348",1910.97217843686,-0.475244422931916,0.12852033448179,-3.69781501774145,0.000217463263905523,0.00833733565575772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16462",1236.07013686885,-0.333574882147268,0.090238602686925,-3.69658740511062,0.000218517048074358,0.00837278243399285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55",1821.35215036912,-0.508001865122827,0.13743907779976,-3.6961966949673,0.000218853438638012,0.00838071563219427,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20384",472.420343414254,-0.481621540476161,0.130309787879813,-3.69597363569013,0.000219045704426717,0.00838312364259909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45788",70.0219304825969,0.39346946582095,0.106468183064013,3.6956530533106,0.000219322307939663,0.0083887546035033,0,6754,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.88e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35476",504.180303979794,-0.7208332130564,0.195087317711541,-3.69492605420018,0.000219950789705795,0.00840782980378028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103417",171.524921951688,0.609214581976677,0.164887234019292,3.69473468094807,0.000220116510422777,0.0084092034550843,0,1920,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.17e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g4357",1668.91742318159,-0.338884703776379,0.0917502390205506,-3.69355663150342,0.00022113923339475,0.00844322957909483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147800",995.514329472703,1.05341156610547,0.285213901476629,3.69340891398237,0.000221267788577517,0.00844322957909483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144700",12002.0900514112,-1.22701059522664,0.33226374382644,-3.69288138722587,0.000221727455942574,0.00845578990752629,0,1654,"sp|Q6X0I2|VGR_SOLIN","Q6X0I2","VGR",3.56e-06,"Vitellogenin receptor (SiVgR)","receptor-mediated endocytosis [GO:0006898]","GO:0005509; GO:0006898; GO:0016021; GO:0038024"
"g72171",14693.6261202841,0.906892467615632,0.245610924092416,3.69239467245518,0.000222152356222688,0.00846701036278624,5198,8714,"sp|O42161|ACTB_SALSA","O42161","ACTB",1e-180,"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]",NA,"GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0015629"
"g160291",21.3544359926671,0.963370976409371,0.260946234273133,3.69183705253631,0.000222640095941398,0.00848061125004762,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65208",93.9606043854802,1.83641729852696,0.497477083029253,3.69146109674961,0.000222969504600026,0.0084839822595666,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142102",908.954084394326,0.625883730717398,0.169550150765384,3.69143718181335,0.000222990474095071,0.0084839822595666,1335,2589,"sp|P18491|EMC_DROME","P18491","EMC",4.25e-09,"Protein extra-macrochaetae","cell differentiation [GO:0030154]; chaeta morphogenesis [GO:0008407]; chorion-containing eggshell pattern formation [GO:0030381]; circadian regulation of gene expression [GO:0032922]; compound eye cone cell differentiation [GO:0042675]; determination of left/right symmetry [GO:0007368]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; head involution [GO:0008258]; hindgut development [GO:0061525]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; midgut development [GO:0007494]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; photoreceptor cell fate commitment [GO:0046552]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; sex determination [GO:0007530]","GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007368; GO:0007391; GO:0007458; GO:0007476; GO:0007494; GO:0007530; GO:0008258; GO:0008407; GO:0008586; GO:0030154; GO:0030381; GO:0032922; GO:0042675; GO:0043392; GO:0045466; GO:0045892; GO:0046552; GO:0046843; GO:0046982; GO:0048056; GO:0061525"
"g104784",1548.14927328664,-0.965443117362171,0.261585508820014,-3.69073624038728,0.000223605908246607,0.00850240470247793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131369",272.840448827198,0.291412983432647,0.0789648647081004,3.69041325543806,0.000223890028825469,0.0085082150367675,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134473",168.11516474561,-0.505197144907809,0.136907533190374,-3.69006097133688,0.000224200309401089,0.00851501210259363,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29760",64.2024995246037,0.748906093142491,0.202977355802475,3.68960414417497,0.00022460326928032,0.00852531905476262,20175,24512,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.59e-23,"PiggyBac transposable element-derived protein 4",NA,NA
"g155574",56.7487374764752,0.415602638755252,0.112648900227058,3.68936259402049,0.000224816611453185,0.00852842078798957,0,794,"sp|Q13131|AAPK1_HUMAN","Q13131","AAPK1",6.07e-14,"5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)","autophagy [GO:0006914]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0015721; GO:0016055; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0038183; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0071466; GO:0097009; GO:0106310; GO:0120188; GO:1901563; GO:1903109; GO:1903829; GO:1903944; GO:1903955; GO:1904428; GO:1904486; GO:1905691; GO:1990044; GO:2000758"
"g44990",231.498218019943,2.34694504468743,0.6361783902403,3.68913040853357,0.00022502186184265,0.00853121210905256,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1566",44.8170650909861,-0.499746623811016,0.135485335572846,-3.68856615882475,0.000225521388099635,0.00854515046733312,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7228",343.741360773804,1.05421572074345,0.285831945414198,3.68823617393706,0.000225814003540951,0.00855123713116823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134330",74.0139072597009,0.677694078535737,0.183806084956022,3.68700567610634,0.000226908297649592,0.00858765731869744,0,2624,"sp|Q9UJW2|TINAG_HUMAN","Q9UJW2","TINAG",1.19e-08,"Tubulointerstitial nephritis antigen (TIN-Ag)","cell adhesion [GO:0007155]","GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0007155"
"g153328",182.202021034261,1.78418459418012,0.4840402598911,3.68602519670891,0.000227783808926637,0.00861575967996707,917,1693,"sp|Q9TTJ6|RGN_RABIT","Q9TTJ6","RGN",9.94e-08,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0008270; GO:0019853; GO:0030234"
"g57992",23.988146800477,1.28181095215044,0.347779857340892,3.68569635386909,0.000228078155855486,0.00862185994885911,0,14087,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.43e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19513",2030.77932567449,-0.702500465168442,0.190629175727391,-3.68516761659322,0.000228552176691961,0.00863314587233624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77834",17.3246609635218,1.38444362594026,0.375690298551069,3.68506621352659,0.00022864319165541,0.00863314587233624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60686",79.7184767799291,-0.479755853614482,0.130209256863356,-3.68449882267547,0.000229153084905487,0.00864232586163053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147829",573.358937504549,0.829198978466532,0.225046229167462,3.68457175014253,0.000229087487959744,0.00864232586163053,0,2176,"sp|Q96KP4|CNDP2_HUMAN","Q96KP4","CNDP2",5.64e-19,"Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase)","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070062; GO:0070573; GO:0103046"
"g80816",306.5645688614,-0.398119602700236,0.108063221897014,-3.68413596884656,0.000229479727547997,0.00864458138780081,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101772",32.1438356196142,-0.443930384519468,0.120494879308134,-3.68422614362087,0.000229398511031871,0.00864458138780081,0,4164,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.06e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g21283",29.3522981188231,1.41117620578453,0.38310124978158,3.68355938955847,0.000229999665822927,0.00865913326418648,45965,47152,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.48e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g8061",1132.11066680825,-0.324481987457819,0.0880933845446218,-3.68338654639225,0.000230155744780702,0.00865997745155403,2447,10344,"sp|P21414|POL_GALV","P21414","POL",8.09e-08,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g29015",128.728153719056,-0.452402188419095,0.122834508823118,-3.68302191911359,0.000230485332640213,0.00866734541947611,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17201",2304.90918272685,-0.443690201400322,0.120490330233485,-3.68237185955538,0.000231074022767117,0.00868237210674787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28295",3671.33353824207,-0.545960614311778,0.148266806502276,-3.68228484305687,0.000231152931399072,0.00868237210674787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121462",312.264634852422,-0.323661522762292,0.0879077169970993,-3.6818328790517,0.000231563190062498,0.00869274262672042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12914",502.096216126384,-0.579698642196828,0.157456124820185,-3.68165190689689,0.00023172765437443,0.00869387950774896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10249",81.4760670411118,-0.887100715794778,0.240964308930371,-3.68146104181393,0.000231901227974089,0.00869535663433168,55754,61054,"sp|A0A345BJN8|CLZ9_COCLU","A0A345BJN8","CLZ9",5.75e-13,"MFS-type transporter clz9 (Squalestatin S1 biosynthesis cluster protein clz9) (Zaragozic acid A biosynthesis cluster protein 9)",NA,"GO:0003676; GO:0016021; GO:0022857"
"g15151",1869.33462521944,-0.766823235598941,0.208336895200086,-3.68068860228759,0.000232604934947274,0.00870264370130083,42474,58364,"sp|Q09666|AHNK_HUMAN","Q09666","AHNK",5.01e-29,"Neuroblast differentiation-associated protein AHNAK (Desmoyokin)","positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385]","GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1901385; GO:1905686"
"g109848",86.7772568990601,1.20916069403214,0.328482806867466,3.68104713169966,0.000232278059054808,0.00870264370130083,3209,5014,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",3.12e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g144698",281.19922046854,-0.304523932759683,0.0827355300121333,-3.68069114581152,0.000232602614464058,0.00870264370130083,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145877",31.7572225205335,0.961661553539331,0.261274355285212,3.68065802895031,0.000232632829019385,0.00870264370130083,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31292",65.331934470743,0.575532930756882,0.156378299021047,3.68038873910134,0.000232878655538185,0.00870681288418096,1801,26226,"sp|P21328|RTJK_DROME","P21328","RTJK",8.92e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g46668",186.763644686564,-0.496934235088603,0.135045835884169,-3.67974496832937,0.000233467322643485,0.0087237879100573,0,5844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.2e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g134561",53.0754651768013,0.703225660799779,0.191122621850806,3.67944753996065,0.000233739763920692,0.00872893401943134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34959",1154.56717975584,0.463035361076347,0.125877002062058,3.67847464978606,0.000234633006558395,0.00875516462764696,17900,29246,"sp|P41383|TBA2_PATVU","P41383","TBA2",9.69e-40,"Tubulin alpha-2/alpha-4 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g148463",260.858151449716,-0.378738986207738,0.10296329571085,-3.67838833822243,0.000234712406559702,0.00875516462764696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10547",733.511035907241,0.412887723412784,0.112265948659401,3.67776452560365,0.000235287016268387,0.00877154870257628,69536,80122,"sp|P54385|DHE3_DROME","P54385","DHE3",4.41e-28,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g158244",88.5259432037276,0.685272990634804,0.186346991993452,3.67740301737141,0.000235620614580273,0.00877893414634827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112112",348.786031118632,0.581991136895987,0.158307553749375,3.67633207078273,0.000236611486472698,0.00881078623162388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121134",31.6829689771026,-1.55752632077621,0.423749051986958,-3.67558656113324,0.000237303561137969,0.00883081936192956,0,2564,"sp|Q9V7U0|RESIL_DROME","Q9V7U0","RESIL",4.57e-09,"Pro-resilin","chitin-based cuticle development [GO:0040003]","GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129"
"g158583",993.216804650924,1.06205501144412,0.288958461101848,3.67545912099033,0.000237422056834555,0.00883081936192956,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61199",603.621027286281,0.471515950323329,0.12831110339409,3.67478680995464,0.000238048100949883,0.00884395103488864,0,13063,"sp|Q4R963|TCPG_MACFA","Q4R963","TCPG",2.93e-34,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g77633",328.443597815633,0.411028682177068,0.111847678252928,3.67489686507024,0.00023794551366885,0.00884395103488864,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7514",81.9634834664719,0.41619713151376,0.113280713351696,3.67403346253319,0.000238751444737608,0.00884663124471329,22365,29146,"sp|P47739|AL3A1_MOUSE","P47739","AL3A1",3.73e-07,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase 4) (Aldehyde dehydrogenase family 3 member A1) (Dioxin-inducible aldehyde dehydrogenase 3)","cellular aldehyde metabolic process [GO:0006081]; lipid metabolic process [GO:0006629]; positive regulation of cell population proliferation [GO:0008284]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]","GO:0001666; GO:0004028; GO:0004029; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006081; GO:0006629; GO:0008106; GO:0008284; GO:0009410; GO:0014070; GO:0016021; GO:0016620; GO:0018479; GO:0051384; GO:0051591"
"g34183",578.73777800483,-0.323248921510666,0.0879833483320697,-3.67397840203409,0.000238802926967474,0.00884663124471329,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41155",2542.78496507633,0.680655232798,0.185253759068043,3.67417771289595,0.000238616618284012,0.00884663124471329,0,5261,"sp|Q04831|GLNA_PANAR","Q04831","GLNA",9.62e-176,"Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase)","glutamine biosynthetic process [GO:0006542]","GO:0004356; GO:0005524; GO:0005739; GO:0005783; GO:0005829; GO:0006542; GO:0046872"
"g90287",64.8939800931131,1.52221389543616,0.414315851398601,3.67404213548103,0.000238743336376296,0.00884663124471329,0,7655,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.74e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g130113",113.903871873253,0.488163875908961,0.132867199287206,3.67407365044059,0.000238713875134377,0.00884663124471329,0,1694,"sp|P23685|NAC1_CANLF","P23685","NAC1",3.59e-11,"Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)","calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular sodium ion homeostasis [GO:0006883]; metal ion transport [GO:0030001]; positive regulation of bone mineralization [GO:0030501]; positive regulation of the force of heart contraction [GO:0098735]; response to muscle stretch [GO:0035994]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]","GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005887; GO:0006883; GO:0007154; GO:0015491; GO:0016020; GO:0030001; GO:0030424; GO:0030501; GO:0030506; GO:0031226; GO:0035725; GO:0035994; GO:0042383; GO:0070588; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:1905060"
"g82311",502.72134978272,0.448223007285011,0.122025784061527,3.67318276815177,0.000239548017872814,0.00886916269830471,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g15071",927.507457867808,-0.366010946309261,0.0996616742736407,-3.67253459242824,0.000240156629620558,0.0088764794654905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69128",208.28927702343,1.23789736932868,0.337044142178701,3.67280487750575,0.000239902666333376,0.0088764794654905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131232",597.721270477634,2.86580483736866,0.7803082088729,3.67265755349174,0.000240041062588586,0.0088764794654905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65729",209.693660710254,-0.402078015570506,0.109487181320255,-3.67237525637279,0.000240306461952485,0.00887695358568264,2739,11776,"sp|P18042|POL_HV2G1","P18042","POL",6.71e-07,"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.47) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0008289; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0055036; GO:0072494; GO:0075713; GO:0075732"
"g17397",212.398302289833,1.42755932339801,0.388832404377262,3.67140008735726,0.000241225378847787,0.00890074941439903,45616,49344,"sp|Q9VD09|PINTA_DROME","Q9VD09","PINTA",3.68e-15,"Retinol-binding protein pinta (Prolonged depolarization afterpotential is not apparent)","phototransduction [GO:0007602]; rhodopsin biosynthetic process [GO:0016063]; visual perception [GO:0007601]","GO:0005501; GO:0007601; GO:0007602; GO:0016063; GO:0016918; GO:0019841; GO:1902936"
"g34055",3199.29621231118,-0.493806168947105,0.1344993279667,-3.67143967492062,0.000241188010763912,0.00890074941439903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3093",26.0268278579569,2.89993243500346,0.790119850527116,3.67024373969191,0.000242319295302817,0.00890561208199401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14271",43.49293643208,0.782181129211295,0.213112613420675,3.6702713962186,0.000242293077717895,0.00890561208199401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19514",1419.69718046919,-0.742428820775767,0.202271328311775,-3.67046000524311,0.000242114352778004,0.00890561208199401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27178",74.8711978137261,1.05733698843666,0.288024041395561,3.67100254309865,0.000241600936025446,0.00890561208199401,35810,37004,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.07e-11,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g54921",351.525679201771,0.367779740405795,0.100195382978372,3.67062562638422,0.00024195751303219,0.00890561208199401,0,15223,"sp|Q6NZS4|RTCB_DANRE","Q6NZS4","RTCB",5.79e-25,"RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0000971; GO:0003972; GO:0005525; GO:0005634; GO:0005737; GO:0006388; GO:0046872; GO:0072669"
"g89881",49.5019845592315,-0.468828178581543,0.127722881492677,-3.67066709662687,0.000241918256506229,0.00890561208199401,2666,7711,"sp|Q8N3Y7|RDHE2_HUMAN","Q8N3Y7","RDHE2",7.83e-08,"Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5)","keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]","GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0016021; GO:0016616; GO:0017053; GO:0031065; GO:0035067; GO:0042572; GO:0042574; GO:0043616; GO:0061629; GO:0140297"
"g153273",21.919482831972,0.576176920290316,0.156971676953289,3.67057886794299,0.000242001782636102,0.00890561208199401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33590",421.225104933483,0.308537856469438,0.0840909166686313,3.66909850305547,0.000243407286244919,0.00893754210557391,6934,19994,"sp|Q0P5L5|SUMF1_BOVIN","Q0P5L5","SUMF1",3.56e-19,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135"
"g118708",95.1693761971896,2.44200335250073,0.665596570612112,3.66889413245468,0.00024360192240587,0.00893754210557391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162007",24.2462631903469,0.599871390419509,0.163500471236547,3.66892759319107,0.000243570045456107,0.00893754210557391,0,470,"sp|Q4VBD2|TAPT1_MOUSE","Q4VBD2","TAPT1",4.97e-16,"Transmembrane anterior posterior transformation protein 1","anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724]","GO:0001503; GO:0005654; GO:0005813; GO:0005829; GO:0014032; GO:0030030; GO:0030176; GO:0035437; GO:0036064; GO:0045724; GO:0048706; GO:0048856; GO:0051216; GO:0061036; GO:1903012"
"g35142",1564.02659430578,-0.353001145729996,0.0962224459497883,-3.66859460124514,0.000243887450371041,0.00894295391731232,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88981",1063.8721031491,0.49720716296955,0.135559168989586,3.66782392276059,0.000244623542963138,0.00896487173032274,375,7828,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.06e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g36862",8997.18010925062,0.381379692551474,0.103991967286442,3.66739568933221,0.000245033458699326,0.00897481791379619,1143,8894,"sp|Q293Y0|TCTP_DROPS","Q293Y0","TCTP",2.28e-11,"Translationally-controlled tumor protein homolog (TCTP)","cellular response to gamma radiation [GO:0071480]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell size [GO:0045793]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of multicellular organism growth [GO:0040018]; regulation of stem cell differentiation [GO:2000736]","GO:0005085; GO:0005509; GO:0005634; GO:0005700; GO:0005737; GO:0005881; GO:0006302; GO:0007095; GO:0031573; GO:0033129; GO:0040018; GO:0045793; GO:0071480; GO:2000736"
"g10117",249.416346564579,0.511091150876783,0.139383559072747,3.66679653093112,0.000245608069634778,0.00898061011311638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51045",706.37475823247,-0.523249708242884,0.142705002246997,-3.66665288535038,0.000245746017788269,0.00898061011311638,0,6362,"sp|Q92519|TRIB2_HUMAN","Q92519","TRIB2",1.24e-15,"Tribbles homolog 2 (TRB-2)","negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]","GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629"
"g64641",679.223687968365,-0.353224329650756,0.0963255462987623,-3.66698496113585,0.000245427223290384,0.00898061011311638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80149",78.5789077267913,0.320951402711954,0.0875266651610629,3.66689856309906,0.000245510128503124,0.00898061011311638,1975,8850,"sp|A4IG72|TGFA1_DANRE","A4IG72","TGFA1",1.13e-14,"Transforming growth factor-beta receptor-associated protein 1 homolog (TGF-beta receptor-associated protein 1 homolog)","autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; intracellular protein transport [GO:0006886]","GO:0005737; GO:0005769; GO:0006886; GO:0006914; GO:0016020; GO:0034058"
"g123234",177.684198024829,0.497269696648948,0.135637801498196,3.666158630974,0.00024622122397057,0.00898783761392966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127065",242.852137374707,0.619730980224887,0.169040220862375,3.66617469536699,0.000246205765144097,0.00898783761392966,0,3866,"sp|P40239|CD9_FELCA","P40239","CD9",3.15e-08,"CD9 antigen (CD antigen CD9)","cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]","GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007338; GO:0007342; GO:0014905; GO:0016020; GO:0030913; GO:0031623; GO:0035036; GO:0051271; GO:0071404; GO:0090331"
"g1676",149.878134719728,0.660518090708069,0.180187066339757,3.66573530567732,0.000246628919782895,0.0089925872816506,10814,28464,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.92e-34,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10527",62.188783582021,0.708270950450696,0.193208391496253,3.66583948536434,0.000246528527786645,0.0089925872816506,14085,27050,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",2.85e-26,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g28395",1223.39903649336,-0.255263593452353,0.0696442664451633,-3.66524922268143,0.000247097837196313,0.00900461764086655,7835,20137,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.47e-36,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6055",786.511577119709,-0.552869348541277,0.150859628128617,-3.66479326112299,0.000247538456914554,0.009011541537647,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152027",1006.05135836771,0.633712911274609,0.17292048708316,3.66476478272841,0.000247566001528123,0.009011541537647,0,1655,"sp|A1ZA47|ZASP_DROME","A1ZA47","ZASP",4.7e-17,"PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]","GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061"
"g136629",594.76030106045,-0.377275097564782,0.102950764281226,-3.66461677287017,0.000247709204580611,0.00901169146119681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39786",2897.94988829389,-0.763608288192068,0.208431002974776,-3.6636022342822,0.000248692888305039,0.00904240084845589,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24136",165.500671650954,1.21169759720622,0.330757562927406,3.66340103150465,0.00024888840682051,0.00904443440444269,13175,35182,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.45e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g138000",33.9050663480579,1.40555727700013,0.383762723018444,3.66256854220981,0.00024969891049377,0.00906880129351057,0,3001,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.27e-10,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g67371",232.830396435785,-0.825331765135566,0.225353407313066,-3.66238866754297,0.000249874359684681,0.00907008929246473,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91431",433.323830727801,0.495319496701157,0.135263330715716,3.66189043312982,0.000250360939859392,0.00908212100839442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124965",3855.40587663529,0.286272894748991,0.0781789933740813,3.66176235320905,0.000250486167363771,0.00908212100839442,796,3854,"sp|O57592|RL7A_TAKRU","O57592","RL7A",6.23e-12,"60S ribosomal protein L7a (Surfeit locus protein 3)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254; GO:1990904"
"g52200",2208.9281384308,-0.271014280510267,0.0740194281213666,-3.66139387169942,0.000250846770278134,0.00908563216112711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145482",83.4652084633166,0.44347214903255,0.121121689808455,3.66137683295095,0.000250863456488454,0.00908563216112711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55605",563.927317144252,0.573729237240866,0.156721903718752,3.6608107968779,0.000251418373148622,0.00909556150274633,9126,14943,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.05e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g124147",25.8214748110207,1.3693272240987,0.374043815810915,3.66087385011309,0.000251356501624573,0.00909556150274633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24917",1274.24677976233,-0.586909427295705,0.160329016375255,-3.66065632138617,0.000251570013907838,0.00909596870040766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51107",101.017416957307,-0.420528740457021,0.11489448796231,-3.66012981053514,0.000252087507587575,0.00910959614005674,10556,13894,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73806",1568.11341625054,0.613145651748435,0.16752846269898,3.65994913264473,0.000252265321098789,0.00911094032884831,2095,10140,"sp|Q5T750|XP32_HUMAN","Q5T750","XP32",5.53e-06,"Skin-specific protein 32","epidermis development [GO:0008544]","GO:0008544"
"g154620",92.464165072267,0.51979242936813,0.142027507705402,3.65980110308139,0.000252411091531358,0.00911112638083078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133150",328.713356200221,0.654524874263566,0.178865605823284,3.65931097401826,0.000252894304556038,0.00912348589927583,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5801",99.5191118600039,0.64657414766768,0.176733033036209,3.6584793264721,0.000253716202434378,0.00914804335243777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70448",383.33995526586,-0.411056286482779,0.112362029003231,-3.65832025399754,0.000253873695170924,0.00914863088498871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13240",349.794298178234,-0.337104631916871,0.0921518138622685,-3.65814429242503,0.000254048016077819,0.00914982384976662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121515",2644.99412573466,-1.41327292402896,0.386373993233309,-3.6577848115558,0.000254404494111732,0.0091524877218109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148414",27.390409797667,1.50314353780995,0.410937670211016,3.65783827274361,0.000254351449822097,0.0091524877218109,0,2117,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",4.33e-19,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g99926",83.3717900207348,0.972190365811442,0.265825497773402,3.65725024105915,0.000254935466733716,0.00916650038628062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20936",7501.28326256663,-0.437646309448069,0.119690349363784,-3.65648786033614,0.000255694514467977,0.0091765722810196,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26508",75.888176169524,1.01934107796775,0.27876466651168,3.65663658426755,0.000255546274543424,0.0091765722810196,27604,39254,"sp|P57789|KCNKA_HUMAN","P57789","KCNKA",2.54e-08,"Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit)","memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322]","GO:0005244; GO:0005267; GO:0005886; GO:0005887; GO:0007165; GO:0007613; GO:0022841; GO:0030322; GO:0034765; GO:0071805"
"g81327",49.8893959052686,-0.535863253642045,0.146554876261035,-3.65640002784757,0.000255782098984788,0.0091765722810196,0,8908,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.09e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g137523",85.4977374250245,0.964661593258361,0.263825632660658,3.65643619814283,0.00025574602740011,0.0091765722810196,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6951",165.179745766633,-0.419062857734086,0.114634019922001,-3.65565874789371,0.000256522407584881,0.00919295152358805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79918",90.7745000499174,0.49977253697803,0.136708460963344,3.65575424853941,0.000256426919455582,0.00919295152358805,0,4004,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.19e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g32526",28.4389957534099,0.61094139744432,0.167162489327607,3.65477566110534,0.000257406959676558,0.00921955176247829,24766,25824,"sp|Q3T186|RPIA_BOVIN","Q3T186","RPIA",3.98e-13,"Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase) (Fragment)","D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004751; GO:0006014; GO:0009052; GO:0043231"
"g100586",122.251725229767,0.910198026007386,0.249106327488145,3.65385349776272,0.000258333705384205,0.00924763302373414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9628",1591.21969302959,-0.689763114541249,0.188848532041607,-3.65246744088686,0.000259732536741382,0.00925387734278203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25778",195.237197588369,0.332079297290482,0.0909135998148535,3.65269110415565,0.000259506332585188,0.00925387734278203,38987,40844,"sp|O14530|TXND9_HUMAN","O14530","TXND9",1.81e-23,"Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4)","microtubule cytoskeleton organization [GO:0000226]; protein folding [GO:0006457]","GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0030496; GO:0045296"
"g27721",1363.98737252661,0.455024012467785,0.124568427286877,3.65280370297908,0.000259392524518695,0.00925387734278203,35909,38234,"sp|Q9TZH6|PHS_CAEEL","Q9TZH6","PHS",7.37e-21,"Putative pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Pterin carbinolamine dehydratase) (PCD)","tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0006729; GO:0008124"
"g35786",850.998230087838,-0.634169474099907,0.17359435956955,-3.65316866096578,0.000259023968685823,0.00925387734278203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50315",3341.87792174625,-0.580786505966539,0.159013137215474,-3.65244354106122,0.000259756719006873,0.00925387734278203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63943",249.055507058507,1.81917494771363,0.497982251458428,3.65309193728463,0.000259101407942887,0.00925387734278203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76484",1808.77102669001,-0.431600704228615,0.11816767339009,-3.65244310771721,0.000259757157491473,0.00925387734278203,3695,7320,"sp|P33124|ACSL6_RAT","P33124","ACSL6",1.01e-09,"Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6) (Long-chain-fatty-acid--CoA ligase, brain isozyme)","cellular response to insulin stimulus [GO:0032869]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; neuron development [GO:0048666]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001666; GO:0001676; GO:0004467; GO:0005524; GO:0005634; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0007405; GO:0007584; GO:0008610; GO:0008654; GO:0009629; GO:0010747; GO:0010976; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0032869; GO:0035338; GO:0042803; GO:0047676; GO:0048545; GO:0048666"
"g82967",1170.11982791681,-0.395202740210325,0.108172538456339,-3.65344796239424,0.000258742245566082,0.00925387734278203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91763",27.6872040527906,1.46418243275081,0.400881493016633,3.65240715337802,0.000259793540760892,0.00925387734278203,0,7472,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.72e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g32260",885.112774313516,-0.25856329578311,0.0707962473581498,-3.65221753174387,0.000259985503619485,0.00925516269768448,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80553",34.8321114550037,0.583202370307691,0.15969005934486,3.65208938302309,0.000260115309871181,0.00925516269768448,0,9032,"sp|P08548|LIN1_NYCCO","P08548","LIN1",8.56e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g120532",149.587175047287,-0.437139719330628,0.119743002447154,-3.65064939409342,0.000261578108122456,0.00929699964869901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130275",85.0452481788905,0.555066768055279,0.152045369160761,3.6506653975656,0.000261561808858907,0.00929699964869901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105095",19.5103996983319,0.647103491084962,0.177283809713374,3.65009919479491,0.00026213905623517,0.00931182887645031,0,5941,"sp|P21328|RTJK_DROME","P21328","RTJK",9.75e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g11116",309.332502529282,0.3591141460737,0.0983915455590844,3.64984759648938,0.000262395945432833,0.00931584684516687,38465,44451,"sp|P15505|GCSP_CHICK","P15505","GCSP",1.78e-20,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))","glycine catabolic process [GO:0006546]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]","GO:0004375; GO:0005739; GO:0006546; GO:0016829; GO:0036255; GO:0042803; GO:0047960; GO:0070280; GO:1903442"
"g29826",2058.14385048261,-0.279341925471124,0.076574313419597,-3.64798472224544,0.000264305350528608,0.00937849757765613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1261",117.179879298503,0.329090971166868,0.0902176766115934,3.6477438072771,0.00026455323211348,0.0093821552098132,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38496",64.9677122458795,1.02535577352863,0.281144750798098,3.64707422286174,0.000265243324263152,0.00939634265116589,21466,24644,"sp|Q91Z53|GRHPR_MOUSE","Q91Z53","GRHPR",8.51e-15,"Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)","dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487]","GO:0005737; GO:0005829; GO:0008465; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0070402; GO:1902494"
"g94863",135.869774113427,0.723349493274756,0.198336016412203,3.64709096390953,0.000265226049928399,0.00939634265116589,0,7099,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.32e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65197",877.994597749719,0.40459545862555,0.110943902198307,3.64684719582294,0.000265477687421033,0.00939950590222459,3188,12018,"sp|Q7ZVZ6|PREP_DANRE","Q7ZVZ6","PREP",0,"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)","protein processing [GO:0016485]; proteolysis [GO:0006508]","GO:0004222; GO:0005759; GO:0006508; GO:0016485; GO:0046872"
"g52271",27.9509579078975,1.55034436348884,0.425157648886305,3.64651645701293,0.000265819461107001,0.00940646659940248,6772,12834,"sp|Q9FWW9|GSXL2_ARATH","Q9FWW9","GSXL2",4.37e-09,"Flavin-containing monooxygenase FMO GS-OX-like 2 (EC 1.8.-.-) (Flavin-monooxygenase glucosinolate S-oxygenase-like 2)","defense response to fungus [GO:0050832]","GO:0004499; GO:0050660; GO:0050661; GO:0050832"
"g23510",37.9868865549539,0.651247237249397,0.17860529229575,3.6462930570445,0.000266050548016458,0.00940950499870653,0,4179,"sp|Q6AXQ5|PDE12_RAT","Q6AXQ5","PDE12",1.56e-06,"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)","cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]","GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503"
"g18161",706.460080911883,-0.35075367695032,0.0962023935238239,-3.64599740300077,0.000266356664731673,0.00941519224111253,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44720",54.6445145661397,0.553530773399522,0.151835584604166,3.64559319109926,0.000266775715293462,0.00942321299883991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47054",672.540761192335,-0.426317198147686,0.116950705683265,-3.64527255869899,0.000267108557609596,0.00942321299883991,0,18968,"sp|P21328|RTJK_DROME","P21328","RTJK",1.49e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g51326",1159.50810462386,-0.501192459640812,0.137493140488183,-3.64521792040883,0.000267165315371551,0.00942321299883991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145114",542.587455421104,-0.295340622614526,0.0810166872913648,-3.64542950950804,0.000266945581390325,0.00942321299883991,0,2420,"sp|P35500|SCNA_DROME","P35500","SCNA",7.18e-33,"Sodium channel protein para (Protein paralytic) (Sodium channel 1) (DmNav1)","male courtship behavior, veined wing generated song production [GO:0045433]; mechanosensory behavior [GO:0007638]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of postsynaptic membrane potential [GO:0060078]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725]","GO:0001518; GO:0001666; GO:0005244; GO:0005248; GO:0005272; GO:0005509; GO:0005887; GO:0007638; GO:0009612; GO:0019228; GO:0034765; GO:0035725; GO:0045433; GO:0060078; GO:0086010"
"g69756",3251.31543115956,-0.678661171598572,0.186193732273946,-3.64491953252251,0.000267475477524157,0.00942901992123108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8449",33.7557543435534,-0.735910453594649,0.201934269766647,-3.64430690464307,0.000268113337678361,0.00944636622522786,58405,65230,"sp|Q95RI5|FAXC_DROME","Q95RI5","FAXC",5.17e-10,"Failed axon connections","axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]","GO:0005737; GO:0005886; GO:0007409; GO:0036099"
"g6852",38.3694379311167,-0.80179193750555,0.220036896245528,-3.64389768800807,0.000268540202729897,0.00945626378015119,0,5910,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.58e-26,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g16461",1036.95876431367,-0.248765387091582,0.0682858600256089,-3.64299998562351,0.000269478853241957,0.0094770626293424,36075,42203,"sp|P62484|ABI2_MOUSE","P62484","ABI2",2.7e-20,"Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1)","actin polymerization or depolymerization [GO:0008154]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; dendrite development [GO:0016358]; learning or memory [GO:0007611]; lens fiber cell morphogenesis [GO:0070309]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186]","GO:0005829; GO:0005912; GO:0007611; GO:0008154; GO:0010592; GO:0016358; GO:0016477; GO:0016601; GO:0017124; GO:0018108; GO:0030027; GO:0030425; GO:0031209; GO:0031625; GO:0032433; GO:0035591; GO:0042802; GO:0043010; GO:0043197; GO:0045186; GO:0061001; GO:0070064; GO:0070309; GO:0098871; GO:0098974; GO:0098978; GO:2000601"
"g89228",993.19773755163,-0.347432559186124,0.0953721733663402,-3.64291330398415,0.000269569651441946,0.0094770626293424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145016",52.3839612130977,-0.415368274255274,0.114019464494744,-3.64295934993117,0.000269521415176539,0.0094770626293424,165,1497,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.78e-10,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3484",1795.79878909183,-0.380074163137553,0.104343315515151,-3.64253485008693,0.000269966414356762,0.00948586436302479,72257,84524,"sp|Q8K083|ZN536_MOUSE","Q8K083","ZN536",4.4e-07,"Zinc finger protein 536","negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387"
"g119240",54.9320595442609,0.96282186092583,0.264365637113882,3.64200836174133,0.000270519283884392,0.00950013873209832,0,4191,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.05e-17,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g19996",1143.17763004281,-0.318676430356791,0.0875126863338863,-3.64148837964987,0.000271066362677655,0.00951419438622606,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41160",32.5485268189626,0.786895373195545,0.216113229973231,3.64112541047586,0.000271448860879493,0.00952093568574183,0,7021,"sp|Q99LB7|SARDH_MOUSE","Q99LB7","SARDH",1.46e-20,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053"
"g158818",72.7850893199689,-0.564777101917702,0.155114766292956,-3.64102732070679,0.00027155231502247,0.00952093568574183,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57459",840.227251561417,-0.415970770700356,0.114254547789639,-3.64073709753966,0.000271858626507109,0.00952652027435108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48945",398.929680936218,0.305643595140048,0.0839570350567687,3.64047628567853,0.000272134172546946,0.00953102131991043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74428",105.010701004766,1.11904574243817,0.307404234490546,3.64030685619131,0.000272313313936854,0.00953149975903862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95376",194.365043969178,0.443072656029724,0.121717065408101,3.64018516667453,0.000272442047038099,0.00953149975903862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34288",3747.34846519716,-0.320653438777182,0.0881353355755776,-3.63819388311304,0.000274556709456557,0.00960029836795397,5086,8434,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.13e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27471",85.9795990198002,-0.40275369251115,0.110708473449758,-3.63796627268939,0.000274799399751842,0.00960360167644072,25545,28465,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",9.14e-16,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g10966",32.683931223495,0.492271077120276,0.135322615839559,3.63775909936534,0.000275020473698137,0.00960614638939266,22635,25203,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.47e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1135",1400.29014447916,0.520047217080215,0.143016843352877,3.63626552571196,0.000276619200327175,0.00961018115109847,172945,180972,"sp|P29401|TKT_HUMAN","P29401","TKT",1.94e-31,"Transketolase (TK) (EC 2.2.1.1)","glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]","GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0005829; GO:0006098; GO:0009052; GO:0016604; GO:0030976; GO:0031982; GO:0040008; GO:0042803; GO:0046166; GO:0046390; GO:0070062"
"g19229",36.6265090148243,0.557060319513385,0.153192832619749,3.63633408944206,0.000276545619134218,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24179",2791.59681588881,-0.43141111708181,0.118609561165683,-3.6372372753254,0.000275578049229521,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54664",116.83579733485,-0.342207508660643,0.0940972839168875,-3.63674161905568,0.000276108645076115,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81493",106.240767276403,1.1497440884081,0.316108677908189,3.6371797699968,0.000275639559159462,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87842",3963.79708886141,-0.545349908627693,0.149965391823178,-3.6365050762559,0.000276362199485228,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135958",2204.67412284818,0.834083598885814,0.229367255083814,3.63645455224647,0.000276416385338547,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150436",98.0666546016237,1.76654458866679,0.485658599081683,3.63742059135181,0.00027538205315276,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151012",50.996220317505,-0.713373767472542,0.196152118611798,-3.63683947194255,0.000276003818598213,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152438",82.9120316860186,0.8983453580141,0.247019195502907,3.63674311295994,0.000276107044426734,0.00961018115109847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127082",268.330581774997,0.372028506962541,0.102315973531815,3.63607454555335,0.000276824253068734,0.00961215103380624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6424",476.502718757503,-0.338918252633034,0.0932312383679123,-3.63524349312602,0.000277718202230738,0.00963802650087638,64875,106417,"sp|Q6GQ33|CMKMT_XENLA","Q6GQ33","CMKMT",1.29e-08,"Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)",NA,"GO:0005634; GO:0005737; GO:0018025"
"g133688",1448.31831800004,1.02531437976109,0.282087379572508,3.6347403464661,0.000278260742669801,0.00965168538533428,0,1000,"sp|Q5UQ13|COLL2_MIMIV","Q5UQ13","COLL2",1.8e-06,"Collagen-like protein 2",NA,NA
"g10094",677.502507183227,-0.573788084295933,0.157960468696144,-3.63247899320736,0.000280711434418829,0.00971800497017605,15045,19754,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.1e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g22808",134.992614915809,0.717799376560358,0.197587080541468,3.63282545899914,0.000280334652340715,0.00971800497017605,14105,22970,"sp|A4IGM9|AURKB_XENTR","A4IGM9","AURKB",4.98e-31,"Aurora kinase B (EC 2.7.11.1) (Aurora/IPL1-related kinase 2) (AIRK2) (XAIRK2) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) (xAurora-B)","abscission [GO:0009838]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spindle assembly [GO:0051225]","GO:0000122; GO:0000775; GO:0000776; GO:0000785; GO:0002903; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005694; GO:0005876; GO:0006468; GO:0007052; GO:0007094; GO:0009838; GO:0030496; GO:0031616; GO:0032133; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0035175; GO:0036089; GO:0043987; GO:0043988; GO:0044878; GO:0046872; GO:0051225; GO:0051233; GO:0051256; GO:0062033; GO:0106310"
"g26071",380.138440997543,-0.326874118882827,0.0899888743912716,-3.63238368180469,0.000280815168910888,0.00971800497017605,0,13902,"sp|Q9VTW2|INP5E_DROME","Q9VTW2","INP5E",8.72e-10,"Inositol polyphosphate 5-phosphatase E (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV)","phosphatidylinositol dephosphorylation [GO:0046856]; protein localization to cilium [GO:0061512]; sensory perception of sound [GO:0007605]","GO:0004439; GO:0005737; GO:0007605; GO:0016020; GO:0046856; GO:0061512; GO:0097546"
"g30322",307.095818733568,0.543024287829772,0.149487396531786,3.63257572496626,0.00028060619076238,0.00971800497017605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78697",11218.9333222968,0.301971639651591,0.0831354492159958,3.6322849337956,0.000280922681603564,0.00971800497017605,3215,6606,"sp|P46791|RS2_CRIGR","P46791","RS2",4.5e-27,"40S ribosomal protein S2 (Fragment)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935"
"g11157",512.20397747378,0.35972868247739,0.0990733435339637,3.630933101133,0.000282398383924494,0.00975230061407298,6422,26834,"sp|P35072|TCB1_CAEBR","P35072","TCB1",1.16e-28,"Transposable element Tcb1 transposase (Transposable element Barney transposase)","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003677; GO:0005634; GO:0006313; GO:0015074"
"g31270",1423.47978356313,-0.333670836102422,0.0918930451770471,-3.63107823295604,0.00028223960619225,0.00975230061407298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32701",82.0249200444483,0.393528693750469,0.108390668696538,3.63065103742679,0.000282707207881311,0.00975230061407298,0,9814,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.12e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g57217",17845.3768244509,0.253007475861643,0.0696863177627989,3.63066214407884,0.000282695041524569,0.00975230061407298,4555,14338,"sp|O16797|RL3_DROME","O16797","RL3",1.27e-34,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g87351",2790.49584109623,0.36297438658131,0.0999777772490596,3.63055067404716,0.000282817169352293,0.00975230061407298,0,7066,"sp|Q24048|ATPB2_DROME","Q24048","ATPB2",1.6e-13,"Sodium/potassium-transporting ATPase subunit beta-2 (Protein nervana 2) (Sodium/potassium-dependent ATPase subunit beta-2)","cation transport [GO:0006812]; cell adhesion involved in heart morphogenesis [GO:0061343]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of glial blood-brain barrier [GO:0060857]; open tracheal system development [GO:0007424]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; regulation of tube size, open tracheal system [GO:0035151]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]","GO:0001671; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007424; GO:0007605; GO:0019991; GO:0030007; GO:0030424; GO:0035151; GO:0035158; GO:0035159; GO:0036376; GO:0060857; GO:0061343; GO:1903408; GO:1990573"
"g106556",39.2637005607456,0.695719929693692,0.191622429809507,3.63068107624619,0.000282674304137541,0.00975230061407298,844,5734,"sp|P05895|POL_SIVVT","P05895","POL",7.16e-13,"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Nucleocapsid protein p7 (NC); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0030430; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0075713; GO:0075732"
"g73518",124.213944267508,0.409314967630037,0.112748391867124,3.63033974012171,0.000283048406242317,0.00975508265194598,5624,8864,"sp|Q5FWL4|EST2A_XENLA","Q5FWL4","EST2A",1.19e-10,"Extended synaptotagmin-2-A (E-Syt2-A)","endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]","GO:0005509; GO:0006869; GO:0006897; GO:0008429; GO:0016021; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268"
"g79158",180.534752357511,0.772308123212696,0.212771104484173,3.62976037129208,0.000283684452745838,0.00977180581964971,0,9257,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.38e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17299",26.2467799246098,0.730059330355989,0.201179341357005,3.62889810370964,0.000284633553146494,0.00978888631052059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41621",459.760712218423,-0.429044074953104,0.118223314472771,-3.62909868384651,0.000284412508847861,0.00978888631052059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65511",532.727429752679,0.582689687401198,0.160567173201222,3.62894653859899,0.000284580161957659,0.00978888631052059,6969,11939,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.64e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g21535",544.338092676413,-0.351237186708907,0.0968206607703531,-3.62770904385789,0.000285947235545714,0.00980977382825104,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24465",275.712951135262,0.294033668252532,0.0810506045260744,3.62777884226563,0.00028586996505996,0.00980977382825104,8944,23510,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.37e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27252",3670.47499349096,2.26280177051809,0.623762901322233,3.6276632767378,0.00028599791276166,0.00980977382825104,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46957",11102.9929450155,-0.775895935119799,0.213882319554699,-3.62767683058238,0.000285982903924716,0.00980977382825104,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144909",161.977410693714,0.351961858930398,0.0970117769635297,3.62803228584003,0.000285589554229315,0.00980977382825104,0,1594,"sp|P53703|CCHL_CAEEL","P53703","CCHL",1.14e-22,"Probable holocytochrome-c-type synthase (EC 4.4.1.17) (Cytochrome c-type heme lyase) (CCHL)","cytochrome c-heme linkage [GO:0018063]","GO:0004408; GO:0005739; GO:0005743; GO:0018063; GO:0046872"
"g2075",2758.32206141427,-0.304937853738177,0.0840739940811443,-3.62701757030676,0.000286713790805665,0.0098187350146255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16220",1290.55667902035,-0.288245188175373,0.0794680906954744,-3.62718149703562,0.00028653189064313,0.0098187350146255,0,19933,"sp|Q96PE1|AGRA2_HUMAN","Q96PE1","AGRA2",6.49e-31,"Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5)","cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]","GO:0002040; GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007417; GO:0009986; GO:0010595; GO:0016021; GO:0016055; GO:0030175; GO:0043542; GO:0045765; GO:0050920; GO:0090210; GO:0090263; GO:1900747; GO:1990909"
"g110063",46.6416095419338,0.431206001425295,0.118882956980193,3.62714734204617,0.000286569781572128,0.0098187350146255,0,5433,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.06e-25,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g9544",52.317165528726,-0.934002195216913,0.257557401652995,-3.62638460095697,0.000287417176757032,0.00981916754394635,25405,29750,"sp|P21328|RTJK_DROME","P21328","RTJK",7.65e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g20543",3799.96425266689,-0.367078651830476,0.10121999357721,-3.62654292751431,0.000287241085222736,0.00981916754394635,20535,35870,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.31e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g25794",567.204765676659,-0.510212117588409,0.14070239238028,-3.62617940574491,0.000287645546305572,0.00981916754394635,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63561",50.2731281343824,0.804992409521855,0.222002435143892,3.62605216019408,0.00028778724809708,0.00981916754394635,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95285",407.869458468818,0.542556329770972,0.149595297557347,3.6268274379613,0.000286924905361314,0.00981916754394635,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104290",83.6531997100636,0.648857965648974,0.178918311709475,3.62655984985248,0.000287222270099513,0.00981916754394635,0,6023,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.29e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g130374",85.123451346475,0.501837194678606,0.138393176949229,3.62617005940047,0.000287655952254227,0.00981916754394635,877,3601,"sp|Q9R0P3|ESTD_MOUSE","Q9R0P3","ESTD",5.82e-07,"S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase 10) (Esterase D) (Sid 478)","formaldehyde catabolic process [GO:0046294]","GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0052689"
"g20608",403.807131462105,-0.456896275682233,0.126015725259928,-3.62570841646794,0.000288170371236775,0.00982189524647257,4085,28347,"sp|P21328|RTJK_DROME","P21328","RTJK",1.13e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g143010",39.0861372503887,0.686289597774408,0.189279012248156,3.62580927289837,0.000288057911152047,0.00982189524647257,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53826",34.2954366324751,0.544413144459761,0.150187691054999,3.6248852394994,0.000289089794816448,0.0098480520901904,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30904",4969.09568994594,-0.42810093519343,0.118113412796892,-3.62449043725113,0.000289531732128726,0.00985792407767555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98644",266.6915261821,0.315646442194952,0.0871001768448109,3.62394720228122,0.000290140858042028,0.00987347511298169,0,6652,"sp|Q9H3K2|GHITM_HUMAN","Q9H3K2","GHITM",2.58e-12,"Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5)","apoptotic process [GO:0006915]; inner mitochondrial membrane organization [GO:0007007]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]","GO:0005739; GO:0006915; GO:0007007; GO:0016020; GO:0031305; GO:0070062; GO:0090201; GO:1905448"
"g143985",27.3857045300173,1.14295954408772,0.315426758599681,3.62353387252821,0.000290605126045559,0.0098840829038687,0,2518,"sp|A0A2R8QPS5|RIC1_DANRE","A0A2R8QPS5","RIC1",3.17e-07,"Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner 1)","intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005829; GO:0006886; GO:0034066; GO:0042147"
"g91463",1952.07324091057,-0.321640197326629,0.088769440220069,-3.62332123002294,0.000290844245375588,0.00988702580830035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10286",8803.81439190099,-0.946620799572429,0.261292706876787,-3.62283666806977,0.000291389830478961,0.00989518935336653,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28104",1944.97312460722,-0.361190437428937,0.0996959103324981,-3.62292130363545,0.000291294467310093,0.00989518935336653,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16982",6483.80981118593,-0.438679965675872,0.121093820553964,-3.62264534778949,0.000291605508493774,0.00989732619792409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145844",40.3538892960902,1.0121933032621,0.279441230890103,3.62220456887469,0.00029210297396909,0.00990901989129804,0,1704,"sp|Q3T094|ETHE1_BOVIN","Q3T094","ETHE1",1.23e-12,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Sulfur dioxygenase ETHE1)","glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]","GO:0005506; GO:0005654; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813"
"g11478",892.729095097332,-0.386165858870525,0.106633295754497,-3.62143790209389,0.000292970132625128,0.00991783314015799,4227,21304,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.36e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g23922",832.782821538525,-0.305010304562453,0.0842181195462365,-3.62167080202972,0.000292706450345376,0.00991783314015799,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25670",267.055775201501,-0.32114752916198,0.0886785680880634,-3.62147851601596,0.000292924134756422,0.00991783314015799,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26658",869.922985415782,0.894972890821682,0.247144515102552,3.6212532997154,0.000293179291926572,0.00991783314015799,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64743",132.437677292447,0.507125922452885,0.140035775446952,3.62140260825701,0.000293010110651037,0.00991783314015799,0,12123,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.18e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g85707",1383.77063090032,0.496285055224326,0.137051273120045,3.62116340787016,0.000293281192359402,0.00991783314015799,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77833",55.2638293483031,1.26788782492184,0.350170100819655,3.62077693656328,0.00029371967013801,0.00992747970122695,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31470",657.926236793729,-0.334475292357547,0.0923851884001041,-3.62044282368071,0.000294099238583761,0.00992994891378719,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36231",6111.09876239957,-0.466059837530535,0.128727459035647,-3.62051609673641,0.000294015957526445,0.00992994891378719,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76469",287.234880405752,1.895061215139,0.52350810240424,3.61992719202593,0.000294685922955581,0.0099445755239901,0,7216,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",3.09e-08,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g107245",404.18151577082,0.810541827296303,0.223923834919184,3.61972108770303,0.000294920734442382,0.00994731866045042,201,5723,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.03e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g74705",259.834427063733,1.95606053647586,0.540519854458808,3.61885048317856,0.00029591453579097,0.00997564543054334,0,7515,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",3.23e-08,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g113626",21.24166801405,0.6673796370958,0.184428186757763,3.6186422955639,0.000296152647731054,0.00997848076153831,0,5093,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.54e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62696",21.1406808378149,1.18838182630075,0.32842645865986,3.61841074300143,0.000296417693829551,0.00998222018518614,1121,4354,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.37e-68,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g117489",174.668516169824,0.409989840680614,0.113313817159379,3.61818047400125,0.000296681491019841,0.00998591368709017,0,4674,"sp|Q3T0Q3|RPB3_BOVIN","Q3T0Q3","RPB3",1.51e-30,"DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II subunit C)","transcription by RNA polymerase II [GO:0006366]","GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005829; GO:0006366; GO:0046983"
"g35980",758.889864212189,-0.473991224032587,0.131034804441214,-3.61729256630618,0.000297700742046926,0.0100058712794675,4028,13224,"sp|Q497V6|BAHD1_MOUSE","Q497V6","BAHD1",5.37e-14,"Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1)","heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]","GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892"
"g87283",682.943835459576,0.352324643462183,0.0974009619091388,3.61726041053734,0.00029773771590779,0.0100058712794675,0,2091,"sp|P80971|COX42_THUOB","P80971","COX42",1.46e-09,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005751; GO:0006123; GO:0016021; GO:0016491"
"g162673",17.670393629868,0.611277047648615,0.168985412000578,3.61733619731936,0.000297650580413114,0.0100058712794675,0,232,"sp|Q9CZT4|RPC5_MOUSE","Q9CZT4","RPC5",9.46e-09,"DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit 5) (RNA polymerase III subunit C5) (Sex-lethal interactor homolog) (Sxl interactor)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]","GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0045087; GO:0051607"
"g21313",1190.74945080481,-0.370563047966209,0.102447307403209,-3.61710871041009,0.000297912204190359,0.0100065450731498,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2401",719.096476944433,-0.438447890447023,0.121228926957229,-3.61669365102699,0.000298390102772787,0.010017404108268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23548",310.425541728015,-0.301845558429672,0.0834625660462091,-3.61653820064141,0.000298569272791082,0.0100182283231241,7355,10630,"sp|Q66JG9|SPRE1_XENTR","Q66JG9","SPRE1",1.56e-17,"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1)","blood vessel morphogenesis [GO:0048514]; lymph vessel development [GO:0001945]; negative regulation of MAPK cascade [GO:0043409]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]","GO:0001945; GO:0005886; GO:0019901; GO:0019902; GO:0030947; GO:0043409; GO:0048514"
"g95295",186.598775750652,0.742972394499606,0.205461867262765,3.61610845067138,0.000299065121270968,0.0100257282792822,0,4768,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g133752",656.558141691175,1.05975999641243,0.293069037177142,3.61607628912319,0.000299102260488825,0.0100257282792822,866,3330,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",1.28e-06,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g42996",17241.0209878649,0.70004488529109,0.193621344229665,3.61553571521913,0.000299727146287671,0.0100414793120047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22790",1480.74155051336,-0.290767109964974,0.0804450365621622,-3.61448166836608,0.000300949107923739,0.0100772070024304,30144,34084,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.54e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g12141",114.351787600011,0.504514156300786,0.13960577927866,3.61384864514634,0.000301685215551276,0.0100865070438882,24315,40290,"sp|P25285|GCST_BOVIN","P25285","GCST",1.46e-25,"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)","glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]","GO:0004047; GO:0005739; GO:0005743; GO:0006546; GO:0008483; GO:0019464; GO:0031405"
"g31560",429.074137174975,-0.362901275751009,0.100430957702952,-3.61344035794594,0.000302160884234207,0.0100865070438882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45629",44.5543141382089,1.25471235014742,0.347232984477353,3.6134595681801,0.000302138487911622,0.0100865070438882,0,19867,"sp|P21328|RTJK_DROME","P21328","RTJK",1.57e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g46732",1420.13393216136,-0.279120386534431,0.0772427871938225,-3.61354628276223,0.000302037410740648,0.0100865070438882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95855",3208.26603429593,-0.492017434364076,0.136160319353899,-3.61351557266296,0.000302073203750223,0.0100865070438882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130772",13616.3923294188,0.760046890280998,0.210331886850155,3.61355998685294,0.000302021439731069,0.0100865070438882,0,1214,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",3.13e-12,"Collagen-like protein 4",NA,NA
"g145253",118.557206080702,0.51851257965891,0.143503431904636,3.61324166800056,0.000302392618858101,0.0100890447753208,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102372",17.9145906143319,0.650628786331585,0.180076557772451,3.61306765511219,0.000302595709015372,0.0100906246908044,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69950",446.457044715612,0.615161628151374,0.170343695011577,3.61129672636,0.000304669834349039,0.0101493432272377,0,3160,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",2.55e-17,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g73459",342.032670011282,-0.534109946504181,0.147897805235628,-3.61134464201986,0.000304613540359899,0.0101493432272377,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9855",535.661724721109,0.542421490610654,0.150237099071448,3.61043639662327,0.000305682256963315,0.0101673873077126,65595,70543,"sp|Q17GM7|CISY1_AEDAE","Q17GM7","CISY1",1.9e-27,"Probable citrate synthase 1, mitochondrial (EC 2.3.3.16)","carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]","GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101"
"g28339",1442.05739796914,-0.25753565824222,0.0713304169544814,-3.61046057541712,0.000305653760763079,0.0101673873077126,7655,20557,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.79e-36,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g48591",2816.33311409676,0.571692421161708,0.158337937565659,3.6105839822793,0.0003055083569063,0.0101673873077126,0,2356,"sp|P08991|H2AV_STRPU","P08991","H2AV",1.09e-32,"Histone H2A.V (H2A.F/Z) (Fragment)",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g29346",407.097515867463,-0.474953709847897,0.131561675802287,-3.61012207355631,0.000306052932542667,0.0101744934111016,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70888",1571.29090128834,-0.381394247248192,0.105654800825762,-3.60981464417466,0.000306415885635625,0.010181335629738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94956",108.376612644886,1.26499776412593,0.35044718098254,3.60966739860564,0.000306589867409697,0.0101818950687219,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76971",115.176362200238,0.44259500719978,0.122631595143379,3.60914335887342,0.000307209810681161,0.0101920354651636,0,9596,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.69e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g82989",29.6097921364802,0.579698020184495,0.160616158910479,3.60921356927477,0.000307126683162057,0.0101920354651636,0,7542,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.65e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g21668",79.5845432238997,0.413712775687987,0.114637094103018,3.60889098703258,0.000307508787200523,0.0101967332902167,0,11268,"sp|B5X9S3|MIX23_SALSA","B5X9S3","MIX23",6.16e-08,"Protein MIX23 (Coiled-coil domain-containing protein 58)",NA,"GO:0005758"
"g32504",2519.88011975705,-0.477595475125322,0.132352284434308,-3.6085170510402,0.000307952277658958,0.0102009979173604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53171",58.7359384417295,-0.443055080597614,0.12277992856889,-3.60853020328173,0.000307936668860721,0.0102009979173604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55444",37.1079479779761,1.12948219660642,0.313031091016876,3.60821090626274,0.000308315813099799,0.0102010032940208,0,6060,"sp|P57432|FABG_BUCAI","P57432","FABG",2.22e-08,"3-oxoacyl-[acyl-carrier-protein] reductase FabG (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-Ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase)","fatty acid biosynthetic process [GO:0006633]","GO:0004316; GO:0006633; GO:0046872; GO:0051287"
"g121585",2007.105991773,2.67615185124147,0.741702722269559,3.60811922471126,0.000308424759665191,0.0102010032940208,1436,4284,"sp|P04069|CBPB_ASTAS","P04069","CBPB",3.01e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g149413",296.436085647604,0.334528565802002,0.0927095664337415,3.60835001899277,0.000308150572168362,0.0102010032940208,0,2040,"sp|Q9D0F6|RFC5_MOUSE","Q9D0F6","RFC5",4.49e-07,"Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36)","DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0017116; GO:0019899; GO:0031390; GO:1900264"
"g40109",1128.18508963972,-0.246700264280851,0.0683831330708607,-3.60761862176178,0.000309020269699597,0.0102154848646153,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12936",3335.25017353304,0.374323146832731,0.10376843170053,3.60729309192036,0.000309408092771754,0.0102230895231822,32885,36816,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.69e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g22717",12916.1358217495,0.439686176923113,0.121912227374092,3.60657980248298,0.000310259470756141,0.0102407752871639,1492,10341,"sp|Q962R1|RS18_SPOFR","Q962R1","RS18",4.59e-27,"40S ribosomal protein S18","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:0019843"
"g71550",294.327280604858,-0.364068902751779,0.100943417675074,-3.60666313006837,0.00031015989841957,0.0102407752871639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148264",34.1809655866455,2.56963796673922,0.71272968845479,3.60534717209584,0.000311735903341142,0.0102842690352254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143467",65.3844202064896,1.04486756286999,0.289827334473602,3.60513808943425,0.000311986992080169,0.0102873145943259,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150432",438.903274513105,1.34108081784463,0.372021016681929,3.60485230056567,0.000312330504100813,0.0102934030275707,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152579",58.0694303591163,1.13479104632668,0.314818785459806,3.60458491912824,0.000312652211385228,0.0102987670220046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21591",898.819563520346,-0.490689910981993,0.136147884467874,-3.60409500962742,0.000313242464491565,0.0103120865779292,5617,13164,"sp|P80363|CCB23_FAXLI","P80363","CCB23",2.93e-19,"Crustacean calcium-binding protein 23 (CCBP-23)",NA,"GO:0005509"
"g60189",131.580166965792,-0.337203434663378,0.0935640446869028,-3.60398522521954,0.000313374878026061,0.0103120865779292,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7249",1667.59300722085,-0.422437733239427,0.117228059358928,-3.60355477647217,0.000313894557992236,0.0103134736795086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22739",106.037259031025,0.394410129515752,0.109446124468762,3.6036920578976,0.000313728730824389,0.0103134736795086,20136,39984,"sp|P53034|RFC2_DROME","P53034","RFC2",4.42e-32,"Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) (Replication factor C subunit 4) (DmRfc4)","DNA damage checkpoint signaling [GO:0000077]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA strand elongation involved in DNA replication [GO:0006271]; leading strand elongation [GO:0006272]; sister chromatid cohesion [GO:0007062]","GO:0000076; GO:0000077; GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006272; GO:0006281; GO:0007062; GO:0016887; GO:0031391"
"g70710",339.992762549907,0.450962256842373,0.125141580447115,3.60361644172259,0.000313820060171186,0.0103134736795086,3995,10754,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.81e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17923",4072.69727209333,-0.298703054923364,0.0829244825483026,-3.60210936196524,0.000315645513504932,0.0103395448718529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31687",2493.84808820792,-0.41279101249631,0.114593642807018,-3.60221564115448,0.000315516457548582,0.0103395448718529,0,10482,"sp|Q8BGC3|MOT12_MOUSE","Q8BGC3","MOT12",2.04e-07,"Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)","creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]","GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0015881; GO:0016021; GO:0016323"
"g52489",14100.4926141298,0.287959697405145,0.0799309789762026,3.60260441062379,0.00031504479134079,0.0103395448718529,8073,13484,"sp|Q4R506|RL7_MACFA","Q4R506","RL7",2.52e-18,"60S ribosomal protein L7","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0003723; GO:0003735; GO:0022625"
"g85389",121.547696174109,0.402723262137916,0.111790031043476,3.60249709548157,0.000315174923133636,0.0103395448718529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137528",826.798861100516,0.807178912913878,0.22406963149329,3.60235747938939,0.000315344298814687,0.0103395448718529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155368",77.8622846439685,-0.564908168091906,0.156805187296137,-3.60261148137299,0.000315036219021166,0.0103395448718529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23440",227.811774759535,-0.32520468506004,0.0902912670854931,-3.60172911021524,0.000316107662084497,0.01034945111139,37705,43130,"sp|O02751|CFDP2_BOVIN","O02751","CFDP2",2.26e-08,"Craniofacial development protein 2 (p97 bucentaur protein)","chromatin remodeling [GO:0006338]","GO:0003824; GO:0005634; GO:0005737; GO:0006338"
"g22737",66.9692182971445,-1.01297162920716,0.281274766659231,-3.60135977086915,0.00031655715436234,0.0103589331831309,9766,13744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.25e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g38309",441.40863658239,-0.350216755696575,0.0972572227221644,-3.60093313272005,0.000317077125009091,0.0103696660529929,0,10447,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.67e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g81255",62.2541612387311,0.699848669237291,0.194364777349194,3.60069699243885,0.000317365267591946,0.0103696660529929,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125422",301.748517367881,-0.76988336013681,0.213814048449014,-3.60071457287988,0.000317343807182026,0.0103696660529929,0,3965,"sp|Q9Y493|ZAN_HUMAN","Q9Y493","ZAN",4.06e-08,"Zonadhesin","binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609]","GO:0005615; GO:0005886; GO:0007339; GO:0016021; GO:0031012; GO:0098609"
"g54337",305.227267865483,-0.355367220750876,0.0987065370705923,-3.60023997698072,0.000317923622385637,0.0103774434585554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160124",109.618092862163,0.653646758913931,0.181551161772985,3.60034467711786,0.000317795624731149,0.0103774434585554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53864",108.993353873024,0.599894415860696,0.166651794591408,3.59968770412284,0.000318599584130214,0.0103845116048975,0,10780,"sp|Q66I12|CCD47_DANRE","Q66I12","CCD47",2.15e-16,"PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein insertion into ER membrane [GO:0045048]","GO:0005509; GO:0005783; GO:0030176; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048"
"g144224",159.871415712164,0.657312119624819,0.182603426252001,3.59967024231899,0.000318620978663377,0.0103845116048975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151740",19.2819700665577,1.99516775947353,0.554242992659749,3.59980691844014,0.000318453556414136,0.0103845116048975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10918",4958.49910508571,-0.570869555610873,0.15863314060711,-3.59867776320939,0.000319839195708007,0.0104189748655148,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47235",86.8257021301445,0.702218270536676,0.195167082237071,3.59803642339483,0.00032062872480977,0.0104309362685896,0,18679,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.42e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g92209",1281.49151240408,-0.522365500519547,0.145182699635216,-3.59798723836955,0.000320689349883944,0.0104309362685896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146580",122.59447142692,0.548048638692065,0.15231937848004,3.5980230759928,0.000320645175651543,0.0104309362685896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94926",19.9291535318381,-0.762564450983734,0.21195340520546,-3.59779287454491,0.000320929026193653,0.0104334944275792,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11264",2114.96651672393,-0.441798481817501,0.122827725806271,-3.59689539896167,0.000322037908463252,0.0104430580341087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22062",24.9740174420063,0.569421112908537,0.158312181197637,3.59682437953193,0.000322125809965537,0.0104430580341087,18751,29774,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.97e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27892",350.77359366594,0.414187073873913,0.115139925246186,3.5972498070354,0.000321599589297875,0.0104430580341087,14543,34094,"sp|Q0QEP2|ATPB_MESAU","Q0QEP2","ATPB",8.19e-35,"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta) (Fragment)",NA,"GO:0005524; GO:0005739; GO:0005753; GO:0045261; GO:0046933; GO:0046961"
"g35187",732.414858069281,-0.359743902693979,0.100006903997917,-3.59719067697038,0.000321672680404788,0.0104430580341087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54737",18.4866385470912,-0.605379267170586,0.168319079786758,-3.59661702011165,0.000322382589447282,0.0104430580341087,0,15290,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.22e-50,"PiggyBac transposable element-derived protein 4",NA,NA
"g65296",225.487545384477,0.291996329765657,0.0811912938634227,3.59639951368238,0.000322652140148375,0.0104430580341087,0,11995,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.42e-29,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g70447",932.1311,-0.2899566,0.08062452,-3.596382,0.0003226738,0.01044306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103999",61.22118,0.3980991,0.1106925,3.59644,0.0003226017,0.01044306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119131",23.33375,0.5294524,0.1472076,3.596639,0.0003223555,0.01044306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161569",106.5572,0.6129656,0.1704568,3.596017,0.0003231264,0.01045248,0,1090,"sp|Q923L3|CSMD1_MOUSE","Q923L3","CSMD1",2.77e-08,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016021; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"g115956",85.89793,0.5045759,0.1403307,3.595621,0.0003236189,0.01045798,0,4872,"sp|A6QLH5|ERI3_BOVIN","A6QLH5","ERI3",7.42e-12,"ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein)","exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]","GO:0000175; GO:0000467; GO:0003676; GO:0046872"
"g140117",87.66894,0.4095137,0.1138888,3.595734,0.0003234783,0.01045798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44122",842.4129,-0.2757962,0.0767298,-3.594382,0.0003251622,0.01049215,6039,10924,"sp|Q15937|ZNF79_HUMAN","Q15937","ZNF79",1.43e-57,"Zinc finger protein 79 (ZNFpT7)","negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872"
"g69302",557.7336,0.2400805,0.06679045,3.594533,0.0003249734,0.01049215,0,3144,"sp|P22464|ANXB9_DROME","P22464","ANXB9",2.65e-13,"Annexin B9 (Annexin IX) (Annexin-9)","endosome transport via multivesicular body sorting pathway [GO:0032509]; maintenance of cell polarity [GO:0030011]; wing disc dorsal/ventral pattern formation [GO:0048190]","GO:0005509; GO:0005544; GO:0005737; GO:0005938; GO:0012505; GO:0030011; GO:0030507; GO:0032509; GO:0048190"
"g104572",52.85309,-0.6256869,0.1740696,-3.594464,0.0003250595,0.01049215,0,5992,"sp|Q03650|CRAM_TRYBB","Q03650","CRAM",3.83e-09,"Cysteine-rich, acidic integral membrane protein","endocytosis [GO:0006897]","GO:0005886; GO:0006897; GO:0016021; GO:0020016"
"g17598",1382.295,-0.4081043,0.1135459,-3.59418,0.0003254154,0.01049284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112083",21.17178,0.6479477,0.1802806,3.594106,0.0003255075,0.01049284,0,1534,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.64e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g10219",3211.1,-0.3351701,0.09326421,-3.59377,0.0003259271,0.01050114,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42221",1813.586,-0.2916768,0.08116758,-3.593514,0.0003262484,0.01050627,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75117",26.05464,1.433109,0.3988382,3.593209,0.0003266304,0.01051334,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103069",1812.881,0.2806174,0.07810972,3.592605,0.0003273887,0.01053252,725,6157,"sp|Q8ISQ3|RL24_BRABE","Q8ISQ3","RL24",3.15e-06,"60S ribosomal protein L24",NA,"GO:0005840"
"g10917",908.1517,-0.4173874,0.1161973,-3.592056,0.0003280791,0.01053609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24757",172.8158,0.3244209,0.0903111,3.592259,0.0003278234,0.01053609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43182",272.1866,0.3922015,0.1091914,3.591871,0.0003283128,0.01053609,1975,19334,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.24e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g48892",269.9299,0.3249454,0.09046554,3.591925,0.0003282449,0.01053609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63783",199.4805,0.3223463,0.0897416,3.591938,0.0003282283,0.01053609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50250",299.2822,0.2191462,0.06103709,3.590377,0.0003301995,0.01058195,0,17229,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.28e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g56034",1987.301,1.082369,0.301456,3.590473,0.0003300788,0.01058195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101022",26.86636,0.5100014,0.1420477,3.590352,0.0003302316,0.01058195,2232,6380,"sp|Q7SYR0|CH2BA_XENLA","Q7SYR0","CH2BA",5.8e-07,"Charged multivesicular body protein 2b-A (Chromatin-modifying protein 2b-A) (CHMP2b-A)","protein transport [GO:0015031]; vacuolar transport [GO:0007034]","GO:0005829; GO:0007034; GO:0015031; GO:0031902"
"g82359",353.5021,0.5633511,0.1569286,3.589856,0.0003308603,0.01059685,0,5534,"sp|P21328|RTJK_DROME","P21328","RTJK",3.06e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g32707",82.04803,0.4007646,0.1116439,3.589669,0.0003310986,0.01059924,0,9814,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.12e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g122",8862.125,-0.7337347,0.2044143,-3.589448,0.0003313789,0.01060298,271730,298224,"sp|Q9VD44|GLD2A_DROME","Q9VD44","GLD2A",3.04e-14,"Poly(A) RNA polymerase gld-2 homolog A (DmGLD2) (EC 2.7.7.19)","long-term memory [GO:0007616]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]","GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006378; GO:0007616; GO:0016779; GO:0031123; GO:0043005; GO:0043631; GO:0046872"
"g85762",263.232,0.5267021,0.1467435,3.589271,0.0003316045,0.01060496,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51593",1494.709,0.3589709,0.1000175,3.589081,0.0003318459,0.01060744,12077,16588,"sp|O75643|U520_HUMAN","O75643","U520",0,"U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]","GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013"
"g69754",709.084,-0.3938858,0.1097581,-3.588673,0.0003323655,0.01061882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60840",878.0078,-0.5072127,0.1413501,-3.588345,0.0003327842,0.01061983,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75930",156.5679,-1.269952,0.3538994,-3.588453,0.0003326453,0.01061983,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98366",169.7567,0.5121168,0.14272,3.588262,0.0003328891,0.01061983,0,5744,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.1e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22579",53.38971,1.100917,0.3069094,3.587108,0.0003343661,0.01066171,20910,37534,"sp|O46051|C4D14_DROME","O46051","C4D14",1.5e-06,"Probable cytochrome P450 4d14 (EC 1.14.-.-) (CYPIVD14)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g75544",29.2934,0.8676059,0.2419477,3.585923,0.0003358877,0.01070496,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26715",3216.337,-0.3014117,0.08407553,-3.585012,0.0003370632,0.01073063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45435",397.1774,-0.4996652,0.1393817,-3.584869,0.0003372476,0.01073063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68451",5745.684,-0.5266951,0.146914,-3.585056,0.0003370053,0.01073063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159568",9649.722,0.9729677,0.2714159,3.584785,0.0003373559,0.01073063,0,1228,"sp|P81577|CUPA3_CANPG","P81577","CUPA3",1.87e-13,"Cuticle protein AM1199 (CPAM1199)",NA,"GO:0042302"
"g19671",1389.65,-0.5524006,0.1541168,-3.584299,0.0003379845,0.01074008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126355",35.32662,0.7068441,0.1972055,3.584302,0.0003379813,0.01074008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94779",3851.912,0.6881447,0.1920034,3.584024,0.0003383405,0.01074086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100286",168.7507,0.3526939,0.09840501,3.584105,0.0003382358,0.01074086,0,1904,"sp|Q8R2N1|AQP3_MOUSE","Q8R2N1","AQP3",3.34e-11,"Aquaporin-3 (AQP-3) (Aquaglyceroporin-3)","cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; renal water absorption [GO:0070295]; response to retinoic acid [GO:0032526]; urea transport [GO:0015840]; water transport [GO:0006833]","GO:0002684; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0015840; GO:0016323; GO:0032526; GO:0042476; GO:0042802; GO:0070295; GO:0071456; GO:0090650"
"g29610",155.6104,0.7643085,0.2132934,3.583367,0.000339193,0.01076265,25796,33754,"sp|P11586|C1TC_HUMAN","P11586","C1TC",1.69e-26,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0048702; GO:0048703; GO:0061053; GO:0070062"
"g54900",1322.178,-0.5746243,0.1603656,-3.583213,0.000339393,0.01076373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10281",4291.233,-0.7519134,0.2098696,-3.582765,0.0003399767,0.01077507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14272",3792.122,-0.4237268,0.1182708,-3.582683,0.0003400834,0.01077507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3597",137.91,0.648939,0.1811498,3.582333,0.0003405395,0.01077898,39865,51404,"sp|P47827|CCNA2_XENLA","P47827","CCNA2",3.28e-25,"Cyclin-A2 (Cyclin-A)","cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]","GO:0000086; GO:0000307; GO:0005634; GO:0005737; GO:0044843; GO:0051301"
"g140636",98.06453,0.5770006,0.1610636,3.582439,0.0003404017,0.01077898,0,2794,"sp|Q920P6|ADA_RAT","Q920P6","ADA",7.92e-10,"Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)","adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; histamine secretion [GO:0001821]; hypoxanthine biosynthetic process [GO:0046101]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of T cell differentiation [GO:0045580]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]","GO:0000255; GO:0001666; GO:0001701; GO:0001821; GO:0001829; GO:0001883; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005615; GO:0005737; GO:0005764; GO:0005829; GO:0006154; GO:0006157; GO:0006196; GO:0007155; GO:0007568; GO:0008270; GO:0009410; GO:0009897; GO:0009986; GO:0010035; GO:0010460; GO:0016020; GO:0030054; GO:0030324; GO:0030890; GO:0032261; GO:0032263; GO:0032839; GO:0033089; GO:0033197; GO:0033632; GO:0042110; GO:0042323; GO:0042542; GO:0043025; GO:0043066; GO:0043103; GO:0043278; GO:0044209; GO:0045187; GO:0045580; GO:0045582; GO:0045987; GO:0046059; GO:0046061; GO:0046085; GO:0046101; GO:0046103; GO:0046111; GO:0046638; GO:0046936; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0050870; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256"
"g42815",314.4651,-0.3238612,0.09041873,-3.581794,0.0003412433,0.01079598,11343,21955,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.25e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g54589",83.48964,0.3591411,0.1002803,3.581372,0.0003417949,0.01080816,0,15360,"sp|Q6P3K3|FBX9_DANRE","Q6P3K3","FBX9",9.73e-13,"F-box only protein 9","protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006"
"g129332",685.6915,0.2865003,0.08000374,3.581086,0.0003421689,0.01081471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121817",324.4958,0.380597,0.1062979,3.580477,0.000342968,0.01083468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6057",148.0267,-0.6019749,0.1681464,-3.580065,0.0003435089,0.01084648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15085",848.2227,-0.3862126,0.1078875,-3.579772,0.0003438943,0.01085301,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132516",193.4302,0.9426598,0.2633383,3.579653,0.0003440508,0.01085301,0,3426,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.23e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g79634",8651.489,-0.4693187,0.1311186,-3.579344,0.0003444576,0.01086056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95505",144.3547,0.6462678,0.1805945,3.578558,0.0003454953,0.01088798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23495",81.89728,0.9677014,0.2704715,3.577831,0.0003464567,0.01091296,31476,32324,"sp|P56941|NPC1_PIG","P56941","NPC1",1.37e-08,"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486]","GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005783; GO:0005887; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030301; GO:0031902; GO:0032367; GO:0042632; GO:0048471; GO:1905103"
"g28881",783.025,-0.3423537,0.09572003,-3.576615,0.0003480719,0.01094615,22805,35944,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.89e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g29261",3678.91,-0.2995064,0.08375054,-3.576173,0.0003486608,0.01094615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32997",2845.233,-0.9845554,0.2752667,-3.576733,0.0003479157,0.01094615,39,4135,"sp|Q9VPW8|PINO_DROME","Q9VPW8","PINO",8.96e-14,"Protein pinocchio","olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]","GO:0007608; GO:0042048"
"g44745",200.3396,0.6373567,0.1781911,3.576816,0.0003478044,0.01094615,1445,5539,"sp|P58242|ASM3B_MOUSE","P58242","ASM3B",1.03e-06,"Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0045824; GO:0046466; GO:0050728"
"g62434",92.33383,0.4144057,0.1158699,3.576474,0.0003482596,0.01094615,0,7014,"sp|Q7ZY60|SAE2B_XENLA","Q7ZY60","SAE2B",1.13e-18,"SUMO-activating enzyme subunit 2-B (EC 2.3.2.-) (Ubiquitin-like 1-activating enzyme E1B-B) (Ubiquitin-like modifier-activating enzyme 2-B)","protein sumoylation [GO:0016925]","GO:0005524; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0046872"
"g86464",35.89155,0.580437,0.1623031,3.576254,0.0003485537,0.01094615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132273",170.3626,2.135344,0.5971071,3.576149,0.0003486929,0.01094615,1125,2072,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",2.22e-22,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g75264",858.0705,1.317537,0.3684397,3.575991,0.000348903,0.01094745,0,2339,"sp|P02515|HSP22_DROME","P02515","HSP22",3.98e-08,"Heat shock protein 22","chaperone-mediated protein folding [GO:0061077]; determination of adult lifespan [GO:0008340]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]","GO:0005759; GO:0006979; GO:0008340; GO:0009408; GO:0042802; GO:0051082; GO:0061077"
"g122986",550.2187,0.7487909,0.2094399,3.575206,0.0003499523,0.01097505,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146615",19.28166,1.383399,0.3869828,3.574833,0.000350452,0.01098541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98463",83.76967,0.5384086,0.150623,3.574544,0.0003508395,0.01099223,0,6673,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.17e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g70588",316.5985,0.2785168,0.07796468,3.572346,0.0003537982,0.01107958,0,10781,"sp|Q19749|ODP2_CAEEL","Q19749","ODP2",2.86e-13,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004742; GO:0005967; GO:0006086; GO:0006096"
"g40853",1030.263,-0.319347,0.08940651,-3.571854,0.0003544633,0.01109435,0,21863,"sp|Q8TBZ3|WDR20_HUMAN","Q8TBZ3","WDR20",7.57e-112,"WD repeat-containing protein 20 (Protein DMR)",NA,"GO:0005654"
"g79266",881.8454,-0.3018754,0.08451766,-3.571744,0.0003546123,0.01109435,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12756",409.0548,-0.3392089,0.09498922,-3.571025,0.0003555871,0.01111948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3201",2476.97,-0.3271834,0.09164497,-3.570119,0.0003568196,0.01114669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37823",1471.564,-0.2940363,0.08236428,-3.56995,0.0003570498,0.01114669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60992",17.29101,1.345805,0.3769837,3.56993,0.0003570763,0.01114669,832,8384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.03e-10,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g110116",18.46642,3.611058,1.011607,3.569627,0.0003574897,0.01114669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131920",129.2548,0.655069,0.1835061,3.569739,0.0003573374,0.01114669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134213",51.91144,0.9792046,0.2743146,3.569641,0.0003574714,0.01114669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156269",582.865,0.4765594,0.1335197,3.569208,0.0003580621,0.01115917,0,1307,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",8.57e-22,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g150093",22.60053,1.079232,0.3024327,3.568503,0.0003590266,0.01118385,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106098",51.32122,-3.081375,0.8635459,-3.568281,0.0003593304,0.01118794,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135882",19.12798,0.8812807,0.2470689,3.566944,0.0003611692,0.01123979,0,3160,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.14e-57,"PiggyBac transposable element-derived protein 4",NA,NA
"g19587",458.9264,-0.4246078,0.1190455,-3.566767,0.0003614121,0.01124195,0,28877,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.88e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g44283",189.3928,0.523909,0.1468916,3.566636,0.0003615935,0.01124219,15729,20872,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",4.96e-12,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g13468",111.8925,0.4149349,0.1163836,3.565236,0.0003635286,0.01126321,6455,11601,"sp|P49642|PRI1_HUMAN","P49642","PRI1",8.12e-16,"DNA primase small subunit (EC 2.7.7.102) (DNA primase 49 kDa subunit) (p49)","DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]","GO:0000287; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0008270; GO:0016020; GO:0032553"
"g14022",2291.151,-0.378812,0.1062408,-3.565598,0.0003630272,0.01126321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15993",660.3751,0.2097418,0.05882896,3.565281,0.0003634669,0.01126321,2611,14194,"sp|Q9VPW1|ASTE_DROME","Q9VPW1","ASTE",2.99e-15,"Protein asteroid","compound eye morphogenesis [GO:0001745]; compound eye photoreceptor fate commitment [GO:0001752]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; larval somatic muscle development [GO:0007526]","GO:0001745; GO:0001752; GO:0007476; GO:0007526; GO:0008586"
"g16174",873.9485,-0.8070847,0.2263312,-3.565945,0.0003625476,0.01126321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21404",1028.202,0.367197,0.1029827,3.565619,0.0003629979,0.01126321,11966,15354,"sp|Q99798|ACON_HUMAN","Q99798","ACON",6.13e-34,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)","citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]","GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539"
"g65388",552.8696,0.4335839,0.1216046,3.565521,0.0003631335,0.01126321,4326,11975,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.22e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g72773",130.9086,0.4215171,0.1182329,3.565141,0.0003636602,0.01126321,0,7095,"sp|P84057|H2A_TIGCA","P84057","H2A",6.41e-22,"Histone H2A",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g153512",17460.31,0.620725,0.1740944,3.56545,0.0003632327,0.01126321,0,1504,"sp|P35416|MYSP2_DROME","P35416","MYSP2",6.06e-21,"Paramyosin, short form (Miniparamyosin)","actomyosin structure organization [GO:0031032]; mesoderm development [GO:0007498]; myofibril assembly [GO:0030239]","GO:0005737; GO:0005856; GO:0005863; GO:0007498; GO:0016459; GO:0030239; GO:0031032"
"g7524",2311.2,0.3104883,0.08709681,3.564865,0.0003640437,0.01126572,0,5434,"sp|Q4GX87|RL38_JULON","Q4GX87","RL38",2.16e-17,"60S ribosomal protein L38","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g63270",2974.077,-0.4094426,0.1148561,-3.564832,0.000364089,0.01126572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1728",102.0682,0.3910223,0.1097002,3.564464,0.0003646004,0.01126637,110185,117050,"sp|Q9D7H3|RTCA_MOUSE","Q9D7H3","RTCA",5.53e-11,"RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1)","RNA processing [GO:0006396]","GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396"
"g60645",208.8444,2.445553,0.6860972,3.564442,0.0003646316,0.01126637,4052,10074,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.54e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g158010",237.6124,0.9672534,0.2713559,3.56452,0.000364523,0.01126637,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12641",618.4433,-0.6736794,0.1890226,-3.564016,0.0003652243,0.01126873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81491",54.61394,1.457549,0.4089583,3.564053,0.0003651724,0.01126873,5405,8290,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.02e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g84115",609.7692,-0.4333313,0.1215862,-3.563986,0.0003652659,0.01126873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101291",2010.539,0.3639177,0.1021126,3.563887,0.0003654036,0.01126873,382,4391,"sp|Q9NB32|TCPD_OCHTR","Q9NB32","TCPD",1.62e-19,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g39945",162.9187,0.6817891,0.1913137,3.563724,0.0003656303,0.01127035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150994",146.4444,0.4044506,0.1135124,3.563052,0.0003665675,0.01128941,0,1824,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",9.2e-14,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g159438",27.93931,0.6621678,0.185844,3.563031,0.0003665971,0.01128941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160403",52.22437,0.9625398,0.2701708,3.562709,0.0003670481,0.01129793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111849",80.89365,1.06869,0.2999868,3.562458,0.0003673987,0.01129799,0,1525,"sp|Q6P0S3|TM45B_DANRE","Q6P0S3","TM45B",1.09e-11,"Transmembrane protein 45B",NA,"GO:0016021"
"g145935",412.5536,-0.5190835,0.1457043,-3.562581,0.0003672262,0.01129799,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48029",49.6959,0.7536372,0.2115698,3.56212,0.0003678716,0.01130717,11965,18371,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.47e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g7595",796.9627,0.4524842,0.1270422,3.561683,0.0003684847,0.01131527,40788,50424,"sp|Q19QT7|CGL_PIG","Q19QT7","CGL",6.44e-08,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; protein sulfhydration [GO:0044524]; transsulfuration [GO:0019346]","GO:0004123; GO:0005516; GO:0005737; GO:0006629; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0051092; GO:0070814; GO:0080146"
"g85751",244.2483,-3.040034,0.8535232,-3.561747,0.0003683957,0.01131527,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21079",1095.002,-0.4218455,0.1184601,-3.561075,0.000369339,0.01133614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137444",247.141,0.3517476,0.09878012,3.560915,0.0003695649,0.0113377,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126094",181.7218,0.7676799,0.2156018,3.560638,0.0003699548,0.01133892,0,2861,"sp|Q2KJI2|STT3A_BOVIN","Q2KJI2","STT3A",1.15e-54,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"g144250",300.8261,-0.5596254,0.1571648,-3.560756,0.000369788,0.01133892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60890",449.9038,-0.3149656,0.08846928,-3.56017,0.0003706152,0.01135379,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29366",1128.847,-0.6015278,0.1689752,-3.559858,0.0003710548,0.01136189,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101559",25.54672,0.494597,0.1389463,3.559628,0.0003713804,0.01136648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93615",25.33025,0.5791632,0.162726,3.559132,0.0003720829,0.01137724,0,7246,"sp|O00370|LORF2_HUMAN","O00370","LORF2",4.62e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g108963",636.2916,2.731859,0.7675478,3.559203,0.0003719813,0.01137724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32998",3828.14,-0.8848335,0.2486548,-3.558482,0.0003730046,0.01140004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9844",561.8267,0.5157831,0.1449726,3.557797,0.0003739787,0.01142442,50515,69091,"sp|Q17GM7|CISY1_AEDAE","Q17GM7","CISY1",8.58e-27,"Probable citrate synthase 1, mitochondrial (EC 2.3.3.16)","carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]","GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101"
"g22396",33.67111,0.8427522,0.2368936,3.557514,0.0003743812,0.01143133,16969,27844,"sp|A1ZAY1|DLISH_DROME","A1ZAY1","DLISH",2.66e-26,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"g22959",354.7863,-0.3686444,0.1036289,-3.55735,0.0003746148,0.01143307,0,5222,"sp|P0C218|DDX20_DANRE","P0C218","DDX20",5.62e-125,"Probable ATP-dependent RNA helicase DDX20 (EC 3.6.1.15) (EC 3.6.4.13) (DEAD box protein 20)","spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0016887; GO:0032797; GO:0034719"
"g133417",21.95409,0.5739383,0.1613458,3.557194,0.0003748367,0.01143446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24859",677.6242,-0.3122155,0.08777326,-3.557068,0.0003750169,0.01143457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141096",52.49236,0.4686558,0.1317652,3.556749,0.0003754729,0.01144309,0,1554,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.32e-27,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g153781",246.2512,0.4100358,0.1152905,3.556544,0.0003757656,0.01144663,0,795,"sp|Q9JHW0|PSB7_RAT","Q9JHW0","PSB7",3.14e-27,"Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z)","proteasomal protein catabolic process [GO:0010498]","GO:0000502; GO:0004298; GO:0005634; GO:0005737; GO:0005839; GO:0010498; GO:0019774"
"g1779",603.7221,-0.2980488,0.08380897,-3.556287,0.0003761329,0.01144705,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134155",18.8092,0.6039364,0.1698215,3.5563,0.000376114,0.01144705,0,3299,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.15e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g30828",40.71567,0.5122446,0.1440493,3.556036,0.0003764927,0.01144725,31354,34131,"sp|Q8R4C1|AT2C2_RAT","Q8R4C1","AT2C2",5.28e-14,"Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2)","calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659]","GO:0000139; GO:0005388; GO:0005524; GO:0005783; GO:0005886; GO:0006828; GO:0006874; GO:0009898; GO:0015662; GO:0016021; GO:0016323; GO:0016887; GO:0031410; GO:0032588; GO:0034220; GO:0046872; GO:0048471; GO:0061180; GO:0070588; GO:0072659; GO:0090280; GO:0140613"
"g116298",103.6537,0.9582633,0.2694665,3.556151,0.0003763284,0.01144725,0,3054,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.38e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g48875",84.01754,0.3859336,0.1085624,3.554948,0.0003780543,0.01148934,0,8214,"sp|B1P1W2|SDHF2_ARTSF","B1P1W2","SDHF2",1.01e-18,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]","GO:0005739; GO:0005759; GO:0006121; GO:0018293"
"g143368",23.51465,0.7767257,0.2185012,3.554789,0.0003782819,0.01149087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14619",34.95775,-0.6093241,0.1714427,-3.554098,0.0003792773,0.01150492,0,16624,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.66e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15847",19.23161,-0.7087663,0.1994171,-3.554191,0.0003791444,0.01150492,29835,55058,"sp|Q6P6Q9|MICU1_RAT","Q6P6Q9","MICU1",1.5e-13,"Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog)","calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]","GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0032592; GO:0034704; GO:0036444; GO:0042802; GO:0046982; GO:0051260; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246"
"g97060",985.8738,-0.3477415,0.09783861,-3.554236,0.0003790794,0.01150492,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41501",63.76985,0.8313747,0.2339436,3.553739,0.0003797958,0.01151526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125950",605.7359,0.4844315,0.1363405,3.553101,0.0003807176,0.01153241,0,3940,"sp|P46479|G6PI_CALFI","P46479","G6PI",1.26e-17,"Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Fragment)","gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]","GO:0004347; GO:0005737; GO:0006094; GO:0006096; GO:0051156"
"g150244",622.3197,0.4644139,0.1307062,3.553113,0.0003807011,0.01153241,0,1204,"sp|Q3T084|TCPW_BOVIN","Q3T084","TCPW",2.91e-23,"T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CCT-zeta-2)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g32746",28.3214,1.417234,0.3988877,3.552965,0.0003809156,0.01153302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16512",409.806,-0.2716876,0.07647812,-3.552487,0.0003816072,0.01154856,41865,45773,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.22e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g48268",532.9557,-0.2884501,0.08120904,-3.551945,0.0003823942,0.01156173,3535,13919,"sp|P08548|LIN1_NYCCO","P08548","LIN1",5.69e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g98447",213.4886,0.3735957,0.1051807,3.551942,0.0003823993,0.01156173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53938",367.1632,0.8178571,0.230277,3.551623,0.0003828627,0.01156434,3603,13248,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.94e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g77255",7445.204,0.3349451,0.0943105,3.551514,0.000383021,0.01156434,0,6385,"sp|Q86FP7|RS23_DERVA","Q86FP7","RS23",1.04e-32,"40S ribosomal protein S23","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022627; GO:0042788"
"g131079",19.43168,-0.9506934,0.2676696,-3.551742,0.0003826901,0.01156434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31009",232.9683,-0.2945771,0.08295548,-3.551027,0.0003837314,0.01158039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13189",14679.07,0.6842563,0.1927046,3.550804,0.0003840557,0.0115822,20325,29074,"sp|Q25009|TBB1_HOMAM","Q25009","TBB1",1.9e-148,"Tubulin beta-1 chain (Beta-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g44841",2482.822,-0.2262454,0.0637178,-3.550741,0.0003841486,0.0115822,6465,11779,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.91e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1464",463.3949,0.3003901,0.08461718,3.54999,0.0003852464,0.01160989,60596,62814,"sp|O43390|HNRPR_HUMAN","O43390","HNRPR",9.65e-21,"Heterogeneous nuclear ribonucleoprotein R (hnRNP R)","mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0071013; GO:1990904"
"g3027",791.1136,-0.5161224,0.1453942,-3.549813,0.0003855046,0.01161227,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81819",43.4683,0.5171602,0.1456935,3.549645,0.0003857513,0.0116143,6015,8830,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.99e-18,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g134664",605.718,0.3724098,0.1049239,3.549333,0.0003862083,0.01162266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g784",2214.914,-0.4777687,0.1346163,-3.549115,0.000386528,0.01162302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6861",33.35618,-0.5969761,0.1682058,-3.54908,0.0003865791,0.01162302,42606,45384,"sp|P14381|YTX2_XENLA","P14381","YTX2",2.58e-12,"Transposon TX1 uncharacterized 149 kDa protein (ORF 2)",NA,"GO:0003824"
"g100996",137.5128,0.8388422,0.2363692,3.548864,0.0003868971,0.01162719,0,1944,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.93e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g8532",24.68256,-0.6579737,0.1854508,-3.547969,0.0003882134,0.01165594,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113864",22.28975,1.149278,0.3239182,3.54805,0.0003880939,0.01165594,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15240",77.1423,0.5588681,0.157545,3.547356,0.0003891187,0.01166906,34875,46432,"sp|P08548|LIN1_NYCCO","P08548","LIN1",5.11e-12,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g121440",53.57845,1.042676,0.2939171,3.547516,0.0003888824,0.01166906,2135,4360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.28e-28,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g147236",53.69146,1.221076,0.3442262,3.547307,0.0003891906,0.01166906,0,1489,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.38e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g35057",1175.789,-0.2842821,0.08014473,-3.54711,0.0003894823,0.0116724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116309",151.0687,-0.6330394,0.1784802,-3.546834,0.0003898908,0.01167924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37992",63.30583,-0.4231707,0.1193179,-3.546582,0.0003902636,0.01167961,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48335",374.3005,0.4684654,0.1320864,3.546658,0.0003901502,0.01167961,0,10823,"sp|Q7ZXA8|THO5B_XENLA","Q7ZXA8","THO5B",1.14e-08,"THO complex subunit 5 homolog B","cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0030154; GO:0051028"
"g97579",54.77307,-0.7502876,0.2115703,-3.54628,0.0003907102,0.01168757,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130880",25.89172,0.6478139,0.1826907,3.54596,0.0003911851,0.01169638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15884",2971.309,-0.4063175,0.1145945,-3.545698,0.0003915753,0.01170265,0,32890,"sp|Q6DGV1|CELF4_DANRE","Q6DGV1","CELF4",6.09e-21,"CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4)","mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904"
"g100290",174.3949,0.5717953,0.1612913,3.545109,0.0003924513,0.01171802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132924",362.8933,0.2467992,0.06961523,3.54519,0.0003923304,0.01171802,0,3394,"sp|Q0IIX9|TFP11_XENTR","Q0IIX9","TFP11",6.33e-93,"Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)","spliceosomal complex disassembly [GO:0000390]","GO:0000390; GO:0003676; GO:0005681; GO:0071008"
"g45289",1408.646,0.5667164,0.1598973,3.544252,0.0003937294,0.01174535,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77445",866.253,-0.4305407,0.1214731,-3.544329,0.0003936144,0.01174535,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41853",3689.449,-0.4238928,0.1196148,-3.543816,0.0003943798,0.01175385,0,16489,"sp|P45845|LYOX_PIG","P45845","LYOX",2.18e-07,"Protein-lysine 6-oxidase (EC 1.4.3.13) (Lysyl oxidase) [Cleaved into: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form]","blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; peptidyl-lysine oxidation [GO:0018057]","GO:0004720; GO:0005507; GO:0005518; GO:0005576; GO:0005615; GO:0018057; GO:0030199; GO:0048514"
"g53304",298.4222,0.3855294,0.1087877,3.54387,0.0003943,0.01175385,2128,15634,"sp|Q16U49|MED14_AEDAE","Q16U49","MED14",4.95e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g118207",82.76789,0.3819871,0.1077934,3.543697,0.0003945583,0.01175385,0,2774,"sp|Q15459|SF3A1_HUMAN","Q15459","SF3A1",9.73e-27,"Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114)","mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]","GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241"
"g144102",191.7566,0.4960069,0.1399802,3.543407,0.000394993,0.01176139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38979",1008.722,-0.3150567,0.08894024,-3.542341,0.0003965925,0.01180359,1321,25037,"sp|Q5EB92|WDR70_RAT","Q5EB92","WDR70",4.81e-159,"WD repeat-containing protein 70","regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173]","GO:0005634; GO:0019899; GO:0035861; GO:1903775; GO:2001173"
"g67720",3967.085,0.6775114,0.1912823,3.541945,0.0003971881,0.01181589,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126446",181.66,0.3375414,0.09530651,3.541641,0.0003976467,0.0118241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7489",199.6542,-0.2956073,0.08349747,-3.540315,0.0003996499,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20978",356.8302,0.2842825,0.08030058,3.54023,0.0003997787,0.01182554,2013,8484,"sp|O88480|CABIN_RAT","O88480","CABIN",6.86e-55,"Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)","DNA replication-independent chromatin assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]","GO:0004864; GO:0005634; GO:0005737; GO:0006336; GO:0014823; GO:0019904; GO:0030346; GO:0060548"
"g24566",34.12448,0.9024501,0.2549151,3.540198,0.0003998263,0.01182554,6455,7017,"sp|Q6PV61|H2A_PENVA","Q6PV61","H2A",6.88e-68,"Histone H2A","defense response to bacterium [GO:0042742]","GO:0000786; GO:0003677; GO:0005634; GO:0042742; GO:0046982"
"g29407",615.2217,1.454785,0.4109328,3.540202,0.0003998214,0.01182554,30377,36179,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.79e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29753",258.1762,-0.2280803,0.06442059,-3.540488,0.0003993876,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48054",1100.15,0.483482,0.1365721,3.540123,0.0003999403,0.01182554,0,6070,"sp|Q08647|PUS7_YEAST","Q08647","PUS7",5.2e-08,"Multisubstrate pseudouridine synthase 7 (EC 5.4.99.-) (EC 5.4.99.27) (RNA pseudouridylate synthase 7) (RNA-uridine isomerase 7) (tRNA pseudouridine(13) synthase)","enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522]; RNA splicing [GO:0008380]; snRNA pseudouridine synthesis [GO:0031120]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119]","GO:0000455; GO:0001522; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006400; GO:0008380; GO:0009982; GO:0031119; GO:0031120; GO:0031429; GO:0106029; GO:1990481"
"g70245",914.4256,-0.5685654,0.1605591,-3.541159,0.0003983741,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92577",4124.776,-0.3341181,0.09437629,-3.540276,0.0003997085,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94365",58.88293,0.7650578,0.216112,3.540098,0.0003999778,0.01182554,0,4474,"sp|O96553|C1TC_DROME","O96553","C1TC",9.07e-23,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g115929",19.99861,0.8802412,0.2485656,3.541283,0.0003981868,0.01182554,0,4875,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.04e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g120191",413.9469,-0.3805346,0.1074887,-3.540228,0.0003997817,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151917",1164.151,0.4169045,0.1177683,3.540039,0.0004000677,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153811",728.546,2.987047,0.8437717,3.540113,0.0003999559,0.01182554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44890",1586.441,-0.3649111,0.1030887,-3.539778,0.0004004644,0.01182648,5487,20034,"sp|Q9VE46|SC5A7_DROME","Q9VE46","SC5A7",4.48e-27,"High-affinity choline transporter 1","acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]","GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021"
"g122417",25.86776,0.9158771,0.2587326,3.539859,0.0004003403,0.01182648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59585",178.3457,-0.5374669,0.1518736,-3.538909,0.0004017838,0.01186003,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141918",562.2781,1.620564,0.4581246,3.537387,0.0004041071,0.01192318,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72657",30.34696,-0.753044,0.2128901,-3.537242,0.0004043289,0.0119243,3973,7234,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.12e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g17180",401.7107,0.2570677,0.07268145,3.53691,0.0004048375,0.01193387,8169,25564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.55e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g59417",3124.492,0.3855391,0.1090116,3.53668,0.0004051903,0.01193883,0,9649,"sp|O16797|RL3_DROME","O16797","RL3",6.9e-26,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g44",237.7361,0.3134612,0.08866653,3.535283,0.0004073392,0.0119967,359715,370168,"sp|Q15269|PWP2_HUMAN","Q15269","PWP2",4.89e-09,"Periodic tryptophan protein 2 homolog","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]","GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388"
"g4298",2411.95,-0.3400305,0.09621337,-3.534129,0.000409121,0.0120437,115405,127806,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.89e-30,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g65456",1248.48,-0.2670197,0.07555946,-3.533902,0.0004094721,0.01204856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79006",38.47983,2.058078,0.5825156,3.533087,0.000410738,0.01207484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119680",141.9997,0.6807612,0.1926778,3.533158,0.0004106266,0.01207484,205,2320,"sp|Q9NDM2|GUTR1_DROME","Q9NDM2","GUTR1",3.7e-73,"Protein trapped in endoderm-1","ectopic germ cell programmed cell death [GO:0035234]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; G protein-coupled receptor signaling pathway [GO:0007186]; pole cell migration [GO:0007280]","GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007280; GO:0007281; GO:0008354; GO:0016021; GO:0035234"
"g32517",3764.769,-0.3125753,0.08848043,-3.532706,0.0004113299,0.01208676,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83627",75.00468,2.601602,0.7364589,3.532583,0.0004115214,0.0120869,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17904",1402.526,0.2814151,0.07968447,3.531618,0.0004130256,0.01212559,10184,25384,"sp|Q5R874|DHX9_PONAB","Q5R874","DHX9",9.64e-47,"ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)","alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]","GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1900152; GO:1903608; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767"
"g12915",246.8548,-0.5324059,0.1507876,-3.530833,0.0004142529,0.01215061,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71022",667.6925,-0.4513235,0.1278214,-3.530893,0.0004141596,0.01215061,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3841",1276.043,0.449098,0.1272012,3.530611,0.0004146005,0.0121553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42570",1221.822,-0.3524459,0.09983079,-3.530433,0.0004148801,0.012158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94232",831.0811,0.4483595,0.1270121,3.530054,0.0004154755,0.01216994,0,7172,"sp|P15259|PGAM2_HUMAN","P15259","PGAM2",1.14e-12,"Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]","GO:0004082; GO:0004619; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0006941; GO:0007219; GO:0007283; GO:0016787; GO:0042802; GO:0046538; GO:0046689; GO:0070062"
"g99851",180.7425,-0.341023,0.09661072,-3.529867,0.0004157685,0.01217302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51207",314.7214,-0.3566974,0.1010716,-3.529156,0.0004168876,0.01220027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22384",297.4827,0.6168037,0.1748023,3.528578,0.0004177985,0.01221466,385,5520,"sp|D0E8I5|PHNZ_UNCHF","D0E8I5","PHNZ",6.46e-10,"2-amino-1-hydroxyethylphosphonate dioxygenase (glycine-forming) (EC 1.13.11.78) (Di-iron oxygenase) (Nonheme iron-dependent oxygenase)",NA,"GO:0016491; GO:0016787; GO:0046872"
"g79195",30.06659,-0.4379279,0.1241121,-3.528485,0.000417945,0.01221466,0,9252,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.65e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g95067",3637.483,-0.2856347,0.08094732,-3.528649,0.0004176867,0.01221466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5000",1898.583,-0.3417994,0.09687462,-3.528265,0.0004182924,0.01221931,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12606",429.8505,-0.2934162,0.08318868,-3.527117,0.0004201112,0.01222936,37855,46478,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.98e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36242",81.9787,0.4117456,0.1167295,3.527347,0.0004197468,0.01222936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52697",33.89995,0.4970334,0.140888,3.527862,0.0004189299,0.01222936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68324",161.2442,0.4869143,0.1380521,3.527032,0.0004202456,0.01222936,0,3204,"sp|Q5M7J9|EMC2_XENTR","Q5M7J9","EMC2",1.68e-14,"ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35)","protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0005737; GO:0005783; GO:0005789; GO:0042406; GO:0045050; GO:0071816; GO:0072546"
"g70855",86.36682,-0.4004173,0.1135253,-3.52712,0.0004201056,0.01222936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105387",32.27729,0.6251115,0.1771999,3.52772,0.0004191554,0.01222936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117498",178.3099,0.6390698,0.1811931,3.52701,0.0004202807,0.01222936,0,2958,"sp|Q06197|IDHC_SOYBN","Q06197","IDHC",4.13e-13,"Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005739; GO:0006097; GO:0006099; GO:0006102; GO:0006739; GO:0051287"
"g143778",422.7221,0.3702586,0.1049791,3.526976,0.0004203353,0.01222936,0,1564,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",1.98e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g152186",20.90001,1.19734,0.3394718,3.527067,0.0004201901,0.01222936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50680",42.85,-0.4361227,0.1236702,-3.526497,0.0004210959,0.0122405,1575,17049,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.56e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g104127",3336.533,0.5321331,0.1508941,3.526534,0.0004210369,0.0122405,945,4069,"sp|Q01842|POK_DROME","Q01842","POK",3e-50,"Ets DNA-binding protein pokkuri (Protein anterior open) (Protein yan)","border follicle cell migration [GO:0007298]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gonad development [GO:0008406]; muscle cell development [GO:0055001]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of compound eye photoreceptor cell differentiation [GO:0110118]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of R7 cell differentiation [GO:0045677]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oenocyte delamination [GO:0060233]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; R3/R4 cell fate commitment [GO:0007464]; regulation of establishment of planar polarity [GO:0090175]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sevenless signaling pathway [GO:0045500]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006897; GO:0007173; GO:0007298; GO:0007391; GO:0007464; GO:0008340; GO:0008406; GO:0008543; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0035155; GO:0035157; GO:0045500; GO:0045677; GO:0045892; GO:0048010; GO:0050767; GO:0055001; GO:0060233; GO:0090090; GO:0090175; GO:0110118; GO:1903688"
"g131075",245.033,0.5599294,0.1587881,3.526268,0.0004214602,0.01224559,0,2994,"sp|Q9N1Q0|RSMB_MACEU","Q9N1Q0","RSMB",2.95e-16,"Small nuclear ribonucleoprotein-associated protein B' (snRNP-B') (snRPB') (Sm protein B') (Sm-B') (SmB')","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005683; GO:0005685; GO:0005687; GO:0005829; GO:0034709; GO:0034719; GO:0046540; GO:0071005; GO:0071007"
"g59198",34.45139,0.5289637,0.1500185,3.525991,0.0004219021,0.01225294,13245,13697,"sp|P61797|APTX_CANLF","P61797","APTX",1.18e-07,"Aprataxin (EC 3.6.1.71) (EC 3.6.1.72) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT)","double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]","GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0030983; GO:0033699; GO:0046872; GO:0120108; GO:1990165"
"g122164",1962.26,-0.6562236,0.1861293,-3.525633,0.0004224726,0.01226401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38724",3299.26,-0.4423005,0.1254667,-3.525243,0.0004230947,0.01226558,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66658",60.48102,0.5152495,0.1461562,3.525335,0.0004229476,0.01226558,0,8255,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.71e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g138706",276.8825,0.8745791,0.2480833,3.525345,0.0004229311,0.01226558,0,2945,"sp|O35604|NPC1_MOUSE","O35604","NPC1",3e-13,"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; viral entry into host cell [GO:0046718]","GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103"
"g35120",5902.038,-0.4181244,0.1186128,-3.525121,0.0004232888,0.01226572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7515",146.7475,0.3618742,0.1026906,3.523927,0.0004252015,0.01231564,29205,51832,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.24e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73253",542.9379,0.3415384,0.09692524,3.52373,0.000425517,0.01231927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35143",633.6729,-0.2776978,0.07882,-3.52319,0.0004263863,0.0123343,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109920",58.0194,0.5106375,0.1449369,3.523171,0.0004264169,0.0123343,0,1954,"sp|Q9UJX6|ANC2_HUMAN","Q9UJX6","ANC2",9.48e-21,"Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]","GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0010629; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0051445; GO:0070979; GO:0090129"
"g97920",1624.857,-0.5239662,0.1487258,-3.523035,0.0004266346,0.01233509,3342,6384,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.24e-06,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62818",73.77026,2.446159,0.6945102,3.522136,0.0004280846,0.01237149,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21282",22.15721,1.289976,0.3662764,3.521864,0.0004285239,0.01237543,39505,44304,"sp|Q8R0M8|MOT5_MOUSE","Q8R0M8","MOT5",1.71e-10,"Monocarboxylate transporter 5 (MCT 5)","monocarboxylic acid transport [GO:0015718]","GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021"
"g111232",58.31969,0.9297066,0.2639851,3.521815,0.0004286029,0.01237543,0,5004,"sp|O02387|CU17_BOMMO","O02387","CU17",2.33e-06,"Larval cuticle protein LCP-17",NA,"GO:0042302"
"g72777",1093.914,0.47087,0.1337144,3.52146,0.0004291773,0.01238118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140321",53.4272,1.025356,0.2911835,3.521338,0.0004293754,0.01238118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155388",113.3677,0.3943491,0.1119882,3.521345,0.0004293629,0.01238118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112210",6271.079,0.2666494,0.07573337,3.520897,0.0004300897,0.01239626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10783",247.38,-0.2885278,0.08196641,-3.520074,0.0004314262,0.01242926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3892",121.7389,-0.4838585,0.1374985,-3.519008,0.000433163,0.01246116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19967",368.1155,1.933724,0.5495217,3.518923,0.000433303,0.01246116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47991",36.16098,0.6455932,0.1834531,3.519119,0.0004329821,0.01246116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105347",263.1348,0.9950989,0.2827735,3.519067,0.0004330675,0.01246116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38071",337.1372,-0.2917166,0.08290365,-3.518743,0.0004335969,0.01246129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58497",27.38974,-0.4749072,0.1349673,-3.518685,0.000433692,0.01246129,0,8146,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.01e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16173",4665.083,-0.3602461,0.102393,-3.518269,0.0004343715,0.01246975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41421",77.15601,0.9894067,0.2812131,3.518352,0.0004342365,0.01246975,5016,13144,"sp|Q3SZP5|ACOX1_BOVIN","Q3SZP5","ACOX1",6.03e-08,"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0009062; GO:0016401; GO:0019395; GO:0033540; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493"
"g64422",646.2407,-0.4075947,0.1158554,-3.518134,0.0004345933,0.01247059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84933",31.33359,0.6157849,0.1750611,3.517543,0.0004355616,0.01249285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85298",1057.856,0.4793503,0.1362943,3.517025,0.0004364132,0.01251173,115,7219,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.23e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g67584",77.61772,0.9687682,0.2755137,3.516225,0.0004377305,0.01253841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136900",682.3042,-0.4202754,0.1195223,-3.516293,0.0004376178,0.01253841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49303",619.2679,-0.4598191,0.1307903,-3.515697,0.000438601,0.01255779,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14250",107.8951,0.3811264,0.1084345,3.514807,0.0004400732,0.0125841,8785,17782,"sp|Q4KLF3|KTI12_XENLA","Q4KLF3","KTI12",3.28e-10,"Protein KTI12 homolog","regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]","GO:0002098; GO:0005524; GO:0006357"
"g56127",20.90705,1.144641,0.3256751,3.514672,0.0004402968,0.0125841,10415,13731,"sp|P48987|ATO_DROME","P48987","ATO",2.86e-10,"Protein atonal","antennal joint morphogenesis [GO:0048801]; antennal morphogenesis [GO:0048800]; Bolwig's organ morphogenesis [GO:0001746]; brain development [GO:0007420]; cell fate commitment [GO:0045165]; eye-antennal disc morphogenesis [GO:0007455]; insect visual primordium development [GO:0001748]; male courtship behavior, veined wing generated song production [GO:0045433]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron recognition [GO:0008038]; oenocyte development [GO:0007438]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; R8 cell fate commitment [GO:0007460]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of sound [GO:0007605]","GO:0000978; GO:0001746; GO:0001748; GO:0005634; GO:0006357; GO:0007399; GO:0007420; GO:0007423; GO:0007438; GO:0007455; GO:0007460; GO:0007605; GO:0008038; GO:0010608; GO:0016360; GO:0030182; GO:0045165; GO:0045433; GO:0045944; GO:0046982; GO:0048800; GO:0048801"
"g98860",76.54535,0.4103425,0.1167471,3.5148,0.0004400859,0.0125841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103914",23.39521,0.932888,0.265424,3.514709,0.0004402368,0.0125841,0,6067,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.36e-66,"PiggyBac transposable element-derived protein 4",NA,NA
"g15515",180.3621,0.3739777,0.1064092,3.514525,0.0004405415,0.01258554,17505,28895,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.2e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g128842",76.78206,0.4545775,0.1293777,3.513569,0.0004421295,0.01262534,552,3725,"sp|Q13011|ECH1_HUMAN","Q13011","ECH1",4.84e-13,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)","fatty acid beta-oxidation [GO:0006635]","GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016020; GO:0051750; GO:0070062"
"g14553",945.7388,-0.2194031,0.06246504,-3.512414,0.0004440556,0.01267475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2471",357.2238,-0.2986095,0.08501886,-3.512273,0.0004442913,0.0126759,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9894",19279.31,-0.40295,0.1147343,-3.512027,0.000444703,0.01268206,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99859",87.28355,0.4775211,0.1359945,3.511326,0.0004458773,0.01270995,0,3084,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.33e-12,"PiggyBac transposable element-derived protein 4",NA,NA
"g36472",47.96051,1.379761,0.3929606,3.511193,0.0004461007,0.01271073,16568,27434,"sp|Q6U6H1|IOD_HALRO","Q6U6H1","IOD",5.02e-10,"Thyroxine 5'-deiodinase (EC 1.21.99.4) (Iodothyronine deiodinase)","hormone biosynthetic process [GO:0042446]","GO:0004800; GO:0005634; GO:0016020; GO:0042446"
"g149790",61.90273,0.4859462,0.1384158,3.510772,0.0004468081,0.01272529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46918",1129.25,-0.5474555,0.1559523,-3.510403,0.0004474277,0.01273175,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103521",834.4468,0.6151561,0.1752327,3.51051,0.000447248,0.01273175,2355,5514,"sp|Q86IC8|CAMT2_DICDI","Q86IC8","CAMT2",2.53e-31,"Probable caffeoyl-CoA O-methyltransferase 2 (EC 2.1.1.104) (O-methyltransferase 6)","methylation [GO:0032259]; response to bacterium [GO:0009617]","GO:0008757; GO:0009617; GO:0032259; GO:0042409; GO:0045335; GO:0046872"
"g49553",1109.639,0.2212901,0.06304514,3.510027,0.0004480618,0.01273626,988,5171,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.78e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73671",54.55394,0.425333,0.1211739,3.510104,0.0004479322,0.01273626,0,7607,"sp|P21328|RTJK_DROME","P21328","RTJK",4.33e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g98555",564.3872,-0.4816553,0.1372299,-3.509842,0.0004483727,0.01273626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139066",66.35638,0.7195755,0.2050108,3.50994,0.0004482078,0.01273626,0,2917,"sp|Q8BYK4|RDH12_MOUSE","Q8BYK4","RDH12",1.18e-13,"Retinol dehydrogenase 12 (EC 1.1.1.300)","cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095"
"g60317",255.8926,0.350632,0.0999055,3.509636,0.0004487199,0.01274054,2047,4644,"sp|Q9TVQ5|SPT4H_DROME","Q9TVQ5","SPT4H",7.91e-06,"Transcription elongation factor SPT4 (DRB sensitivity-inducing factor small subunit) (DSIF small subunit) (dSpt4)","chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0005634; GO:0005703; GO:0005705; GO:0006325; GO:0006368; GO:0006397; GO:0008023; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0045944; GO:0046982"
"g25929",973.8105,0.7556847,0.2153352,3.509341,0.0004492177,0.01274909,36375,41157,"sp|Q8IZJ3|CPMD8_HUMAN","Q8IZJ3","CPMD8",3.46e-12,"C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8","eye development [GO:0001654]","GO:0001654; GO:0004867; GO:0005615; GO:0005886"
"g88191",27.67438,1.665342,0.4746429,3.508621,0.0004504366,0.01277808,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2642",936.5545,-0.4005512,0.1141742,-3.508245,0.0004510736,0.01278627,72852,83144,"sp|Q9P055|JKAMP_HUMAN","Q9P055","JKAMP",6.59e-08,"JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4)","response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625"
"g86110",1573.692,0.2308659,0.06580719,3.508218,0.00045112,0.01278627,0,8212,"sp|P21328|RTJK_DROME","P21328","RTJK",1.37e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g40784",75.08721,-0.4444585,0.1267038,-3.507853,0.0004517378,0.01279819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14956",621.9028,-0.2878674,0.08206891,-3.50763,0.0004521167,0.01280332,49896,58424,"sp|A8MQ14|ZN850_HUMAN","A8MQ14","ZN850",1.14e-74,"Zinc finger protein 850","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g19177",96.4174,0.5203385,0.1483555,3.507375,0.000452551,0.01281002,44285,51157,"sp|Q04451|GARS_BOMMO","Q04451","GARS",1.84e-36,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]","GO:0004820; GO:0005524; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983"
"g28065",299.4803,-0.4405921,0.1256259,-3.507176,0.0004528898,0.01281401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42885",8077.24,-0.2498376,0.07124424,-3.506776,0.0004535714,0.0128277,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28003",1663.379,0.349369,0.0996462,3.506095,0.0004547337,0.01285496,135,11931,"sp|P80455|RS12_DROME","P80455","RS12",7.68e-07,"40S ribosomal protein S12","cytoplasmic translation [GO:0002181]; positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0002181; GO:0003735; GO:0022626; GO:0022627; GO:0090263"
"g130219",134.1504,-0.4723146,0.1347203,-3.505891,0.0004550817,0.01285918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56985",658.0828,-0.3185166,0.09086243,-3.505482,0.0004557816,0.01286774,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74478",178.7562,0.5489492,0.1565925,3.505591,0.0004555949,0.01286774,0,4028,"sp|Q0P5L8|KBL_BOVIN","Q0P5L8","KBL",2.51e-14,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)","biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]","GO:0005634; GO:0005739; GO:0008890; GO:0009058; GO:0019518; GO:0030170"
"g157545",23.25717,-0.5839943,0.1666941,-3.503389,0.0004593775,0.01296361,0,1371,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.3e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9873",153.0575,0.3808744,0.1087198,3.503265,0.0004595913,0.012964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38061",871.8174,-0.4839202,0.1381439,-3.503016,0.0004600221,0.0129705,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146826",91.26434,2.435055,0.6951755,3.502792,0.0004604097,0.01297578,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160141",1391.936,0.3662211,0.104557,3.502598,0.000460744,0.01297956,0,1100,"sp|Q9GV27|EIF3H_BOMMO","Q9GV27","EIF3H",1.36e-18,"Eukaryotic translation initiation factor 3 subunit H (eIF3h)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0070122; GO:0140492"
"g88294",714.8228,-0.3122453,0.08916546,-3.501864,0.0004620147,0.01300405,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121200",47.09945,-1.43375,0.4094191,-3.501913,0.0004619297,0.01300405,0,4383,"sp|Q9V7U0|RESIL_DROME","Q9V7U0","RESIL",1.06e-08,"Pro-resilin","chitin-based cuticle development [GO:0040003]","GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129"
"g8652",124.2313,-0.5831076,0.1665431,-3.501241,0.0004630966,0.01302884,65595,80713,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.54e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g30863",47.47482,0.6599014,0.1884926,3.500941,0.0004636191,0.01303058,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59380",31.36815,0.8076588,0.230688,3.501087,0.0004633649,0.01303058,0,7294,"sp|Q26454|MCM4_DROME","Q26454","MCM4",7.14e-13,"DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)","DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006268; GO:0006271; GO:0007052; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g69001",157.8255,0.3868252,0.1104944,3.500859,0.0004637618,0.01303058,0,7794,"sp|Q5RFB3|PEPD_PONAB","Q5RFB3","PEPD",1.18e-24,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","collagen catabolic process [GO:0030574]","GO:0030145; GO:0030574; GO:0070006; GO:0102009"
"g19669",1195.845,-0.4738848,0.1354066,-3.499718,0.0004657514,0.01308081,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25610",5740.512,-0.5846597,0.1670911,-3.499047,0.0004669243,0.01310239,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67334",51.16824,0.8809865,0.2517741,3.499115,0.0004668061,0.01310239,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62352",19.12003,-0.9501783,0.2715694,-3.498842,0.000467284,0.01310681,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140508",57.41399,0.5574083,0.1593202,3.498667,0.0004675902,0.01310973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101690",72.93583,-0.7588962,0.2169336,-3.498289,0.0004682539,0.01312265,0,3904,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.54e-41,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g21063",3205.718,-0.3043062,0.08699594,-3.497936,0.0004688735,0.01313174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93798",3470.837,0.9779306,0.2795786,3.497874,0.0004689835,0.01313174,3705,7224,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.37e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g32291",901.4048,0.6109016,0.174671,3.497441,0.0004697455,0.01314172,25493,31884,"sp|Q86VE3|SATL1_HUMAN","Q86VE3","SATL1",8.35e-15,"Spermidine/spermine N(1)-acetyltransferase-like protein 1 (EC 2.3.1.-)",NA,"GO:0008080"
"g36373",299.8985,0.8359304,0.2390109,3.497456,0.0004697174,0.01314172,2081,7814,"sp|P29400|CO4A5_HUMAN","P29400","CO4A5",1.37e-20,"Collagen alpha-5(IV) chain","collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]","GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023"
"g71365",631.3514,-0.3603756,0.1030599,-3.49676,0.0004709456,0.01316961,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10150",5317.415,0.676928,0.1936155,3.496248,0.0004718494,0.0131835,72995,81220,"sp|P34714|SPRC_CAEEL","P34714","SPRC",4.31e-09,"SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)","anatomical structure development [GO:0048856]","GO:0005509; GO:0005518; GO:0005604; GO:0005615; GO:0048856; GO:0050840"
"g129729",94.38967,0.7200713,0.205951,3.496323,0.0004717174,0.0131835,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21955",46.37189,1.243523,0.3557513,3.495483,0.0004732045,0.01321566,30645,41400,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",1.98e-08,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g114042",68.44083,-0.3797567,0.1086531,-3.495131,0.000473829,0.0132274,271,5058,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",3.01e-109,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g13012",132.6403,0.6384332,0.1827039,3.494359,0.0004752008,0.01325999,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128832",61.98813,-0.5808841,0.1662588,-3.493854,0.000476102,0.01327941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22306",165.3721,-0.3586285,0.1026629,-3.493263,0.0004771565,0.0133031,16322,33184,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.41e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g11452",1439.881,-0.3885404,0.1112348,-3.492974,0.000477673,0.01330706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23483",253.2016,-0.3127042,0.08954201,-3.492263,0.0004789465,0.01330706,37615,43167,"sp|O02751|CFDP2_BOVIN","O02751","CFDP2",2.36e-08,"Craniofacial development protein 2 (p97 bucentaur protein)","chromatin remodeling [GO:0006338]","GO:0003824; GO:0005634; GO:0005737; GO:0006338"
"g27198",140.0914,-0.8784645,0.2515169,-3.492666,0.0004782235,0.01330706,23915,27390,"sp|Q8R511|FNBP1_RAT","Q8R511","FNBP1",7.02e-06,"Formin-binding protein 1 (Formin-binding protein 17) (Rapostlin)","cell differentiation [GO:0030154]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; signal transduction [GO:0007165]","GO:0005764; GO:0005856; GO:0005905; GO:0005938; GO:0006897; GO:0007165; GO:0007399; GO:0008289; GO:0030154; GO:0031410; GO:0042802"
"g42038",87.35029,0.4204155,0.1203617,3.492933,0.0004777468,0.01330706,0,21784,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-39,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g73628",363.4948,2.555252,0.731713,3.492151,0.0004791471,0.01330706,0,5254,"sp|H2N0D4|AMY_ORYLA","H2N0D4","AMY",1.01e-26,"Alpha-amylase (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g81639",37.06172,0.4964844,0.1421639,3.492338,0.0004788121,0.01330706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107847",693.2116,0.861397,0.2466592,3.492255,0.0004789606,0.01330706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110952",288.2427,0.4981749,0.1426299,3.49278,0.0004780209,0.01330706,0,4984,"sp|Q5R971|HEM2_PONAB","Q5R971","HEM2",3.38e-30,"Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)","heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]","GO:0004655; GO:0006782; GO:0006783; GO:0008270"
"g126113",198.6476,0.3761547,0.1077061,3.492416,0.0004786718,0.01330706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60888",121.4255,0.4604091,0.1318752,3.491249,0.000480768,0.01334636,0,8231,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.75e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34044",4538.955,-0.3582401,0.1026165,-3.491059,0.0004811106,0.01335015,0,29361,"sp|P08548|LIN1_NYCCO","P08548","LIN1",5.32e-13,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g60498",75.74409,0.7297042,0.2090446,3.490662,0.0004818249,0.01336425,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121325",78.34421,0.7458122,0.2136689,3.490504,0.00048211,0.01336643,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4587",466.5678,-0.4129628,0.1183274,-3.490001,0.0004830195,0.01338592,10548,24504,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.16e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g79538",1773.46,0.853022,0.244451,3.489541,0.0004838506,0.01340322,85,5342,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",4.02e-22,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g38331",721.7374,-0.5247328,0.1503886,-3.48918,0.0004845048,0.01340801,0,25878,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g50481",23.7043,-1.079392,0.309362,-3.489092,0.0004846636,0.01340801,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65084",322.4057,-0.3913247,0.1121515,-3.48925,0.0004843779,0.01340801,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141131",25.91272,0.7147895,0.2048701,3.488989,0.0004848513,0.01340801,0,2374,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.02e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g96945",193.9848,-0.3626194,0.1039411,-3.488702,0.0004853721,0.01341669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64583",49.84148,0.5217178,0.1495552,3.488462,0.0004858075,0.013423,0,4954,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",4.14e-19,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g22510",962.5557,-0.3808245,0.1091736,-3.488247,0.000486198,0.01342806,4094,23524,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.01e-45,"PiggyBac transposable element-derived protein 4",NA,NA
"g37773",115450.5,0.5372472,0.1540414,3.487682,0.0004872275,0.01345076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3881",837.2442,0.3044056,0.08729146,3.487233,0.0004880466,0.0134619,105965,115318,"sp|Q5R664|COPB2_PONAB","Q5R664","COPB2",7.35e-29,"Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663"
"g32910",1848.609,-0.4862993,0.1394488,-3.487297,0.0004879288,0.0134619,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162590",111.9983,0.6314833,0.1810986,3.486959,0.0004885468,0.01346996,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65111",47.78323,-0.3616009,0.1037194,-3.486338,0.0004896816,0.01349551,0,10410,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.06e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g62754",86.74282,1.621781,0.4652249,3.486014,0.0004902754,0.01350613,3209,4334,"sp|P45441|YBX2B_XENLA","P45441","YBX2B",6.04e-20,"Y-box-binding protein 2-B (Cytoplasmic RNA-binding protein p54) (Frog Y-box protein 2-B) (FRGY2b) (Messenger ribonucleoprotein particle 3) (mRNP3)","regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0006417; GO:1990904"
"g141",2645.924,0.7401457,0.2123526,3.485456,0.0004912992,0.01351285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5333",565.8646,0.2331568,0.06689229,3.485555,0.000491117,0.01351285,15196,16404,"sp|Q5TTG1|VATA_ANOGA","Q5TTG1","VATA",7.96e-115,"V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)","proton transmembrane transport [GO:1902600]","GO:0005524; GO:0033180; GO:0046933; GO:0046961; GO:1902600"
"g31683",182.4628,0.3754858,0.107731,3.4854,0.000491401,0.01351285,21915,28562,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.2e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g43078",32.79111,0.7347971,0.2108267,3.485313,0.0004915621,0.01351285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109535",67.93473,0.3769351,0.1081363,3.485742,0.000490775,0.01351285,0,5489,"sp|Q99LG0|UBP16_MOUSE","Q99LG0","UBP16",1.38e-12,"Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16)","cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000278; GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006325; GO:0006357; GO:0006511; GO:0006974; GO:0008270; GO:0016578; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537; GO:0140014"
"g5685",871.8319,-0.560255,0.1607643,-3.484947,0.0004922342,0.01352558,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19176",35.34475,0.6554941,0.1881349,3.484171,0.0004936649,0.013547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45954",221.5271,0.6524817,0.1872602,3.484359,0.0004933172,0.013547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49415",2884.545,0.3164027,0.09081706,3.483957,0.000494059,0.013547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77463",122.6726,0.295645,0.08485686,3.484044,0.0004938979,0.013547,0,7571,"sp|Q99PT0|DDX52_RAT","Q99PT0","DDX52",2.31e-06,"Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (rROK1L) (DEAD box protein 52)","maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0016887; GO:0030490"
"g101957",332.9643,-0.5704964,0.1637374,-3.484216,0.0004935809,0.013547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45495",266.1395,0.2671169,0.07669178,3.482992,0.0004958426,0.01358441,14692,19594,"sp|P30044|PRDX5_HUMAN","P30044","PRDX5",9.67e-11,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)","cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]","GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034599; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057"
"g144333",473.3152,1.030606,0.2958887,3.483087,0.0004956681,0.01358441,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7007",291.8278,-0.3057635,0.08781228,-3.482013,0.0004976596,0.01362843,46874,57514,"sp|Q96N38|ZN714_HUMAN","Q96N38","ZN714",3.67e-56,"Zinc finger protein 714","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g96117",172.6032,0.8055788,0.231375,3.481702,0.0004982375,0.01363273,0,4114,"sp|Q5R432|CNDP2_PONAB","Q5R432","CNDP2",7.85e-09,"Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase)",NA,"GO:0004180; GO:0005737; GO:0046872; GO:0070573; GO:0103046"
"g118463",177.3814,0.9490597,0.2725772,3.481801,0.0004980527,0.01363273,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12497",1157.271,-0.3591654,0.103169,-3.481331,0.0004989278,0.01363434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58872",1379.519,-0.3932655,0.1129611,-3.481424,0.0004987553,0.01363434,1875,13799,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.04e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g143545",17.29897,1.557982,0.4475237,3.481339,0.0004989128,0.01363434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20418",2080.987,-0.325695,0.09355811,-3.481206,0.0004991616,0.01363498,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5854",1699.178,-0.3040646,0.08735073,-3.480963,0.0004996154,0.01364006,31548,55064,"sp|Q9BSU3|NAA11_HUMAN","Q9BSU3","NAA11",4.69e-21,"N-alpha-acetyltransferase 11 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog B) (hARD2) (NatA catalytic subunit Naa11)","N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]","GO:0004596; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0006474; GO:0017198; GO:0018002; GO:0031415; GO:1990189; GO:1990190"
"g30877",691.3227,-0.4331051,0.124424,-3.48088,0.0004997684,0.01364006,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12757",555.7402,-0.4020962,0.1155364,-3.480255,0.000500936,0.01365108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13017",572.1777,-0.2547028,0.07318789,-3.480122,0.0005011858,0.01365108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19281",1861.305,0.7188406,0.2065614,3.480033,0.0005013524,0.01365108,6098,10686,"sp|Q9CY50|SSRA_MOUSE","Q9CY50","SSRA",1.17e-26,"Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)",NA,"GO:0005783; GO:0005789; GO:0016021"
"g25419",1123.023,-0.3658474,0.1051252,-3.480112,0.0005012048,0.01365108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88460",42.18744,-0.443273,0.1273721,-3.480142,0.0005011475,0.01365108,0,7895,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.19e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g104172",426.3349,0.2915366,0.08377518,3.479988,0.0005014365,0.01365108,1834,5429,"sp|P23228|HMCS1_CHICK","P23228","HMCS1",1.03e-18,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)","acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]","GO:0004421; GO:0005829; GO:0006084; GO:0006695; GO:0010142"
"g89089",8939.296,0.3939266,0.1132028,3.479831,0.0005017293,0.01365332,0,2814,"sp|Q9XTL9|PYG_DROME","Q9XTL9","PYG",0,"Glycogen phosphorylase (EC 2.4.1.1)","defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]","GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499"
"g52702",690.7873,0.4389575,0.1261485,3.479689,0.000501997,0.01365406,2145,6176,"sp|Q5BK63|NDUA9_RAT","Q5BK63","NDUA9",7.3e-18,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit) (Sperm flagella protein 3)","circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006]","GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0007623; GO:0009749; GO:0031966; GO:0032981; GO:0044877; GO:1901006"
"g102393",450.4069,0.2950699,0.08480013,3.479592,0.000502178,0.01365406,1566,3314,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.68e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g117961",104.8132,1.421896,0.4086703,3.479323,0.0005026822,0.01365631,1156,4661,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",9.54e-08,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g157469",17.88923,0.65605,0.188553,3.479392,0.0005025527,0.01365631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146264",61.8684,-0.8523861,0.2450207,-3.478833,0.0005036032,0.01367559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138036",6683.329,0.5428367,0.1560864,3.477797,0.0005055528,0.01371704,0,2999,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",8.32e-26,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g148474",615.3,-0.6463905,0.1858601,-3.477834,0.0005054829,0.01371704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49495",32.14322,0.4072115,0.1170976,3.477539,0.0005060394,0.01372368,0,6926,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.07e-25,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g143544",17.91215,1.333851,0.3835723,3.477443,0.0005062212,0.01372368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27237",25.30592,0.9678161,0.2783375,3.477131,0.0005068095,0.01372424,34985,36634,"sp|Q9EPL9|ACOX3_MOUSE","Q9EPL9","ACOX3",7.32e-12,"Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]","GO:0003997; GO:0005504; GO:0005739; GO:0005777; GO:0005782; GO:0006635; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"g44971",248.0773,2.284672,0.6570846,3.476983,0.0005070892,0.01372424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58994",38.91796,-0.498708,0.1434282,-3.477058,0.000506949,0.01372424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157133",77.31674,-0.6238871,0.1794202,-3.47724,0.0005066043,0.01372424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3094",25.38886,2.755382,0.7926535,3.47615,0.000508668,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13722",2610.032,-0.3042771,0.08752681,-3.476387,0.0005082179,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20025",868.0206,-0.4666645,0.1342424,-3.476283,0.000508415,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47390",21.65587,0.7601688,0.2186459,3.476712,0.0005076027,0.01372649,12296,16824,"sp|Q06647|ATPO_RAT","Q06647","ATPO",2.27e-07,"ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4)","ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]","GO:0000274; GO:0000276; GO:0005739; GO:0005753; GO:0005886; GO:0006754; GO:0009986; GO:0015986; GO:0042776; GO:0044877; GO:0045261; GO:0046034; GO:0046933; GO:0071320; GO:0071345; GO:1903924"
"g60299",228899.7,-0.4751595,0.1366907,-3.476166,0.0005086383,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87705",153.1599,-0.369407,0.1062566,-3.476558,0.0005078952,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98815",516.6153,-0.8288482,0.2384458,-3.476045,0.0005088671,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162171",29.20997,0.8115245,0.2334577,3.47611,0.0005087434,0.01372649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126684",49.59161,0.8723065,0.2509978,3.475356,0.0005101765,0.01375608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83013",66.53891,0.3953112,0.1137633,3.474858,0.0005111231,0.01377015,0,8513,"sp|P21328|RTJK_DROME","P21328","RTJK",9.31e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g136554",110.2892,0.5764866,0.1659007,3.474889,0.000511065,0.01377015,0,3108,"sp|P47738|ALDH2_MOUSE","P47738","ALDH2",6.04e-08,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (AHD-M1) (ALDH class 2) (ALDH-E2) (ALDHI)","acetaldehyde metabolic process [GO:0006117]; aldehyde catabolic process [GO:0046185]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of serotonin biosynthetic process [GO:1905627]; response to organic cyclic compound [GO:0014070]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0006117; GO:0008631; GO:0008957; GO:0014070; GO:0018547; GO:0042802; GO:0043066; GO:0043878; GO:0046185; GO:0048149; GO:0050727; GO:0051287; GO:0052689; GO:0070404; GO:0110095; GO:1903179; GO:1905627; GO:2000377"
"g6681",26.36101,0.4919649,0.1415855,3.474684,0.0005114548,0.01377336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17573",93.88137,1.946224,0.560235,3.473943,0.00051287,0.01380573,0,7989,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.48e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g65681",25.13129,1.562932,0.4499241,3.473769,0.0005132028,0.01380895,0,6670,"sp|P82968|MCPI_MELCP","P82968","MCPI",1.79e-06,"Four-domain proteases inhibitor (McaPI)",NA,"GO:0004867"
"g40809",477.7541,0.4224056,0.1216044,3.473606,0.0005135151,0.01381162,13609,23477,"sp|Q68FS3|FBX7_RAT","Q68FS3","FBX7",2.55e-21,"F-box only protein 7","autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000422; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0031625; GO:0031647; GO:0040012; GO:0043130; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1901215; GO:1903204; GO:1903599; GO:1990037; GO:1990038; GO:1990756; GO:2000134"
"g63151",222.1485,0.3436417,0.09893298,3.473479,0.0005137569,0.01381239,7837,11134,"sp|O17953|DLDH_CAEEL","O17953","DLDH",9.61e-21,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; fatty acid biosynthetic process [GO:0006633]","GO:0004148; GO:0005739; GO:0005759; GO:0006633; GO:0045252; GO:0045454; GO:0050660"
"g91319",198.3516,0.5007185,0.1441603,3.473345,0.0005140135,0.01381355,6995,7523,"sp|B3NQ53|KAD2_DROER","B3NQ53","KAD2",5.79e-86,"Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]","GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034"
"g27727",5737.121,0.2559621,0.07369821,3.473111,0.0005144619,0.01381987,5341,17844,"sp|Q6GPM1|ZFR_XENLA","Q6GPM1","ZFR",4.17e-30,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0008270"
"g86639",26.14441,0.5375629,0.154786,3.472942,0.0005147866,0.01382286,2115,8141,"sp|Q12980|NPRL3_HUMAN","Q12980","NPRL3",3.26e-09,"GATOR complex protein NPRL3 (-14 gene protein) (Alpha-globin regulatory element-containing gene protein) (Nitrogen permease regulator 3-like protein) (Protein CGTHBA)","aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281]","GO:0003281; GO:0005096; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1904262; GO:1990130"
"g37978",62.66282,0.4196136,0.1208276,3.472828,0.0005150047,0.01382299,0,19709,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.15e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g8880",327.7872,0.6552909,0.188782,3.471151,0.0005182325,0.01389924,52172,66064,"sp|Q3TDQ1|STT3B_MOUSE","Q3TDQ1","STT3B",1.36e-35,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (B6dom1 antigen) (Source of immunodominant MHC-associated peptides)","co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872"
"g65153",97.99004,0.9932864,0.2861566,3.471129,0.0005182745,0.01389924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137975",47.25945,0.4836663,0.139365,3.470501,0.0005194884,0.01392603,0,1984,"sp|Q9W1R5|VIR_DROME","Q9W1R5","VIR",1.58e-06,"Protein virilizer","cell differentiation [GO:0030154]; dosage compensation [GO:0007549]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; positive regulation of border follicle cell migration [GO:1903688]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing, via transesterification reactions [GO:0000375]; sex differentiation [GO:0007548]","GO:0000375; GO:0000381; GO:0005634; GO:0006397; GO:0007539; GO:0007548; GO:0007549; GO:0030154; GO:0036396; GO:0048024; GO:0080009; GO:1903688"
"g18003",122.6924,1.025705,0.2955987,3.469925,0.0005206035,0.01394438,38106,43224,"sp|Q9JHE3|ASAH2_MOUSE","Q9JHE3","ASAH2",7.87e-15,"Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (N-acylsphingosine amidohydrolase 2) [Cleaved into: Neutral ceramidase soluble form]","apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]","GO:0000139; GO:0005509; GO:0005576; GO:0005615; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006670; GO:0006672; GO:0006915; GO:0007346; GO:0008270; GO:0010033; GO:0016020; GO:0017040; GO:0042759; GO:0044241; GO:0046512; GO:0046513; GO:0046514; GO:0070062; GO:0070774; GO:0071633; GO:0102121; GO:2001234"
"g131274",56.68917,1.278109,0.3683306,3.470006,0.0005204465,0.01394438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113186",183.5576,-0.3721656,0.1072591,-3.469782,0.0005208802,0.01394603,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25797",1005.347,-0.2603898,0.07505025,-3.469539,0.0005213526,0.01395291,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53543",126.8936,1.151056,0.3317988,3.469139,0.0005221302,0.01396795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17630",174.0028,2.215103,0.6385974,3.468701,0.000522982,0.01398497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99870",434.2525,0.5105951,0.1472119,3.468438,0.0005234941,0.01399288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123559",57.42637,0.4939658,0.1424302,3.468127,0.0005241004,0.01400331,0,4170,"sp|Q9VFR0|BCCIP_DROME","Q9VFR0","BCCIP",1.74e-09,"Protein BCCIP homolog","regulation of protein kinase activity [GO:0045859]","GO:0005634; GO:0019887; GO:0045859"
"g9824",1619.704,-0.4323348,0.1246697,-3.467841,0.0005246583,0.01401244,19025,50811,"sp|P16423|POLR_DROME","P16423","POLR",1.04e-06,"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]",NA,"GO:0003964; GO:0004190; GO:0004519; GO:0046872"
"g89209",30.90349,0.6115509,0.1763605,3.467619,0.0005250913,0.01401245,0,7797,"sp|P22771|GLRA2_RAT","P22771","GLRA2",4.96e-17,"Glycine receptor subunit alpha-2 (Glycine receptor strychnine-binding subunit)","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glycinergic [GO:0060012]","GO:0004888; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0007416; GO:0016594; GO:0016934; GO:0021510; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315"
"g123866",77.96984,1.824755,0.5262125,3.467716,0.0005249023,0.01401245,2153,4145,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",1.04e-17,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g143853",330.4727,-0.4472012,0.128973,-3.467401,0.0005255164,0.01401802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53092",180.1942,0.7847253,0.2263261,3.467234,0.0005258447,0.01402101,12259,15935,"sp|P36513|UDB14_RABIT","P36513","UDB14",3.25e-12,"UDP-glucuronosyltransferase 2B14 (UDPGT 2B14) (EC 2.4.1.17) (EGT12)",NA,"GO:0005789; GO:0015020; GO:0016021"
"g98543",35.14774,0.4942792,0.142569,3.466947,0.0005264062,0.01403021,0,6664,"sp|Q3T138|BOLA1_BOVIN","Q3T138","BOLA1",1.67e-11,"BolA-like protein 1",NA,"GO:0005739; GO:1990229"
"g30327",165.9344,0.4187028,0.1207805,3.466643,0.000527001,0.01404029,0,8554,"sp|P21328|RTJK_DROME","P21328","RTJK",9.38e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g114608",47.63646,0.7773049,0.2242499,3.466244,0.0005277845,0.01405538,0,4674,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",3.07e-43,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g36104",75.80241,0.5240591,0.1512077,3.465823,0.0005286121,0.01406842,0,22380,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.34e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g76938",2750.82,0.6034283,0.1741131,3.465726,0.0005288017,0.01406842,5325,9603,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.26e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g151707",76.17624,0.7650169,0.2207419,3.465663,0.0005289254,0.01406842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14395",60.6082,-0.4404756,0.127112,-3.465255,0.0005297285,0.014084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72405",106.0197,0.5703012,0.1646148,3.464459,0.0005312991,0.01411779,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147471",32.10006,0.5120549,0.1478052,3.46439,0.0005314352,0.01411779,0,1754,"sp|Q8R2K1|FUCM_MOUSE","Q8R2K1","FUCM",3.4e-06,"Fucose mutarotase (EC 5.1.3.29)","female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665]","GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806; GO:0045665; GO:0060180"
"g12506",26332.86,2.011516,0.5807257,3.463797,0.000532608,0.014133,58930,68894,"sp|P04069|CBPB_ASTAS","P04069","CBPB",4.45e-24,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g18635",30.35157,-0.6920042,0.1997812,-3.463811,0.0005325815,0.014133,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139993",49.80331,-0.4650483,0.1342608,-3.46377,0.0005326622,0.014133,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12270",179.956,-0.444532,0.1283468,-3.463523,0.0005331506,0.01414017,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97424",84.34629,0.3511071,0.1013776,3.463361,0.0005334715,0.01414289,0,6039,"sp|Q9QXA5|LSM4_MOUSE","Q9QXA5","LSM4",4.49e-22,"U6 snRNA-associated Sm-like protein LSm4","mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005688; GO:0005737; GO:0005829; GO:0016020; GO:0017070; GO:0032991; GO:0033962; GO:0042731; GO:0043005; GO:0046540; GO:0071005; GO:0097526; GO:0120115"
"g41287",277.0758,-0.5436142,0.1569819,-3.462909,0.0005343686,0.01415163,2857,23050,"sp|P13360|GLAS_DROME","P13360","GLAS",2.73e-06,"Protein glass","circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045944; GO:0046530; GO:0046872; GO:0060086"
"g59480",323.762,0.5095503,0.147147,3.462865,0.0005344565,0.01415163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132555",356.2465,0.4211621,0.1216171,3.463017,0.0005341547,0.01415163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22214",654.3493,-0.6294719,0.1817944,-3.462547,0.0005350877,0.01415592,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31281",2157.264,-0.3540024,0.1022357,-3.462609,0.0005349656,0.01415592,13022,33054,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.67e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g131357",120.5885,0.5171595,0.1493621,3.462454,0.000535274,0.01415592,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15235",135.5914,0.4627404,0.1336523,3.462272,0.0005356361,0.01415972,0,5704,"sp|Q06561|UNC52_CAEEL","Q06561","UNC52",3.04e-08,"Basement membrane proteoglycan (Perlecan homolog) (Uncoordinated protein 52) (Protein unc-52)","animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hemidesmosome assembly [GO:0031581]; locomotion [GO:0040011]; mitochondrion organization [GO:0007005]; modulation of age-related behavioral decline [GO:0090647]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; myofibril assembly [GO:0030239]; nematode larval development [GO:0002119]; pharyngeal gland morphogenesis [GO:1905905]; pharynx development [GO:0060465]; positive regulation of locomotion [GO:0040017]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; tissue development [GO:0009888]","GO:0002119; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007005; GO:0007517; GO:0008543; GO:0009792; GO:0009887; GO:0009888; GO:0016477; GO:0030239; GO:0031012; GO:0031430; GO:0031581; GO:0040011; GO:0040017; GO:0046716; GO:0048644; GO:0055120; GO:0060279; GO:0060298; GO:0060465; GO:0090647; GO:1905905"
"g41689",3154.411,-0.298248,0.08615616,-3.461715,0.0005367455,0.01417684,3139,22741,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g59445",547.3897,-0.298203,0.08614556,-3.461617,0.0005369403,0.01417684,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153374",626.2631,-0.5263488,0.1520456,-3.461783,0.0005366102,0.01417684,0,1689,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.32e-07,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g40246",1100.059,-0.2543031,0.07346616,-3.461499,0.0005371756,0.01417728,7030,12214,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.43e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g103853",37.30479,0.8654161,0.25003,3.461249,0.0005376751,0.01418468,974,6073,"sp|Q99LB7|SARDH_MOUSE","Q99LB7","SARDH",1.32e-06,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053"
"g142209",56.05339,2.432565,0.7028277,3.461112,0.0005379492,0.01418614,0,2667,"sp|P04746|AMYP_HUMAN","P04746","AMYP",5.01e-14,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]","GO:0004556; GO:0005509; GO:0005576; GO:0005615; GO:0005975; GO:0016052; GO:0031404; GO:0044245; GO:0070062"
"g15777",179.5642,2.040047,0.5894907,3.460694,0.0005387844,0.01420238,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28974",601.8717,-0.3144998,0.09088479,-3.460423,0.0005393276,0.01421092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42836",386.2198,-0.4461031,0.1289566,-3.459326,0.0005415283,0.01426311,1946,21941,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.53e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g63005",107.1767,-0.4375109,0.1264915,-3.458817,0.0005425529,0.01428429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16659",133.9323,0.371309,0.1073704,3.458205,0.0005437872,0.01430152,0,17001,"sp|Q16HH9|MED23_AEDAE","Q16HH9","MED23",4.28e-18,"Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)",NA,"GO:0005634"
"g23996",1000.728,0.2553494,0.07384191,3.458055,0.0005440905,0.01430152,0,5474,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.18e-22,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g91681",33.78819,1.013817,0.2931742,3.45807,0.0005440602,0.01430152,0,7390,"sp|Q9YGX2|RPE65_CHICK","Q9YGX2","RPE65",1.25e-07,"Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)","response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]","GO:0001523; GO:0001786; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0046872; GO:0050251; GO:0050896; GO:0052884; GO:0052885; GO:1901612; GO:1901827"
"g131470",62.1889,0.3768213,0.1089625,3.458267,0.0005436631,0.01430152,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29127",2926.087,0.2368828,0.0685151,3.45738,0.0005454541,0.01431778,0,6403,"sp|P67874|CSK2B_RAT","P67874","CSK2B",1.44e-54,"Casein kinase II subunit beta (CK II beta) (Phosvitin)","adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; liver regeneration [GO:0097421]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; response to testosterone [GO:0033574]; Wnt signaling pathway [GO:0016055]","GO:0000785; GO:0003682; GO:0004674; GO:0005102; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0005956; GO:0006468; GO:0010862; GO:0016055; GO:0016363; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0033574; GO:0042802; GO:0042995; GO:0043021; GO:0043537; GO:0046872; GO:0061154; GO:0061629; GO:0080163; GO:0097421; GO:0098685; GO:0098794; GO:0098978; GO:0099170"
"g80321",70.81431,-0.6632871,0.1918505,-3.457312,0.0005455928,0.01431778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84143",55.18088,0.60918,0.1761997,3.457327,0.0005455633,0.01431778,0,7552,"sp|Q6DDP3|ENPP6_XENLA","Q6DDP3","ENPP6",4.07e-06,"Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6)","choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]","GO:0005886; GO:0006629; GO:0008081; GO:0016042; GO:0019695; GO:0031225; GO:0046872; GO:0047390"
"g142841",26.63621,0.8867548,0.2564733,3.457494,0.000545225,0.01431778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119897",52.08564,0.4304832,0.1245199,3.457145,0.0005459306,0.01432084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23153",56.75771,0.5659019,0.1637415,3.456069,0.000548115,0.01437233,9846,13284,"sp|A7RLE5|DNPH1_NEMVE","A7RLE5","DNPH1",1.22e-07,"Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-)","deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307]","GO:0005634; GO:0005737; GO:0009116; GO:0009117; GO:0009159; GO:0030307; GO:0070694"
"g24358",27.93321,-0.5233599,0.1514531,-3.45559,0.0005490902,0.01438219,0,4654,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.09e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g38260",425.8216,-0.4604375,0.1332455,-3.455557,0.0005491572,0.01438219,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92968",462.817,-0.2774839,0.08029857,-3.455652,0.0005489635,0.01438219,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32310",32.52739,0.6127155,0.1773309,3.455211,0.0005498623,0.01438965,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75798",175.0169,0.2890295,0.0836506,3.455199,0.0005498861,0.01438965,3205,7140,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.38e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27568",495.1809,-0.1930321,0.05588195,-3.454284,0.0005517562,0.01442693,9235,11836,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.92e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g139494",123.0752,0.5178432,0.1499115,3.454326,0.0005516707,0.01442693,0,1044,"sp|P08906|AATC_HORSE","P08906","AATC",2.85e-22,"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)","aspartate biosynthetic process [GO:0006532]; glycerol biosynthetic process [GO:0006114]","GO:0004069; GO:0005829; GO:0006114; GO:0006532; GO:0030170; GO:0047801"
"g116618",37.02481,0.7948712,0.2301478,3.453742,0.0005528665,0.01445013,1455,4530,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",9.58e-18,"PiggyBac transposable element-derived protein 4",NA,NA
"g73825",318.9856,-0.2729483,0.07904142,-3.453232,0.0005539128,0.01445998,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117933",21.97802,-0.5851581,0.16945,-3.453278,0.000553818,0.01445998,0,4147,"sp|P21328|RTJK_DROME","P21328","RTJK",1.03e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g131059",27.43693,1.008913,0.2921574,3.453321,0.0005537291,0.01445998,0,3284,"sp|Q62270|SRMS_MOUSE","Q62270","SRMS",8.77e-14,"Tyrosine-protein kinase Srms (EC 2.7.10.2) (PTK70)","cell differentiation [GO:0030154]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0007169; GO:0018108; GO:0030154; GO:0031234; GO:0038083; GO:0045087"
"g70772",59.2849,2.490897,0.7214092,3.452821,0.0005547573,0.01447619,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112789",184.89,0.4899296,0.1419233,3.452073,0.0005562979,0.01450471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131143",45.68307,-0.9651734,0.279589,-3.452116,0.0005562094,0.01450471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37845",1353.608,-0.2897337,0.08394046,-3.451657,0.0005571551,0.01452122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7834",3834.161,0.4439753,0.1286445,3.45118,0.0005581408,0.01452953,0,9127,"sp|P11024|NNTM_BOVIN","P11024","NNTM",8.1e-23,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)","NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]","GO:0005743; GO:0006740; GO:0008746; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600"
"g22553",199.4139,0.4064368,0.1177656,3.451236,0.0005580247,0.01452953,1533,41414,"sp|P21328|RTJK_DROME","P21328","RTJK",1.24e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g67134",77.5262,0.4488361,0.130053,3.451177,0.0005581465,0.01452953,0,10053,"sp|Q2L969|MTX2_PIG","Q2L969","MTX2",4.15e-06,"Metaxin-2 (Mitochondrial outer membrane import complex protein 2)","mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031]","GO:0001401; GO:0005737; GO:0006839; GO:0007005; GO:0015031"
"g155817",26.69172,0.6681163,0.1936072,3.450885,0.000558752,0.01453944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74935",66.04237,-0.36496,0.1057698,-3.450511,0.0005595258,0.01455116,0,9734,"sp|P17192|DPOL_HPBDB","P17192","DPOL",7.82e-12,"Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]","DNA replication [GO:0006260]","GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872"
"g120808",24.90949,0.4858308,0.1408021,3.450451,0.0005596512,0.01455116,0,3262,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.74e-58,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g9290",2110.356,0.264664,0.07671595,3.449922,0.0005607485,0.01457384,50798,60474,"sp|Q562A2|ZFR_RAT","Q562A2","ZFR",6.02e-12,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g138715",45.50936,0.4255309,0.1233517,3.449738,0.0005611305,0.01457792,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11905",241.4923,0.7644067,0.2216038,3.449429,0.0005617725,0.01458306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61544",318.5607,0.3563461,0.1033059,3.449427,0.0005617784,0.01458306,0,4895,"sp|Q0V9J0|TMM69_XENTR","Q0V9J0","TMM69",1.72e-28,"Transmembrane protein 69",NA,"GO:0016021"
"g148483",72.14325,0.3893232,0.1128698,3.449311,0.0005620182,0.01458344,0,1424,"sp|O95985|TOP3B_HUMAN","O95985","TOP3B",1.83e-23,"DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)","chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]","GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059; GO:0140225"
"g23634",42.03608,0.4132533,0.1198147,3.449102,0.0005624535,0.01458889,40466,41994,"sp|P14735|IDE_HUMAN","P14735","IDE",5.24e-26,"Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]","GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"g118452",26.08909,1.254928,0.3638933,3.448616,0.0005634665,0.01460932,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40659",258.513,-0.3992496,0.1157794,-3.448365,0.0005639908,0.01461122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85661",2575.554,-0.2431784,0.07051972,-3.448374,0.000563973,0.01461122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62371",183.4666,0.3816299,0.1106994,3.447444,0.0005659169,0.01465526,6485,9622,"sp|Q1LZH9|GNS_BOVIN","Q1LZH9","GNS",5.64e-110,"N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S)","glycosaminoglycan metabolic process [GO:0030203]","GO:0005539; GO:0005764; GO:0008449; GO:0030203; GO:0046872"
"g17901",1476.048,0.3677643,0.1066847,3.447208,0.0005664127,0.01465638,0,7881,"sp|P80977|CX6C1_THUOB","P80977","CX6C1",9.74e-06,"Cytochrome c oxidase subunit 6C-1 (Cytochrome c oxidase polypeptide VIc-1)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005751; GO:0006123; GO:0016021"
"g143745",84.8824,1.450887,0.4208857,3.447222,0.0005663828,0.01465638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36240",983.8151,0.5339649,0.1549167,3.446787,0.0005672957,0.01466751,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50425",195.1082,0.5117693,0.1484738,3.446866,0.00056713,0.01466751,9815,16609,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.07e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g20958",244.7382,-0.4630471,0.1343463,-3.446667,0.0005675472,0.01466816,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24290",70.64068,0.407875,0.1183619,3.446,0.0005689494,0.01469854,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77414",44.74563,0.481552,0.1397479,3.445862,0.0005692414,0.01470022,0,9525,"sp|Q4WAU7|XYL2_ASPFU","Q4WAU7","XYL2",2.32e-16,"Probable D-xylulose reductase A (EC 1.1.1.9) (Xylitol dehydrogenase A)","D-xylose metabolic process [GO:0042732]; L-arabinose catabolic process to xylulose 5-phosphate [GO:0019569]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006062; GO:0008270; GO:0019569; GO:0042732; GO:0046526"
"g3486",664.2559,-0.2495753,0.07244573,-3.444997,0.0005710667,0.01472389,84733,116934,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.02e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13515",428.0958,0.3198772,0.09284783,3.445177,0.0005706859,0.01472389,1825,11387,"sp|O46037|VINC_DROME","O46037","VINC",7.97e-27,"Vinculin","cell adhesion [GO:0007155]","GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592"
"g50447",1904.945,0.629756,0.1828002,3.445052,0.0005709502,0.01472389,0,6209,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",1.63e-13,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g75836",488.4708,0.5183078,0.150451,3.445027,0.0005710016,0.01472389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g868",135.4646,-0.3479962,0.1010355,-3.444295,0.00057255,0.01475626,53333,56554,"sp|Q8N1W2|ZN710_HUMAN","Q8N1W2","ZN710",1.68e-07,"Zinc finger protein 710","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872"
"g3617",2939.712,-0.2625937,0.07624287,-3.444174,0.0005728071,0.01475701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41531",2148.488,-0.3202934,0.09300081,-3.443986,0.0005732064,0.01476049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130746",86.42514,-0.7372098,0.2140628,-3.443895,0.0005733976,0.01476049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104359",1882.109,-0.3901663,0.113296,-3.443779,0.0005736452,0.014761,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68644",312.5109,0.2487006,0.07222334,3.443494,0.0005742493,0.01477068,0,11229,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.18e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16633",93.59038,0.4905021,0.1424565,3.44317,0.0005749375,0.01478251,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77697",172.5219,0.3920601,0.1138737,3.442939,0.0005754292,0.01478928,0,8951,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.67e-31,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85361",124.1526,-0.3776366,0.1096945,-3.442622,0.0005761039,0.01480075,0,5984,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",6.88e-09,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g2527",845.8105,0.7118007,0.2067769,3.442361,0.0005766601,0.01480917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12044",3762.168,0.3339591,0.09703398,3.441672,0.0005781312,0.01484107,48250,54274,"sp|P11240|COX5A_RAT","P11240","COX5A",1.75e-16,"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0031966; GO:0046872"
"g145983",36.20835,-0.862416,0.250642,-3.440828,0.0005799366,0.01488152,0,2267,"sp|E9Q4S1|PDE8B_MOUSE","E9Q4S1","PDE8B",4.62e-16,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (PDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)","behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; signal transduction [GO:0007165]; visual learning [GO:0008542]","GO:0001662; GO:0004114; GO:0004115; GO:0006198; GO:0007165; GO:0008542; GO:0035106; GO:0046676; GO:0046872; GO:0050885; GO:0061179; GO:0090032"
"g111770",22.06158,0.8170192,0.2374846,3.440304,0.0005810608,0.01490446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108840",28.4704,1.165834,0.3389308,3.439739,0.0005822746,0.01492969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60814",1150.648,0.4218418,0.1226556,3.439239,0.0005833519,0.01495139,1152,5794,"sp|Q0EF98|GPX2_CALJA","Q0EF98","GPX2",1.44e-15,"Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI)","response to oxidative stress [GO:0006979]","GO:0004602; GO:0005737; GO:0006979"
"g75090",176.2472,1.656835,0.4818125,3.438754,0.0005843973,0.01497226,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2638",4334.009,-0.358857,0.1043742,-3.438178,0.0005856432,0.01499233,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25943",72.42699,0.7396458,0.2151234,3.438239,0.0005855103,0.01499233,9135,16613,"sp|Q9U8W7|TL5B_TACTR","Q9U8W7","TL5B",3.84e-09,"Techylectin-5B","cell-cell adhesion [GO:0098609]","GO:0005576; GO:0030246; GO:0046872; GO:0098609"
"g128451",67.16709,-0.5497334,0.1599037,-3.437902,0.000586239,0.01500165,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23533",197.4583,0.421409,0.1226031,3.437181,0.0005878023,0.01502224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65246",34.8192,-0.4841086,0.1408478,-3.437104,0.0005879709,0.01502224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109387",584.9519,-0.4375728,0.1273084,-3.437109,0.0005879597,0.01502224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128880",153.8165,-1.190931,0.3464878,-3.43715,0.00058787,0.01502224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58560",39.06318,-0.5249573,0.1527441,-3.436842,0.0005885388,0.0150257,4726,13494,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.99e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g135700",72.49713,-0.6724295,0.1956541,-3.436828,0.0005885701,0.0150257,993,3124,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.32e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g60029",116.3271,0.6455539,0.1878421,3.436684,0.0005888833,0.01502777,1496,7024,"sp|A1Z877|NDG_DROME","A1Z877","NDG",1.3e-10,"Nidogen (Entactin)","basement membrane assembly involved in embryonic body morphogenesis [GO:2001197]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; regulation of basement membrane organization [GO:0110011]","GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007160; GO:0071711; GO:0110011; GO:2001197"
"g97061",1026.99,-0.2649328,0.0771009,-3.436183,0.0005899721,0.01504963,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107713",118.6394,0.4743869,0.1380773,3.435663,0.0005911058,0.01507262,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128505",41.38018,0.5665447,0.1649158,3.435357,0.0005917729,0.01508369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14501",109.4666,0.7534224,0.2193477,3.434831,0.0005929231,0.01510113,9490,35434,"sp|Q6P9P6|KIF11_MOUSE","Q6P9P6","KIF11",6.12e-23,"Kinesin-like protein KIF11 (Kinesin-related motor protein Eg5)","cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; spindle assembly [GO:0051225]; spindle organization [GO:0007051]","GO:0000922; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005874; GO:0005876; GO:0007018; GO:0007051; GO:0007100; GO:0008017; GO:0008574; GO:0019901; GO:0032991; GO:0046602; GO:0051225; GO:0051301; GO:0072686; GO:0090307"
"g136804",35.09951,1.412726,0.4112829,3.434925,0.000592717,0.01510113,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22694",401.5879,-0.2814576,0.0819497,-3.434516,0.0005936123,0.01510866,13623,22994,"sp|P14381|YTX2_XENLA","P14381","YTX2",2.78e-11,"Transposon TX1 uncharacterized 149 kDa protein (ORF 2)",NA,"GO:0003824"
"g111509",67.253,-0.4606649,0.1341293,-3.434483,0.0005936854,0.01510866,0,5198,"sp|Q5R4A5|SNX17_PONAB","Q5R4A5","SNX17",6.08e-09,"Sorting nexin-17","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]","GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0030659; GO:0031410; GO:0032456; GO:0035091"
"g14456",838.6683,-0.3213651,0.09358403,-3.433974,0.0005948018,0.01512991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46454",1242.776,0.7326321,0.2133534,3.433889,0.0005949872,0.01512991,5495,8967,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.47e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g45456",41.15582,0.6841699,0.1992602,3.43355,0.0005957326,0.01513388,0,10331,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.13e-10,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55919",385.4372,0.6030044,0.1756239,3.433499,0.0005958441,0.01513388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94736",25.52092,1.321643,0.3849123,3.433622,0.0005955752,0.01513388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2184",87.16968,2.349078,0.6842152,3.433245,0.0005964034,0.01513909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7923",79.99476,0.4072867,0.1186446,3.432829,0.0005973186,0.01513909,75956,90564,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.72e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17462",224.5863,0.5706743,0.1662364,3.432908,0.0005971457,0.01513909,482,13744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.67e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g32348",699.2097,-0.3475406,0.1012444,-3.432689,0.0005976264,0.01513909,5070,9984,"sp|Q8BQN6|OZF_MOUSE","Q8BQN6","OZF",9.31e-58,"Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)","negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005730; GO:0005829; GO:0006357; GO:0046872"
"g37159",271.8514,0.2705662,0.07882039,3.432693,0.0005976184,0.01513909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42837",610.5732,-0.4088036,0.1190763,-3.433124,0.0005966685,0.01513909,958,21939,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.67e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g65231",378.3315,-0.3126327,0.09107585,-3.432663,0.0005976846,0.01513909,24,7534,"sp|Q17239|5HTR_BOMMO","Q17239","5HTR",6.75e-60,"5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)",NA,"GO:0004930; GO:0005886; GO:0016021"
"g19506",1493.516,-0.2890748,0.08421648,-3.43252,0.0005979991,0.01514113,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26382",1339.001,-0.4598521,0.1339867,-3.432072,0.0005989875,0.01514922,24135,35372,"sp|Q5RCM6|SOCS6_PONAB","Q5RCM6","SOCS6",9.95e-17,"Suppressor of cytokine signaling 6 (SOCS-6)","intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]","GO:0001772; GO:0005942; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0040008; GO:0046854; GO:0046935; GO:0050868"
"g29008",1673.637,-0.3044342,0.08870054,-3.432158,0.0005987988,0.01514922,6195,34898,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.28e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g123307",66.41501,0.5848358,0.1704038,3.432058,0.0005990199,0.01514922,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64822",19.2475,0.6482053,0.1889195,3.431119,0.0006010977,0.01519584,5615,12105,"sp|Q9VYV5|FUT8_DROME","Q9VYV5","FUT8",1.05e-21,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)","GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0006487; GO:0008424; GO:0016021; GO:0018279; GO:0032580; GO:0033578; GO:0036071; GO:0046368; GO:0046872; GO:0046921"
"g112406",30.77269,-0.5901632,0.1720428,-3.430328,0.0006028531,0.01523427,1306,5212,"sp|Q9VS29|DSCL_DROME","Q9VS29","DSCL",8.45e-19,"Down syndrome cell adhesion molecule-like protein Dscam2","axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]","GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632"
"g96223",360.5913,-0.3465298,0.1010265,-3.430089,0.0006033832,0.01524172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24293",17051.42,0.2678935,0.07811989,3.429262,0.000605226,0.01528231,0,12331,"sp|P41824|YBOXH_APLCA","P41824","YBOXH",5.35e-23,"Y-box factor homolog (APY1)",NA,"GO:0003723; GO:0005634"
"g74677",198.1038,0.2914949,0.08500554,3.429128,0.0006055235,0.01528387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31812",1774.429,-0.4853833,0.1415564,-3.428903,0.0006060265,0.0152906,16657,25914,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-06,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g37504",34.06124,-0.3945763,0.1150781,-3.428769,0.0006063252,0.01529219,20902,26644,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.09e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g113121",87.54953,1.02299,0.2983909,3.428354,0.0006072536,0.01530964,0,2824,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.07e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g116730",21.87993,1.053281,0.3072519,3.428071,0.0006078873,0.01531966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103415",110.8711,0.3188781,0.09302519,3.427868,0.0006083415,0.01532514,0,6120,"sp|Q6NWF4|VPS25_DANRE","Q6NWF4","VPS25",1.1e-06,"Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25)","protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]","GO:0000814; GO:0005198; GO:0042803; GO:0043328"
"g28922",35.71077,1.279864,0.3734018,3.427579,0.0006089884,0.01533548,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11556",150.7633,0.778269,0.2270703,3.427436,0.0006093088,0.01533759,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141909",91.31559,1.020328,0.2977282,3.427045,0.000610188,0.01535375,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38128",729.5486,-0.3730916,0.108889,-3.426348,0.0006117558,0.0153714,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51273",284.3425,-0.7139613,0.2083701,-3.42641,0.0006116161,0.0153714,5655,16736,"sp|P21328|RTJK_DROME","P21328","RTJK",7.58e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g87382",1209.528,0.3977474,0.1160862,3.426311,0.0006118384,0.0153714,4459,8041,"sp|Q2NKZ1|TCPH_BOVIN","Q2NKZ1","TCPH",3.8e-22,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g146426",33.26225,2.293837,0.6694748,3.426324,0.0006118105,0.0153714,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44068",41.03812,0.4243901,0.1238669,3.426179,0.0006121368,0.01537294,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48030",30.15093,0.4345797,0.1268457,3.426051,0.000612426,0.01537424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95133",61.91878,0.9205953,0.2687246,3.425795,0.0006130031,0.01538277,1965,7066,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.22e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g47504",56.60483,0.7742196,0.2260138,3.425541,0.0006135772,0.01539121,855,8226,"sp|P39951|CDK1_RAT","P39951","CDK1",3.72e-27,"Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)","animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; chromosome condensation [GO:0030261]; epithelial cell differentiation [GO:0030855]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]","GO:0000086; GO:0000278; GO:0000307; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005876; GO:0006468; GO:0006915; GO:0007095; GO:0007569; GO:0008283; GO:0008353; GO:0009410; GO:0009636; GO:0010243; GO:0010628; GO:0010629; GO:0010971; GO:0014070; GO:0014075; GO:0014823; GO:0016301; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0034501; GO:0035173; GO:0042307; GO:0042542; GO:0042752; GO:0043066; GO:0044772; GO:0045471; GO:0045740; GO:0045931; GO:0046686; GO:0046688; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070301; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:0106310; GO:1900182; GO:1905448"
"g22983",164.8075,0.4203326,0.1227156,3.425258,0.0006142155,0.01540126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38662",93.17915,0.3059355,0.08932215,3.42508,0.0006146185,0.01540523,16354,24624,"sp|P10394|POL4_DROME","P10394","POL4",2.03e-39,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g54845",122.8981,0.5324992,0.1554752,3.424978,0.0006148494,0.01540523,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1245",46.15925,-1.262905,0.3687681,-3.424658,0.0006155732,0.01541671,20445,24951,"sp|Q5ZHW4|RAB5B_CHICK","Q5ZHW4","RAB5B",6.57e-11,"Ras-related protein Rab-5B (EC 3.6.5.2)","antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]","GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0012505; GO:0019003; GO:0019882; GO:0030100; GO:0030139; GO:0030742; GO:0031901; GO:0048227; GO:0070062"
"g66853",40.15432,0.4748863,0.1386705,3.424566,0.0006157834,0.01541671,0,9284,"sp|A6QLA0|NFX1_BOVIN","A6QLA0","NFX1",4.65e-13,"Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)","negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0008270; GO:0045347; GO:0051865; GO:0061630"
"g48602",297.9233,-0.6427214,0.1876919,-3.424342,0.000616289,0.01541917,8178,12214,"sp|Q9VV43|TPPP_DROME","Q9VV43","TPPP",7.74e-17,"Tubulin polymerization-promoting protein homolog (TPPP) (Protein ringmaker)","microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","GO:0000226; GO:0001578; GO:0005737; GO:0005856; GO:0008582; GO:0030424; GO:0031594; GO:0032273; GO:0043025; GO:0046785; GO:0098793"
"g57851",98.11993,0.8284985,0.2419608,3.424103,0.0006168334,0.01541917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106347",148.3348,1.227806,0.3585768,3.424109,0.0006168185,0.01541917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134394",26.96074,0.559497,0.1633937,3.424227,0.0006165515,0.01541917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27181",3367.536,0.3368551,0.09839528,3.423488,0.00061823,0.01544812,7150,35204,"sp|Q3SZ71|MPPB_BOVIN","Q3SZ71","MPPB",7.06e-18,"Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)","protein processing involved in protein targeting to mitochondrion [GO:0006627]","GO:0004222; GO:0006627; GO:0017087; GO:0046872"
"g74687",190.2478,0.4959529,0.1448862,3.423052,0.0006192233,0.01546697,0,9982,"sp|P47727|CBR1_RAT","P47727","CBR1",9.32e-08,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","epithelial cell differentiation [GO:0030855]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0001542; GO:0004090; GO:0005634; GO:0005737; GO:0005886; GO:0005902; GO:0006706; GO:0006805; GO:0016491; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0035003; GO:0042373; GO:0042376; GO:0043231; GO:0047020; GO:0047021; GO:0050221; GO:1905344; GO:2000379"
"g141468",2098.727,-0.3338002,0.09752463,-3.422728,0.0006199618,0.01547945,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10731",1465.656,0.3676685,0.1074345,3.422257,0.0006210352,0.01549649,34875,57870,"sp|P21328|RTJK_DROME","P21328","RTJK",7.78e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g25209",716.1576,-0.3210804,0.09383683,-3.421688,0.0006223364,0.01549649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28192",184.0457,0.3974284,0.1161377,3.422045,0.0006215208,0.01549649,17970,33587,"sp|A8Y236|GLT10_CAEBR","A8Y236","GLT10",1.03e-16,"Putative polypeptide N-acetylgalactosaminyltransferase 10 (pp-GaNTase 10) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)","protein glycosylation [GO:0006486]","GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872"
"g31969",958.8933,-0.3193968,0.09334511,-3.421677,0.0006223622,0.01549649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44690",357.4404,-0.3694265,0.1079519,-3.422139,0.000621305,0.01549649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86709",81.27108,0.5117989,0.1495676,3.421857,0.0006219491,0.01549649,1601,8131,"sp|Q9NZK5|ADA2_HUMAN","Q9NZK5","ADA2",1.83e-07,"Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)","adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]","GO:0004000; GO:0005576; GO:0005615; GO:0006154; GO:0008083; GO:0008201; GO:0008270; GO:0031685; GO:0035578; GO:0042803; GO:0043394; GO:0046103"
"g153214",66.19598,0.4870468,0.142337,3.421786,0.0006221124,0.01549649,0,1663,"sp|Q68FX0|IDH3B_RAT","Q68FX0","IDH3B",6.8e-32,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)","2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004449; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0051287"
"g160084",488.9205,2.153345,0.6293401,3.421592,0.0006225573,0.01549649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39290",499.0457,0.5384559,0.1573751,3.421481,0.0006228099,0.01549682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23704",41.8293,-0.6643338,0.1941755,-3.421305,0.0006232129,0.0155009,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36845",948.7571,-0.384071,0.112269,-3.420989,0.0006239376,0.01551297,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10546",1067.16,0.3532671,0.1032713,3.420768,0.0006244447,0.01551962,45194,56624,"sp|P54385|DHE3_DROME","P54385","DHE3",1.44e-33,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g12697",1139.909,0.6760586,0.1976489,3.420503,0.0006250548,0.01552883,36735,50491,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.36e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3351",46.82831,0.4984697,0.1457603,3.419791,0.0006266921,0.01555336,137765,143440,"sp|Q9VYA0|NADE_DROME","Q9VYA0","NADE",2.34e-26,"Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing])","NAD biosynthetic process [GO:0009435]; negative regulation of neuromuscular synaptic transmission [GO:1900074]","GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:1900074"
"g42413",1226.916,-0.4701892,0.1374849,-3.419933,0.0006263653,0.01555336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55019",10741.51,0.7977008,0.2332639,3.419735,0.000626821,0.01555336,3658,5934,"sp|Q7Z1E6|CALR_BOMMO","Q7Z1E6","CALR",8.63e-101,"Calreticulin","protein folding [GO:0006457]","GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082"
"g140970",121.9288,0.351001,0.1026422,3.419657,0.0006270024,0.01555336,0,2647,"sp|Q99PE9|ARL4D_MOUSE","Q99PE9","ARL4D",3.26e-13,"ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0016192"
"g87664",45.95946,0.5384594,0.1574876,3.419059,0.0006283806,0.01558158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56276",172.0506,-0.7326417,0.2142911,-3.418909,0.0006287286,0.01558424,1464,14686,"sp|P21328|RTJK_DROME","P21328","RTJK",1.02e-40,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g143051",324.4818,0.3958133,0.1157777,3.418734,0.0006291309,0.01558825,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36005",1106.659,-0.3896182,0.1139748,-3.418458,0.0006297694,0.01558997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82891",460.9905,0.3166023,0.09262295,3.418185,0.0006304035,0.01558997,6268,7944,"sp|Q69BK3|UCRI_PONPY","Q69BK3","UCRI",1.68e-22,"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]","respiratory electron transport chain [GO:0022904]","GO:0005739; GO:0005743; GO:0008121; GO:0016021; GO:0022904; GO:0046872; GO:0051537; GO:0070469"
"g119563",1381.895,1.006508,0.2944415,3.418362,0.0006299931,0.01558997,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154608",355.0986,2.232926,0.653178,3.418556,0.0006295425,0.01558997,795,1284,"sp|Q03168|ASPP_AEDAE","Q03168","ASPP",1.76e-11,"Lysosomal aspartic protease (EC 3.4.23.-)",NA,"GO:0004190; GO:0005764"
"g162844",297.5508,0.4011467,0.1173547,3.418241,0.0006302731,0.01558997,0,1006,"sp|O35737|HNRH1_MOUSE","O35737","HNRH1",7.47e-08,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]","cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]","GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0014069; GO:0019899; GO:0042802; GO:0043484; GO:0071013; GO:0098761; GO:1990904"
"g8399",4043.96,-0.3810276,0.1114768,-3.417998,0.0006308365,0.015591,11795,21200,"sp|Q08499|PDE4D_HUMAN","Q08499","PDE4D",2.59e-20,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)","adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; establishment of endothelial barrier [GO:0061028]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]","GO:0002027; GO:0004114; GO:0004115; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0007165; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0048471; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901363; GO:1901844; GO:1901898"
"g47644",53.85764,0.8066907,0.2360265,3.417797,0.000631301,0.015591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92829",56.42231,0.7442907,0.217772,3.417751,0.0006314074,0.015591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119314",1108.948,-1.118988,0.327397,-3.417833,0.0006312184,0.015591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24935",1290.889,-0.3290214,0.09630155,-3.416574,0.0006341436,0.01564664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134965",27.20845,0.8883068,0.2599978,3.416593,0.0006340993,0.01564664,0,1264,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",5.36e-17,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g18167",1564.551,-0.2125433,0.06222161,-3.415909,0.0006356956,0.01566864,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19714",362.755,0.3772667,0.1104483,3.415777,0.0006360029,0.01566864,40125,44066,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.12e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34752",29.83161,0.8182278,0.2395317,3.415948,0.0006356036,0.01566864,18052,20594,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.38e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g80419",64.74839,0.5079024,0.1486916,3.415812,0.0006359209,0.01566864,0,5669,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",3.2e-69,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g17215",20.25865,-0.5162154,0.1511321,-3.415658,0.0006362819,0.01566956,46535,47601,"sp|Q9C0G0|ZN407_HUMAN","Q9C0G0","ZN407",9.38e-07,"Zinc finger protein 407","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]","GO:0003677; GO:0005634; GO:0008270; GO:0010468; GO:0045944"
"g41329",1587.806,-0.2604069,0.07624942,-3.415199,0.0006373553,0.0156882,3658,18494,"sp|Q5HZM1|EIF1A_XENLA","Q5HZM1","EIF1A",3.46e-18,"Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein)",NA,"GO:0003743; GO:0005634"
"g119114",248.7733,-0.3760991,0.1101274,-3.415127,0.0006375232,0.0156882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31291",2182.605,-0.3667864,0.1074086,-3.414869,0.0006381272,0.01569115,16651,33004,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.6e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g81523",49.86521,0.4813177,0.1409445,3.414945,0.0006379479,0.01569115,0,8656,"sp|P04323|POL3_DROME","P04323","POL3",9.05e-10,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g1028",3013.458,-0.3889281,0.1139065,-3.414449,0.0006391106,0.01570752,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45499",50.73185,0.8759955,0.2565664,3.414303,0.0006394539,0.01570752,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83001",14356.89,0.789502,0.2312356,3.414275,0.0006395201,0.01570752,0,3568,"sp|Q91822|PIM3_XENLA","Q91822","PIM3",1.33e-36,"Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Pim-1)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006915; GO:0043066; GO:0106310"
"g10284",25074.13,-0.7607007,0.2228098,-3.414126,0.0006398709,0.01571018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6111",118.6065,0.5827972,0.1707447,3.413266,0.0006418925,0.01574788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13406",3313.31,-0.3450038,0.1010768,-3.413285,0.0006418486,0.01574788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96241",724.8858,-0.4751653,0.1392222,-3.412999,0.0006425224,0.01575384,0,2440,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.84e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g97005",90.31559,-0.4767889,0.1396997,-3.412957,0.0006426219,0.01575384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63655",305.4723,-0.4430781,0.12984,-3.412494,0.0006437146,0.01577079,9521,12394,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.8e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g64421",967.6264,-0.4063344,0.1190738,-3.412457,0.0006438002,0.01577079,85,3207,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.72e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g90635",222.4155,0.2880991,0.0844318,3.412211,0.0006443827,0.01577469,0,4106,"sp|Q80U95|UBE3C_MOUSE","Q80U95","UBE3C",5.79e-20,"Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (RTA-associated ubiquitin ligase) (RAUL)","protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0005634; GO:0006511; GO:0035519; GO:0061630; GO:0070936"
"g106928",91.43514,0.7615677,0.2231907,3.412184,0.0006444462,0.01577469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38982",34.23042,0.9825333,0.2880024,3.411545,0.0006459574,0.01579805,17435,20477,"sp|P09487|PPBT_BOVIN","P09487","PPBT",1.06e-07,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)","biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]","GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0010259; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031214; GO:0031225; GO:0031966; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071407; GO:0120162; GO:1904383"
"g100277",60.3563,-0.4324516,0.1267616,-3.411536,0.0006459806,0.01579805,0,3594,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.29e-41,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119562",1016.797,0.4703775,0.1378811,3.411472,0.0006461322,0.01579805,1885,2581,"sp|Q13148|TADBP_HUMAN","Q13148","TADBP",9.39e-31,"TAR DNA-binding protein 43 (TDP-43)","3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]","GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010629; GO:0031647; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157"
"g22648",240.2282,-0.3818173,0.1119334,-3.41111,0.0006469898,0.01581306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53815",1946.531,-0.3390092,0.09938937,-3.410921,0.0006474395,0.01581808,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33248",913.777,-0.3746014,0.1098304,-3.410727,0.0006478983,0.01582207,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48217",716.6968,-0.2469063,0.07239281,-3.410646,0.0006480911,0.01582207,6391,10664,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.43e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g6191",550.7032,-0.4535981,0.1330057,-3.410365,0.0006487591,0.01582644,59085,78750,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",6.7e-55,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g29439",1638.794,-0.4842386,0.1419945,-3.410263,0.0006490031,0.01582644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147276",41.59373,0.4934466,0.144694,3.410276,0.0006489721,0.01582644,0,1744,"sp|Q6TGW5|OSTF1_DANRE","Q6TGW5","OSTF1",2.95e-07,"Osteoclast-stimulating factor 1","signal transduction [GO:0007165]","GO:0005737; GO:0007165"
"g60091",2178.365,-0.3008642,0.08822827,-3.410066,0.0006494719,0.01583192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32745",78.00957,1.297323,0.3804762,3.409733,0.0006502639,0.01584526,0,31280,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.27e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9987",34.68944,0.5285983,0.1550518,3.409174,0.0006515999,0.0158648,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22238",37.90294,0.8147912,0.2390055,3.40909,0.0006518002,0.0158648,0,8724,"sp|Q9D6A1|MYO1H_MOUSE","Q9D6A1","MYO1H",3.37e-13,"Unconventional myosin-Ih","actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0051015"
"g137767",563.0519,0.4965809,0.1456603,3.409171,0.0006516061,0.0158648,1032,3018,"sp|Q28F07|ANM1_XENTR","Q28F07","ANM1",2.7e-23,"Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1)","cardiac muscle tissue development [GO:0048738]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]","GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0008380; GO:0016274; GO:0016571; GO:0018216; GO:0022008; GO:0031056; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0048738; GO:0051260; GO:1904047"
"g49234",4739.267,-0.4011505,0.1176891,-3.408562,0.000653062,0.01588525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80184",150.3048,1.267629,0.3718988,3.408533,0.0006531308,0.01588525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77083",817.1687,0.6185938,0.1815133,3.407981,0.0006544539,0.01591146,364,9044,"sp|Q9VLM5|DAD1_DROME","Q9VLM5","DAD1",4.18e-26,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (DAD-1) (Oligosaccharyl transferase subunit DAD1) (Defender against apoptotic cell death 1) (Defender against cell death 1)","apoptotic process [GO:0006915]; protein N-linked glycosylation [GO:0006487]","GO:0006487; GO:0006915; GO:0008250; GO:0012505; GO:0030176"
"g92404",73.62957,0.6042612,0.1773239,3.407668,0.0006552046,0.01592373,0,4564,"sp|P12080|ITA2_DROME","P12080","ITA2",1.4e-07,"Integrin alpha-PS2 (Position-specific antigen subunit alpha-2) (Protein inflated) [Cleaved into: Integrin alpha-PS2 heavy chain; Integrin alpha-PS2 light chain]","apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; central nervous system morphogenesis [GO:0021551]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived wing morphogenesis [GO:0007476]; integrin-mediated signaling pathway [GO:0007229]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; maintenance of protein location [GO:0045185]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; myofibril assembly [GO:0030239]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; ventral cord development [GO:0007419]","GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0007157; GO:0007160; GO:0007229; GO:0007298; GO:0007411; GO:0007414; GO:0007419; GO:0007431; GO:0007435; GO:0007475; GO:0007476; GO:0007494; GO:0007608; GO:0008305; GO:0009897; GO:0009925; GO:0016203; GO:0016324; GO:0016328; GO:0016477; GO:0021551; GO:0030239; GO:0033627; GO:0034446; GO:0035099; GO:0035160; GO:0042383; GO:0045185; GO:0045214; GO:0046982; GO:0050840; GO:0051492; GO:0098609"
"g37439",1186.872,-0.2805456,0.08234413,-3.40699,0.000656836,0.01595075,0,26661,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.61e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g40573",92.77184,0.9920216,0.2911686,3.407035,0.0006567279,0.01595075,7767,22964,"sp|P22105|TENX_HUMAN","P22105","TENX",5.68e-11,"Tenascin-X (TN-X) (Hexabrachion-like protein)","actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641]","GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0043506; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0098609; GO:0098633; GO:1904028; GO:1905935"
"g48307",95.36804,0.4840799,0.1420924,3.406797,0.000657301,0.01595075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97370",34.16565,-0.5046912,0.1481404,-3.406845,0.0006571849,0.01595075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83685",32.16705,0.660572,0.1939358,3.406137,0.0006588915,0.01598336,3236,6824,"sp|Q2W9A4|GCSH_MAGSA","Q2W9A4","GCSH",6.96e-06,"Glycine cleavage system H protein","glycine decarboxylation via glycine cleavage system [GO:0019464]","GO:0005960; GO:0019464"
"g110259",8808.474,0.3990225,0.1171588,3.405827,0.0006596402,0.01599553,785,5413,"sp|Q6P823|H33_XENTR","Q6P823","H33",1.43e-53,"Histone H3.3",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g95876",9689.58,0.6120026,0.1797128,3.405448,0.0006605566,0.01601176,0,4664,"sp|A1ZA47|ZASP_DROME","A1ZA47","ZASP",3.26e-22,"PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]","GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061"
"g110136",285.7604,0.7530464,0.2211369,3.40534,0.0006608184,0.01601212,0,4398,"sp|Q1L8P7|TSP3B_DANRE","Q1L8P7","TSP3B",7.26e-24,"Thrombospondin-3b (Thbs3b)","cell adhesion [GO:0007155]","GO:0005509; GO:0005576; GO:0007155; GO:0008201; GO:0062023"
"g110013",136.7708,0.9882554,0.2902325,3.405047,0.0006615261,0.01602328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71610",17.27646,-2.569357,0.7546674,-3.404622,0.0006625567,0.01603701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158717",774.5397,2.213529,0.6501565,3.404609,0.0006625882,0.01603701,0,470,"sp|Q21966|ASP4_CAEEL","Q21966","ASP4",1.06e-21,"Aspartic protease 4 (EC 3.4.23.-)","cell death [GO:0008219]; necrotic cell death [GO:0070265]; programmed cell death [GO:0012501]","GO:0004190; GO:0005576; GO:0005737; GO:0005764; GO:0008219; GO:0012501; GO:0070265"
"g53784",169.9383,-0.3325693,0.09768734,-3.404426,0.0006630327,0.01604178,8636,11474,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.44e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61741",713.7001,0.2926504,0.08596606,3.404255,0.0006634469,0.01604581,0,12913,"sp|Q562C7|PUM3_RAT","Q562C7","PUM3",1.14e-83,"Pumilio homolog 3","regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]","GO:0003677; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835"
"g31777",69.11873,-0.3622739,0.1064227,-3.404104,0.0006638144,0.0160487,0,19760,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.16e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g133506",407.0246,-0.2543638,0.07473307,-3.403631,0.0006649643,0.01607051,0,3277,"sp|P78424|PO6F2_HUMAN","P78424","PO6F2",9.42e-10,"POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1)","central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]","GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601"
"g134389",136.909,0.749186,0.2201235,3.403481,0.0006653308,0.01607337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92158",923.1389,-0.3956978,0.1162665,-3.40337,0.0006656013,0.01607391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76632",163.4872,-0.5818871,0.1710086,-3.402677,0.0006672915,0.01610873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127608",166.6546,-0.4850923,0.1425955,-3.401877,0.0006692475,0.01614993,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17801",1973.639,-0.3516643,0.1033785,-3.401716,0.0006696431,0.01615346,0,26402,"sp|Q6P1C6|LRIG3_MOUSE","Q6P1C6","LRIG3",2.18e-67,"Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)","otolith morphogenesis [GO:0032474]","GO:0005886; GO:0016021; GO:0030659; GO:0032474"
"g106941",1628.574,-0.4611782,0.135589,-3.401296,0.000670672,0.01617226,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150183",61.61797,1.007125,0.2961405,3.400836,0.0006718009,0.01619345,0,1873,"sp|Q9V427|INX2_DROME","Q9V427","INX2",3.46e-12,"Innexin inx2 (Innexin-2) (Gap junction protein prp33) (Pas-related protein 33)","cell communication [GO:0007154]; foregut morphogenesis [GO:0007440]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; male germ-line stem cell population maintenance [GO:0036098]; morphogenesis of embryonic epithelium [GO:0016331]; phototransduction [GO:0007602]; spermatogenesis [GO:0007283]","GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007154; GO:0007283; GO:0007293; GO:0007440; GO:0007602; GO:0010496; GO:0016021; GO:0016323; GO:0016324; GO:0016327; GO:0016328; GO:0016331; GO:0030727; GO:0036098"
"g24202",6613.665,-0.4414645,0.1298216,-3.400548,0.0006725093,0.01620044,0,39900,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.82e-22,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g94207",114.7354,-0.3507284,0.1031398,-3.400515,0.0006725909,0.01620044,2265,4828,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.77e-22,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g7864",728.1311,0.6478734,0.1905892,3.399318,0.0006755404,0.01626123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59001",463.9819,-0.3719136,0.1094093,-3.399287,0.0006756167,0.01626123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52490",11031.49,0.2645678,0.07783604,3.399039,0.0006762296,0.01626994,13574,16188,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.3e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g26791",266.9539,0.2681404,0.07889175,3.398839,0.0006767245,0.01627391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92399",1048.838,-0.2756378,0.08109927,-3.39877,0.000676897,0.01627391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14611",561.5495,-0.486173,0.1430659,-3.398245,0.0006781955,0.01628861,57432,65133,"sp|P21328|RTJK_DROME","P21328","RTJK",5.53e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g94962",147.9455,0.2910265,0.08564139,3.398199,0.0006783113,0.01628861,0,5691,"sp|Q9R1A0|CCNH_RAT","Q9R1A0","CCNH",4.03e-09,"Cyclin-H","cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000079; GO:0000439; GO:0005634; GO:0005675; GO:0006357; GO:0006366; GO:0006367; GO:0007049; GO:0016301; GO:0016538; GO:0019907; GO:0050821; GO:0070516; GO:0070816; GO:0070985; GO:2000045"
"g104355",824.1115,-0.364054,0.1071315,-3.398198,0.0006783121,0.01628861,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107688",130.2424,1.959187,0.5765508,3.398117,0.0006785141,0.01628861,0,5676,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.54e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34307",4047.306,0.5785627,0.1702764,3.397786,0.0006793347,0.01629245,22172,25544,"sp|P45883|ACBP_PELRI","P45883","ACBP",6.16e-14,"Acyl-CoA-binding protein homolog (ACBP) (Diazepam-binding inhibitor homolog) (DBI)",NA,"GO:0000062; GO:0005783; GO:0005794; GO:0008289"
"g35669",59.95421,0.3608048,0.1061832,3.397945,0.0006789414,0.01629245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77376",897.2743,0.8477354,0.2494992,3.397749,0.0006794284,0.01629245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29088",419.8507,0.6256557,0.1841497,3.397539,0.0006799494,0.01629289,4685,12508,"sp|Q9D1A2|CNDP2_MOUSE","Q9D1A2","CNDP2",1.69e-11,"Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Threonyl dipeptidase)","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070573; GO:0103046"
"g149795",248.9925,0.876105,0.2578644,3.397542,0.0006799414,0.01629289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24456",1364.537,0.821269,0.2417533,3.397137,0.0006809482,0.01630476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149113",131.1919,0.3917357,0.1153111,3.397206,0.0006807767,0.01630476,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38161",1500.302,-0.4495625,0.1323439,-3.396926,0.0006814741,0.0163053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84729",131.8756,-0.3930144,0.1156938,-3.397023,0.0006812317,0.0163053,5385,8258,"sp|Q08ER8|ZN543_HUMAN","Q08ER8","ZN543",2.65e-70,"Zinc finger protein 543","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g10635",3341.908,-0.3074795,0.0905282,-3.396506,0.0006825216,0.01630628,50033,79678,"sp|P31792|POL_FENV1","P31792","POL",4.36e-11,"Pol polyprotein [Cleaved into: Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]","GO:0003676; GO:0003887; GO:0003964; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713"
"g43505",197.7635,-0.2782383,0.08191471,-3.396683,0.0006820791,0.01630628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60380",1634.418,0.3213219,0.09459635,3.396769,0.0006818651,0.01630628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120096",86.2353,0.6208359,0.1827833,3.396569,0.000682364,0.01630628,229,4450,"sp|Q29444|MANBA_BOVIN","Q29444","MANBA",5.15e-14,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]","GO:0004567; GO:0005764; GO:0005975; GO:0006516"
"g9594",27.48404,2.184238,0.6431738,3.39603,0.000683708,0.01632258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10034",3756.923,-0.273974,0.08067428,-3.396051,0.0006836571,0.01632258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23497",193.9215,0.8811397,0.259471,3.395908,0.000684013,0.01632385,32386,42724,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.52e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g25551",107.4106,0.4106248,0.1209262,3.395664,0.0006846246,0.01632609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137737",303.1416,-0.3444921,0.1014521,-3.395613,0.0006847515,0.01632609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138594",105.537,1.58238,0.4660272,3.395468,0.0006851149,0.01632609,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154355",91.6712,0.3996766,0.1177073,3.395511,0.000685005,0.01632609,0,1607,"sp|Q03249|GALT_MOUSE","Q03249","GALT",7.92e-21,"Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)","galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]","GO:0005737; GO:0005794; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0033499; GO:0061623"
"g6596",453.2244,1.106915,0.3260273,3.39516,0.0006858843,0.01633564,29125,61439,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.66e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g49052",3209.418,-0.2965277,0.08734042,-3.39508,0.0006860863,0.01633564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100342",296.5192,0.6600447,0.1944164,3.395006,0.0006862718,0.01633564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12384",754.1791,0.5191662,0.1529257,3.394892,0.0006865571,0.01633643,60206,69134,"sp|P50238|CRIP1_HUMAN","P50238","CRIP1",2.33e-16,"Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP)","cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to organic substance [GO:0010033]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008630; GO:0010033; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493"
"g15718",92.80807,0.8430012,0.2483387,3.394563,0.0006873831,0.01634408,55349,57004,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g62560",220.1395,0.7345871,0.216395,3.394658,0.0006871434,0.01634408,0,4054,"sp|P50897|PPT1_HUMAN","P50897","PPT1",3.05e-14,"Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)","adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]","GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146"
"g136848",11556.29,0.6723287,0.1980709,3.394384,0.0006878305,0.01634872,2715,3084,"sp|P10994|ACTS_PLEWA","P10994","ACTS",3.6e-75,"Actin, alpha skeletal muscle (Fragment)",NA,"GO:0005524; GO:0005737; GO:0005856"
"g74100",40.14537,0.5512012,0.1623939,3.394223,0.0006882356,0.01635235,2079,10044,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.86e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g142272",137.1158,-0.5292269,0.1559309,-3.393983,0.0006888391,0.01636068,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140870",299.3025,0.6176637,0.1820331,3.39314,0.0006909636,0.01640513,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26627",320.7065,0.4721126,0.1391484,3.392871,0.0006916422,0.01641523,2203,33454,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.52e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g2072",3089.213,-0.3276061,0.09656713,-3.392522,0.000692524,0.0164284,42566,57994,"sp|Q5XGI3|FBXL5_XENTR","Q5XGI3","FBXL5",3.51e-09,"F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5)","iron ion homeostasis [GO:0055072]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005506; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072"
"g21336",3487.435,-0.2336947,0.0688867,-3.39245,0.0006927045,0.0164284,12144,32794,"sp|O55164|MPDZ_RAT","O55164","MPDZ",1.8e-24,"Multiple PDZ domain protein (Multi-PDZ domain protein 1)","cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; microtubule organizing center organization [GO:0031023]; myelination [GO:0042552]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192]","GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0008022; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031023; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0070507; GO:0120192"
"g38719",1784.603,-0.6691836,0.197265,-3.392307,0.0006930668,0.01643098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13963",29514.9,0.5074933,0.1496182,3.391922,0.0006940415,0.01644388,0,11271,"sp|P54399|PDI_DROME","P54399","PDI",7.7e-94,"Protein disulfide-isomerase (PDI) (dPDI) (EC 5.3.4.1)",NA,"GO:0003756; GO:0005615; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005791; GO:0012505; GO:0015035; GO:0043025; GO:0045169; GO:0048471; GO:0060187; GO:0070732"
"g85329",202.4507,0.4395617,0.1295919,3.391892,0.0006941185,0.01644388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143692",126.0147,2.069179,0.6100674,3.391722,0.0006945478,0.01644804,0,2054,"sp|P91885|AMPN_MANSE","P91885","AMPN",7.97e-20,"Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn2) (Microsomal aminopeptidase)",NA,"GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225"
"g7083",239.4729,-0.2982652,0.0879461,-3.391454,0.0006952274,0.01645211,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99751",1755.709,-0.5456148,0.1608753,-3.391539,0.000695013,0.01645211,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99963",175.8688,0.9264805,0.2732003,3.391213,0.0006958401,0.01646059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152548",89.75328,-2.45155,0.723012,-3.390746,0.0006970257,0.01648262,1260,1763,"sp|P81584|CUPC5_CANPG","P81584","CUPC5",3.3e-08,"Cuticle protein CP1876 (CPCP1876)",NA,"GO:0042302"
"g40170",5029.837,0.6790158,0.2002679,3.390538,0.0006975561,0.01648915,0,11288,"sp|B7Z0W9|OTOP_DROME","B7Z0W9","OTOP",1.46e-23,"Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc)","proton transmembrane transport [GO:1902600]","GO:0005886; GO:0015252; GO:0016021; GO:1902600"
"g70366",233.7609,-0.4765174,0.1405529,-3.390307,0.0006981431,0.01649043,4726,10124,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",4.51e-06,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g101781",410.7275,0.4173081,0.1230919,3.390217,0.0006983738,0.01649043,1842,3664,"sp|Q5RFK0|ETFB_PONAB","Q5RFK0","ETFB",1.13e-07,"Electron transfer flavoprotein subunit beta (Beta-ETF)","cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0000166; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251"
"g102807",247.981,0.2752239,0.08117957,3.390309,0.0006981379,0.01649043,0,6187,"sp|Q4U0S5|PAF1_DANRE","Q4U0S5","PAF1",2.84e-23,"RNA polymerase II-associated factor 1 homolog (PD2-like protein)","heart development [GO:0007507]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0000791; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0016570; GO:0016593"
"g39831",1012.795,-0.294226,0.08679164,-3.390027,0.0006988579,0.01649585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10835",961.5251,-0.3031715,0.08943545,-3.389836,0.0006993441,0.01650131,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96791",322.5012,-0.2002542,0.05908032,-3.389524,0.0007001402,0.01651408,554,4564,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.2e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g28199",362.6405,-0.2469531,0.07286404,-3.389232,0.0007008878,0.01651969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127359",2660.588,0.6124104,0.1806915,3.389259,0.0007008181,0.01651969,0,3054,"sp|P10984|ACT2_CAEEL","P10984","ACT2",0,"Actin-2","cortical actin cytoskeleton organization [GO:0030866]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]","GO:0000281; GO:0005524; GO:0005737; GO:0005884; GO:0005938; GO:0007111; GO:0009792; GO:0030866; GO:0040011"
"g9637",98.42286,-0.4419244,0.1304255,-3.388327,0.0007032038,0.01655621,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10833",103.3589,-0.4409364,0.1301297,-3.388436,0.0007029234,0.01655621,12575,20351,"sp|Q9BY12|SCAPE_HUMAN","Q9BY12","SCAPE",2.5e-13,"S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917"
"g118065",56.27946,0.5364236,0.1583143,3.388347,0.0007031529,0.01655621,0,3505,"sp|P21328|RTJK_DROME","P21328","RTJK",7.57e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g1505",266.084,-0.4206875,0.1241644,-3.388149,0.000703661,0.01656096,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31753",682.0255,0.4901003,0.1446679,3.387762,0.0007046534,0.01657829,0,8678,"sp|P11047|LAMC1_HUMAN","P11047","LAMC1",1.06e-19,"Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma)","animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0009887; GO:0009888; GO:0016477; GO:0022617; GO:0031581; GO:0034446; GO:0035633; GO:0043259; GO:0043260; GO:0045785; GO:0050679; GO:0051149; GO:0062023; GO:0065003; GO:0070062; GO:0098637; GO:0110011; GO:2001046"
"g51549",4186.708,-0.4583144,0.1353004,-3.387383,0.0007056275,0.01659518,0,16595,"sp|P47236|PAX1_CHICK","P47236","PAX1",2.71e-16,"Paired box protein Pax-1 (Fragment)","anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0048856; GO:0061056"
"g27973",766.2713,-0.3869859,0.1142714,-3.38655,0.0007077739,0.01659834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59371",28.30828,0.8015301,0.236651,3.386971,0.0007066874,0.01659834,0,10964,"sp|Q26454|MCM4_DROME","Q26454","MCM4",1.13e-12,"DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)","DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006268; GO:0006271; GO:0007052; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g75699",64.30957,0.4445573,0.1312703,3.38658,0.0007076957,0.01659834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82693",743.6612,-0.218182,0.06442491,-3.38661,0.0007076194,0.01659834,0,3944,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.23e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g82943",122.4833,0.3153065,0.09310591,3.386536,0.0007078111,0.01659834,0,8668,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.09e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g99968",68.38033,0.4008301,0.1183558,3.386654,0.0007075047,0.01659834,0,6110,"sp|P11369|LORF2_MOUSE","P11369","LORF2",8.2e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g121501",41.1654,-0.4851191,0.1432337,-3.386907,0.0007068535,0.01659834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143317",25.75712,0.6218117,0.1836016,3.386744,0.0007072744,0.01659834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137019",30.93263,0.6527342,0.192816,3.38527,0.000711082,0.01666901,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3639",783.7509,-0.2392406,0.07068999,-3.384363,0.0007134368,0.01667077,54100,60804,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g11555",160.0516,0.8618661,0.254612,3.385017,0.0007117389,0.01667077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17466",1783.709,-0.4613589,0.1363038,-3.384784,0.0007123437,0.01667077,16116,27244,"sp|Q6P5C7|ZN728_MOUSE","Q6P5C7","ZN728",1.89e-08,"Zinc finger protein 728","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0045892; GO:0046872; GO:0070895"
"g23308",152.7074,0.3425355,0.1011956,3.384886,0.0007120778,0.01667077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50296",41.22385,0.4138848,0.1222941,3.38434,0.0007134969,0.01667077,0,9255,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.18e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g54070",211.4586,-0.3778851,0.1116482,-3.384604,0.0007128093,0.01667077,7825,15555,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.12e-23,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g65133",277.1551,0.3815869,0.1127506,3.384346,0.0007134802,0.01667077,8289,11894,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.35e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g127808",54.75873,3.076752,0.9091385,3.38425,0.00071373,0.01667077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131025",25.27772,1.012108,0.2989919,3.385068,0.0007116065,0.01667077,0,2484,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.75e-13,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g132443",42.24949,0.5243574,0.1549256,3.384576,0.0007128821,0.01667077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10299",36.0077,0.561779,0.1660078,3.384052,0.0007142435,0.01667432,29015,32670,"sp|Q9NYA1|SPHK1_HUMAN","Q9NYA1","SPHK1",1.15e-11,"Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)","blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]","GO:0000287; GO:0001568; GO:0001727; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006665; GO:0006670; GO:0006954; GO:0007420; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016020; GO:0016310; GO:0016407; GO:0017050; GO:0019722; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0043231; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071363; GO:0071897; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364"
"g127103",2263.152,-2.107506,0.6227866,-3.383994,0.0007143969,0.01667432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115087",27.14168,-0.8580246,0.2535902,-3.383509,0.0007156598,0.01669778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50059",61.43904,0.6288039,0.1858508,3.38338,0.0007159944,0.01669958,2175,5378,"sp|P83871|PHF5A_RAT","P83871","PHF5A",3.38e-28,"PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]","GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011"
"g42309",4909.912,0.8884533,0.2626261,3.382958,0.0007170949,0.01671923,0,5514,"sp|O15540|FABP7_HUMAN","O15540","FABP7",1.33e-12,"Fatty acid-binding protein, brain (Brain lipid-binding protein) (BLBP) (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)","epithelial cell proliferation [GO:0050673]; fatty acid transport [GO:0015908]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]","GO:0005504; GO:0005634; GO:0005829; GO:0007399; GO:0008285; GO:0008289; GO:0015908; GO:0050673"
"g18709",49.59212,1.739643,0.5142707,3.382738,0.0007176703,0.01672662,8493,11194,"sp|Q8IW92|GLBL2_HUMAN","Q8IW92","GLBL2",1.72e-07,"Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005576; GO:0005773; GO:0005975"
"g78011",2076.104,0.6037371,0.1784907,3.382456,0.0007184071,0.01673778,0,9434,"sp|P41386|TBB_HALDI","P41386","TBB",5.36e-35,"Tubulin beta chain (Beta-tubulin) (Fragment)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g18874",127.1812,0.6103359,0.1804518,3.382266,0.0007189042,0.01674334,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28785",1158.633,0.5376505,0.1589905,3.381652,0.0007205134,0.01677478,8646,14804,"sp|Q24799|MYPH_ECHGR","Q24799","MYPH",1.66e-09,"Myophilin",NA,NA
"g151638",910.9717,-1.106741,0.3272921,-3.381509,0.0007208878,0.01677747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138366",41.12754,0.395525,0.1169709,3.381395,0.0007211868,0.0167784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33792",286.0475,-0.3143268,0.09296335,-3.381191,0.000721724,0.01678488,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94187",658.2316,-0.311509,0.09213611,-3.380965,0.0007223165,0.0167866,2035,7004,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.39e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g141606",214.53,-0.3000107,0.08873281,-3.381057,0.0007220755,0.0167866,0,2529,"sp|P51522|ZNF83_HUMAN","P51522","ZNF83",2.16e-37,"Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g35300",47.30463,0.4184566,0.1237783,3.380695,0.0007230263,0.0167894,0,21299,"sp|P21328|RTJK_DROME","P21328","RTJK",1.17e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g73687",170.7584,0.4886559,0.1445461,3.380624,0.0007232142,0.0167894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87570",5160.679,-0.2779001,0.08220272,-3.380667,0.0007231001,0.0167894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48193",86.82432,0.3276822,0.0969456,3.380063,0.0007246925,0.01681125,1635,10654,"sp|Q99797|MIPEP_HUMAN","Q99797","MIPEP",5.21e-21,"Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)","peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]","GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872"
"g72431",74.6465,-0.3620784,0.1071264,-3.379918,0.0007250751,0.01681125,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73241",40.0814,0.5256579,0.1555259,3.379873,0.0007251931,0.01681125,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122936",30.24425,0.9193392,0.2719837,3.380127,0.0007245247,0.01681125,0,4144,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.05e-27,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g124883",78.50834,0.49963,0.1478407,3.379516,0.0007261353,0.01682707,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32973",438.5616,0.4084307,0.1208678,3.379152,0.0007270976,0.01683732,1415,30874,"sp|P62294|ASPM_PONPY","P62294","ASPM",1.82e-113,"Abnormal spindle-like microcephaly-associated protein homolog","cell division [GO:0051301]; spindle organization [GO:0007051]","GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0051301"
"g65667",25.58018,0.4621399,0.136759,3.379229,0.0007268946,0.01683732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10680",50.93793,-0.4796293,0.1419457,-3.378963,0.0007275991,0.01684252,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47215",58.59099,0.4075896,0.1206324,3.378773,0.0007281017,0.01684252,5005,5934,"sp|Q9D0A0|DET1_MOUSE","Q9D0A0","DET1",2.35e-12,"DET1 homolog (De-etiolated-1 homolog)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein-containing complex assembly [GO:0065003]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756"
"g138835",4636.513,0.6094685,0.1803768,3.378863,0.000727862,0.01684252,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16728",32.24625,-0.545947,0.1616037,-3.378308,0.0007293328,0.01685896,41045,51838,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.82e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g123655",4951.19,0.9183763,0.2718378,3.378398,0.0007290947,0.01685896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49455",944.6785,-0.4218123,0.1248872,-3.377547,0.0007313547,0.01689967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79114",197.9076,-0.3116524,0.09228157,-3.37719,0.0007323047,0.01691517,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128260",160.5011,1.008872,0.2987392,3.377099,0.0007325479,0.01691517,1716,3324,"sp|Q924Z4|CERS2_MOUSE","Q924Z4","CERS2",1.54e-53,"Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297)","ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]","GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0019216; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045"
"g18301",34.49834,0.6738625,0.1995588,3.376762,0.0007334444,0.01692984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2464",321.477,0.8242787,0.2441284,3.376415,0.0007343717,0.01693836,48821,69124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.22e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g22257",21.05429,1.239843,0.3672082,3.376404,0.0007343993,0.01693836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118394",128.6087,0.3844959,0.1138798,3.37633,0.0007345977,0.01693836,0,4414,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.6e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g24805",305.8594,-0.3378057,0.1000618,-3.375972,0.0007355538,0.01695437,4703,11294,"sp|Q960X4|TIP60_DROME","Q960X4","TIP60",2.48e-23,"Histone acetyltransferase Tip60 (EC 2.3.1.48)","histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H4 acetylation [GO:0043967]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of synaptic plasticity [GO:0048167]; regulation of terminal button organization [GO:2000331]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000123; GO:0003712; GO:0004402; GO:0005634; GO:0005705; GO:0006355; GO:0007399; GO:0010468; GO:0016573; GO:0035267; GO:0042393; GO:0043486; GO:0043524; GO:0043967; GO:0045892; GO:0045944; GO:0046872; GO:0048167; GO:1990188; GO:2000331"
"g89679",83.70124,0.3811089,0.1128995,3.375646,0.0007364252,0.01696842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4807",396.7418,1.765218,0.5229736,3.375348,0.0007372232,0.01697244,99995,119783,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.81e-11,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g17723",4086.938,-0.4583563,0.1358056,-3.375092,0.0007379094,0.01697244,33955,44160,"sp|Q26473|SEM1A_SCHAM","Q26473","SEM1A",1.99e-11,"Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0007399; GO:0016021; GO:0030154; GO:0030215"
"g48704",2628.192,-0.4574406,0.1355307,-3.375181,0.0007376721,0.01697244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49826",131.6609,0.3209758,0.09509887,3.37518,0.0007376743,0.01697244,7108,17442,"sp|P21328|RTJK_DROME","P21328","RTJK",1.36e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g84125",20.11405,1.996887,0.5915991,3.375406,0.0007370692,0.01697244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12502",177.6673,-0.845357,0.2504901,-3.374812,0.0007386608,0.01697767,51875,57990,"sp|P19213|CREA_FLASU","P19213","CREA",5.38e-33,"Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)",NA,"GO:0016980"
"g83780",50.06766,0.5069618,0.150218,3.37484,0.0007385864,0.01697767,0,8370,"sp|P27008|PARP1_RAT","P27008","PARP1",1.81e-16,"Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)","apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA metabolic process [GO:0006259]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]","GO:0000723; GO:0003677; GO:0003682; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0006259; GO:0006284; GO:0006302; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016540; GO:0016604; GO:0016763; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030331; GO:0030592; GO:0032042; GO:0032700; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0040009; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0046332; GO:0047485; GO:0048148; GO:0050790; GO:0050882; GO:0051287; GO:0051901; GO:0060391; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0071451; GO:0071560; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903516; GO:1903518; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170"
"g5094",2419.052,-0.4035251,0.1195878,-3.374299,0.0007400401,0.01700334,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17601",2117.813,-0.2474332,0.07333677,-3.37393,0.0007410309,0.01701638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83621",118.2481,2.465291,0.7306963,3.373893,0.000741133,0.01701638,0,3514,"sp|Q04519|ASM_MOUSE","Q04519","ASM",5.12e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g24238",959.645,-0.3534883,0.1047869,-3.373403,0.0007424522,0.01704063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107883",713.5119,0.8332837,0.2470244,3.373285,0.0007427706,0.0170419,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50117",1752.203,-0.2966648,0.08794877,-3.373154,0.0007431232,0.01704396,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100619",1072.76,0.4006351,0.1187781,3.37297,0.0007436213,0.01704935,2426,6427,"sp|Q66LN0|PGES2_BOVIN","Q66LN0","PGES2",7.37e-14,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form]","glutathione metabolic process [GO:0006749]; prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005739; GO:0005783; GO:0006749; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220"
"g56035",195.1587,-0.6198125,0.1837667,-3.372822,0.00074402,0.01704959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127205",394.0709,-1.150562,0.3411425,-3.372674,0.0007444211,0.01704959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156625",27.30122,-0.8223797,0.2438321,-3.37273,0.000744269,0.01704959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86020",20.88532,-1.693014,0.5020716,-3.372058,0.0007460886,0.01708174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66178",91.04667,0.9634077,0.2857221,3.371835,0.000746693,0.01708954,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69724",379.527,0.4673904,0.1386275,3.371556,0.0007474485,0.01709475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130554",49.43136,0.9947993,0.2950492,3.371638,0.000747225,0.01709475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115396",11115.33,0.7147812,0.2120368,3.371024,0.0007488943,0.01712177,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38726",8685.808,-0.2830326,0.08397428,-3.370468,0.0007504057,0.0171486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162198",201.7204,0.9926076,0.2945075,3.370398,0.0007505968,0.0171486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62653",121.2237,-0.7050242,0.2091916,-3.370232,0.0007510504,0.01715291,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14403",658.0066,-0.3607553,0.1070527,-3.369887,0.000751991,0.01716834,59325,64369,"sp|Q8NI51|CTCFL_HUMAN","Q8NI51","CTCFL",1.96e-16,"Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T)","cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006349; GO:0006357; GO:0007049; GO:0010628; GO:0016571; GO:0016604; GO:0042393; GO:0043035; GO:0043046; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0051569"
"g131223",1066.775,0.4817406,0.1429917,3.369012,0.0007543823,0.01721687,0,1034,"sp|P38377|S61A1_CANLF","P38377","S61A1",3.26e-26,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g92208",2295.034,-0.5269236,0.156411,-3.36884,0.0007548532,0.01722155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34716",45.50921,-0.4420985,0.131237,-3.368703,0.0007552287,0.01722405,0,9354,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.5e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g15053",1710.693,-0.4990722,0.1481655,-3.368343,0.0007562141,0.01722838,14224,18364,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.27e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17607",102.4238,0.7546886,0.2240489,3.36841,0.00075603,0.01722838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160032",271.8484,1.605531,0.4766531,3.368342,0.0007562162,0.01722838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5791",6096.19,-0.2460573,0.07306141,-3.367814,0.0007576659,0.01724322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17568",633.8678,-0.3944249,0.1171156,-3.367826,0.0007576337,0.01724322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75039",92.07308,-0.5372366,0.1595195,-3.367843,0.0007575871,0.01724322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84613",28.89959,0.4776503,0.1418481,3.367338,0.0007589757,0.0172662,3190,5454,"sp|P36871|PGM1_HUMAN","P36871","PGM1",3.65e-18,"Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)","carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0006006; GO:0006094; GO:0006096; GO:0070062; GO:1904724; GO:1904813"
"g86570",148.6994,-0.4503026,0.1337299,-3.367254,0.0007592086,0.0172662,1986,8149,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.99e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g10509",863.4041,-0.3733134,0.1108753,-3.366965,0.0007600024,0.01726769,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26949",103.8078,0.3314055,0.0984293,3.36694,0.0007600736,0.01726769,12761,27344,"sp|Q7TQK1|INT7_MOUSE","Q7TQK1","INT7",1.17e-10,"Integrator complex subunit 7 (Int7)","cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0000077; GO:0005634; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0071479"
"g139873",260.4472,0.4109935,0.1220633,3.367052,0.0007597632,0.01726769,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4764",511.814,-0.4649007,0.1380873,-3.366717,0.0007606878,0.01727559,48154,51544,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.68e-16,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g5049",1916.533,0.3559643,0.1057375,3.36649,0.0007613128,0.01728372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70370",17.5324,0.6063034,0.1801241,3.366031,0.0007625815,0.0173004,6815,10224,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.63e-29,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104241",201.4882,0.7617391,0.2262968,3.366106,0.0007623734,0.0173004,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128625",155.0925,0.8798758,0.2614478,3.365398,0.0007643342,0.01733409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83205",1405.033,0.6029384,0.1791724,3.36513,0.0007650772,0.01734487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52416",1252.027,-0.2551579,0.07583484,-3.364652,0.0007664024,0.01736884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106130",353.3996,0.2929869,0.08708432,3.364405,0.0007670892,0.01737225,0,5110,"sp|Q5R434|TSR1_PONAB","Q5R434","TSR1",1.98e-20,"Pre-rRNA-processing protein TSR1 homolog","ribosome biogenesis [GO:0042254]","GO:0005730; GO:0042254"
"g158761",248.3832,-0.422277,0.1255126,-3.364419,0.0007670492,0.01737225,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12755",1741.424,-0.2981822,0.08864283,-3.363861,0.0007686026,0.01738483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66006",38.12892,1.47709,0.439111,3.36382,0.0007687179,0.01738483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134969",57.9413,0.5987879,0.1780079,3.363828,0.0007686939,0.01738483,0,3233,"sp|Q9BUD6|SPON2_HUMAN","Q9BUD6","SPON2",2.75e-13,"Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin)","cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]","GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222"
"g155701",19.66146,2.852391,0.847946,3.363882,0.0007685431,0.01738483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38725",1902.924,-0.3394676,0.1009309,-3.363366,0.0007699807,0.01740731,8941,25494,"sp|P21521|SY65_DROME","P21521","SY65",2.79e-28,"Synaptotagmin 1 (p65)","calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073"
"g18867",30.82033,0.6621168,0.1968897,3.362883,0.0007713314,0.01740974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55446",59.18916,1.298769,0.3862112,3.362847,0.0007714313,0.01740974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107166",109.3593,0.4475328,0.1330715,3.363101,0.0007707211,0.01740974,215,5730,"sp|Q7CVK1|PY2CR_AGRFC","Q7CVK1","PY2CR",1.2e-09,"Delta(1)-pyrroline-2-carboxylate reductase (Pyr2C reductase) (EC 1.5.1.49) (Proline ketimine reductase)",NA,"GO:0016491"
"g147672",2174.654,0.3417447,0.1016205,3.362952,0.0007711384,0.01740974,264,1750,"sp|O00567|NOP56_HUMAN","O00567","NOP56",7.83e-55,"Nucleolar protein 56 (Nucleolar protein 5A)","rRNA processing [GO:0006364]","GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226"
"g160774",902.8057,-1.089434,0.3239372,-3.363102,0.0007707189,0.01740974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15776",200.8321,1.901034,0.5653334,3.362677,0.0007719055,0.01741437,53086,56954,"sp|A0A2R8QPS5|RIC1_DANRE","A0A2R8QPS5","RIC1",4.71e-06,"Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner 1)","intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005829; GO:0006886; GO:0034066; GO:0042147"
"g151116",31.04501,0.9247694,0.2750254,3.362488,0.0007724351,0.01742025,845,1411,"sp|P84057|H2A_TIGCA","P84057","H2A",6.65e-68,"Histone H2A",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g101719",85.87694,-0.5463897,0.162509,-3.362212,0.0007732077,0.01743158,0,4004,"sp|Q96T58|MINT_HUMAN","Q96T58","MINT",1.1e-07,"Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog)","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0045892; GO:0050769; GO:0061629; GO:0070062"
"g131807",7448.133,0.5532263,0.164547,3.362116,0.0007734752,0.01743158,0,3484,"sp|Q86RN8|MYSP_RHIMP","Q86RN8","MYSP",2.98e-15,"Paramyosin",NA,"GO:0016459; GO:0030016; GO:0032982"
"g29328",69.87871,0.4973995,0.1479496,3.361952,0.0007739356,0.01743589,28815,35920,"sp|Q6PB66|LPPRC_MOUSE","Q6PB66","LPPRC",3.09e-12,"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130)","mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]","GO:0000794; GO:0000961; GO:0003697; GO:0003723; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005856; GO:0005874; GO:0031625; GO:0042645; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904"
"g3795",2599.084,-0.399141,0.1187304,-3.361743,0.0007745213,0.01744302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49299",40.05446,0.6786969,0.2019063,3.361445,0.0007753591,0.01745582,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26867",23.35064,0.7648636,0.2275474,3.361337,0.0007756615,0.01745656,0,13624,"sp|P70032|PLK1_XENLA","P70032","PLK1",9.02e-28,"Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1)","centrosome cycle [GO:0007098]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte maturation [GO:0001556]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]","GO:0000086; GO:0000122; GO:0000278; GO:0000281; GO:0000776; GO:0001556; GO:0001578; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007095; GO:0007098; GO:0008017; GO:0019901; GO:0030496; GO:0043066; GO:0051233; GO:0071168; GO:0106310; GO:1904668"
"g17567",964.124,-0.3393418,0.1009621,-3.361081,0.0007763813,0.01746425,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21717",48.37481,0.6492965,0.1931842,3.361023,0.0007765424,0.01746425,46085,48446,"sp|Q9GKZ4|TRAM1_BOVIN","Q9GKZ4","TRAM1",2.37e-13,"Translocating chain-associated membrane protein 1 (Protein TRAM1)","cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0006613; GO:0006616; GO:0006986; GO:0030176; GO:0045048"
"g16039",384.3153,0.6391717,0.1901864,3.360765,0.0007772694,0.01746631,26206,36094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65673",1603.329,-0.343359,0.1021665,-3.360778,0.000777233,0.01746631,4623,11504,"sp|Q8IWF2|FXRD2_HUMAN","Q8IWF2","FXRD2",3.51e-18,"FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation)","ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005788; GO:0016491; GO:0030433; GO:0050660"
"g108584",67.03609,0.4217276,0.1254915,3.360608,0.0007777121,0.01746631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113088",25.74712,3.96233,1.179031,3.360666,0.0007775479,0.01746631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65550",557.9255,-0.521559,0.1552034,-3.360488,0.0007780504,0.01746785,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21531",3074.628,-0.264383,0.07867948,-3.360254,0.0007787098,0.0174766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47917",1395.879,-0.3087637,0.09191247,-3.359323,0.0007813373,0.0175295,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39508",999.6528,-0.2951766,0.08787905,-3.358897,0.0007825435,0.0175445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135901",29.93208,0.6941814,0.2066696,3.358895,0.0007825476,0.0175445,1315,2843,"sp|Q3U0B3|DHR11_MOUSE","Q3U0B3","DHR11",8.22e-09,"Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)","estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]","GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0044594; GO:0072555; GO:0072582; GO:0102176"
"g99971",42.78071,0.8434913,0.2511549,3.35845,0.0007838085,0.01756669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28330",2214.978,-0.2788251,0.08303882,-3.357768,0.0007857463,0.01760403,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148306",70.48013,0.4526599,0.1348261,3.357362,0.0007869012,0.01762381,0,2138,"sp|Q2TBL8|CDK10_BOVIN","Q2TBL8","CDK10",1.28e-22,"Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10)","cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mitotic cell cycle [GO:0007346]","GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007346; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0106310; GO:1902018"
"g143345",299.5604,0.3559306,0.1060224,3.357126,0.0007875715,0.01763273,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99143",44.54214,-0.4730828,0.1409315,-3.356829,0.0007884193,0.01764561,3575,6601,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g148499",795.1568,0.5807599,0.1730235,3.356538,0.0007892478,0.01765806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96332",435.0665,0.4049983,0.1206702,3.356242,0.0007900946,0.0176709,0,6514,"sp|Q01205|ODO2_RAT","Q01205","ODO2",6.16e-38,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)","2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; NADH metabolic process [GO:0006734]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]","GO:0004149; GO:0005634; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0016746; GO:0031072; GO:0033512; GO:0043231; GO:0045252; GO:0051087; GO:0106077"
"g44876",25.10975,0.7331592,0.2184919,3.355544,0.0007920895,0.0177033,0,10241,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.01e-10,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g45979",233.0685,0.5157699,0.1537057,3.355568,0.0007920232,0.0177033,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34412",39.13664,0.5246011,0.1563486,3.35533,0.0007927043,0.01771093,21607,25394,"sp|Q2YDE9|TES_BOVIN","Q2YDE9","TES",1.74e-07,"Testin","negative regulation of cell population proliferation [GO:0008285]","GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0008270; GO:0008285; GO:0032991"
"g36577",23.25961,2.422974,0.7222746,3.354643,0.0007946736,0.01773658,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46360",4835.897,-0.3395554,0.1012189,-3.354664,0.0007946153,0.01773658,14390,19354,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.91e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g48065",2111.38,-0.4942801,0.1473354,-3.354795,0.0007942372,0.01773658,0,8244,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.38e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g98126",148.5748,0.4320716,0.1288026,3.354526,0.0007950106,0.01773799,0,5984,"sp|O00716|E2F3_HUMAN","O00716","E2F3",3.04e-06,"Transcription factor E2F3 (E2F-3)","G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000082; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0006606; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837"
"g91891",279.3451,0.3160893,0.09423309,3.354334,0.0007955614,0.01773806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139427",186.7358,-0.4056873,0.120943,-3.354368,0.0007954663,0.01773806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106622",541.6193,-0.4114038,0.1226593,-3.354038,0.0007964136,0.01775096,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33407",1260.121,-0.4293413,0.1280117,-3.353924,0.0007967436,0.0177522,20802,30644,"sp|P08548|LIN1_NYCCO","P08548","LIN1",8.96e-21,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g121357",392.6774,-0.2921272,0.0871042,-3.353767,0.0007971946,0.01775615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53822",3207.352,-0.2106197,0.0628142,-3.353059,0.0007992366,0.01779331,4628,15660,"sp|P25228|RAB3_DROME","P25228","RAB3",9.36e-09,"Ras-related protein Rab-3","cytoskeletal matrix organization at active zone [GO:0048789]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]; viral entry into host cell [GO:0046718]","GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006904; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0017157; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0048172; GO:0048786; GO:0048789; GO:0048790; GO:0072659"
"g95496",21.51192,2.6467,0.7893532,3.352998,0.0007994125,0.01779331,0,7023,"sp|P46197|ANPRB_BOVIN","P46197","ANPRB",2.72e-08,"Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)","bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; receptor guanylyl cyclase signaling pathway [GO:0007168]; reproductive process [GO:0022414]; signal transduction [GO:0007165]","GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0016941; GO:0017046; GO:0022414; GO:0035556; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194"
"g33059",47.80408,0.4607534,0.1374344,3.352534,0.0008007528,0.01781702,0,31436,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.43e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g43017",182.0368,0.3105595,0.09264657,3.352088,0.0008020441,0.01783351,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84569",1198.799,0.2787305,0.08315041,3.352124,0.0008019411,0.01783351,0,8310,"sp|Q4R5X8|NDUS6_MACFA","Q4R5X8","NDUS6",5.53e-16,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005747; GO:0006120"
"g121391",103.0886,0.4555293,0.1359107,3.351682,0.0008032229,0.01785359,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2971",1171.448,-0.5021593,0.1498314,-3.351496,0.0008037622,0.01785945,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39505",549.4869,-0.4572035,0.1364281,-3.351241,0.0008045012,0.01786492,0,11685,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.51e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g53038",211.0873,0.3789437,0.1130763,3.351221,0.0008045598,0.01786492,0,15954,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.2e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g111121",136.5554,-0.5370104,0.1602534,-3.351008,0.0008051791,0.01787255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131848",199.4738,1.54616,0.461424,3.350845,0.0008056533,0.01787684,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145548",1023.237,-0.6870422,0.2050412,-3.350752,0.0008059243,0.01787684,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86706",18.50098,-0.661745,0.1974976,-3.350648,0.0008062269,0.01787743,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142416",1570.94,0.6925844,0.2067104,3.350506,0.0008066402,0.01788048,0,2649,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",1.55e-16,"Collagen-like protein 4",NA,NA
"g26673",1846.054,0.3636755,0.1085471,3.350393,0.0008069707,0.01788169,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27607",695.932,-0.2389624,0.07132713,-3.350231,0.0008074412,0.01788178,10892,38204,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.7e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g92270",66.74683,-0.3678748,0.1098068,-3.350202,0.0008075267,0.01788178,3504,7354,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.61e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73748",111.9799,1.091616,0.3258875,3.349672,0.0008090727,0.01790989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28074",6424.951,-0.4250666,0.1269022,-3.349559,0.0008094029,0.01791108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124460",128.3589,0.6413215,0.1914754,3.349368,0.0008099612,0.01791731,0,3964,"sp|O75521|ECI2_HUMAN","O75521","ECI2",2.3e-28,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]","GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231"
"g76687",600.0042,0.3825225,0.1142137,3.349181,0.0008105075,0.01792328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124428",21.29459,1.036994,0.3096577,3.348838,0.0008115113,0.01793914,0,4090,"sp|Q93789|LIPL1_CAEEL","Q93789","LIPL1",1.69e-07,"Lipase lipl-1 (EC 3.1.1.-) (Lipase-like 1)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0005764; GO:0016042; GO:0016788; GO:0043202"
"g138477",18.95633,-0.5020372,0.1499179,-3.348747,0.0008117784,0.01793914,0,2284,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.95e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g117184",29.77334,0.8278984,0.2472535,3.348378,0.0008128593,0.0179569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31003",268.4872,0.3954623,0.1181146,3.348125,0.0008136044,0.01796724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22834",1812.039,-0.3834801,0.1145507,-3.347688,0.000814886,0.01797716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69692",105.1834,1.090367,0.3257044,3.34772,0.000814792,0.01797716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87450",96.91075,0.4146823,0.1238654,3.347847,0.0008144205,0.01797716,2974,7534,"sp|P42695|CNDD3_HUMAN","P42695","CNDD3",2.13e-07,"Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3)","cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]","GO:0000779; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0035064; GO:0042393; GO:0051301"
"g34568",177.6022,-0.4766994,0.1424069,-3.347446,0.0008155973,0.01798672,11276,29636,"sp|Q8TDY8|IGDC4_HUMAN","Q8TDY8","IGDC4",4.99e-08,"Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36)","cell-cell adhesion [GO:0098609]","GO:0005886; GO:0016021; GO:0098609"
"g3572",860.6661,0.2547759,0.07611623,3.347195,0.0008163373,0.01799692,16438,28624,"sp|B0W6M9|SUR8_CULQU","B0W6M9","SUR8",9.42e-30,"Leucine-rich repeat protein soc-2 homolog (Protein Sur-8 homolog) (Protein soc-2 homolog)",NA,NA
"g122805",39.25505,-0.3630454,0.1084678,-3.347036,0.0008168065,0.01800114,0,3694,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.82e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g604",2207.801,-0.4073977,0.121726,-3.346843,0.0008173751,0.01800754,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53380",358.1452,-0.3282346,0.09808032,-3.34659,0.0008181223,0.01801788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141462",69.73122,-0.6081309,0.1817338,-3.346274,0.0008190554,0.0180323,0,2729,"sp|Q5R8X1|ZN665_PONAB","Q5R8X1","ZN665",4.46e-145,"Zinc finger protein 665",NA,"GO:0003677; GO:0005634; GO:0046872"
"g1639",1141.499,-0.3406346,0.1018189,-3.345495,0.0008213581,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3290",6125.768,-0.41248,0.1232988,-3.345368,0.0008217344,0.01804126,19526,70784,"sp|Q25637|PER_PERAM","Q25637","PER",1.08e-10,"Period circadian protein","regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]","GO:0005634; GO:0006355; GO:0048511"
"g6440",29.51541,-0.6307058,0.1885335,-3.345326,0.00082186,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28887",1032.368,-0.264142,0.0789572,-3.345381,0.000821695,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75223",229.9239,0.5673306,0.1695563,3.345973,0.0008199451,0.01804126,0,9890,"sp|Q9Y6N6|LAMC3_HUMAN","Q9Y6N6","LAMC3",2.48e-17,"Laminin subunit gamma-3 (Laminin-12 subunit gamma) (Laminin-14 subunit gamma) (Laminin-15 subunit gamma)","animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; cell migration [GO:0016477]; retina development in camera-type eye [GO:0060041]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]","GO:0005198; GO:0005576; GO:0005604; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0016020; GO:0016477; GO:0031012; GO:0034446; GO:0060041"
"g91005",77.22931,0.5560513,0.1662131,3.345412,0.0008216031,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95528",92.94456,0.92996,0.2779873,3.345332,0.0008218403,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134994",117.5404,-0.3023443,0.09037911,-3.345289,0.0008219685,0.01804126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148502",10914.79,0.7514709,0.2246258,3.345434,0.000821538,0.01804126,0,2054,"sp|P30163|ACT2_ONCVO","P30163","ACT2",4.25e-113,"Actin-2",NA,"GO:0005524; GO:0005737; GO:0005856"
"g21677",606.7756,0.3607098,0.107844,3.344737,0.0008236068,0.01805887,39476,48424,"sp|Q9CQA3|SDHB_MOUSE","Q9CQA3","SDHB",1.3e-39,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)","aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","GO:0005654; GO:0005739; GO:0005743; GO:0005749; GO:0005886; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0042776; GO:0045273; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539"
"g36889",582.4902,-0.3616181,0.1081125,-3.344831,0.0008233282,0.01805887,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107615",33.83972,0.5398593,0.1614007,3.344838,0.000823307,0.01805887,494,5683,"sp|Q9UR07|TF211_SCHPO","Q9UR07","TF211",9.64e-45,"Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0015074; GO:0046872"
"g23627",1486.999,0.4790677,0.143247,3.344346,0.0008247675,0.0180782,9306,13504,"sp|O02751|CFDP2_BOVIN","O02751","CFDP2",8.02e-12,"Craniofacial development protein 2 (p97 bucentaur protein)","chromatin remodeling [GO:0006338]","GO:0003824; GO:0005634; GO:0005737; GO:0006338"
"g33606",306.4012,-0.6308574,0.188651,-3.344046,0.0008256617,0.01808672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40289",1822.057,-0.2893724,0.08653409,-3.344028,0.0008257147,0.01808672,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25927",241.1601,0.7422662,0.2220022,3.343508,0.0008272646,0.01810078,29585,36322,"sp|P20742|PZP_HUMAN","P20742","PZP",6.18e-14,"Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)","female pregnancy [GO:0007565]","GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0007565; GO:0070062; GO:0072562"
"g39067",145.4527,-0.3080315,0.09212315,-3.343692,0.0008267132,0.01810078,6745,24934,"sp|Q96IR2|ZN845_HUMAN","Q96IR2","ZN845",1.22e-114,"Zinc finger protein 845","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g82435",569.0516,-0.4208675,0.1258765,-3.343497,0.000827296,0.01810078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122463",27.65979,-0.5897422,0.176388,-3.343437,0.0008274736,0.01810078,2825,3758,"sp|B4KR21|QVR_DROMO","B4KR21","QVR",2.2e-14,"Protein quiver (Protein sleepless)","negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]","GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818"
"g14736",4318.564,-0.2508064,0.07502251,-3.343082,0.0008285341,0.01811786,18115,40088,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.42e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g34533",156.4479,-0.3036169,0.09082238,-3.342974,0.0008288553,0.01811877,2995,29668,"sp|P17019|ZN708_HUMAN","P17019","ZN708",9.5e-65,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g20998",43.1721,0.5927141,0.1773146,3.342727,0.000829595,0.01812271,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39295",59.0234,-0.4677859,0.1399387,-3.342792,0.0008293997,0.01812271,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109450",23.57239,0.6758814,0.2022412,3.341957,0.0008318985,0.0181669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41060",442.4471,-0.6390566,0.1912547,-3.341391,0.0008335973,0.01819174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41244",2622.402,0.5212253,0.15599,3.341403,0.0008335607,0.01819174,14355,18284,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",2.41e-07,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g86254",1031.28,-0.491606,0.1471524,-3.340795,0.0008353894,0.01822471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111214",34.45073,-0.4415575,0.1321873,-3.340394,0.0008365957,0.01822745,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142884",494.7135,0.501386,0.1500863,3.340651,0.0008358218,0.01822745,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146346",67.30307,2.220334,0.6646951,3.340379,0.0008366401,0.01822745,0,1844,"sp|Q55C09|SGMA_DICDI","Q55C09","SGMA",2.16e-06,"Sphingomyelin phosphodiesterase A (EC 3.1.4.-) (Acid sphingomyelinase A) (aSMase A)","ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005615; GO:0006685; GO:0008081; GO:0016798; GO:0046513; GO:0046872"
"g152565",88.93395,-2.266415,0.6784689,-3.340485,0.0008363209,0.01822745,0,494,"sp|P81583|CUPC4_CANPG","P81583","CUPC4",1.33e-07,"Cuticle protein CP1499 (CPCP1499)",NA,"GO:0042302"
"g28105",5415.762,-0.379093,0.1134921,-3.34026,0.0008369995,0.01822886,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34175",577.2953,-0.4508267,0.1349774,-3.340015,0.0008377394,0.01822886,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49949",23.27749,-0.8800411,0.2634798,-3.34007,0.0008375732,0.01822886,0,5623,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.41e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g161922",3736.119,0.2534987,0.07589817,3.339985,0.0008378302,0.01822886,0,585,"sp|P27659|RL3_MOUSE","P27659","RL3",1.44e-25,"60S ribosomal protein L3 (J1 protein)","cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0008097; GO:0022625; GO:0022626; GO:0032991; GO:0045202; GO:0071353"
"g9293",11148.36,0.1969505,0.05897039,3.33982,0.0008383263,0.01823021,57916,72634,"sp|Q5REX3|ZFR_PONAB","Q5REX3","ZFR",6.75e-26,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g50314",1490.61,-0.4755445,0.1423901,-3.339729,0.0008386007,0.01823021,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71909",708.6392,-0.3685317,0.1103492,-3.339684,0.0008387363,0.01823021,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41608",157.7285,0.3938725,0.1179563,3.339139,0.0008403864,0.01823712,0,22094,"sp|P21328|RTJK_DROME","P21328","RTJK",9.08e-40,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g77444",619.7279,-0.4686745,0.1403589,-3.339114,0.0008404619,0.01823712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88784",7131.259,0.6269922,0.1877636,3.339264,0.0008400074,0.01823712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96900",29.30552,-0.5392248,0.1614832,-3.339201,0.0008401985,0.01823712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120962",306.2379,-0.4722674,0.1414348,-3.339118,0.0008404495,0.01823712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71361",773.9715,0.4580688,0.1371981,3.338739,0.0008415947,0.01824948,1231,9994,"sp|Q9W141|ATPK_DROME","Q9W141","ATPK",1.44e-07,"Putative ATP synthase subunit f, mitochondrial","mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0042776; GO:1902600"
"g117631",55.28086,0.5703016,0.1708093,3.33882,0.0008413508,0.01824948,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18274",444.9314,-0.3127268,0.09366958,-3.338616,0.0008419674,0.01825145,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10479",379.7067,-0.2254723,0.06753816,-3.338443,0.0008424925,0.01825673,63955,67537,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.05e-17,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g107294",76.97708,0.4006252,0.120011,3.338237,0.0008431181,0.01825807,125,5719,"sp|P24155|THOP1_RAT","P24155","THOP1",6.2e-24,"Thimet oligopeptidase (EC 3.4.24.15) (Endo-oligopeptidase A) (Endopeptidase 24.15) (PZ-peptidase) (Soluble metallo-endopeptidase)","intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]","GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0046872"
"g146100",30.70575,1.48642,0.4452623,3.338301,0.0008429238,0.01825807,0,2333,"sp|P40939|ECHA_HUMAN","P40939","ECHA",1.26e-152,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403"
"g12834",2213.578,-0.2647424,0.07931904,-3.337691,0.000844777,0.01827567,30098,40314,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",2.71e-20,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g54944",216.32,0.3694522,0.110687,3.337811,0.000844412,0.01827567,2969,10644,"sp|P10735|RT12_DROME","P10735","RT12",5.15e-23,"40S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Protein technical knockout locus)","courtship behavior [GO:0007619]; male courtship behavior [GO:0008049]; mechanosensory behavior [GO:0007638]; mitochondrial translation [GO:0032543]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of sound [GO:0007605]; translation [GO:0006412]","GO:0001666; GO:0003735; GO:0005763; GO:0005840; GO:0006412; GO:0007605; GO:0007619; GO:0007638; GO:0008049; GO:0009612; GO:0032543"
"g161927",156.9955,2.760857,0.8271744,3.337696,0.0008447619,0.01827567,0,594,"sp|P28622|GUN4_BACS5","P28622","GUN4",2.14e-06,"Endoglucanase 4 (EC 3.2.1.4) (Cellulase 4) (EG-IV) (Endo-1,4-beta-glucanase 4)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"g93014",1070.59,0.5303817,0.1589173,3.337469,0.0008454505,0.01827804,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125056",40.54165,0.4431419,0.1327771,3.337487,0.0008453959,0.01827804,2932,3824,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.12e-06,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g67373",570.0631,-0.6935316,0.2078577,-3.336569,0.0008481934,0.018322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114749",31.07045,-1.07216,0.3213272,-3.336662,0.0008479094,0.018322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133107",38.4208,1.438977,0.4312803,3.336524,0.0008483326,0.018322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46332",606.9011,0.2737706,0.08206265,3.336117,0.0008495736,0.01834269,5865,17690,"sp|O97159|CHDM_DROME","O97159","CHDM",2.45e-28,"Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2)","chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000122; GO:0000791; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0042766; GO:0045892; GO:0051276; GO:0051312; GO:0071923; GO:0140658"
"g84735",38.72109,0.6490431,0.1945801,3.335608,0.0008511301,0.01837018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62323",38.32387,-0.3931007,0.1178659,-3.335153,0.0008525261,0.01839418,0,6284,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.53e-22,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g94270",2036.3,0.3437874,0.1030937,3.334708,0.000853889,0.01841745,0,5214,"sp|Q2KJC9|AL7A1_BOVIN","Q2KJC9","AL7A1",2.73e-30,"Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)","glycine betaine biosynthetic process from choline [GO:0019285]","GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0008802; GO:0019285; GO:0042802; GO:0043878"
"g51515",61.46334,1.359061,0.4076009,3.334293,0.0008551639,0.01843881,3485,10490,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.95e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g4702",41.34554,1.819135,0.5456973,3.333597,0.0008573089,0.01846663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11376",106.6095,0.8392743,0.2517607,3.333619,0.0008572393,0.01846663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58222",29.32241,2.011209,0.6033113,3.333617,0.0008572464,0.01846663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37560",82.94803,-0.4871947,0.1461759,-3.332935,0.0008593496,0.01850443,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39510",142.9948,-0.5479829,0.1644393,-3.332433,0.0008609012,0.01852105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108678",288.0376,-0.3937027,0.1181409,-3.332486,0.0008607394,0.01852105,0,5579,"sp|Q8IRW8|TRR_DROME","Q8IRW8","TRR",3.89e-26,"Histone-lysine N-methyltransferase trr (EC 2.1.1.354) (Lysine N-methyltransferase 2C) (Trithorax-related protein)","chromatin organization [GO:0006325]; compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]","GO:0001046; GO:0003713; GO:0005102; GO:0005634; GO:0005700; GO:0005703; GO:0006325; GO:0007458; GO:0016571; GO:0035075; GO:0042393; GO:0042800; GO:0044666; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0051568; GO:0097692; GO:1900114"
"g137099",475.3609,-0.4807456,0.1442637,-3.332408,0.0008609787,0.01852105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34954",103.2969,-1.189987,0.3571148,-3.332225,0.0008615471,0.01852712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6045",96.79365,0.5676179,0.1703471,3.332125,0.0008618543,0.01852758,101361,103914,"sp|Q94688|ALDH9_POLMI","Q94688","ALDH9",1.83e-16,"Aldehyde dehydrogenase 9 (EC 1.2.1.3) (PM-ALDH9) (Fragment)","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g88756",79.92627,0.3338237,0.1001875,3.33199,0.0008622723,0.01853042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31614",319.6832,-0.5561311,0.1669133,-3.331855,0.0008626915,0.01853125,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83224",84.73392,0.2958808,0.08880527,3.331793,0.000862883,0.01853125,0,8625,"sp|P20825|POL2_DROME","P20825","POL2",4.67e-56,"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g6297",43.33262,0.7964173,0.2390572,3.331493,0.0008638142,0.01853282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46503",88.12047,0.4070595,0.1221796,3.331649,0.0008633294,0.01853282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123524",42.99441,0.9062175,0.2720147,3.331502,0.0008637859,0.01853282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43068",1226.652,-0.3125284,0.09381904,-3.331183,0.0008647784,0.01854736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124867",118.8459,0.463774,0.1392279,3.331042,0.0008652146,0.01855058,0,4052,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.8e-16,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g2911",151.9825,0.4553421,0.1367156,3.33058,0.0008666534,0.01857528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99819",236.6427,0.5178946,0.1555063,3.330377,0.0008672836,0.0185765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116342",113.2633,2.468095,0.741081,3.330399,0.0008672156,0.0185765,2825,4836,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",1.41e-11,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g27344",202.7047,-0.4958468,0.1489016,-3.330031,0.0008683641,0.0185935,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18805",213.9941,-0.3539421,0.1063258,-3.328846,0.0008720668,0.01865604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28241",3640.034,0.4248688,0.1276335,3.32882,0.0008721491,0.01865604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95316",912.149,0.656533,0.1972263,3.328831,0.0008721116,0.01865604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122790",66.02295,0.4350378,0.1306933,3.328693,0.0008725463,0.01865838,0,4237,"sp|Q5XGR8|LACB2_XENLA","Q5XGR8","LACB2",1.18e-14,"Endoribonuclease LACTB2 (Beta-lactamase-like protein 2) (EC 3.1.27.-)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003727; GO:0004521; GO:0005759; GO:0008270; GO:0090502"
"g99306",21.42151,0.9666732,0.2904213,3.32852,0.0008730874,0.01866379,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60017",38.96789,0.827313,0.2485751,3.328221,0.0008740235,0.01867764,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54612",31.14248,0.9084525,0.2729762,3.327955,0.0008748587,0.01868932,4155,11180,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.42e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g61766",39.85127,0.8718234,0.2619813,3.327808,0.0008753216,0.01868998,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150471",547.4839,-0.3304376,0.09929724,-3.327762,0.0008754664,0.01868998,0,1944,"sp|Q9QZS6|HS3SB_MOUSE","Q9QZS6","HS3SB",1.23e-27,"Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (m3-OST-3B)","branching involved in ureteric bud morphogenesis [GO:0001658]; glycosaminoglycan biosynthetic process [GO:0006024]; protein sulfation [GO:0006477]","GO:0000139; GO:0001658; GO:0005887; GO:0006024; GO:0006477; GO:0008467; GO:0033872"
"g2695",1091.488,0.7376373,0.2216723,3.327602,0.000875968,0.01869453,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36879",112.9926,-0.6200294,0.1863387,-3.327432,0.0008765046,0.01869961,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46967",17.35416,-0.5219417,0.1568644,-3.327343,0.0008767833,0.01869961,14505,18562,"sp|P21414|POL_GALV","P21414","POL",6.62e-09,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g51632",1548.782,0.5915033,0.1778031,3.326733,0.0008787052,0.01873443,14348,15894,"sp|P49871|ACT_MANSE","P49871","ACT",0,"Actin, muscle",NA,"GO:0005524; GO:0005737; GO:0005856"
"g68568",3006,-0.3115388,0.09366793,-3.325993,0.0008810428,0.01877192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108888",63.81671,1.340716,0.4030976,3.326034,0.0008809124,0.01877192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69696",366.9356,0.4685986,0.1408948,3.325876,0.0008814118,0.01877361,0,10980,"sp|O62742|SCP2_RABIT","O62742","SCP2",2.52e-23,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"g128394",39.04406,1.315562,0.3955823,3.325633,0.0008821798,0.01878379,0,3334,"sp|Q58D31|DHSO_BOVIN","Q58D31","DHSO",2.59e-17,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)","flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526"
"g27291",696.9988,-0.2338047,0.07031372,-3.325164,0.0008836641,0.01880921,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38003",3071.997,0.3286696,0.09885151,3.324882,0.000884561,0.01882212,6985,11813,"sp|Q58D84|FSTL1_BOVIN","Q58D84","FSTL1",1.76e-06,"Follistatin-related protein 1 (Follistatin-like protein 1)","cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510]","GO:0005509; GO:0005576; GO:0008201; GO:0030154; GO:0030510; GO:0043066; GO:0043542; GO:0045446"
"g123462",22.28061,0.6704132,0.2016573,3.324518,0.0008857149,0.01884049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48378",106.5231,-0.5278228,0.1587955,-3.323916,0.0008876291,0.01887501,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20857",1844.24,-0.2374853,0.07146136,-3.323268,0.0008896928,0.01890035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89162",883.452,-0.3745576,0.1127076,-3.323267,0.0008896961,0.01890035,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148966",121.7581,0.4328359,0.1302432,3.323291,0.0008896211,0.01890035,0,2079,"sp|Q8K4G6|MACD1_RAT","Q8K4G6","MACD1",1.34e-27,"ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.1.1.106) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-) (Fragment)","cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]","GO:0005634; GO:0005654; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293"
"g134340",173.2148,2.194701,0.6604251,3.323165,0.0008900226,0.01890109,795,2072,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",1.08e-21,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g25820",205.4451,0.3167251,0.09532579,3.322554,0.0008919737,0.01892392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57177",817.579,0.3545096,0.1066969,3.322587,0.0008918701,0.01892392,5105,5891,"sp|Q9XTL9|PYG_DROME","Q9XTL9","PYG",1.05e-35,"Glycogen phosphorylase (EC 2.4.1.1)","defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]; positive regulation of glycogen catabolic process [GO:0045819]","GO:0005737; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0032991; GO:0042803; GO:0045819; GO:0045824; GO:0050829; GO:0102250; GO:0102499"
"g161378",140.3563,0.5301915,0.1595649,3.322733,0.0008914017,0.01892392,0,494,"sp|P15215|LAMC1_DROME","P15215","LAMC1",2.73e-33,"Laminin subunit gamma-1 (Laminin B2 chain)","animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005576; GO:0005604; GO:0007435; GO:0007494; GO:0009887; GO:0009888; GO:0016477; GO:0033627; GO:0034446; GO:0061031; GO:0070831; GO:0071711; GO:0085029"
"g8040",228.2962,0.4697412,0.1413882,3.322351,0.0008926241,0.01893152,89416,91154,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",1.41e-14,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g14402",197.0519,-0.3562552,0.1072454,-3.321869,0.0008941678,0.01895806,53215,59248,"sp|Q8NI51|CTCFL_HUMAN","Q8NI51","CTCFL",1.46e-16,"Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T)","cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006349; GO:0006357; GO:0007049; GO:0010628; GO:0016571; GO:0016604; GO:0042393; GO:0043035; GO:0043046; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0051569"
"g52288",55.74431,0.3573494,0.1075822,3.32164,0.0008949002,0.01896738,9712,16270,"sp|Q95ZQ4|AAPK2_CAEEL","Q95ZQ4","AAPK2",9.37e-18,"5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1)","determination of adult lifespan [GO:0008340]; intracellular signal transduction [GO:0035556]; negative regulation of protein secretion [GO:0050709]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dauer larval development [GO:0061066]; positive regulation of protein secretion [GO:0050714]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008340; GO:0018105; GO:0030424; GO:0035556; GO:0043025; GO:0050709; GO:0050714; GO:0061066; GO:0106310"
"g12612",452.1384,0.349942,0.1053609,3.321366,0.0008957787,0.01897358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22549",757.8651,0.7832589,0.2358213,3.321408,0.0008956447,0.01897358,11945,20325,"sp|P55059|PDI_HUMIN","P55059","PDI",4.72e-21,"Protein disulfide-isomerase (PDI) (EC 5.3.4.1)",NA,"GO:0003756; GO:0005788"
"g25456",4755.771,-0.6708848,0.2020069,-3.321099,0.0008966374,0.01898556,0,31308,"sp|Q9W596|FUTSC_DROME","Q9W596","FUTSC",2.64e-110,"Microtubule-associated protein futsch (MAP1B homolog) [Cleaved into: Futsch heavy chain; Futsch light chain LC(f)]","axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neurofilament cytoskeleton organization [GO:0060052]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","GO:0000226; GO:0003779; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0008017; GO:0008088; GO:0008355; GO:0008582; GO:0015630; GO:0016358; GO:0019900; GO:0030424; GO:0030425; GO:0031114; GO:0031594; GO:0043025; GO:0043524; GO:0045202; GO:0048813; GO:0060052; GO:1901215"
"g96239",646.7947,0.3278993,0.09873903,3.320868,0.0008973784,0.01899505,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2580",53.87442,0.5069236,0.1526616,3.320571,0.0008983344,0.01900907,49505,59308,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.3e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g23990",997.7998,0.2609809,0.07860559,3.320132,0.0008997481,0.01903277,0,5504,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.75e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g21076",596.3322,-0.3264481,0.09833571,-3.31973,0.0009010442,0.01905397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130172",22.85199,0.6030156,0.1816622,3.319433,0.0009020054,0.01906807,0,3619,"sp|Q01458|DIAC_BOVIN","Q01458","DIAC",3.34e-11,"Di-N-acetylchitobiase (EC 3.2.1.-) (Fragment)","carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]","GO:0004568; GO:0005764; GO:0005975; GO:0006032"
"g30482",542.0845,-0.2446439,0.07370738,-3.319123,0.0009030056,0.01906815,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33312",1195.713,0.3824943,0.1152415,3.319067,0.0009031862,0.01906815,0,5414,"sp|Q9SF16|TCPH_ARATH","Q9SF16","TCPH",4.42e-17,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)","protein folding [GO:0006457]","GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g49298",49.89994,0.6684335,0.2013878,3.319136,0.0009029628,0.01906815,0,444,"sp|O95831|AIFM1_HUMAN","O95831","AIFM1",1.61e-23,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]","GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045"
"g131758",28.75699,0.8563187,0.2579838,3.319273,0.0009025203,0.01906815,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16769",2098.283,-0.3795379,0.114359,-3.318829,0.0009039587,0.01907824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86756",476.039,-0.3739589,0.1126847,-3.318631,0.0009046002,0.01908556,1945,5758,"sp|P21328|RTJK_DROME","P21328","RTJK",2.15e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42677",1252.735,-0.2966143,0.08939419,-3.318049,0.0009064867,0.01911914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9269",4284.836,-0.2113012,0.06368706,-3.317803,0.000907283,0.01912971,15131,44764,"sp|Q6IQE1|PI42C_DANRE","Q6IQE1","PI42C",6.89e-09,"Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma)","1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]","GO:0005524; GO:0005783; GO:0005886; GO:0016308; GO:0016309; GO:0046854; GO:1902635"
"g25918",257.6573,0.8092832,0.2439508,3.317403,0.0009085833,0.01915089,0,14402,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.1e-18,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83577",47.23372,-1.106705,0.3336235,-3.317228,0.0009091543,0.01915669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40047",84.78456,0.6528347,0.1968295,3.316752,0.0009107045,0.01918312,6591,21184,"sp|P79779|TBX6L_CHICK","P79779","TBX6L",2.68e-66,"T-box-containing protein TBX6L (Fragment)","cardiac chamber development [GO:0003205]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; heart looping [GO:0001947]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001708; GO:0001947; GO:0003205; GO:0005634; GO:0006357; GO:0007417; GO:0008284"
"g35436",59.68956,1.155622,0.3484626,3.316344,0.0009120353,0.01920491,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103969",104.12,0.9354968,0.2821287,3.315852,0.0009136423,0.0192325,0,5382,"sp|Q9WUW8|ST1C2_RAT","Q9WUW8","ST1C2",2.98e-07,"Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1)","sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923"
"g7363",185.1039,0.5783623,0.1745005,3.314387,0.0009184438,0.01931728,9615,18033,"sp|Q6NS19|ERGI1_XENLA","Q6NS19","ERGI1",1.78e-10,"Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32)","vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0016021; GO:0016192; GO:0033116"
"g64990",4001.37,-0.4408851,0.1330184,-3.314466,0.0009181828,0.01931728,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132869",973.4307,-0.2661851,0.08031292,-3.31435,0.0009185645,0.01931728,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14243",1170.992,-0.2669783,0.08056531,-3.313811,0.0009203355,0.01934197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33123",17.72227,0.7275942,0.2195613,3.313855,0.0009201921,0.01934197,0,31313,"sp|Q9U943|APLP_LOCMI","Q9U943","APLP",4.42e-06,"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055"
"g126149",41.83836,-0.8878341,0.2679653,-3.313243,0.000922207,0.01937502,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45765",59.21774,1.403582,0.423677,3.312859,0.0009234752,0.01939537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87208",243.5911,0.7461373,0.2252531,3.31244,0.0009248595,0.01941186,0,3048,"sp|P79733|RIR2_DANRE","P79733","RIR2",1.85e-152,"Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)","deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]","GO:0004748; GO:0005829; GO:0006260; GO:0009263; GO:0046872"
"g108677",53.78812,0.5239398,0.1581698,3.312514,0.0009246151,0.01941186,0,5579,"sp|Q8QZR0|TR1L1_MOUSE","Q8QZR0","TR1L1",3.57e-07,"Translocating chain-associated membrane protein 1-like 1","protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0006616; GO:0030176; GO:0045048"
"g147353",22.11927,1.292747,0.3902952,3.312229,0.0009255566,0.01941895,0,2219,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.12e-13,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g159656",211.8352,0.39061,0.1179322,3.312157,0.0009257968,0.01941895,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113264",32.40424,2.39438,0.7229795,3.311822,0.0009269034,0.01943587,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39140",98.86694,0.7901579,0.2385938,3.311729,0.0009272148,0.01943611,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95853",275.8622,0.6886199,0.2079425,3.311588,0.0009276795,0.01943957,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46240",34.29352,0.4647585,0.140383,3.310647,0.0009308058,0.01949877,825,19479,"sp|P21328|RTJK_DROME","P21328","RTJK",1.61e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g60867",17.72249,0.9377303,0.2832704,3.310372,0.0009317202,0.01950531,4497,8364,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.48e-49,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g129395",27.34585,0.4913584,0.1484298,3.310376,0.0009317061,0.01950531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13956",3309.066,-0.3015272,0.09109267,-3.310114,0.0009325783,0.01951067,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43361",263.1113,-0.2940157,0.08882339,-3.310116,0.0009325727,0.01951067,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10432",25.36522,-0.6421487,0.1940308,-3.30952,0.0009345623,0.01953115,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39523",3948.782,-0.6066436,0.1833002,-3.309563,0.0009344189,0.01953115,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55928",274.4609,0.4134725,0.1249334,3.309544,0.0009344803,0.01953115,5592,9914,"sp|Q3T094|ETHE1_BOVIN","Q3T094","ETHE1",1.77e-89,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Sulfur dioxygenase ETHE1)","glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]","GO:0005506; GO:0005654; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813"
"g131896",295.6366,0.2363253,0.07140904,3.30946,0.0009347628,0.01953115,0,3174,"sp|Q9Y6D9|MD1L1_HUMAN","Q9Y6D9","MD1L1",6.29e-08,"Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]","GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728"
"g4956",4388.793,-0.4757745,0.1437883,-3.308853,0.0009367893,0.01955199,63608,67824,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.9e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g12490",679.1995,-0.4850977,0.1466118,-3.308721,0.0009372312,0.01955199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27858",106.9436,-2.638287,0.7973764,-3.30871,0.0009372691,0.01955199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38209",1622.208,-0.3847376,0.1162794,-3.308734,0.0009371896,0.01955199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157016",38.10027,1.411056,0.4264648,3.308727,0.0009372113,0.01955199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20075",116.6896,0.4094452,0.1237625,3.308314,0.0009385966,0.01957094,13235,27982,"sp|Q9HAV4|XPO5_HUMAN","Q9HAV4","XPO5",6e-26,"Exportin-5 (Exp5) (Ran-binding protein 21)","miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405]","GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1900370; GO:1905172"
"g123768",120.2633,0.3879021,0.1172527,3.308258,0.0009387817,0.01957094,0,4153,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.02e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g29540",1252.674,0.3624536,0.1095665,3.30807,0.0009394132,0.01957781,18705,21548,"sp|P40423|SQH_DROME","P40423","SQH",6.5e-26,"Myosin regulatory light chain sqh (Myosin regulatory light chain, nonmuscle) (MRLC-C) (Protein spaghetti-squash)","actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte [GO:0019749]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear axial expansion [GO:0035191]; positive regulation of border follicle cell migration [GO:1903688]; post-embryonic development [GO:0009791]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length, open tracheal system [GO:0035159]; spiracle morphogenesis, open tracheal system [GO:0035277]; syncytial embryo cellularization [GO:0110069]; tube formation [GO:0035148]; wound healing [GO:0042060]","GO:0000281; GO:0003384; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0007298; GO:0009791; GO:0016324; GO:0016460; GO:0019749; GO:0030048; GO:0030496; GO:0031036; GO:0032036; GO:0032154; GO:0032956; GO:0035148; GO:0035159; GO:0035183; GO:0035191; GO:0035277; GO:0035317; GO:0040011; GO:0042060; GO:0045177; GO:0045179; GO:0045879; GO:0051233; GO:0060288; GO:0060289; GO:0090254; GO:0106037; GO:0110069; GO:0110071; GO:1903144; GO:1903688"
"g72577",1918.001,-0.3277071,0.09907207,-3.307764,0.0009404387,0.01959288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64142",2807.463,-0.3772518,0.1140641,-3.307366,0.000941779,0.01961449,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134461",78.62088,0.4916314,0.148687,3.306485,0.000944745,0.01966994,1440,3274,"sp|P35072|TCB1_CAEBR","P35072","TCB1",1.7e-09,"Transposable element Tcb1 transposase (Transposable element Barney transposase)","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003677; GO:0005634; GO:0006313; GO:0015074"
"g54890",115.4109,0.3027425,0.09158065,3.305747,0.0009472357,0.01971546,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126253",171.8211,2.016956,0.6102302,3.305239,0.0009489557,0.01974492,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79406",19.42568,2.010998,0.6085053,3.304816,0.0009503885,0.01976839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7739",1121.791,-0.2499358,0.07563347,-3.304566,0.0009512343,0.01977376,17594,24924,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.84e-16,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g14255",74.28019,0.7523901,0.2276824,3.30456,0.0009512573,0.01977376,22274,30014,"sp|Q9VTH0|PLOD_DROME","Q9VTH0","PLOD",5.17e-08,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase (Procollagen lysyl hydroxylase) (EC 1.14.11.4)","growth of a germarium-derived egg chamber [GO:0007295]; peptidyl-lysine hydroxylation [GO:0017185]","GO:0005506; GO:0005615; GO:0005783; GO:0007295; GO:0008475; GO:0017185; GO:0031418; GO:0033823; GO:0048471; GO:0050211"
"g13919",90.30368,0.5208597,0.1576368,3.304175,0.0009525625,0.01979454,48415,54269,"sp|Q6P8E9|NH2L1_XENTR","Q6P8E9","NH2L1",5.8e-27,"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein)","mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]","GO:0000398; GO:0005634; GO:0005690; GO:0005730; GO:0030622; GO:0042254; GO:0046540; GO:0071005"
"g11521",4287.216,0.2463733,0.0745667,3.304066,0.0009529353,0.01979594,21762,35154,"sp|P13395|SPTCA_DROME","P13395","SPTCA",0,"Spectrin alpha chain","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; plasma membrane organization [GO:0007009]; positive regulation of hippo signaling [GO:0035332]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","GO:0003779; GO:0005509; GO:0005516; GO:0005794; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008360; GO:0016199; GO:0016323; GO:0016324; GO:0016328; GO:0030036; GO:0030054; GO:0030727; GO:0030864; GO:0031594; GO:0035332; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0045478; GO:0048790; GO:0050807; GO:0051015; GO:0051693"
"g37455",80.85882,0.4473435,0.1354129,3.303552,0.0009546837,0.01981955,0,4019,"sp|Q96IR7|HPDL_HUMAN","Q96IR7","HPDL",4.02e-08,"4-hydroxyphenylpyruvate dioxygenase-like protein (HPD-like protein) (EC 1.13.-.-) (Glyoxalase domain-containing protein 1)","aromatic amino acid family metabolic process [GO:0009072]","GO:0003868; GO:0005739; GO:0009072; GO:0046872"
"g41967",236.4394,0.7947357,0.2405666,3.303599,0.0009545217,0.01981955,11090,20774,"sp|Q9JHX0|RGS2_RAT","Q9JHX0","RGS2",3.85e-12,"Regulator of G-protein signaling 2 (RGS2)","brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]","GO:0001965; GO:0001975; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007049; GO:0007283; GO:0007420; GO:0008277; GO:0009898; GO:0010519; GO:0010614; GO:0010855; GO:0010976; GO:0017148; GO:0030728; GO:0043005; GO:0043407; GO:0045471; GO:0045744; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0140194; GO:1900924"
"g35229",206.7131,0.3172691,0.09604867,3.303212,0.0009558411,0.01982278,8475,15867,"sp|P21328|RTJK_DROME","P21328","RTJK",1.96e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g36111",99.68404,0.6103119,0.1847632,3.303211,0.0009558442,0.01982278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68959",455.8732,0.3025412,0.0915918,3.303147,0.0009560628,0.01982278,100,4131,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",4.9e-17,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g128877",96.68491,0.5332857,0.1614352,3.303404,0.0009551875,0.01982278,0,3231,"sp|Q12769|NU160_HUMAN","Q12769","NU160",5.11e-28,"Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160)","mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]","GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006913; GO:0015031; GO:0017056; GO:0031080; GO:0072006"
"g30089",819.9182,-0.3540338,0.1071877,-3.302933,0.0009567916,0.01983154,22881,35215,"sp|Q9V4A7|PLXB_DROME","Q9V4A7","PLXB",2.93e-81,"Plexin-B","axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory neuron axon guidance [GO:0097374]","GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0043087; GO:0050772; GO:0070593; GO:0071678; GO:0097374; GO:1902287"
"g11410",21.67904,0.9006206,0.272709,3.302497,0.0009582796,0.0198393,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75053",242.1915,0.3699704,0.1120255,3.302555,0.0009580818,0.0198393,0,6647,"sp|B9ENE7|MGN_SALSA","B9ENE7","MGN",2.8e-30,"Protein mago nashi homolog","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","GO:0000184; GO:0000381; GO:0003723; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0051028"
"g86628",60.69002,-0.5276796,0.1597833,-3.30247,0.0009583751,0.0198393,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88149",24.81759,1.008273,0.3053091,3.302465,0.0009583907,0.0198393,3535,6613,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",9.63e-73,"PiggyBac transposable element-derived protein 4",NA,NA
"g8628",313.7684,0.4741787,0.1436147,3.301742,0.0009608653,0.01986613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46853",64.48573,-1.01589,0.3076826,-3.301748,0.0009608447,0.01986613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49051",757.1502,-0.2644981,0.08010691,-3.301813,0.00096062,0.01986613,2565,10450,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.28e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g72416",110.359,0.5187013,0.1571,3.301728,0.0009609133,0.01986613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66408",34.05625,0.691372,0.2094089,3.30154,0.0009615546,0.01987024,0,9624,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.2e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g74077",224.9182,0.5720182,0.1732606,3.301491,0.0009617256,0.01987024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2393",226.0704,0.4376268,0.1325587,3.301382,0.0009620972,0.01987158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55741",31.47013,0.7156263,0.2167717,3.301291,0.0009624107,0.01987173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46408",631.3242,0.3077295,0.09323116,3.300715,0.0009643878,0.01987458,15966,19367,"sp|Q24524|SING_DROME","Q24524","SING",1.28e-27,"Protein singed","actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060]","GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017"
"g47455",911.7043,-0.7825218,0.2370617,-3.30092,0.0009636835,0.01987458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75000",207.1809,0.2674714,0.08103409,3.300727,0.0009643464,0.01987458,3015,9414,"sp|Q80WQ9|ZBED4_MOUSE","Q80WQ9","ZBED4",3.1e-30,"Zinc finger BED domain-containing protein 4","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000976; GO:0000977; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983"
"g138110",64.32628,2.041665,0.6185225,3.300875,0.0009638383,0.01987458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139764",553.6017,0.7600861,0.2302775,3.30074,0.0009643025,0.01987458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161140",589.3593,0.3939445,0.1193513,3.300715,0.0009643893,0.01987458,0,1118,"sp|B3CM42|NUOB_WOLPP","B3CM42","NUOB",4.44e-23,"NADH-quinone oxidoreductase subunit B (EC 7.1.1.-) (NADH dehydrogenase I subunit B) (NDH-1 subunit B)",NA,"GO:0005506; GO:0005886; GO:0008137; GO:0048038; GO:0051539"
"g58067",175.3861,0.7933202,0.240381,3.300261,0.0009659479,0.01990037,9770,11747,"sp|A2VE54|UN93A_BOVIN","A2VE54","UN93A",1.37e-22,"Protein unc-93 homolog A (Unc-93A)",NA,"GO:0005886; GO:0016021"
"g113275",34.39225,0.427501,0.129547,3.299968,0.0009669602,0.01991489,0,5128,"sp|O14802|RPC1_HUMAN","O14802","RPC1",6.29e-17,"DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032728; GO:0045087; GO:0046872; GO:0051607"
"g128778",2567.524,0.3585792,0.1086768,3.299502,0.0009685659,0.01994162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46586",22.8028,-0.6676224,0.2023773,-3.2989,0.0009706454,0.01996541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64118",411.8805,0.8573316,0.2598837,3.298904,0.0009706299,0.01996541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85210",377.9613,-0.321094,0.09732993,-3.299026,0.0009702091,0.01996541,0,8335,"sp|O61366|GPRS_DROME","O61366","GPRS",1.57e-22,"Serine-enriched protein",NA,NA
"g63431",33.56029,0.4904078,0.1486695,3.298644,0.0009715307,0.01997727,3096,8004,"sp|Q24134|NELFD_DROME","Q24134","NELFD",4.61e-15,"Negative elongation factor D","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]","GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244"
"g12158",87.5879,1.124979,0.3410901,3.298188,0.0009731086,0.01999703,31558,46724,"sp|Q9GKT2|FXDC2_MACFA","Q9GKT2","FXDC2",5.85e-24,"Fatty acid hydroxylase domain-containing protein 2","lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]","GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654"
"g121153",25.37772,0.6514038,0.1975011,3.298229,0.0009729682,0.01999703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121170",208.7111,0.6020201,0.1825432,3.297959,0.0009739037,0.02000702,0,2190,"sp|Q6DF67|ISOC2_XENTR","Q6DF67","ISOC2",1.94e-13,"Isochorismatase domain-containing protein 2",NA,"GO:0005737"
"g91548",83.78861,0.7669172,0.2325515,3.297838,0.0009743236,0.0200076,0,7454,"sp|P05895|POL_SIVVT","P05895","POL",7.25e-12,"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Nucleocapsid protein p7 (NC); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0030430; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0075713; GO:0075732"
"g104844",20.76354,-0.4751065,0.1440689,-3.297773,0.0009745496,0.0200076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33477",290.6096,-0.3670341,0.1113069,-3.297497,0.0009755069,0.02002091,10155,14382,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.25e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g19111",1251.487,-0.3200478,0.09706314,-3.297316,0.0009761378,0.02002137,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103997",82.89822,-0.4520143,0.1370856,-3.297313,0.0009761472,0.02002137,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86324",201.902,0.5389422,0.163454,3.29721,0.0009765053,0.02002238,4051,7924,"sp|Q96J01|THOC3_HUMAN","Q96J01","THOC3",1.41e-22,"THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45)","mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]","GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784"
"g5774",1551.495,-0.3696149,0.1121199,-3.296605,0.0009786094,0.02005917,7923,22464,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.49e-17,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34267",140.6096,-0.4268981,0.1295106,-3.296241,0.0009798775,0.02006503,0,27964,"sp|Q9VJ79|PDE11_DROME","Q9VJ79","PDE11",4.84e-27,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)","cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165]","GO:0004114; GO:0004115; GO:0005829; GO:0007165; GO:0046058; GO:0046068; GO:0046872; GO:0047555"
"g102578",262.3891,-0.6055859,0.1837162,-3.296312,0.0009796311,0.02006503,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109832",70.66583,0.5808061,0.1762065,3.296168,0.0009801338,0.02006503,2029,5458,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.82e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g129693",260.7678,0.6843459,0.207605,3.296385,0.0009793762,0.02006503,0,3652,"sp|Q90577|SRCA_CHICK","Q90577","SRCA",7.56e-10,"Sarcalumenin","endocytosis [GO:0006897]; endosomal transport [GO:0016197]","GO:0005525; GO:0006897; GO:0016197; GO:0033017; GO:0033018; GO:0043231"
"g23737",394.3425,-0.3196522,0.09698879,-3.295764,0.0009815428,0.02006924,2324,21644,"sp|Q9UQ26|RIMS2_HUMAN","Q9UQ26","RIMS2",1.3e-17,"Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]","GO:0006886; GO:0007188; GO:0017156; GO:0017157; GO:0030073; GO:0030154; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0097151; GO:1903861; GO:2000463"
"g29973",4765.87,-0.2918865,0.08855981,-3.295925,0.0009809804,0.02006924,4789,35400,"sp|E9Q2Z1|CECR2_MOUSE","E9Q2Z1","CECR2",4.38e-09,"Cat eye syndrome critical region protein 2 homolog","chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338]","GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658"
"g58169",243.97,0.2893213,0.08779078,3.295577,0.000982198,0.02006924,8016,13044,"sp|Q80X41|VRK1_MOUSE","Q80X41","VRK1",7.05e-34,"Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)","cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0006974; GO:0007049; GO:0007165; GO:0016572; GO:0018105; GO:0019901; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166; GO:0106310; GO:0120187"
"g79479",75.39398,0.5536684,0.1679936,3.295771,0.0009815215,0.02006924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131751",376.4607,-0.3616792,0.1097429,-3.295697,0.0009817781,0.02006924,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158234",142.6212,1.368146,0.4151365,3.295653,0.0009819316,0.02006924,0,1322,"sp|P04762|CATA_RAT","P04762","CATA",9.93e-18,"Catalase (EC 1.11.1.6)","aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to oxidative stress [GO:0006979]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]","GO:0000268; GO:0000302; GO:0001657; GO:0001666; GO:0001822; GO:0004046; GO:0004096; GO:0005615; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006641; GO:0006979; GO:0007568; GO:0008203; GO:0009060; GO:0009314; GO:0009410; GO:0009411; GO:0009636; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070542; GO:0071363; GO:0080184"
"g38678",87.73091,-0.2809059,0.08524306,-3.295352,0.0009829852,0.02007266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63965",89.13697,1.174151,0.3563033,3.29537,0.0009829205,0.02007266,0,6726,"sp|P20136|GSTM2_CHICK","P20136","GSTM2",2.21e-14,"Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)","glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171"
"g54208",1066.704,0.3964606,0.1203215,3.29501,0.0009841827,0.02009079,0,5124,"sp|Q68FU3|ETFB_RAT","Q68FU3","ETFB",1.05e-30,"Electron transfer flavoprotein subunit beta (Beta-ETF)","cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0000166; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251"
"g105678",332.8263,0.3656711,0.1109838,3.294815,0.0009848652,0.02009838,1510,5885,"sp|B0WCT9|RTCB1_CULQU","B0WCT9","RTCB1",5.34e-28,"RNA-splicing ligase RtcB homolog 1 (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase 1)","tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003972; GO:0005525; GO:0006388; GO:0046872; GO:0072669"
"g45212",3594.029,-0.2771241,0.08411758,-3.294485,0.0009860233,0.02010302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76915",548.9008,0.2570719,0.07803073,3.294496,0.0009859843,0.02010302,0,4020,"sp|B0WAM5|EIF3E_CULQU","B0WAM5","EIF3E",3.6e-14,"Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003743; GO:0016282; GO:0033290; GO:0071540"
"g97263",99.51799,0.5556029,0.1686426,3.294558,0.0009857671,0.02010302,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g970",147.1696,-0.3891444,0.118135,-3.294064,0.0009874984,0.02012521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14721",113.7555,-0.3379926,0.1026086,-3.293998,0.0009877325,0.02012521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10726",381.4076,-0.3649774,0.1108069,-3.293814,0.0009883784,0.02013203,26705,34513,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.87e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g149045",2011.133,0.2984284,0.0906117,3.293487,0.0009895303,0.02014916,0,2073,"sp|O16797|RL3_DROME","O16797","RL3",1.24e-29,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g6017",505.1751,0.5449934,0.1654916,3.293178,0.0009906163,0.02015207,97810,103964,"sp|P51977|AL1A1_SHEEP","P51977","AL1A1",1.94e-16,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.3) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1) (RALDH 1) (RalDH1)","cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]","GO:0001523; GO:0001758; GO:0004029; GO:0005829; GO:0009449; GO:0018479; GO:0019145; GO:0030392; GO:0030424; GO:0036438; GO:0042572; GO:0043878; GO:0045202; GO:0051287; GO:0106373; GO:0110095"
"g50450",533.4058,0.5199961,0.1578933,3.293338,0.0009900525,0.02015207,9825,13686,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",5.68e-11,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g129737",185.1651,0.4210202,0.1278495,3.293093,0.0009909173,0.02015207,0,2954,"sp|Q5RA77|COPD_PONAB","Q5RA77","COPD",1.68e-26,"Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP)","protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0006890; GO:0015031; GO:0030126"
"g157253",51.78728,0.468638,0.1423064,3.293162,0.0009906726,0.02015207,0,1392,"sp|Q9H0A0|NAT10_HUMAN","Q9H0A0","NAT10",2.77e-12,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883"
"g24721",1464.859,-0.3649764,0.1108375,-3.292898,0.0009916058,0.02015975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48216",898.7691,-0.3151157,0.09569876,-3.292787,0.0009919942,0.02016132,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6117",163.4567,0.5640036,0.1712989,3.292511,0.0009929686,0.02016215,44225,64020,"sp|P21328|RTJK_DROME","P21328","RTJK",2.38e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g90499",69.78169,-0.3769914,0.1144985,-3.292543,0.0009928557,0.02016215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129132",33.53383,0.674979,0.2050033,3.292528,0.0009929092,0.02016215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110334",142.9264,-0.517638,0.1572236,-3.292369,0.0009934713,0.02016472,0,4214,"sp|Q8IRW8|TRR_DROME","Q8IRW8","TRR",3.09e-25,"Histone-lysine N-methyltransferase trr (EC 2.1.1.354) (Lysine N-methyltransferase 2C) (Trithorax-related protein)","chromatin organization [GO:0006325]; compound eye development [GO:0048749]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone methylation [GO:0016571]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progression of morphogenetic furrow involved in compound eye morphogenesis [GO:0007458]; response to ecdysone [GO:0035075]","GO:0001046; GO:0003713; GO:0005102; GO:0005634; GO:0005700; GO:0005703; GO:0006325; GO:0007458; GO:0016571; GO:0035075; GO:0042393; GO:0042800; GO:0044666; GO:0045893; GO:0045944; GO:0046872; GO:0048749; GO:0051568; GO:0097692; GO:1900114"
"g116634",92.87961,2.469629,0.7501391,3.292228,0.0009939714,0.02016472,0,4534,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.32e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g132759",89.55231,0.6008609,0.1825098,3.292211,0.0009940288,0.02016472,0,1720,"sp|Q9LDU6|ST7R_ARATH","Q9LDU6","ST7R",1.56e-80,"7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Protein DWARF 5) (Sterol Delta(7)-reductase)","brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]; unidimensional cell growth [GO:0009826]","GO:0005634; GO:0005794; GO:0006695; GO:0009826; GO:0009918; GO:0016126; GO:0016132; GO:0016627; GO:0030176; GO:0047598"
"g47102",360.6231,-0.668951,0.2032107,-3.291908,0.0009951021,0.02017386,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64439",99.00711,1.72526,0.5240866,3.291938,0.0009949969,0.02017386,0,5791,"sp|P20136|GSTM2_CHICK","P20136","GSTM2",4.23e-12,"Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)","glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171"
"g155705",25.76228,0.6925754,0.2104108,3.291539,0.0009964092,0.02019404,385,930,"sp|P69478|CHSTB_RAT","P69478","CHSTB",7.77e-27,"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016021; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"
"g2400",393.2031,-0.4431944,0.1346566,-3.291293,0.0009972807,0.02020538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113759",290.7364,0.3468267,0.1053849,3.291046,0.0009981541,0.02021676,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70051",36.40852,0.5303289,0.1611504,3.290895,0.000998691,0.02022131,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33676",25.17658,1.241159,0.3771856,3.29058,0.0009998099,0.02023764,4635,16330,"sp|P29788|VTNC_MOUSE","P29788","VTNC",2.43e-15,"Vitronectin (VN) (S-protein) (Serum-spreading factor)","cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; protein polymerization [GO:0051258]; regulation of cell adhesion [GO:0030155]; smooth muscle cell-matrix adhesion [GO:0061302]","GO:0005044; GO:0005178; GO:0005518; GO:0005604; GO:0005615; GO:0005783; GO:0005796; GO:0006955; GO:0007160; GO:0008201; GO:0010811; GO:0010951; GO:0014911; GO:0016477; GO:0030155; GO:0030198; GO:0030247; GO:0031012; GO:0032092; GO:0033627; GO:0035987; GO:0042802; GO:0043231; GO:0048237; GO:0048260; GO:0048709; GO:0050731; GO:0050840; GO:0051258; GO:0051918; GO:0061302; GO:0062023; GO:0097421; GO:0098637; GO:1904090"
"g30988",679.4394,-0.4147784,0.1260564,-3.290419,0.001000384,0.02024294,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111336",556.1612,0.598721,0.1819668,3.290276,0.00100089,0.02024685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33334",3069.948,-0.249205,0.07575446,-3.289641,0.001003153,0.0202863,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6725",208.0792,-0.2350487,0.07145407,-3.289507,0.001003629,0.02028959,13740,18824,"sp|P21328|RTJK_DROME","P21328","RTJK",1.27e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g109662",88.56181,0.3964787,0.1205317,3.289414,0.001003962,0.02029,0,5477,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.09e-34,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g20819",873.3083,-0.2788012,0.084761,-3.289263,0.001004501,0.02029455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14242",359.1743,-0.4209052,0.1279731,-3.289012,0.001005397,0.02029481,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32259",1088.589,-0.3810687,0.1158639,-3.288934,0.001005677,0.02029481,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64218",147.7587,-0.397709,0.1209234,-3.288932,0.001005683,0.02029481,1916,12243,"sp|Q5RDX1|Z585A_PONAB","Q5RDX1","Z585A",1.84e-41,"Zinc finger protein 585A","regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006355; GO:0046872"
"g85118",196.2014,0.3687533,0.1121202,3.288909,0.001005766,0.02029481,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12151",3467.687,-0.5506171,0.1674243,-3.288753,0.001006324,0.02029974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5050",2668.406,0.3658286,0.1112423,3.288575,0.001006961,0.02029994,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10945",85.22477,0.5070601,0.1541867,3.288611,0.001006831,0.02029994,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20893",65.8151,-0.5218406,0.1586956,-3.288313,0.001007899,0.02030621,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112967",3853.22,1.43017,0.4349248,3.288316,0.001007886,0.02030621,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26973",63.55947,0.4481573,0.1363079,3.287831,0.001009624,0.02033465,27144,31434,"sp|Q8N0X4|CLYBL_HUMAN","Q8N0X4","CLYBL",3.59e-06,"Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)","positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]","GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121"
"g9119",2679.822,-0.4194606,0.1275894,-3.287581,0.001010522,0.0203464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64674",908.9695,0.3256846,0.09906827,3.287477,0.001010896,0.02034762,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10285",9291.039,-0.7670292,0.2333301,-3.287314,0.001011482,0.02034789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40121",114.2097,-0.3503021,0.1065623,-3.287298,0.001011538,0.02034789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5119",64.68771,0.7411015,0.2254766,3.286823,0.001013244,0.0203759,10480,14904,"sp|Q3SZJ0|ARLY_BOVIN","Q3SZJ0","ARLY",2.86e-07,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; urea cycle [GO:0000050]","GO:0000050; GO:0004056; GO:0005829; GO:0006526; GO:0042450; GO:0045429"
"g112932",29.44315,-0.4609949,0.1402676,-3.28654,0.001014265,0.02039009,2835,5160,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.99e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g33250",128.4751,-0.4289336,0.1305319,-3.286044,0.001016053,0.02040704,11530,16604,"sp|Q6UB98|ANR12_HUMAN","Q6UB98","ANR12",4.09e-08,"Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein)",NA,"GO:0005654; GO:0005829"
"g53054",172.4724,2.183089,0.6643461,3.286072,0.00101595,0.02040704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61691",129.4004,-0.57119,0.1738216,-3.286071,0.001015954,0.02040704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59418",980.466,0.387343,0.1178827,3.285834,0.001016808,0.02041587,9695,13618,"sp|O16797|RL3_DROME","O16797","RL3",2.36e-26,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g100759",845.4863,-1.697905,0.5167698,-3.285613,0.001017608,0.02042561,1853,5104,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104163",91.45215,0.3136974,0.09548099,3.285444,0.001018219,0.02043155,4832,6038,"sp|Q0II91|DJC21_BOVIN","Q0II91","DJC21",9.84e-19,"DnaJ homolog subfamily C member 21",NA,"GO:0003676; GO:0005730; GO:0005737; GO:0008270"
"g61516",46.68722,-0.5553546,0.1690508,-3.285134,0.00101934,0.02044771,0,11684,"sp|P31396|HR3_DROME","P31396","HR3",1.25e-20,"Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)","metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944"
"g31767",4142.207,-0.2757226,0.0839339,-3.284996,0.001019837,0.02045134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30962",154.8143,0.3722267,0.1133197,3.284749,0.001020734,0.020463,11636,26574,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",2.61e-33,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g122011",387.8258,-0.4776696,0.1454699,-3.283633,0.001024784,0.02053784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29825",1625.241,-0.5699616,0.1735816,-3.283538,0.00102513,0.02053842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10730",431.9215,-0.3475327,0.1058695,-3.282651,0.001028358,0.02056551,26725,35112,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.24e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17938",43.75015,0.6360986,0.193802,3.282209,0.001029973,0.02056551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28020",1696.741,0.3166607,0.09647332,3.282366,0.0010294,0.02056551,135,14300,"sp|P80455|RS12_DROME","P80455","RS12",9.25e-07,"40S ribosomal protein S12","cytoplasmic translation [GO:0002181]; positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0002181; GO:0003735; GO:0022626; GO:0022627; GO:0090263"
"g28419",1798.661,-0.3595786,0.1095468,-3.282419,0.001029204,0.02056551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35778",200.7493,1.802487,0.5490307,3.283035,0.001026958,0.02056551,0,6590,"sp|P37898|AAP1_YEAST","P37898","AAP1",1.88e-09,"Alanine/arginine aminopeptidase (EC 3.4.11.-)","glycogen metabolic process [GO:0005977]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0005634; GO:0005737; GO:0005977; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006"
"g43074",450.983,-0.5213454,0.158827,-3.282473,0.00102901,0.02056551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78431",38.11121,0.5428995,0.1654035,3.282273,0.00102974,0.02056551,5477,9372,"sp|P30837|AL1B1_HUMAN","P30837","AL1B1",1.21e-16,"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)","carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]","GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005975; GO:0006068; GO:0043878; GO:0051287"
"g90460",130.4459,1.16079,0.3536105,3.282681,0.00102825,0.02056551,1128,7574,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.4e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g106810",239.4463,-0.2157776,0.0657381,-3.282382,0.00102934,0.02056551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117887",18.95426,0.8904349,0.271243,3.282794,0.001027838,0.02056551,0,4164,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.97e-53,"PiggyBac transposable element-derived protein 4",NA,NA
"g147275",42.76455,0.4188339,0.1275821,3.282859,0.001027601,0.02056551,0,1744,"sp|Q6TGW5|OSTF1_DANRE","Q6TGW5","OSTF1",2.95e-07,"Osteoclast-stimulating factor 1","signal transduction [GO:0007165]","GO:0005737; GO:0007165"
"g16647",123.8775,0.3886548,0.1184373,3.281523,0.00103248,0.02060285,0,12218,"sp|Q16HH9|MED23_AEDAE","Q16HH9","MED23",2.98e-18,"Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)",NA,"GO:0005634"
"g33107",19.16356,0.6099125,0.1858594,3.28158,0.001032271,0.02060285,18455,22054,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.78e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g74413",31.96232,1.263747,0.3851218,3.281422,0.001032852,0.02060394,3149,9984,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.04e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g112309",121.5209,0.354898,0.1081661,3.281046,0.001034229,0.02062506,0,4911,"sp|Q7JUX9|MRRP1_DROME","Q7JUX9","MRRP1",1.19e-11,"Mitochondrial ribonuclease P protein 1 homolog (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C)","mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA processing [GO:0090646]; positive regulation of mitochondrial translation [GO:0070131]","GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0009019; GO:0030678; GO:0070131; GO:0090646; GO:0097745"
"g71220",78.29229,0.4220474,0.1286453,3.280705,0.00103548,0.02063282,0,8291,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.42e-30,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g88588",230.5274,0.4312276,0.1314446,3.280679,0.001035574,0.02063282,0,3484,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.22e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g162791",28.54873,1.404122,0.4279942,3.280702,0.00103549,0.02063282,0,364,"sp|Q8R3U1|PLAT3_MOUSE","Q8R3U1","PLAT3",2.58e-24,"Phospholipase A and acyltransferase 3 (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A2) (H-rev 107 protein homolog) (HRAS-like suppressor 3) (HRSL3)","ether lipid metabolic process [GO:0046485]; lens fiber cell differentiation [GO:0070306]; lipid catabolic process [GO:0016042]; membrane disassembly [GO:0030397]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of cell cycle [GO:0045786]; organelle disassembly [GO:1903008]; peroxisome organization [GO:0007031]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; regulation of adipose tissue development [GO:1904177]; response to bacterium [GO:0009617]; triglyceride metabolic process [GO:0006641]","GO:0004620; GO:0004623; GO:0005635; GO:0005737; GO:0005739; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006641; GO:0006644; GO:0007031; GO:0008654; GO:0008970; GO:0009617; GO:0016020; GO:0016021; GO:0016042; GO:0016410; GO:0030397; GO:0031966; GO:0045786; GO:0046485; GO:0048471; GO:0052739; GO:0052740; GO:0070292; GO:0070306; GO:1903008; GO:1904177"
"g20661",103.859,-0.6697666,0.2042135,-3.279737,0.001039038,0.02069548,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21407",472.917,0.3630642,0.1107056,3.279547,0.001039739,0.02070307,17449,20954,"sp|Q99KI0|ACON_MOUSE","Q99KI0","ACON",2.85e-35,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)","citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]","GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0043209; GO:0047780; GO:0051538; GO:0051539"
"g39712",337.9149,-0.2943396,0.08975748,-3.279277,0.001040735,0.02071018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46796",88.1219,0.5089342,0.1551963,3.279293,0.001040674,0.02071018,0,17744,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.11e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g45287",1158.595,0.5797136,0.1768096,3.278745,0.001042697,0.02074285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8796",1565.056,-0.2989051,0.09116771,-3.278629,0.001043127,0.02074504,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122014",392.0681,0.9376554,0.286012,3.278377,0.001044057,0.02075716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27537",539.5364,-0.4446036,0.1356388,-3.277849,0.001046015,0.0207897,0,24700,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g151143",20.01573,1.35965,0.4148322,3.277589,0.001046976,0.02080243,0,1880,"sp|Q8AV57|SDK2_CHICK","Q8AV57","SDK2",1.46e-07,"Protein sidekick-2","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0042802; GO:0045202; GO:0060219"
"g7386",14500.99,0.2814605,0.08590881,3.27627,0.001051879,0.02080474,88425,91220,"sp|Q95V32|RS6_SPOFR","Q95V32","RS6",2.11e-32,"40S ribosomal protein S6","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g17457",422.0755,-0.2236669,0.06827097,-3.276163,0.001052277,0.02080474,0,5827,"sp|P08045|XFIN_XENLA","P08045","XFIN",2.98e-14,"Zinc finger protein Xfin (Xenopus fingers protein) (Xfin)","regulation of transcription, DNA-templated [GO:0006355]","GO:0003723; GO:0005737; GO:0006355; GO:0046872"
"g27328",2204.006,-0.5273752,0.1609124,-3.277405,0.001047659,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32503",167.3656,0.3405296,0.1039365,3.276324,0.001051679,0.02080474,28216,32028,"sp|Q2T9M1|PICK1_BOVIN","Q2T9M1","PICK1",1.88e-20,"PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)","cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]","GO:0002092; GO:0005856; GO:0014069; GO:0016020; GO:0019904; GO:0021782; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062"
"g33969",358.9832,0.416222,0.1270203,3.276816,0.001049847,0.02080474,13477,28334,"sp|Q94HW2|POLR1_ARATH","Q94HW2","POLR1",3.41e-25,"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g44049",213.0013,0.2733853,0.08344069,3.276403,0.001051385,0.02080474,15671,21075,"sp|Q9VPC0|KP58_DROME","Q9VPC0","KP58",1.55e-38,"Serine/threonine-protein kinase PITSLRE (EC 2.7.11.22) (Cell division cycle 2-like)","cell cycle [GO:0007049]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]","GO:0002225; GO:0004674; GO:0004693; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0006468; GO:0007049; GO:0007346; GO:0045752; GO:0106310"
"g45108",31.75912,-0.6372372,0.1944861,-3.276517,0.00105096,0.02080474,10525,13725,"sp|P16423|POLR_DROME","P16423","POLR",4.33e-15,"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]",NA,"GO:0003964; GO:0004190; GO:0004519; GO:0046872"
"g53377",195.4936,-0.3820187,0.1165701,-3.277158,0.001048578,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62374",86.56063,0.5164975,0.1576347,3.276546,0.001050853,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63100",34.12729,0.5014398,0.1530558,3.276189,0.00105218,0.02080474,0,4516,"sp|Q5R8F1|TM9S1_PONAB","Q5R8F1","TM9S1",3.8e-18,"Transmembrane 9 superfamily member 1","autophagy [GO:0006914]","GO:0000421; GO:0005765; GO:0006914; GO:0016021; GO:0031410"
"g71030",139.958,0.703529,0.2147466,3.27609,0.001052551,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85425",88.27132,-0.9350496,0.2853133,-3.277273,0.001048148,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85463",26.62883,1.039048,0.3171495,3.27621,0.001052102,0.02080474,0,4641,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",1.73e-10,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g90071",3732.22,-0.5113925,0.1560445,-3.277222,0.00104834,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112833",244.1216,0.3879696,0.118397,3.276852,0.001049712,0.02080474,3235,4437,"sp|P56519|HDAC2_CHICK","P56519","HDAC2",3.84e-53,"Histone deacetylase 2 (HD2) (EC 3.5.1.98) (Protein deacylase HDAC2) (EC 3.5.1.-)","chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000118; GO:0004407; GO:0005634; GO:0005737; GO:0006325; GO:0006357; GO:0035098; GO:0140297; GO:0160009; GO:0160010"
"g131024",3191.755,0.5877123,0.1793889,3.276192,0.001052172,0.02080474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137545",34.23842,1.488843,0.454331,3.277002,0.001049157,0.02080474,0,2714,"sp|Q6K332|ODD33_ORYSJ","Q6K332","ODD33",3.95e-07,"2-oxoglutarate-dependent dioxygenase 33 (EC 1.14.11.-) (Melatonin 2-hydroxylase)",NA,"GO:0005737; GO:0031418; GO:0046872; GO:0051213"
"g116742",66.42534,0.5285441,0.1613385,3.275994,0.001052908,0.02080545,599,4794,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",6.93e-71,"PiggyBac transposable element-derived protein 4",NA,NA
"g118715",52.23982,0.4172139,0.1273616,3.275822,0.001053551,0.0208118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6778",1596.819,-0.3743271,0.1142747,-3.275677,0.00105409,0.02081611,0,55540,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.33e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g7593",1805.258,0.4197605,0.1281491,3.275564,0.001054512,0.02081809,32771,36564,"sp|P55216|CGL2_CAEEL","P55216","CGL2",6.32e-30,"Putative cystathionine gamma-lyase 2 (EC 4.4.1.1) (Gamma-cystathionase)","cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]","GO:0004123; GO:0005737; GO:0005783; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146"
"g32818",62.6869,0.4237087,0.1293866,3.27475,0.001057555,0.02085275,24005,31731,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.33e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g59240",106.109,-0.5238222,0.1599456,-3.275003,0.001056608,0.02085275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87071",586.2901,1.067788,0.3260592,3.274828,0.001057262,0.02085275,1715,6270,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.28e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g153283",42.03175,1.223291,0.3735494,3.274776,0.001057459,0.02085275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2154",93.62041,0.2928047,0.08941662,3.274612,0.001058073,0.02085662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151554",24.10034,0.7063422,0.2157107,3.274488,0.001058537,0.02085942,0,1846,"sp|O77460|IPYR_DROME","O77460","IPYR",2.28e-14,"Inorganic pyrophosphatase (EC 3.6.1.1) (Nucleosome-remodeling factor 38 kDa subunit) (Pyrophosphate phospho-hydrolase) (PPase)","chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; nucleosome mobilization [GO:0042766]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hemocyte proliferation [GO:0035206]","GO:0000287; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006796; GO:0016589; GO:0035076; GO:0035206; GO:0042766; GO:0045893"
"g29363",77.0418,0.4567866,0.1395093,3.274238,0.001059474,0.0208652,11725,15030,"sp|Q93XX8|NOP10_ARATH","Q93XX8","NOP10",2.46e-06,"H/ACA ribonucleoprotein complex subunit 3-like protein (Nucleolar protein 10)","polar nucleus fusion [GO:0010197]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]","GO:0005730; GO:0005739; GO:0010197; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0070034; GO:0090661"
"g136752",1091.067,0.2804155,0.08564292,3.27424,0.001059467,0.0208652,476,3091,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.79e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g152695",3984.676,-0.3270223,0.0998867,-3.273932,0.001060621,0.02088143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4269",129.9999,-0.4168931,0.1273481,-3.273649,0.001061686,0.02089605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139623",1706.629,0.3148803,0.09619533,3.273343,0.001062835,0.02090881,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144826",33.99503,2.146239,0.6556795,3.273304,0.001062979,0.02090881,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115029",1031.798,1.755262,0.5362634,3.273135,0.001063618,0.02091503,0,4959,"sp|P97821|CATC_MOUSE","P97821","CATC",1.16e-09,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235"
"g12126",1361.215,-0.4655745,0.1422469,-3.273003,0.001064112,0.02091839,38966,58824,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",6.48e-34,"PiggyBac transposable element-derived protein 4",NA,NA
"g1758",282.746,-0.2691815,0.08225446,-3.272546,0.001065837,0.02093959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40111",424.9294,-0.2746676,0.08392962,-3.272595,0.001065651,0.02093959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27466",7977.164,-0.461565,0.1411038,-3.271103,0.001071289,0.02104033,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115124",28.16205,0.9125353,0.2789774,3.271001,0.001071675,0.02104153,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24134",25.87379,1.282235,0.3920602,3.270506,0.001073552,0.02107199,0,14005,"sp|Q6AZB8|HARB1_DANRE","Q6AZB8","HARB1",1.67e-06,"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)",NA,"GO:0004518; GO:0005634; GO:0005737; GO:0046872"
"g40017",364.4966,0.4206631,0.12864,3.27008,0.001075172,0.02109741,1575,4534,"sp|P45594|CADF_DROME","P45594","CADF",3.8e-16,"Cofilin/actin-depolymerizing factor homolog (Protein D61) (Protein twinstar)","actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actomyosin contractile ring assembly [GO:0000915]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; centrosome separation [GO:0051299]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; epithelial structure maintenance [GO:0010669]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; female gonad development [GO:0008585]; imaginal disc-derived leg segmentation [GO:0036011]; lamellipodium assembly [GO:0030032]; meiotic cytokinesis [GO:0033206]; mitotic cytokinesis [GO:0000281]; mushroom body development [GO:0016319]; positive regulation of protein secretion [GO:0050714]; regulation of lamellipodium assembly [GO:0010591]; rhabdomere development [GO:0042052]","GO:0000281; GO:0000902; GO:0000915; GO:0001736; GO:0001737; GO:0001745; GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0007015; GO:0007298; GO:0007409; GO:0008585; GO:0010591; GO:0010669; GO:0015629; GO:0016319; GO:0016363; GO:0030032; GO:0030041; GO:0030042; GO:0030043; GO:0033206; GO:0036011; GO:0042052; GO:0042067; GO:0048749; GO:0048870; GO:0050714; GO:0051014; GO:0051015; GO:0051299"
"g97511",665.5058,-0.7162462,0.2190446,-3.269864,0.001075991,0.02110708,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28389",1782.363,-0.2442898,0.07471406,-3.269663,0.001076757,0.02111571,15815,37526,"sp|Q9HAV4|XPO5_HUMAN","Q9HAV4","XPO5",1.76e-13,"Exportin-5 (Exp5) (Ran-binding protein 21)","miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405]","GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1900370; GO:1905172"
"g47840",217.4047,-0.4476783,0.1369403,-3.26915,0.001078712,0.02114766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136703",52.73214,0.3712702,0.1135862,3.268619,0.001080736,0.02118093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66948",4090.436,1.578547,0.4829773,3.268366,0.001081703,0.02119347,2759,11559,"sp|P02515|HSP22_DROME","P02515","HSP22",1.34e-09,"Heat shock protein 22","chaperone-mediated protein folding [GO:0061077]; determination of adult lifespan [GO:0008340]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]","GO:0005759; GO:0006979; GO:0008340; GO:0009408; GO:0042802; GO:0051082; GO:0061077"
"g144952",51.27197,0.4976267,0.1522712,3.268028,0.001082998,0.02121241,0,2433,"sp|P53914|NAT10_YEAST","P53914","NAT10",4.3e-12,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (Killer toxin-resistance protein 33) (Ribosomal RNA cytidine acetyltransferase 1)","maturation of SSU-rRNA [GO:0030490]; mRNA modification [GO:0016556]; ribosomal small subunit biogenesis [GO:0042274]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0005524; GO:0005730; GO:0016556; GO:0030490; GO:0030515; GO:0030686; GO:0030688; GO:0032040; GO:0042274; GO:0051391; GO:1904812; GO:1990883"
"g37073",3204.355,2.76519,0.8462524,3.267571,0.001084747,0.02123385,2815,18897,"sp|C0HLU7|HCY_SCYOL","C0HLU7","HCY",0,"Hemocyanin subunit",NA,"GO:0005344; GO:0005615; GO:0016491; GO:0046872"
"g102917",73.82298,0.6146573,0.1881053,3.267624,0.001084543,0.02123385,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33482",231.3063,-0.3637663,0.1113594,-3.266599,0.001088479,0.02130046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2947",207.888,-0.2964903,0.09077315,-3.266278,0.001089714,0.02131175,65220,70274,"sp|P21328|RTJK_DROME","P21328","RTJK",3.26e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g139384",273.9227,0.4030689,0.1234022,3.266302,0.001089619,0.02131175,157,2891,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.71e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g88186",26.39267,0.7874479,0.2411018,3.266039,0.001090633,0.0213233,0,7733,"sp|Q96FC9|DDX11_HUMAN","Q96FC9","DDX11",1.73e-14,"ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (CHL1-related protein 1) (hCHLR1) (DEAD/H-box protein 11) (Keratinocyte growth factor-regulated gene 2 protein) (KRG-2)","cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]","GO:0000785; GO:0000922; GO:0003677; GO:0003678; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0008094; GO:0008186; GO:0016887; GO:0030496; GO:0031297; GO:0032079; GO:0032091; GO:0032508; GO:0034085; GO:0035563; GO:0043139; GO:0044806; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:1901838; GO:1904976; GO:1990700; GO:2000781"
"g35974",1404.957,-0.292343,0.08951879,-3.265716,0.001091875,0.02134114,8965,22824,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.43e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g30642",91.00983,0.3897069,0.1193443,3.265402,0.001093089,0.0213533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160428",518.8037,2.118439,0.6487564,3.265384,0.001093157,0.0213533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13311",24.09836,1.317741,0.4035607,3.265286,0.001093537,0.02135402,57127,59954,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.73e-71,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g151795",1746.222,-0.4973064,0.1523048,-3.265204,0.001093852,0.02135402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15319",19.4579,0.6210051,0.1902005,3.265002,0.001094633,0.02136282,0,5074,"sp|Q96P70|IPO9_HUMAN","Q96P70","IPO9",2.41e-31,"Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9)","protein import into nucleus [GO:0006606]","GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031267; GO:0042393; GO:0061608"
"g98846",716.1035,-0.3150339,0.09649213,-3.264867,0.001095156,0.0213666,3171,6632,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.33e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17922",1979.148,-0.249282,0.07636117,-3.264513,0.001096525,0.02137138,27565,30674,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.3e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g37732",143.807,-0.5449398,0.1669342,-3.2644,0.001096962,0.02137138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69690",30.53758,-0.5881323,0.1801584,-3.264529,0.001096463,0.02137138,3966,8244,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.14e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g93052",29.34086,0.7923622,0.24273,3.264377,0.001097051,0.02137138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105055",22.18592,1.852636,0.5674886,3.264623,0.001096099,0.02137138,0,5945,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.52e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g131420",46.39364,0.4643579,0.1422716,3.263884,0.001098963,0.0214022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44751",144.9536,1.193318,0.3657397,3.262751,0.001103364,0.02147657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57927",23.66475,0.8929914,0.2736945,3.26273,0.001103445,0.02147657,5076,13748,"sp|Q28I80|YLAT2_XENTR","Q28I80","YLAT2",5.26e-15,"Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)",NA,"GO:0015179; GO:0016021; GO:0016323"
"g111484",74.86864,0.4660438,0.1428452,3.262579,0.001104035,0.02148161,0,4481,"sp|Q9JLZ1|GLRX3_RAT","Q9JLZ1","GLRX3",4.5e-08,"Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2)","[2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026]","GO:0002026; GO:0005080; GO:0005634; GO:0005829; GO:0005938; GO:0006879; GO:0010614; GO:0016226; GO:0030018; GO:0030425; GO:0042802; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0055072; GO:0097428; GO:0097573; GO:1990229"
"g32457",228.982,-0.3094999,0.09486653,-3.262477,0.00110443,0.02148284,11145,14228,"sp|P14381|YTX2_XENLA","P14381","YTX2",9.03e-18,"Transposon TX1 uncharacterized 149 kDa protein (ORF 2)",NA,"GO:0003824"
"g74329",101.3965,0.8517635,0.2610865,3.262381,0.001104807,0.02148372,4334,5304,"sp|Q91XV4|DCXR_MESAU","Q91XV4","DCXR",1.69e-91,"L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (Sperm antigen P26h)","D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xylulose metabolic process [GO:0005997]","GO:0001669; GO:0005881; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016020; GO:0016655; GO:0042732; GO:0042802; GO:0050038; GO:2000379"
"g49454",1518.888,-0.4073395,0.1248664,-3.262202,0.001105504,0.02149083,0,13914,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.63e-36,"PiggyBac transposable element-derived protein 4",NA,NA
"g4300",779.1629,-0.5371746,0.1646836,-3.261858,0.001106845,0.02150889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95972",191.2677,0.3793498,0.116301,3.261794,0.001107097,0.02150889,3046,6794,"sp|Q7Q6S8|MED14_ANOGA","Q7Q6S8","MED14",2.45e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592; GO:0070847"
"g38136",597.1545,0.3060084,0.09383256,3.261217,0.001109351,0.02154622,16575,25478,"sp|Q6DDM4|API5A_XENLA","Q6DDM4","API5A",4.19e-17,"Apoptosis inhibitor 5-A (API-5A)","apoptotic process [GO:0006915]","GO:0005634; GO:0006915"
"g12420",509.174,-0.2905947,0.08912502,-3.260529,0.001112045,0.02157914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102207",1099.177,-0.7841308,0.2404893,-3.260564,0.001111908,0.02157914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110867",6674.979,-0.605458,0.1856923,-3.260544,0.001111986,0.02157914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30765",115.3002,0.6269267,0.1922839,3.260422,0.001112467,0.02158087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56420",20.51588,1.444213,0.4430126,3.259982,0.001114193,0.02160788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26384",537.6969,-0.3607666,0.1106871,-3.259336,0.001116732,0.02165064,0,33027,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.81e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g108212",25.72718,0.7639055,0.2343851,3.259189,0.00111731,0.02165536,0,5625,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7.02e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g117081",458.2232,0.3584619,0.1099902,3.259034,0.001117922,0.02166074,0,4761,"sp|Q94572|TBA3_HOMAM","Q94572","TBA3",1.29e-154,"Tubulin alpha-3 chain (Alpha-III tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g60030",96.26379,0.358297,0.1099535,3.258623,0.001119542,0.02167917,0,6964,"sp|P58405|STRN3_RAT","P58405","STRN3",2.22e-19,"Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)","negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription, DNA-templated [GO:0045892]; response to estradiol [GO:0032355]","GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443"
"g89114",440.0397,0.3231322,0.09916207,3.258627,0.001119526,0.02167917,0,7605,"sp|Q24K02|IDE_BOVIN","Q24K02","IDE",2.88e-16,"Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]","GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008270; GO:0008340; GO:0009897; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0032092; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0050435; GO:0051603; GO:0140036; GO:0150094; GO:1901143; GO:1903715"
"g11032",5694.474,-0.2233712,0.06855377,-3.258336,0.001120677,0.02168171,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57475",965.4496,0.4842161,0.1486072,3.258363,0.001120569,0.02168171,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136733",39.24569,-0.4509451,0.1383926,-3.258448,0.001120234,0.02168171,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37407",541.1848,-0.4697357,0.144176,-3.258072,0.001121719,0.02169538,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15669",1909.904,-0.294537,0.09040908,-3.257826,0.001122692,0.02170773,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g491",89.55018,0.4136113,0.1269818,3.257249,0.001124976,0.0217454,83615,97749,"sp|Q7TQP6|TNI3K_RAT","Q7TQP6","TNI3K",5.19e-20,"Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"g407",982.9274,-0.2068102,0.06350156,-3.256773,0.001126863,0.02176889,13845,35650,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.85e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g115195",456.038,0.3542728,0.1087778,3.256848,0.001126569,0.02176889,0,4941,"sp|Q9W770|SPON1_CHICK","Q9W770","SPON1",1.29e-11,"Spondin-1 (F-spondin)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872"
"g21998",772.3113,-0.6748572,0.2072555,-3.25616,0.001129299,0.02179645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66779",118.2025,-0.5959646,0.1830259,-3.256177,0.001129235,0.02179645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127908",216.5137,-0.2473076,0.07594779,-3.256284,0.001128809,0.02179645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37062",38.20913,1.593459,0.489417,3.25583,0.001130614,0.02180519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58108",32.58936,0.9289072,0.2853239,3.255624,0.001131435,0.02180519,11045,14052,"sp|P10394|POL4_DROME","P10394","POL4",3.21e-25,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g84610",4960.126,-0.338143,0.1038627,-3.255671,0.001131246,0.02180519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107554",662.2525,0.2810837,0.08633061,3.255898,0.001130343,0.02180519,0,5690,"sp|Q5R8D7|PRS7_PONAB","Q5R8D7","PRS7",7.58e-27,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0006511; GO:0016887; GO:0022624; GO:0036402"
"g130657",1830.528,0.384188,0.1180069,3.255641,0.001131369,0.02180519,1192,3536,"sp|P31161|SODM1_CAEEL","P31161","SODM1",4.53e-25,"Superoxide dismutase [Mn] 1, mitochondrial (EC 1.15.1.1)","removal of superoxide radicals [GO:0019430]","GO:0004784; GO:0005739; GO:0005746; GO:0005759; GO:0019430; GO:0030145; GO:0042803"
"g82583",200.4133,0.3818485,0.1172966,3.25541,0.001132288,0.02180866,0,8727,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.86e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g137114",45.37063,-0.5429021,0.166767,-3.255452,0.001132119,0.02180866,0,3066,"sp|Q9Y4I1|MYO5A_HUMAN","Q9Y4I1","MYO5A",2.03e-11,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)","actin filament-based movement [GO:0030048]; actin filament organization [GO:0007015]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001726; GO:0003723; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006892; GO:0007015; GO:0015031; GO:0015629; GO:0016020; GO:0016192; GO:0016459; GO:0030048; GO:0030050; GO:0030426; GO:0031267; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0042470; GO:0043005; GO:0051015; GO:0070062; GO:0072659"
"g22265",44.71456,0.7049729,0.2165856,3.254938,0.00113417,0.02183841,0,8783,"sp|Q9D6A1|MYO1H_MOUSE","Q9D6A1","MYO1H",3.72e-13,"Unconventional myosin-Ih","actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0051015"
"g25162",1710.994,-0.4947074,0.1519977,-3.254703,0.001135109,0.02185,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137831",705.8391,0.4252863,0.1306729,3.254588,0.001135571,0.02185241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81729",230.0982,0.5324777,0.1636146,3.254463,0.001136069,0.0218555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50521",218.0045,2.124253,0.6527725,3.254201,0.001137116,0.02186915,0,17117,"sp|Q05487|ESTS_DROVI","Q05487","ESTS",1.86e-06,"Esterase S (Est-S) (EC 3.1.1.1) (Carboxylic-ester hydrolase S) (Carboxylesterase-S)",NA,"GO:0005576; GO:0080030"
"g85662",4800.54,-0.3020168,0.0928117,-3.254081,0.001137597,0.02187191,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9463",177.0816,-0.4430794,0.1361753,-3.253743,0.001138952,0.02189145,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57265",869.8329,-0.2677467,0.08230665,-3.253038,0.001141782,0.02193935,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25683",657.2868,-0.3558945,0.1094167,-3.252653,0.001143329,0.02196256,0,19718,"sp|P41696|AZF1_YEAST","P41696","AZF1",4.35e-07,"Asparagine-rich zinc finger protein AZF1","cellular response to carbohydrate stimulus [GO:0071322]; regulation of fungal-type cell wall organization [GO:0060237]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0043565; GO:0046872; GO:0060237; GO:0071322"
"g2391",1525.148,-0.3888756,0.1195764,-3.252111,0.001145511,0.02197721,39157,94274,"sp|Q9VXE5|PAKM_DROME","Q9VXE5","PAKM",2.3e-45,"Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)","compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]","GO:0001751; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0018105; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047"
"g21021",22.11177,-0.6465023,0.1987916,-3.252162,0.001145308,0.02197721,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38163",512.1205,-0.356266,0.1095473,-3.252166,0.00114529,0.02197721,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65216",41.89594,-0.499784,0.1536831,-3.252043,0.001145787,0.02197721,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111172",66.02361,-0.440301,0.1353868,-3.25217,0.001145273,0.02197721,2574,4174,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.41e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18736",45.18899,0.7662024,0.2356353,3.251646,0.00114739,0.02198841,0,3991,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.59e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g19172",70.07842,0.5389975,0.1657598,3.251679,0.001147257,0.02198841,44285,48010,"sp|Q04451|GARS_BOMMO","Q04451","GARS",6.92e-37,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]","GO:0004820; GO:0005524; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983"
"g149595",388.4301,-1.066271,0.3279136,-3.251681,0.001147245,0.02198841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123644",4903.965,0.892094,0.2743654,3.251481,0.001148054,0.02199464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62876",34.98621,1.649852,0.5074748,3.251101,0.00114959,0.02201755,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13841",411.2524,0.4492334,0.1381925,3.25078,0.001150889,0.02202916,6725,19600,"sp|P21328|RTJK_DROME","P21328","RTJK",1.43e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g21049",355.0845,-0.2421486,0.07449158,-3.250684,0.001151277,0.02202916,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22927",954.0592,-0.3875649,0.1192282,-3.250615,0.001151556,0.02202916,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64705",214.1247,0.884272,0.272022,3.250737,0.001151065,0.02202916,0,8444,"sp|Q64581|CP3AI_RAT","Q64581","CP3AI",1.06e-29,"Cytochrome P450 3A18 (EC 1.14.14.1) (CYPIIIA18) (Cytochrome P450(6)beta-2)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0008390; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"g109525",944.9447,1.173907,0.3611671,3.250315,0.001152772,0.02204591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14120",975.6506,0.2933167,0.09024681,3.250161,0.001153397,0.02205135,0,7637,"sp|Q3T1I9|RPAP1_RAT","Q3T1I9","RPAP1",1.71e-30,"RNA polymerase II-associated protein 1","transcription by RNA polymerase II [GO:0006366]","GO:0003677; GO:0003899; GO:0005634; GO:0006366"
"g151305",39.52017,0.4889559,0.1504516,3.249922,0.001154365,0.02206336,0,1064,"sp|Q92547|TOPB1_HUMAN","Q92547","TOPB1",1.54e-10,"DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)","cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212]","GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0042802; GO:0043231; GO:0070532"
"g10762",3731.317,-0.4614653,0.1420082,-3.249568,0.001155805,0.02207278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34275",57.35551,-0.5879076,0.1809197,-3.249549,0.00115588,0.02207278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160066",427.2314,1.724075,0.5305477,3.249613,0.001155621,0.02207278,95,1192,"sp|P53634|CATC_HUMAN","P53634","CATC",3.8e-23,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235"
"g44729",477.2535,0.4603451,0.1416682,3.249459,0.001156249,0.02207331,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21133",51503.28,0.5117305,0.157504,3.249001,0.001158111,0.02209208,25655,31589,"sp|P84185|ACT5C_ANOGA","P84185","ACT5C",0,"Actin-5C (Actin-1D, cytoplasmic)","mitotic cytokinesis [GO:0000281]","GO:0000281; GO:0005524; GO:0005737; GO:0005856"
"g24990",747.7496,-0.4395463,0.1352881,-3.248966,0.001158255,0.02209208,24709,38922,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.98e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g116906",49.11131,0.7759105,0.238814,3.249016,0.00115805,0.02209208,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31679",111.8794,0.422274,0.1299772,3.24883,0.001158806,0.02209605,6685,11420,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",8.05e-11,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g41431",360.4341,0.8943616,0.2753121,3.248537,0.001160001,0.02209605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48525",256.8896,-0.3932251,0.1210502,-3.248447,0.001160367,0.02209605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99119",20660.35,0.7249935,0.2231763,3.248524,0.001160056,0.02209605,0,573,"sp|P10994|ACTS_PLEWA","P10994","ACTS",1.98e-69,"Actin, alpha skeletal muscle (Fragment)",NA,"GO:0005524; GO:0005737; GO:0005856"
"g123975",80.65176,1.783756,0.5490954,3.248535,0.001160008,0.02209605,2153,4135,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",1.03e-17,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g135281",18.44597,0.8536316,0.2627842,3.248413,0.001160509,0.02209605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6442",68.95585,-0.3249379,0.1000585,-3.24748,0.001164318,0.02215555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32553",719.4355,-0.3110946,0.09579548,-3.247487,0.001164291,0.02215555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25777",418.421,0.2498659,0.07695387,3.246957,0.001166462,0.02217947,35045,38976,"sp|O18883|TXND9_BOVIN","O18883","TXND9",6.33e-07,"Thioredoxin domain-containing protein 9 (Protein 1-4)","protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005815; GO:0006457; GO:0030496"
"g67177",2172.946,0.4465846,0.1375444,3.246839,0.001166944,0.02217947,0,4430,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",9.72e-14,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g70571",66.32665,-0.3945733,0.1215166,-3.247072,0.001165988,0.02217947,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138606",57.52838,-0.7298323,0.2247798,-3.246877,0.001166788,0.02217947,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13920",75.47631,0.577792,0.1779767,3.246448,0.001168549,0.02219044,53020,62574,"sp|Q6P8E9|NH2L1_XENTR","Q6P8E9","NH2L1",9.61e-27,"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein)","mRNA splicing, via spliceosome [GO:0000398]; ribosome biogenesis [GO:0042254]","GO:0000398; GO:0005634; GO:0005690; GO:0005730; GO:0030622; GO:0042254; GO:0046540; GO:0071005"
"g41883",523.5461,-0.3091737,0.09523441,-3.24645,0.001168541,0.02219044,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77733",58.21212,0.4087197,0.1258935,3.246551,0.001168124,0.02219044,6111,9476,"sp|Q99LS1|MMAD_MOUSE","Q99LS1","MMAD",8.82e-27,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D homolog, mitochondrial)","cobalamin metabolic process [GO:0009235]","GO:0005737; GO:0005739; GO:0005829; GO:0009235"
"g23290",2287.916,-0.357951,0.1102743,-3.246007,0.001170361,0.02221835,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27179",75.03794,0.9056623,0.2790405,3.24563,0.001171911,0.02223954,37067,39249,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.1e-13,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g32872",20.41117,0.4878439,0.1503108,3.245568,0.001172164,0.02223954,5474,10310,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.44e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17358",1882.953,-0.2419624,0.07456389,-3.245034,0.001174364,0.0222687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30620",1745.921,-0.3494371,0.1076866,-3.244945,0.001174732,0.0222687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60298",136190.7,-0.5216639,0.1607619,-3.244948,0.001174719,0.0222687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34202",310.9644,-0.1961955,0.0604637,-3.244847,0.001175136,0.02226985,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124",2550.1,-0.4301558,0.1325981,-3.244056,0.001178406,0.02227317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62557",24.32449,1.704411,0.5253619,3.24426,0.001177561,0.02227317,0,6764,"sp|P21328|RTJK_DROME","P21328","RTJK",7.33e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g63093",178.109,1.021685,0.3149109,3.244363,0.001177135,0.02227317,8437,11694,"sp|P21328|RTJK_DROME","P21328","RTJK",8.79e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g63359",66.9174,-0.466641,0.1438393,-3.244183,0.00117788,0.02227317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77664",163.6933,0.4290885,0.132269,3.244059,0.001178392,0.02227317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99347",103.7858,0.288293,0.08886463,3.244182,0.001177886,0.02227317,3326,6578,"sp|P34378|RM18_CAEEL","P34378","RM18",7.44e-12,"39S ribosomal protein L18, mitochondrial","translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0008097"
"g110911",86.12436,0.3833424,0.1181661,3.244096,0.001178239,0.02227317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116147",2271.901,-0.5480914,0.168924,-3.244603,0.001176143,0.02227317,0,4790,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.45e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g128632",56.61188,0.486937,0.1500716,3.244698,0.001175752,0.02227317,669,3741,"sp|Q505D1|ANR28_MOUSE","Q505D1","ANR28",5.2e-43,"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK)",NA,"GO:0005654"
"g15756",45.07915,-0.3804998,0.1173027,-3.243742,0.001179707,0.02229127,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42216",752.4931,0.3081352,0.09499908,3.243559,0.001180462,0.02229903,11557,14554,"sp|Q9DBV3|DHX34_MOUSE","Q9DBV3","DHX34",1.31e-66,"Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34)","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]","GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623"
"g22786",480.2034,-0.6079585,0.1874611,-3.243119,0.001182289,0.02232703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17816",146.5716,0.3701535,0.1141627,3.242333,0.001185553,0.02238214,43296,47674,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.45e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g16763",811.9296,-0.3731096,0.1150866,-3.241989,0.001186988,0.02240271,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9950",434.0112,-0.3494622,0.1078055,-3.241599,0.001188613,0.02241572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17043",119.1714,1.328947,0.4099543,3.241696,0.001188208,0.02241572,32534,40114,"sp|Q03013|GSTM4_HUMAN","Q03013","GSTM4",2.72e-13,"Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4) (Leukotriene C4 synthase GSTM4) (EC 4.4.1.20)","glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0004464; GO:0005737; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171"
"g88351",46.79922,-0.4779402,0.1474408,-3.241574,0.001188715,0.02241572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77718",532.0088,0.3190091,0.09842106,3.241268,0.001189991,0.02243326,0,8661,"sp|Q5R922|COPB_PONAB","Q5R922","COPB",1.17e-33,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005793; GO:0005886; GO:0006886; GO:0016192; GO:0030126"
"g86757",38.58729,-0.5461862,0.168515,-3.241171,0.001190396,0.02243435,6695,7938,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.27e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36590",602.9109,1.110475,0.3426432,3.240907,0.001191499,0.02244861,15147,23764,"sp|Q8R151|ZNFX1_MOUSE","Q8R151","ZNFX1",1.37e-49,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of viral genome replication [GO:0045071]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0051607"
"g12909",350.6407,-0.2865995,0.08844414,-3.240458,0.001193377,0.02246466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42768",165.6539,0.3570907,0.1101942,3.240559,0.001192955,0.02246466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125283",17064.87,2.08375,0.6430424,3.240455,0.00119339,0.02246466,0,2128,"sp|P00765|TRYP_ASTAS","P00765","TRYP",1.28e-75,"Trypsin-1 (EC 3.4.21.4) (Trypsin I)","digestion [GO:0007586]","GO:0004252; GO:0005615; GO:0007586; GO:0046872"
"g75936",23.29409,-0.6850968,0.2114405,-3.24014,0.00119471,0.02248296,0,6411,"sp|P21328|RTJK_DROME","P21328","RTJK",9.63e-41,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g40893",404.1176,0.2804069,0.08654585,3.239981,0.001195376,0.02248896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67269",17.24384,0.9477677,0.2925732,3.239421,0.001197726,0.02252664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51",154.4036,0.5295824,0.1634924,3.239185,0.001198716,0.02253871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90311",4999.789,0.532877,0.1645238,3.238906,0.001199893,0.02255429,3045,6609,"sp|Q8BJ66|KAZD1_MOUSE","Q8BJ66","KAZD1",1.4e-08,"Kazal-type serine protease inhibitor domain-containing protein 1 (Bone and odontoblast-expressed protein 1) (Insulin-like growth factor-binding-related protein 10) (IGFBP-rP10) (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4)","cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]","GO:0001503; GO:0001558; GO:0005520; GO:0005576; GO:0005614; GO:0009966; GO:0030154; GO:0030198; GO:0031012"
"g31939",47.15491,0.9678065,0.2988409,3.238534,0.001201456,0.02257713,25359,32709,"sp|Q5R5F3|DHSO_PONAB","Q5R5F3","DHSO",6.14e-15,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)","flagellated sperm motility [GO:0030317]","GO:0003939; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526"
"g2151",83.05182,0.4267993,0.1318049,3.238114,0.001203229,0.02260078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127758",43.49667,0.4635795,0.1431654,3.23807,0.001203412,0.02260078,0,3809,"sp|P21328|RTJK_DROME","P21328","RTJK",7.42e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g72281",138.1221,0.3944375,0.1218448,3.237212,0.001207037,0.02266229,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15335",115.3572,0.3856931,0.1191515,3.236997,0.001207947,0.02266623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123845",292.0361,0.343082,0.1059855,3.237066,0.001207656,0.02266623,0,4147,"sp|O00567|NOP56_HUMAN","O00567","NOP56",2.14e-15,"Nucleolar protein 56 (Nucleolar protein 5A)","rRNA processing [GO:0006364]","GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226"
"g15881",526.8946,-0.4650655,0.1436931,-3.236519,0.001209972,0.02269702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16505",1401.161,-0.2028119,0.06266982,-3.236197,0.001211339,0.02269702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36230",3471.694,-0.4601836,0.1421897,-3.236407,0.001210446,0.02269702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56618",12250.18,0.782491,0.2417873,3.236279,0.001210991,0.02269702,9802,12014,"sp|P12981|JUN_COTJA","P12981","JUN",1.68e-49,"Transcription factor Jun (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun)","Ras protein signal transduction [GO:0007265]","GO:0000976; GO:0003700; GO:0005634; GO:0007265"
"g92323",45.95433,-0.3744312,0.1157003,-3.236215,0.001211262,0.02269702,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58707",62.50385,0.6677429,0.2063437,3.236071,0.001211874,0.02270048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30345",21.36974,1.624224,0.501951,3.235823,0.001212927,0.02271347,0,6294,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.81e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g98021",57.00113,0.7739129,0.2391763,3.235742,0.001213269,0.02271347,4665,6354,"sp|O96553|C1TC_DROME","O96553","C1TC",2.96e-09,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g85500",56.85499,0.6807684,0.2104023,3.235556,0.00121406,0.02272173,1015,7011,"sp|P21328|RTJK_DROME","P21328","RTJK",2.98e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31819",1537.804,-0.4658241,0.1439853,-3.235221,0.001215486,0.02273846,17694,26194,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.03e-06,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g81556",48.4398,2.702514,0.8353518,3.235181,0.001215657,0.02273846,0,7784,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.48e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g50088",77.51239,1.219327,0.3769077,3.23508,0.001216088,0.02273997,3755,7349,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.94e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36169",920.9028,-0.6775918,0.20946,-3.234947,0.001216655,0.02274401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7282",79.88433,0.8685645,0.2685439,3.234349,0.001219205,0.02276056,81375,90854,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.37e-12,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18791",4644.934,-0.2629523,0.08129885,-3.234391,0.001219023,0.02276056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26979",221.8471,0.4502151,0.1391894,3.234551,0.001218343,0.02276056,0,11034,"sp|P97852|DHB4_RAT","P97852","DHB4",5.49e-17,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","aging [GO:0007568]; androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0006635; GO:0007568; GO:0008203; GO:0008209; GO:0008210; GO:0009410; GO:0014070; GO:0016508; GO:0016853; GO:0018812; GO:0030283; GO:0033989; GO:0036111; GO:0036112; GO:0042802; GO:0042803; GO:0044594; GO:0048545; GO:0060009; GO:0071407; GO:0106386"
"g28158",1296.714,-0.4717018,0.1458293,-3.234616,0.001218063,0.02276056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34891",147.0818,0.6851335,0.2118372,3.234245,0.001219648,0.02276056,21298,26684,"sp|Q9Z2Z6|MCAT_MOUSE","Q9Z2Z6","MCAT",6.28e-19,"Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (mCAC) (Solute carrier family 25 member 20)","carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; lipid transport [GO:0006869]","GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0006869; GO:0015227; GO:0016021; GO:1902603"
"g148297",67.32512,2.088046,0.6456004,3.23427,0.001219539,0.02276056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7003",4187.015,0.3433697,0.1061748,3.234003,0.001220681,0.02276672,94293,100264,"sp|O75564|JERKY_HUMAN","O75564","JERKY",7.46e-29,"Jerky protein homolog","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g149354",391.1121,0.5356501,0.1656285,3.234045,0.001220504,0.02276672,0,1968,"sp|O18994|GPX5_PIG","O18994","GPX5",2.28e-07,"Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5)","response to oxidative stress [GO:0006979]","GO:0004601; GO:0004602; GO:0005576; GO:0006979"
"g63746",183.4458,0.3553738,0.1098906,3.233887,0.001221177,0.02276941,0,12368,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.06e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g23210",75.14811,0.432059,0.1336116,3.233692,0.00122201,0.02277184,30617,35534,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.1e-12,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65244",149.1734,-0.3990416,0.1233981,-3.233774,0.00122166,0.02277184,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24996",877.9786,-0.2579364,0.07978102,-3.233055,0.001224741,0.02280306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63695",72.76174,-0.3436811,0.1063004,-3.233114,0.001224489,0.02280306,0,12381,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.86e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g120708",79.59783,-0.9879927,0.305583,-3.233141,0.001224373,0.02280306,0,4428,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.35e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g7037",9785.936,0.2333853,0.07220296,3.232351,0.001227761,0.02285273,79585,102106,"sp|P37276|DYHC_DROME","P37276","DYHC",0,"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)","axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]","GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904"
"g15873",310.588,-0.4628469,0.1432035,-3.232092,0.001228875,0.02285376,20255,50649,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.01e-13,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g50724",203.7637,-0.561473,0.173713,-3.232187,0.001228467,0.02285376,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101698",379.7334,0.4311626,0.1333974,3.232166,0.001228556,0.02285376,2474,6302,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.18e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55974",3170.94,0.3840544,0.1188401,3.231691,0.0012306,0.022876,0,12200,"sp|Q9M888|TCPZA_ARATH","Q9M888","TCPZA",6.91e-35,"T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)","protein folding [GO:0006457]; response to zinc ion [GO:0010043]","GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0016887; GO:0051082"
"g75088",530.0272,-0.661969,0.2048393,-3.23165,0.001230777,0.022876,2761,9912,"sp|Q292F9|GDAP2_DROPS","Q292F9","GDAP2",8.31e-15,"Protein GDAP2 homolog","response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0006979; GO:0042594"
"g101703",296.3414,-0.3771352,0.1167052,-3.231519,0.00123134,0.0228799,0,6302,"sp|Q7JQ32|GC76C_DROME","Q7JQ32","GC76C",4.03e-20,"Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1)","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872"
"g113208",117.5954,0.3335142,0.1032212,3.231063,0.001233307,0.02290989,0,3374,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.48e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g21493",1371.689,-0.2927226,0.0906149,-3.230402,0.001236161,0.02295632,10405,13310,"sp|Q52118|YMO3_PANSE","Q52118","YMO3",6.28e-11,"Uncharacterized protein in mobD 3'region",NA,NA
"g16904",195.4751,0.3730147,0.1154844,3.230001,0.001237898,0.02296882,47586,55713,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.67e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104567",66.34749,1.304916,0.4039848,3.230113,0.001237415,0.02296882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150938",82.42846,1.205429,0.373189,3.230076,0.001237574,0.02296882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g755",571.3751,0.3290065,0.1018693,3.229692,0.001239238,0.02298006,27652,39554,"sp|O62619|KPYK_DROME","O62619","KPYK",3.63e-27,"Pyruvate kinase (PK) (EC 2.7.1.40)","glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; pyruvate metabolic process [GO:0006090]; response to sucrose [GO:0009744]","GO:0000287; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006090; GO:0006096; GO:0009744; GO:0016301; GO:0030955; GO:0042593; GO:0043186"
"g29265",230.4898,0.7531125,0.233183,3.229706,0.001239175,0.02298006,32514,36210,"sp|Q26454|MCM4_DROME","Q26454","MCM4",3.83e-19,"DNA replication licensing factor MCM4 (EC 3.6.4.12) (Protein disc proliferation abnormal)","DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; mitotic spindle organization [GO:0007052]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006268; GO:0006271; GO:0007052; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g81108",1160.305,-0.3986222,0.1234271,-3.229616,0.001239568,0.02298006,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128952",139.4774,-0.4434449,0.137311,-3.229493,0.0012401,0.02298336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51514",79.85383,1.295817,0.4012688,3.2293,0.001240935,0.02299224,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150995",36.87344,1.430951,0.4431489,3.229052,0.001242014,0.02300567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101254",29.38618,0.5908959,0.1830119,3.22873,0.001243413,0.0230202,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149570",104.3197,1.255574,0.3888781,3.228708,0.001243509,0.0230202,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6691",1867.213,-0.345945,0.1071508,-3.22858,0.001244067,0.02302394,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154165",240.8615,-0.9936244,0.3077673,-3.228493,0.001244443,0.02302433,0,1623,"sp|P04323|POL3_DROME","P04323","POL3",7.54e-97,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g106402",107.3888,-0.3126338,0.09685628,-3.227811,0.001247413,0.02307269,2905,5544,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g89761",1252.215,2.174254,0.6736272,3.227682,0.001247977,0.02307653,0,7102,"sp|P00771|COGS_LEPPG","P00771","COGS",5.88e-18,"Brachyurin (EC 3.4.21.32) (Collagenolytic protease)","collagen catabolic process [GO:0030574]","GO:0004252; GO:0030574"
"g3976",285.2647,-0.5021396,0.1555857,-3.227416,0.001249139,0.02308485,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76682",41.49787,-0.4657161,0.1442967,-3.227491,0.001248811,0.02308485,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89700",674.8385,0.1909951,0.05918102,3.227302,0.001249633,0.02308739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27251",185.2541,2.427206,0.7521282,3.227117,0.001250442,0.02309574,10265,14388,"sp|P82120|CUO7_BLACR","P82120","CUO7",1.4e-06,"Cuticle protein 7 (BcNCP15.0)",NA,"GO:0042302"
"g10283",11552.83,-0.7493465,0.2322975,-3.225805,0.00125619,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14343",2020.207,-0.2675472,0.08294269,-3.225687,0.001256706,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23416",597.6077,-0.2993495,0.09278994,-3.226099,0.001254899,0.02311204,0,14668,"sp|Q5JVG2|ZN484_HUMAN","Q5JVG2","ZN484",3.11e-08,"Zinc finger protein 484","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g45774",72.96051,-0.3336837,0.1034261,-3.226302,0.001254011,0.02311204,0,15364,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.86e-48,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g61394",159.7263,0.3634701,0.1126461,3.226656,0.001252461,0.02311204,2404,6284,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.39e-14,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83538",168.3136,0.2126751,0.06592688,3.225924,0.001255665,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107633",6797.549,0.7956302,0.2465981,3.226425,0.001253472,0.02311204,4205,5681,"sp|P49055|ACTS_CARAU","P49055","ACTS",9.93e-39,"Actin, alpha skeletal muscle (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form]",NA,"GO:0005524; GO:0005737; GO:0005856"
"g113651",79.2139,0.5187446,0.1608189,3.225645,0.001256891,0.02311204,0,5091,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.2e-15,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113993",5134.379,0.617872,0.19155,3.225644,0.001256897,0.02311204,0,939,"sp|Q9UEW3|MARCO_HUMAN","Q9UEW3","MARCO",1.64e-08,"Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amyloid-beta clearance [GO:0097242]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; receptor-mediated endocytosis [GO:0006898]","GO:0001540; GO:0001664; GO:0001934; GO:0004888; GO:0005044; GO:0005581; GO:0005737; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0006911; GO:0007166; GO:0007193; GO:0030666; GO:0038024; GO:0038187; GO:0043277; GO:0045087; GO:0070374; GO:0097242"
"g138226",57.68788,0.6520186,0.2020949,3.2263,0.00125402,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142367",135.7733,0.7112388,0.2204472,3.226346,0.001253818,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142548",176.3845,-1.590593,0.4931133,-3.225613,0.001257031,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149756",26.22413,0.610985,0.1893757,3.226312,0.001253964,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150160",24.77706,0.4567154,0.1415732,3.226002,0.001255326,0.02311204,0,1971,"sp|Q5EB97|ZCH10_RAT","Q5EB97","ZCH10",2.11e-11,"Zinc finger CCHC domain-containing protein 10",NA,"GO:0003676; GO:0008270"
"g155369",70.82731,0.7345964,0.2277317,3.22571,0.001256606,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162240",23.8477,0.7400689,0.2294122,3.225935,0.001255619,0.02311204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116032",384.6692,0.2813254,0.08722245,3.225379,0.001258062,0.02312443,0,954,"sp|Q7Z7H5|TMED4_HUMAN","Q7Z7H5","TMED4",6.79e-10,"Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]","GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0043123"
"g62054",468.3141,-0.4827693,0.149693,-3.225062,0.001259455,0.02313691,245,12760,"sp|P21329|RTJK_DROFU","P21329","RTJK",8e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g152748",29.65755,0.6770231,0.209921,3.225132,0.001259145,0.02313691,0,1743,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.82e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g156496",134.4864,0.5173326,0.1604246,3.22477,0.001260737,0.02315389,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19272",30.52666,0.4585514,0.1422025,3.224636,0.001261328,0.02315818,20175,25318,"sp|Q9VUM0|MSH6_DROME","Q9VUM0","MSH6",8.94e-06,"Probable DNA mismatch repair protein Msh6","DNA repair [GO:0006281]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]","GO:0000710; GO:0003690; GO:0005524; GO:0005634; GO:0006281; GO:0006298; GO:0030983; GO:0032301"
"g155490",18.0295,1.289897,0.4000562,3.224289,0.001262857,0.02317968,0,1428,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",5.78e-14,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g142352",20.17307,0.6916234,0.2145166,3.224102,0.001263683,0.02318827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24049",20.64199,2.590172,0.8034021,3.224004,0.001264114,0.02318963,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145462",32.77279,0.5952484,0.18464,3.223832,0.001264877,0.02319705,0,2164,"sp|Q640V9|TATD1_XENLA","Q640V9","TATD1",5.68e-19,"Deoxyribonuclease TATDN1 (EC 3.1.21.-)",NA,"GO:0004518; GO:0005634; GO:0046872"
"g110691",82.36777,0.7184955,0.2228891,3.223556,0.001266095,0.02321282,0,2904,"sp|Q739D2|XYLA_BACC1","Q739D2","XYLA",4.98e-20,"Xylose isomerase (EC 5.3.1.5)","D-xylose metabolic process [GO:0042732]","GO:0000287; GO:0005737; GO:0009045; GO:0042732"
"g36537",206.2187,-0.2493796,0.07738216,-3.222702,0.001269878,0.02327558,5546,13114,"sp|Q9P255|ZN492_HUMAN","Q9P255","ZN492",2.66e-44,"Zinc finger protein 492 (Zinc finger protein 115)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g21419",347.6177,0.2317294,0.07190757,3.222601,0.001270322,0.02327713,17485,23790,"sp|P14604|ECHM_RAT","P14604","ECHM",4.33e-24,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)","fatty acid beta-oxidation [GO:0006635]","GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092"
"g100627",781.3797,1.613473,0.5007,3.222434,0.001271065,0.02328417,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3097",140.1407,-0.5108628,0.1585586,-3.221919,0.001273352,0.02331711,144438,146374,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.03e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g14227",468.0704,-0.2926607,0.09083594,-3.221861,0.00127361,0.02331711,2,11330,"sp|P31368|PDM1_DROME","P31368","PDM1",2.09e-67,"Protein nubbin (POU domain protein 1) (PDM-1) (Protein twain) (dOCT1) (dPOU-19)","appendage morphogenesis [GO:0035107]; dendrite morphogenesis [GO:0048813]; negative regulation of antibacterial peptide biosynthetic process [GO:0002809]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002809; GO:0005634; GO:0006357; GO:0035107; GO:0048813; GO:0050767; GO:2000177"
"g52245",3558.984,-0.3212962,0.09972821,-3.221719,0.001274242,0.02331711,0,9422,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.82e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g88006",405.3075,0.8133276,0.2524525,3.221705,0.001274303,0.02331711,1809,7804,"sp|P30039|PBLD_HUMAN","P30039","PBLD",7.36e-15,"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392; GO:0070062"
"g124890",91.44089,0.321492,0.09979941,3.221382,0.001275741,0.02333685,0,4050,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.21e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g156580",556.2495,0.4494151,0.1395271,3.220989,0.001277492,0.02336227,0,1441,"sp|Q18359|NDUA5_CAEEL","Q18359","NDUA5",3.26e-12,"Probable NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; respiratory electron transport chain [GO:0022904]","GO:0005747; GO:0006120; GO:0022904"
"g32866",193.0635,0.7143773,0.2217962,3.220872,0.00127801,0.02336515,22446,28114,"sp|Q4V8U5|ANO10_DANRE","Q4V8U5","ANO10",2.54e-06,"Anoctamin-10 (Transmembrane protein 16K)","transmembrane transport [GO:0055085]","GO:0005886; GO:0016021; GO:0055085"
"g12617",43.45841,0.6462443,0.2006669,3.220483,0.001279747,0.02338044,36790,44344,"sp|Q99LC5|ETFA_MOUSE","Q99LC5","ETFA",6.5e-18,"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)","cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0017133; GO:0022904; GO:0033539; GO:0045251; GO:0050660"
"g35232",882.0801,0.2639511,0.08195959,3.220503,0.001279658,0.02338044,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113601",276.0986,-0.3249314,0.1008965,-3.220442,0.001279929,0.02338044,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2348",65.67479,-0.4058381,0.1260257,-3.220279,0.001280659,0.02338718,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145542",89.72321,0.6429402,0.1996637,3.220115,0.001281391,0.02339396,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89327",48.92817,0.6784141,0.2106976,3.219848,0.001282588,0.02340921,1825,7783,"sp|A8DYP0|OBSCN_DROME","A8DYP0","OBSCN",1.3e-14,"Obscurin (EC 2.7.11.1) (Muscle M-line assembly protein Unc-89)","adult somatic muscle development [GO:0007527]; muscle contraction [GO:0006936]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; sarcomere organization [GO:0045214]","GO:0005085; GO:0005523; GO:0005524; GO:0006468; GO:0006936; GO:0007527; GO:0016301; GO:0019901; GO:0031430; GO:0036309; GO:0045214; GO:0046872; GO:0051015"
"g51919",176.462,0.2979243,0.09253225,3.219681,0.001283333,0.02341622,8835,12690,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.41e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g114108",20.03205,0.4825127,0.1498689,3.219565,0.001283853,0.02341911,0,5051,"sp|Q66K14|TBC9B_HUMAN","Q66K14","TBC9B",4.72e-08,"TBC1 domain family member 9B","activation of GTPase activity [GO:0090630]","GO:0005096; GO:0005509; GO:0016021; GO:0090630"
"g7328",891.0698,0.1897776,0.05894673,3.219477,0.001284248,0.02341972,95354,100704,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.58e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g15686",873.9875,0.3042743,0.09451706,3.219253,0.00128525,0.02343141,39073,54474,"sp|Q9VT65|CANB_DROME","Q9VT65","CANB",3.1e-20,"Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2]","border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]","GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540"
"g113804",117.1949,0.6047139,0.1878598,3.218963,0.00128655,0.0234485,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111593",307.7072,0.2958724,0.09192177,3.218742,0.001287544,0.02346003,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74595",163.4374,0.2825732,0.08779972,3.218384,0.001289152,0.02348272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6684",1368.705,-0.470189,0.1461219,-3.217786,0.001291842,0.0235251,37675,42622,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.63e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g27068",81.56364,0.2753476,0.08557274,3.217702,0.00129222,0.02352537,18265,37712,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.39e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g272",1167.669,0.3039909,0.09448852,3.217225,0.001294369,0.02353145,65895,81554,"sp|Q92616|GCN1_HUMAN","Q92616","GCN1",1.29e-22,"eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1)","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253"
"g8806",220.1698,0.2271403,0.07059771,3.21739,0.001293627,0.02353145,29645,84080,"sp|Q9VEV4|CL16A_DROME","Q9VEV4","CL16A",5.29e-32,"Protein CLEC16A homolog (Endosomal maturation defective protein)","autophagy [GO:0006914]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; regulation of autophagosome maturation [GO:1901096]","GO:0000139; GO:0000421; GO:0005770; GO:0005794; GO:0006914; GO:0008333; GO:0016021; GO:0016197; GO:0031267; GO:0031902; GO:0036020; GO:1901096"
"g11583",103.6634,0.5133957,0.1595698,3.217373,0.001293703,0.02353145,0,11028,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.24e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22542",510.5247,0.7493886,0.2329248,3.217299,0.001294036,0.02353145,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119235",4236.696,0.8566384,0.266248,3.217445,0.001293377,0.02353145,0,4538,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.66e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g47456",58.46315,-0.3438482,0.1068943,-3.216713,0.001296684,0.02356691,0,18736,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",5.83e-09,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g48351",624.4854,-0.3467563,0.1078225,-3.21599,0.001299952,0.02361348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84772",139.9655,0.7933645,0.2466941,3.215985,0.001299975,0.02361348,0,3889,"sp|O75132|ZBED4_HUMAN","O75132","ZBED4",2.65e-16,"Zinc finger BED domain-containing protein 4","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983"
"g100741",224.9948,-0.6553066,0.2037758,-3.215822,0.001300715,0.02361406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126811",22.59176,0.5169779,0.1607609,3.215817,0.001300736,0.02361406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45290",318.4617,0.5386661,0.1675267,3.215405,0.001302606,0.02364138,14966,16744,"sp|A1ZA47|ZASP_DROME","A1ZA47","ZASP",1.08e-08,"PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]","GO:0001725; GO:0001952; GO:0003779; GO:0005912; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061"
"g47464",2199.122,-0.3029512,0.09422714,-3.215116,0.001303919,0.0236576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145314",2953.567,1.094479,0.3404238,3.215047,0.00130423,0.0236576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134388",136.2752,0.7362683,0.2290219,3.214838,0.001305181,0.02366824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134898",1343.242,0.4403699,0.1369852,3.214726,0.001305693,0.02367089,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141070",33.34649,-0.6631244,0.2063251,-3.213979,0.001309094,0.023722,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155655",85.31044,0.7544278,0.2347357,3.213946,0.001309244,0.023722,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107992",52.28984,-0.3321963,0.1033712,-3.213627,0.0013107,0.02374173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29039",35.58356,-1.040143,0.3236973,-3.21332,0.001312101,0.02376047,28525,31639,"sp|P11369|LORF2_MOUSE","P11369","LORF2",8.09e-27,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g7892",288.8752,-0.5552823,0.1728292,-3.212895,0.001314041,0.02377566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47553",46.38754,0.3556949,0.1107072,3.212934,0.001313867,0.02377566,0,4794,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.48e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g126988",3720.532,0.363243,0.1130565,3.212934,0.001313863,0.02377566,0,2977,"sp|Q8JGS9|RS18_DANRE","Q8JGS9","RS18",2.14e-14,"40S ribosomal protein S18","regulation of cell cycle [GO:0051726]; translation [GO:0006412]","GO:0003735; GO:0005829; GO:0006412; GO:0015935; GO:0019843; GO:0051726"
"g3975",493.2402,-0.5581283,0.1737371,-3.212488,0.001315906,0.02380275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86394",32.05271,1.041639,0.3242785,3.212173,0.001317348,0.02382106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162688",110.3294,0.4022509,0.1252296,3.212107,0.001317653,0.02382106,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58304",48.41303,0.9757509,0.3038109,3.211705,0.001319499,0.02384778,0,13992,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.4e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18210",2158.143,-0.378575,0.1178815,-3.211486,0.001320502,0.02385925,38396,53604,"sp|Q8MQW8|SPRI_DROME","Q8MQW8","SPRI",3.3e-16,"Protein sprint (SH2 poly-proline-containing Ras-interactor protein)","axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]","GO:0005085; GO:0005096; GO:0005829; GO:0005938; GO:0007165; GO:0016192; GO:0019901; GO:0030139; GO:0030971; GO:0031267; GO:0032483; GO:0048260; GO:0048675; GO:1903688"
"g1731",1885.213,0.262612,0.08177777,3.211289,0.001321411,0.02386903,121635,134847,"sp|Q7PVF6|COPG_ANOGA","Q7PVF6","COPG",1.91e-27,"Coatomer subunit gamma (Gamma-coat protein) (Gamma-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]","GO:0000139; GO:0005198; GO:0005783; GO:0005793; GO:0006886; GO:0006888; GO:0006891; GO:0009306; GO:0030126; GO:0072384"
"g15055",135.1969,-0.3540376,0.1102557,-3.21106,0.001322461,0.02387838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155274",24.50821,-0.8143202,0.253602,-3.211016,0.001322666,0.02387838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18984",243.3165,0.3974993,0.1237967,3.210902,0.001323189,0.02388117,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32097",489.7074,-0.3800336,0.1183811,-3.210256,0.001326169,0.02392828,0,17842,"sp|Q9ESJ0|XPO4_MOUSE","Q9ESJ0","XPO4",1.4e-08,"Exportin-4 (Exp4)","positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]","GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827"
"g134418",459.3642,0.3374207,0.1051205,3.209847,0.001328055,0.02395564,1785,3152,"sp|P67777|PP2AA_RABIT","P67777","PP2AA",4.81e-60,"Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)","meiotic cell cycle [GO:0051321]; protein dephosphorylation [GO:0006470]","GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005737; GO:0006470; GO:0045121; GO:0046872; GO:0046982; GO:0051321"
"g5037",1263.067,-0.2448342,0.07628931,-3.209286,0.001330652,0.02395579,10335,37240,"sp|Q01484|ANK2_HUMAN","Q01484","ANK2",4e-22,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"g22902",438.6383,-0.2973433,0.09264477,-3.209499,0.001329664,0.02395579,12698,26954,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.12e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g36863",12283.66,0.2290884,0.07137845,3.20949,0.001329704,0.02395579,8946,10744,"sp|Q5MIP6|TCTP_AEDAL","Q5MIP6","TCTP",1.03e-24,"Translationally-controlled tumor protein homolog (TCTP)",NA,"GO:0005737"
"g70960",30.9363,-0.7618059,0.2373726,-3.209325,0.00133047,0.02395579,0,10700,"sp|O00255|MEN1_HUMAN","O00255","MEN1",3.26e-15,"Menin","brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807"
"g103529",91.88542,0.5172896,0.1611791,3.209408,0.001330087,0.02395579,0,6107,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.49e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g118872",389.7343,0.2038406,0.06350994,3.209586,0.001329263,0.02395579,0,4592,"sp|Q7SXW4|EMC3_DANRE","Q7SXW4","EMC3",2.04e-24,"ER membrane protein complex subunit 3 (Protein pob) (Transmembrane protein 111)","photoreceptor cell maintenance [GO:0045494]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; retina development in camera-type eye [GO:0060041]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0005794; GO:0016021; GO:0030140; GO:0030176; GO:0045050; GO:0045494; GO:0060041; GO:0071816; GO:0072546"
"g128576",54.20011,0.3032246,0.09447624,3.209533,0.001329509,0.02395579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32006",94.82244,-0.3113936,0.09704342,-3.208806,0.001332872,0.02398244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58505",1671.09,-0.3849813,0.1199742,-3.208867,0.001332593,0.02398244,0,12095,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.78e-26,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20585",1768.275,-0.340536,0.1061376,-3.208438,0.001334582,0.02400654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95884",453.6662,-0.58306,0.181749,-3.20805,0.001336385,0.0240323,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61013",33.93547,0.457569,0.1426391,3.207879,0.001337178,0.0240399,0,4352,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.01e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g221",485.2746,-0.2163313,0.06744179,-3.207674,0.001338131,0.02404368,69320,77714,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.28e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g143008",19.67434,0.5883536,0.1834202,3.207681,0.001338097,0.02404368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21304",227.9664,0.300395,0.09365578,3.207437,0.001339234,0.02405683,37099,49105,"sp|P21328|RTJK_DROME","P21328","RTJK",3.79e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15112",71.60564,1.381691,0.4308197,3.20712,0.001340711,0.02407001,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17337",29.96864,0.6296723,0.1963336,3.207154,0.00134055,0.02407001,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22397",42.6709,0.8778257,0.2737376,3.206815,0.001342133,0.0240822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49033",33.88231,0.7004078,0.2184106,3.206841,0.001342013,0.0240822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38677",2322.611,-0.2397884,0.07477884,-3.206634,0.001342975,0.02409064,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58864",1366.671,-0.3670786,0.1144777,-3.206553,0.001343358,0.02409069,1875,13801,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.68e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84238",26.98735,-0.9043648,0.2820433,-3.206475,0.001343721,0.02409069,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102780",1649.188,-0.4581103,0.1428774,-3.206318,0.001344455,0.02409717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13715",23.87685,0.619283,0.1931597,3.206068,0.001345624,0.02410876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65067",324.537,0.4001749,0.1248199,3.20602,0.001345846,0.02410876,0,10444,"sp|Q21832|RBM8A_CAEEL","Q21832","RBM8A",5.56e-19,"RNA-binding protein rnp-4 (RNA-binding protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein rnp-4)","embryonic morphogenesis [GO:0048598]; feminization of hermaphroditic germ-line [GO:0040022]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear mRNA surveillance [GO:0071028]; positive regulation of oogenesis [GO:1905881]; RNA splicing [GO:0008380]","GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0030620; GO:0035145; GO:0036002; GO:0040022; GO:0048598; GO:0051028; GO:0071028; GO:1905881"
"g32170",108.2362,0.505736,0.1577596,3.205739,0.001347162,0.02411941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34201",201.7638,-0.2830564,0.08829934,-3.205646,0.001347597,0.02411941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36919",138.2634,0.3646071,0.1137391,3.205645,0.0013476,0.02411941,0,24395,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.81e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g131425",75.99534,1.157227,0.3610135,3.205495,0.001348302,0.02411941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143170",30.78538,0.6268767,0.1955621,3.205513,0.001348219,0.02411941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12632",396.9808,-0.4580945,0.1429359,-3.204895,0.001351119,0.02415078,6665,9330,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.87e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g55409",9371.033,-0.2659812,0.0829909,-3.204945,0.001350885,0.02415078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60469",254.9627,0.3731522,0.1164324,3.204883,0.001351173,0.02415078,3297,5864,"sp|A9URZ4|PESC_MONBE","A9URZ4","PESC",2.7e-16,"Pescadillo homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g33293",313.4725,0.3576402,0.1116003,3.204652,0.001352258,0.02415908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93637",51.68756,-0.4860993,0.1516868,-3.204625,0.001352384,0.02415908,0,6744,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.59e-32,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g5463",361.9735,-0.598001,0.1866329,-3.204156,0.001354589,0.0241918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22587",18.58088,0.7844046,0.2448575,3.203515,0.001357611,0.02420874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40748",32.14588,0.6033372,0.1883329,3.203567,0.001357364,0.02420874,2265,22248,"sp|O15943|CADN_DROME","O15943","CADN",1.9e-07,"Neural-cadherin (Cadherin-N) (dN-cadherin)","axonal fasciculation [GO:0007413]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290]","GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016021; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609"
"g70550",86.19808,-0.488402,0.1524461,-3.203767,0.00135642,0.02420874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84506",164.4272,-0.3955511,0.1234673,-3.203691,0.00135678,0.02420874,0,8044,"sp|Q99PG2|OGFR_MOUSE","Q99PG2","OGFR",7.17e-10,"Opioid growth factor receptor (OGFr) (Zeta-type opioid receptor)","regulation of growth [GO:0040008]","GO:0005634; GO:0005737; GO:0016020; GO:0040008; GO:0140625"
"g91849",505.975,1.89414,0.5912747,3.203486,0.001357746,0.02420874,0,1650,"sp|P80067|CATC_RAT","P80067","CATC",3.7e-11,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g103468",17.5565,-0.5299707,0.165436,-3.203479,0.001357779,0.02420874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8446",39.92936,-0.5708867,0.1782166,-3.203331,0.001358478,0.02421086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121809",52.78178,0.4872964,0.1521235,3.203296,0.001358645,0.02421086,0,3531,"sp|Q03278|PO21_NASVI","Q03278","PO21",8.54e-11,"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)",NA,"GO:0003964; GO:0004519; GO:0046872"
"g29946",107.9231,0.5036332,0.1572311,3.203139,0.001359381,0.02421732,5992,7690,"sp|P91885|AMPN_MANSE","P91885","AMPN",2.64e-19,"Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn2) (Microsomal aminopeptidase)",NA,"GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225"
"g99399",45.99795,-0.479783,0.1498039,-3.202741,0.001361263,0.02424418,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83054",112.1162,0.4119515,0.1286358,3.202464,0.001362572,0.02426082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g899",264.0466,-0.3617191,0.1129674,-3.201978,0.001364874,0.02429513,61835,78395,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.49e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g14966",43.88175,0.5053402,0.1578372,3.201654,0.00136641,0.02430285,3007,17414,"sp|A7S7F2|BYST_NEMVE","A7S7F2","BYST",2.31e-25,"Bystin","rRNA processing [GO:0006364]","GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688"
"g57168",28.24313,0.5840203,0.1824208,3.2015,0.001367139,0.02430285,4495,14359,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.82e-62,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g112736",27.8047,0.8902317,0.2780723,3.201439,0.001367428,0.02430285,0,3841,"sp|Q8SPU8|DHRS4_BOVIN","Q8SPU8","DHRS4",8.57e-10,"Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (EC 1.1.1.300) (NADPH-dependent carbonyl reductase) (CR) (NADPH-dependent retinol dehydrogenase/reductase) (NDRD) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (Short chain dehydrogenase/reductase family 25C member 2) (Protein SDR25C2)","cellular ketone metabolic process [GO:0042180]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]","GO:0001523; GO:0004090; GO:0005739; GO:0005777; GO:0008202; GO:0042180; GO:0042802; GO:0052650"
"g123127",126.5994,0.3190646,0.09966211,3.201464,0.001367314,0.02430285,0,4207,"sp|Q9GK13|MUTA_BOVIN","Q9GK13","MUTA",5.73e-26,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",NA,"GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0031419; GO:0042802; GO:0042803; GO:0046872"
"g137809",306.6561,-0.4124452,0.1288245,-3.201605,0.001366643,0.02430285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145357",94.27732,-0.408829,0.1277027,-3.201412,0.001367558,0.02430285,0,2400,"sp|O97596|S20A1_FELCA","O97596","S20A1",5.03e-10,"Sodium-dependent phosphate transporter 1 (Feline leukemia virus subtype-B receptor) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1)","phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0005887; GO:0015293; GO:0035435"
"g3205",1927.627,0.5253765,0.1641185,3.201202,0.001368553,0.02431387,13098,15224,"sp|P40614|MPCP_CAEEL","P40614","MPCP",3.93e-08,"Phosphate carrier protein, mitochondrial (PTP)","mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0031305; GO:0035435; GO:1990547"
"g1172",36040.8,0.6057646,0.1892375,3.201081,0.001369131,0.02431747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8795",1159.477,-0.5569616,0.1740239,-3.200489,0.001371946,0.02431943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15635",234.8396,-0.3721603,0.1162799,-3.200555,0.001371632,0.02431943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79115",228.5914,-0.21497,0.06716113,-3.20081,0.001370418,0.02431943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85746",525.9958,0.2842002,0.08879247,3.200724,0.001370829,0.02431943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90463",19.61606,0.7561754,0.2362734,3.200426,0.001372245,0.02431943,2997,7632,"sp|Q3T0V9|DEOC_BOVIN","Q3T0V9","DEOC",3.74e-14,"Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase)","carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]","GO:0004139; GO:0005654; GO:0005737; GO:0009264; GO:0016052; GO:0046121; GO:0046386"
"g138234",274.6112,0.357176,0.1115901,3.200784,0.001370541,0.02431943,0,2983,"sp|Q00725|SGS4_DROME","Q00725","SGS4",1.61e-11,"Salivary glue protein Sgs-4","puparial adhesion [GO:0007594]","GO:0005576; GO:0007594; GO:0062130"
"g148625",28.05282,0.4757643,0.1486494,3.200581,0.001371509,0.02431943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159849",118.0595,0.4118624,0.1286758,3.200776,0.001370582,0.02431943,0,544,"sp|P0C2B8|RM55_BOVIN","P0C2B8","RM55",1.46e-09,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)","translation [GO:0006412]","GO:0003735; GO:0005743; GO:0005762; GO:0006412"
"g4601",84.54494,-0.2847696,0.0889817,-3.200317,0.001372767,0.02432204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132116",180.799,0.3487755,0.1089849,3.200219,0.001373234,0.02432366,1405,3459,"sp|P12646|G6PD_DROME","P12646","G6PD",1.47e-83,"Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) (Zwischenferment)","glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]","GO:0004345; GO:0005829; GO:0006006; GO:0006098; GO:0006739; GO:0009051; GO:0050661; GO:0051156"
"g36397",656.4013,0.3892503,0.1216382,3.200066,0.001373961,0.02432989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8536",3157.559,-0.2076138,0.06488423,-3.199757,0.001375435,0.02434933,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33874",57.81832,-0.4663113,0.1457424,-3.199559,0.001376378,0.02435272,24765,30434,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.62e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g152037",129.8129,-0.5156532,0.1611625,-3.199585,0.001376257,0.02435272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39330",313.5792,0.5375818,0.1680555,3.198835,0.001379843,0.02438892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41884",129.9317,-0.5556805,0.1737187,-3.198738,0.001380306,0.02438892,11215,13132,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.25e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g47196",224.7944,2.141851,0.6695887,3.198757,0.001380216,0.02438892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104999",208.0254,0.4455715,0.1392891,3.198897,0.001379545,0.02438892,0,3612,"sp|Q95SS8|TMM70_DROME","Q95SS8","TMM70",1.53e-12,"Transmembrane protein 70 homolog, mitochondrial","mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]","GO:0032592; GO:0033615"
"g158030",43.68032,1.700484,0.5315787,3.198931,0.001379381,0.02438892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48664",185.6953,0.4491785,0.1404348,3.198483,0.001381525,0.02439249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113402",875.773,0.508372,0.1589427,3.19846,0.001381637,0.02439249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137111",147.5531,0.9751042,0.3048647,3.198482,0.001381533,0.02439249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131859",2914.327,0.3154163,0.09862109,3.198264,0.001382577,0.02440243,0,3114,"sp|P54385|DHE3_DROME","P54385","DHE3",1.17e-21,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g22870",43.4488,0.5686136,0.1777987,3.198076,0.001383479,0.02440687,0,13980,"sp|B2RRL2|JERKL_MOUSE","B2RRL2","JERKL",2.53e-29,"Jerky protein homolog-like",NA,"GO:0003677; GO:0005634"
"g23441",450.2319,-0.3291137,0.1029131,-3.197976,0.001383959,0.02440687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107902",46.07214,0.349215,0.1091969,3.19803,0.0013837,0.02440687,1150,5656,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.07e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3801",82.61459,-0.3785655,0.1183798,-3.19789,0.001384373,0.02440752,14514,17494,"sp|Q2EI20|REST_DANRE","Q2EI20","REST",6.91e-10,"RE1-silencing transcription factor (Neural-restrictive silencer factor)","branchiomotor neuron axon guidance [GO:0021785]; facial nerve morphogenesis [GO:0021610]; facial nucleus development [GO:0021754]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron maturation [GO:0014043]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of neuron differentiation [GO:0045666]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]","GO:0000381; GO:0000977; GO:0000981; GO:0001666; GO:0001764; GO:0005634; GO:0005737; GO:0006357; GO:0007626; GO:0010629; GO:0014043; GO:0021610; GO:0021754; GO:0021785; GO:0042551; GO:0045666; GO:0045667; GO:0045879; GO:0045892; GO:0046872; GO:0060831; GO:0097475"
"g56133",166.353,-0.4594238,0.1436701,-3.197769,0.001384951,0.02441108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136745",591.8089,0.2707564,0.08467556,3.197575,0.001385884,0.02442088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24189",53.99349,0.3412311,0.1067278,3.197209,0.001387645,0.02442712,17219,24334,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.06e-18,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35741",46.5987,0.5749108,0.1798236,3.197082,0.001388254,0.02442712,20243,28436,"sp|Q96FV9|THOC1_HUMAN","Q96FV9","THOC1",1.27e-08,"THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) (p84N5) (hTREX84)","apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]","GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002"
"g42907",804.6859,-0.2083351,0.06516235,-3.19717,0.00138783,0.02442712,0,19021,"sp|Q9W676|LDB2_CHICK","Q9W676","LDB2",5.24e-12,"LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1) (cLdb2)","negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0003712; GO:0005634; GO:0005667; GO:0007399; GO:0030274; GO:0045944"
"g45814",269.076,0.9636704,0.3014272,3.197026,0.001388526,0.02442712,0,19480,"sp|Q13231|CHIT1_HUMAN","Q13231","CHIT1",1.82e-18,"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724"
"g51209",390.9411,-0.5276308,0.1650333,-3.197117,0.001388086,0.02442712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105226",139.9382,0.6335313,0.1981673,3.196953,0.001388877,0.02442712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153748",640.4498,0.9776094,0.3057713,3.197192,0.001387725,0.02442712,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2396",1316.937,0.4109658,0.1285627,3.196617,0.001390496,0.02444895,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100556",173.3778,0.2845013,0.08900779,3.196364,0.001391713,0.02446184,0,6434,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.24e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121277",47.70069,-0.7695996,0.2407819,-3.196252,0.001392256,0.02446184,0,3960,"sp|P21329|RTJK_DROFU","P21329","RTJK",7.44e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g129532",265.1696,0.4528605,0.1416858,3.19623,0.001392361,0.02446184,0,3535,"sp|Q99N87|RT05_MOUSE","Q99N87","RT05",3.71e-12,"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543"
"g34075",93.89292,0.4003775,0.1252735,3.196028,0.001393335,0.02446912,18768,30190,"sp|P21328|RTJK_DROME","P21328","RTJK",3.59e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g137367",31.48492,0.8647213,0.2705647,3.195988,0.001393531,0.02446912,505,3048,"sp|Q86MA7|PRQFV_APLCA","Q86MA7","PRQFV",6.88e-09,"Protein PRQFV-amide [Cleaved into: AREFV-amide; PRQFV-amide (PRQFVa); VRDFV-amide; VREFV-amide; IREFV-amide]","neuropeptide signaling pathway [GO:0007218]","GO:0005576; GO:0007218"
"g17854",1679.922,-0.3490951,0.1092327,-3.195885,0.001394024,0.02447115,9985,26088,"sp|Q6P1C6|LRIG3_MOUSE","Q6P1C6","LRIG3",2.13e-08,"Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)","otolith morphogenesis [GO:0032474]","GO:0005886; GO:0016021; GO:0030659; GO:0032474"
"g148734",50.87136,0.4468314,0.1398391,3.195325,0.001396735,0.02451209,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118136",139.2954,0.6244176,0.1954523,3.194732,0.001399609,0.02455588,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26353",107.8567,0.3149704,0.09859934,3.194447,0.001400991,0.02456682,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143693",129.1702,1.958542,0.6130958,3.194512,0.001400672,0.02456682,0,2054,"sp|P91885|AMPN_MANSE","P91885","AMPN",7.97e-20,"Aminopeptidase N (AP-N) (EC 3.4.11.2) (Apn2) (Microsomal aminopeptidase)",NA,"GO:0004177; GO:0005886; GO:0008237; GO:0008270; GO:0031225"
"g10906",1528.351,0.4132983,0.1293932,3.194126,0.00140255,0.02458085,40406,62154,"sp|Q02253|MMSA_RAT","Q02253","MMSA",1.33e-34,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0016790; GO:0018478; GO:0019484; GO:0019859; GO:0050873; GO:0102662"
"g26418",194.1778,0.9543195,0.2987696,3.194165,0.001402357,0.02458085,468,8194,"sp|Q13231|CHIT1_HUMAN","Q13231","CHIT1",2.05e-11,"Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)","chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]","GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724"
"g99607",116.0227,0.5334126,0.1670024,3.194041,0.001402961,0.0245814,0,1314,"sp|Q90744|NAGAB_CHICK","Q90744","NAGAB",4.73e-23,"Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)","glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311]","GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016139; GO:0046477"
"g99684",136.9828,1.370668,0.429149,3.19392,0.001403548,0.02458505,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137063",1975.193,1.427775,0.4470522,3.193754,0.001404356,0.02458772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142680",95.84015,0.3953379,0.1237855,3.193733,0.001404459,0.02458772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14576",38.6629,-0.4331414,0.1356337,-3.193464,0.001405766,0.02460395,0,16644,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.66e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g4394",430.242,0.3039312,0.09519435,3.192744,0.001409278,0.02463644,19905,28902,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.04e-40,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g8848",609.3897,-0.2472494,0.07744154,-3.192723,0.001409379,0.02463644,717,3704,"sp|Q7L3S4|ZN771_HUMAN","Q7L3S4","ZN771",2.19e-14,"Zinc finger protein 771 (Mesenchymal stem cell protein DSC43)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0046872; GO:1990837"
"g96630",155.8814,1.827942,0.572553,3.192616,0.001409904,0.02463644,0,6885,"sp|Q9UB00|GLCM4_CAEEL","Q9UB00","GLCM4",9.25e-08,"Putative glucosylceramidase 4 (EC 3.2.1.45)","glucosylceramide catabolic process [GO:0006680]","GO:0004348; GO:0006680"
"g116549",297.3528,-0.199342,0.06243468,-3.192809,0.001408959,0.02463644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128273",287.4812,0.4451701,0.1394295,3.192796,0.001409024,0.02463644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158874",83.22646,0.9106858,0.2852416,3.192683,0.001409578,0.02463644,0,1241,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",7.48e-16,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g92969",54.24991,0.9950556,0.3117189,3.192157,0.001412145,0.02466894,2805,6080,"sp|Q00796|DHSO_HUMAN","Q00796","DHSO",4.9e-11,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)","flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; L-xylitol catabolic process [GO:0051160]; L-xylitol metabolic process [GO:0051164]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; response to xenobiotic stimulus [GO:0009410]; sorbitol catabolic process [GO:0006062]","GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0006970; GO:0008270; GO:0009410; GO:0009725; GO:0016020; GO:0030246; GO:0030317; GO:0031514; GO:0031667; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0046686; GO:0046688; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062"
"g154993",51.97218,0.6247455,0.1957322,3.191838,0.001413708,0.02468958,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15799",172.2826,-0.3027324,0.09486458,-3.191206,0.001416802,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16276",50.26328,0.7499503,0.2349985,3.191298,0.001416352,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23067",1570.626,-0.3358527,0.1052476,-3.191073,0.001417455,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43949",18.16551,-0.6618042,0.2073715,-3.191395,0.001415878,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66640",266.3088,-0.6889494,0.2158618,-3.191623,0.00141476,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76940",222.4769,0.3334145,0.1044813,3.19114,0.001417125,0.0246984,6485,9198,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.88e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g93930",73.93105,2.130732,0.6676468,3.191406,0.001415821,0.0246984,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121551",123.1174,0.4159096,0.1303369,3.191035,0.001417643,0.0246984,0,4350,"sp|Q9CQN1|TRAP1_MOUSE","Q9CQN1","TRAP1",1.59e-23,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)","negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]","GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016887; GO:0019901; GO:0051082; GO:0071944; GO:1901856; GO:1903751"
"g150117",111.2215,0.6524447,0.2044464,3.191275,0.001416464,0.0246984,0,1975,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.14e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g114807",110.1412,0.5076442,0.1590915,3.190894,0.001418332,0.02470376,0,4979,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.61e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13134",81.34231,-0.4285155,0.134297,-3.190805,0.001418772,0.02470478,47,4164,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.23e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g48132",317.8263,0.2446517,0.07667767,3.190651,0.001419525,0.02471125,11116,14874,"sp|Q2TJ56|VATA_AEDAL","Q2TJ56","VATA",3.77e-21,"V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)",NA,"GO:0005524; GO:0033180; GO:0046933; GO:0046961"
"g4765",170.6402,-0.4121023,0.1291641,-3.190534,0.001420103,0.02471467,51608,53974,"sp|O02751|CFDP2_BOVIN","O02751","CFDP2",2.16e-07,"Craniofacial development protein 2 (p97 bucentaur protein)","chromatin remodeling [GO:0006338]","GO:0003824; GO:0005634; GO:0005737; GO:0006338"
"g147888",60.47895,0.3465616,0.108631,3.190264,0.001421429,0.0247311,0,2172,"sp|Q9VT41|INT7_DROME","Q9VT41","INT7",8.21e-07,"Integrator complex subunit 7 (Protein deflated)","snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0005634; GO:0005737; GO:0016180; GO:0032039; GO:0034472"
"g23932",946.0187,0.6356074,0.1992604,3.189833,0.001423548,0.0247547,28766,40034,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",1.46e-13,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g46692",19.87086,-0.7615143,0.2387491,-3.189601,0.001424695,0.0247547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73777",44.62182,0.4764362,0.149369,3.18966,0.001424401,0.0247547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111473",94.75275,0.4471567,0.1401883,3.189685,0.001424278,0.0247547,0,5298,"sp|Q55DA6|BUD23_DICDI","Q55DA6","BUD23",1.41e-18,"Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog)","rRNA (guanine-N7)-methylation [GO:0070476]","GO:0005654; GO:0005730; GO:0016435; GO:0048471; GO:0070476"
"g146845",67.67551,-0.8784351,0.2753905,-3.189779,0.001423814,0.0247547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40660",327.8012,-0.2993699,0.0938656,-3.189346,0.00142595,0.02476986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98375",35.78706,1.100081,0.3449379,3.189214,0.001426603,0.02477455,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155784",97.55589,-0.4491015,0.140845,-3.188622,0.001429527,0.02481869,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44026",4893.659,-0.2490639,0.0781138,-3.188475,0.001430255,0.02482468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85224",165.4399,0.6773412,0.2124468,3.188285,0.001431192,0.02483429,2465,6390,"sp|P49735|MCM2_DROME","P49735","MCM2",2.37e-06,"DNA replication licensing factor Mcm2 (Minichromosome maintenance 2 protein) (DmMCM2)","cell division [GO:0051301]; chromosome condensation [GO:0030261]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006268; GO:0016887; GO:0030174; GO:0030261; GO:0042555; GO:0046872; GO:0051301; GO:0071162; GO:1902975; GO:1905775"
"g7635",2522.143,-0.206581,0.06479779,-3.188087,0.001432175,0.02483805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22518",424.383,-0.3901658,0.1223815,-3.188112,0.001432051,0.02483805,9255,21925,"sp|P21328|RTJK_DROME","P21328","RTJK",1.03e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g121726",202.3088,0.4724314,0.1481991,3.187816,0.001433519,0.02484141,0,4333,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.06e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g133124",487.722,0.530803,0.1665026,3.187957,0.001432819,0.02484141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139997",78.14938,0.4721155,0.1480967,3.187888,0.001433162,0.02484141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19985",30.62427,0.8255824,0.2590046,3.18752,0.001434983,0.02486013,43169,49614,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.34e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119056",55.36031,0.7788218,0.24435,3.187321,0.001435971,0.02486395,0,4575,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.3e-17,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g124960",30.68181,0.6788148,0.2129708,3.187361,0.001435775,0.02486395,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37250",19.24718,0.4687104,0.1470702,3.186985,0.001437642,0.02487957,0,26900,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.68e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g66155",1595.179,0.1619892,0.0508273,3.187051,0.001437317,0.02487957,2310,11795,"sp|P07207|NOTCH_DROME","P07207","NOTCH",0,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral axis specification [GO:0009950]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016021; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"g38676",419.2254,-0.7064494,0.2217196,-3.186229,0.001441407,0.02493141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54899",105.9075,-0.5517574,0.1731674,-3.186266,0.001441223,0.02493141,6651,10374,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.27e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g96060",30.64313,-0.4174947,0.1310347,-3.186139,0.001441852,0.02493246,586,6954,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.01e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g31346",538.5921,-0.3776094,0.1185192,-3.186061,0.001442243,0.02493256,21245,27714,"sp|O75437|ZN254_HUMAN","O75437","ZN254",1.95e-60,"Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)","negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g30856",201.1703,0.4129543,0.129629,3.185664,0.001444223,0.02495795,2461,12754,"sp|P52899|ODPA_CAEEL","P52899","ODPA",5.43e-32,"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096"
"g31141",1729.028,-0.293809,0.09223363,-3.185486,0.001445109,0.02495795,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95438",208.877,0.465887,0.1462543,3.185458,0.001445252,0.02495795,1918,6064,"sp|P21328|RTJK_DROME","P21328","RTJK",1.1e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g135176",9584.371,0.5601899,0.1758562,3.1855,0.001445043,0.02495795,804,3114,"sp|P49871|ACT_MANSE","P49871","ACT",0,"Actin, muscle",NA,"GO:0005524; GO:0005737; GO:0005856"
"g120939",37.66911,0.9409689,0.2954061,3.18534,0.001445842,0.02496148,0,4408,"sp|P07742|RIR1_MOUSE","P07742","RIR1",1.03e-27,"Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)","2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]","GO:0000731; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005971; GO:0006264; GO:0006281; GO:0009185; GO:0009263; GO:0009265; GO:0010971; GO:0017076; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0061731; GO:0070318; GO:0097718; GO:1900087"
"g95519",23.72087,0.521527,0.1637377,3.185136,0.001446859,0.02497239,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g829",4168.413,-0.1821038,0.05717864,-3.184822,0.001448429,0.02497907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g945",300.0331,0.2276258,0.07147538,3.184674,0.001449174,0.02497907,55990,61154,"sp|P21328|RTJK_DROME","P21328","RTJK",1.13e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g76118",229.6713,0.8106972,0.2545498,3.184828,0.001448402,0.02497907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87801",169.4926,0.3478458,0.1092216,3.18477,0.00144869,0.02497907,3778,7224,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.81e-09,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g135349",1522.76,0.4797613,0.1506449,3.184716,0.00144896,0.02497907,352,3203,"sp|Q24439|ATPO_DROME","Q24439","ATPO",2.25e-17,"ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)","ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000274; GO:0005739; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600"
"g16983",1519.59,-0.274485,0.08620421,-3.184126,0.00145192,0.02501974,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19950",7909.195,-0.3499152,0.1099012,-3.183907,0.001453015,0.02503197,22275,34142,"sp|Q9VVE5|MSIR6_DROME","Q9VVE5","MSIR6",5.82e-21,"RNA-binding protein Musashi homolog Rbp6","stem cell development [GO:0048864]","GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864"
"g44073",2547.968,0.2089859,0.0656459,3.183534,0.001454892,0.02505763,11251,21055,"sp|Q8STF0|CALM_STRIE","Q8STF0","CALM",1.53e-22,"Calmodulin (CaM)","calcium-mediated signaling [GO:0019722]","GO:0005509; GO:0019722"
"g1599",109.8977,0.3639364,0.1143227,3.183414,0.001455495,0.02506135,45156,48894,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.27e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22789",505.2724,-0.2503256,0.07864161,-3.183119,0.001456976,0.02506687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26301",86.04769,0.317467,0.09973428,3.183128,0.001456931,0.02506687,0,7014,"sp|Q9JHR7|IDE_MOUSE","Q9JHR7","IDE",4.89e-24,"Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; response to oxidative stress [GO:0006979]; ubiquitin recycling [GO:0010992]","GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006979; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"g103898",431.5778,0.3127277,0.09824325,3.183198,0.001456581,0.02506687,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45918",513.9339,-0.3233402,0.1015937,-3.182678,0.001459196,0.02509841,0,12193,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.56e-90,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g23484",474.9435,-0.3202983,0.1006444,-3.182474,0.001460228,0.02510533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33776",23.02657,0.5469566,0.1718733,3.182325,0.001460977,0.02510533,26266,30515,"sp|O94761|RECQ4_HUMAN","O94761","RECQ4",0,"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)","DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]","GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0032508; GO:0043138; GO:0061820; GO:0061821; GO:1990814"
"g36186",112.7835,-0.5148014,0.1617796,-3.182116,0.001462034,0.02510533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36533",84.7302,-0.6175796,0.1940688,-3.182272,0.001461246,0.02510533,4109,17324,"sp|A6NP11|ZN716_HUMAN","A6NP11","ZN716",4.85e-45,"Zinc finger protein 716","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g46710",516.9135,-0.4619885,0.1451694,-3.18241,0.001460549,0.02510533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56088",618.8267,-0.4218619,0.132575,-3.182061,0.001462311,0.02510533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67890",1021.4,-0.3354567,0.105418,-3.182158,0.001461819,0.02510533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9858",277.1301,0.5071964,0.1594208,3.181496,0.001465167,0.0251477,74055,82419,"sp|Q16P20|CISY2_AEDAE","Q16P20","CISY2",6.6e-27,"Probable citrate synthase 2, mitochondrial (EC 2.3.3.16)","carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]","GO:0004108; GO:0005759; GO:0005975; GO:0006099; GO:0006101"
"g49151",42.76143,-0.4662278,0.1465509,-3.181337,0.001465971,0.02515484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1109",48.83196,0.3567962,0.1121821,3.18051,0.001470158,0.02521262,160601,163814,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.84e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19607",1422.75,0.3258497,0.1024542,3.180442,0.001470506,0.02521262,0,8244,"sp|Q5ZM14|NHRF1_CHICK","Q5ZM14","NHRF1",1.68e-18,"Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)","bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; protein localization to plasma membrane [GO:0072659]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; Wnt signaling pathway [GO:0016055]","GO:0001726; GO:0005102; GO:0005737; GO:0005902; GO:0010642; GO:0012505; GO:0014067; GO:0016055; GO:0016324; GO:0017081; GO:0030175; GO:0031528; GO:0032782; GO:0034635; GO:0043495; GO:0045859; GO:0051898; GO:0070293; GO:0071944; GO:0072659; GO:2000146"
"g154487",33.66211,1.137203,0.3575476,3.180564,0.001469884,0.02521262,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2860",260.382,0.35569,0.1118565,3.179878,0.001473369,0.02525387,0,4319,"sp|P23927|CRYAB_MOUSE","P23927","CRYAB",1.31e-07,"Alpha-crystallin B chain (Alpha(B)-crystallin) (P23)","apoptotic process involved in morphogenesis [GO:0060561]; camera-type eye development [GO:0043010]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021]","GO:0001540; GO:0001666; GO:0002088; GO:0005198; GO:0005212; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006457; GO:0007021; GO:0007517; GO:0008017; GO:0008092; GO:0009986; GO:0010259; GO:0010629; GO:0010941; GO:0014069; GO:0015630; GO:0030018; GO:0030308; GO:0030424; GO:0031109; GO:0031333; GO:0031430; GO:0031674; GO:0032355; GO:0032387; GO:0032432; GO:0032991; GO:0042542; GO:0042802; GO:0042803; GO:0043010; GO:0043066; GO:0043154; GO:0043197; GO:0043204; GO:0043209; GO:0043292; GO:0044877; GO:0045202; GO:0045892; GO:0046872; GO:0050821; GO:0051082; GO:0051403; GO:0060561; GO:0071480; GO:0097060; GO:0097512; GO:1905907; GO:2000378"
"g13216",5664.509,-0.6067769,0.1908214,-3.179815,0.001473691,0.02525387,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136188",54.81291,-0.6811757,0.214243,-3.179453,0.001475531,0.0252787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17399",549.4419,1.295408,0.4074427,3.179364,0.001475988,0.02527986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52415",912.3183,-0.2270058,0.07140214,-3.179257,0.001476532,0.02528249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38506",208.8612,0.2715164,0.08540663,3.179102,0.001477322,0.02528934,415,22128,"sp|Q6NRJ7|MCS1B_XENLA","Q6NRJ7","MCS1B",5.46e-40,"Malignant T-cell-amplified sequence 1-B (MCT-1B)","cell cycle [GO:0007049]; regulation of growth [GO:0040008]","GO:0003723; GO:0005737; GO:0007049; GO:0040008"
"g1490",240.1435,-0.3501287,0.1101467,-3.178749,0.00147912,0.0253002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27337",1363.633,-0.4102101,0.1290539,-3.178595,0.001479909,0.0253002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28417",8698.275,-0.3485264,0.109647,-3.178622,0.001479768,0.0253002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116297",994.5625,0.3523178,0.1108378,3.17868,0.001479472,0.0253002,0,2556,"sp|P26443|DHE3_MOUSE","P26443","DHE3",8.12e-13,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)","cerebellum development [GO:0021549]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005783; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0043531; GO:0070403; GO:0070728; GO:0072350"
"g154204",45675.8,0.5498836,0.1729917,3.17867,0.001479524,0.0253002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63673",33.29398,-0.5007723,0.157563,-3.178236,0.00148174,0.0253048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81576",76.71286,0.3429389,0.1078971,3.178388,0.001480962,0.0253048,0,6654,"sp|Q9UI36|DACH1_HUMAN","Q9UI36","DACH1",1.68e-40,"Dachshund homolog 1 (Dach1)","cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0008283; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279"
"g130030",25.82297,0.547028,0.1721164,3.178244,0.001481701,0.0253048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155668",18.8612,0.7039874,0.2214907,3.178406,0.001480875,0.0253048,0,888,"sp|Q9XZU1|XPO2_DROME","Q9XZU1","XPO2",2.11e-09,"Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein homolog) (Chromosome segregation protein 1) (Importin-alpha re-exporter)","protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]","GO:0005049; GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006611; GO:0031267"
"g26940",209.8448,0.2281919,0.07181161,3.177647,0.001484754,0.02534896,0,27364,"sp|Q9NVH2|INT7_HUMAN","Q9NVH2","INT7",9.43e-16,"Integrator complex subunit 7 (Int7)","cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0071479"
"g36347",170.1597,-1.041645,0.3278348,-3.177349,0.001486283,0.02534896,1545,25973,"sp|P18173|DHGL_DROME","P18173","DHGL",1.55e-13,"Glucose dehydrogenase [FAD, quinone] (EC 1.1.5.9) [Cleaved into: Glucose dehydrogenase [FAD, quinone] short protein]","glucose metabolic process [GO:0006006]; pupal chitin-based cuticle development [GO:0008364]; sperm storage [GO:0046693]","GO:0005576; GO:0006006; GO:0008364; GO:0016491; GO:0016614; GO:0046693; GO:0050660"
"g47779",108.2079,0.2739174,0.08620439,3.177534,0.001485333,0.02534896,8685,18304,"sp|Q6A0A9|F120A_MOUSE","Q6A0A9","F120A",2.73e-11,"Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)",NA,"GO:0003723; GO:0005634; GO:0005829; GO:0005886"
"g54159",252.6338,-0.4412152,0.1388619,-3.177367,0.001486187,0.02534896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159744",28.24646,0.9766213,0.3073557,3.177496,0.001485529,0.02534896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81487",112.2382,1.281192,0.4032532,3.177141,0.001487346,0.02536042,0,8274,"sp|P21328|RTJK_DROME","P21328","RTJK",1.41e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g40856",3045.627,-0.3775345,0.1188364,-3.176928,0.001488442,0.02536391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79934",20.6363,1.4358,0.4519539,3.176873,0.001488725,0.02536391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129080",999.0678,0.3688284,0.1160954,3.176943,0.001488363,0.02536391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77593",35.12286,-0.4322656,0.1360824,-3.176498,0.001490651,0.02538529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158048",114.0331,0.6499331,0.2046082,3.176476,0.001490763,0.02538529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17261",59.89169,-0.5389884,0.169704,-3.17605,0.001492953,0.02540601,41435,47299,"sp|P03360|POL_AVIRE","P03360","POL",1.28e-15,"Gag-Pol polyprotein [Cleaved into: Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)] (Fragment)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0046872; GO:0075713"
"g53567",17.55292,0.6692896,0.2107238,3.176146,0.00149246,0.02540601,10615,14647,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g92689",53.10793,1.602002,0.5044071,3.17601,0.001493156,0.02540601,0,6631,"sp|Q8CHN6|SGPL1_RAT","Q8CHN6","SGPL1",2.81e-15,"Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0006807; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016021; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190"
"g15531",394.5414,-0.4435584,0.1396752,-3.175642,0.001495056,0.02543165,37522,43354,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.76e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g16506",482.4787,-0.2986806,0.09405684,-3.175533,0.001495613,0.02543445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37454",116.8456,-0.3112441,0.0980162,-3.175435,0.001496119,0.02543638,0,19514,"sp|Q8MLZ5|GAP2_CAEEL","Q8MLZ5","GAP2",3.33e-11,"Ras GTPase-activating protein gap-2 (GTPase-activating protein 2)","associative learning [GO:0008306]; long-term memory [GO:0007616]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; short-term memory [GO:0007614]; signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0007165; GO:0007614; GO:0007616; GO:0008306; GO:0043087; GO:0046580"
"g107728",129.1288,0.7977718,0.2512394,3.175345,0.001496584,0.02543761,0,4851,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.33e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g9304",1790.851,-0.2986091,0.09404648,-3.175123,0.001497732,0.02545045,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79138",481.8554,1.235079,0.3890496,3.174606,0.0015004,0.02548242,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142089",23.67683,1.679879,0.5291597,3.174617,0.001500344,0.02548242,0,2678,"sp|B1AVD1|XPP2_MOUSE","B1AVD1","XPP2",5.57e-10,"Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (mAPP) (X-prolyl aminopeptidase 2)",NA,"GO:0005886; GO:0031225; GO:0046872; GO:0070006; GO:0070062"
"g48131",323.7651,0.2411198,0.07595836,3.174369,0.001501629,0.02549508,7475,11096,"sp|Q27331|VATA2_DROME","Q27331","VATA2",5.71e-36,"V-type proton ATPase catalytic subunit A isoform 2 (V-ATPase subunit A 2) (EC 7.1.2.2) (V-ATPase 69 kDa subunit 2) (Vacuolar proton pump subunit alpha 2)","endosomal lumen acidification [GO:0048388]; endosomal transport [GO:0016197]; imaginal disc growth [GO:0007446]; lumen formation, open tracheal system [GO:0035149]; proton transmembrane transport [GO:1902600]","GO:0000221; GO:0005524; GO:0005886; GO:0007446; GO:0016197; GO:0033181; GO:0035149; GO:0046933; GO:0046961; GO:0048388; GO:1902600"
"g111698",23.1977,1.689751,0.5323207,3.17431,0.001501933,0.02549508,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42414",276.3636,0.2891358,0.09109084,3.174148,0.001502772,0.02549526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77706",51.19259,-0.6600502,0.2079437,-3.174177,0.001502619,0.02549526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161895",27.01144,0.6430581,0.2025967,3.17408,0.001503123,0.02549526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127766",2472.498,0.2121378,0.06683612,3.174,0.001503539,0.02549563,0,3808,"sp|P29693|EF1D_XENLA","P29693","EF1D",1.98e-25,"Elongation factor 1-delta (EF-1-delta) (P36)",NA,"GO:0003746; GO:0005853"
"g8875",436.6626,0.608634,0.1917656,3.173843,0.001504349,0.02550269,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74678",213.2311,0.282165,0.08891566,3.173401,0.001506644,0.02553491,6373,9984,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.25e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85761",285.5965,0.3410082,0.1074616,3.173302,0.001507157,0.02553693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g436",500.9175,0.2449886,0.07720897,3.173058,0.001508422,0.02553833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70940",1702.048,-0.3504187,0.1104308,-3.173197,0.001507703,0.02553833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79363",2179.668,-0.736101,0.2319843,-3.173064,0.001508394,0.02553833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28255",24.95484,1.51367,0.4770734,3.172825,0.001509637,0.02555222,28044,33514,"sp|P04069|CBPB_ASTAS","P04069","CBPB",2.75e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g158631",43.15788,0.4340492,0.1368062,3.17273,0.001510131,0.02555391,0,934,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.14e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g10146",1614.97,-0.3095605,0.09758158,-3.172326,0.001512233,0.0255828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128024",161.5527,1.421958,0.4482727,3.172082,0.001513501,0.02559757,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99341",380.4247,-0.4042565,0.1274453,-3.172,0.001513931,0.02559816,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4112",293.4966,-0.5617886,0.1771225,-3.171751,0.001515228,0.02560037,17866,27244,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-17,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13413",633.8005,-0.4441052,0.1400134,-3.171877,0.00151457,0.02560037,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76585",117.8271,0.5528367,0.1743026,3.171707,0.00151546,0.02560037,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155988",65.73735,0.3925333,0.1237623,3.171672,0.001515642,0.02560037,0,1484,"sp|Q5XJQ5|EXOS9_DANRE","Q5XJQ5","EXOS9",1.26e-08,"Exosome complex component RRP45 (Exosome component 9)","exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]","GO:0000176; GO:0000177; GO:0000467; GO:0003723; GO:0005654; GO:0005730; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042"
"g12087",150.8798,-0.2760066,0.0870273,-3.171495,0.001516566,0.02560929,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4104",1116.187,-0.3851273,0.121439,-3.171364,0.00151725,0.02561416,63505,104106,"sp|Q17031|CDC42_ANOGA","Q17031","CDC42",3.64e-13,"Cdc42 homolog (25 kDa GTP-binding protein)","Cdc42 protein signal transduction [GO:0032488]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; endocytosis [GO:0006897]","GO:0003924; GO:0005525; GO:0005886; GO:0005912; GO:0006897; GO:0016477; GO:0030031; GO:0032488"
"g67034",40.50274,0.4167261,0.1314129,3.17112,0.001518522,0.02562896,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45059",1199.531,-0.3186369,0.1004924,-3.170754,0.001520436,0.0256479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107678",863.784,0.2625904,0.0828152,3.170799,0.001520202,0.0256479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12433",27.52054,0.5998131,0.1891942,3.170357,0.001522516,0.02567632,19335,22484,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",7.89e-72,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g55089",540.0351,0.9933597,0.3133479,3.17015,0.001523605,0.02568798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13858",532.7926,0.9553638,0.301374,3.170027,0.001524246,0.02569212,11654,15309,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.72e-15,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g127910",265.7313,-0.3238578,0.1021698,-3.169801,0.001525433,0.02570543,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48431",23.03975,0.7458968,0.2354022,3.168605,0.001531724,0.02577791,8585,17207,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.07e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g74676",49.24398,0.3681696,0.1161891,3.168711,0.001531167,0.02577791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96168",277.4255,-0.2681865,0.08463852,-3.168611,0.001531694,0.02577791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106306",18.95104,-0.4704517,0.148468,-3.168707,0.001531186,0.02577791,0,4094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.41e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g156185",38.31587,0.8677348,0.2738443,3.168716,0.001531138,0.02577791,0,1470,"sp|Q9I7S8|PUR6_DROME","Q9I7S8","PUR6",2.19e-22,"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) (Protein adenosine-5) [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0043727"
"g60041",152.7549,0.3169228,0.1000276,3.168355,0.001533043,0.02578673,9584,13430,"sp|Q4R4I6|CAP1_MACFA","Q4R4I6","CAP1",1.26e-07,"Adenylyl cyclase-associated protein 1 (CAP 1)","actin cytoskeleton organization [GO:0030036]","GO:0003779; GO:0005886; GO:0030036"
"g151197",310.0479,0.3065665,0.09675775,3.168393,0.001532844,0.02578673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126290",724.9743,0.5413352,0.1708701,3.16811,0.001534333,0.02580173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129451",59.68944,0.6311927,0.1992601,3.167683,0.001536592,0.02583301,0,3450,"sp|Q9D819|IPYR_MOUSE","Q9D819","IPYR",4.99e-15,"Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)","phosphate-containing compound metabolic process [GO:0006796]","GO:0000287; GO:0004427; GO:0005829; GO:0006796; GO:0016462"
"g148199",1497.467,0.621808,0.1963063,3.167539,0.00153735,0.02583904,0,2147,"sp|P14318|MP20_DROME","P14318","MP20",2.06e-14,"Muscle-specific protein 20","myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]","GO:0005737; GO:0005856; GO:0007520; GO:1901739"
"g25702",577.6069,-0.6446173,0.2035275,-3.167225,0.001539011,0.02585354,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70546",27.13522,0.7403419,0.2337475,3.167272,0.001538764,0.02585354,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11678",263.7678,0.336047,0.1061082,3.16702,0.001540095,0.02585465,375,8473,"sp|Q9VFS6|INT5_DROME","Q9VFS6","INT5",1.37e-30,"Integrator complex subunit 5 (Protein oocyte maintenance defects)","positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; snRNA 3'-end processing [GO:0034472]","GO:0003677; GO:0005634; GO:0005737; GO:0010628; GO:0016021; GO:0031965; GO:0032039; GO:0034472; GO:0045666"
"g36591",40.24295,1.05016,0.331604,3.166911,0.001540673,0.02585465,23816,27614,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.62e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g39738",3310.059,-0.5520741,0.1743207,-3.167003,0.001540188,0.02585465,7438,23824,"sp|Q1EHB4|SC5AC_HUMAN","Q1EHB4","SC5AC",1.78e-17,"Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","ion transport [GO:0006811]; sodium ion transport [GO:0006814]","GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324; GO:0070062"
"g90591",487.8503,0.5143873,0.1624237,3.166948,0.00154048,0.02585465,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74831",802.6492,0.3215064,0.1015232,3.166825,0.001541129,0.02585561,0,9957,"sp|O75643|U520_HUMAN","O75643","U520",0,"U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]","GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013"
"g123380",24.70168,-0.4676493,0.1476787,-3.166668,0.001541962,0.02586289,0,2497,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.47e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g75507",113.6596,0.421679,0.1331723,3.166416,0.001543302,0.02587866,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41210",148.9064,-0.2494848,0.07879912,-3.166086,0.001545049,0.02589802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101037",100.6985,0.3921133,0.1238495,3.166048,0.001545255,0.02589802,0,3351,"sp|Q6P2B1|TNPO3_MOUSE","Q6P2B1","TNPO3",9.06e-08,"Transportin-3","protein import into nucleus [GO:0006606]","GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0031267; GO:0042802; GO:0043231"
"g16661",244.2075,0.9156324,0.2892345,3.16571,0.001547051,0.02591322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81775",1459.802,-0.2651235,0.08375008,-3.165651,0.001547363,0.02591322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125461",142.423,0.6007487,0.1897695,3.165676,0.001547229,0.02591322,0,3998,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.38e-11,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g36931",126.5559,0.398585,0.1259171,3.165457,0.001548398,0.02591716,23570,24024,"sp|Q0VD19|ASM_BOVIN","Q0VD19","ASM",2.24e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005811; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0043065; GO:0043407; GO:0045121; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g138636",171.8965,0.3215443,0.1015772,3.165516,0.001548079,0.02591716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10894",1757.761,0.2089104,0.06600227,3.1652,0.001549765,0.02593061,4556,20276,"sp|O18497|MAN2_SPOFR","O18497","MAN2",2.32e-145,"Alpha-mannosidase 2 (EC 3.2.1.114) (Alpha-mannosidase II) (Class II alpha-mannosidase) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)","mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]","GO:0000139; GO:0004572; GO:0005783; GO:0006013; GO:0006486; GO:0006491; GO:0016021; GO:0030246; GO:0046872"
"g29243",1122.69,1.47095,0.4647323,3.165155,0.001550002,0.02593061,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133510",651.1617,-0.3781477,0.1195015,-3.164376,0.001554159,0.02599344,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46063",3427.758,-0.3405304,0.10762,-3.164193,0.001555137,0.02599638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103921",270.9604,0.2858637,0.09034167,3.164251,0.001554828,0.02599638,0,6004,"sp|Q7TNG5|EMAL2_MOUSE","Q7TNG5","EMAL2",1.8e-19,"Echinoderm microtubule-associated protein-like 2 (EMAP-2)","microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]","GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115"
"g27042",2203.421,-0.3630804,0.1147586,-3.163862,0.001556907,0.02601657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32676",34.63834,0.6122177,0.1935061,3.163817,0.001557148,0.02601657,0,6739,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.58e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g17150",95.21601,-0.30356,0.09595174,-3.163673,0.001557915,0.02602269,28245,58161,"sp|Q6GNY1|MIB1_XENLA","Q6GNY1","MIB1",6.48e-37,"E3 ubiquitin-protein ligase mib1 (EC 2.3.2.27) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase mib1)","Notch signaling pathway [GO:0007219]","GO:0004842; GO:0005737; GO:0005815; GO:0007219; GO:0008270"
"g45920",1559.769,-0.4028762,0.1273528,-3.163466,0.001559023,0.02603448,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148112",36.57935,0.57885,0.1829909,3.163272,0.001560067,0.0260452,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12978",57.49325,0.6840254,0.2162617,3.162953,0.001561776,0.02605525,0,10225,"sp|P05106|ITB3_HUMAN","P05106","ITB3",4.77e-07,"Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)","activation of protein kinase activity [GO:0032147]; angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; negative chemotaxis [GO:0050919]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of bone resorption [GO:0045124]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of serotonin uptake [GO:0051611]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; tube development [GO:0035295]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001618; GO:0001934; GO:0001938; GO:0001968; GO:0002020; GO:0003756; GO:0005161; GO:0005178; GO:0005634; GO:0005654; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0007596; GO:0008305; GO:0009986; GO:0010595; GO:0010745; GO:0010888; GO:0014909; GO:0015026; GO:0016477; GO:0019899; GO:0030168; GO:0030949; GO:0031092; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032147; GO:0032369; GO:0032587; GO:0032880; GO:0032991; GO:0033627; GO:0034113; GO:0034446; GO:0034683; GO:0035295; GO:0035866; GO:0035867; GO:0035868; GO:0038027; GO:0042060; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0043277; GO:0045124; GO:0045202; GO:0045211; GO:0046718; GO:0048333; GO:0050731; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0051611; GO:0060055; GO:0070062; GO:0070527; GO:0071062; GO:0098978; GO:0099149; GO:1905598"
"g31598",331.1497,-0.3077842,0.09730522,-3.16308,0.001561094,0.02605525,13418,23524,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.3e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61975",133.1877,0.386575,0.1222204,3.162934,0.001561875,0.02605525,595,12850,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.76e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g321",38.72781,-0.4675253,0.1478271,-3.16265,0.001563401,0.02607383,4176,8004,"sp|Q29419|ZFY_PIG","Q29419","ZFY",2.19e-11,"Zinc finger Y-chromosomal protein (Fragment)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0005634; GO:0005694; GO:0006357; GO:0043035; GO:0046872"
"g34274",2002.113,-0.2671002,0.08446051,-3.162427,0.001564599,0.02607383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64304",95.12004,-0.3828487,0.1210565,-3.162563,0.00156387,0.02607383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71067",72.43693,0.5267321,0.1665567,3.162479,0.00156432,0.02607383,0,10673,"sp|Q9D0N7|CAF1B_MOUSE","Q9D0N7","CAF1B",1.36e-10,"Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)","cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]","GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186"
"g9680",317.4013,0.4288668,0.1356243,3.162167,0.001565997,0.02607699,69994,73694,"sp|A8X6I9|TCPQ_CAEBR","A8X6I9","TCPQ",1.22e-10,"T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g33997",430.6447,-0.3527375,0.1115508,-3.162126,0.001566219,0.02607699,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55257",1362.26,-0.3552991,0.1123561,-3.162259,0.0015655,0.02607699,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76667",261.4992,-0.5056991,0.1599255,-3.162092,0.001566398,0.02607699,0,9648,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.44e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g96271",2300.82,-0.3638487,0.1150863,-3.16153,0.001569428,0.02612072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89937",51.22444,0.8782699,0.2778617,3.160817,0.001573274,0.02617128,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133133",122.0476,1.879814,0.5947188,3.160845,0.001573125,0.02617128,0,3377,"sp|P97449|AMPN_MOUSE","P97449","AMPN",8.4e-16,"Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0031526; GO:0035814; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g43619",67.89617,-0.3166552,0.1001923,-3.160474,0.001575126,0.02618865,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87501",1162.782,0.3722362,0.1177783,3.160482,0.001575085,0.02618865,455,6717,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.24e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g121411",112.6568,0.5859883,0.1854187,3.160352,0.001575786,0.02619289,0,4363,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.56e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87284",1091.644,-0.44,0.1392352,-3.160119,0.001577046,0.02620711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7155",366.0313,-0.4731951,0.1497504,-3.159891,0.001578282,0.02620829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21080",2573.653,-0.3480174,0.1101314,-3.160021,0.001577579,0.02620829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95490",78.33066,1.365586,0.4321636,3.159882,0.00157833,0.02620829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21432",1094.932,0.3073765,0.09728711,3.159479,0.001580518,0.02623789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56254",1161.402,-0.3384881,0.1071373,-3.159387,0.001581016,0.02623943,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42568",925.3166,2.267127,0.7176152,3.159252,0.001581747,0.02624485,13347,19244,"sp|W4VS99|NEP_TRILK","W4VS99","NEP",6.07e-81,"Neprilysin-1 (EC 3.4.24.-)",NA,"GO:0004222; GO:0005576; GO:0046872"
"g57087",498.068,0.3769521,0.1193258,3.159015,0.001583031,0.02625943,12117,14392,"sp|Q5R821|OLA1_PONAB","Q5R821","OLA1",1.25e-06,"Obg-like ATPase 1",NA,"GO:0005524; GO:0005525; GO:0005730; GO:0005737; GO:0016887; GO:0043022; GO:0043023; GO:0046872"
"g4718",847.2106,0.1549861,0.04906329,3.158902,0.001583646,0.0262629,83595,128358,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.56e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g4284",6241.375,-0.2638781,0.08354276,-3.158599,0.001585295,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14298",27.69776,1.988009,0.6294866,3.158143,0.001587777,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18181",630.033,-0.2833112,0.08969998,-3.158432,0.001586206,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33646",207.0882,0.3365035,0.1065432,3.158376,0.001586508,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53055",71.06926,2.197387,0.6957852,3.15814,0.001587793,0.02627116,10696,14024,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",9.81e-19,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g58472",273.1221,0.4599772,0.1456415,3.158284,0.001587011,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95361",29.5537,0.4365529,0.1382068,3.158693,0.001584781,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121518",73.63173,1.032994,0.3270472,3.158548,0.00158557,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155700",19.42156,2.489859,0.7883931,3.158145,0.001587768,0.02627116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27963",356.5202,-0.2547085,0.08065667,-3.157934,0.001588915,0.02627298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46548",538.6347,-0.256593,0.08125695,-3.157797,0.001589662,0.02627298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60182",19.52302,-0.7067005,0.2237951,-3.157801,0.001589641,0.02627298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75451",289.1368,0.4306957,0.1363933,3.157748,0.00158993,0.02627298,0,6902,"sp|O88998|NOE1_MOUSE","O88998","NOE1",9.59e-07,"Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin)","atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165]","GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0007399; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0032281; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0060317; GO:0097060; GO:0098978; GO:0099243"
"g127646",1032.169,-0.3967803,0.125648,-3.157871,0.00158926,0.02627298,0,3818,"sp|E2A6Z3|ALLSC_CAMFO","E2A6Z3","ALLSC",3.51e-20,"Allatostatin C [Cleaved into: Peptide LRSQLDIGDLQ; Allatostatin C (SYWKQCAFNAVSCF-amide)]",NA,"GO:0005576"
"g52030",232.1064,-0.402352,0.1274241,-3.157582,0.001590833,0.0262812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55718",3318.987,0.2245438,0.0711147,3.157488,0.001591348,0.02628301,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61003",57.90052,0.4565029,0.1445893,3.157238,0.001592714,0.02629886,0,13120,"sp|Q2TCH3|ACLY_SHEEP","Q2TCH3","ACLY",7.36e-31,"ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)","acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; lipid biosynthetic process [GO:0008610]","GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0008610; GO:0046872"
"g8900",106.4415,0.4007807,0.1269467,3.157078,0.001593586,0.02630002,86964,89134,"sp|Q4KM65|CPSF5_RAT","Q4KM65","CPSF5",3.69e-31,"Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Nudix hydrolase 21)","cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]","GO:0003682; GO:0003729; GO:0005634; GO:0005737; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0030154; GO:0031124; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975"
"g29023",1661.996,2.189084,0.6934033,3.157015,0.001593933,0.02630002,1135,6799,"sp|Q6L6Q6|LYS_CRAGI","Q6L6Q6","LYS",3.97e-08,"Lysozyme (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase) (Invertebrate-type lysozyme)","cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]","GO:0003796; GO:0005576; GO:0008152; GO:0019835; GO:0042742"
"g72978",220.6841,0.6497543,0.2058137,3.157002,0.001594002,0.02630002,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28794",2117.092,0.3206695,0.1015789,3.156851,0.00159483,0.02630698,0,13371,"sp|Q99KI0|ACON_MOUSE","Q99KI0","ACON",1.87e-34,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)","citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]","GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0043209; GO:0047780; GO:0051538; GO:0051539"
"g143161",65.3712,0.3485475,0.110414,3.156733,0.001595472,0.02631087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121132",24.83336,-0.8585867,0.2720125,-3.156424,0.001597164,0.02633208,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107618",981.9245,0.4294357,0.1360796,3.155767,0.001600764,0.02638472,0,4945,"sp|Q3ZBH0|TCPB_BOVIN","Q3ZBH0","TCPB",4.24e-24,"T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]","GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874"
"g39236",132.7629,1.433074,0.4541358,3.155607,0.001601645,0.02638905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86877",372.5983,-0.2030755,0.06435461,-3.155571,0.001601842,0.02638905,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74391",44.0065,0.532537,0.1687852,3.155116,0.001604344,0.02642355,0,10034,"sp|Q9Z0J1|RECK_MOUSE","Q9Z0J1","RECK",1.89e-20,"Reversion-inducing cysteine-rich protein with Kazal motifs (mRECK)","blood vessel maturation [GO:0001955]; embryo implantation [GO:0007566]; embryonic forelimb morphogenesis [GO:0035115]; extracellular matrix organization [GO:0030198]; negative regulation of cell migration [GO:0030336]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]","GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0007566; GO:0008191; GO:0017147; GO:0030198; GO:0030336; GO:0031225; GO:0035115; GO:0045765; GO:0090210; GO:0090263; GO:1904684; GO:1904928; GO:1990909"
"g107191",146.0309,-0.4907142,0.1555345,-3.155019,0.001604878,0.02642564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27199",1666.331,-0.3427169,0.1086306,-3.154883,0.001605623,0.02642564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30764",560.7982,0.7995029,0.2534186,3.15487,0.001605694,0.02642564,11646,34144,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.29e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g131539",68.25738,1.888067,0.5985011,3.15466,0.001606854,0.02643801,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21350",46.72512,0.3697485,0.1172275,3.154109,0.001609889,0.02648122,15035,26057,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.37e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35312",205.8821,0.4189687,0.1328369,3.154008,0.001610446,0.02648366,0,11390,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.02e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g86221",37.53928,-0.360614,0.1143383,-3.153921,0.001610926,0.02648484,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28943",75.70092,1.310513,0.4155287,3.153846,0.001611343,0.02648497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45060",1062.761,-0.2035019,0.06452731,-3.153733,0.001611967,0.02648851,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131457",23.83872,1.115721,0.3538018,3.153518,0.001613152,0.02649904,0,3513,"sp|A0A3Q2HW92|MFS12_HORSE","A0A3Q2HW92","MFS12",5.08e-10,"Major facilitator superfamily domain-containing protein 12","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]","GO:0005764; GO:0005765; GO:0008643; GO:0015293; GO:0016021; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:1903712"
"g133113",123.1898,1.847834,0.5859687,3.153469,0.001613426,0.02649904,0,3378,"sp|P97449|AMPN_MOUSE","P97449","AMPN",8.4e-16,"Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of renal sodium excretion [GO:0035814]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0004177; GO:0005615; GO:0005737; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0031526; GO:0035814; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g35141",947.6679,-0.3548886,0.1125672,-3.152682,0.00161778,0.02656382,18085,22670,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.47e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g25860",113.4379,0.3610036,0.1145111,3.152566,0.001618425,0.02656767,25555,31132,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.51e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g873",53.86352,-0.4086028,0.1296169,-3.152388,0.001619409,0.02656777,67245,70480,"sp|O15090|ZN536_HUMAN","O15090","ZN536",2.3e-09,"Zinc finger protein 536","negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387"
"g1377",1816.204,0.1155009,0.03663875,3.152425,0.001619204,0.02656777,16936,38754,"sp|Q14562|DHX8_HUMAN","Q14562","DHX8",1.03e-174,"ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1)","mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]","GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013"
"g7070",85.01245,0.4208332,0.1335044,3.152205,0.001620427,0.02656777,33006,58664,"sp|Q9VXK0|NIPSN_DROME","Q9VXK0","NIPSN",2.02e-16,"Protein NipSnap","mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]","GO:0005739; GO:0005741; GO:0006119; GO:0007005"
"g47839",506.594,-0.3455819,0.1096383,-3.152019,0.001621457,0.02656777,9496,15014,"sp|Q96BV0|ZN775_HUMAN","Q96BV0","ZN775",8.51e-06,"Zinc finger protein 775","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g114282",773.8182,0.3500645,0.1110587,3.152068,0.001621184,0.02656777,2462,4894,"sp|P12261|EF1G_ARTSA","P12261","EF1G",6.19e-11,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g124884",123.9798,0.4837229,0.1534667,3.151973,0.001621711,0.02656777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133644",29.58841,-0.5535277,0.1755935,-3.152324,0.001619763,0.02656777,0,2824,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.98e-08,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g154114",13627.67,0.5300693,0.1681642,3.152093,0.001621045,0.02656777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g767",755.4718,0.263087,0.08348125,3.15145,0.00162462,0.02660847,106720,128444,"sp|Q8CIW5|PEO1_MOUSE","Q8CIW5","PEO1",3.01e-14,"Twinkle mtDNA helicase (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)","cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]","GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333"
"g115985",983.3784,1.443714,0.4581214,3.151379,0.001625017,0.02660847,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65008",24.00166,-1.27843,0.4056836,-3.151297,0.001625468,0.02660914,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127782",57.45679,-0.5930736,0.1882054,-3.151203,0.001625992,0.02661099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33153",189.221,0.4993023,0.1584662,3.150844,0.001627993,0.02662356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42397",10804.41,0.6257405,0.1985936,3.15086,0.001627904,0.02662356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88454",1975.343,0.4984161,0.1581791,3.15096,0.001627346,0.02662356,6899,7454,"sp|Q9I7U4|TITIN_DROME","Q9I7U4","TITIN",1.86e-17,"Titin (D-Titin) (Kettin)","cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]","GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301"
"g769",237.1484,0.6254435,0.198546,3.150118,0.001632045,0.02664275,131445,139735,"sp|P49010|HEXC_BOMMO","P49010","HEXC",3.73e-55,"Chitooligosaccharidolytic beta-N-acetylglucosaminidase (EC 3.2.1.52) (Beta-GlcNAcase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004563; GO:0006032; GO:0102148"
"g26610",5619.056,-0.2773063,0.08802805,-3.150203,0.001631569,0.02664275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35295",144.4576,0.3450103,0.1095225,3.15013,0.001631976,0.02664275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70263",23.61572,0.7555278,0.2398198,3.150398,0.001630479,0.02664275,0,10833,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.11e-11,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g126327",46.18466,0.5359777,0.170142,3.150178,0.001631712,0.02664275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131151",38.95825,0.4903712,0.1556652,3.150165,0.001631784,0.02664275,0,3461,"sp|P21328|RTJK_DROME","P21328","RTJK",2.15e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g147489",336.8735,0.3603896,0.1143985,3.150301,0.001631021,0.02664275,0,2207,"sp|Q13630|FCL_HUMAN","Q13630","FCL",8.69e-26,"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of endothelial cell migration [GO:0010595]","GO:0005829; GO:0007159; GO:0009055; GO:0010595; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0070062; GO:1904906"
"g7250",806.0012,-0.3976988,0.1262539,-3.149993,0.001632742,0.02664742,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11557",232.908,0.733299,0.2328176,3.149671,0.001634542,0.02665364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16810",252.1287,0.3269854,0.1038163,3.149653,0.001634643,0.02665364,14984,18334,"sp|P04323|POL3_DROME","P04323","POL3",3.66e-08,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g32321",7464.899,2.719879,0.8635612,3.149608,0.001634899,0.02665364,5250,13374,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.93e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g125936",21.5471,-0.5518664,0.1752079,-3.14978,0.001633937,0.02665364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141291",163.9011,0.6728236,0.2136248,3.149557,0.00163518,0.02665364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22225",1318.463,0.6588648,0.2092048,3.149378,0.001636186,0.02666333,11035,19380,"sp|P27393|CO4A2_ASCSU","P27393","CO4A2",1.12e-20,"Collagen alpha-2(IV) chain",NA,"GO:0005201; GO:0005576; GO:0005581; GO:0005604"
"g4738",1425.883,-0.4318485,0.1371519,-3.148689,0.001640048,0.02671283,96866,121154,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",2.94e-29,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g25263",237.8552,0.4495059,0.1427586,3.148712,0.001639916,0.02671283,30486,34764,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.74e-62,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g54424",185.7069,0.6091384,0.1934789,3.148345,0.001641976,0.02673079,6586,10644,"sp|Q03278|PO21_NASVI","Q03278","PO21",1.24e-09,"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)",NA,"GO:0003964; GO:0004519; GO:0046872"
"g135030",27.06629,2.57307,0.8172741,3.148356,0.001641917,0.02673079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43274",239.2154,-0.5484997,0.1742351,-3.148044,0.001643671,0.02674494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159355",52.44454,1.225825,0.3893921,3.148049,0.00164364,0.02674494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84438",243.9817,-0.385324,0.1224073,-3.147884,0.001644569,0.02675284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3066",292.3576,-0.2721375,0.08645847,-3.147609,0.001646115,0.02677066,3935,7471,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.72e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13044",158.7246,0.3970419,0.1261455,3.147492,0.001646778,0.02677066,12695,65291,"sp|P21328|RTJK_DROME","P21328","RTJK",2.89e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52228",544.6573,0.2477952,0.07873021,3.147396,0.001647317,0.02677066,7286,11944,"sp|P21856|GDIA_BOVIN","P21856","GDIA",4.22e-11,"Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (SMG p25A GDI)","negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]","GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0015031; GO:0016192; GO:0030496; GO:0032482; GO:0050771; GO:0090315"
"g96504",206.8312,0.3443376,0.1094016,3.147464,0.001646935,0.02677066,0,6014,"sp|P53621|COPA_HUMAN","P53621","COPA",1.67e-28,"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062"
"g129011",353.8212,0.657144,0.208813,3.147046,0.00164929,0.02679599,0,3711,"sp|P13666|SRCA_RABIT","P13666","SRCA",3.53e-19,"Sarcalumenin",NA,"GO:0005525; GO:0033017; GO:0033018"
"g114666",413.394,0.4886436,0.1552944,3.146563,0.001652018,0.02683359,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104520",440.0312,1.512485,0.4807279,3.14624,0.001653844,0.02685652,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49868",25.33993,-0.4553137,0.1447225,-3.146116,0.001654541,0.02686111,0,17416,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.42e-29,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g95160",349.4032,0.2407527,0.07652617,3.146018,0.001655096,0.02686338,0,7062,"sp|Q14746|COG2_HUMAN","Q14746","COG2",2.33e-09,"Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"g59108",119.4929,-0.5350664,0.1700831,-3.145912,0.001655697,0.02686641,0,8284,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.51e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g15809",604.1608,-0.264093,0.08395169,-3.145773,0.001656485,0.02687247,37045,56430,"sp|Q60520|SIN3A_MOUSE","Q60520","SIN3A",5.86e-31,"Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]","GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0006476; GO:0007568; GO:0010243; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0032991; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678"
"g97473",334.2393,0.6566833,0.2088046,3.144966,0.001661064,0.02694,984,5374,"sp|O62742|SCP2_RABIT","O62742","SCP2",1e-19,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"g6043",96.48576,0.2878652,0.09153712,3.144792,0.001662047,0.0269492,93682,96554,"sp|Q0VFM6|GMPPA_XENTR","Q0VFM6","GMPPA",1.03e-06,"Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GTP-mannose-1-phosphate guanylyltransferase alpha)","biosynthetic process [GO:0009058]","GO:0005737; GO:0009058; GO:0016779"
"g86148",24.31598,0.7432089,0.2363477,3.144557,0.001663386,0.02696416,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5270",2681.818,-0.4179323,0.1329172,-3.144306,0.001664815,0.02697529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29750",162.4712,-0.5514124,0.175377,-3.144154,0.001665675,0.02697529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38494",1596.899,-0.272034,0.08651711,-3.14428,0.001664961,0.02697529,0,21510,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.46e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g39990",967.4973,0.3096864,0.09849628,3.144144,0.001665737,0.02697529,13255,23527,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",1.7e-42,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g113678",221.6933,0.2804122,0.08918897,3.144024,0.001666418,0.02697957,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51086",20.95323,-0.5508956,0.1752258,-3.143918,0.001667021,0.02698259,0,16654,"sp|B1H1X1|FXL17_XENLA","B1H1X1","FXL17",4.07e-06,"F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17)","nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0000209; GO:0005634; GO:0005737; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043161"
"g10508",149.5291,0.3604378,0.1146538,3.143705,0.001668236,0.02698876,46805,79715,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.31e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g138076",116.2853,0.794808,0.2528242,3.143718,0.00166816,0.02698876,0,2995,"sp|O35604|NPC1_MOUSE","O35604","NPC1",4.03e-06,"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; viral entry into host cell [GO:0046718]","GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0015485; GO:0016020; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0071383; GO:0071404; GO:0090150; GO:1905103"
"g102537",33717.65,0.2675705,0.08512059,3.143429,0.00166981,0.02700749,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114148",79.12895,0.5399675,0.1717971,3.143054,0.00167195,0.02703536,0,5047,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.15e-15,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22273",218.8589,-0.3500273,0.1113741,-3.142807,0.001673359,0.02705139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144385",19.62227,0.8339247,0.2653686,3.142514,0.001675035,0.02707172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65642",22.16119,-0.4720879,0.1502363,-3.142303,0.001676247,0.02707845,3,11909,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.67e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g90472",72.43999,-1.817127,0.57828,-3.142296,0.001676287,0.02707845,0,7585,"sp|A0A0H3G4K1|BTAF_BRUSU","A0A0H3G4K1","BTAF",7.61e-10,"Autotransporter adhesin BtaF (Brucella trimeric autotransporter) (Type 5 secretion system autotransporter BtaF)","cell adhesion [GO:0007155]; protein transport [GO:0015031]","GO:0007155; GO:0009279; GO:0009986; GO:0015031; GO:0016021"
"g5619",123.023,0.4275093,0.1360669,3.141906,0.001678519,0.02709423,66756,79944,"sp|Q96EZ8|MCRS1_HUMAN","Q96EZ8","MCRS1",2.53e-23,"Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)","cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751"
"g94746",19.31574,0.4845692,0.154223,3.142003,0.001677963,0.02709423,5374,6764,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.22e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g125847",17.66041,0.6131142,0.1951399,3.141922,0.00167843,0.02709423,0,3967,"sp|Q68G58|APEX2_MOUSE","Q68G58","APEX2",4.73e-17,"DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2) (APEX nuclease 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2)","base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]","GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006284; GO:0006310; GO:0007049; GO:0008081; GO:0008270; GO:0008311; GO:0043231"
"g66410",158.4522,0.7793052,0.2480484,3.141746,0.001679437,0.0271023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42229",381.3136,-0.3898604,0.1240978,-3.141559,0.00168051,0.02711287,13835,17646,"sp|P60319|KEN_DROYA","P60319","KEN",7.72e-09,"Probable transcription factor Ken (Protein Ken and Barbie) (Fragment)","female analia development [GO:0045497]; female genitalia development [GO:0030540]; male analia development [GO:0045496]; male genitalia development [GO:0030539]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]","GO:0003677; GO:0003700; GO:0005634; GO:0030539; GO:0030540; GO:0045496; GO:0045497; GO:0046426; GO:0046872"
"g36795",36.6908,2.342571,0.7457607,3.141183,0.001682668,0.02714092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100707",33.19754,-0.3885504,0.1237006,-3.141056,0.001683401,0.02714599,0,2484,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.48e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g52775",264.0472,1.460497,0.4650147,3.140754,0.001685136,0.02716046,1035,15730,"sp|F4KGU4|DEAHC_ARATH","F4KGU4","DEAHC",3.2e-130,"ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)",NA,"GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0016887; GO:0046872"
"g66929",99.77702,0.3312383,0.1054644,3.14076,0.001685099,0.02716046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47946",36.35792,-0.4704214,0.1497833,-3.140679,0.001685566,0.02716056,1935,17967,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.15e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g79633",1067.058,-0.4350747,0.1385364,-3.140508,0.00168655,0.02716056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119900",36.81666,0.9750449,0.3104782,3.140461,0.001686819,0.02716056,0,4453,"sp|A8D8P8|SIWI_BOMMO","A8D8P8","SIWI",6.18e-10,"Piwi-like protein Siwi (EC 3.1.26.-)","cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]","GO:0000287; GO:0004521; GO:0005737; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0051321; GO:1990923"
"g130975",153.3283,2.095223,0.6671681,3.140473,0.001686753,0.02716056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23905",96.66831,0.2753726,0.08769948,3.139957,0.001689728,0.02720063,26515,29490,"sp|Q6PBD6|WDR61_XENTR","Q6PBD6","WDR61",3.56e-14,"WD repeat-containing protein 61","histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000791; GO:0005634; GO:0005737; GO:0006368; GO:0016593; GO:0051568; GO:0051571; GO:0055087; GO:0080182; GO:2001162"
"g3842",1037.961,0.3959205,0.126115,3.139361,0.001693166,0.0272378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7284",1202.104,0.388834,0.1238586,3.139338,0.001693298,0.0272378,0,10835,"sp|Q66X93|SND1_RAT","Q66X93","SND1",7.37e-18,"Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (SND p102) (p100 co-activator) (p105 coactivator)","gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; regulation of cell cycle process [GO:0010564]","GO:0003713; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172"
"g71136",49.26902,-0.3115694,0.09924378,-3.139434,0.001692743,0.0272378,3995,10656,"sp|P21328|RTJK_DROME","P21328","RTJK",8.42e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g74159",197.4414,0.7789582,0.2481594,3.138943,0.001695584,0.02726779,6375,10079,"sp|P38658|ERP60_SCHMA","P38658","ERP60",8.4e-06,"Probable protein disulfide-isomerase ER-60 (EC 5.3.4.1) (ERP60)",NA,"GO:0003756; GO:0005788"
"g15653",4574.602,-0.3314776,0.1056301,-3.138097,0.001700488,0.02729923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28707",137.3453,0.3800275,0.1210878,3.138447,0.001698457,0.02729923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77832",52.80104,1.246809,0.3972826,3.138342,0.001699066,0.02729923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88791",4805.231,0.5668761,0.1806345,3.13825,0.0016996,0.02729923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102903",61.77455,1.146396,0.3653122,3.138128,0.001700308,0.02729923,0,6176,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",3.3e-07,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g120650",1436.666,-0.4103475,0.1307595,-3.138184,0.001699981,0.02729923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150805",205.5089,0.3124535,0.09956099,3.138313,0.001699233,0.02729923,0,1912,"sp|Q04047|NONA_DROME","Q04047","NONA",7.01e-08,"Protein no-on-transient A (Puff-specific protein Bj6)","male courtship behavior, veined wing generated song production [GO:0045433]; mRNA splicing, via spliceosome [GO:0000398]; phototaxis [GO:0042331]; regulation of transcription, DNA-templated [GO:0006355]; visual behavior [GO:0007632]; visual perception [GO:0007601]","GO:0000398; GO:0003729; GO:0005634; GO:0006355; GO:0007601; GO:0007632; GO:0042331; GO:0045433; GO:0071011; GO:0071013"
"g102625",88.36697,1.731303,0.5517229,3.137994,0.001701082,0.02730091,0,5548,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.77e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g134769",27.38797,2.402838,0.7657391,3.137933,0.001701435,0.02730091,0,3250,"sp|Q5VT66|MARC1_HUMAN","Q5VT66","MARC1",4.17e-13,"Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1)","cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]","GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016021; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958"
"g28356",575.8753,-0.216651,0.06905108,-3.137547,0.001703681,0.02732544,5165,22244,"sp|P21328|RTJK_DROME","P21328","RTJK",1.42e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g126807",434.2214,1.090415,0.3475399,3.137525,0.001703807,0.02732544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124038",35.18979,1.562325,0.4979876,3.137278,0.001705244,0.02734172,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g929",321.5208,-0.2989223,0.09528928,-3.136998,0.001706872,0.02736105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141578",87.04849,0.3656695,0.1165901,3.136368,0.001710543,0.0274131,0,2720,"sp|Q6DCT2|ARMD3_XENLA","Q6DCT2","ARMD3",1.1e-21,"Armadillo-like helical domain-containing protein 3","regulation of Golgi organization [GO:1903358]","GO:0000139; GO:0005829; GO:0016021; GO:1903358"
"g55486",1697.109,-0.3391723,0.108161,-3.135809,0.00171381,0.02745868,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36534",482.8482,-0.2367849,0.0755126,-3.1357,0.001714442,0.02746202,17445,24627,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.53e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g37964",16768.87,0.4258269,0.1358131,3.135388,0.001716269,0.0274694,16158,20164,"sp|Q25008|TBA1_HOMAM","Q25008","TBA1",0,"Tubulin alpha-1 chain (Alpha-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g74037",167.537,0.3487739,0.1112342,3.135492,0.001715661,0.0274694,1975,5235,"sp|Q8BU03|PWP2_MOUSE","Q8BU03","PWP2",7.12e-07,"Periodic tryptophan protein 2 homolog","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]","GO:0000028; GO:0000462; GO:0032040; GO:0034388"
"g141294",48.66447,-0.4127573,0.1316471,-3.135332,0.001716599,0.0274694,0,2741,"sp|Q6NUV0|RB3GP_DANRE","Q6NUV0","RB3GP",5.14e-09,"Rab3 GTPase-activating protein catalytic subunit","positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0043547"
"g143348",113.7989,0.4676568,0.1491552,3.13537,0.001716376,0.0274694,0,2572,"sp|Q9XYZ5|DDB1_DROME","Q9XYZ5","DDB1",5.01e-12,"DNA damage-binding protein 1 (D-DDB1) (Damage-specific DNA-binding protein 1) (Protein piccolo)","cellular response to DNA damage stimulus [GO:0006974]; defense response to fungus [GO:0050832]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc development [GO:0035220]","GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0006511; GO:0006974; GO:0007307; GO:0016567; GO:0035220; GO:0035861; GO:0043161; GO:0045732; GO:0045879; GO:0050832"
"g98525",250.5077,-0.3325102,0.1060625,-3.135041,0.001718304,0.02748989,0,6074,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.07e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g152243",30.84473,0.4298303,0.1371236,3.13462,0.00172077,0.02752255,0,1788,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.18e-27,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g149662",263.2831,-0.4083995,0.1302934,-3.134461,0.001721704,0.02753069,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16979",475.9189,-0.3020649,0.09637435,-3.134287,0.00172272,0.02753572,14225,50423,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.03e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g87896",145.8444,1.788711,0.5706961,3.134262,0.001722869,0.02753572,0,7725,"sp|Q64380|SARDH_RAT","Q64380","SARDH",3.59e-20,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053"
"g26861",516.9457,0.4414126,0.1408541,3.133828,0.001725417,0.02756966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36214",1361.419,0.2855349,0.09111918,3.133642,0.001726516,0.0275804,0,27962,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.33e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g70018",345.765,-0.2456444,0.07839937,-3.133244,0.001728856,0.02761099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78326",368.6831,1.268542,0.4048975,3.132994,0.001730328,0.02762768,0,9197,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.9e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g131197",93.1471,0.4253927,0.1358013,3.132465,0.001733452,0.02767075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69605",41.19294,0.3489548,0.1114111,3.132136,0.001735394,0.02769492,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27549",96.32247,0.7147958,0.2282323,3.131878,0.001736922,0.02770567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49032",55247.6,0.5226742,0.1668865,3.131914,0.001736707,0.02770567,2085,7522,"sp|P53777|MLP1_DROME","P53777","MLP1",9.88e-07,"Muscle LIM protein 1","actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]","GO:0005634; GO:0005737; GO:0007517; GO:0030018; GO:0030036; GO:0030154; GO:0046872; GO:0060537"
"g12491",466.9834,-0.4151476,0.1325764,-3.131383,0.001739849,0.02774551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103063",30.47759,0.7083,0.2262038,3.131247,0.001740655,0.02775153,0,5236,"sp|Q99758|ABCA3_HUMAN","Q99758","ABCA3",2.49e-14,"Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form]","cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016021; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0044267; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140"
"g111415",4977.51,-0.2739645,0.08749612,-3.131162,0.001741161,0.02775277,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28919",5850.672,-0.5965831,0.1905497,-3.130853,0.001742996,0.02777519,11195,23663,"sp|Q6P9X4|TP4A2_RAT","Q6P9X4","TP4A2",1.01e-18,"Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2)",NA,"GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0008138"
"g30868",573.3422,0.3991476,0.1274924,3.130756,0.001743572,0.02777754,3530,17214,"sp|P52899|ODPA_CAEEL","P52899","ODPA",7.4e-32,"Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial (PDHE1-A) (EC 1.2.4.1)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004739; GO:0005739; GO:0005759; GO:0006086; GO:0006096"
"g37965",303.654,0.4422072,0.1412524,3.130618,0.001744391,0.02778375,18374,21904,"sp|Q25008|TBA1_HOMAM","Q25008","TBA1",1.04e-27,"Tubulin alpha-1 chain (Alpha-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g47861",547.0441,0.3181396,0.1016375,3.130139,0.001747234,0.0278222,10566,15234,"sp|Q32P85|DLRB2_BOVIN","Q32P85","DLRB2",4.35e-21,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505"
"g11875",135.1656,-0.4212013,0.1345697,-3.129985,0.001748153,0.02783,0,7614,"sp|Q66403|DPOL_DHBVQ","Q66403","DPOL",2e-06,"Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]","DNA replication [GO:0006260]","GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872"
"g85527",91.7037,1.246506,0.3982647,3.129843,0.001749,0.02783664,0,7993,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.98e-18,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g30480",539.8125,-0.1960257,0.06263269,-3.129767,0.001749452,0.02783699,21515,34522,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.23e-16,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g15882",1266.892,-0.3810599,0.12176,-3.1296,0.001750446,0.02784057,54395,60846,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",6.98e-13,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g72350",650.3005,0.3079508,0.09839989,3.129585,0.001750536,0.02784057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66594",2022.074,-0.4224858,0.1350232,-3.128986,0.001754105,0.02788365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77731",189.5923,0.3289997,0.1051455,3.128995,0.001754051,0.02788365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g443",92.33343,0.2973255,0.09502628,3.128876,0.001754762,0.02788725,63305,72215,"sp|O94805|ACL6B_HUMAN","O94805","ACL6B",4.53e-24,"Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]","GO:0000776; GO:0000785; GO:0003682; GO:0003713; GO:0005200; GO:0005634; GO:0006325; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0016358; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0035060; GO:0035267; GO:0042551; GO:0043967; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0070316; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819"
"g24375",78.7954,0.5004286,0.1599458,3.128738,0.001755591,0.02789357,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138380",210.2343,0.3595507,0.1149237,3.128604,0.001756391,0.02789945,0,2924,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.49e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g45844",61.31524,0.4033051,0.1289157,3.128441,0.001757365,0.02790808,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75759",50.89332,-0.3310689,0.1058302,-3.128302,0.001758194,0.0279144,2446,9797,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.29e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3889",39.38168,-0.4295826,0.1373265,-3.128185,0.001758894,0.02791867,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110358",346.7719,0.2942824,0.0940816,3.127949,0.001760308,0.02793041,0,5401,"sp|P29218|IMPA1_HUMAN","P29218","IMPA1",9.06e-26,"Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)","inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165]","GO:0000287; GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0042802; GO:0042803; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834"
"g112121",23.94402,0.5344247,0.1708564,3.127918,0.001760496,0.02793041,0,5189,"sp|O18498|MA1A1_SPOFR","O18498","MA1A1",8.83e-22,"Mannosyl-oligosaccharide alpha-1,2-mannosidase IA (EC 3.2.1.113) (Alpha-1,2-mannosidase) (Class I alpha-1,2-mannosidase) (Man(9)-alpha-mannosidase) (SfManI)","carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]","GO:0000139; GO:0004571; GO:0005509; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0016021"
"g69505",22.21742,-0.7427343,0.2374697,-3.127702,0.001761788,0.02794406,0,5544,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.21e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g130292",163.1435,0.2676412,0.08557372,3.12761,0.001762341,0.027946,0,3608,"sp|Q6DEU3|VPS29_XENTR","Q6DEU3","VPS29",1.34e-29,"Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0032456; GO:0042147; GO:0046872"
"g19433",21.19692,-0.4639066,0.148355,-3.127002,0.001765985,0.02799598,46465,51647,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.03e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g104694",356.2259,0.5064097,0.1619505,3.12694,0.001766357,0.02799598,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77399",247.26,0.2451436,0.0784051,3.126628,0.001768233,0.02801885,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48772",72.40501,0.2878146,0.09205696,3.126483,0.001769106,0.02802583,8445,17395,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.65e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g38757",722.4305,-0.3290854,0.1052608,-3.126383,0.001769709,0.02802853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56657",128.6062,0.2949038,0.09433004,3.126298,0.001770222,0.0280286,4435,14309,"sp|Q95327|MANBA_CAPHI","Q95327","MANBA",2.29e-19,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","carbohydrate metabolic process [GO:0005975]; glycoprotein catabolic process [GO:0006516]","GO:0004567; GO:0005764; GO:0005975; GO:0006516"
"g140799",668.5772,-0.4054866,0.1297043,-3.126239,0.001770578,0.0280286,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47357",734.5206,-0.1680583,0.05376103,-3.126024,0.00177187,0.0280422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46007",46.21489,-0.3448468,0.110328,-3.125652,0.001774112,0.02806398,15165,19653,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.17e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g77121",5247.874,0.5680575,0.1817371,3.12571,0.001773762,0.02806398,0,5484,"sp|Q91060|TBA_NOTVI","Q91060","TBA",9.67e-37,"Tubulin alpha chain [Cleaved into: Detyrosinated tubulin alpha chain]","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g161564",382.0169,0.4044558,0.1294042,3.125524,0.001774888,0.02806939,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95680",94.53071,0.5224859,0.1671738,3.125406,0.001775601,0.02807381,0,3691,"sp|P12262|EF1B_ARTSA","P12262","EF1B",1.7e-18,"Elongation factor 1-beta (EF-1-beta)",NA,"GO:0003746; GO:0005853"
"g8194",239.8773,-0.311178,0.09957609,-3.125028,0.001777883,0.02810304,0,2954,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.39e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g31966",196.639,1.525663,0.4882299,3.124887,0.001778732,0.0281036,25845,32670,"sp|O95497|VNN1_HUMAN","O95497","VNN1",4.8e-08,"Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1)","acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979]","GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0035577; GO:0045087; GO:0098609; GO:1902176"
"g159527",2121.764,2.249044,0.7197222,3.124878,0.001778785,0.0281036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120150",147.8842,0.4538028,0.1452309,3.124698,0.001779877,0.02811399,0,4476,"sp|O35156|UGPA_CRIGR","O35156","UGPA",2.66e-13,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glycogen biosynthetic process [GO:0005978]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005737; GO:0005978; GO:0006011; GO:0007420; GO:0042802; GO:0046872"
"g1892",215.2197,-0.6780592,0.2170329,-3.124223,0.00178275,0.02815251,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95400",77.23695,0.8902011,0.2849788,3.123745,0.001785651,0.02819144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42284",77.49438,-0.304261,0.09741033,-3.123498,0.001787148,0.02820821,5598,19624,"sp|P21328|RTJK_DROME","P21328","RTJK",4.81e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38289",60.14507,1.121525,0.3590919,3.123226,0.001788805,0.02822749,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76736",183.2553,1.895147,0.6068232,3.123063,0.001789792,0.02823618,0,8774,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.01e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g71555",21.63143,-0.577326,0.1848696,-3.122882,0.001790895,0.0282467,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5498",72889.31,0.2456609,0.07866859,3.122731,0.001791814,0.02825384,56627,94494,"sp|P13607|ATNA_DROME","P13607","ATNA",0,"Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)","adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]","GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0016887; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573"
"g10834",255.9031,-0.3625654,0.1161077,-3.122664,0.001792219,0.02825384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10953",1804.702,-0.1833533,0.05872145,-3.122425,0.00179368,0.02825624,56116,64854,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.35e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g82283",31.9742,0.5418367,0.1735283,3.122468,0.001793416,0.02825624,0,8084,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.92e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g98112",399.2804,0.3134268,0.100375,3.12256,0.001792857,0.02825624,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35163",3390.171,-0.2553062,0.08177237,-3.122158,0.001795307,0.02826772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87745",261.3403,1.054292,0.3376877,3.12209,0.001795718,0.02826772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160310",117.0789,0.9409202,0.3013709,3.122134,0.001795453,0.02826772,0,466,"sp|P90648|MHCKB_DICDI","P90648","MHCKB",7.64e-06,"Myosin heavy chain kinase B (MHCK-B) (EC 2.7.11.7)","mitotic cytokinesis [GO:0000281]; myosin II filament disassembly [GO:0031037]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; response to differentiation-inducing factor 1 [GO:1903013]","GO:0000281; GO:0004674; GO:0005524; GO:0005737; GO:0005826; GO:0016905; GO:0018107; GO:0031037; GO:0045159; GO:0046777; GO:1903013"
"g3419",4043.833,-0.3396116,0.1088166,-3.120955,0.001802654,0.0283356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62914",1827.889,-0.3470752,0.1111991,-3.121204,0.001801133,0.0283356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63312",202.6784,0.2038127,0.06530054,3.121148,0.001801473,0.0283356,0,10568,"sp|Q4FZQ6|PR38A_XENLA","Q4FZQ6","PR38A",6.45e-25,"Pre-mRNA-splicing factor 38A","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0005634; GO:0071005"
"g86338",28.95208,0.7986457,0.2558923,3.121023,0.001802241,0.0283356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92863",23.32514,-0.6636432,0.2126184,-3.121287,0.001800624,0.0283356,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126925",529.378,-0.3745331,0.1200057,-3.120962,0.001802613,0.0283356,0,2761,"sp|Q8K0U4|HS12A_MOUSE","Q8K0U4","HS12A",1.54e-06,"Heat shock 70 kDa protein 12A",NA,"GO:0005524; GO:0005634; GO:0005737"
"g124657",143.3818,1.888613,0.6051698,3.120799,0.00180361,0.02834376,0,1072,"sp|Q9D9Q0|LRC69_MOUSE","Q9D9Q0","LRC69",8.81e-08,"Leucine-rich repeat-containing protein 69","signal transduction [GO:0007165]","GO:0007165"
"g17747",28.57088,0.5578221,0.1787926,3.119939,0.001808884,0.02837266,39471,56910,"sp|Q9VVT2|INDY1_DROME","Q9VVT2","INDY1",7.73e-20,"Protein I'm not dead yet (INDY transporter protein) (drIndy)","anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; determination of adult lifespan [GO:0008340]; pyruvate transport [GO:0006848]; regulation of sequestering of triglyceride [GO:0010889]; succinate transport [GO:0015744]","GO:0005886; GO:0005887; GO:0006848; GO:0008340; GO:0010889; GO:0015137; GO:0015141; GO:0015744; GO:0015746; GO:0016021; GO:0016323; GO:0050833; GO:0098656"
"g27299",94.9192,-0.3561265,0.1141483,-3.119857,0.00180939,0.02837266,26025,28737,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.63e-15,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g41508",303.6318,-0.3813334,0.1222235,-3.119967,0.001808713,0.02837266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80040",66.70467,-0.3131767,0.1003724,-3.120147,0.001807609,0.02837266,5739,8464,"sp|P21328|RTJK_DROME","P21328","RTJK",4.5e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g81305",92.43339,0.7062432,0.2263491,3.120151,0.001807584,0.02837266,2660,8744,"sp|P21328|RTJK_DROME","P21328","RTJK",1.23e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g94235",44.41453,0.4013518,0.1286423,3.119905,0.001809096,0.02837266,0,1934,"sp|Q96JB2|COG3_HUMAN","Q96JB2","COG3",1.31e-21,"Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0032588; GO:0033365; GO:0050821; GO:0070085"
"g104642",210.6609,-0.2883167,0.0924052,-3.120135,0.001807682,0.02837266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114164",39.11142,-0.8601154,0.2756787,-3.119992,0.001808557,0.02837266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148969",1394.533,-0.9992741,0.3202777,-3.120024,0.001808365,0.02837266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87621",1528.329,0.8343229,0.2674461,3.119592,0.001811014,0.02838439,2778,5864,"sp|O88207|CO5A1_MOUSE","O88207","CO5A1",1.36e-11,"Collagen alpha-1(V) chain","blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001568; GO:0003007; GO:0005201; GO:0005581; GO:0005588; GO:0005592; GO:0005604; GO:0005615; GO:0007155; GO:0008201; GO:0016477; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225"
"g140243",78.43345,0.3358932,0.1076718,3.119602,0.001810953,0.02838439,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g785",1117.059,-0.401156,0.1285975,-3.119469,0.001811774,0.02838909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35475",1443.484,-0.680965,0.2183018,-3.119374,0.001812356,0.02838909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70460",47.07584,1.713296,0.5492514,3.11933,0.001812629,0.02838909,0,7954,"sp|A0JPQ8|ALKMO_RAT","A0JPQ8","ALKMO",5.81e-32,"Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)","ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]","GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0016021; GO:0046485; GO:0050479"
"g73156",262.3619,-0.3762628,0.1206342,-3.119039,0.001814418,0.02841025,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121101",32.04392,1.122364,0.3598516,3.118965,0.001814876,0.02841055,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9192",57.66143,0.4490244,0.1439875,3.118496,0.001817768,0.02844208,11835,16000,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.5e-40,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g69390",40.49137,-0.5113599,0.1639753,-3.118518,0.00181763,0.02844208,5665,11055,"sp|P35789|ZNF93_HUMAN","P35789","ZNF93",4.15e-75,"Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895"
"g26157",55.21084,0.3754297,0.1203979,3.11824,0.001819344,0.02845312,30985,40729,"sp|Q8C3X4|GUF1_MOUSE","Q8C3X4","GUF1",4.6e-12,"Translation factor Guf1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase Guf1) (Ribosomal back-translocase)","positive regulation of translation [GO:0045727]; translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727; GO:0097177"
"g45624",2029.99,-0.3535833,0.113392,-3.118239,0.001819352,0.02845312,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105589",169.9386,0.3573059,0.11459,3.118126,0.001820051,0.02845718,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6391",86.5131,-0.5362932,0.1720234,-3.11756,0.001823549,0.02850499,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143782",35.63058,1.911467,0.6132487,3.116952,0.001827314,0.02855696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141231",143.9143,0.4115583,0.1320581,3.116494,0.001830152,0.02859441,0,2747,"sp|Q8K0C9|GMDS_MOUSE","Q8K0C9","GMDS",1.72e-35,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]","GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401"
"g40502",1381.641,-0.2915835,0.0935689,-3.116244,0.001831706,0.02859739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71515",2013.909,-0.4336591,0.1391568,-3.116335,0.001831142,0.02859739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114888",114.4083,-0.6886646,0.2209935,-3.116221,0.001831847,0.02859739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162079",113.6477,2.071263,0.6646804,3.116179,0.001832108,0.02859739,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136909",21.25425,0.6308413,0.2024456,3.116103,0.001832582,0.0285979,0,3080,"sp|Q2PZL6|FAT4_MOUSE","Q2PZL6","FAT4",6.47e-19,"Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609"
"g160643",48.03751,0.544211,0.1746538,3.115941,0.001833588,0.02860672,0,1153,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",1.29e-13,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g158488",51.24571,0.8275446,0.2656042,3.115706,0.001835051,0.02862264,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24374",51.03573,0.4246633,0.1363076,3.115477,0.001836476,0.02863797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11681",202.2732,0.3077307,0.09878966,3.115009,0.001839393,0.02866483,48816,73414,"sp|A4Z943|ZBED5_BOVIN","A4Z943","ZBED5",9.17e-33,"Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein)",NA,"GO:0003677; GO:0046872"
"g47855",220.3585,0.8524278,0.2736496,3.115034,0.001839236,0.02866483,3926,14554,"sp|Q8IFN0|YD115_PLAF7","Q8IFN0","YD115",3.76e-06,"Uncharacterized protein PFD1115c",NA,"GO:0016021"
"g87502",534.5146,0.4205721,0.1350187,3.114917,0.001839968,0.02866483,0,2485,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.32e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g148761",44.88694,0.5948839,0.1909769,3.114952,0.001839747,0.02866483,0,2099,"sp|Q5WRU0|OIG4_CAEEL","Q5WRU0","OIG4",4.42e-07,"Immunoglobulin domain-containing protein oig-4",NA,"GO:0005615; GO:0031594"
"g13019",769.2491,0.3799723,0.1220006,3.114512,0.001842493,0.02869727,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15097",286.4828,0.3939778,0.1265065,3.114289,0.001843889,0.02871211,9805,36732,"sp|Q8MI17|AL1A1_RABIT","Q8MI17","AL1A1",3.99e-20,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.3) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1) (RALDH 1) (RalDH1)","cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]","GO:0001523; GO:0001758; GO:0004029; GO:0005829; GO:0009449; GO:0018479; GO:0019145; GO:0030392; GO:0030424; GO:0036438; GO:0042572; GO:0043878; GO:0045202; GO:0106373; GO:0110095"
"g12887",4146.127,-0.2821361,0.09060463,-3.113926,0.00184616,0.02872677,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27473",29.72865,-0.7346331,0.2359116,-3.114019,0.001845578,0.02872677,33246,36564,"sp|A6NNF4|ZN726_HUMAN","A6NNF4","ZN726",1.76e-61,"Zinc finger protein 726","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g151538",552.4907,0.3861084,0.1239933,3.113947,0.001846026,0.02872677,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101090",70.58408,0.3427614,0.1100783,3.113797,0.001846965,0.02873239,0,6372,"sp|P17425|HMCS1_RAT","P17425","HMCS1",1.89e-16,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)","acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to organic cyclic compound [GO:0071407]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; liver development [GO:0001889]; male gonad development [GO:0008584]; response to cholesterol [GO:0070723]; response to gonadotropin [GO:0034698]; response to hormone [GO:0009725]; response to low light intensity stimulus [GO:0009645]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]","GO:0001889; GO:0004421; GO:0005829; GO:0006084; GO:0006695; GO:0007420; GO:0008584; GO:0009410; GO:0009645; GO:0009725; GO:0010033; GO:0010142; GO:0014070; GO:0014074; GO:0016853; GO:0033197; GO:0034698; GO:0036094; GO:0042803; GO:0043177; GO:0046690; GO:0070723; GO:0071372; GO:0071397; GO:0071404; GO:0071407"
"g79487",276.0738,-0.4784051,0.1536761,-3.113074,0.001851496,0.02879448,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148798",33.45409,-0.8039151,0.258243,-3.113018,0.001851845,0.02879448,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128179",41.17615,1.278241,0.4106462,3.112756,0.001853493,0.02881319,0,3354,"sp|Q58D31|DHSO_BOVIN","Q58D31","DHSO",2.61e-17,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)","flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526"
"g29993",691.9585,0.3907223,0.1255358,3.112437,0.001855496,0.02883741,0,6174,"sp|Q01604|PGK_DROME","Q01604","PGK",8.5e-28,"Phosphoglycerate kinase (EC 2.7.2.3)","chemical synaptic transmission [GO:0007268]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; phosphorylation [GO:0016310]","GO:0004618; GO:0005524; GO:0005829; GO:0006094; GO:0006096; GO:0007268; GO:0016310; GO:0030018; GO:0031430; GO:0043531; GO:0045202; GO:0046716"
"g119636",230.9501,0.4673656,0.1501731,3.112179,0.001857117,0.02885569,0,4522,"sp|P40301|PSA2_DROME","P40301","PSA2",6.37e-24,"Proteasome subunit alpha type-2 (PROS-Dm25) (Proteasome 25 kDa subunit)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161"
"g144956",120.97,0.3243171,0.1042145,3.112014,0.001858154,0.02886487,0,1811,"sp|A1Z9L3|DHX8_DROME","A1Z9L3","DHX8",1.68e-18,"ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (Peanuts)","chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex disassembly [GO:0000390]; ventral cord development [GO:0007419]","GO:0000381; GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006325; GO:0007419; GO:0016887; GO:0030261; GO:0048477; GO:0071011; GO:0071013"
"g69523",236.6649,-0.8094642,0.2601333,-3.111728,0.001859958,0.02888596,0,11022,"sp|P19213|CREA_FLASU","P19213","CREA",5.2e-34,"Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)",NA,"GO:0016980"
"g143218",47.73073,0.8387218,0.2695431,3.111643,0.001860495,0.02888738,0,2584,"sp|O95571|ETHE1_HUMAN","O95571","ETHE1",1.51e-06,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)","glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]","GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813"
"g64835",54.99341,0.8890582,0.2857763,3.111028,0.001864371,0.02893421,0,7534,"sp|Q5DRA3|PCDGL_PANTR","Q5DRA3","PCDGL",4e-08,"Protocadherin gamma-C4 (PCDH-gamma-C4)","cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005887; GO:0007155; GO:0007156"
"g69755",1713.512,-0.4548888,0.1462239,-3.110906,0.001865145,0.02893421,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92454",343.316,-0.2947612,0.09474969,-3.110946,0.001864888,0.02893421,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113217",66.40282,0.3527284,0.1133854,3.110882,0.001865297,0.02893421,3211,4534,"sp|Q9VF89|RM09_DROME","Q9VF89","RM09",3.13e-12,"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543"
"g91653",30.33795,0.3899735,0.1253716,3.110541,0.001867448,0.02894678,425,2933,"sp|P21328|RTJK_DROME","P21328","RTJK",1.25e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g117541",184.265,0.4813658,0.1547463,3.110677,0.001866592,0.02894678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158446",238.7789,0.363618,0.116896,3.11061,0.001867013,0.02894678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61397",158.6902,-0.3515043,0.1130133,-3.110291,0.001869034,0.02895668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69804",55.34009,-0.4778655,0.153638,-3.110334,0.001868761,0.02895668,3571,10955,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.16e-28,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83795",189.6313,0.2495781,0.0802443,3.110228,0.001869427,0.02895668,5116,8294,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.86e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g67179",3811.764,0.4625278,0.1487225,3.110006,0.001870835,0.02896463,7915,11555,"sp|Q9VEN1|FLNA_DROME","Q9VEN1","FLNA",1.96e-39,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","actin crosslink formation [GO:0051764]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]; syncytial embryo cellularization [GO:0110069]","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051015; GO:0051495; GO:0051764; GO:0110069"
"g112264",38.9257,0.6744703,0.2168692,3.110032,0.001870669,0.02896463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87344",1871.527,-0.3260691,0.1048558,-3.109692,0.001872827,0.02898163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88734",26.49176,0.5826934,0.1873777,3.109727,0.001872606,0.02898163,0,5121,"sp|P58742|AAAS_MOUSE","P58742","AAAS",1.72e-06,"Aladin (Adracalin)","fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]","GO:0000922; GO:0001578; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0031965; GO:0051028; GO:0072686; GO:0090307"
"g6539",398.9351,-0.4215641,0.1355702,-3.109563,0.001873643,0.02898733,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65094",842.838,-0.406452,0.1307192,-3.109353,0.001874978,0.02900107,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19515",1674.372,-0.6080175,0.1955571,-3.109156,0.001876225,0.02901342,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68055",30.58577,0.7368672,0.2370183,3.108904,0.001877829,0.0290313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37575",828.5628,-0.3147425,0.1012539,-3.108448,0.001880724,0.02905526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90212",562.0917,-0.3119797,0.1003643,-3.108472,0.001880575,0.02905526,0,5734,"sp|Q8IUZ5|AT2L2_HUMAN","Q8IUZ5","AT2L2",1.3e-07,"5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2)",NA,"GO:0005759; GO:0008483; GO:0016829; GO:0030170; GO:0042802"
"g151147",984.6019,0.2625588,0.08446288,3.108571,0.001879946,0.02905526,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153831",82.69799,0.539054,0.1734326,3.108148,0.001882639,0.02907791,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83299",43.95994,2.009007,0.6465587,3.107231,0.001888488,0.02916129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15662",51.82285,0.644265,0.2073493,3.107149,0.001889015,0.02916248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126092",469.5733,0.3235713,0.1041459,3.106903,0.001890585,0.02917555,1012,3014,"sp|Q8MKK4|TRE12_DROME","Q8MKK4","TRE12",2.23e-94,"Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)",NA,"GO:0005886; GO:0016020; GO:0016021; GO:0051119"
"g136803",24.36376,1.146936,0.3691605,3.106875,0.001890762,0.02917555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87729",817.3177,0.3187809,0.102611,3.106694,0.001891923,0.02918234,0,7995,"sp|P54385|DHE3_DROME","P54385","DHE3",7.42e-29,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g127906",39.42202,0.4633175,0.1491366,3.106666,0.001892102,0.02918234,0,3796,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.62e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g28964",1646.344,-0.1965694,0.06328345,-3.106174,0.001895251,0.02922394,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7496",672.2471,-0.2995724,0.09644875,-3.106027,0.001896196,0.02922559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20292",225.2931,-0.3980859,0.1281677,-3.105977,0.001896518,0.02922559,34985,39981,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.5e-10,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g46843",48.97867,-0.380782,0.1226033,-3.105806,0.001897614,0.02922559,2565,10826,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.14e-31,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g53017",167.7127,0.843751,0.2716676,3.105821,0.001897516,0.02922559,10735,14015,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.08e-10,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g135060",631.0646,-0.3887535,0.1251686,-3.105839,0.0018974,0.02922559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89278",154.3862,-0.3294728,0.1061015,-3.10526,0.001901118,0.02927261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4942",554.6248,-0.2886574,0.09298899,-3.10421,0.001907877,0.02935519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18506",4042.41,0.353138,0.113763,3.104156,0.001908224,0.02935519,5345,22275,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.48e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g75713",136.8238,0.7000929,0.2255363,3.104124,0.001908431,0.02935519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100394",26.33788,1.176549,0.3790215,3.104174,0.001908113,0.02935519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121188",98.31354,0.3005811,0.09683435,3.104075,0.001908746,0.02935519,0,4384,"sp|Q9H553|ALG2_HUMAN","Q9H553","ALG2",4.09e-40,"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)","dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]","GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704"
"g26983",127.5815,0.4556443,0.1467927,3.103998,0.001909246,0.02935591,32730,36234,"sp|P51659|DHB4_HUMAN","P51659","DHB4",4.89e-15,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"g94452",97.67621,0.5335034,0.1718843,3.103852,0.00191019,0.02936345,2155,4243,"sp|Q9GUM2|BRE4_CAEEL","Q9GUM2","BRE4",9.74e-18,"Beta-1,4-N-acetylgalactosaminyltransferase bre-4 (EC 2.4.1.-) (Bacillus thuringiensis toxin-resistant protein 4) (Bt toxin-resistant protein 4) (Beta-4-GalNAcT)","carbohydrate metabolic process [GO:0005975]; glycosylation [GO:0070085]; positive regulation of Notch signaling pathway [GO:0045747]; protein glycosylation [GO:0006486]; response to toxic substance [GO:0009636]","GO:0005794; GO:0005975; GO:0006486; GO:0008376; GO:0009636; GO:0016021; GO:0033207; GO:0045747; GO:0046872; GO:0070085"
"g115960",92.16751,1.013857,0.3267,3.103327,0.001913583,0.02940863,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152053",36.25899,0.4562863,0.1470382,3.103182,0.001914517,0.02941601,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94306",41.8162,0.5177421,0.1668553,3.10294,0.001916082,0.02943307,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64483",70.87865,0.4515816,0.1455584,3.102409,0.001919523,0.02947195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137788",38.31655,0.4606693,0.1484869,3.102424,0.00191943,0.02947195,0,3016,"sp|Q8C1A5|THOP1_MOUSE","Q8C1A5","THOP1",8.77e-24,"Thimet oligopeptidase (EC 3.4.24.15)","intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]","GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0046872"
"g33458",707.2935,0.8879974,0.2862434,3.102246,0.001920582,0.02948123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142928",31.82724,0.9133566,0.294432,3.102097,0.001921549,0.02948908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75711",2914.058,-0.4588195,0.1479144,-3.101926,0.001922662,0.02949918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25579",20.49054,-0.6268594,0.2020966,-3.101781,0.0019236,0.02950658,5693,10764,"sp|Q32PP1|MRNIP_DANRE","Q32PP1","MRNIP",2.97e-06,"MRN complex-interacting protein (MRN-interacting protein)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]","GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032"
"g151263",748.5252,0.5777352,0.1862647,3.101689,0.001924197,0.02950876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78248",26.69565,0.6163202,0.198727,3.10134,0.001926467,0.02952959,0,7721,"sp|Q96PD6|MOGT1_HUMAN","Q96PD6","MOGT1",7.48e-13,"2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Diacylglycerol O-acyltransferase candidate 2) (hDC2) (Diacylglycerol acyltransferase 2-like protein 1) (Monoacylglycerol O-acyltransferase 1)","diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006629; GO:0006651; GO:0016021; GO:0019432"
"g109954",540.0805,0.2927771,0.09440291,3.101356,0.001926363,0.02952959,0,4664,"sp|O97159|CHDM_DROME","O97159","CHDM",7e-29,"Chromodomain-helicase-DNA-binding protein Mi-2 homolog (EC 3.6.4.12) (ATP-dependent helicase Mi-2) (dMi-2)","chromosome condensation [GO:0030261]; chromosome decondensation [GO:0051312]; chromosome organization [GO:0051276]; negative regulation of cohesin loading [GO:0071923]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000122; GO:0000791; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005700; GO:0005829; GO:0006357; GO:0007283; GO:0008270; GO:0016581; GO:0016887; GO:0030261; GO:0031491; GO:0042766; GO:0045892; GO:0051276; GO:0051312; GO:0071923; GO:0140658"
"g18628",55.21832,1.115449,0.3596752,3.101266,0.001926949,0.02953,0,16970,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.03e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g28947",1739.207,-0.2135019,0.06884795,-3.101065,0.001928262,0.02953615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41174",2268.906,-0.2074113,0.06688368,-3.101076,0.001928191,0.02953615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5147",2208.055,-0.2733637,0.08815872,-3.100813,0.001929899,0.02955423,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72505",34.32903,-0.4610448,0.1486959,-3.100589,0.001931363,0.02956966,0,6803,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.4e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g81455",68.97987,-0.8908163,0.2873195,-3.100439,0.001932343,0.02957768,0,8891,"sp|P21328|RTJK_DROME","P21328","RTJK",1.29e-36,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68475",332.0552,-0.4200949,0.1355041,-3.100238,0.00193365,0.02958444,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91438",66.32703,-0.4390894,0.1416312,-3.100231,0.001933698,0.02958444,0,6380,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.29e-26,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13517",224.5201,0.3014707,0.09724808,3.100017,0.001935097,0.02959886,9625,14374,"sp|O46037|VINC_DROME","O46037","VINC",2.81e-15,"Vinculin","cell adhesion [GO:0007155]","GO:0005198; GO:0005737; GO:0005912; GO:0005925; GO:0007155; GO:0015629; GO:0051015; GO:0098592"
"g53348",104.4894,0.3827802,0.1234902,3.09968,0.001937298,0.02962553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23925",1424.311,0.5920293,0.1910151,3.099385,0.001939229,0.02964805,2288,4934,"sp|P70691|UD12_MOUSE","P70691","UD12",3.24e-12,"UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2)","flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]","GO:0001972; GO:0005783; GO:0005789; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0046982; GO:0052696; GO:0052697"
"g115026",36.33291,1.232151,0.3976361,3.098691,0.001943779,0.02970361,0,4959,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.35e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g134139",17.38546,1.715867,0.5537279,3.098755,0.001943353,0.02970361,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7979",53.92924,-0.9222125,0.2976223,-3.0986,0.001944374,0.0297048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64754",2886.104,-0.2597001,0.08381562,-3.098469,0.001945233,0.0297048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90089",52.71768,-0.8348833,0.2694473,-3.098503,0.001945007,0.0297048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14600",101.796,-0.3440997,0.1110651,-3.098181,0.001947128,0.02971973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137967",102.4405,0.3104,0.1001862,3.09823,0.001946802,0.02971973,0,1270,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.17e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g50404",2029.779,-0.2947384,0.09514685,-3.097721,0.00195015,0.02975885,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53532",23.93713,1.215328,0.3924357,3.096885,0.001955658,0.02983587,11801,15775,"sp|A8YPR9|SVMI1_CERCE","A8YPR9","SVMI1",9e-13,"Snake venom metalloprotease inhibitor 02A10 (01F09) [Cleaved into: Tripeptide pEKW 1; Tripeptide pEKW 2; Tripeptide pEKW 3; Tripeptide pEKW 4; Tripeptide pEKW 5; Tripeptide pEKW 6; Tripeptide pEKW 7; Tripeptide pEKW 8; Tripeptide pEKW 9; Tripeptide pEKW 10; Tripeptide pEKW 11; Tripeptide pEKW 12; Tripeptide pEKW 13; Tripeptide pEKW 14; Tripeptide pEKW 15; Tripeptide pEKW 16; Tripeptide pEKW 17; C-type natriuretic peptide (CNP)]","regulation of blood pressure [GO:0008217]; vasodilation [GO:0042311]","GO:0005576; GO:0008191; GO:0008217; GO:0042311; GO:0090729"
"g77865",187.8656,-0.2842729,0.09179655,-3.096772,0.001956405,0.02984024,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2739",23.04867,-0.5508649,0.1778966,-3.096545,0.001957903,0.02985606,88505,98724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.11e-45,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65015",17.22341,-0.6265082,0.2023375,-3.096352,0.001959178,0.02986848,1995,3595,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.96e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g91226",48.47756,0.6431644,0.2077567,3.095757,0.001963113,0.02991438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145664",1092.821,0.9985129,0.3225407,3.095774,0.001963,0.02991438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15142",31.70425,1.07493,0.3472404,3.095635,0.00196392,0.02991965,0,2074,"sp|Q9H3S4|TPK1_HUMAN","Q9H3S4","TPK1",1.5e-06,"Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1)","thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0042802"
"g45627",4369.294,0.7153192,0.2310967,3.095325,0.001965976,0.02994393,12888,13964,"sp|P15870|H1D_STRPU","P15870","H1D",9.09e-10,"Histone H1-delta","chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]","GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0016584; GO:0030261; GO:0031492; GO:0045910"
"g57769",32.63966,0.6105047,0.1972461,3.095142,0.001967185,0.02994826,0,11614,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.05e-65,"PiggyBac transposable element-derived protein 4",NA,NA
"g143878",221.2085,0.2910101,0.09402063,3.095173,0.001966985,0.02994826,0,2525,"sp|Q5U3N5|PPTC7_DANRE","Q5U3N5","PPTC7",3e-17,"Protein phosphatase PTC7 homolog (EC 3.1.3.16)",NA,"GO:0004722; GO:0005739; GO:0005759; GO:0046872"
"g139863",1721.912,0.8539661,0.2759214,3.094961,0.001968386,0.02995951,0,2854,"sp|P53464|ACTM_HELTB","P53464","ACTM",6.75e-19,"Actin, cytoskeletal (M)",NA,"GO:0005524; GO:0005737; GO:0005856"
"g132105",97.803,0.6536999,0.2112498,3.09444,0.001971846,0.03000512,0,3460,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.69e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g34419",409.8903,0.3218755,0.1040214,3.09432,0.001972645,0.03001005,0,28565,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.62e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g104912",192.8251,0.3977862,0.1285594,3.094183,0.001973559,0.03001005,0,3824,"sp|P21328|RTJK_DROME","P21328","RTJK",1.65e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g148648",61.41154,0.702485,0.2270298,3.094242,0.001973166,0.03001005,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17997",1082.002,-0.3172587,0.1025619,-3.09334,0.001979174,0.03007798,6836,16484,"sp|O73792|TIE1_DANRE","O73792","TIE1",9.71e-30,"Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) (Fragment)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004712; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0007507; GO:0033674; GO:0043235; GO:0045766; GO:0071603"
"g19622",380.0747,-0.1781775,0.05760244,-3.093228,0.00197992,0.03007798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27294",3965.42,-0.4980692,0.1610234,-3.093149,0.00198045,0.03007798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27550",133.8272,0.7567036,0.2446484,3.093025,0.001981276,0.03007798,30155,33882,"sp|Q28CN3|UBP33_XENTR","Q28CN3","UBP33",3.66e-08,"Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33)","axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108"
"g39776",750.7337,-0.4588842,0.1483519,-3.093214,0.00198001,0.03007798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81524",183.9795,0.3753742,0.1213611,3.093037,0.001981198,0.03007798,0,7824,"sp|P33947|ERD22_HUMAN","P33947","ERD22",1.08e-15,"ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0035437; GO:0046923"
"g107487",57.94821,-0.3737044,0.1208117,-3.09328,0.001979573,0.03007798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102329",571.9066,-0.4072109,0.1316604,-3.092888,0.001982186,0.03008475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6670",127.5618,0.3146142,0.1017484,3.092082,0.00198758,0.03013838,66745,73635,"sp|Q3UGY8|BIG3_MOUSE","Q3UGY8","BIG3",1.01e-16,"Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3)","actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]","GO:0005085; GO:0016021; GO:0030036; GO:0030658; GO:0032012"
"g42874",1465.407,-0.3706439,0.1198637,-3.092211,0.001986719,0.03013838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46209",1581.04,-0.3215572,0.1039895,-3.092207,0.001986743,0.03013838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73688",121.5738,-0.5746339,0.1858388,-3.09211,0.001987392,0.03013838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38427",109.5138,-0.4285131,0.138591,-3.091926,0.001988621,0.0301471,478,3294,"sp|Q8TF32|ZN431_HUMAN","Q8TF32","ZN431",1.54e-56,"Zinc finger protein 431","cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872"
"g27145",74.62009,0.3375877,0.1091868,3.091836,0.001989228,0.03014925,0,39304,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.88e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11702",1078.011,0.6992187,0.2261645,3.091637,0.001990558,0.0301509,1715,27340,"sp|Q66H76|PAXI_RAT","Q66H76","PAXI",1.08e-33,"Paxillin","branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001725; GO:0003712; GO:0005078; GO:0005178; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0017166; GO:0018108; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0031252; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0045860; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1901652"
"g11744",1366.764,-0.4174102,0.1350083,-3.091737,0.001989888,0.0301509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15052",209.9428,-0.4110255,0.1329536,-3.091496,0.001991507,0.0301509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25045",2779.938,-0.3015947,0.09756163,-3.091325,0.001992657,0.0301509,15726,32384,"sp|Q08BB5|CTL2A_DANRE","Q08BB5","CTL2A",5.47e-11,"CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-)",NA,"GO:0004721"
"g48952",479.7715,0.2829084,0.09151671,3.091331,0.001992613,0.0301509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82308",502.7821,0.4141938,0.1339884,3.091267,0.001993044,0.0301509,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g88455",477.6511,0.5123618,0.1657488,3.091195,0.001993525,0.0301509,7506,7896,"sp|Q9I7U4|TITIN_DROME","Q9I7U4","TITIN",6.79e-10,"Titin (D-Titin) (Kettin)","cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]","GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301"
"g103514",22.32643,0.6468416,0.2092419,3.091358,0.001992433,0.0301509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147015",197.129,0.6123432,0.1980894,3.091246,0.001993183,0.0301509,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14069",1631.696,-0.4142406,0.1340206,-3.090872,0.001995697,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17724",2345.255,-0.4754971,0.1538488,-3.090678,0.001997003,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80548",170.7974,-0.3260599,0.1055044,-3.090486,0.00199829,0.03015797,2336,6394,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.06e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g89272",6341.818,1.930522,0.6246768,3.090433,0.001998647,0.03015797,395,5154,"sp|P25782|CYSP2_HOMAM","P25782","CYSP2",1.79e-24,"Digestive cysteine proteinase 2 (EC 3.4.22.-)",NA,"GO:0008234"
"g90424",52.23185,0.8532539,0.2760682,3.090736,0.001996608,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92214",120.2216,0.3788981,0.1225882,3.09082,0.001996046,0.03015797,0,7420,"sp|Q5ZIT8|TAF2_CHICK","Q5ZIT8","TAF2",1.62e-17,"Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)","transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000976; GO:0003682; GO:0005669; GO:0006367"
"g110037",954.4055,0.8071058,0.2611515,3.090565,0.001997758,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126147",60.04517,0.3760716,0.1216787,3.090693,0.001996899,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136160",85.65949,0.5937872,0.1921025,3.090992,0.001994887,0.03015797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152815",152.064,0.4177974,0.1351838,3.090588,0.001997603,0.03015797,225,1738,"sp|Q7K4Q5|Y0417_DROME","Q7K4Q5","Y0417",5.66e-07,"Probable protein phosphatase CG10417 (EC 3.1.3.16)","protein dephosphorylation [GO:0006470]","GO:0004722; GO:0005737; GO:0006470; GO:0046872"
"g6355",2505.682,-0.2074838,0.06714226,-3.090212,0.002000139,0.03017346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114159",142.7049,0.3136588,0.1015033,3.090134,0.002000665,0.03017437,1892,4194,"sp|Q8R3F5|FABD_MOUSE","Q8R3F5","FABD",3.51e-14,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase)","fatty acid biosynthetic process [GO:0006633]","GO:0004312; GO:0004314; GO:0005739; GO:0006633"
"g41474",58.42184,0.6629069,0.2145526,3.089717,0.002003476,0.03020806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139632",71.33143,0.3812965,0.1234103,3.089664,0.002003831,0.03020806,0,2564,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.17e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16191",330.7086,0.4202937,0.1360448,3.089377,0.00200577,0.03023025,9185,11301,"sp|P12613|TCPA_DROME","P12613","TCPA",3.28e-13,"T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing TCP1 subunit 1)","ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]","GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0030707; GO:0051082"
"g6003",1631.757,-0.2867938,0.09284386,-3.08899,0.00200838,0.0302553,82345,89894,"sp|P21329|RTJK_DROFU","P21329","RTJK",4.96e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g23092",3075.837,-0.2443763,0.0791147,-3.088886,0.002009083,0.0302553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36853",193.1111,0.3037589,0.09833724,3.088951,0.002008646,0.0302553,2874,27053,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.85e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g70106",53.53473,-0.5125156,0.1659264,-3.088813,0.002009577,0.0302553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102208",1877.58,-0.7578912,0.2453687,-3.088785,0.002009766,0.0302553,1836,4344,"sp|Q5XIV0|TET5C_RAT","Q5XIV0","TET5C",5.64e-145,"Terminal nucleotidyltransferase 5C (EC 2.7.7.19)","in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596]","GO:0001701; GO:0003723; GO:0004652; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0045596; GO:0048255; GO:1990817"
"g104010",102.2455,0.4154922,0.1345198,3.088706,0.002010303,0.03025634,0,6057,"sp|Q29DG0|U389_DROPS","Q29DG0","U389",1.09e-13,"UPF0389 protein GA21628",NA,"GO:0016021"
"g55484",2367.385,-0.3969506,0.1285229,-3.088559,0.002011298,0.0302598,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99255",104.5139,0.7401083,0.2396309,3.088534,0.002011467,0.0302598,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39783",1299.823,0.4232989,0.1370663,3.088279,0.002013193,0.03027875,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96841",66.01113,0.4059449,0.1314535,3.088126,0.002014229,0.03028729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72980",2146.096,0.6193073,0.2005684,3.087762,0.002016701,0.03031743,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66156",122.1843,1.688831,0.547012,3.087375,0.002019327,0.03034282,0,10398,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.67e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85120",183.0069,0.3159732,0.1023417,3.087435,0.002018922,0.03034282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138579",59.17511,0.6548947,0.2121294,3.087242,0.002020228,0.03034932,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41885",137.83,-0.3576055,0.1158396,-3.087075,0.002021365,0.03035936,13242,15814,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.9e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g157241",49.62648,0.7801092,0.2527297,3.086733,0.002023694,0.0303873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99543",22.78978,0.5331292,0.1727212,3.086646,0.002024285,0.03038913,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66713",27.75255,0.406636,0.1317502,3.086415,0.002025856,0.03040234,0,11667,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",1.58e-112,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g145194",252.5203,0.4520788,0.1464755,3.086379,0.002026103,0.03040234,0,1674,"sp|P18422|PSA3_RAT","P18422","PSA3",6.98e-14,"Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit K)","proteasomal protein catabolic process [GO:0010498]; regulation of endopeptidase activity [GO:0052548]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0010498; GO:0019773; GO:0031625; GO:0045202; GO:0052548"
"g9070",744.6764,-0.3137839,0.1016753,-3.086136,0.002027759,0.03042015,9069,12014,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.7e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g59079",228.6959,0.725743,0.2351915,3.085753,0.002030375,0.03045233,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38392",74.92187,-0.3356028,0.108767,-3.08552,0.002031969,0.03046918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76233",405.3119,0.2070852,0.06712111,3.085247,0.002033833,0.03048773,0,8874,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.59e-21,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g80350",19.63413,0.6720855,0.2178417,3.085201,0.002034146,0.03048773,3665,9064,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",5.28e-60,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g89184",347.2907,1.944243,0.6302169,3.085039,0.002035258,0.03049028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160456",28.21465,0.5648914,0.183103,3.085102,0.002034823,0.03049028,0,1164,"sp|Q13011|ECH1_HUMAN","Q13011","ECH1",2.54e-12,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)","fatty acid beta-oxidation [GO:0006635]","GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016020; GO:0051750; GO:0070062"
"g66465",49.89393,0.8316648,0.2695871,3.084957,0.002035813,0.03049154,5866,8594,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.53e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g132164",89.40839,-0.3790356,0.1228854,-3.084464,0.00203919,0.03053507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98995",488.3538,-0.3603759,0.1168393,-3.084372,0.002039826,0.03053753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13496",959.9674,-0.2754856,0.08932252,-3.084167,0.002041231,0.03054445,45752,60644,"sp|Q6ZMW2|ZN782_HUMAN","Q6ZMW2","ZN782",2.16e-65,"Zinc finger protein 782","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g31960",189.2923,1.53026,0.4961632,3.084187,0.002041092,0.03054445,25667,31354,"sp|O95497|VNN1_HUMAN","O95497","VNN1",3.9e-08,"Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1)","acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979]","GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0035577; GO:0045087; GO:0098609; GO:1902176"
"g17907",64.44404,0.3623881,0.1175071,3.083968,0.002042595,0.03055308,33219,35334,"sp|P24785|MLE_DROME","P24785","MLE",4.25e-14,"Dosage compensation regulator (EC 3.6.4.13) (ATP-dependent RNA helicase mle) (Protein male-less) (Protein maleless) (Protein no action potential)","axon extension [GO:0048675]; determination of adult lifespan [GO:0008340]; DNA duplex unwinding [GO:0032508]; dosage compensation [GO:0007549]; dosage compensation by hyperactivation of X chromosome [GO:0009047]; male courtship behavior, veined wing generated song production [GO:0045433]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]","GO:0000228; GO:0000785; GO:0000805; GO:0001069; GO:0003678; GO:0003682; GO:0003690; GO:0003723; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005694; GO:0005700; GO:0005730; GO:0005737; GO:0005829; GO:0007549; GO:0008340; GO:0009047; GO:0016456; GO:0016887; GO:0031453; GO:0032508; GO:0033679; GO:0034458; GO:0043138; GO:0045433; GO:0045944; GO:0048675; GO:0050684; GO:0072487; GO:0106222; GO:1990904; GO:2000373; GO:2000765"
"g92630",221.5441,0.7976658,0.2586568,3.083877,0.002043222,0.03055308,0,4913,"sp|P0DMQ6|DHSO_CHICK","P0DMQ6","DHSO",1.32e-08,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase)","fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; L-xylitol catabolic process [GO:0051160]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006000; GO:0006061; GO:0006062; GO:0006116; GO:0006735; GO:0008270; GO:0031514; GO:0031966; GO:0032991; GO:0042802; GO:0046370; GO:0051160; GO:0051287; GO:0070062"
"g102898",139.7802,0.6861788,0.2225033,3.083904,0.002043033,0.03055308,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2066",236.373,-0.371167,0.1203604,-3.083798,0.002043762,0.0305541,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128721",132.0501,0.42134,0.1366377,3.083629,0.002044923,0.03056441,0,3416,"sp|P20232|TFS2_DROME","P20232","TFS2",3.09e-16,"Transcription elongation factor S-II (RNA polymerase II elongation factor DMS-II) (TFIIS)","transcription, DNA-templated [GO:0006351]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0003677; GO:0005634; GO:0006351; GO:0006368; GO:0008270"
"g24248",112.456,0.516587,0.1675604,3.08299,0.002049318,0.03061633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27265",1818.935,-0.2571345,0.08340434,-3.082987,0.002049342,0.03061633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32580",1325.608,0.4292653,0.1392426,3.082859,0.002050225,0.03062247,1875,6778,"sp|Q96I24|FUBP3_HUMAN","Q96I24","FUBP3",5.6e-10,"Far upstream element-binding protein 3 (FUSE-binding protein 3)","positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]","GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006351; GO:0010468; GO:0010628; GO:0016020; GO:0045893; GO:0045944"
"g20506",683.0432,0.7143756,0.2317508,3.082516,0.002052589,0.0306507,0,11923,"sp|Q8MJC3|CASP3_RABIT","Q8MJC3","CASP3",5.79e-06,"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]","positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]","GO:0004175; GO:0005737; GO:0006508; GO:0031647; GO:0097153; GO:0097199; GO:1902004"
"g114002",79.65251,-0.2867714,0.09303375,-3.082445,0.002053079,0.03065096,1540,5061,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.39e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g30564",18.77773,-0.5600905,0.1817283,-3.082021,0.002056005,0.0306805,18305,23070,"sp|P21328|RTJK_DROME","P21328","RTJK",7.12e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g101626",209.9081,0.3907816,0.1267928,3.082049,0.002055813,0.0306805,0,3374,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.36e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g49762",94.15222,0.4715428,0.1530028,3.081922,0.002056689,0.03068364,0,11216,"sp|Q4LDE5|SVEP1_HUMAN","Q4LDE5","SVEP1",8.11e-14,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193"
"g3282",774.7367,-0.3877856,0.1258517,-3.08129,0.002061061,0.03074178,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25757",1558.92,-0.2796219,0.09075233,-3.081154,0.002062003,0.03074519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74618",184.7403,0.2928499,0.0950466,3.08112,0.002062238,0.03074519,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82876",301.9488,0.3049771,0.09899959,3.080589,0.002065913,0.03079289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120655",336.5849,0.4132979,0.1341657,3.080504,0.002066504,0.03079462,575,3887,"sp|Q5XHA2|ERD21_XENTR","Q5XHA2","ERD21",2.72e-12,"ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1) (KDEL receptor 1)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mesendoderm development [GO:0048382]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030663; GO:0033116; GO:0046923; GO:0048382"
"g64423",225.1274,-0.6130088,0.1990043,-3.080379,0.002067374,0.0308005,6615,12196,"sp|Q6IQ26|DEN5A_HUMAN","Q6IQ26","DEN5A",1.37e-06,"DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1)","negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147"
"g82887",1412.541,-0.4047786,0.1314108,-3.080254,0.002068238,0.03080629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154398",482.4026,1.943685,0.6310378,3.08014,0.002069035,0.03081108,0,1604,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",7.31e-20,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g62057",45.38652,1.193095,0.3873837,3.07988,0.002070843,0.03083091,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83365",194.1261,-0.5157994,0.1674779,-3.079806,0.002071356,0.03083146,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68703",70.09091,0.6102976,0.1981709,3.079653,0.002072419,0.03084021,0,11216,"sp|Q09326|MGAT2_RAT","Q09326","MGAT2",2.02e-18,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803"
"g34352",269.4034,0.5507955,0.1788702,3.079302,0.002074863,0.03085798,0,5874,"sp|Q9PTW9|PSA7_CARAU","Q9PTW9","PSA7",5.59e-19,"Proteasome subunit alpha type-7 (Proteasome subunit alpha 4)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773"
"g65331",18.18804,1.056118,0.3429768,3.079271,0.002075081,0.03085798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90796",147.1219,-0.2610065,0.08476418,-3.079208,0.002075519,0.03085798,0,7589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.9e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g121232",310.3125,0.2482581,0.08062144,3.079307,0.002074829,0.03085798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33186",1637.727,-0.332624,0.1080281,-3.079049,0.002076623,0.03086731,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124191",342.7767,2.27737,0.7396901,3.078816,0.002078251,0.03088443,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1883",224.5854,-0.352732,0.1146002,-3.077936,0.0020844,0.03092746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12706",82.98761,0.3918385,0.1273012,3.078043,0.002083646,0.03092746,40795,42810,"sp|P42695|CNDD3_HUMAN","P42695","CNDD3",1.86e-48,"Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3)","cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]","GO:0000779; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0035064; GO:0042393; GO:0051301"
"g24900",265.8451,-0.4800413,0.1559552,-3.078072,0.002083446,0.03092746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32400",142.8248,1.45554,0.472867,3.078116,0.002083135,0.03092746,0,31219,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7.88e-65,"PiggyBac transposable element-derived protein 4",NA,NA
"g34281",23.34932,-0.6019632,0.1955531,-3.07826,0.002082132,0.03092746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56288",45.48823,0.8599249,0.2793848,3.077923,0.002084488,0.03092746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75628",88.73943,0.5402658,0.1755283,3.077941,0.002084363,0.03092746,0,9530,"sp|Q9HAC7|SUCHY_HUMAN","Q9HAC7","SUCHY",1.68e-133,"Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase)",NA,"GO:0005739; GO:0047369"
"g28561",859.2605,-0.391695,0.1272677,-3.077726,0.00208587,0.03094088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25217",42.53083,0.3614397,0.1174415,3.077615,0.002086644,0.03094527,26665,36321,"sp|Q80V03|ADCK5_MOUSE","Q80V03","ADCK5",2.12e-15,"Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-)",NA,"GO:0004674; GO:0005739; GO:0016021"
"g19117",108.0943,-0.3738045,0.1214733,-3.077256,0.00208916,0.03097549,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10253",6937.663,0.2314038,0.07520089,3.077142,0.002089954,0.03098018,0,8725,"sp|Q5R8K6|RL35A_PONAB","Q5R8K6","RL35A",7.73e-12,"60S ribosomal protein L35a","ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0000049; GO:0003735; GO:0006364; GO:0006412; GO:0022625; GO:0042273"
"g84964",779.8279,0.7608992,0.2472911,3.076937,0.002091392,0.03099442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25194",34.9935,-0.9031079,0.2935306,-3.076707,0.002093007,0.03100492,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53653",129.5696,0.3595921,0.1168811,3.076564,0.002094015,0.03100492,0,11794,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.44e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g109548",145.106,0.2703116,0.08786067,3.076594,0.002093804,0.03100492,194,5488,"sp|Q496Z0|ELP2_RAT","Q496Z0","ELP2",6.39e-06,"Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1)","regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; tRNA wobble uridine modification [GO:0002098]","GO:0000993; GO:0002098; GO:0005829; GO:0008023; GO:0019901; GO:0033588; GO:0046425"
"g151474",115.8974,0.385989,0.125458,3.07664,0.002093478,0.03100492,0,1444,"sp|Q9UK45|LSM7_HUMAN","Q9UK45","LSM7",1.26e-21,"U6 snRNA-associated Sm-like protein LSm7","mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]","GO:0000398; GO:0000956; GO:0005634; GO:0005654; GO:0005688; GO:0005689; GO:0005829; GO:0017070; GO:0046540; GO:0071004; GO:0071005; GO:0071013; GO:0097526; GO:0120115; GO:1990726; GO:1990904"
"g69459",450.9,0.3682295,0.1196928,3.076456,0.002094774,0.03100907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84447",2396.644,-0.4473731,0.1454246,-3.076324,0.0020957,0.0310157,0,8284,"sp|Q9HCC6|HES4_HUMAN","Q9HCC6","HES4",7.44e-13,"Transcription factor HES-4 (hHES4) (Class B basic helix-loop-helix protein 42) (bHLHb42) (Hairy and enhancer of split 4) (bHLH factor Hes4)","anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007399; GO:0009952; GO:0030154; GO:0046983"
"g9411",382.6614,0.321068,0.1043757,3.07608,0.002097416,0.031034,0,8348,"sp|Q9CQJ8|NDUB9_MOUSE","Q9CQJ8","NDUB9",1.24e-08,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)","aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0009060; GO:0032981; GO:0042776"
"g55957",298.0208,1.075732,0.3497674,3.075565,0.002101043,0.03108056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46304",33.72962,-0.5209952,0.1694135,-3.075287,0.002103004,0.03110248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135088",57.49965,0.4699534,0.1528329,3.074949,0.002105386,0.0311306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20544",1732.91,-0.2797323,0.09100077,-3.073955,0.00211241,0.03122733,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8240",41.64045,-0.4930328,0.1603973,-3.073823,0.00211335,0.03122738,34345,44414,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.06e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g74389",11552.34,0.3134428,0.1019759,3.073695,0.002114253,0.03122738,0,10035,"sp|P55833|RS27_HOMAM","P55833","RS27",4.4e-17,"40S ribosomal protein S27","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0046872"
"g99151",47.41097,0.3992594,0.1298908,3.073809,0.002113446,0.03122738,0,6572,"sp|Q9VCD0|GATB_DROME","Q9VCD0","GATB",1.3e-11,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)","glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]","GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681"
"g139387",70.82484,0.3716247,0.1209053,3.073683,0.002114342,0.03122738,0,2829,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.66e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g17395",42.7026,1.607073,0.5228962,3.073407,0.002116296,0.03124912,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g892",1979.978,0.6201114,0.2017772,3.073249,0.002117419,0.03125858,15575,28800,"sp|Q3T149|HSPB1_BOVIN","Q3T149","HSPB1",1.07e-06,"Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27)","anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]","GO:0001533; GO:0001932; GO:0005080; GO:0005634; GO:0005737; GO:0005819; GO:0006469; GO:0008426; GO:0009615; GO:0030018; GO:0032731; GO:0032760; GO:0035556; GO:0038033; GO:0042802; GO:0042803; GO:0043122; GO:0043536; GO:0044183; GO:0045766; GO:0061077; GO:0061629; GO:0099641; GO:1902176; GO:1904115"
"g126924",640.4727,-0.4107918,0.1336806,-3.072936,0.002119643,0.03128428,0,2761,"sp|Q8K0U4|HS12A_MOUSE","Q8K0U4","HS12A",1.54e-06,"Heat shock 70 kDa protein 12A",NA,"GO:0005524; GO:0005634; GO:0005737"
"g129364",20.36574,1.688813,0.5495999,3.072804,0.00212058,0.03129099,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28786",376.3113,0.4698613,0.1529136,3.072725,0.002121141,0.03129213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76817",375.4211,0.3212892,0.1045668,3.072573,0.002122219,0.03130092,5515,9070,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.18e-10,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g82652",1031.439,-0.460381,0.1498492,-3.072296,0.002124187,0.03132282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52374",490.2732,-0.3403346,0.1107799,-3.072169,0.002125093,0.03132904,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46018",1150.544,-0.1943762,0.06327296,-3.072027,0.002126104,0.03132969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155911",302.1051,0.5293695,0.1723183,3.072045,0.002125979,0.03132969,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76831",760.509,-0.3693347,0.1202308,-3.071881,0.002127142,0.03133786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161678",242.1747,1.631847,0.5312395,3.071772,0.002127925,0.03134227,0,798,"sp|P09470|ACE_MOUSE","P09470","ACE",3.03e-14,"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]","aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]","GO:0001666; GO:0001822; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019233; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0031982; GO:0032091; GO:0032092; GO:0032496; GO:0034616; GO:0035814; GO:0042310; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0045907; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:1900086; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170"
"g142956",44.45372,1.103487,0.3592959,3.071248,0.00213166,0.03139015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39802",1365.327,-0.3085274,0.1004671,-3.070929,0.002133942,0.03141662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8032",63.79397,-0.42263,0.1376288,-3.070796,0.002134893,0.03142347,46455,50560,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.22e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g57253",193.3288,-0.4324276,0.1408303,-3.070557,0.002136597,0.03144141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25607",106.6786,0.4803421,0.1564513,3.070233,0.002138917,0.03145337,34363,40374,"sp|Q5I0C3|MCCA_RAT","Q5I0C3","MCCA",1.59e-07,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)","leucine catabolic process [GO:0006552]","GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0046872; GO:1905202"
"g41629",43.00677,-0.4779582,0.1556848,-3.070037,0.002140322,0.03145337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76750",183.1175,0.3279485,0.1068221,3.070044,0.002140275,0.03145337,75,9186,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.85e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87541",385.3971,-0.3189494,0.1038891,-3.070094,0.002139916,0.03145337,3600,8020,"sp|Q9W436|NEP_DROME","Q9W436","NEP",3.46e-10,"Neprilysin-1 (EC 3.4.24.11)","protein processing [GO:0016485]; proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021; GO:0016485; GO:0046872"
"g127257",62.06987,0.4028915,0.1312246,3.070244,0.002138836,0.03145337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156616",23.2705,0.6302691,0.2052899,3.070143,0.002139566,0.03145337,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85283",33.70453,0.532194,0.173359,3.069896,0.00214133,0.03145718,0,7051,"sp|Q9V726|CPSF1_DROME","Q9V726","CPSF1",4.24e-24,"Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) (dCPSF 160)","mRNA polyadenylation [GO:0006378]; positive regulation of autophagy [GO:0010508]; pre-mRNA cleavage required for polyadenylation [GO:0098789]","GO:0003730; GO:0005634; GO:0005847; GO:0006378; GO:0010508; GO:0017022; GO:0098789"
"g112607",131.7208,0.5195073,0.169228,3.069865,0.002141553,0.03145718,0,5192,"sp|P08928|LAM0_DROME","P08928","LAM0",1.15e-16,"Lamin Dm0","adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin assembly [GO:0031507]; heterochromatin organization [GO:0070828]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching, open tracheal system [GO:0007430]","GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005641; GO:0005652; GO:0005737; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031507; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0051664; GO:0070828; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433"
"g97552",145.8075,-0.4316352,0.1406077,-3.069783,0.002142141,0.0314587,2584,6779,"sp|Q9EQQ3|GPR63_MOUSE","Q9EQQ3","GPR63",3.96e-14,"Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0016021; GO:0043235"
"g7040",371.8985,0.853438,0.2780314,3.069574,0.002143642,0.03145934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88928",53.89182,0.3692239,0.1202819,3.069656,0.002143057,0.03145934,0,3698,"sp|Q9V8K2|EXOC3_DROME","Q9V8K2","EXOC3",5.55e-08,"Exocyst complex component 3 (Exocyst complex component Sec6)","border follicle cell migration [GO:0007298]; endocytic recycling [GO:0032456]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; rhabdomere membrane biogenesis [GO:0045313]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; vesicle-mediated transport [GO:0016192]","GO:0000145; GO:0000149; GO:0005737; GO:0005915; GO:0006887; GO:0007009; GO:0007269; GO:0007298; GO:0016020; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030707; GO:0032456; GO:0043001; GO:0045313; GO:0051601; GO:0072659; GO:0072697; GO:0098793"
"g107251",282.6039,0.6693662,0.2180637,3.069591,0.002143523,0.03145934,0,5722,"sp|Q8N8A2|ANR44_HUMAN","Q8N8A2","ANR44",7.43e-45,"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)",NA,NA
"g28387",1596.004,-0.3028294,0.09866263,-3.069343,0.002145302,0.03147192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47832",135.1321,-0.3720817,0.1212263,-3.069315,0.0021455,0.03147192,2429,13254,"sp|P21328|RTJK_DROME","P21328","RTJK",1.74e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g95569",141.9424,0.5995154,0.1953295,3.069252,0.002145956,0.03147192,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138134",38.26011,0.6988163,0.2277118,3.068863,0.002148749,0.03150575,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121890",100.9787,1.084492,0.3534081,3.068667,0.002150161,0.03151931,0,4223,"sp|Q17058|MAL1_APIME","Q17058","MAL1",9.3e-12,"Alpha-glucosidase (EC 3.2.1.20) (Maltase)",NA,"GO:0032450"
"g77461",103.0909,0.4464008,0.1454785,3.068499,0.002151371,0.03152992,5405,9516,"sp|P21328|RTJK_DROME","P21328","RTJK",8.45e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g141638",236.0788,0.3255489,0.1060987,3.068359,0.002152379,0.03153756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93334",17.51355,-0.5955164,0.1940884,-3.068274,0.002152993,0.03153942,0,3524,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.42e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g60752",62.65557,0.4692917,0.1529621,3.068027,0.002154773,0.03155124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116598",162.4973,0.4612501,0.1503391,3.068065,0.0021545,0.03155124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19282",249.1191,0.3552164,0.1158023,3.067438,0.002159026,0.03160229,27589,47394,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",8.04e-24,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g153305",41241.09,2.210275,0.7205676,3.067409,0.002159235,0.03160229,0,1695,"sp|Q00871|CTRB1_PENVA","Q00871","CTRB1",3.54e-25,"Chymotrypsin BI (EC 3.4.21.1)","collagen catabolic process [GO:0030574]","GO:0004252; GO:0005615; GO:0030574"
"g9629",5852.039,-0.5438595,0.1773161,-3.067175,0.002160925,0.03161987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83197",638.0683,-0.3446856,0.1123968,-3.066685,0.002164466,0.03165025,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119281",42.49195,0.4893931,0.1595827,3.066706,0.002164315,0.03165025,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141270",108.6016,0.3335607,0.108765,3.066803,0.002163617,0.03165025,0,2744,"sp|Q24740|CDC37_DROVI","Q24740","CDC37",2.3e-22,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)","positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]","GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628"
"g24178",515.6162,-0.3161352,0.1031207,-3.065682,0.00217174,0.03174571,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44434",119.0526,0.294573,0.09608843,3.065645,0.002172011,0.03174571,10126,15864,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.46e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g109259",64.09595,2.145696,0.6999308,3.065583,0.002172464,0.03174571,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76237",345.048,0.2888347,0.09422171,3.065479,0.002173216,0.03174953,0,9721,"sp|P08266|RPB2_DROME","P08266","RPB2",2.39e-76,"DNA-directed RNA polymerase II subunit RPB2 (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide)","transcription by RNA polymerase II [GO:0006366]","GO:0003677; GO:0003899; GO:0005665; GO:0006366; GO:0032549; GO:0046872"
"g29009",657.0348,-0.3010064,0.09819842,-3.065288,0.002174608,0.03176271,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36067",313.478,-0.3998081,0.1304364,-3.065157,0.002175557,0.03176941,13122,28087,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.78e-09,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g103816",178.1159,0.3313226,0.1081003,3.064956,0.002177019,0.03177644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149931",18.14715,0.5104605,0.1665447,3.065006,0.002176654,0.03177644,0,1992,"sp|Q9NFU0|FMR1_DROME","Q9NFU0","FMR1",1.08e-07,"Synaptic functional regulator FMR1 (Fragile X mental retardation syndrome-related protein 1) (dFMR1)","adult locomotory behavior [GO:0008344]; anterograde axonal transport [GO:0008089]; associative learning [GO:0008306]; axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellularization [GO:0007349]; central nervous system development [GO:0007417]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle, sleep [GO:0050802]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; gene silencing by RNA [GO:0031047]; germarium-derived oocyte fate determination [GO:0007294]; germ cell development [GO:0007281]; germ-line cyst formation [GO:0048134]; grooming behavior [GO:0007625]; habituation [GO:0046959]; heterochromatin assembly [GO:0031507]; larval locomotory behavior [GO:0008345]; locomotor rhythm [GO:0045475]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; mitotic cell cycle, embryonic [GO:0045448]; mRNA transport [GO:0051028]; mushroom body development [GO:0016319]; negative regulation of axon extension [GO:0030517]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of synapse assembly [GO:0051964]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; negative regulation of translation [GO:0017148]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; neuron remodeling [GO:0016322]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; oocyte dorsal/ventral axis specification [GO:0007310]; pole cell formation [GO:0007279]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of programmed cell death [GO:0043068]; positive regulation of translation [GO:0045727]; post-embryonic digestive tract morphogenesis [GO:0048621]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of cell population proliferation [GO:0042127]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine development [GO:0060998]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of modification of synaptic structure [GO:1905244]; regulation of mRNA stability [GO:0043488]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of olfactory learning [GO:0090328]; regulation of synapse organization [GO:0050807]; regulation of synapse structural plasticity [GO:0051823]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to odorant [GO:1990834]; short-term memory [GO:0007614]; social behavior [GO:0035176]; sperm axoneme assembly [GO:0007288]; synapse organization [GO:0050808]; synapse pruning [GO:0098883]; synaptic vesicle budding [GO:0070142]; synaptic vesicle clustering [GO:0097091]; terminal button organization [GO:0072553]; visual perception [GO:0007601]","GO:0000139; GO:0000900; GO:0002052; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005844; GO:0006417; GO:0007279; GO:0007281; GO:0007288; GO:0007294; GO:0007310; GO:0007349; GO:0007409; GO:0007411; GO:0007413; GO:0007417; GO:0007420; GO:0007528; GO:0007601; GO:0007614; GO:0007616; GO:0007623; GO:0007625; GO:0008049; GO:0008089; GO:0008306; GO:0008344; GO:0008345; GO:0008355; GO:0009794; GO:0010494; GO:0010608; GO:0010629; GO:0014069; GO:0016020; GO:0016319; GO:0016322; GO:0016442; GO:0017148; GO:0017151; GO:0030424; GO:0030517; GO:0031047; GO:0031507; GO:0032838; GO:0035176; GO:0036464; GO:0042048; GO:0042127; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043186; GO:0043197; GO:0043204; GO:0043488; GO:0043621; GO:0045182; GO:0045448; GO:0045475; GO:0045727; GO:0045886; GO:0046627; GO:0046959; GO:0048134; GO:0048621; GO:0048812; GO:0048814; GO:0050774; GO:0050802; GO:0050807; GO:0050808; GO:0050976; GO:0051028; GO:0051823; GO:0051964; GO:0060998; GO:0070142; GO:0071598; GO:0072375; GO:0072553; GO:0090328; GO:0097091; GO:0098793; GO:0098883; GO:0099578; GO:1900073; GO:1900364; GO:1904115; GO:1905244; GO:1990124; GO:1990247; GO:1990834; GO:2000647"
"g32358",11626.83,-0.527958,0.1722647,-3.064807,0.002178107,0.031778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131818",54.26633,-0.4523033,0.1475769,-3.064864,0.002177691,0.031778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158678",26.5784,0.5398521,0.1761539,3.064662,0.002179161,0.03178621,0,712,"sp|Q4R180|ORC3_RAT","Q4R180","ORC3",3.44e-08,"Origin recognition complex subunit 3","DNA replication initiation [GO:0006270]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0000808; GO:0003688; GO:0005656; GO:0005664; GO:0006270; GO:0006275; GO:0031261; GO:0061351"
"g142353",118.8384,0.5093347,0.1662012,3.064566,0.002179859,0.03178925,0,614,"sp|Q91XD4|FTCD_MOUSE","Q91XD4","FTCD",1.06e-27,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","cytoskeleton organization [GO:0007010]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0000139; GO:0005542; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0006548; GO:0007010; GO:0008017; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0030868; GO:0035999"
"g36851",19.66353,1.002595,0.327258,3.063622,0.002186749,0.03185693,0,27324,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.63e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g42321",1861.938,-0.3645043,0.1189814,-3.063539,0.002187353,0.03185693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61482",157.2334,1.544762,0.5042278,3.063619,0.00218677,0.03185693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92508",82.17939,-0.4115765,0.1343332,-3.063847,0.002185104,0.03185693,2308,6446,"sp|P51814|ZNF41_HUMAN","P51814","ZNF41",1.8e-18,"Zinc finger protein 41","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g100961",31.43794,1.680016,0.548393,3.063526,0.002187451,0.03185693,0,6387,"sp|Q7Z2H8|S36A1_HUMAN","Q7Z2H8","S36A1",1.81e-08,"Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1)","alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transport [GO:0015734]","GO:0003333; GO:0005280; GO:0005368; GO:0005765; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016021; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600"
"g106619",2236.228,1.251999,0.4086573,3.063689,0.002186258,0.03185693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2358",4598.592,-0.3023834,0.09871573,-3.063173,0.002190033,0.03186516,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17262",44.80284,-0.5260485,0.1717313,-3.063207,0.002189782,0.03186516,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39050",48.94463,0.3928207,0.1282451,3.063046,0.002190967,0.03186516,22715,24949,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.58e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g66723",416.4281,1.12028,0.3657217,3.063204,0.002189809,0.03186516,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91131",4314.897,2.026281,0.661521,3.063063,0.002190837,0.03186516,0,2592,"sp|P00765|TRYP_ASTAS","P00765","TRYP",1.66e-44,"Trypsin-1 (EC 3.4.21.4) (Trypsin I)","digestion [GO:0007586]","GO:0004252; GO:0005615; GO:0007586; GO:0046872"
"g104660",130.2967,0.2587236,0.08446396,3.063124,0.002190391,0.03186516,4305,5983,"sp|A5D7H2|STRN3_BOVIN","A5D7H2","STRN3",3.83e-11,"Striatin-3","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443"
"g20919",1815.15,-0.2955514,0.09649418,-3.062894,0.002192078,0.03187417,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68729",82.42485,0.2470578,0.0806656,3.06274,0.002193206,0.03187626,0,10994,"sp|P21328|RTJK_DROME","P21328","RTJK",1.82e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g71887",89.84238,0.3148664,0.1028034,3.0628,0.002192768,0.03187626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11454",3590.461,-0.3190016,0.1041815,-3.061981,0.002198776,0.0319429,10525,13966,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.21e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g36059",159.3981,-0.3275161,0.106962,-3.061984,0.00219875,0.0319429,14950,24974,"sp|Q9VM91|TTL3A_DROME","Q9VM91","TTL3A",3.49e-06,"Tubulin glycylase 3A (dmTTLL3A) (EC 6.3.2.-)","protein polyglycylation [GO:0018094]","GO:0005524; GO:0005737; GO:0005874; GO:0015630; GO:0018094; GO:0070735; GO:0070736; GO:0070737"
"g12319",167413.4,0.4856639,0.1586227,3.061756,0.002200425,0.03195968,15935,62684,"sp|Q9UM11|FZR1_HUMAN","Q9UM11","FZR1",1.55e-31,"Fizzy-related protein homolog (Fzr) (CDC20-like protein 1) (Cdh1/Hct1 homolog) (hCDH1)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]","GO:0005654; GO:0005680; GO:0005829; GO:0006281; GO:0007095; GO:0007346; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0051445; GO:0070306; GO:0070979; GO:0090344; GO:1904668; GO:1905786; GO:1990757"
"g3984",2846.632,-0.3292063,0.1075565,-3.060776,0.002207642,0.03205014,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9034",293.5017,0.2618217,0.08554031,3.060799,0.00220747,0.03205014,12651,32504,"sp|Q7KZN9|COX15_HUMAN","Q7KZN9","COX15",9.71e-10,"Cytochrome c oxidase assembly protein COX15 homolog","cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005746; GO:0006123; GO:0006783; GO:0006784; GO:0007585; GO:0008535; GO:0016021; GO:0016627; GO:0016653; GO:0020037; GO:0045333; GO:0060090; GO:0070069; GO:1902600"
"g29053",32.68594,-0.4684695,0.1530605,-3.060682,0.002208339,0.03205306,0,14763,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.93e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27569",470.3064,-0.2249691,0.07350611,-3.06055,0.002209312,0.03206001,11917,27594,"sp|P17192|DPOL_HPBDB","P17192","DPOL",5.08e-08,"Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]","DNA replication [GO:0006260]","GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872"
"g21342",26.1912,0.8862338,0.2895777,3.060435,0.002210158,0.0320651,0,43181,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",9.27e-55,"PiggyBac transposable element-derived protein 4",NA,NA
"g61573",43.09908,0.4549465,0.1486628,3.060257,0.00221147,0.03207696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77077",43.85716,-0.4223401,0.138022,-3.059948,0.002213757,0.03210294,3515,4904,"sp|P11369|LORF2_MOUSE","P11369","LORF2",8.56e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g48997",2430.271,1.813389,0.5926555,3.059769,0.002215079,0.03210774,13788,17534,"sp|P55115|NAS15_CAEEL","P55115","NAS15",9.01e-10,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)",NA,"GO:0004222; GO:0005576; GO:0008270"
"g52277",557.5817,-0.3006099,0.09824563,-3.059779,0.002215007,0.03210774,5768,12824,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.65e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g61443",644.095,-0.2595538,0.08483258,-3.0596,0.002216325,0.03211862,6136,10164,"sp|P21328|RTJK_DROME","P21328","RTJK",1.01e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g85727",143.6022,0.4859362,0.158827,3.059531,0.002216839,0.03211888,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135029",77.39453,0.5567413,0.1819791,3.05937,0.002218031,0.03212897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2417",2700.154,-0.2289775,0.07485137,-3.059096,0.002220058,0.03214396,122736,139954,"sp|P21328|RTJK_DROME","P21328","RTJK",9.56e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g47461",250.1442,-0.2195031,0.07175336,-3.059133,0.002219788,0.03214396,10306,16304,"sp|Q62130|PTN14_MOUSE","Q62130","PTN14",6.8e-21,"Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase PTP36)","lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; regulation of protein export from nucleus [GO:0046825]","GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0008285; GO:0030971; GO:0046825"
"g11350",82.36629,-0.3541887,0.1157892,-3.05891,0.002221438,0.03215675,0,7895,"sp|Q7Z7L9|ZSCA2_HUMAN","Q7Z7L9","ZSCA2",6.95e-63,"Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854)","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872"
"g15593",96.0021,0.374031,0.1222855,3.05867,0.002223218,0.03216814,31524,44598,"sp|P55786|PSA_HUMAN","P55786","PSA",1.1e-16,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"g40401",6285.286,-0.4295612,0.1404384,-3.058717,0.002222873,0.03216814,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82339",32.23055,0.7792947,0.2547911,3.058564,0.002224008,0.0321724,0,8763,"sp|P70704|AT8A1_MOUSE","P70704","AT8A1",3e-14,"Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)","aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]","GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016021; GO:0016887; GO:0030335; GO:0031090; GO:0031410; GO:0042584; GO:0043231; GO:0045332; GO:0061092; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531"
"g100260",1141.87,0.8246462,0.2696408,3.058314,0.002225865,0.03219208,2896,6470,"sp|Q9GLP1|FA5_PIG","Q9GLP1","FA5",5.84e-12,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]","GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091"
"g152783",78.0979,-0.3770403,0.1232956,-3.05802,0.002228047,0.03221644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34059",27.0013,-0.5278916,0.1726328,-3.057886,0.002229043,0.03222364,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114865",1972.371,0.5061907,0.1655468,3.057689,0.002230509,0.03223765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6619",1369.635,0.1748267,0.05717799,3.057587,0.002231265,0.03224139,39826,78274,"sp|O61199|ODO1_CAEEL","O61199","ODO1",1.06e-36,"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0045252"
"g64133",322.2692,-0.534382,0.1747778,-3.057494,0.002231965,0.03224267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101284",18.84098,0.7197215,0.2353999,3.057442,0.002232349,0.03224267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69230",731.9219,0.6084287,0.1990072,3.05732,0.002233254,0.03224854,626,11093,"sp|P0CT40|TF29_SCHPO","P0CT40","TF29",8.58e-59,"Transposon Tf2-9 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005737; GO:0006310; GO:0015074; GO:0046872"
"g34056",4778.126,-0.3986364,0.1303929,-3.057193,0.002234206,0.0322551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8329",323.9531,0.4360711,0.14265,3.05693,0.002236165,0.03227261,0,27133,"sp|P21328|RTJK_DROME","P21328","RTJK",9.76e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g65727",52.88563,-0.3874779,0.1267553,-3.056897,0.002236415,0.03227261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140724",194.0402,0.6884596,0.2252256,3.056756,0.002237465,0.03227682,0,2367,"sp|P57093|PAHX_RAT","P57093","PAHX",6.55e-11,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)","2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]","GO:0001561; GO:0003824; GO:0005739; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731"
"g142452",61.34191,-0.3598845,0.1177354,-3.056724,0.002237703,0.03227682,0,2424,"sp|A6NNF4|ZN726_HUMAN","A6NNF4","ZN726",1.19e-73,"Zinc finger protein 726","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g62007",42.8601,-0.4278281,0.1399743,-3.056476,0.002239556,0.03229636,0,9872,"sp|Q96SE7|ZN347_HUMAN","Q96SE7","ZN347",2.95e-74,"Zinc finger protein 347 (Zinc finger protein 1111)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g30876",427.0371,0.4296676,0.1405961,3.056041,0.002242803,0.03232161,19355,29068,"sp|P83877|TXN4A_MOUSE","P83877","TXN4A",1.42e-60,"Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD)","cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005737; GO:0005829; GO:0007049; GO:0031965; GO:0046540; GO:0051301; GO:0071005"
"g94718",211.9664,-0.3361429,0.1099911,-3.056091,0.002242433,0.03232161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138337",437.8285,0.3311546,0.1083561,3.056169,0.002241851,0.03232161,0,734,"sp|Q5ZJK8|TCPH_CHICK","Q5ZJK8","TCPH",1.22e-15,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g88964",67.0576,0.4350852,0.1423838,3.055722,0.002245197,0.03234891,0,6314,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.58e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g51144",88.14446,0.6769003,0.2215573,3.055193,0.002249155,0.03239873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69214",207.8297,-0.3047711,0.09975731,-3.055125,0.002249665,0.03239888,3376,11096,"sp|Q0VCK5|AP2A2_BOVIN","Q0VCK5","AP2A2",1.14e-14,"AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)","clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]","GO:0006886; GO:0006898; GO:0008289; GO:0030122; GO:0035615; GO:0048268; GO:0072583; GO:0140312"
"g61830",34.24947,0.9036899,0.2958098,3.054969,0.002250838,0.03240856,0,9981,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.88e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g75532",53.21706,0.9416453,0.3082445,3.054865,0.002251617,0.03241257,1485,9160,"sp|O54697|NALDL_RAT","O54697","NALDL",2.72e-12,"Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L)","peptide catabolic process [GO:0043171]","GO:0004177; GO:0004180; GO:0005509; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171"
"g14341",203.2853,-0.3053155,0.09995527,-3.054521,0.002254203,0.03243284,0,30755,"sp|Q8IZ73|RUSD2_HUMAN","Q8IZ73","RUSD2",5.49e-20,"Pseudouridylate synthase RPUSD2 (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 2)","enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]","GO:0000455; GO:0003723; GO:0009982; GO:1990481"
"g101186",186.3547,-0.4439785,0.145354,-3.054465,0.002254626,0.03243284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111412",1317.416,1.933866,0.6331302,3.054452,0.002254723,0.03243284,0,4944,"sp|Q95029|CATL_DROME","Q95029","CATL",2.01e-24,"Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"g141979",165.1111,0.6764769,0.2214754,3.054411,0.002255027,0.03243284,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79523",70.08761,-0.4841921,0.1585342,-3.054181,0.002256759,0.03244222,5575,9203,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.04e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g100351",1701.965,0.7256899,0.2376098,3.054125,0.002257181,0.03244222,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103595",852.6899,1.016087,0.3326796,3.054252,0.002256228,0.03244222,0,3215,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.68e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g58659",62.35496,-0.5530218,0.1810849,-3.053937,0.002258593,0.03245531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44424",502.8953,0.4145008,0.1357405,3.053626,0.002260935,0.03248177,0,19091,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.86e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29311",133.9,0.3931227,0.1287594,3.053158,0.00226447,0.03251812,3235,5415,"sp|Q5BU09|EAPP_MOUSE","Q5BU09","EAPP",1.28e-09,"E2F-associated phosphoprotein (EAPP)","negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]","GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244"
"g90805",105.6355,0.4291905,0.1405711,3.053191,0.002264218,0.03251812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70319",687.0841,-0.3132152,0.1025933,-3.052979,0.002265818,0.03253028,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81919",226.8162,1.857614,0.6085286,3.052633,0.002268434,0.03256061,1023,2644,"sp|P79098|AMPN_BOVIN","P79098","AMPN",9.73e-24,"Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0001618; GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0030154; GO:0042277; GO:0043171; GO:0070006"
"g8013",565.9838,-0.3322214,0.1088425,-3.052313,0.00227085,0.03257976,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49982",43.93628,-0.5779151,0.1893409,-3.052247,0.002271352,0.03257976,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72500",967.2397,0.1789022,0.05861436,3.052191,0.002271779,0.03257976,1228,4044,"sp|A5D7H2|STRN3_BOVIN","A5D7H2","STRN3",1.18e-22,"Striatin-3","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443"
"g85893",133.5056,0.8644238,0.2832105,3.052231,0.002271472,0.03257976,0,7334,"sp|Q78EH2|PCSK4_RAT","Q78EH2","PCSK4",4.27e-115,"Proprotein convertase subtilisin/kexin type 4 (PC4) (EC 3.4.21.-) (KEX2-like endoprotease 3) (Neuroendocrine convertase 3) (NEC 3) (Prohormone convertase 3)","acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240]","GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0030173; GO:0048240"
"g87289",184.0221,-0.5457726,0.1788363,-3.0518,0.002274737,0.03261496,755,6163,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",4.26e-09,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g126020",69.48518,0.5633581,0.1846099,3.051614,0.002276148,0.03262312,0,3953,"sp|Q9YH58|FTCD_CHICK","Q9YH58","FTCD",3.25e-15,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005794; GO:0005814; GO:0005829; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0035999"
"g137708",19.90377,-0.5427238,0.1778494,-3.051592,0.002276313,0.03262312,888,3022,"sp|O15090|ZN536_HUMAN","O15090","ZN536",6.33e-11,"Zinc finger protein 536","negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387"
"g133985",54.3286,0.6349847,0.2081036,3.051291,0.002278593,0.03264858,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8262",174.5227,0.6791642,0.2225955,3.051115,0.002279935,0.03265446,2466,10744,"sp|P45971|OST48_CAEEL","P45971","OST48",7.64e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Oligosaccharyl transferase 48 kDa subunit) (Oligosaccharyl transferase beta subunit 1)","protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0006487; GO:0008250; GO:0016021; GO:0018279"
"g11914",156.8675,0.8730752,0.2861505,3.051105,0.002280012,0.03265446,30206,34124,"sp|P04068|HYEP_RABIT","P04068","HYEP",1.82e-20,"Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH)","arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; response to toxic substance [GO:0009636]","GO:0004301; GO:0005789; GO:0009636; GO:0016021; GO:0019369; GO:0019439; GO:0033961"
"g76070",612.591,-0.2911115,0.09541714,-3.050935,0.002281299,0.03265918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94296",23.36819,0.6573621,0.215463,3.050929,0.002281349,0.03265918,0,3420,"sp|Q7Q9C0|ENOPH_ANOGA","Q7Q9C0","ENOPH",1.04e-08,"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase)","L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]","GO:0000287; GO:0005634; GO:0005737; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874"
"g10048",106.0476,-0.4687572,0.1536604,-3.050604,0.002283814,0.03267445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35793",1582.264,-0.6570377,0.2153853,-3.050523,0.002284433,0.03267445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90789",1541.481,0.5752904,0.1885838,3.050583,0.002283978,0.03267445,2431,2870,"sp|Q07903|ACTC_STRPU","Q07903","ACTC",4.71e-54,"Actin, cytoskeletal 2A (Actin, cytoskeletal IIA) [Cleaved into: Actin, cytoskeletal 2A, intermediate form]",NA,"GO:0005524; GO:0005737; GO:0005856"
"g117979",750.5939,0.4325714,0.1417969,3.050641,0.002283536,0.03267445,0,4364,"sp|Q5E9K0|PSB2_BOVIN","Q5E9K0","PSB2",3.87e-19,"Proteasome subunit beta type-2","proteasomal protein catabolic process [GO:0010498]","GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005839; GO:0008233; GO:0010498; GO:0019774"
"g43630",138.1451,0.2485289,0.0814727,3.050456,0.002284941,0.03267451,8966,21370,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.19e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g30535",6167.675,-0.4386124,0.1438026,-3.050101,0.002287643,0.03267709,11665,28693,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.57e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g53981",858.6782,-0.516785,0.1694189,-3.050338,0.002285838,0.03267709,1051,8664,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.16e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g65518",218.9303,0.3598353,0.1179725,3.050163,0.002287174,0.03267709,0,10354,"sp|Q9D0S9|HINT2_MOUSE","Q9D0S9","HINT2",2.17e-19,"Adenosine 5'-monophosphoramidase HINT2 (EC 3.9.1.-) (HINT-3) (Histidine triad nucleotide-binding protein 2, mitochondrial) (HINT-2)","apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]","GO:0000166; GO:0005737; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:0043530; GO:2000757"
"g90825",184.2272,-0.3612066,0.1184209,-3.050192,0.002286951,0.03267709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106997",142.2143,0.4361678,0.1429958,3.050214,0.002286787,0.03267709,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47374",67.68675,-0.6752957,0.2214107,-3.049969,0.002288654,0.03268033,105,3864,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.15e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g90896",185.9932,0.341772,0.1120586,3.049939,0.002288879,0.03268033,0,5854,"sp|Q16851|UGPA_HUMAN","Q16851","UGPA",1.3e-13,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062"
"g85784",53.30143,-0.340337,0.1115969,-3.0497,0.002290697,0.03269908,1364,5910,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.28e-11,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g48273",95.28296,0.3599849,0.118077,3.04873,0.00229811,0.03279767,0,12284,"sp|Q641G7|ARPC4_XENLA","Q641G7","ARPC4",1.05e-19,"Actin-related protein 2/3 complex subunit 4","actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030041; GO:0030833; GO:0034314; GO:0035861; GO:0042995"
"g92451",48.72665,0.3913448,0.128372,3.048522,0.002299701,0.03281315,4856,7105,"sp|P57740|NU107_HUMAN","P57740","NU107",3.82e-10,"Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)","female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006355; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006"
"g19984",39.69636,0.6927219,0.2272673,3.048049,0.002303322,0.03282348,40256,45044,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.42e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g41393",132.1558,0.4404253,0.1444925,3.048085,0.002303048,0.03282348,10116,18364,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.21e-15,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g53783",272.6364,-0.3889846,0.1276208,-3.047971,0.002303925,0.03282348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56555",335.0405,1.150655,0.3774857,3.048207,0.002302112,0.03282348,415,12624,"sp|Q2LKW6|NL1B1_MOUSE","Q2LKW6","NL1B1",3.43e-06,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; neuron apoptotic process [GO:0051402]; NLRP1 inflammasome complex assembly [GO:1904784]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; protein catabolic process [GO:0030163]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; self proteolysis [GO:0097264]","GO:0002221; GO:0003690; GO:0003725; GO:0004175; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006919; GO:0006954; GO:0008233; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0030163; GO:0032731; GO:0042981; GO:0043621; GO:0050729; GO:0051260; GO:0051402; GO:0051607; GO:0061702; GO:0070269; GO:0072558; GO:0097264; GO:0140374; GO:0140608; GO:1904784"
"g103716",153.7029,0.315926,0.1036407,3.048281,0.002301549,0.03282348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136693",19.2525,0.7631266,0.250359,3.048129,0.002302708,0.03282348,0,3096,"sp|P21328|RTJK_DROME","P21328","RTJK",4.82e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g146042",822.2654,2.27898,0.7477057,3.047965,0.002303971,0.03282348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8958",49.38093,-0.3694243,0.1212258,-3.047407,0.002308248,0.03287718,17217,20644,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.05e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g72213",102.3065,1.322983,0.4342352,3.046695,0.002313721,0.03293341,0,10440,"sp|Q9U943|APLP_LOCMI","Q9U943","APLP",2.68e-10,"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055"
"g113828",96.84376,-0.541933,0.1778715,-3.046768,0.002313164,0.03293341,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149454",120.4844,0.3947841,0.1295775,3.046703,0.002313664,0.03293341,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41586",295.8162,0.5376476,0.1765018,3.046131,0.002318067,0.03296802,17215,22825,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.07e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g52285",4372.402,0.7616815,0.2500501,3.046116,0.002318187,0.03296802,6065,8283,"sp|P04070|PROC_HUMAN","P04070","PROC",3.46e-10,"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]","blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508]","GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005794; GO:0005796; GO:0006508; GO:0007596; GO:0030195; GO:0043066; GO:0050728; GO:0050819; GO:1903142; GO:1905370"
"g68271",21.89607,0.7503247,0.2463128,3.046227,0.002317325,0.03296802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77185",211.6364,0.4401432,0.1444883,3.046221,0.002317373,0.03296802,0,3371,"sp|P98160|PGBM_HUMAN","P98160","PGBM",5e-09,"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"g92418",31.53349,0.4019309,0.1319615,3.045819,0.002320476,0.03298633,0,7398,"sp|P50136|ODBA_MOUSE","P50136","ODBA",3.18e-28,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)","branched-chain amino acid catabolic process [GO:0009083]","GO:0003863; GO:0005739; GO:0005947; GO:0009083; GO:0044877; GO:0046872"
"g94976",40.34156,0.6568707,0.2156632,3.045817,0.002320493,0.03298633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17953",6625.39,-0.4818393,0.1582097,-3.045573,0.002322371,0.03299131,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52808",36.08213,-0.3579024,0.117514,-3.045615,0.002322049,0.03299131,5075,9805,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.59e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g162046",1399.927,0.7037272,0.2310571,3.045685,0.002321508,0.03299131,0,1059,"sp|P10982|ACT1_ABSGL","P10982","ACT1",3.65e-27,"Actin-1 (Fragment)",NA,"GO:0005524; GO:0005737; GO:0005856"
"g20093",63.68936,1.318631,0.4330617,3.044903,0.002327556,0.03301027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47261",50.1898,0.3633086,0.1193181,3.044874,0.002327781,0.03301027,0,6524,"sp|O60524|NEMF_HUMAN","O60524","NEMF",4.84e-23,"Ribosome quality control complex subunit NEMF (Antigen NY-CO-1) (Nuclear export mediator factor) (Serologically defined colon cancer antigen 1)","CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0005829; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140708; GO:1990112; GO:1990116"
"g48663",466.3351,0.4277734,0.1404708,3.045283,0.002324612,0.03301027,5645,8771,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.15e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g67942",1065.22,-0.4247046,0.1394739,-3.045048,0.002326434,0.03301027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70006",18.55797,-0.4931937,0.1619643,-3.045076,0.002326214,0.03301027,9025,10913,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.81e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g70782",143.5411,0.3097258,0.1017128,3.045101,0.002326021,0.03301027,2963,7224,"sp|Q9D7B6|ACAD8_MOUSE","Q9D7B6","ACAD8",2.72e-17,"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.-) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)","lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574]","GO:0003995; GO:0005739; GO:0006574; GO:0006629; GO:0050660"
"g87909",49.72253,0.5431205,0.1783702,3.044905,0.002327535,0.03301027,4450,7674,"sp|Q9UJM8|HAOX1_HUMAN","Q9UJM8","HAOX1",1.32e-06,"2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GO) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5)","fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979]","GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0010181; GO:0046296; GO:0047969"
"g132455",25.85022,1.417519,0.4655358,3.044921,0.002327418,0.03301027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13416",54.78724,-0.5243186,0.1722064,-3.04471,0.002329047,0.03302099,10135,14034,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.67e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g19717",1197.509,-0.2163832,0.07107262,-3.044537,0.002330384,0.03303272,10435,31204,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.13e-16,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19125",1532.852,-0.4638591,0.1523736,-3.044222,0.002332828,0.03304806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23549",558.5985,-0.2949647,0.09689608,-3.044135,0.002333506,0.03304806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86415",2782.386,-0.2347655,0.07711584,-3.044323,0.002332049,0.03304806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90910",146.1219,1.56556,0.5142767,3.044199,0.002333009,0.03304806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9211",24.51486,-0.4307653,0.1415165,-3.043923,0.002335149,0.0330606,33876,39934,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.97e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g19615",419.6211,-0.2360145,0.07753716,-3.043889,0.002335412,0.0330606,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23170",556.0689,-0.2351733,0.07726662,-3.04366,0.002337193,0.03307661,8335,33951,"sp|P21328|RTJK_DROME","P21328","RTJK",3.09e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38976",17.98863,1.237341,0.4065391,3.043597,0.002337677,0.03307661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146954",30.50421,1.140682,0.3747872,3.043546,0.002338075,0.03307661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36224",1734.278,-0.3049988,0.1002242,-3.043165,0.00234104,0.03308414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43729",5623.342,-0.3805159,0.1250392,-3.043173,0.00234098,0.03308414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46017",183.9391,0.3116687,0.1024173,3.043126,0.002341339,0.03308414,0,14451,"sp|Q920M5|CORO6_MOUSE","Q920M5","CORO6",7.78e-21,"Coronin-6 (Coronin-like protein E) (Clipin-E)","actin filament organization [GO:0007015]; cell migration [GO:0016477]","GO:0007015; GO:0016477; GO:0051015"
"g82803",54.66389,0.5843914,0.1920315,3.043206,0.002340717,0.03308414,6116,8524,"sp|Q24498|RYR_DROME","Q24498","RYR",2.31e-32,"Ryanodine receptor (Ryanodine receptor 44F)","calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347]","GO:0005219; GO:0005509; GO:0005790; GO:0005886; GO:0006816; GO:0006936; GO:0016021; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0035206; GO:0042383; GO:0048763; GO:0051209; GO:0060047; GO:0072347"
"g106650",6793.094,-0.5537196,0.181954,-3.043184,0.002340892,0.03308414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111841",1474.678,-0.369547,0.1214383,-3.043084,0.00234167,0.03308414,915,4231,"sp|Q7T2G1|I2B2B_DANRE","Q7T2G1","I2B2B",1.1e-13,"Interferon regulatory factor 2-binding protein 2-B (IRF-2-binding protein 2-B) (IRF-2BP2-B)","negative regulation of macrophage differentiation [GO:0045650]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001227; GO:0003714; GO:0005634; GO:0006357; GO:0045650; GO:0046872"
"g21685",170.3418,-0.4804222,0.1578912,-3.042742,0.002344331,0.03311451,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94113",48.79882,1.788773,0.5879577,3.042349,0.002347393,0.03315053,0,7188,"sp|Q1JPJ2|XPP1_BOVIN","Q1JPJ2","XPP1",1.42e-12,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]","GO:0005737; GO:0010815; GO:0030145; GO:0070006"
"g22006",91.08984,-0.4479972,0.1472663,-3.04209,0.002349415,0.0331551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44534",591.1407,-0.2488789,0.081813,-3.042046,0.002349763,0.0331551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54158",296.9395,-0.4533872,0.1490363,-3.042126,0.002349133,0.0331551,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88763",33.44869,-0.4039667,0.1327904,-3.042139,0.002349035,0.0331551,0,7164,"sp|P21328|RTJK_DROME","P21328","RTJK",3.01e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16129",1659.905,-0.2179325,0.07164642,-3.041778,0.002351856,0.03317741,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35201",5155.408,-0.2236958,0.07354479,-3.041627,0.002353033,0.03318677,0,20137,"sp|O61307|TENM_DROME","O61307","TENM",9.41e-86,"Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)","cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]","GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0097090; GO:0099190; GO:0099559; GO:2000331"
"g11212",20.35216,1.473101,0.4843469,3.041417,0.002354676,0.03320273,43811,47924,"sp|P09523|POL_FMVD","P09523","POL",1.33e-06,"Enzymatic polyprotein [Includes: Aspartic protease (EC 3.4.23.-); Endonuclease; Reverse transcriptase (EC 2.7.7.49)]",NA,"GO:0003964; GO:0004190; GO:0004519"
"g72485",51.39905,-0.3811128,0.1253231,-3.041042,0.002357613,0.03322534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73226",270.3733,-0.5285296,0.1737933,-3.041139,0.002356853,0.03322534,6184,10047,"sp|Q8C079|STRP1_MOUSE","Q8C079","STRP1",3.58e-15,"Striatin-interacting protein 1 (Protein FAM40A)","cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]","GO:0005634; GO:0005829; GO:0007010; GO:0019901; GO:0022604; GO:0030866; GO:0031267"
"g92062",110.7997,0.413689,0.1360365,3.041015,0.002357818,0.03322534,1126,4504,"sp|Q9Y3B2|EXOS1_HUMAN","Q9Y3B2","EXOS1",2.8e-12,"Exosome complex component CSL4 (Exosome component 1)","RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]","GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0101019"
"g80026",56.29336,-0.5451111,0.1792837,-3.040494,0.002361905,0.03326845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110671",123.6329,0.3332151,0.1095921,3.040503,0.00236183,0.03326845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62853",305.546,0.9696035,0.3189091,3.040376,0.00236283,0.03327426,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57451",290.3907,-0.7306958,0.24034,-3.040259,0.002363751,0.03327511,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139051",37.32085,0.4440469,0.1460567,3.040237,0.002363918,0.03327511,361,2134,"sp|Q2TBJ5|ATG12_RAT","Q2TBJ5","ATG12",7.24e-09,"Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like)","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096]","GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0006497; GO:0006501; GO:0006914; GO:0016020; GO:0016236; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0044804; GO:0045087; GO:0045824; GO:0050687; GO:1901096; GO:1904973; GO:1990234"
"g33132",247.8142,-0.2345113,0.07713966,-3.040088,0.00236509,0.03328438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4800",828.08,-0.3223358,0.1060383,-3.039805,0.002367312,0.03330841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3208",426.6639,-0.4326573,0.1423372,-3.039665,0.002368414,0.03331669,59998,71714,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.94e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g90856",6657.368,0.2529716,0.08322596,3.039576,0.002369117,0.03331934,0,7583,"sp|Q5RKI1|IF4A2_RAT","Q5RKI1","IF4A2",4.68e-37,"Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]","GO:0002183; GO:0003724; GO:0003743; GO:0005524; GO:0016887; GO:0048471; GO:1900260; GO:1990830"
"g22213",1379.897,-0.2739006,0.0901227,-3.039197,0.002372097,0.03334678,12885,42812,"sp|Q7KRI2|LOLAL_DROME","Q7KRI2","LOLAL",1.76e-14,"Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)","dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin assembly [GO:0031507]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]","GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0031208; GO:0031507; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944"
"g158906",71.84033,-0.4596162,0.1512293,-3.0392,0.002372073,0.03334678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34594",18.136,0.5100299,0.167821,3.03913,0.002372622,0.03334692,18591,29622,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.95e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g67306",79.96887,-0.6210331,0.2043735,-3.038717,0.002375881,0.03338548,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53018",635.6579,1.131816,0.3724882,3.038529,0.002377362,0.03339904,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4834",194.1168,-0.4295552,0.141373,-3.038454,0.002377953,0.03340011,8971,12394,"sp|Q7Z340|ZN551_HUMAN","Q7Z340","ZN551",6.05e-41,"Zinc finger protein 551 (Zinc finger protein KOX23)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g9872",534.1378,-0.3193861,0.105125,-3.038155,0.002380317,0.03342606,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79140",530.1728,1.221755,0.402167,3.03793,0.00238209,0.03344372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4561",174.9024,0.5983442,0.1969741,3.037679,0.002384076,0.03346435,102724,107304,"sp|Q9U8W7|TL5B_TACTR","Q9U8W7","TL5B",1.98e-14,"Techylectin-5B","cell-cell adhesion [GO:0098609]","GO:0005576; GO:0030246; GO:0046872; GO:0098609"
"g13981",856.5602,-0.3212299,0.1057656,-3.037186,0.002387979,0.03347694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17440",119.8046,0.3491316,0.1149453,3.037371,0.002386517,0.03347694,0,17254,"sp|Q7SZE5|SC23A_DANRE","Q7SZE5","SC23A",1.43e-06,"Protein transport protein Sec23A (SEC23-related protein A)","cartilage development [GO:0051216]; COPII-coated vesicle cargo loading [GO:0090110]; embryonic neurocranium morphogenesis [GO:0048702]; pectoral fin morphogenesis [GO:0035138]; protein targeting [GO:0006605]","GO:0005096; GO:0005789; GO:0005829; GO:0006605; GO:0008270; GO:0019898; GO:0030127; GO:0035138; GO:0048702; GO:0051216; GO:0070971; GO:0090110"
"g21335",601.7128,0.2403805,0.07914368,3.037267,0.002387343,0.03347694,21455,48498,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.76e-27,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g22878",157.9618,-0.3317113,0.1092161,-3.037203,0.002387849,0.03347694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24451",390.8731,0.7509299,0.2472569,3.037044,0.002389107,0.03347694,7145,16340,"sp|Q27245|YH24_CAEEL","Q27245","YH24",1.05e-13,"Putative aminopeptidase W07G4.4 (EC 3.4.11.-)",NA,"GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g38179",20242.22,0.599641,0.1974397,3.037084,0.002388786,0.03347694,1845,6131,"sp|P53501|ACT3_DROME","P53501","ACT3",0,"Actin-57B","mitotic cytokinesis [GO:0000281]; regulation of synapse organization [GO:0050807]","GO:0000281; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0050807"
"g98514",4444.36,0.6987239,0.2300631,3.037097,0.002388683,0.03347694,29,5037,"sp|Q86V86|PIM3_HUMAN","Q86V86","PIM3",7.84e-08,"Serine/threonine-protein kinase pim-3 (EC 2.7.11.1)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]","GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179; GO:0106310"
"g104739",46687.69,0.464876,0.1530475,3.037463,0.002385788,0.03347694,0,5623,"sp|Q9BMM8|MYSP_SARSC","Q9BMM8","MYSP",2.82e-08,"Paramyosin",NA,"GO:0016459; GO:0030016; GO:0032982"
"g21962",459.9853,0.4416625,0.145431,3.03692,0.002390085,0.03348341,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45766",331.6571,1.045639,0.344383,3.036267,0.00239527,0.0335488,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33314",238.8952,0.3872346,0.1275463,3.036031,0.002397146,0.03356782,6495,10395,"sp|P80313|TCPH_MOUSE","P80313","TCPH",1.25e-20,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g45719",83.37895,0.4688577,0.1544441,3.035776,0.002399178,0.03358901,685,19821,"sp|A4XI37|EFTU_CALS8","A4XI37","EFTU",4.41e-22,"Elongation factor Tu (EF-Tu)",NA,"GO:0003746; GO:0003924; GO:0005525; GO:0005737"
"g89909",107.3336,-0.4780759,0.15749,-3.035594,0.00240062,0.03360194,0,5844,"sp|P49867|FTZF1_BOMMO","P49867","FTZF1",1.24e-38,"Nuclear hormone receptor FTZ-F1 (BmFTZ-F1) (Nuclear receptor subfamily 5 group A member 3)",NA,"GO:0004879; GO:0005634; GO:0008270; GO:0043565"
"g39891",125.2154,-0.3365547,0.1108721,-3.03552,0.00240121,0.03360294,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26056",1035.361,-0.2711519,0.08933375,-3.035269,0.002403214,0.03360777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36617",139.6621,0.5472834,0.1803098,3.035238,0.002403456,0.03360777,0,2249,"sp|P51174|ACADL_MOUSE","P51174","ACADL",3.01e-25,"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)","carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659]","GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0009062; GO:0009409; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0090181; GO:0120162"
"g39706",139.7164,0.3678167,0.121183,3.035217,0.00240363,0.03360777,0,11014,"sp|Q5ZML6|F210A_CHICK","Q5ZML6","F210A",1.75e-06,"Protein FAM210A",NA,"GO:0005737; GO:0005739; GO:0016021"
"g124761",42.80403,-0.3691626,0.1216249,-3.035254,0.002403329,0.03360777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6070",3318.981,-0.2610323,0.0860136,-3.034779,0.00240712,0.0336493,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89365",174.0148,-0.4266402,0.1405941,-3.034553,0.002408923,0.03366725,0,5794,"sp|Q8TF32|ZN431_HUMAN","Q8TF32","ZN431",2.34e-65,"Zinc finger protein 431","cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872"
"g30861",192.9783,0.4094521,0.1349348,3.034444,0.002409794,0.03367215,14804,18194,"sp|P26268|ODPT_ASCSU","P26268","ODPT",5.78e-13,"Pyruvate dehydrogenase E1 component subunit alpha type II, mitochondrial (PDHA2) (PDHE1-A) (EC 1.2.4.1) (Fragment)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099]","GO:0004739; GO:0005759; GO:0006006; GO:0006086; GO:0006099"
"g6680",101.6957,0.5501491,0.1813297,3.033971,0.002413578,0.03371433,96218,104204,"sp|Q8CHY3|DYM_MOUSE","Q8CHY3","DYM",1.02e-18,"Dymeclin","bone development [GO:0060348]; Golgi organization [GO:0007030]","GO:0005737; GO:0005794; GO:0007030; GO:0016020; GO:0019899; GO:0060348"
"g15546",72.78398,1.642624,0.5414168,3.033936,0.002413853,0.03371433,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8311",911.5836,-0.5669209,0.1868753,-3.033685,0.002415866,0.03373517,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150598",227.8535,1.221603,0.4027207,3.033376,0.00241834,0.03376244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38896",147.0568,0.7528632,0.2482066,3.033212,0.002419659,0.03377358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10430",5682.091,-0.2147904,0.07081695,-3.033036,0.002421064,0.03378592,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53600",18571.15,-0.2448693,0.08074241,-3.032722,0.002423587,0.03381384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1627",5830.063,-0.1922819,0.06341652,-3.032048,0.002429006,0.03387486,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106967",169.1425,0.4994729,0.1647286,3.032095,0.002428626,0.03387486,612,5750,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.27e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g142537",41.04508,0.9034881,0.2979906,3.031935,0.002429917,0.03388027,0,2638,"sp|Q11174|CHIT_CAEEL","Q11174","CHIT",1.98e-13,"Probable endochitinase (EC 3.2.1.14)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]; response to fungus [GO:0009620]","GO:0000272; GO:0004568; GO:0005576; GO:0006032; GO:0008061; GO:0009620"
"g18074",1161.952,-0.2275762,0.07506312,-3.031798,0.002431019,0.03388696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35298",38.61813,0.4454957,0.1469478,3.031659,0.002432139,0.03388696,0,9784,"sp|O60678|ANM3_HUMAN","O60678","ANM3",6.75e-08,"Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)","dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; protein methylation [GO:0006479]","GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016274; GO:0031397; GO:0035241; GO:0035242; GO:0043022; GO:0046872; GO:0060997; GO:0072341; GO:1900053"
"g81248",329.0403,1.909731,0.6299239,3.031685,0.002431932,0.03388696,0,8671,"sp|P32138|SQASE_ECOLI","P32138","SQASE",9.26e-10,"Sulfoquinovosidase (SQase) (EC 3.2.1.199)","6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]","GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929"
"g102736",377.5838,0.4789565,0.1579872,3.031615,0.002432489,0.03388696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98796",43.29434,-0.3893403,0.1284386,-3.031333,0.002434762,0.03391133,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36932",117.4725,-0.618869,0.2041667,-3.031195,0.00243588,0.03391961,7215,11015,"sp|Q852K5|SAP6_ORYSJ","Q852K5","SAP6",1.86e-13,"Zinc finger A20 and AN1 domain-containing stress-associated protein 6 (OsSAP6)",NA,"GO:0003677; GO:0008270"
"g98565",147.6653,0.4388721,0.144795,3.030988,0.002437547,0.03393553,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5461",2287.769,-0.4191066,0.138282,-3.030812,0.002438972,0.03393973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13475",43.07198,0.3222754,0.106331,3.03087,0.002438498,0.03393973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144903",231.3575,0.4945715,0.1631842,3.030756,0.00243942,0.03393973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70781",35.71722,2.572332,0.8488053,3.030533,0.002441226,0.03395756,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73765",919.1494,-0.3690516,0.1217829,-3.030405,0.002442258,0.03396464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27618",3571.964,-0.4194056,0.1384242,-3.029858,0.00244669,0.03400437,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93254",140.261,0.2879734,0.09504125,3.029983,0.002445673,0.03400437,0,7295,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",5.21e-69,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g107483",24.47823,-2.054598,0.6781136,-3.029873,0.002446568,0.03400437,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8125",1410.85,-0.3903091,0.1288327,-3.029581,0.002448936,0.034008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14955",428.6295,-0.3197952,0.1055581,-3.029566,0.00244905,0.034008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33927",946.1057,-0.2421872,0.07993798,-3.029688,0.002448062,0.034008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112759",63.20181,0.5059166,0.166984,3.02973,0.002447724,0.034008,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7462",163.5055,-0.554177,0.1829473,-3.029161,0.002452339,0.03404046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40389",47.05907,0.7319935,0.2416565,3.029066,0.002453111,0.03404046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83623",154.8688,2.17881,0.7192914,3.029106,0.002452784,0.03404046,2180,8566,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.08e-12,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g105377",632.7897,2.153846,0.7110703,3.029019,0.002453489,0.03404046,0,5915,"sp|Q8S8Q4|GUN14_ARATH","Q8S8Q4","GUN14",4.56e-10,"Endoglucanase 14 (EC 3.2.1.4) (Endo-1,4-beta glucanase 14)","cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]","GO:0005576; GO:0008810; GO:0030245; GO:0071555"
"g117997",1644.295,0.2791744,0.09217164,3.028854,0.002454836,0.03405185,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64732",332.1427,0.2030113,0.06702728,3.028787,0.002455381,0.03405212,745,10236,"sp|Q9NQZ8|ZNF71_HUMAN","Q9NQZ8","ZNF71",2.21e-16,"Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g68597",62.06947,0.3525546,0.1164066,3.028648,0.002456506,0.03405566,0,11237,"sp|Q27237|TID_DROME","Q27237","TID",9.04e-19,"Protein tumorous imaginal discs, mitochondrial (Protein lethal(2)tumorous imaginal discs) (TID50) (TID56)","mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; response to heat [GO:0009408]","GO:0005113; GO:0005524; GO:0005739; GO:0005741; GO:0005829; GO:0006457; GO:0007005; GO:0009408; GO:0031072; GO:0043066; GO:0045879; GO:0046872; GO:0051082"
"g75476",50.60032,0.9328606,0.3080145,3.028626,0.002456687,0.03405566,1692,9282,"sp|O54697|NALDL_RAT","O54697","NALDL",2.69e-12,"Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L)","peptide catabolic process [GO:0043171]","GO:0004177; GO:0004180; GO:0005509; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171"
"g38888",153.9963,-0.4747529,0.1567588,-3.028557,0.002457248,0.03405615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144671",18.60486,1.679874,0.5547077,3.028394,0.002458569,0.03406717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34335",1265.263,-0.239709,0.07915874,-3.028206,0.002460104,0.03407613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81253",107.7771,0.5346659,0.1765631,3.028186,0.002460268,0.03407613,0,8920,"sp|P21910|LAML2_XENLA","P21910","LAML2",2.14e-08,"Lamin-L(II)",NA,"GO:0005637; GO:0005882"
"g107783",839.2457,-0.2143107,0.07077423,-3.02809,0.002461048,0.03407965,0,5433,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.09e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g55178",96.94616,0.8028398,0.2652012,3.027285,0.002467609,0.03415591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139380",36.65131,-2.635847,0.8706937,-3.027295,0.002467528,0.03415591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132888",26.99043,-0.4875906,0.1610691,-3.027214,0.00246819,0.03415664,0,3244,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",7.3e-83,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g44473",1687.102,-0.6468941,0.2137214,-3.02681,0.002471491,0.0341892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99440",19.97663,0.6448968,0.213065,3.026761,0.002471892,0.0341892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117608",828.8713,0.6775212,0.2238457,3.026733,0.002472125,0.0341892,678,4711,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.42e-08,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g43364",43.63781,0.4738218,0.1565648,3.026362,0.002475155,0.03422379,3755,20891,"sp|Q99741|CDC6_HUMAN","Q99741","CDC6",1.85e-08,"Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)","cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089]","GO:0000076; GO:0000079; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:1904117; GO:1904385"
"g2201",216.8545,-0.308729,0.1020174,-3.026239,0.002476165,0.03422822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109252",35.80366,1.509884,0.4989383,3.026194,0.002476532,0.03422822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44848",24.96696,0.6109386,0.201897,3.025992,0.002478188,0.03424381,18196,19641,"sp|Q14674|ESPL1_HUMAN","Q14674","ESPL1",2.67e-07,"Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)","apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]","GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686"
"g90526",1053.441,0.3963097,0.1309808,3.025709,0.002480512,0.03426861,0,7624,"sp|Q4R6F8|TCPB_MACFA","Q4R6F8","TCPB",1.08e-19,"T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g29482",247.7129,-0.4044772,0.1336852,-3.025594,0.002481449,0.03427426,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3633",3975.905,-0.3818719,0.1262299,-3.025211,0.0024846,0.03430184,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120245",121.4366,-0.5394521,0.178322,-3.025158,0.002485035,0.03430184,0,3254,"sp|Q6Q760|NALCN_RAT","Q6Q760","NALCN",8.53e-12,"Sodium leak channel NALCN (Four domain-type voltage-gated ion channel alpha-1 subunit) (Rb21-channel) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1)","calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]","GO:0005244; GO:0005248; GO:0005261; GO:0005886; GO:0016021; GO:0022840; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805"
"g155842",163.8636,0.8890833,0.2938878,3.025247,0.002484299,0.03430184,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18808",731.8666,-0.2513281,0.08309863,-3.024455,0.002490815,0.03437431,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108391",88.00141,-0.3781381,0.12503,-3.024378,0.002491448,0.03437573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64746",155.3487,0.948497,0.3136342,3.024214,0.002492799,0.03438704,4975,12122,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.49e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19591",2173.58,-0.3467575,0.114664,-3.024117,0.002493597,0.03439072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1785",438.1931,0.5990091,0.198087,3.02397,0.002494813,0.03440018,265,51173,"sp|Q9W534|MOODY_DROME","Q9W534","MOODY",1.35e-16,"G-protein coupled receptor moody","axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419]","GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016021; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857"
"g101233",137.4469,-0.5219055,0.1725938,-3.023894,0.002495439,0.03440148,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4275",463.1827,-0.2407278,0.07961562,-3.023626,0.002497653,0.03441736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46711",1023.147,-0.2489569,0.08233554,-3.023687,0.002497144,0.03441736,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44319",759.7051,-0.5011324,0.1657446,-3.023521,0.002498514,0.03441873,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62647",153.3935,0.3048561,0.1008294,3.023485,0.002498815,0.03441873,0,6764,"sp|P12956|XRCC6_HUMAN","P12956","XRCC6",2.74e-11,"X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6)","activation of innate immune response [GO:0002218]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA ligation [GO:0006266]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000725; GO:0000781; GO:0000783; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006266; GO:0006303; GO:0008022; GO:0008094; GO:0016020; GO:0016787; GO:0030332; GO:0032991; GO:0032993; GO:0034774; GO:0042162; GO:0043564; GO:0044877; GO:0045087; GO:0045621; GO:0045860; GO:0045892; GO:0045893; GO:0045944; GO:0048660; GO:0051575; GO:0070418; GO:0070419; GO:0071480; GO:0071481; GO:0097110; GO:0097680; GO:1904813"
"g136908",22.67675,0.5286367,0.1748487,3.023396,0.002499549,0.03442152,0,3080,"sp|Q2PZL6|FAT4_MOUSE","Q2PZL6","FAT4",6.47e-19,"Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609"
"g295",2286.833,-0.4034171,0.1334448,-3.023102,0.002501979,0.03443303,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42050",57.82391,0.4340224,0.1435685,3.023104,0.002501967,0.03443303,6345,21740,"sp|Q9N0X0|AURKB_PIG","Q9N0X0","AURKB",2.71e-11,"Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)","abscission [GO:0009838]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]","GO:0000122; GO:0000776; GO:0002903; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005876; GO:0006468; GO:0007052; GO:0007094; GO:0009838; GO:0030496; GO:0031616; GO:0032133; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0036089; GO:0043988; GO:0044878; GO:0046872; GO:0051233; GO:0051256; GO:0062033; GO:0106310"
"g120400",103.4636,0.4178957,0.1382324,3.023139,0.002501672,0.03443303,475,3618,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.94e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g4552",56.21657,0.4254951,0.1407528,3.022997,0.002502851,0.03443772,118956,129987,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.75e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15750",26.86417,0.6189104,0.2047462,3.022817,0.002504336,0.03444352,0,2495,"sp|Q9VY77|AJUBA_DROME","Q9VY77","AJUBA",3.74e-19,"LIM domain-containing protein jub","cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]","GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311; GO:2000637"
"g119628",29.94635,1.870944,0.6189277,3.02288,0.002503816,0.03444352,2645,4524,"sp|Q03013|GSTM4_HUMAN","Q03013","GSTM4",3.03e-13,"Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4) (Leukotriene C4 synthase GSTM4) (EC 4.4.1.20)","glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0004464; GO:0005737; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171"
"g58259",52.37937,0.3702427,0.1224869,3.022712,0.002505207,0.03444819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71640",2380.38,0.47348,0.1566523,3.02249,0.002507043,0.03446139,4055,7565,"sp|Q94516|AT5F1_DROME","Q94516","AT5F1",4.18e-12,"ATP synthase subunit b, mitochondrial (ATPase subunit b) (FO-ATP synthase subunit b)","ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]","GO:0000274; GO:0000276; GO:0005739; GO:0015078; GO:0015986; GO:1902600"
"g147565",1792.446,1.887012,0.6243415,3.022403,0.002507763,0.03446139,0,1968,"sp|P53634|CATC_HUMAN","P53634","CATC",1.77e-22,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235"
"g151078",341.2375,0.3010101,0.09959279,3.022408,0.00250772,0.03446139,0,1542,"sp|Q54V61|NDUB7_DICDI","Q54V61","NDUB7",2.9e-09,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7",NA,"GO:0005747; GO:0005758"
"g40517",157.4824,0.3982355,0.1317647,3.022322,0.002508436,0.03446333,20075,23732,"sp|Q922Q1|MARC2_MOUSE","Q922Q1","MARC2",7.39e-10,"Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)","cellular detoxification of nitrogen compound [GO:0070458]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]","GO:0005739; GO:0005741; GO:0005743; GO:0005777; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0070458; GO:0098809"
"g12235",54.60079,-0.3286632,0.1087563,-3.022017,0.002510967,0.03446889,65418,73165,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.24e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g30446",163.5215,0.3286582,0.1087499,3.022148,0.002509875,0.03446889,8868,16694,"sp|P10394|POL4_DROME","P10394","POL4",2.3e-24,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g68039",26.2352,0.6920988,0.2290113,3.022117,0.002510139,0.03446889,0,10804,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.13e-63,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g74627",136.1424,0.3408312,0.1127827,3.022017,0.002510968,0.03446889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32343",54.00806,0.3947814,0.1306397,3.021909,0.002511858,0.0344738,13836,32229,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",1.58e-70,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g38330",35.10633,-0.3360302,0.1112104,-3.021572,0.002514656,0.03447569,0,23714,"sp|P21328|RTJK_DROME","P21328","RTJK",8.53e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g56892",10275.39,1.031498,0.3413778,3.021573,0.002514649,0.03447569,2465,14465,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",9.77e-49,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g63142",202.5107,1.108844,0.3669681,3.021636,0.002514128,0.03447569,1399,8094,"sp|Q9CPP7|LIPG_MOUSE","Q9CPP7","LIPG",3.19e-13,"Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]","GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231"
"g83630",191.7967,-0.252168,0.08345101,-3.021749,0.002513185,0.03447569,0,8288,"sp|Q13106|ZN154_HUMAN","Q13106","ZN154",1.87e-45,"Zinc finger protein 154","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g114476",62.69324,0.5678273,0.1879099,3.021806,0.002512714,0.03447569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7354",8426.037,-0.570707,0.1888983,-3.021239,0.002517422,0.03449172,4495,75452,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.85e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g32864",725.5336,0.5962316,0.1973458,3.021253,0.002517311,0.03449172,17588,23914,"sp|Q8BH79|ANO10_MOUSE","Q8BH79","ANO10",1.37e-17,"Anoctamin-10 (Transmembrane protein 16K)","cation transport [GO:0006812]; chloride transport [GO:0006821]; transmembrane transport [GO:0055085]","GO:0005227; GO:0005229; GO:0005886; GO:0006812; GO:0006821; GO:0016021; GO:0043231; GO:0055085"
"g42674",4744.798,0.3482978,0.1152794,3.021336,0.002516618,0.03449172,0,6965,"sp|Q78P75|DYL2_RAT","Q78P75","DYL2",4.87e-29,"Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2)","cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]","GO:0005737; GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0030286; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0051959; GO:0060271; GO:0097110; GO:0097731; GO:0098794; GO:0098978"
"g32889",636.7787,-0.3136094,0.1038107,-3.020974,0.00251963,0.03451466,9595,13622,"sp|O01404|PHM_DROME","O01404","PHM",6.82e-07,"Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3)","memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]","GO:0004504; GO:0005507; GO:0005576; GO:0005615; GO:0006518; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719"
"g71611",39.65249,-1.579814,0.5229965,-3.020698,0.00252193,0.03453887,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22268",60.69938,0.6720139,0.2224854,3.020485,0.0025237,0.03455581,6705,14621,"sp|Q23979|MY61F_DROME","Q23979","MY61F",3.64e-23,"Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C)","actin filament organization [GO:0007015]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0032528; GO:0042742; GO:0048803; GO:0051015"
"g7891",848.417,-0.2323564,0.07693211,-3.020278,0.002525428,0.03457216,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11391",69.52676,-0.3847763,0.1274074,-3.020048,0.002527347,0.03458382,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59057",361.5041,-0.5461899,0.1808527,-3.020081,0.00252707,0.03458382,0,10672,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.76e-09,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g79033",151.0367,1.218377,0.403459,3.019828,0.002529183,0.03460163,2126,8764,"sp|O75310|UDB11_HUMAN","O75310","UDB11",2.85e-12,"UDP-glucuronosyltransferase 2B11 (UDPGT 2B11) (EC 2.4.1.17)","estrogen metabolic process [GO:0008210]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805]","GO:0005789; GO:0006805; GO:0008210; GO:0015020; GO:0016021; GO:0043231; GO:0052697"
"g48434",18.67679,1.499426,0.4965609,3.019621,0.002530914,0.03460369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130711",65.06228,0.3789341,0.1254907,3.019618,0.002530935,0.03460369,0,3575,"sp|Q94511|NDUS1_DROME","Q94511","NDUS1",3.41e-11,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]","GO:0005747; GO:0008137; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593"
"g156129",47.36312,0.4314531,0.1428802,3.019684,0.002530381,0.03460369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8319",823.8658,-0.5835369,0.1932709,-3.019269,0.002533854,0.03463539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15715",82.07901,1.233842,0.4086888,3.019027,0.002535881,0.03463539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34233",324.272,-0.3182503,0.105415,-3.019021,0.002535926,0.03463539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43293",281.1666,-0.3815073,0.1263632,-3.019132,0.002534999,0.03463539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146186",706.3635,0.2734457,0.09057167,3.019109,0.002535196,0.03463539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7364",413.7,0.5235508,0.1734259,3.018874,0.00253716,0.03464487,17095,21357,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.77e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g95351",72139.97,0.3047575,0.1009528,3.018811,0.00253769,0.03464487,5758,6844,"sp|Q1HPK6|EF2_BOMMO","Q1HPK6","EF2",1.2e-170,"Translation elongation factor 2 (EF-2)",NA,"GO:0003746; GO:0003924; GO:0005525; GO:0005737"
"g44037",48.54917,1.105077,0.3660898,3.018596,0.00253949,0.03466214,10185,19514,"sp|A7RX26|HUTI_NEMVE","A7RX26","HUTI",9.24e-23,"Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog)","histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]","GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480"
"g38671",5435.858,-0.245062,0.08118629,-3.018514,0.002540173,0.03466417,10060,22894,"sp|P29174|CSDE1_CAVPO","P29174","CSDE1",3.01e-14,"Cold shock domain-containing protein E1 (Protein UNR) (Fragment)","stress granule assembly [GO:0034063]","GO:0000932; GO:0003723; GO:0010494; GO:0034063"
"g153231",175.5093,-0.3429732,0.1136295,-3.018346,0.002541582,0.03467608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55489",109.7737,-0.35126,0.1163818,-3.018169,0.002543067,0.03468904,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106612",24.9011,-0.6108495,0.2024063,-3.017938,0.00254501,0.03469363,2225,5789,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.02e-33,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g115973",72.80402,-0.3897426,0.129141,-3.017962,0.00254481,0.03469363,745,4870,"sp|Q99NI3|GT2D2_MOUSE","Q99NI3","GT2D2",1.64e-08,"General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)","transition between fast and slow fiber [GO:0014883]","GO:0003677; GO:0005634; GO:0005654; GO:0014883"
"g140299",103.6821,0.8516327,0.2821887,3.017955,0.002544865,0.03469363,665,2760,"sp|Q9C8L4|ETHE1_ARATH","Q9C8L4","ETHE1",6.23e-22,"Persulfide dioxygenase ETHE1 homolog, mitochondrial (EC 1.13.11.18) (Glyoxalase II) (Glx II) (Sulfur dioxygenase ETHE1)","embryo development ending in seed dormancy [GO:0009793]; endosperm development [GO:0009960]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; seed development [GO:0048316]","GO:0005634; GO:0005739; GO:0006749; GO:0009793; GO:0009960; GO:0016788; GO:0046872; GO:0048316; GO:0050313; GO:0070813"
"g28801",218.7681,0.4812344,0.1595006,3.017133,0.002551781,0.03477131,21586,31854,"sp|Q9VIH3|MTP_DROME","Q9VIH3","MTP",6.46e-06,"Microsomal triacylglycerol transfer protein (MTP)","dendrite morphogenesis [GO:0048813]; lipoprotein metabolic process [GO:0042157]; lumen formation, open tracheal system [GO:0035149]; synaptic target recognition [GO:0008039]","GO:0005548; GO:0005783; GO:0005794; GO:0008039; GO:0008289; GO:0008525; GO:0012505; GO:0016323; GO:0035149; GO:0042157; GO:0048813; GO:0120013"
"g102435",105.4996,0.3359999,0.111362,3.017187,0.002551327,0.03477131,0,6228,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.5e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g16483",380.5979,-0.3413266,0.1131388,-3.016883,0.002553883,0.03479263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5390",322.6675,-0.2779456,0.09214204,-3.01649,0.002557195,0.03483043,73930,77544,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.17e-16,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g127362",623.2198,-0.4140941,0.1372823,-3.01637,0.002558211,0.03483694,657,3764,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",3.93e-13,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g103954",305.1469,1.521369,0.5043843,3.01629,0.002558887,0.03483883,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71004",128.9808,0.328763,0.1090026,3.016103,0.002560461,0.03485293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103218",109.33,0.4276518,0.1417985,3.015912,0.002562073,0.03486755,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159200",30.07435,0.8820352,0.2925062,3.015441,0.002566062,0.0349145,0,774,"sp|P84057|H2A_TIGCA","P84057","H2A",1.67e-66,"Histone H2A",NA,"GO:0000786; GO:0003677; GO:0005634; GO:0046982"
"g161057",93.52169,-0.2690573,0.08922944,-3.015342,0.002566896,0.03491852,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45650",976.8676,-0.3317891,0.1100441,-3.015056,0.002569319,0.0349368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66686",101.6519,0.47134,0.156327,3.01509,0.002569028,0.0349368,5096,11672,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.73e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g30492",638.766,-0.3431037,0.1138,-3.01497,0.002570046,0.03493935,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104524",32.28774,0.693509,0.2300345,3.014804,0.002571454,0.03494384,0,5997,"sp|Q7RTU7|SCX_HUMAN","Q7RTU7","SCX",1.56e-16,"Basic helix-loop-helix transcription factor scleraxis (Class A basic helix-loop-helix protein 41) (bHLHa41) (Class A basic helix-loop-helix protein 48) (bHLHa48)","BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; deltoid tuberosity development [GO:0035993]; developmental process [GO:0032502]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; face morphogenesis [GO:0060325]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cartilage development [GO:0061035]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; Sertoli cell differentiation [GO:0060008]; skeletal muscle cell differentiation [GO:0035914]; tendon cell differentiation [GO:0035990]; tendon development [GO:0035989]; tendon formation [GO:0035992]; tissue homeostasis [GO:0001894]; transcription, DNA-templated [GO:0006351]","GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001707; GO:0001894; GO:0001958; GO:0002062; GO:0003179; GO:0003188; GO:0003677; GO:0005634; GO:0005667; GO:0006351; GO:0006357; GO:0008284; GO:0010628; GO:0030154; GO:0030199; GO:0030509; GO:0032502; GO:0032967; GO:0035914; GO:0035989; GO:0035990; GO:0035992; GO:0035993; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048706; GO:0060008; GO:0060325; GO:0061035; GO:0061036; GO:0061056; GO:0070888; GO:0071260; GO:0071560; GO:2000543"
"g105356",84.76579,-0.5012857,0.1662743,-3.014812,0.002571389,0.03494384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85386",163.8949,-0.4209109,0.1396384,-3.014292,0.002575798,0.03499553,1759,8314,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.21e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g25609",3086.382,-0.5123037,0.1699727,-3.014036,0.002577976,0.03501777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47609",148.9323,0.3339317,0.1107982,3.013874,0.002579347,0.03502171,0,8304,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",5.14e-19,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g94256",17.95947,-0.4852097,0.1609905,-3.013902,0.002579111,0.03502171,0,7084,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.33e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17552",272.92,0.5986287,0.1986458,3.013549,0.002582117,0.03502263,0,57245,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.31e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18288",172.2719,0.3643518,0.1209039,3.013564,0.002581985,0.03502263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58445",18.83819,0.8081597,0.2681713,3.013595,0.002581722,0.03502263,8134,13942,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.46e-23,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119908",35.56416,1.036513,0.3439362,3.013678,0.002581016,0.03502263,0,4496,"sp|P21329|RTJK_DROFU","P21329","RTJK",9.48e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g120112",108.5557,1.411495,0.4683466,3.013782,0.002580132,0.03502263,0,4481,"sp|O62839|CATA_PIG","O62839","CATA",2.87e-27,"Catalase (EC 1.11.1.6)","hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]","GO:0004096; GO:0005737; GO:0005739; GO:0005777; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781"
"g115854",114.6066,-0.2823301,0.09369094,-3.01342,0.002583215,0.03503019,1807,4654,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.73e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g24436",2201.772,-0.2404489,0.07979958,-3.01316,0.002585424,0.03505281,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152171",155.7878,-0.3976942,0.132001,-3.012812,0.002588395,0.03508575,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43489",514.6392,-0.4749275,0.1576566,-3.012417,0.002591764,0.03512406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93514",35.42075,1.510016,0.5012864,3.012282,0.002592912,0.03512699,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119803",1945.581,-0.5860064,0.1945401,-3.012265,0.002593064,0.03512699,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4283",1113.771,-0.5378283,0.1785682,-3.011892,0.002596248,0.03515961,118457,121484,"sp|P15791|KCC2D_RAT","P15791","KCC2D",3.13e-08,"Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17)","calcium ion transport [GO:0006816]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular potassium ion homeostasis [GO:0030007]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cellular localization [GO:0060341]; regulation of membrane depolarization [GO:0003254]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to hypoxia [GO:0001666]","GO:0000082; GO:0001666; GO:0002028; GO:0003254; GO:0004672; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010613; GO:0010649; GO:0010666; GO:0010880; GO:0010881; GO:0010971; GO:0014704; GO:0014911; GO:0018105; GO:0018107; GO:0019871; GO:0030007; GO:0030315; GO:0031432; GO:0031594; GO:0032469; GO:0032991; GO:0033017; GO:0035022; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043194; GO:0044325; GO:0046777; GO:0048471; GO:0050998; GO:0055119; GO:0060048; GO:0060341; GO:0061049; GO:0070374; GO:0086003; GO:0098901; GO:0098909; GO:0106310; GO:1901844; GO:1901897; GO:1902306; GO:1902514; GO:1903076; GO:1904707; GO:2000573; GO:2000650"
"g96202",68.30932,0.4913449,0.1631369,3.011856,0.002596557,0.03515961,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50288",271.7303,-0.4416254,0.1466476,-3.011475,0.002599819,0.0351948,11996,15584,"sp|Q9HCG1|ZN160_HUMAN","Q9HCG1","ZN160",5.81e-24,"Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18)","hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872"
"g71416",272.0672,0.2188547,0.07267632,3.011362,0.002600786,0.0351948,0,8580,"sp|O08788|DCTN1_MOUSE","O08788","DCTN1",2.17e-11,"Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p150-glued)","cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]","GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005868; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0007528; GO:0008017; GO:0010457; GO:0015630; GO:0015631; GO:0019901; GO:0021517; GO:0030424; GO:0031116; GO:0031122; GO:0031252; GO:0032402; GO:0032991; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0042802; GO:0043005; GO:0043025; GO:0045171; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0090316; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535"
"g111605",75.40019,0.8404029,0.2790718,3.011422,0.002600271,0.0351948,1636,5283,"sp|P45963|ACR7_CAEEL","P45963","ACR7",2.01e-06,"Acetylcholine receptor subunit alpha-type acr-7","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]","GO:0004888; GO:0005230; GO:0005887; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877"
"g29604",28.33495,0.5397303,0.1792471,3.011096,0.002603066,0.03519626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91840",60.08183,-0.4102385,0.1362392,-3.011165,0.002602478,0.03519626,0,7463,"sp|P04323|POL3_DROME","P04323","POL3",1.37e-38,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g121238",100.686,0.3991551,0.1325602,3.011123,0.002602834,0.03519626,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141647",69.17567,0.7229576,0.240088,3.011219,0.002602009,0.03519626,0,404,"sp|Q7JK39|DHDH_MACFU","Q7JK39","DHDH",8.7e-25,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Jmo2DD)",NA,"GO:0000166; GO:0047115; GO:0047837"
"g87088",30.12295,0.9173563,0.3046758,3.010926,0.002604521,0.03520858,0,8081,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.72e-51,"PiggyBac transposable element-derived protein 4",NA,NA
"g96148",80.72112,0.344586,0.1144566,3.010626,0.002607101,0.0352361,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138",2615.815,0.6305414,0.2094446,3.01054,0.002607835,0.03523867,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39818",1313.226,0.3974854,0.132037,3.01041,0.002608954,0.03524645,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22581",72.51028,0.9760856,0.3242636,3.010161,0.002611092,0.03526798,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55128",113.1463,0.2781828,0.09241935,3.010006,0.002612422,0.03527858,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87919",65.92784,0.7069769,0.2348945,3.009764,0.002614512,0.03529945,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115294",22.80866,-0.4724935,0.1569911,-3.009683,0.002615205,0.03530146,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21779",7311.945,0.3876818,0.1288173,3.009548,0.002616366,0.03530977,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11720",27.6587,0.7269616,0.2415717,3.0093,0.002618503,0.03531655,61675,63973,"sp|Q9W6S5|ALLC_XENLA","Q9W6S5","ALLC",4.04e-06,"Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)","allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]","GO:0000256; GO:0004037; GO:0006144"
"g17363",3503.579,-0.2696769,0.08961186,-3.009389,0.00261774,0.03531655,16896,32134,"sp|Q8BHN5|RBM45_MOUSE","Q8BHN5","RBM45",1.56e-08,"RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904"
"g76186",23.12632,0.5868419,0.1950071,3.009336,0.002618195,0.03531655,6695,9350,"sp|Q9D3S9|CPVL_MOUSE","Q9D3S9","CPVL",2.07e-09,"Probable serine carboxypeptidase CPVL (EC 3.4.16.-)",NA,"GO:0004185"
"g28588",102.3859,0.9128884,0.3033679,3.009179,0.002619545,0.03532325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43442",85.77021,-0.4446383,0.147777,-3.008847,0.002622414,0.03535457,0,5854,"sp|Q29S22|DDX47_BOVIN","Q29S22","DDX47",2.4e-25,"Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)","extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016887"
"g21564",2574.317,-0.4091602,0.1360043,-3.008437,0.002625957,0.03539497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20606",323.849,0.299511,0.09956178,3.008292,0.002627202,0.03540157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159732",33.77004,0.99864,0.3319667,3.008253,0.002627539,0.03540157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42688",1174.893,-0.2469016,0.08207845,-3.008117,0.002628716,0.03541007,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10035",60.5071,-0.5562284,0.1849363,-3.007675,0.002632543,0.03545425,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34231",403.9328,-0.266981,0.08877212,-3.007487,0.002634172,0.03546632,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43554",47.23301,0.5378933,0.1788539,3.007445,0.002634534,0.03546632,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40056",132.3539,0.3938679,0.1309802,3.007078,0.002637717,0.03550178,0,10324,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.83e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g113071",158.9918,-0.3926613,0.1305857,-3.006925,0.002639046,0.0355123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60575",89.8417,0.4046406,0.1345735,3.006837,0.00263981,0.0355152,0,2449,"sp|P16905|KAPR1_DROME","P16905","KAPR1",7.67e-10,"cAMP-dependent protein kinase type I regulatory subunit (DRI class I to class IV)","actin filament organization [GO:0007015]; cAMP-mediated signaling [GO:0019933]; molting cycle, chitin-based cuticle [GO:0007591]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of smoothened signaling pathway [GO:0045879]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of feeding behavior [GO:2000253]; positive regulation of smoothened signaling pathway [GO:0045880]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]; ventral cord development [GO:0007419]","GO:0004862; GO:0005737; GO:0005952; GO:0007015; GO:0007274; GO:0007283; GO:0007419; GO:0007591; GO:0008103; GO:0008355; GO:0008603; GO:0019933; GO:0030552; GO:0034236; GO:0045202; GO:0045471; GO:0045879; GO:0045880; GO:2000253; GO:2000480"
"g49897",19.76408,1.648819,0.548374,3.006741,0.002640644,0.03551904,0,11682,"sp|P17193|DPOL_HPBDW","P17193","DPOL",2.56e-11,"Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]","DNA replication [GO:0006260]","GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872"
"g17393",46.56555,1.288635,0.4286087,3.006554,0.002642273,0.03553358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89",261.3767,0.6800048,0.2262035,3.006164,0.002645663,0.03557179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46958",30932.83,-0.5765718,0.1918178,-3.005831,0.002648564,0.03559602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141426",18.69463,0.9387431,0.3123038,3.005865,0.002648267,0.03559602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129557",681.7223,0.4530478,0.1507367,3.005558,0.002650939,0.03562055,0,3434,"sp|Q9V9A7|MCCB_DROME","Q9V9A7","MCCB",4.78e-39,"Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)","coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]; regulation of eclosion [GO:0007563]","GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0007563; GO:0015936; GO:1905202"
"g40258",359.5876,-0.3038653,0.1011055,-3.005427,0.002652084,0.03562854,0,11025,"sp|Q98SJ5|SIM1A_DANRE","Q98SJ5","SIM1A",6.9e-29,"Single-minded homolog 1-A","axon guidance [GO:0007411]; diencephalon development [GO:0021536]; dopaminergic neuron differentiation [GO:0071542]; hypothalamus cell differentiation [GO:0021979]; pronephric proximal tubule development [GO:0035776]; pronephros development [GO:0048793]; proximal straight tubule development [GO:0072020]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007411; GO:0021536; GO:0021979; GO:0035776; GO:0046983; GO:0048793; GO:0071542; GO:0072020"
"g33335",1271.504,-0.4470749,0.1487681,-3.005179,0.002654242,0.03565015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41854",294.5085,-0.5613112,0.1867949,-3.00496,0.002656158,0.03566848,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31454",122.4187,1.183153,0.3937579,3.004772,0.002657801,0.03568315,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56603",405.975,-0.5021646,0.1671353,-3.004539,0.00265984,0.03570313,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71438",22.57914,0.4713946,0.1569038,3.004354,0.002661454,0.03571,0,10593,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.27e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g139225",362.8783,0.3328394,0.1107842,3.004393,0.002661113,0.03571,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133518",58.18513,0.5766696,0.1919673,3.004,0.002664556,0.03574422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6220",1866.701,-0.4314582,0.1436586,-3.003358,0.002670182,0.03581228,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21572",35.48832,-0.755679,0.2516737,-3.002614,0.002676715,0.03589148,37555,39938,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.44e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g49249",296.7259,0.3030525,0.1009314,3.00256,0.002677195,0.03589148,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66164",59.82905,0.6718938,0.2237838,3.002425,0.002678384,0.03589999,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101504",2856.285,2.261782,0.7533451,3.002319,0.002679313,0.03590501,0,6325,"sp|P26225|GUNB_CELFI","P26225","GUNB",7.27e-07,"Endoglucanase B (EC 3.2.1.4) (Cellulase B) (Endo-1,4-beta-glucanase B)","cellulose catabolic process [GO:0030245]","GO:0008810; GO:0030245; GO:0030248"
"g27168",43.47881,0.7334233,0.2442934,3.002223,0.002680158,0.03590574,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67271",55.2245,-0.4162417,0.138652,-3.002061,0.002681584,0.03590574,3665,5492,"sp|Q9BWM5|ZN416_HUMAN","Q9BWM5","ZN416",1.36e-49,"Zinc finger protein 416","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g128552",328.4058,0.6627743,0.2207694,3.002112,0.002681135,0.03590574,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146519",26.9139,0.7689767,0.2561394,3.002181,0.002680531,0.03590574,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75981",3717.864,-0.3802528,0.1266783,-3.001721,0.002684579,0.03593841,1305,5939,"sp|Q13530|SERC3_HUMAN","Q13530","SERC3",9.3e-14,"Serine incorporator 3 (Tumor differentially expressed protein 1)","defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; phosphatidylserine metabolic process [GO:0006658]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; sphingolipid metabolic process [GO:0006665]","GO:0000139; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0009597; GO:0015194; GO:0016020; GO:0016021; GO:0045087; GO:0048471; GO:0051607; GO:1902237"
"g27531",44903.74,0.5253076,0.1750213,3.001392,0.002687488,0.03594267,905,7892,"sp|P84185|ACT5C_ANOGA","P84185","ACT5C",0,"Actin-5C (Actin-1D, cytoplasmic)","mitotic cytokinesis [GO:0000281]","GO:0000281; GO:0005524; GO:0005737; GO:0005856"
"g32505",539.6479,-0.42241,0.140742,-3.001308,0.002688225,0.03594267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33318",31.26433,-0.4494997,0.1497598,-3.001471,0.002686784,0.03594267,16335,20030,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.32e-18,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g41815",29.44887,-0.8224215,0.2739993,-3.001546,0.002686123,0.03594267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64436",76.07464,1.789531,0.5962245,3.001438,0.00268708,0.03594267,0,12054,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.08e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g83063",28.42085,0.4293585,0.1430567,3.001317,0.002688148,0.03594267,0,7974,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.84e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73438",1200.689,0.3847126,0.1281866,3.001193,0.002689239,0.03594881,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7754",83.12251,0.4864304,0.1620947,3.000903,0.002691801,0.03596143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18051",486.6312,-0.2660714,0.08866578,-3.000835,0.002692403,0.03596143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78278",189.6022,0.4009859,0.1336236,3.00086,0.002692182,0.03596143,0,9395,"sp|Q6GPQ6|EDF1_XENLA","Q6GPQ6","EDF1",4.92e-18,"Endothelial differentiation-related factor 1 homolog (EDF-1)",NA,"GO:0003677; GO:0005634"
"g99153",33.54349,0.7485357,0.2494287,3.001,0.002690945,0.03596143,3115,3991,"sp|P41894|DEI_DROME","P41894","DEI",1.17e-12,"Helix-loop-helix protein delilah (Protein taxi)","cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983"
"g154455",1941.126,0.3048283,0.1015848,3.000727,0.00269336,0.03596679,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27166",30.60991,0.7325341,0.2441759,3.000026,0.002699566,0.03601852,25226,29964,"sp|P35465|PAK1_RAT","P35465","PAK1",3.88e-19,"Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (Protein kinase MUK2) (p21-activated kinase 1) (PAK-1) (p68-PAK)","actin cytoskeleton reorganization [GO:0031532]; amygdala development [GO:0021764]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; observational learning [GO:0098597]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of gene expression [GO:0010468]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; small GTPase mediated signal transduction [GO:0007264]; transmission of nerve impulse [GO:0019226]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]; wound healing [GO:0042060]","GO:0001666; GO:0001726; GO:0001934; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005518; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0007264; GO:0007528; GO:0008284; GO:0010033; GO:0010468; GO:0010763; GO:0014069; GO:0014704; GO:0016020; GO:0016310; GO:0016358; GO:0016477; GO:0019226; GO:0019901; GO:0021549; GO:0021764; GO:0030010; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031116; GO:0031532; GO:0031965; GO:0032587; GO:0032869; GO:0032956; GO:0032991; GO:0033138; GO:0033148; GO:0035556; GO:0042060; GO:0043015; GO:0043113; GO:0043408; GO:0043507; GO:0045773; GO:0046628; GO:0046777; GO:0048012; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0060996; GO:0061052; GO:0061534; GO:0061535; GO:0071407; GO:0090063; GO:0090314; GO:0098597; GO:0098793; GO:0098978; GO:0098982; GO:0099553; GO:0106310; GO:1900271; GO:1904707; GO:1904754"
"g28664",327.343,0.4651359,0.1550466,2.999976,0.002700013,0.03601852,8008,10434,"sp|P35270|SPRE_HUMAN","P35270","SPRE",2.1e-23,"Sepiapterin reductase (SPR) (EC 1.1.1.153)","nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0004033; GO:0004757; GO:0005654; GO:0005829; GO:0006729; GO:0006809; GO:0050661; GO:0070062"
"g54297",19.14534,0.4547968,0.1515976,3.000027,0.002699561,0.03601852,0,4623,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.99e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g100808",349.8081,-0.3201553,0.1067143,-3.000117,0.002698764,0.03601852,2234,6324,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.13e-66,"PiggyBac transposable element-derived protein 4",NA,NA
"g110145",35.70724,0.643216,0.2144065,2.999984,0.002699937,0.03601852,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39231",494.4005,1.383281,0.4611704,2.999501,0.002704225,0.03605275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79294",21.69318,0.5917338,0.1972769,2.999509,0.002704152,0.03605275,0,6144,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.41e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g99475",76.60064,0.4582063,0.152761,2.999498,0.002704249,0.03605275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69666",55.95069,-0.2950577,0.09837424,-2.999339,0.002705661,0.03606416,0,10986,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.11e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10070",1846.416,-0.3164569,0.1055374,-2.998529,0.002712862,0.03613785,25295,70950,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.36e-21,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g34811",634.3541,-0.1955519,0.06521339,-2.998646,0.00271182,0.03613785,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95931",23.26199,0.8151388,0.2718412,2.998585,0.002712368,0.03613785,476,5464,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.57e-39,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g46966",608.2262,-0.3274841,0.1092243,-2.998271,0.002715157,0.03616098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49941",157.278,-0.3439466,0.1147258,-2.997989,0.002717678,0.03618712,0,6460,"sp|Q5R8X1|ZN665_PONAB","Q5R8X1","ZN665",1.62e-77,"Zinc finger protein 665",NA,"GO:0003677; GO:0005634; GO:0046872"
"g50155",307.7482,-0.3958425,0.1320628,-2.997381,0.0027231,0.03623698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131453",264.0516,0.5731349,0.1912091,2.997425,0.002722709,0.03623698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157688",53.86074,1.165634,0.3888809,2.997408,0.002722865,0.03623698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126252",185.5419,1.82704,0.6095704,2.997258,0.002724198,0.03624414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162056",83.52105,0.8401668,0.2803361,2.996998,0.002726526,0.03626767,0,1059,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.29e-15,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g5948",549.8975,-0.3061065,0.1021591,-2.996369,0.002732157,0.03631797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12907",22.67629,0.5474033,0.1826915,2.996325,0.00273255,0.03631797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41745",167.9458,-0.2810145,0.09378428,-2.996392,0.002731948,0.03631797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79658",77.18243,0.6763347,0.2257173,2.996379,0.002732065,0.03631797,0,5750,"sp|F1PJP5|STT3A_CANLF","F1PJP5","STT3A",4.65e-26,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043687; GO:0046872"
"g14892",795.5451,-0.2205281,0.07360395,-2.996145,0.002734166,0.036332,7290,15784,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.68e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16065",27.06321,0.5239018,0.1748659,2.996021,0.002735279,0.03633909,16561,22424,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.03e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g30766",665.014,0.7655072,0.2555185,2.995898,0.002736382,0.03633909,8582,34134,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.48e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g45228",4417.395,0.2251917,0.07516612,2.995921,0.002736174,0.03633909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11429",1152.169,-0.2715761,0.0906528,-2.995783,0.002737412,0.03634531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86499",466.9835,-0.3539741,0.1181614,-2.995682,0.002738316,0.03634987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82313",32.22936,0.5555974,0.1854833,2.995403,0.00274082,0.03636821,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161812",168.694,0.7221997,0.241101,2.995423,0.002740643,0.03636821,0,814,"sp|Q11126|FUT3_BOVIN","Q11126","FUT3",5.84e-06,"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 (EC 2.4.1.65) (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (Alpha-3-fucosyltransferase FUT3) (EC 2.4.1.-) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (FUTB) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III)","fucosylation [GO:0036065]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell-cell adhesion [GO:0022409]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]","GO:0006487; GO:0006493; GO:0006629; GO:0009311; GO:0016021; GO:0017060; GO:0017083; GO:0022409; GO:0030334; GO:0032580; GO:0036065; GO:0042127; GO:0046920"
"g78255",89.82392,0.5018673,0.167568,2.995007,0.002744387,0.03640062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132134",28.10298,0.8210617,0.274143,2.995012,0.002744342,0.03640062,2245,2940,"sp|Q9Y0A7|AMOS_DROME","Q9Y0A7","AMOS",2.12e-11,"Basic helix-loop-helix transcription factor amos (Absent MD neurons and olfactory sensilla protein) (Amos protein) (Reduced olfactory organs protein) (Rough eye protein)","dendrite morphogenesis [GO:0048813]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ boundary specification [GO:0008052]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007423; GO:0008052; GO:0016360; GO:0030182; GO:0046982; GO:0048813"
"g17453",923.4903,0.5578238,0.1862796,2.994552,0.002748481,0.03643719,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53587",19.94079,0.5750411,0.1920316,2.994513,0.002748831,0.03643719,13102,14384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.65e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g143251",97.08796,0.6541662,0.2184493,2.99459,0.002748139,0.03643719,1209,2581,"sp|Q7SX99|FUMH_DANRE","Q7SX99","FUMH",7.1e-13,"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]","GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0045239; GO:2001034"
"g27480",2769.861,-0.2096996,0.07003231,-2.994326,0.002750518,0.03644464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35667",42.18628,-0.4023437,0.1343664,-2.994377,0.002750057,0.03644464,0,28510,"sp|P21328|RTJK_DROME","P21328","RTJK",2.55e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13607",1448.361,-0.3808012,0.1271815,-2.994156,0.002752052,0.03645255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26539",1742.476,0.6449274,0.2154002,2.99409,0.002752651,0.03645255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45238",133.3536,0.3983953,0.133062,2.994057,0.002752946,0.03645255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154302",152.3766,-0.6557381,0.2190166,-2.99401,0.002753365,0.03645255,0,1612,"sp|P13821|SANT_PLAFW","P13821","SANT",1.3e-15,"S-antigen protein",NA,"GO:0020003"
"g112055",202.6871,0.7276988,0.2430833,2.993619,0.002756895,0.03649183,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31363",695.5165,-0.3217072,0.1074736,-2.993359,0.002759247,0.0365155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68110",37.06581,0.6849492,0.2288437,2.993087,0.002761712,0.03651829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75717",735.045,0.3174836,0.1060706,2.993135,0.002761277,0.03651829,3081,5184,"sp|P45437|COPB_DROME","P45437","COPB",1.16e-28,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","cell morphogenesis [GO:0000902]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of innate immune response [GO:0045089]; regulation of lipid storage [GO:0010883]","GO:0000139; GO:0000902; GO:0005198; GO:0005794; GO:0006886; GO:0006888; GO:0006891; GO:0010883; GO:0030126; GO:0045089; GO:0046597; GO:0050829"
"g126373",187.502,0.3587142,0.1198452,2.993147,0.002761164,0.03651829,0,3921,"sp|Q9XYZ5|DDB1_DROME","Q9XYZ5","DDB1",3.6e-08,"DNA damage-binding protein 1 (D-DDB1) (Damage-specific DNA-binding protein 1) (Protein piccolo)","cellular response to DNA damage stimulus [GO:0006974]; defense response to fungus [GO:0050832]; DNA repair [GO:0006281]; eggshell chorion gene amplification [GO:0007307]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; wing disc development [GO:0035220]","GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:0006511; GO:0006974; GO:0007307; GO:0016567; GO:0035220; GO:0035861; GO:0043161; GO:0045732; GO:0045879; GO:0050832"
"g140116",61.25153,0.6365443,0.2126642,2.993189,0.002760783,0.03651829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8380",145.704,0.590946,0.1974527,2.992848,0.00276387,0.03653937,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33530",192.8763,0.2827769,0.09448915,2.992692,0.002765286,0.03654317,16308,21284,"sp|A1Z9A8|PTCD3_DROME","A1Z9A8","PTCD3",3.21e-19,"Protein PTCD3 homolog, mitochondrial","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024"
"g146491",29.67191,1.107624,0.370109,2.992696,0.00276525,0.03654317,378,2299,"sp|P10394|POL4_DROME","P10394","POL4",1.87e-41,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g111474",35.48712,1.858467,0.6210289,2.992561,0.002766473,0.03655141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28305",20.81282,-0.5547986,0.1853981,-2.992472,0.002767277,0.03655457,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8730",201.0154,0.5178026,0.173051,2.992197,0.002769779,0.03658017,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107390",60.18381,0.4484035,0.1498772,2.991806,0.002773326,0.03661955,4214,5084,"sp|Q90260|ASL1B_DANRE","Q90260","ASL1B",2.88e-19,"Achaete-scute homolog 1b (Zash-1b)","brain development [GO:0007420]; chordate embryonic development [GO:0043009]; endocrine pancreas development [GO:0031018]; hindbrain morphogenesis [GO:0021575]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]","GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007423; GO:0021575; GO:0030182; GO:0031018; GO:0043009; GO:0045666; GO:0045944; GO:0046983; GO:0050767; GO:0090575"
"g11685",1362.375,0.6965775,0.2328924,2.990985,0.002780794,0.0367032,0,26125,"sp|Q66H76|PAXI_RAT","Q66H76","PAXI",1.1e-33,"Paxillin","branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; endothelial cell migration [GO:0043542]; focal adhesion assembly [GO:0048041]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; response to peptide [GO:1901652]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001725; GO:0003712; GO:0005078; GO:0005178; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008013; GO:0008360; GO:0017166; GO:0018108; GO:0019901; GO:0019903; GO:0030027; GO:0030032; GO:0031252; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0044877; GO:0045766; GO:0045860; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:0051496; GO:0060396; GO:1901652"
"g140507",54.98181,0.5028882,0.1681324,2.991025,0.002780426,0.0367032,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17431",27.81159,0.4155571,0.1389439,2.990827,0.002782235,0.03671473,31316,37294,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.62e-51,"PiggyBac transposable element-derived protein 4",NA,NA
"g98189",69.81793,-0.5469171,0.1828818,-2.990549,0.002784764,0.03674062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42572",1403.939,-0.3306056,0.1105592,-2.990303,0.002787007,0.03676274,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34548",47.72076,0.3621002,0.1210974,2.990156,0.002788348,0.03677293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37757",24.00873,1.432812,0.4792102,2.989945,0.002790275,0.03679086,20086,25014,"sp|P91778|AMY_PECMA","P91778","AMY",2.68e-07,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005975; GO:0046872"
"g17599",1713.745,-0.2992531,0.1001018,-2.989488,0.002794456,0.03683849,4876,29674,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.04e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28481",243.8198,0.554785,0.185584,2.989402,0.002795243,0.03684137,26135,26819,"sp|P02552|TBA1_CHICK","P02552","TBA1",2.6e-39,"Tubulin alpha-1 chain [Cleaved into: Detyrosinated tubulin alpha-1 chain] (Fragment)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874"
"g25080",4234.608,-0.4051603,0.1355381,-2.989272,0.002796433,0.03684956,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86568",19.03541,0.7488174,0.2505164,2.989096,0.002798046,0.03686332,3715,8150,"sp|P21328|RTJK_DROME","P21328","RTJK",4.49e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g44624",290.7184,-0.4447209,0.1488026,-2.988662,0.002802016,0.03690812,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1893",37.28531,-0.7202324,0.241046,-2.987946,0.002808593,0.03697399,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25257",200.375,0.3017566,0.1009918,2.987931,0.002808729,0.03697399,37685,42086,"sp|Q9Y5Q9|TF3C3_HUMAN","Q9Y5Q9","TF3C3",2.48e-13,"General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma)","5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]","GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0031965; GO:0042791; GO:0042797"
"g32386",100.0752,1.238697,0.4145509,2.988047,0.002807666,0.03697399,0,29957,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.61e-65,"PiggyBac transposable element-derived protein 4",NA,NA
"g31826",479.2098,-0.2652771,0.08878537,-2.987847,0.0028095,0.03697663,0,7148,"sp|Q9VIL0|BRUN_DROME","Q9VIL0","BRUN",1.93e-23,"Protein brunelleschi (NIK- and IKBKB-binding protein)","actomyosin contractile ring contraction [GO:0000916]; Golgi vesicle transport [GO:0048193]; intra-Golgi vesicle-mediated transport [GO:0006891]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; meiotic spindle organization [GO:0000212]; regulation of GTPase activity [GO:0043087]; spermatocyte division [GO:0048137]","GO:0000212; GO:0000916; GO:0005737; GO:0005794; GO:0005802; GO:0006891; GO:0007110; GO:0007111; GO:0007112; GO:0030008; GO:0036063; GO:0043087; GO:0048137; GO:0048193; GO:1990071"
"g19516",2296.484,-0.6661057,0.222973,-2.987383,0.002813767,0.03701775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39507",884.4424,-0.2840768,0.095091,-2.987421,0.002813421,0.03701775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34128",3402.046,-0.2401555,0.08040097,-2.986973,0.002817547,0.03705879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35403",781.4032,-0.2575071,0.08621371,-2.986846,0.002818713,0.03705879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64235",589.2502,0.2755201,0.09224603,2.986796,0.002819174,0.03705879,2206,6714,"sp|Q03701|CEBPZ_HUMAN","Q03701","CEBPZ",3.55e-10,"CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944"
"g79738",329.6671,0.2328744,0.07796668,2.986845,0.002818722,0.03705879,0,9055,"sp|P08461|ODP2_RAT","P08461","ODP2",1.25e-19,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; sleep [GO:0030431]; tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004742; GO:0005739; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0030431; GO:0042802; GO:0045254"
"g41683",218.3897,0.3134661,0.1049543,2.986692,0.002820141,0.03706231,16532,22750,"sp|Q9VYG2|BAP60_DROME","Q9VYG2","BAP60",4.83e-37,"Brahma-associated protein of 60 kDa (BRM-associated protein 60)","negative regulation of neuroblast proliferation [GO:0007406]; positive regulation of gene expression [GO:0010628]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000791; GO:0003677; GO:0003712; GO:0005634; GO:0006357; GO:0007406; GO:0008134; GO:0010628; GO:0016514; GO:0017022; GO:0019904; GO:0031453; GO:0035060; GO:0045893; GO:0061629; GO:0071564; GO:0071565"
"g88279",41.62329,0.6539598,0.2189615,2.986643,0.002820586,0.03706231,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130808",206.054,-0.7407519,0.2480325,-2.986512,0.002821802,0.03707077,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27772",76.21002,0.2981968,0.09985069,2.986427,0.002822579,0.03707346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74794",2317.683,-0.4313003,0.144437,-2.986079,0.002825797,0.03710821,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11278",336.9011,0.7320318,0.2451545,2.986001,0.002826513,0.03711008,3035,22091,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.65e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g89246",216.1631,0.752055,0.2519043,2.985479,0.002831349,0.03716605,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101322",999.3661,1.9964,0.6687669,2.985196,0.002833964,0.03719284,0,1363,"sp|P25784|CYSP3_HOMAM","P25784","CYSP3",3.78e-29,"Digestive cysteine proteinase 3 (EC 3.4.22.-)",NA,"GO:0008234"
"g15273",1992.643,-0.2737927,0.09172012,-2.985089,0.002834961,0.03719786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21964",256.8337,0.4444036,0.1488774,2.985031,0.002835495,0.03719786,34195,36880,"sp|Q9XZJ4|PSA6_DROME","Q9XZJ4","PSA6",4.2e-17,"Proteasome subunit alpha type-6 (20S proteasome subunit alpha-1)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161"
"g67418",828.9793,0.4038691,0.1353245,2.98445,0.00284089,0.03726109,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162682",69.36012,-0.4801429,0.160889,-2.984311,0.002842174,0.03727038,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26790",1255.612,0.156991,0.05261203,2.983938,0.002845647,0.03727807,7015,11694,"sp|Q9SL56|GLPT5_ARATH","Q9SL56","GLPT5",2.11e-26,"Putative glycerol-3-phosphate transporter 5 (G-3-P transporter 5) (Glycerol-3-phosphate permease 5) (AtG3Pp5) (G-3-P permease 5)","carbohydrate transport [GO:0008643]; phosphate ion homeostasis [GO:0055062]","GO:0008643; GO:0016021; GO:0055062; GO:0061513"
"g42790",207.3706,0.395722,0.1326095,2.984116,0.002843993,0.03727807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80101",43.40635,0.5371317,0.180006,2.983965,0.002845391,0.03727807,0,8141,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.39e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g85239",34.73306,1.019224,0.3415681,2.983957,0.002845469,0.03727807,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95121",25.46303,-0.5806856,0.1946078,-2.983877,0.002846212,0.03727807,0,7067,"sp|Q172G3|MED1_AEDAE","Q172G3","MED1",4.06e-09,"Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g158172",45.30748,0.4431318,0.1484989,2.984073,0.002844385,0.03727807,0,1297,"sp|Q9BTC8|MTA3_HUMAN","Q9BTC8","MTA3",4.31e-27,"Metastasis-associated protein MTA3","chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]","GO:0000122; GO:0003682; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0006338; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042659; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0046872; GO:2000736"
"g88810",384.7558,0.8547214,0.286473,2.983601,0.002848776,0.03730411,578,7850,"sp|P12105|CO3A1_CHICK","P12105","CO3A1",1.78e-06,"Collagen alpha-1(III) chain (Fragments)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0030198; GO:0031012; GO:0046872"
"g10748",1157.419,-0.2808498,0.09414257,-2.983239,0.00285215,0.03734075,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8629",1210.066,0.1673794,0.056113,2.982899,0.002855319,0.03735959,59896,87764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.09e-51,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g70341",331.5985,-0.3255938,0.1091531,-2.98291,0.002855222,0.03735959,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97314",101.2471,0.3722905,0.1248032,2.983021,0.002854189,0.03735959,2295,6803,"sp|Q04931|SSRP1_RAT","Q04931","SSRP1",3.69e-18,"FACT complex subunit SSRP1 (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (T160)","DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275]","GO:0003677; GO:0003682; GO:0005634; GO:0005730; GO:0006260; GO:0006281; GO:0006337; GO:0031491; GO:0035101; GO:0042393; GO:1902275"
"g114647",24.22779,-0.9299074,0.311797,-2.982412,0.002859864,0.03740395,0,1174,"sp|Q7JQF1|OAMB_DROME","Q7JQF1","OAMB",1.37e-25,"Octopamine receptor Oamb (Octopamine receptor in mushroom bodies)","cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled receptor signaling pathway involved in social behavior [GO:1904068]; learning [GO:0007612]; male courtship behavior [GO:0008049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; octopamine or tyramine signaling pathway [GO:0007211]; ovulation [GO:0030728]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of ovulation [GO:0060279]; regulation of olfactory learning [GO:0090328]; regulation of ovulation [GO:0060278]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0000122; GO:0004989; GO:0004993; GO:0005887; GO:0006874; GO:0006979; GO:0007187; GO:0007211; GO:0007268; GO:0007612; GO:0008049; GO:0008227; GO:0010841; GO:0016021; GO:0030425; GO:0030594; GO:0030728; GO:0042594; GO:0045202; GO:0051482; GO:0060278; GO:0060279; GO:0090328; GO:1904068; GO:1905050"
"g124501",28.69382,1.59114,0.5335048,2.982429,0.00285971,0.03740395,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g800",265.0447,-0.3115358,0.1044672,-2.982139,0.002862415,0.03742976,159855,172364,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.43e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61871",24.07947,1.332313,0.4467959,2.981927,0.002864407,0.03744825,4085,12868,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",4.31e-68,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g11280",2490.123,0.4068184,0.136467,2.981074,0.002872392,0.0374639,56655,71420,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.1e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13136",2510.386,-0.3925927,0.1316988,-2.980989,0.002873187,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14720",325.8094,-0.2818438,0.09454483,-2.98106,0.002872524,0.0374639,3294,5904,"sp|P21328|RTJK_DROME","P21328","RTJK",1.09e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15610",449.6285,-0.2299972,0.07714445,-2.981383,0.002869496,0.0374639,10125,14388,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.4e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g26613",101.0754,-0.3631803,0.121842,-2.980747,0.002875461,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29240",8449.377,-0.3428248,0.1149996,-2.981094,0.002872202,0.0374639,26530,31034,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.72e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g35569",32.9477,0.9104506,0.3054298,2.980884,0.00287418,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38447",148.1803,0.961881,0.3227043,2.980689,0.002876012,0.0374639,0,6318,"sp|Q1LZI1|UD3A1_BOVIN","Q1LZI1","UD3A1",6.53e-09,"UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17)",NA,"GO:0015020; GO:0016021; GO:0043231"
"g48526",102.4172,-0.6141241,0.2059729,-2.981577,0.002867678,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55799",635.5457,-0.4419492,0.1482331,-2.981449,0.002868882,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58966",36.27121,0.476649,0.1598653,2.981566,0.002867783,0.0374639,0,6191,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.23e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g59423",1372.892,-0.2670422,0.08957649,-2.981164,0.002871553,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77352",1015.673,-0.2737216,0.0918264,-2.980859,0.002874408,0.0374639,2955,8866,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.51e-08,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g80867",116.1051,-0.5330754,0.1788006,-2.981397,0.00286937,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91302",448.964,0.3782416,0.126893,2.980793,0.002875035,0.0374639,5497,6764,"sp|Q9XYN7|PSB3_DROME","Q9XYN7","PSB3",4.03e-12,"Proteasome subunit beta type-3 (20S proteasome subunit beta-3)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0000502; GO:0004298; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161"
"g101959",22.66024,0.7833786,0.2627936,2.980966,0.002873409,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106096",50.85567,-0.448029,0.1502956,-2.980986,0.002873224,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152921",58.04118,1.251543,0.4198621,2.980844,0.002874552,0.0374639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2955",252.0011,-0.3802984,0.1276047,-2.980285,0.002879801,0.0374882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8727",1318.791,-0.2292787,0.07693288,-2.980244,0.002880191,0.0374882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42646",756.7165,-0.202761,0.06803184,-2.980384,0.002878874,0.0374882,0,21960,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.19e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g44472",1203.024,-0.619008,0.2076955,-2.980363,0.00287907,0.0374882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106326",2994.34,-0.3283954,0.1101943,-2.980148,0.002881091,0.03749237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144583",31.6734,-0.3354371,0.1125654,-2.979931,0.002883137,0.03751147,0,2370,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.12e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g108812",106.7544,0.3194099,0.1071958,2.979688,0.002885422,0.03753366,1475,5565,"sp|Q9VNV3|DDX1_DROME","Q9VNV3","DDX1",9.37e-17,"ATP-dependent RNA helicase Ddx1 (DEAD box protein 1) (EC 3.6.4.13)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; embryonic development via the syncytial blastoderm [GO:0001700]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; tRNA processing [GO:0008033]","GO:0001700; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0006302; GO:0007283; GO:0008033; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0048477"
"g116642",32.3983,0.8081902,0.2712544,2.979454,0.002887623,0.03753967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121877",20.24277,-0.7793405,0.2615633,-2.979548,0.002886743,0.03753967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145571",39.10584,-0.480725,0.1613459,-2.979469,0.00288748,0.03753967,745,2381,"sp|Q8TF05|PP4R1_HUMAN","Q8TF05","PP4R1",4.96e-15,"Serine/threonine-protein phosphatase 4 regulatory subunit 1","protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0006468; GO:0006470; GO:0007165; GO:0019888; GO:0030289"
"g2444",41.13917,-0.571498,0.1918169,-2.979392,0.002888206,0.03753972,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16504",1318.346,-0.2006582,0.06736011,-2.978888,0.002892968,0.037579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63339",51.374,0.5294823,0.1777439,2.978905,0.002892801,0.037579,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108699",274.9231,0.3276896,0.1100029,2.978917,0.002892692,0.037579,0,5575,"sp|P00765|TRYP_ASTAS","P00765","TRYP",4.75e-10,"Trypsin-1 (EC 3.4.21.4) (Trypsin I)","digestion [GO:0007586]","GO:0004252; GO:0005615; GO:0007586; GO:0046872"
"g91040",6649.973,0.2451087,0.08228452,2.978795,0.002893847,0.03758289,0,5974,"sp|Q5RKI1|IF4A2_RAT","Q5RKI1","IF4A2",2.55e-37,"Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]","GO:0002183; GO:0003724; GO:0003743; GO:0005524; GO:0016887; GO:0048471; GO:1900260; GO:1990830"
"g41900",185.6356,0.3382324,0.1135624,2.978383,0.00289774,0.0376259,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46965",555.8149,-0.219279,0.07362638,-2.978267,0.002898837,0.0376326,15665,19018,"sp|P0C6U3|R1A_CVHN1","P0C6U3","R1A",1.11e-07,"Replicase polyprotein 1a (pp1a) (ORF1a polyprotein) [Cleaved into: Non-structural protein 1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Non-structural protein 3 (nsp3) (EC 3.4.19.12) (EC 3.4.22.69) (PL1-PRO/PL2-PRO) (PL1/PL2) (Papain-like proteinases 1/2) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Non-structural protein 9 (nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); Non-structural protein 11 (nsp11)]","induction by virus of catabolism of host mRNA [GO:0039595]; induction by virus of host autophagy [GO:0039520]; modulation by virus of host protein ubiquitination [GO:0039648]; suppression by virus of host gene expression [GO:0039657]; suppression by virus of host ISG15-protein conjugation [GO:0039579]; suppression by virus of host type I interferon-mediated signaling pathway [GO:0039502]; suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF3 activity [GO:0039548]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]","GO:0003727; GO:0003968; GO:0004197; GO:0004843; GO:0008270; GO:0016021; GO:0019079; GO:0019082; GO:0033644; GO:0039502; GO:0039520; GO:0039548; GO:0039579; GO:0039595; GO:0039648; GO:0039657; GO:0044220"
"g3336",1350.366,-0.2480024,0.08327276,-2.978193,0.002899531,0.03763408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7722",2881.594,-0.2646824,0.08888268,-2.977885,0.002902452,0.03765543,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33246",1085.685,-0.2618774,0.08794219,-2.977836,0.002902911,0.03765543,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34088",445.4384,0.4256493,0.1429392,2.977835,0.00290292,0.03765543,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97537",19.89349,-0.5672231,0.1905006,-2.97754,0.00290572,0.03768421,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39801",571.9849,-0.3020078,0.1014327,-2.97742,0.002906859,0.03769143,0,15793,"sp|Q0IHW3|SMAG1_XENTR","Q0IHW3","SMAG1",1.27e-17,"Protein Smaug homolog 1 (Smaug 1) (Sterile alpha motif domain-containing protein 4A)","nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]","GO:0000289; GO:0000932; GO:0003729; GO:0030371; GO:0030425; GO:0045202"
"g78804",5546.116,0.2156889,0.07244419,2.977311,0.002907885,0.03769719,0,5207,"sp|Q27268|DX39B_DROME","Q27268","DX39B",1.88e-21,"ATP-dependent RNA helicase WM6 (DEAD box protein UAP56) (Dmrnahel) (EC 3.6.4.13) (HEL/UAP56)","chromatin remodeling [GO:0006338]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","GO:0000346; GO:0000381; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0006338; GO:0006406; GO:0016607; GO:0016887"
"g45625",248.5935,-0.4944894,0.1661006,-2.977048,0.002910384,0.03772204,16286,19654,"sp|Q9NJB5|ONEC_DROME","Q9NJB5","ONEC",3.61e-19,"Homeobox protein onecut","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0045944"
"g83201",1188.829,0.1826635,0.06136012,2.976909,0.002911705,0.03773162,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37430",491.6759,0.338365,0.1136705,2.976718,0.00291352,0.03774033,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78111",365.0573,0.3057714,0.1027211,2.976716,0.002913542,0.03774033,0,6961,"sp|P42675|NEUL_RABIT","P42675","NEUL",3.5e-19,"Neurolysin, mitochondrial (EC 3.4.24.16) (Microsomal endopeptidase) (MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)",NA,"GO:0004222; GO:0005739; GO:0046872"
"g78465",44.76091,-0.4712098,0.1583035,-2.976623,0.002914418,0.03774413,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12125",2229.856,-0.4927993,0.1655697,-2.976385,0.002916684,0.03775577,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46538",41.14108,0.525677,0.176616,2.976383,0.002916704,0.03775577,7132,17064,"sp|O76511|TYSY_DROME","O76511","TYSY",3.08e-26,"Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)","dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]","GO:0004799; GO:0005739; GO:0005829; GO:0006231; GO:0006235; GO:0032259"
"g100889",39.93636,0.3508252,0.1178712,2.976345,0.002917065,0.03775577,0,5794,"sp|Q5R8Y6|TM9S2_PONAB","Q5R8Y6","TM9S2",4.38e-07,"Transmembrane 9 superfamily member 2","ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908]","GO:0005794; GO:0005856; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016021"
"g40923",64.56771,0.6953126,0.2336363,2.976046,0.002919907,0.03778501,0,5990,"sp|Q9BYV1|AGT2_HUMAN","Q9BYV1","AGT2",9.9e-26,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]","GO:0005739; GO:0005759; GO:0008453; GO:0009436; GO:0019265; GO:0019481; GO:0030170; GO:0045429; GO:0047305"
"g154531",44.09304,1.984411,0.6668194,2.975935,0.002920966,0.03779117,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62870",260.0886,-0.3047848,0.1024235,-2.975732,0.0029229,0.03780471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150584",51.01715,0.4615721,0.1551136,2.975703,0.00292318,0.03780471,0,1933,"sp|Q9VMU8|SENJU_DROME","Q9VMU8","SENJU",1.95e-16,"UDP-galactose transporter senju","carbohydrate transport [GO:0008643]; negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; UDP-galactose transmembrane transport [GO:0072334]","GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0008643; GO:0030173; GO:0045751; GO:0045824; GO:0060050; GO:0072334"
"g10352",1928.256,-0.3817384,0.1283176,-2.97495,0.002930359,0.03787409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101625",62.57708,-0.5515896,0.1854224,-2.974773,0.002932052,0.03787409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106653",1166.052,0.7543634,0.2535858,2.974786,0.002931935,0.03787409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111972",243.2653,-0.2079314,0.06989493,-2.974914,0.002930706,0.03787409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129058",228.1591,-0.2954902,0.0993301,-2.97483,0.00293151,0.03787409,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132119",68.62919,-0.5453035,0.1832996,-2.974931,0.002930545,0.03787409,1802,2834,"sp|Q96N38|ZN714_HUMAN","Q96N38","ZN714",2.51e-74,"Zinc finger protein 714","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g5870",363.9737,-0.2879292,0.09679622,-2.974592,0.002933787,0.0378814,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147636",217.4503,0.4439974,0.1492629,2.974599,0.002933717,0.0378814,0,2195,"sp|P25787|PSA2_HUMAN","P25787","PSA2",3.46e-18,"Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)","proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]","GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0009615; GO:0010498; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813"
"g72714",85.78518,0.3278908,0.1102359,2.974446,0.002935179,0.03789182,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23666",520.3271,-0.2325987,0.07821016,-2.974021,0.002939246,0.03793676,30420,33184,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.39e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g123653",20.64546,0.5867952,0.1973158,2.973889,0.002940516,0.0379456,0,4163,"sp|Q19842|PCCA_CAEEL","Q19842","PCCA",3.18e-15,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","lipid catabolic process [GO:0016042]","GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0046872"
"g68077",586.6405,-0.2285184,0.07684508,-2.973755,0.002941803,0.03795465,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159309",27.61408,1.127168,0.3790665,2.973537,0.002943888,0.03797399,0,1245,"sp|Q9ZT94|POLR2_ARATH","Q9ZT94","POLR2",3.55e-16,"Retrovirus-related Pol polyprotein from transposon RE2 (Retro element 2) (AtRE2) [Includes: Protease RE2 (EC 3.4.23.-); Reverse transcriptase RE2 (EC 2.7.7.49); Endonuclease RE2]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g89374",544.4358,0.1639312,0.05513262,2.973397,0.002945229,0.03798372,0,7684,"sp|A0A0B4KGY6|NOVA_DROME","A0A0B4KGY6","NOVA",4.87e-15,"RNA-binding protein Pasilla","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]","GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0033120; GO:0051252; GO:0097157"
"g100943",38.74971,1.634287,0.5497056,2.973022,0.00294883,0.0380226,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64608",518.5018,-0.324597,0.1092046,-2.972375,0.002955051,0.03809523,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85665",27.01773,-0.7580277,0.2550334,-2.972268,0.002956085,0.03810098,2337,8274,"sp|Q05319|STUB_DROME","Q05319","STUB",2.48e-15,"Serine proteinase stubble (EC 3.4.21.-) (Protein stubble-stubbloid) [Cleaved into: Serine proteinase stubble non-catalytic chain; Serine proteinase stubble catalytic chain]","actin filament bundle assembly [GO:0051017]; cytoskeleton organization [GO:0007010]; proteolysis [GO:0006508]; wing disc development [GO:0035220]","GO:0004252; GO:0005886; GO:0006508; GO:0007010; GO:0016021; GO:0035220; GO:0051017"
"g40961",8604.266,0.3040389,0.1022947,2.972185,0.002956884,0.0381037,18745,20502,"sp|Q9VZS3|ETIF1_DROME","Q9VZS3","ETIF1",5.45e-10,"Eukaryotic translation initiation factor eIF1 (Protein translation factor SUI1 homolog)","cellular response to hypoxia [GO:0071456]; formation of translation preinitiation complex [GO:0001731]","GO:0001731; GO:0003723; GO:0003743; GO:0016282; GO:0043024; GO:0043614; GO:0071456"
"g147607",132.7176,-0.9672652,0.3254591,-2.972002,0.002958645,0.03811881,0,2197,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.15e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g131126",37.01038,-0.4269138,0.1436578,-2.971742,0.002961151,0.03814352,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127194",458.4584,1.002943,0.3375074,2.971619,0.002962342,0.03814369,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150952",344.0893,0.2790011,0.09388835,2.971626,0.002962272,0.03814369,0,1264,"sp|Q7KRI2|LOLAL_DROME","Q7KRI2","LOLAL",4.31e-29,"Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)","dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin assembly [GO:0031507]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]","GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0031208; GO:0031507; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944"
"g110456",31.3976,0.5874682,0.1976975,2.971551,0.002962994,0.03814451,0,5392,"sp|P21414|POL_GALV","P21414","POL",1.28e-11,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g46934",96.13917,1.53834,0.5177199,2.971376,0.002964687,0.03815871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9989",72.70143,0.4616274,0.1553847,2.970867,0.002969603,0.03816999,27691,46384,"sp|Q1JP73|QSPP_BOVIN","Q1JP73","QSPP",7.71e-54,"Queuosine salvage protein","tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]","GO:0006400; GO:0101030"
"g11754",111.6915,-0.3570207,0.1201641,-2.971109,0.00296726,0.03816999,70547,74004,"sp|P17019|ZN708_HUMAN","P17019","ZN708",1.07e-61,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g15679",988.3309,0.2580745,0.08686604,2.970948,0.002968817,0.03816999,7846,18504,"sp|Q11002|CANA_DROME","Q11002","CANA",1.24e-16,"Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]","cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]","GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832"
"g22734",250.2945,1.075845,0.3621305,2.970877,0.002969505,0.03816999,35513,44524,"sp|O45228|PROD_CAEEL","O45228","PROD",2.36e-07,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase)","proline catabolic process to glutamate [GO:0010133]","GO:0004657; GO:0005739; GO:0005759; GO:0010133; GO:0071949"
"g30201",45.33664,0.4226209,0.1422513,2.970945,0.00296885,0.03816999,15248,18724,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.93e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g106591",113.8141,0.2775657,0.09343073,2.970818,0.002970081,0.03816999,671,5791,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.53e-41,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g106881",374.5823,0.3241852,0.1091261,2.97074,0.002970835,0.03816999,0,5441,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.67e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g117951",306.0011,1.486047,0.500215,2.970816,0.002970093,0.03816999,0,3218,"sp|Q10751|ACE_CHICK","Q10751","ACE",1.1e-09,"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)","cell population proliferation [GO:0008283]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]","GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0060319"
"g134753",51.23597,0.3069157,0.103313,2.970737,0.002970865,0.03816999,0,3252,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.07e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g90458",26640.7,0.6366311,0.2143123,2.970577,0.002972408,0.03818224,2881,4464,"sp|P45885|ACT2_BACDO","P45885","ACT2",0,"Actin-2, muscle-specific",NA,"GO:0005524; GO:0005737; GO:0005856"
"g13489",673.0602,-0.3253843,0.1095496,-2.9702,0.002976061,0.03821402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106522",81.08821,0.5178734,0.174354,2.970241,0.002975663,0.03821402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69488",106.1463,0.2972376,0.1000907,2.969682,0.00298108,0.03827087,0,11030,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.46e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g68339",35.25791,-0.5863766,0.1974769,-2.969342,0.002984382,0.03830567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16327",3173.473,-0.3520315,0.1186019,-2.968177,0.002995714,0.03843179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96714",2635.483,-0.304734,0.102668,-2.968149,0.002995987,0.03843179,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143875",33.70801,0.6368684,0.2145644,2.968193,0.002995565,0.03843179,0,2526,"sp|Q5RAE3|LAT2_PONAB","Q5RAE3","LAT2",1.03e-17,"Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8)","amino acid transport [GO:0006865]","GO:0005737; GO:0006865; GO:0016021; GO:0016323; GO:0022857"
"g116229",165.7109,-0.3578706,0.1205737,-2.968064,0.002996817,0.03843483,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107457",178.2688,0.4340982,0.1462633,2.967922,0.002998199,0.03844495,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32416",71.91271,1.241998,0.4185026,2.967718,0.003000191,0.03844766,22096,32145,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.19e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g47061",78.76691,-0.375505,0.1265276,-2.967772,0.002999666,0.03844766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66666",815.8262,0.2123306,0.07154616,2.967743,0.002999949,0.03844766,865,2560,"sp|Q3SZE9|TBCC_BOVIN","Q3SZE9","TBCC",6.57e-70,"Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC)","post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]","GO:0003924; GO:0005737; GO:0005829; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391"
"g120888",23.16713,0.5655759,0.1905853,2.967574,0.003001604,0.03845816,0,4413,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.65e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11033",1570.108,-0.2994647,0.1009187,-2.967385,0.003003451,0.0384609,9758,14234,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.16e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g78144",57.99563,0.6125272,0.206414,2.967469,0.003002624,0.0384609,0,9305,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.3e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g122390",23.75436,1.211521,0.4082894,2.967309,0.003004192,0.0384609,0,3894,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",4.34e-13,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g124328",131.47,0.5538287,0.1866425,2.967323,0.003004051,0.0384609,0,3964,"sp|O75521|ECI2_HUMAN","O75521","ECI2",2.3e-28,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]","GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231"
"g25493",402.6352,-0.3411023,0.114959,-2.967165,0.003005595,0.03847126,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13966",352.7776,-0.1995205,0.06726303,-2.966272,0.003014336,0.03856563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20028",483.5457,-0.4821312,0.162535,-2.966323,0.00301384,0.03856563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105684",12161.75,0.3210294,0.1082281,2.96623,0.003014753,0.03856563,0,2850,"sp|P04764|ENOA_RAT","P04764","ENOA",2.22e-25,"Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 1) (Non-neural enolase) (NNE)","canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; ERK1 and ERK2 cascade [GO:0070371]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of binding [GO:0051099]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615]","GO:0000015; GO:0000122; GO:0000287; GO:0000977; GO:0001222; GO:0001227; GO:0001701; GO:0003714; GO:0003723; GO:0004634; GO:0005640; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006096; GO:0009615; GO:0009986; GO:0010756; GO:0016020; GO:0019897; GO:0019899; GO:0030308; GO:0030426; GO:0031072; GO:0042802; GO:0042803; GO:0043005; GO:0044877; GO:0045121; GO:0045892; GO:0045933; GO:0051020; GO:0051099; GO:0061621; GO:0070371; GO:0071456; GO:0097060; GO:0098761; GO:1903298; GO:2001171"
"g147508",23.64841,0.4252986,0.1433847,2.966136,0.003015666,0.03856969,3,2206,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.64e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g41738",148.4442,1.086607,0.3663569,2.96598,0.003017206,0.03858177,8705,20034,"sp|P21328|RTJK_DROME","P21328","RTJK",5.24e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g11279",442.8886,0.7090526,0.2390855,2.965686,0.003020087,0.03860337,20615,27603,"sp|P09327|VILI_HUMAN","P09327","VILI",1.73e-08,"Villin-1","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]","GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0065003; GO:0070062; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394"
"g61603",56.74719,0.3595871,0.1212468,2.965744,0.003019519,0.03860337,5156,12948,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.02e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5299",35.1841,-0.6205057,0.2092446,-2.965456,0.003022345,0.03862462,12365,14790,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",2.8e-06,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g7578",89.57586,-0.346002,0.1166868,-2.965219,0.00302467,0.03864671,37875,44774,"sp|Q00963|SPTCB_DROME","Q00963","SPTCB",1.24e-10,"Spectrin beta chain","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; neuron development [GO:0048666]; photoreceptor cell axon guidance [GO:0072499]; regulation of plasma membrane organization [GO:1903729]; regulation of synapse organization [GO:0050807]","GO:0005200; GO:0005516; GO:0005546; GO:0005886; GO:0007026; GO:0007274; GO:0007399; GO:0007409; GO:0007411; GO:0008017; GO:0008091; GO:0016199; GO:0016328; GO:0030036; GO:0030054; GO:0030424; GO:0030506; GO:0030864; GO:0031594; GO:0042062; GO:0042995; GO:0045169; GO:0045170; GO:0048666; GO:0048790; GO:0050807; GO:0051015; GO:0051693; GO:0072499; GO:1903729"
"g38753",161.7839,0.4621313,0.1558608,2.965026,0.003026574,0.03866341,0,6401,"sp|Q8UWA5|CAH2_TRIHK","Q8UWA5","CAH2",3.91e-09,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)",NA,"GO:0004089; GO:0005737; GO:0005886; GO:0008270"
"g55851",67.13623,-0.5267773,0.1776882,-2.964616,0.003030611,0.03870734,6675,14835,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.46e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g131933",213.8559,0.9925008,0.3348291,2.964201,0.003034701,0.03875195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84640",198.7709,-0.467619,0.1577614,-2.964089,0.0030358,0.03875835,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98319",20.96169,0.8723287,0.2943518,2.963558,0.003041045,0.03881766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91",368.1808,0.7113606,0.2400675,2.963169,0.003044892,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3820",177.4747,-0.2627996,0.08869236,-2.963047,0.003046104,0.03884118,84369,86524,"sp|Q5R633|TZAP_PONAB","Q5R633","TZAP",2.65e-16,"Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3 homolog) (Zinc finger and BTB domain-containing protein 48)","positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomere lengthening [GO:0010833]","GO:0000781; GO:0000976; GO:0003691; GO:0005634; GO:0010833; GO:0045893; GO:0046872"
"g7219",9452.511,-0.575801,0.1943395,-2.962862,0.003047932,0.03884118,4495,72746,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.66e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g10145",1097.136,-0.4492747,0.1516372,-2.962827,0.003048283,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13191",293.024,-0.3075206,0.1037846,-2.963066,0.003045913,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39175",2065.304,-0.3054674,0.1030978,-2.962889,0.003047668,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44226",121.4419,-0.2645127,0.08926798,-2.963131,0.003045269,0.03884118,199,6584,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.86e-45,"PiggyBac transposable element-derived protein 4",NA,NA
"g63782",281.8003,0.278089,0.09385469,2.962974,0.003046822,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128641",463.3544,-0.321414,0.1084796,-2.962898,0.003047572,0.03884118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43675",55.45151,0.2887581,0.09746974,2.962541,0.003051117,0.03886964,8375,21342,"sp|Q6IQU7|INT12_DANRE","Q6IQU7","INT12",1.03e-19,"Integrator complex subunit 12 (Int12)","snRNA 3'-end processing [GO:0034472]","GO:0032039; GO:0034472; GO:0046872"
"g45561",2448.731,-0.4298427,0.1450992,-2.962405,0.003052463,0.03887915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90893",399.9953,0.2683389,0.09058425,2.962313,0.003053374,0.03888312,0,6344,"sp|Q5R648|CSN4_PONAB","Q5R648","CSN4",7.55e-26,"COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4)","protein deneddylation [GO:0000338]","GO:0000338; GO:0008021; GO:0008180"
"g42695",431.118,0.5067723,0.1711048,2.961766,0.003058798,0.03894452,0,21210,"sp|P0C6B8|SVEP1_RAT","P0C6B8","SVEP1",4.04e-111,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0001945; GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193"
"g43823",94.50021,0.2697553,0.0910836,2.961623,0.003060219,0.03895497,0,19234,"sp|Q7ZVA0|SMU1_DANRE","Q7ZVA0","SMU1",2.31e-37,"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)","mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011"
"g122915",146.3783,-0.2496325,0.0842921,-2.961517,0.00306128,0.03896082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52111",421.9129,-0.297082,0.1003163,-2.961454,0.003061903,0.0389611,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10446",252.5164,0.2966625,0.1001901,2.960995,0.003066464,0.03901147,900,14714,"sp|P56558|OGT1_RAT","P56558","OGT1",1.09e-39,"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)","apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]","GO:0000123; GO:0000791; GO:0001933; GO:0001934; GO:0005547; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006041; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0010628; GO:0010801; GO:0016262; GO:0016485; GO:0017122; GO:0019904; GO:0030900; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032869; GO:0032922; GO:0032991; GO:0033137; GO:0035020; GO:0042277; GO:0042588; GO:0042802; GO:0043005; GO:0043025; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0044877; GO:0045793; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0048029; GO:0048312; GO:0051571; GO:0060548; GO:0061087; GO:0071222; GO:0071333; GO:0080182; GO:0090315; GO:0097237; GO:0097363; GO:0120162; GO:1900038; GO:1900095; GO:1900182; GO:1903428"
"g28063",660.212,-0.3596227,0.1214617,-2.960791,0.003068496,0.03902966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63808",183.1501,0.3108596,0.1049951,2.960707,0.003069338,0.03903271,0,4384,"sp|P21328|RTJK_DROME","P21328","RTJK",2.54e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g30226",36.96548,0.680247,0.2297727,2.960522,0.003071182,0.03904849,27942,31324,"sp|P48592|RIR2_DROME","P48592","RIR2",1.06e-14,"Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small subunit)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]","GO:0004748; GO:0005829; GO:0006260; GO:0006919; GO:0009263; GO:0046872"
"g52340",139.0692,-0.2594166,0.08762921,-2.960389,0.003072506,0.03905766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65576",82.94125,0.5668078,0.1914719,2.960267,0.003073728,0.03906552,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34968",1398.255,-0.3574036,0.1207458,-2.959968,0.003076711,0.03908991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39931",60.39245,-0.5588265,0.1887995,-2.959893,0.003077456,0.03908991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142712",843.6575,0.3563107,0.1203791,2.959906,0.003077328,0.03908991,903,2626,"sp|P50310|PGK1_CRIGR","P50310","PGK1",3.24e-25,"Phosphoglycerate kinase 1 (EC 2.7.2.3)","glycolytic process [GO:0006096]; phosphorylation [GO:0016310]","GO:0004618; GO:0005524; GO:0005737; GO:0006096; GO:0016310"
"g48749",284.4541,-0.1992526,0.06731973,-2.959795,0.003078438,0.03909471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12599",1422.95,-0.3825043,0.1292406,-2.959629,0.003080097,0.03910324,24814,52758,"sp|A2ARV4|LRP2_MOUSE","A2ARV4","LRP2",1.47e-14,"Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)","amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; chemoattraction of axon [GO:0061642]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; endocytic hemoglobin import into cell [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; heart development [GO:0007507]; hormone secretion [GO:0046879]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin metabolic process [GO:0006766]","GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006766; GO:0006897; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0009986; GO:0010165; GO:0015031; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0016922; GO:0017124; GO:0020028; GO:0030001; GO:0030139; GO:0030165; GO:0030424; GO:0030425; GO:0030492; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0032991; GO:0035904; GO:0042562; GO:0043066; GO:0043235; GO:0044295; GO:0044321; GO:0044877; GO:0045056; GO:0045121; GO:0045177; GO:0045807; GO:0046879; GO:0050750; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0061642; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140077; GO:0140318; GO:1904447"
"g63081",210.896,1.224653,0.4137891,2.959607,0.003080316,0.03910324,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114697",253.9574,-0.4585354,0.1549392,-2.959453,0.003081855,0.03911401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123418",36.71876,0.7609948,0.2571501,2.959341,0.003082975,0.03911401,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139671",64.36638,1.946846,0.6578607,2.959359,0.0030828,0.03911401,0,2869,"sp|Q6Q4G3|AMPQ_HUMAN","Q6Q4G3","AMPQ",1.28e-07,"Aminopeptidase Q (AP-Q) (APQ) (EC 3.4.11.-) (CHL2 antigen) (Laeverin)","peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006"
"g23515",136.7339,0.5052295,0.1707349,2.959147,0.003084919,0.03911964,0,22494,"sp|P21328|RTJK_DROME","P21328","RTJK",4.34e-32,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g93564",2920.446,-0.2645059,0.08938771,-2.959085,0.003085538,0.03911964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146036",70.1424,0.8185167,0.2766142,2.959056,0.003085834,0.03911964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160612",1029.046,1.044127,0.3528435,2.959178,0.003084609,0.03911964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77166",51.9668,-0.4763715,0.1610108,-2.958631,0.003090084,0.03916585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81444",353.6203,-0.278878,0.09426572,-2.958424,0.003092165,0.03918455,5745,8894,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.29e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g15274",343.296,-0.2637332,0.08915099,-2.958276,0.003093648,0.03918802,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64826",89.53574,0.8716307,0.2946403,2.958287,0.003093536,0.03918802,0,12034,"sp|Q5DRA3|PCDGL_PANTR","Q5DRA3","PCDGL",6.66e-08,"Protocadherin gamma-C4 (PCDH-gamma-C4)","cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005887; GO:0007155; GO:0007156"
"g82899",82.63037,0.2914957,0.09854025,2.958138,0.003095034,0.03919025,5750,8304,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.09e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g105175",88.56535,0.2991997,0.1011427,2.958194,0.003094478,0.03919025,0,5934,"sp|O35156|UGPA_CRIGR","O35156","UGPA",4.28e-14,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glycogen biosynthetic process [GO:0005978]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005737; GO:0005978; GO:0006011; GO:0007420; GO:0042802; GO:0046872"
"g88840",79.58361,-0.3509073,0.1186288,-2.958028,0.003096139,0.03919659,249,7845,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.62e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62770",706.55,-0.2058585,0.06959615,-2.957901,0.003097417,0.03920511,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134924",193.7584,0.85045,0.287535,2.957727,0.003099161,0.03921952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158078",5564.911,0.2370815,0.08016163,2.957543,0.003101013,0.0392353,0,1334,"sp|Q95WA0|RL26_LITLI","Q95WA0","RL26",4.19e-21,"60S ribosomal protein L26","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g33764",135.8119,-0.4020347,0.1359698,-2.956794,0.003108555,0.03932303,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34536",150.5738,-0.2520504,0.08524897,-2.956639,0.003110123,0.03932752,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112703",68.45828,0.4158035,0.1406328,2.95666,0.003109905,0.03932752,0,4818,"sp|O13046|WDHD1_XENLA","O13046","WDHD1",2.54e-11,"WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)",NA,"GO:0003677; GO:0005654; GO:0005737"
"g31252",330.4954,-0.3349222,0.1132894,-2.956342,0.003113113,0.03935765,17383,33628,"sp|O15033|AREL1_HUMAN","O15033","AREL1",0,"Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0045732; GO:0050727; GO:0061630; GO:0070979; GO:1990390"
"g38099",1616.942,-0.2163172,0.07317601,-2.956122,0.00311534,0.03937043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42342",143.8972,0.2827808,0.09565935,2.956123,0.003115326,0.03937043,18554,22303,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.62e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g78836",439.7342,0.8896253,0.3009552,2.956005,0.003116518,0.03937091,0,8893,"sp|A0A173GP47|LST_PHOPY","A0A173GP47","LST",6.78e-06,"Luciferin sulfotransferase (EC 2.8.2.-)",NA,"GO:0008146"
"g97105",24.99554,0.6456227,0.2184111,2.955998,0.003116593,0.03937091,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131055",84.42725,2.015155,0.6817428,2.955888,0.003117704,0.03937727,0,3546,"sp|Q64285|CEL_MOUSE","Q64285","CEL",4.94e-08,"Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase)","ceramide catabolic process [GO:0046514]; chemical synaptic transmission [GO:0007268]; cholesterol catabolic process [GO:0006707]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; pancreatic juice secretion [GO:0030157]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]","GO:0004622; GO:0004771; GO:0004806; GO:0005615; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0005887; GO:0006707; GO:0007158; GO:0007268; GO:0008126; GO:0009986; GO:0030157; GO:0032991; GO:0038023; GO:0042043; GO:0042588; GO:0043208; GO:0043231; GO:0044877; GO:0045121; GO:0045202; GO:0046514; GO:0048488; GO:0050253; GO:0050804; GO:0052689; GO:0097104; GO:0097105; GO:0098793; GO:0099060"
"g153775",15520.52,0.7424908,0.2512022,2.955749,0.003119105,0.03938728,1152,1654,"sp|P10994|ACTS_PLEWA","P10994","ACTS",4.06e-60,"Actin, alpha skeletal muscle (Fragment)",NA,"GO:0005524; GO:0005737; GO:0005856"
"g67605",472.8986,-0.684871,0.2317191,-2.955608,0.003120531,0.03939762,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66807",210.8693,0.240591,0.08140609,2.955442,0.00312221,0.03940346,0,9723,"sp|Q8BHY8|SNX14_MOUSE","Q8BHY8","SNX14",4.2e-07,"Sorting nexin-14","autophagosome maturation [GO:0097352]; protein transport [GO:0015031]","GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016021; GO:0030425; GO:0031902; GO:0035091; GO:0043231; GO:0080025; GO:0097352"
"g115593",68.18297,0.3356367,0.1135639,2.955489,0.00312174,0.03940346,0,4904,"sp|Q9JI69|ORC1_CRIGR","Q9JI69","ORC1",1.21e-21,"Origin recognition complex subunit 1","DNA replication [GO:0006260]","GO:0003677; GO:0003682; GO:0005524; GO:0005664; GO:0006260; GO:0016887; GO:0046872"
"g108116",73.4778,0.5941542,0.2010436,2.955349,0.003123151,0.03940766,0,5443,"sp|Q5ZLA6|MYO1C_CHICK","Q5ZLA6","MYO1C",1.94e-26,"Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)","actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001726; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031410; GO:0031982; GO:0051015; GO:0060171"
"g28322",439.8092,-0.4010888,0.1357345,-2.954951,0.003127184,0.03945086,14673,37594,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.69e-46,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38218",53.13561,-0.5144413,0.1741112,-2.954671,0.003130031,0.03947909,4995,11760,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.47e-72,"PiggyBac transposable element-derived protein 4",NA,NA
"g124158",19.72853,2.00609,0.6789953,2.954498,0.003131784,0.03949351,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1668",540.9318,-0.2625181,0.0888556,-2.954434,0.003132427,0.03949393,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108822",75.22392,0.3389331,0.114741,2.953897,0.00313789,0.03955512,0,1024,"sp|Q5XJD3|FIP1_DANRE","Q5XJD3","FIP1",1.42e-06,"Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)","mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]","GO:0005847; GO:0006378; GO:0098789"
"g5931",150.0837,0.5563572,0.188355,2.953769,0.00313919,0.03956381,26915,30354,"sp|P21328|RTJK_DROME","P21328","RTJK",5.49e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g19705",340.2237,0.3196649,0.1082297,2.953579,0.003141123,0.03956508,0,14836,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",3.87e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g20056",252.9027,-0.2554923,0.0865021,-2.953596,0.003140945,0.03956508,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39866",179.0356,0.4085674,0.1383283,2.953607,0.003140837,0.03956508,23086,24416,"sp|Q5RBV4|APC13_PONAB","Q5RBV4","APC13",1.15e-17,"Anaphase-promoting complex subunit 13 (APC13) (Cyclosome subunit 13)","cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]","GO:0005680; GO:0007049; GO:0051301; GO:0070979"
"g46144",478.5404,0.2919674,0.09886352,2.953237,0.003144605,0.03959355,12405,17214,"sp|Q90511|EI2BB_TAKRU","Q90511","EI2BB",1.01e-16,"Translation initiation factor eIF-2B subunit beta (S20I15) (eIF-2B GDP-GTP exchange factor subunit beta)","central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; regulation of catalytic activity [GO:0050790]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]","GO:0003743; GO:0005524; GO:0005525; GO:0005737; GO:0005851; GO:0006413; GO:0007417; GO:0014003; GO:0042552; GO:0050790; GO:0050852"
"g154244",76.46962,0.4672467,0.1582136,2.953264,0.003144327,0.03959355,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117616",21.07114,-0.7918398,0.2681441,-2.953039,0.003146624,0.03961127,0,4134,"sp|Q25190|5HTR_HELVI","Q25190","5HTR",1.53e-38,"5-hydroxytryptamine receptor (5-HT receptor) (Serotonin receptor)",NA,"GO:0004930; GO:0005886; GO:0016021"
"g22131",264.1935,0.3553402,0.1203434,2.95272,0.00314988,0.03962925,2276,36714,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.4e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g61392",171.359,0.2917497,0.09880436,2.952802,0.003149039,0.03962925,6155,13002,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g138990",165.9111,0.3391145,0.1148482,2.952719,0.003149887,0.03962925,0,2922,"sp|B2KI97|THOC2_RHIFE","B2KI97","THOC2",4.89e-23,"THO complex subunit 2 (Tho2)","generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380]","GO:0000347; GO:0003723; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0048666; GO:0048699"
"g150918",414.8155,0.4952281,0.1677316,2.952503,0.003152087,0.03964923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159001",25.88964,-0.382463,0.1295591,-2.952036,0.003156864,0.03970161,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81427",45.20698,-0.6840148,0.2317146,-2.951971,0.00315753,0.03970228,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36486",886.6019,-0.2700835,0.09149877,-2.951772,0.003159564,0.03971244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138967",406.1029,-0.2825417,0.0957189,-2.951786,0.003159415,0.03971244,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76615",338.9863,0.3378648,0.1144695,2.951569,0.003161637,0.03972309,3710,9234,"sp|Q5ZJF4|PRDX6_CHICK","Q5ZJF4","PRDX6",2.16e-23,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0008379; GO:0016042; GO:0045454; GO:0047184"
"g102626",29.86918,1.839628,0.6232689,2.951581,0.00316152,0.03972309,4195,6163,"sp|P14410|SUIS_HUMAN","P14410","SUIS",1.12e-09,"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]","polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]","GO:0004553; GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062"
"g153617",29055.54,0.6761833,0.2291104,2.951343,0.00316395,0.03974444,0,1084,"sp|Q26065|ACT_PLAMG","Q26065","ACT",0,"Actin, adductor muscle",NA,"GO:0005524; GO:0005737; GO:0005856"
"g3130",811.047,-0.302667,0.1025582,-2.951173,0.003165691,0.03974778,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21015",406.2954,-0.2638768,0.089414,-2.95118,0.003165625,0.03974778,3065,8732,"sp|P10394|POL4_DROME","P10394","POL4",2.07e-28,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g134441",459.5716,0.3109469,0.1053651,2.951138,0.003166057,0.03974778,0,3150,"sp|P67777|PP2AA_RABIT","P67777","PP2AA",1.26e-56,"Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)","meiotic cell cycle [GO:0051321]; protein dephosphorylation [GO:0006470]","GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005737; GO:0006470; GO:0045121; GO:0046872; GO:0046982; GO:0051321"
"g56204",136.8191,0.3997461,0.1354822,2.950544,0.003172152,0.03981659,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81042",22.88626,0.7652882,0.2593906,2.950332,0.003174331,0.03983622,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56251",409.7087,-0.4141153,0.1403761,-2.950041,0.003177317,0.03986597,3608,14692,"sp|P21328|RTJK_DROME","P21328","RTJK",3.68e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g55112",32.19844,0.4192986,0.1421399,2.949901,0.003178753,0.03987627,705,15147,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.11e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g17401",450.5671,-0.4301023,0.1458185,-2.949573,0.003182138,0.03989556,0,31413,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.61e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42507",186.0972,-0.3399224,0.115241,-2.949665,0.003181182,0.03989556,7518,12954,"sp|A6NN14|ZN729_HUMAN","A6NN14","ZN729",2.67e-126,"Zinc finger protein 729","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g47565",111.3192,0.2754532,0.09338707,2.949587,0.003181994,0.03989556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92996",28.85212,-0.8538398,0.2894852,-2.94951,0.003182778,0.03989587,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1167",14199.03,0.507935,0.1722363,2.949059,0.003187431,0.03993874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74656",212.9034,0.4283739,0.1452564,2.949088,0.003187132,0.03993874,5305,7828,"sp|P21328|RTJK_DROME","P21328","RTJK",8.62e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g1421",195.8399,0.2794241,0.09475764,2.948829,0.003189801,0.0399576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27547",96.94738,0.5412811,0.1835655,2.948708,0.003191053,0.0399576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65424",21.3635,0.7199375,0.2441554,2.948686,0.003191279,0.0399576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85534",131.6391,-0.4490844,0.1523004,-2.948674,0.003191403,0.0399576,0,8234,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.86e-21,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g30571",770.8998,-0.4244962,0.1439782,-2.948336,0.003194896,0.03998588,30095,32514,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.94e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34034",56.24357,1.26172,0.4279405,2.948354,0.003194705,0.03998588,23115,28644,"sp|Q80XI3|IF4G3_MOUSE","Q80XI3","IF4G3",2.29e-07,"Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; translational initiation [GO:0006413]","GO:0000339; GO:0001934; GO:0003729; GO:0003743; GO:0006413; GO:0007283; GO:0016281; GO:0045727; GO:0060903"
"g113508",2113.847,0.3337579,0.1132059,2.948238,0.003195906,0.03999079,0,4800,"sp|Q0MQG3|NDUS2_PONPY","Q0MQG3","NDUS2",1.97e-36,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)","cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; response to oxidative stress [GO:0006979]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0019826; GO:0022008; GO:0032981; GO:0042063; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453"
"g132026",143.7497,0.3396408,0.1152046,2.948155,0.003196772,0.03999391,915,3466,"sp|Q3SZ22|RM46_BOVIN","Q3SZ22","RM46",8.8e-09,"39S ribosomal protein L46, mitochondrial (L46mt) (MRP-L46)",NA,"GO:0003735; GO:0005654; GO:0005743; GO:0005762; GO:0030054"
"g17308",2192.376,-0.4603768,0.1561684,-2.947952,0.003198872,0.04000832,16031,27284,"sp|Q6P5C7|ZN728_MOUSE","Q6P5C7","ZN728",1.91e-08,"Zinc finger protein 728","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0045892; GO:0046872; GO:0070895"
"g62380",162.7606,0.2974269,0.1008937,2.947924,0.003199159,0.04000832,0,12735,"sp|Q12931|TRAP1_HUMAN","Q12931","TRAP1",1.22e-10,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)","chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]","GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0071944; GO:1901856; GO:1903427; GO:1903751"
"g103516",36.59193,0.5228169,0.1773568,2.947825,0.003200178,0.04001334,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94700",467.3045,0.3576416,0.1213291,2.947698,0.003201495,0.04002208,0,324,"sp|P08574|CY1_HUMAN","P08574","CY1",2.1e-08,"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)","cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]","GO:0005634; GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0016020; GO:0020037; GO:0033762; GO:0045333; GO:0046872"
"g65301",203.3807,1.316542,0.446681,2.947387,0.003204723,0.04004698,0,2059,"sp|Q8BMS1|ECHA_MOUSE","Q8BMS1","ECHA",5.08e-12,"Trifunctional enzyme subunit alpha, mitochondrial (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003988; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0051287; GO:0070403"
"g92614",179.1501,0.913015,0.309769,2.947406,0.003204519,0.04004698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88409",240.1781,0.3858687,0.130928,2.947181,0.00320685,0.04006584,0,4072,"sp|Q3TJZ6|FA98A_MOUSE","Q3TJZ6","FA98A",5.37e-08,"Protein FAM98A","lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]","GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029"
"g20950",219.8021,-0.307003,0.1041733,-2.947042,0.003208293,0.04007614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25704",1008.431,-0.531791,0.1804534,-2.946971,0.003209032,0.04007764,13205,20660,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",7.44e-48,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g35639",233.5926,-0.3897265,0.132253,-2.946825,0.003210548,0.04008885,18838,21244,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g4124",144.7448,-0.5266501,0.1787335,-2.946567,0.003213228,0.04010686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152338",21.39384,2.624063,0.8905445,2.946583,0.003213066,0.04010686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67591",666.1983,0.38999,0.1323684,2.946247,0.003216556,0.04014067,0,4189,"sp|Q8VCN5|CGL_MOUSE","Q8VCN5","CGL",1.99e-10,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; protein sulfhydration [GO:0044524]; transsulfuration [GO:0019346]","GO:0004121; GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006629; GO:0006749; GO:0008285; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030308; GO:0042802; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0050667; GO:0051092; GO:0051289; GO:0070814; GO:0080146; GO:1904831; GO:1990830; GO:2001234"
"g23848",177.7792,0.3539109,0.1201288,2.946096,0.003218124,0.04014477,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110512",16727.69,1.296921,0.4402159,2.946101,0.003218071,0.04014477,2139,4634,"sp|Q9BZP6|CHIA_HUMAN","Q9BZP6","CHIA",1.24e-13,"Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Lung-specific protein TSA1902)","apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; chitin metabolic process [GO:0006030]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532]","GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006030; GO:0006032; GO:0006915; GO:0008061; GO:0019900; GO:0032722; GO:0044245"
"g4167",37.64592,-0.463757,0.1574487,-2.945449,0.003224866,0.0402073,35895,46962,"sp|O60504|VINEX_HUMAN","O60504","VINEX",3.05e-10,"Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3)","actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496]","GO:0000122; GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007155; GO:0017166; GO:0030055; GO:0031589; GO:0043410; GO:0051495; GO:0051496"
"g11562",347.467,-0.1989253,0.0675352,-2.945506,0.003224274,0.0402073,18912,46364,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.61e-34,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g136018",81.90352,0.3868948,0.131354,2.945436,0.003224999,0.0402073,0,2920,"sp|Q5RFQ0|FCF1_PONAB","Q5RFQ0","FCF1",4.97e-23,"rRNA-processing protein FCF1 homolog","rRNA processing [GO:0006364]","GO:0005730; GO:0006364; GO:0032040"
"g62916",5024.857,-0.3902529,0.1324981,-2.945348,0.003225917,0.04021101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44627",188.8712,0.4841583,0.1644062,2.944891,0.00323068,0.0402549,7977,18884,"sp|P21328|RTJK_DROME","P21328","RTJK",1.4e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g136177",37.38499,1.046201,0.3552548,2.944932,0.003230252,0.0402549,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88788",167.7319,0.2793065,0.09485148,2.944672,0.003232976,0.04027576,0,7854,"sp|Q9GK13|MUTA_BOVIN","Q9GK13","MUTA",8.75e-30,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",NA,"GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0031419; GO:0042802; GO:0042803; GO:0046872"
"g84435",97.45286,0.2724765,0.0925371,2.944511,0.003234653,0.0402889,4534,8184,"sp|P85001|CE290_DANRE","P85001","CE290",5.59e-23,"Centrosomal protein of 290 kDa (Cep290)","camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; eye development [GO:0001654]; eye photoreceptor cell development [GO:0042462]; gastrulation [GO:0007369]; head development [GO:0060322]; hindbrain development [GO:0030902]; inner ear development [GO:0048839]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; photoreceptor cell maintenance [GO:0045494]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein transport [GO:0015031]","GO:0001654; GO:0001822; GO:0005634; GO:0005737; GO:0005813; GO:0007369; GO:0015031; GO:0021549; GO:0030902; GO:0030916; GO:0034451; GO:0035869; GO:0042462; GO:0043010; GO:0045494; GO:0048793; GO:0048839; GO:0060322; GO:0090316; GO:0097711; GO:1905349; GO:1905515"
"g40508",4268.513,-0.3060452,0.1039495,-2.944172,0.003238196,0.04031753,15203,23735,"sp|Q14978|NOLC1_HUMAN","Q14978","NOLC1",2.13e-13,"Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)","box H/ACA RNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364]","GO:0000278; GO:0001093; GO:0001650; GO:0003723; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0006970; GO:0007000; GO:0008139; GO:0008284; GO:0014029; GO:0014032; GO:0015030; GO:0019904; GO:0030674; GO:0031428; GO:0031429; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893; GO:0046982; GO:0062064; GO:0062065"
"g94305",316.7417,0.3698375,0.1256164,2.944181,0.003238108,0.04031753,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44618",269.4796,0.4375734,0.1486268,2.944109,0.003238862,0.04031808,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13121",47.14225,0.432989,0.1470809,2.943883,0.003241228,0.0403334,22755,33403,"sp|Q61292|LAMB2_MOUSE","Q61292","LAMB2",4.66e-20,"Laminin subunit beta-2 (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta)","animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; cell morphogenesis involved in differentiation [GO:0000904]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; synapse organization [GO:0050808]; tissue development [GO:0009888]; visual perception [GO:0007601]","GO:0000904; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031175; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0045202; GO:0045785; GO:0048677; GO:0050808; GO:0051149; GO:0060041; GO:0062023; GO:0070831; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:2001046"
"g129216",165.5993,0.5188028,0.1762314,2.943872,0.003241338,0.0403334,0,3254,"sp|P11047|LAMC1_HUMAN","P11047","LAMC1",6.92e-29,"Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma)","animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0009887; GO:0009888; GO:0016477; GO:0022617; GO:0031581; GO:0034446; GO:0035633; GO:0043259; GO:0043260; GO:0045785; GO:0050679; GO:0051149; GO:0062023; GO:0065003; GO:0070062; GO:0098637; GO:0110011; GO:2001046"
"g135673",79.99883,0.3247864,0.1103365,2.9436,0.003244188,0.04036111,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74290",44.9743,0.4074274,0.1384349,2.943098,0.003249457,0.0404189,5456,9864,"sp|A8XY95|METH_CAEBR","A8XY95","METH",1.87e-19,"Probable methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)","methylation [GO:0032259]; pteridine-containing compound metabolic process [GO:0042558]","GO:0005829; GO:0008270; GO:0008705; GO:0031419; GO:0032259; GO:0042558"
"g7366",116.2904,-0.3023304,0.1027362,-2.942783,0.003252761,0.04043782,69095,71564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.3e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18256",134.6911,-0.4890049,0.1661658,-2.942874,0.00325181,0.04043782,44555,55668,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.9e-43,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g47614",181.2325,0.4116745,0.1398961,2.942715,0.003253474,0.04043782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105098",212.8471,0.3150006,0.1070422,2.942771,0.003252889,0.04043782,0,5941,"sp|Q28WL0|NTAQ1_DROPS","Q28WL0","NTAQ1",2.96e-14,"Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (Protein tungus)",NA,"GO:0008418; GO:0070773"
"g10530",1847.451,0.3096847,0.1052488,2.942406,0.003256722,0.0404394,46125,74554,"sp|P54385|DHE3_DROME","P54385","DHE3",3.97e-33,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g21453",123.8182,0.3301526,0.1122041,2.94243,0.003256476,0.0404394,0,12451,"sp|O02751|CFDP2_BOVIN","O02751","CFDP2",1.96e-14,"Craniofacial development protein 2 (p97 bucentaur protein)","chromatin remodeling [GO:0006338]","GO:0003824; GO:0005634; GO:0005737; GO:0006338"
"g22455",327.4058,0.2443694,0.08304767,2.942519,0.003255534,0.0404394,0,10750,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.19e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g70174",46.48775,0.649928,0.22088,2.942448,0.003256284,0.0404394,2203,10311,"sp|P21328|RTJK_DROME","P21328","RTJK",5.46e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g128388",72.65678,0.3191031,0.1084487,2.942433,0.00325644,0.0404394,0,3758,"sp|P21328|RTJK_DROME","P21328","RTJK",2.07e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g106301",19.52991,-0.4777234,0.1623755,-2.942091,0.003260046,0.04047292,0,5364,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.23e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g74467",34.24681,-0.4440923,0.1509515,-2.941954,0.003261482,0.04047805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96017",155.0825,0.280513,0.09535759,2.941695,0.003264208,0.04047805,0,6958,"sp|P07207|NOTCH_DROME","P07207","NOTCH",6.55e-28,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral axis specification [GO:0009950]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016021; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"g123941",190.0465,0.3622296,0.1231349,2.941729,0.003263852,0.04047805,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g132985",270.0722,0.4623591,0.1571686,2.941802,0.003263083,0.04047805,0,2054,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.97e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g149242",23.08806,0.3950105,0.134279,2.941715,0.003264001,0.04047805,45,1975,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.9e-27,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g156775",37.63043,0.37725,0.1282324,2.941925,0.00326179,0.04047805,0,1426,"sp|A6QLJ0|ERCC2_BOVIN","A6QLJ0","ERCC2",4.43e-24,"General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein)","chromosome segregation [GO:0007059]; hair cell differentiation [GO:0035315]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of mitotic recombination [GO:0045951]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; transcription by RNA polymerase II [GO:0006366]","GO:0000717; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005675; GO:0005737; GO:0005819; GO:0006366; GO:0006979; GO:0007059; GO:0008022; GO:0016887; GO:0033683; GO:0035315; GO:0043139; GO:0045951; GO:0046872; GO:0051539; GO:0070516; GO:0071817; GO:1901990"
"g162790",17.39854,0.6100363,0.2073828,2.941596,0.003265261,0.04048336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15771",2477.682,1.866472,0.6345675,2.94133,0.003268063,0.0405026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53037",79.62558,0.4225777,0.1436684,2.941341,0.003267944,0.0405026,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37059",47.27063,1.430981,0.4865256,2.941225,0.003269171,0.04050554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117578",302.6531,0.8472941,0.2880788,2.941189,0.00326955,0.04050554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14289",5977.004,0.9148139,0.3110622,2.940935,0.003272227,0.04051818,58089,61714,"sp|P10760|SAHH_RAT","P10760","SAHH",1.36e-87,"Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)","chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353]","GO:0001666; GO:0002439; GO:0004013; GO:0005507; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0043621; GO:0051287; GO:0098604"
"g42134",411.0551,-0.4888306,0.1662192,-2.940879,0.003272824,0.04051818,0,14130,"sp|Q66KB0|UBE2Z_XENTR","Q66KB0","UBE2Z",1.03e-30,"Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0043066; GO:0061631"
"g48086",65.26558,0.7633314,0.259561,2.940855,0.003273072,0.04051818,924,3884,"sp|P00982|VKTHD_DENAN","P00982","VKTHD",1.63e-07,"Kunitz-type serine protease inhibitor homolog delta-dendrotoxin (Delta-DTX) (Dendrotoxin delta-DaTX) (Protease inhibitor K) (Toxin C13S1C3) (Venom basic protease inhibitor K)",NA,"GO:0004867; GO:0005576; GO:0015459; GO:0090729"
"g158723",35.73247,1.252062,0.425722,2.941031,0.00327122,0.04051818,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54691",48.64366,0.3807593,0.1294761,2.94077,0.003273976,0.04052163,0,6184,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.6e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g120801",49.49008,-0.5290635,0.1799121,-2.940677,0.003274956,0.04052602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66645",274.5643,0.3025875,0.1029074,2.940386,0.003278035,0.04055637,0,11680,"sp|P23612|SYWC_RABIT","P23612","SYWC",3.19e-24,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS) [Cleaved into: T1-TrpRS; T2-TrpRS]","angiogenesis [GO:0001525]; tryptophanyl-tRNA aminoacylation [GO:0006436]","GO:0001525; GO:0004830; GO:0005524; GO:0005737; GO:0006436"
"g92868",48.36021,-0.3262509,0.1109586,-2.940295,0.003278997,0.04055698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104364",56.8778,0.4778848,0.1625313,2.940263,0.003279336,0.04055698,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93420",159.0341,0.3841658,0.1306609,2.940175,0.003280273,0.04056083,0,7273,"sp|Q9VHD2|MAAI2_DROME","Q9VHD2","MAAI2",8.04e-08,"Probable maleylacetoacetate isomerase 2 (MAAI 2) (EC 5.2.1.2) (Glutathione S-transferase zeta 2) (EC 2.5.1.18)","glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]","GO:0004364; GO:0005737; GO:0005739; GO:0006559; GO:0006572; GO:0006749; GO:0016034"
"g14444",70.43969,0.8225697,0.2797768,2.940092,0.003281144,0.04056385,53703,64954,"sp|B2RQC6|PYR1_MOUSE","B2RQC6","PYR1",4.01e-25,"CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228]","GO:0002134; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006207; GO:0006225; GO:0006228; GO:0006541; GO:0006807; GO:0008270; GO:0016363; GO:0016597; GO:0018107; GO:0019240; GO:0019899; GO:0042802; GO:0044205; GO:0046777"
"g73581",482.2799,0.4405142,0.1498444,2.939811,0.003284127,0.04059298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1628",1914.706,-0.3143026,0.1069247,-2.939478,0.003287661,0.04061343,108661,117444,"sp|Q23356|MIG15_CAEEL","Q23356","MIG15",5.44e-28,"Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15)","body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproduction [GO:0000003]","GO:0000003; GO:0000165; GO:0002119; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0010171; GO:0030334; GO:0032228; GO:0033563; GO:0035556; GO:0043408; GO:0048812; GO:0106310"
"g26144",81.25375,0.4356426,0.1481992,2.939574,0.00328664,0.04061343,0,13396,"sp|Q9VFC8|GYS_DROME","Q9VFC8","GYS",1.8e-38,"Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase)","cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744]","GO:0004373; GO:0005737; GO:0005776; GO:0005977; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0045819; GO:0061723; GO:0071329"
"g49651",30.12971,-0.3813529,0.1297344,-2.939489,0.003287535,0.04061343,7226,16304,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.69e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5973",63.8552,-0.6076594,0.2067575,-2.938996,0.003292772,0.04063782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9964",1045.339,0.2599635,0.08845096,2.93907,0.003291991,0.04063782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22595",536.9671,-0.2956648,0.1005981,-2.939069,0.003291998,0.04063782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74343",505.4781,-0.3137093,0.1067366,-2.939096,0.003291708,0.04063782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95142",22.82606,-0.6513319,0.2216143,-2.939034,0.003292369,0.04063782,0,7065,"sp|Q172G3|MED1_AEDAE","Q172G3","MED1",4.06e-09,"Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g73826",40.70463,-0.6349914,0.2160799,-2.938688,0.00329605,0.04067053,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55258",2783.96,-0.3471872,0.118148,-2.93858,0.003297199,0.04067076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117995",141.9411,-0.4350839,0.1480598,-2.938568,0.003297324,0.04067076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122807",370.8789,0.7048654,0.2398723,2.938502,0.003298026,0.04067168,0,4235,"sp|Q9V7U0|RESIL_DROME","Q9V7U0","RESIL",2.3e-07,"Pro-resilin","chitin-based cuticle development [GO:0040003]","GO:0005576; GO:0008010; GO:0008061; GO:0030023; GO:0031012; GO:0032992; GO:0040003; GO:0042302; GO:0062129"
"g75383",299.5072,0.2943628,0.1001822,2.938275,0.003300444,0.04069376,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41358",63.89036,-0.5983442,0.2036439,-2.938188,0.003301364,0.04069379,3345,15929,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.5e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g93795",377.9121,-0.2376402,0.08088072,-2.938157,0.003301703,0.04069379,2373,6744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.53e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g12635",406.1794,-0.4300521,0.1463798,-2.93792,0.003304221,0.04071342,7235,9330,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.31e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g32823",23.27616,0.4817088,0.1639643,2.937889,0.003304552,0.04071342,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8960",657.4301,0.3628015,0.1234943,2.937798,0.003305521,0.04071622,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134700",859.468,0.3078306,0.1047845,2.93775,0.003306037,0.04071622,0,3255,"sp|P53451|TCPD_TAKRU","P53451","TCPD",6.05e-34,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]; response to hypoxia [GO:0001666]","GO:0001666; GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g30637",1880.545,-0.2883775,0.09816603,-2.937651,0.00330709,0.04071799,22745,31439,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.66e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g56002",201.9717,0.2836147,0.09654578,2.937619,0.003307437,0.04071799,0,3514,"sp|Q9GZR7|DDX24_HUMAN","Q9GZR7","DDX24",3.25e-16,"ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)","RNA metabolic process [GO:0016070]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887"
"g30162",618.3924,-0.3571855,0.1216113,-2.937109,0.003312877,0.04072981,6315,9927,"sp|Q9D115|ZN706_MOUSE","Q9D115","ZN706",8e-06,"Zinc finger protein 706","negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]","GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455"
"g53691",196.4995,0.446269,0.1519387,2.937164,0.003312284,0.04072981,219,15374,"sp|Q5RCU5|CBR1_PONAB","Q5RCU5","CBR1",2.45e-07,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","lipid metabolic process [GO:0006629]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0004090; GO:0005737; GO:0006629; GO:0006805; GO:0042373; GO:0047020; GO:0047021; GO:0050221"
"g53958",583.9523,-0.4111544,0.1399831,-2.937173,0.003312198,0.04072981,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82213",18.54562,0.5201275,0.1770825,2.937205,0.003311849,0.04072981,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97728",135.846,0.463148,0.1576798,2.937269,0.003311163,0.04072981,0,5934,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.35e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g99043",55.15555,0.8287105,0.2821369,2.937264,0.003311219,0.04072981,0,6613,"sp|P21328|RTJK_DROME","P21328","RTJK",5.6e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g115429",263.9024,-0.484504,0.1649457,-2.937355,0.003310246,0.04072981,691,4919,"sp|P22003|BMP5_HUMAN","P22003","BMP5",1.3e-08,"Bone morphogenetic protein 5 (BMP-5)","allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]","GO:0001501; GO:0001503; GO:0003272; GO:0003323; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0008083; GO:0008284; GO:0008285; GO:0010719; GO:0010862; GO:0010894; GO:0021502; GO:0030509; GO:0030539; GO:0030902; GO:0031982; GO:0032348; GO:0043569; GO:0043583; GO:0045944; GO:0048738; GO:0050679; GO:0051216; GO:0060037; GO:0060395; GO:0060411; GO:0060710; GO:0061384; GO:0070700; GO:0071676; GO:0097065; GO:1900006; GO:1902042; GO:1905069; GO:2000065"
"g153167",1505.628,0.3586007,0.1220952,2.937058,0.003313426,0.04072981,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6892",709.4849,-0.1746405,0.05946358,-2.936932,0.003314771,0.04073088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27804",1417.492,-0.3017215,0.1027325,-2.936961,0.003314456,0.04073088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15114",317.4881,1.903514,0.6481934,2.936645,0.003317842,0.04076089,32199,53844,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.16e-32,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g17253",618.6055,0.291431,0.09925091,2.936306,0.003321468,0.04079771,49980,57446,"sp|P59999|ARPC4_MOUSE","P59999","ARPC4",1.97e-24,"Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)","actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0005200; GO:0005634; GO:0005737; GO:0005885; GO:0019899; GO:0030041; GO:0030674; GO:0030833; GO:0034314; GO:0035861; GO:0042995; GO:0051015"
"g62519",34.41569,1.93951,0.6606035,2.935966,0.003325103,0.04083461,0,12690,"sp|A2AIG8|1A1L1_MOUSE","A2AIG8","1A1L1",1.95e-08,"1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1)","biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]","GO:0006520; GO:0008483; GO:0009058; GO:0030170; GO:0042802"
"g2813",62.06328,0.4021283,0.1369731,2.935819,0.003326682,0.04084625,94985,100259,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.71e-22,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g156114",295.6936,1.581208,0.538635,2.935584,0.003329203,0.04086946,0,1476,"sp|Q5RB02|CATC_PONAB","Q5RB02","CATC",6.41e-17,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]",NA,"GO:0005764; GO:0008234; GO:0008239"
"g72831",437.6716,0.8922065,0.3039552,2.935322,0.003332014,0.04089623,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25379",164.9194,0.3740033,0.1274236,2.935118,0.003334214,0.04090773,25993,32284,"sp|P0CT43|TF28_SCHPO","P0CT43","TF28",4.61e-56,"Transposon Tf2-8 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g88087",236.2732,-0.4117308,0.1402757,-2.935153,0.003333832,0.04090773,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58679",315.78,0.2512784,0.08562234,2.934729,0.003338386,0.04094822,2265,13844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.05e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g83170",113.0137,0.4780878,0.1629116,2.934646,0.003339281,0.04094822,1076,8384,"sp|P21439|MDR3_HUMAN","P21439","MDR3",2.91e-19,"Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)","bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140"
"g161385",1764.422,0.5624252,0.1916509,2.934634,0.00333941,0.04094822,0,320,"sp|Q2KI95|FHL2_BOVIN","Q2KI95","FHL2",1.48e-14,"Four and a half LIM domains protein 2 (FHL-2)","atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]","GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885"
"g50346",63.5384,-0.331903,0.1131077,-2.934398,0.003341952,0.04097163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77591",1879.639,-0.3125407,0.1065153,-2.934234,0.003343725,0.04098561,0,3734,"sp|P54356|TSG_DROME","P54356","TSG",1.08e-10,"Protein twisted gastrulation","amnioserosa formation [GO:0007378]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of metalloendopeptidase activity [GO:1904685]; regulation of BMP signaling pathway [GO:0030510]","GO:0005576; GO:0005615; GO:0007378; GO:0008201; GO:0030510; GO:0030514; GO:0036122; GO:1904685"
"g31736",84.07931,-0.4813785,0.1640825,-2.93376,0.003348836,0.0410405,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143831",35.68528,1.863898,0.6353485,2.933662,0.003349892,0.04104568,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161060",61.51298,0.3515386,0.1198419,2.933352,0.003353236,0.04107888,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30570",2755.906,-0.3504676,0.1194874,-2.933092,0.003356045,0.04109775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43475",457.702,-0.3813841,0.1300257,-2.933144,0.003355487,0.04109775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139680",244.4111,-0.3560028,0.1213873,-2.932785,0.003359363,0.04113061,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101906",32.1244,0.4819069,0.1643249,2.932647,0.003360856,0.04114111,45,6028,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",2.04e-64,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g33387",297.8254,-0.3192725,0.1088737,-2.932504,0.003362404,0.04115229,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159762",30.54599,-0.4951769,0.1688764,-2.932186,0.00336585,0.04118669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139949",72.70981,0.368543,0.1256946,2.932052,0.003367308,0.04119675,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3284",1210.006,-0.399519,0.1362723,-2.931771,0.003370353,0.04121438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4791",405.5288,-0.2730614,0.09313961,-2.931743,0.003370657,0.04121438,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55408",971.9149,-0.2711296,0.09247734,-2.931849,0.003369509,0.04121438,2135,5880,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.8e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g71641",548.357,0.4872732,0.1662139,2.931604,0.003372169,0.04122508,5931,10552,"sp|Q94516|AT5F1_DROME","Q94516","AT5F1",6.39e-14,"ATP synthase subunit b, mitochondrial (ATPase subunit b) (FO-ATP synthase subunit b)","ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]","GO:0000274; GO:0000276; GO:0005739; GO:0015078; GO:0015986; GO:1902600"
"g26607",2917.247,-0.1768529,0.06033384,-2.931239,0.003376128,0.04125092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66522",317.2903,0.7112588,0.242644,2.931285,0.003375625,0.04125092,0,7434,"sp|P07742|RIR1_MOUSE","P07742","RIR1",4.29e-26,"Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)","2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]","GO:0000731; GO:0004748; GO:0005524; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005971; GO:0006264; GO:0006281; GO:0009185; GO:0009263; GO:0009265; GO:0010971; GO:0017076; GO:0042802; GO:0042995; GO:0043025; GO:0051290; GO:0061731; GO:0070318; GO:0097718; GO:1900087"
"g74090",51.96094,0.3259373,0.1111946,2.931233,0.003376192,0.04125092,0,8044,"sp|P21329|RTJK_DROFU","P21329","RTJK",8.74e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g116118",152.6906,-0.6569592,0.2241449,-2.930958,0.003379189,0.04127975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126588",650.2008,0.3055089,0.1042418,2.930771,0.003381221,0.04129679,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133386",188.0012,-0.4337156,0.1480031,-2.93045,0.003384719,0.04133172,1505,3358,"sp|Q27421|OSP_DROME","Q27421","OSP",4.97e-09,"Protein outspread","actin filament organization [GO:0007015]","GO:0007015; GO:0015629; GO:0051015"
"g157065",19898.5,1.001997,0.341941,2.930323,0.003386099,0.04134078,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12119",494.924,1.629751,0.5561864,2.930225,0.003387166,0.04134601,19729,54734,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.13e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g8084",189.8051,-0.3023007,0.1031708,-2.930099,0.003388545,0.04135088,9458,12574,"sp|P20662|ZFY2_MOUSE","P20662","ZFY2",7.73e-11,"Zinc finger Y-chromosomal protein 2","dosage compensation by inactivation of X chromosome [GO:0009048]; meiotic recombination checkpoint signaling [GO:0051598]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007283; GO:0007286; GO:0009048; GO:0046872; GO:0051598"
"g145242",40.38979,0.5456332,0.1862184,2.930071,0.003388841,0.04135088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52378",31.88923,0.5972139,0.2038656,2.929449,0.003395638,0.04142601,0,14571,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.44e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11453",2246.908,-0.2959242,0.1010566,-2.9283,0.003408212,0.04152469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12590",130.3866,0.3325147,0.113552,2.928304,0.003408169,0.04152469,308,16380,"sp|Q60976|JERKY_MOUSE","Q60976","JERKY",8.6e-31,"Jerky protein","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g33729",536.648,-0.2313895,0.07901522,-2.928417,0.003406927,0.04152469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39954",29.89712,0.4771517,0.1629415,2.928361,0.00340754,0.04152469,19615,22730,"sp|Q5RB98|NUP42_PONAB","Q5RB98","NUP42",7.44e-07,"Nucleoporin NUP42 (Nucleoporin-like protein 2)","mRNA transport [GO:0051028]; protein transport [GO:0015031]","GO:0005643; GO:0015031; GO:0031965; GO:0046872; GO:0051028"
"g76436",213.364,0.6441904,0.2199661,2.92859,0.003405031,0.04152469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84187",402.2092,0.526299,0.1797224,2.928399,0.003407123,0.04152469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123416",67.65028,0.5456217,0.1863089,2.928587,0.003405067,0.04152469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34074",48.81841,0.3538867,0.1208602,2.928067,0.003410762,0.04154013,16405,18730,"sp|Q9CR27|WASC3_MOUSE","Q9CR27","WASC3",1.39e-07,"WASH complex subunit 3 (Coiled-coil domain-containing protein 53)","actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]","GO:0006887; GO:0015031; GO:0016197; GO:0030041; GO:0031901; GO:0034315; GO:0071203"
"g41420",371.1551,0.840018,0.2868807,2.92811,0.003410299,0.04154013,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71323",814.1437,0.3961803,0.1353073,2.928003,0.003411464,0.04154087,1231,9984,"sp|Q9W141|ATPK_DROME","Q9W141","ATPK",6.7e-06,"Putative ATP synthase subunit f, mitochondrial","mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0042776; GO:1902600"
"g153876",39.03718,0.393772,0.1344888,2.927916,0.003412421,0.04154471,0,1645,"sp|Q6DFR2|CBLB_XENTR","Q6DFR2","CBLB",5.17e-09,"E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)","cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165]","GO:0001784; GO:0005509; GO:0005737; GO:0005886; GO:0007165; GO:0007166; GO:0007175; GO:0017124; GO:0030971; GO:0045121; GO:0061630; GO:2000583"
"g65242",1743.484,0.3002787,0.1025645,2.927707,0.003414719,0.04156489,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31109",1189.717,-0.4752847,0.1623504,-2.927524,0.00341673,0.04158155,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1796",808.9411,-0.3498377,0.1195127,-2.927202,0.003420265,0.04159332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7680",29.48194,0.8807961,0.3008843,2.927358,0.003418556,0.04159332,68875,72007,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.2e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g26211",29.17488,1.017273,0.3475103,2.927316,0.00341901,0.04159332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71053",245.9048,0.5972066,0.204019,2.927211,0.003420165,0.04159332,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37966",2976.51,0.3904697,0.1333985,2.927093,0.003421461,0.04160006,18616,23924,"sp|P18258|TBA1_PARLI","P18258","TBA1",2.78e-38,"Tubulin alpha-1 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g104717",54.2827,1.891176,0.6461104,2.927016,0.003422311,0.04160259,0,2311,"sp|P38487|CREA_BACB0","P38487","CREA",2.38e-27,"Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)",NA,"GO:0016980"
"g142087",22.55472,1.422049,0.4858546,2.926903,0.003423553,0.04160988,0,2678,"sp|B1AVD1|XPP2_MOUSE","B1AVD1","XPP2",5.57e-10,"Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (mAPP) (X-prolyl aminopeptidase 2)",NA,"GO:0005886; GO:0031225; GO:0046872; GO:0070006; GO:0070062"
"g45039",417.7267,-0.2427547,0.0829466,-2.926638,0.003426476,0.04163043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129771",21.43421,0.7290712,0.249116,2.926633,0.003426529,0.04163043,0,3639,"sp|P21328|RTJK_DROME","P21328","RTJK",8.59e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31600",63.53815,0.3912932,0.1337116,2.926396,0.003429145,0.0416544,0,29464,"sp|O54956|DPOE2_MOUSE","O54956","DPOE2",1.18e-14,"DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)","DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]","GO:0003677; GO:0005654; GO:0006261; GO:0008622; GO:0016604; GO:0042276; GO:0043231"
"g8247",496.1011,-0.3133312,0.1070765,-2.926236,0.003430911,0.04166777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26925",107.0612,-0.2893955,0.09890149,-2.926099,0.003432416,0.04166777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46713",103.0729,0.2410354,0.08237535,2.926063,0.003432818,0.04166777,706,3964,"sp|Q5REU2|RL23_PONAB","Q5REU2","RL23",6.16e-17,"60S ribosomal protein L23","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g78097",1413.91,-0.2877677,0.09834592,-2.926077,0.00343266,0.04166777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131689",37.09175,0.8962402,0.3063238,2.925793,0.00343579,0.04169604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56692",71.72365,0.3966134,0.135562,2.925697,0.003436856,0.04170116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10361",1411.335,-0.3843212,0.1313676,-2.925541,0.003438575,0.04171314,62680,75034,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.64e-26,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g98425",41.22885,0.3930852,0.1343682,2.925433,0.003439775,0.04171314,0,2064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.18e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g133902",83.29319,0.3168052,0.1082921,2.92547,0.003439359,0.04171314,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2965",173.3731,-0.4516289,0.1543913,-2.925223,0.003442094,0.04173346,78924,87194,"sp|P21328|RTJK_DROME","P21328","RTJK",2.46e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g10889",364.5185,-0.2708745,0.09261112,-2.924859,0.003446119,0.04177444,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50253",499.9171,-0.2354029,0.08048675,-2.924741,0.003447429,0.0417825,6075,11784,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.39e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g31362",413.991,-0.3279726,0.1121437,-2.924574,0.003449284,0.04179717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15377",463.5534,-0.3178305,0.1086846,-2.924338,0.003451897,0.04180537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33224",193.7326,0.5862065,0.200451,2.924437,0.003450796,0.04180537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60582",517.4036,0.7671729,0.2623356,2.924395,0.003451266,0.04180537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17362",3083.693,-0.2986208,0.1021189,-2.924246,0.003452914,0.04180988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48062",21.23472,-0.478418,0.1636233,-2.923899,0.003456765,0.04184869,4818,12890,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.71e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g39007",212.8468,-0.3784221,0.129429,-2.923783,0.003458062,0.04185657,0,3727,"sp|P16924|P4HA1_CHICK","P16924","P4HA1",4.6e-18,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]","GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0018401; GO:0031418"
"g65722",174.5783,0.2816392,0.09633203,2.92363,0.003459759,0.04186259,0,11891,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.79e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g86128",5737.815,0.2944505,0.1007143,2.923622,0.003459851,0.04186259,0,5300,"sp|O46585|COX41_PITPI","O46585","COX41",3.29e-09,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1) (Fragment)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005743; GO:0005751; GO:0006123; GO:0016021; GO:0016491"
"g107819",2459.793,-0.7027948,0.2403946,-2.923506,0.00346114,0.04187036,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35215",71.26101,0.2896581,0.09908289,2.923392,0.003462403,0.04187782,6805,12034,"sp|A4FUY7|MOC2B_BOVIN","A4FUY7","MOC2B",2.2e-22,"Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"g22955",94.82332,0.3687458,0.1261451,2.923187,0.003464681,0.04189085,19648,45514,"sp|E9Q5G3|KIF23_MOUSE","E9Q5G3","KIF23",9.42e-24,"Kinesin-like protein KIF23","microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]","GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072686; GO:0090543; GO:0097149"
"g50415",72.29829,-0.2663811,0.09112787,-2.923157,0.003465013,0.04189085,7907,14684,"sp|Q6Q760|NALCN_RAT","Q6Q760","NALCN",1.79e-15,"Sodium leak channel NALCN (Four domain-type voltage-gated ion channel alpha-1 subunit) (Rb21-channel) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1)","calcium ion transmembrane transport [GO:0070588]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]","GO:0005244; GO:0005248; GO:0005261; GO:0005886; GO:0016021; GO:0022840; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805"
"g137950",26.1016,-0.5460502,0.1868038,-2.923121,0.00346542,0.04189085,0,1514,"sp|P21328|RTJK_DROME","P21328","RTJK",8.71e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42365",41.25033,0.4010234,0.1371942,2.923033,0.003466392,0.04189479,2214,7054,"sp|P16332|MUTA_MOUSE","P16332","MUTA",5.62e-15,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)","homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]","GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0046906; GO:0050667; GO:0072341"
"g105333",135.1911,0.2812649,0.09622677,2.922938,0.003467456,0.04189982,0,5919,"sp|Q178A5|UFC1_AEDAE","Q178A5","UFC1",3.97e-31,"Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1)","protein ufmylation [GO:0071569]","GO:0061657; GO:0071569"
"g48628",249.0056,0.4116989,0.1408583,2.922787,0.003469137,0.04191232,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44987",19.33038,1.827454,0.6252608,2.922707,0.003470028,0.04191527,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31246",127.5267,0.368237,0.1260033,2.922439,0.003473019,0.04194358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104668",98.75935,1.792233,0.6132981,2.922286,0.00347472,0.0419563,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5520",1107.942,-0.6796427,0.2325894,-2.922071,0.003477118,0.04197744,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57387",272.4351,-0.4319095,0.1478138,-2.921984,0.003478095,0.04198141,7998,14064,"sp|Q9BYW2|SETD2_HUMAN","Q9BYW2","SETD2",2.9e-10,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634"
"g65423",17.75922,1.085135,0.3713888,2.921831,0.003479804,0.04198326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141372",19.90435,-0.8670369,0.2967427,-2.921847,0.003479622,0.04198326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148856",18.12941,0.8370942,0.2864999,2.921796,0.003480193,0.04198326,0,2090,"sp|P35465|PAK1_RAT","P35465","PAK1",1.73e-23,"Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (Protein kinase MUK2) (p21-activated kinase 1) (PAK-1) (p68-PAK)","actin cytoskeleton reorganization [GO:0031532]; amygdala development [GO:0021764]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; observational learning [GO:0098597]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of gene expression [GO:0010468]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; small GTPase mediated signal transduction [GO:0007264]; transmission of nerve impulse [GO:0019226]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]; wound healing [GO:0042060]","GO:0001666; GO:0001726; GO:0001934; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005518; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0007264; GO:0007528; GO:0008284; GO:0010033; GO:0010468; GO:0010763; GO:0014069; GO:0014704; GO:0016020; GO:0016310; GO:0016358; GO:0016477; GO:0019226; GO:0019901; GO:0021549; GO:0021764; GO:0030010; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0031116; GO:0031532; GO:0031965; GO:0032587; GO:0032869; GO:0032956; GO:0032991; GO:0033138; GO:0033148; GO:0035556; GO:0042060; GO:0043015; GO:0043113; GO:0043408; GO:0043507; GO:0045773; GO:0046628; GO:0046777; GO:0048012; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0060996; GO:0061052; GO:0061534; GO:0061535; GO:0071407; GO:0090063; GO:0090314; GO:0098597; GO:0098793; GO:0098978; GO:0098982; GO:0099553; GO:0106310; GO:1900271; GO:1904707; GO:1904754"
"g118909",124.7357,-0.3609473,0.1235537,-2.921379,0.003484854,0.04203168,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85466",22.27306,1.895403,0.6488212,2.921302,0.003485716,0.04203424,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141085",504.8885,-0.2702578,0.09251797,-2.921139,0.003487542,0.04204844,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72757",500.2995,1.482561,0.5075468,2.921033,0.003488731,0.04205494,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22100",1005.787,0.2722334,0.09320232,2.920887,0.003490366,0.04206683,36175,47692,"sp|P21328|RTJK_DROME","P21328","RTJK",2.69e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g14776",184.4326,0.6062142,0.2075589,2.920685,0.003492628,0.04208627,61044,64180,"sp|Q9I3S3|GBUA_PSEAE","Q9I3S3","GBUA",2.3e-17,"Guanidinobutyrase (EC 3.5.3.7)","arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]","GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971"
"g87038",248.3468,0.2073245,0.07099086,2.92044,0.003495373,0.04211151,735,8088,"sp|P21328|RTJK_DROME","P21328","RTJK",4.08e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g104933",304.8895,0.24502,0.08390826,2.920094,0.003499256,0.04215046,2615,5100,"sp|Q5ZLF0|F10A1_CHICK","Q5ZLF0","F10A1",6.91e-06,"Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog)","chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]","GO:0005737; GO:0031072; GO:0046983; GO:0051085; GO:0065003"
"g131966",44.46172,0.582334,0.1994549,2.919628,0.003504494,0.0422057,0,3472,"sp|Q9RCG8|PAXA_PASAE","Q9RCG8","PAXA",3.99e-08,"Exotoxin PaxA","cytolysis [GO:0019835]","GO:0005509; GO:0005576; GO:0016021; GO:0019835; GO:0020002; GO:0090729"
"g55724",61.4727,-0.3780052,0.129473,-2.919567,0.003505185,0.04220618,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88057",32.85455,-0.4760367,0.1630586,-2.919421,0.00350682,0.04221018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93204",103.8884,-0.7501768,0.2569583,-2.91945,0.003506496,0.04221018,0,6114,"sp|Q25322|OAR2_LOCMI","Q25322","OAR2",2.62e-131,"Putative tyramine receptor 2 (Tyr-Loc2)",NA,"GO:0004989; GO:0005886; GO:0016021"
"g74196",888.3144,-0.535719,0.1835063,-2.91935,0.003507623,0.042212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8914",1856.721,-0.4302222,0.1473911,-2.918916,0.003512509,0.04225485,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48209",111.1063,0.5656512,0.1937918,2.91886,0.00351314,0.04225485,0,8764,"sp|Q9Z0X1|AIFM1_MOUSE","Q9Z0X1","AIFM1",8.01e-14,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]","GO:0002931; GO:0003677; GO:0003954; GO:0004174; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0006979; GO:0008637; GO:0009636; GO:0010942; GO:0012501; GO:0016174; GO:0016651; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045"
"g72703",6904.37,0.4417615,0.1513426,2.918951,0.003512114,0.04225485,0,8514,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.54e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g9792",19.41833,0.4294085,0.1471205,2.918754,0.003514329,0.04226131,63886,82954,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.12e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g64888",278.2748,-2.680659,0.9184661,-2.918626,0.003515778,0.04226856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147740",783.7982,0.5272095,0.1806387,2.918585,0.003516237,0.04226856,185,2186,"sp|P06708|TNNC2_ASTLP","P06708","TNNC2",1.08e-14,"Troponin C, isotype gamma",NA,"GO:0005509"
"g20348",641.167,-0.300523,0.1029718,-2.918497,0.003517228,0.04227246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128429",95.39538,0.7970093,0.2730942,2.918441,0.003517866,0.04227246,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130926",54.63037,0.8298992,0.2843735,2.918342,0.003518977,0.04227797,0,1844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.19e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g102041",682.2221,0.5006425,0.1715608,2.918164,0.003520994,0.04229435,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26932",270.6095,1.004627,0.3442974,2.917904,0.003523926,0.04232173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87737",154.3373,-0.4120556,0.1412277,-2.917668,0.003526595,0.04234593,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136274",52.51667,1.770612,0.6068939,2.917499,0.003528509,0.04236107,0,3132,"sp|P38487|CREA_BACB0","P38487","CREA",1.54e-11,"Creatinase (EC 3.5.3.3) (Creatine amidinohydrolase)",NA,"GO:0016980"
"g154331",25.33387,0.8434961,0.2892428,2.916221,0.003542992,0.04252706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63150",441.5377,0.2567568,0.08804724,2.916125,0.003544081,0.04253226,4255,10430,"sp|P49819|DLDH_CANLF","P49819","DLDH",1.8e-26,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]","GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077"
"g99024",41.19333,0.5274019,0.1808662,2.915978,0.003545754,0.04253657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141269",107.03,0.330828,0.1134527,2.916001,0.003545498,0.04253657,0,2744,"sp|Q24740|CDC37_DROVI","Q24740","CDC37",2.3e-22,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit)","positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neuroblast proliferation [GO:0002052]","GO:0002052; GO:0005158; GO:0005737; GO:0019901; GO:0046628"
"g14566",25.50072,0.5911068,0.2027322,2.915702,0.003548888,0.04256133,9455,14570,"sp|Q80Y17|L2GL1_MOUSE","Q80Y17","L2GL1",2.33e-08,"Lethal(2) giant larvae protein homolog 1 (LLGL) (Mgl-1) (Mlgl)","axonogenesis [GO:0007409]; brain development [GO:0007420]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; maintenance of apical/basal cell polarity [GO:0035090]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]","GO:0000137; GO:0000139; GO:0005096; GO:0005737; GO:0005856; GO:0005886; GO:0006887; GO:0006893; GO:0007409; GO:0007420; GO:0008593; GO:0016323; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031267; GO:0031901; GO:0032588; GO:0032878; GO:0035090; GO:0035748; GO:0045159; GO:0050708; GO:0051294; GO:0065003"
"g104616",54.49965,0.705455,0.2419521,2.915681,0.003549131,0.04256133,2918,5988,"sp|A9CB25|S22A4_PAPAN","A9CB25","S22A4",9.17e-09,"Solute carrier family 22 member 4 (Organic cation/carnitine transporter 1)","amino acid import across plasma membrane [GO:0089718]; carnitine metabolic process [GO:0009437]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0005739; GO:0006641; GO:0006814; GO:0009437; GO:0015171; GO:0015226; GO:0015293; GO:0015491; GO:0016021; GO:0016324; GO:0030165; GO:0042908; GO:0089718"
"g135973",55.56688,-0.4230657,0.1451223,-2.915236,0.003554202,0.04261425,0,2685,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.34e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g84321",258.0815,0.2282369,0.07829549,2.915071,0.00355608,0.04262888,0,7228,"sp|Q3ULF4|SPG7_MOUSE","Q3ULF4","SPG7",9.88e-07,"Paraplegin (EC 3.4.24.-) (Spastic paraplegia 7 protein)","anterograde axonal transport [GO:0008089]; cell adhesion [GO:0007155]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of mitochondrial membrane permeability [GO:0046902]","GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0007005; GO:0007155; GO:0008089; GO:0008270; GO:0016887; GO:0030155; GO:0034982; GO:0046902; GO:0065003; GO:1902686; GO:1904115"
"g40894",1429.829,-0.2467078,0.08463377,-2.915004,0.003556838,0.04263008,16966,23380,"sp|P21328|RTJK_DROME","P21328","RTJK",1.44e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g7227",159.0771,0.4727038,0.1621714,2.914841,0.003558694,0.04263985,39480,51204,"sp|P24635|TBA_OCTVU","P24635","TBA",1.05e-28,"Tubulin alpha chain (Fragment)","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g45484",1402.328,-0.3620845,0.124222,-2.914817,0.003558969,0.04263985,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123263",50.78401,0.5378545,0.1845359,2.914634,0.003561057,0.04265698,0,4196,"sp|P97852|DHB4_RAT","P97852","DHB4",2.07e-16,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","aging [GO:0007568]; androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0006635; GO:0007568; GO:0008203; GO:0008209; GO:0008210; GO:0009410; GO:0014070; GO:0016508; GO:0016853; GO:0018812; GO:0030283; GO:0033989; GO:0036111; GO:0036112; GO:0042802; GO:0042803; GO:0044594; GO:0048545; GO:0060009; GO:0071407; GO:0106386"
"g110975",39.78987,0.4900242,0.1681387,2.914405,0.003563676,0.04268045,0,5344,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",4.23e-66,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g5116",631.3016,-0.296967,0.1019056,-2.914139,0.003566709,0.04270889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35162",82.17394,-0.6176712,0.2119625,-2.914058,0.003567631,0.04271203,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24246",562.5925,-0.3089514,0.1060297,-2.913818,0.003570382,0.04272918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116185",169.0335,1.069874,0.3671713,2.913827,0.003570273,0.04272918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71682",154.9813,0.2233119,0.07664332,2.913651,0.003572286,0.04274407,0,8864,"sp|Q5ZHS1|ELP3_CHICK","Q5ZHS1","ELP3",1.18e-35,"Elongator complex protein 3 (EC 2.3.1.-) (tRNA uridine(34) acetyltransferase)","central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]","GO:0000049; GO:0001764; GO:0002098; GO:0002926; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0007417; GO:0008080; GO:0008607; GO:0030335; GO:0033588; GO:0046872; GO:0051539; GO:0106261"
"g81980",69.10528,0.4131967,0.1418274,2.913377,0.003575425,0.04277373,4587,8624,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",2.58e-15,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g6710",94.88644,-0.6641336,0.2279711,-2.913236,0.003577038,0.04278513,62325,81724,"sp|Q9VIK2|CART_DROME","Q9VIK2","CART",5.96e-07,"Carcinine transporter","carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]","GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0016021; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131"
"g134575",517.258,0.4095622,0.1406013,2.912933,0.003580511,0.04281877,696,3266,"sp|P17955|NUP62_RAT","P17955","NUP62",3.96e-33,"Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62)","cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]","GO:0000278; GO:0000922; GO:0005543; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005813; GO:0006405; GO:0006606; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0007283; GO:0007569; GO:0008219; GO:0008285; GO:0017056; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0032991; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0044613; GO:0044877; GO:0045840; GO:0045893; GO:0046580; GO:0046601; GO:0046966; GO:0051028; GO:0051425; GO:0051879; GO:0060236; GO:0072686; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904"
"g40462",81.57161,0.7060397,0.2423958,2.912755,0.003582556,0.0428195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100006",70.91786,0.3165579,0.1086782,2.9128,0.00358204,0.0428195,0,6501,"sp|Q9ULI0|ATD2B_HUMAN","Q9ULI0","ATD2B",1.52e-25,"ATPase family AAA domain-containing protein 2B","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0042393; GO:0045944; GO:0070577"
"g106364",103.0097,-0.4052719,0.1391345,-2.912807,0.003581958,0.0428195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121124",79.97548,0.977184,0.3355003,2.912618,0.003584132,0.04283044,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46189",774.4382,0.3937358,0.1351928,2.912402,0.003586606,0.04285211,2943,4034,"sp|Q3ZBH0|TCPB_BOVIN","Q3ZBH0","TCPB",1.19e-16,"T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone mediated protein folding independent of cofactor [GO:0051086]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]","GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0090666; GO:1901998; GO:1904851; GO:1904874"
"g96994",146.5611,-0.3818999,0.1311414,-2.912123,0.003589817,0.04288257,0,6840,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.65e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55857",17.56372,-0.5271296,0.1810161,-2.912059,0.003590553,0.04288345,0,14846,"sp|F1M3J4|MRP4_RAT","F1M3J4","MRP4",1.05e-06,"ATP-binding cassette subfamily C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4)","bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]","GO:0001409; GO:0005524; GO:0005886; GO:0008559; GO:0009410; GO:0010033; GO:0010243; GO:0014070; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031088; GO:0032310; GO:0034634; GO:0038183; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115"
"g8065",963.3382,-0.2637492,0.09057337,-2.911996,0.003591276,0.04288418,40375,52312,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g95929",1136.861,-0.2456576,0.08436363,-2.91189,0.003592494,0.04289081,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16935",221.1089,-0.3089442,0.1061058,-2.911661,0.003595131,0.04291406,24805,30974,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.67e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g114857",890.1081,0.3971064,0.1363874,2.911605,0.003595765,0.04291406,0,4974,"sp|C6KFA3|AGRG6_DANRE","C6KFA3","AGRG6",8.31e-47,"Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879]","GO:0001503; GO:0004930; GO:0005518; GO:0005887; GO:0007005; GO:0007166; GO:0007186; GO:0007189; GO:0007507; GO:0014037; GO:0019933; GO:0022011; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0060347; GO:0060879; GO:1903670"
"g11160",461.1425,-0.3113673,0.1069465,-2.911429,0.003597792,0.04291742,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24832",242.8062,-0.2335907,0.08023447,-2.911351,0.003598696,0.04291742,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34969",763.4531,-0.1950056,0.06697777,-2.911497,0.003597015,0.04291742,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55195",36.07615,-0.4862687,0.1670249,-2.911355,0.003598648,0.04291742,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150946",46.87196,1.004757,0.3451243,2.911289,0.003599407,0.042918,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12241",65.95815,0.353427,0.1214069,2.911094,0.003601652,0.04293686,23275,25331,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1561",6853.07,-0.3053579,0.1049018,-2.910893,0.00360398,0.04295671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108327",568.8893,-0.5153416,0.1770523,-2.910675,0.003606485,0.04297247,0,4288,"sp|P35859|ALS_RAT","P35859","ALS",5.19e-31,"Insulin-like growth factor-binding protein complex acid labile subunit (ALS)","aging [GO:0007568]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to interleukin-1 [GO:0071347]; response to nutrient levels [GO:0031667]","GO:0005520; GO:0005615; GO:0007155; GO:0007568; GO:0031012; GO:0031667; GO:0042567; GO:0071347; GO:0071364; GO:0071378; GO:0071549"
"g117212",220.7159,0.4973774,0.1708845,2.910605,0.003607292,0.04297247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138638",265.1904,1.443161,0.495822,2.910644,0.003606849,0.04297247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70859",1445.656,0.5748869,0.1975187,2.910545,0.00360799,0.04297289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1384",52.96048,-0.4301127,0.1477828,-2.910438,0.003609221,0.04297965,90155,93900,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.34e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g158316",36.56244,1.082778,0.3720412,2.910372,0.003609992,0.04298092,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124821",96.01817,-0.488102,0.1677223,-2.910179,0.003612222,0.04299958,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10645",244.4124,0.4070713,0.1398826,2.910093,0.003613211,0.04300345,57480,62214,"sp|Q96SY0|INT14_HUMAN","Q96SY0","INT14",1.68e-16,"Integrator complex subunit 14 (von Willebrand factor A domain-containing protein 9)","snRNA 3'-end processing [GO:0034472]","GO:0005654; GO:0032039; GO:0034472"
"g10134",1969.654,-0.3013037,0.1035438,-2.909916,0.003615254,0.04301986,45385,65097,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.4e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g67368",156.5611,-0.3215764,0.110515,-2.9098,0.003616602,0.04302801,0,9500,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.61e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g94530",48.88523,-0.4068859,0.139846,-2.909529,0.003619737,0.0430574,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4149",56.77207,-0.4644701,0.1596462,-2.909371,0.003621569,0.04307128,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24947",665.7817,-0.2147154,0.07380472,-2.909237,0.003623125,0.04308062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32757",425.2556,-0.2677806,0.09204648,-2.909188,0.003623684,0.04308062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59669",36.45545,0.621108,0.2135037,2.909121,0.003624461,0.04308195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109418",25.58707,-0.70853,0.2435625,-2.909027,0.003625552,0.04308701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31001",3976.306,0.3229929,0.1110433,2.908712,0.003629208,0.04311464,6425,13528,"sp|Q9Y3Q8|T22D4_HUMAN","Q9Y3Q8","T22D4",4.91e-11,"TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1)","negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]","GO:0005634; GO:0006357; GO:0006970; GO:0045892"
"g108345",22.80792,-0.5096596,0.1752157,-2.908756,0.0036287,0.04311464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3341",2063.474,-0.2052219,0.070559,-2.908515,0.003631498,0.04313394,64565,89436,"sp|Q9W345|ZDHC8_DROME","Q9W345","ZDHC8",1.46e-07,"Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (Zinc finger DHHC-type containing 8)","protein palmitoylation [GO:0018345]","GO:0000139; GO:0005886; GO:0016021; GO:0016409; GO:0018345; GO:0019706"
"g52974",228.5664,-0.3830285,0.131707,-2.908187,0.00363531,0.0431713,0,12854,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.36e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g23834",288.9506,-0.4189004,0.1440557,-2.907905,0.003638586,0.04319986,34218,38984,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.17e-11,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g46127",555.8097,-0.4944079,0.1700245,-2.907862,0.003639083,0.04319986,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64930",20.41298,-0.4279788,0.1471826,-2.907808,0.003639715,0.04319986,0,4744,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.37e-58,"PiggyBac transposable element-derived protein 4",NA,NA
"g111967",532.5605,0.175634,0.06040798,2.907463,0.003643731,0.0432396,2080,5014,"sp|Q32PI5|2AAA_BOVIN","Q32PI5","2AAA",3.41e-10,"Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)","chromosome segregation [GO:0007059]; protein-containing complex assembly [GO:0065003]","GO:0000775; GO:0005634; GO:0005737; GO:0007059; GO:0016328; GO:0019888; GO:0030425; GO:0065003"
"g90042",24.01052,0.7168397,0.2466021,2.906868,0.003650678,0.04331411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4479",229.1356,-0.443436,0.1525586,-2.906661,0.003653093,0.04333086,65255,72276,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.77e-08,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g127903",242.0538,1.328023,0.4568942,2.906632,0.003653427,0.04333086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9413",352.6455,-0.4111796,0.1414754,-2.906368,0.003656516,0.04335923,7362,15504,"sp|Q9CQJ8|NDUB9_MOUSE","Q9CQJ8","NDUB9",1.75e-08,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)","aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0009060; GO:0032981; GO:0042776"
"g93747",276.2631,0.3242041,0.1115517,2.906313,0.003657157,0.04335923,0,2614,"sp|Q5E9X4|LRC59_BOVIN","Q5E9X4","LRC59",3.05e-10,"Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]",NA,"GO:0005635; GO:0005789; GO:0016021; GO:0042645"
"g106450",90.68169,0.4426311,0.1523053,2.90621,0.003658362,0.04336558,0,1924,"sp|Q99MR8|MCCA_MOUSE","Q99MR8","MCCA",2.75e-09,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)","leucine catabolic process [GO:0006552]","GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0046872; GO:1905202"
"g142556",1210.456,1.474137,0.5072544,2.90611,0.003659532,0.04337152,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114668",518.7821,-0.3161834,0.108806,-2.905936,0.003661559,0.0433876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28103",555.1981,-0.3124029,0.1075118,-2.905754,0.003663699,0.04338915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35015",83.97952,0.3510411,0.1208048,2.905852,0.003662542,0.04338915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82111",49.21841,-0.3103903,0.1068185,-2.905773,0.003663468,0.04338915,3473,8790,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.44e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13287",886.4578,-0.2547685,0.08767964,-2.905675,0.003664622,0.04339216,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134447",25.1642,-0.744387,0.2562538,-2.904881,0.003673923,0.04349434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4016",3330.606,-0.4092893,0.1409041,-2.904736,0.003675629,0.04350658,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22509",2602.375,-0.1853508,0.06381929,-2.904307,0.003680666,0.04355458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98488",373.157,0.5332135,0.183596,2.904277,0.003681028,0.04355458,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22905",186.6698,0.3751749,0.1291879,2.904103,0.003683073,0.04357081,0,23190,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.77e-49,"PiggyBac transposable element-derived protein 4",NA,NA
"g232",66.22838,-0.3067654,0.1056523,-2.903537,0.003689729,0.04362365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24477",383.5257,-0.3030262,0.1043701,-2.90338,0.003691579,0.04362365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52809",47.06261,-0.3790025,0.1305363,-2.903426,0.00369104,0.04362365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78792",100.992,-0.7872717,0.2711333,-2.903633,0.003688598,0.04362365,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94469",3761.275,0.9444077,0.3252736,2.903426,0.003691046,0.04362365,3865,5762,"sp|Q24133|DNAJ1_DROME","Q24133","DNAJ1",7.77e-121,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0000122; GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087"
"g112809",74.825,0.312073,0.1074852,2.903406,0.003691283,0.04362365,0,4984,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.56e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g46035",1095.154,-0.205386,0.07074749,-2.903085,0.003695064,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105918",17.83829,0.4971614,0.1712536,2.903071,0.003695233,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125861",1066.989,1.076228,0.3707376,2.902937,0.003696811,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133906",134.2867,0.4095273,0.1410744,2.902917,0.003697049,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136368",255.6523,0.5565029,0.1916991,2.903003,0.003696033,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161083",129.8891,0.4879535,0.1680805,2.903093,0.003694963,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161365",30.84417,0.4123512,0.1420401,2.903061,0.003695344,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161979",33.38273,0.7697002,0.2651417,2.902977,0.003696334,0.04362464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69484",22.77913,1.196259,0.4121008,2.90283,0.003698073,0.04362877,2754,9744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.57e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1094",6345.324,-0.4970276,0.1712338,-2.902625,0.003700493,0.04363462,0,2354,"sp|P85831|PROH4_APIME","P85831","PROH4",2.37e-28,"Prohormone-4 [Cleaved into: Brain peptide IDLSRFYGHFNT; Brain peptide IDLSRFYGHFN; Brain peptide IDLSRFYGHF; Brain peptide DLSRFYGHFNT; Brain peptide DLSRFYGHFN; Brain peptide DLSRFYGHF]",NA,"GO:0005576"
"g65220",73.896,-0.7645639,0.263405,-2.902617,0.003700589,0.04363462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138803",54.14382,-0.5590864,0.1926123,-2.902651,0.003700187,0.04363462,750,2938,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.78e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11031",1725.06,-0.2718956,0.09368675,-2.902178,0.003705782,0.04368434,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27637",1490.386,-0.4473208,0.1541345,-2.902146,0.003706153,0.04368434,17965,25470,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.29e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g47197",1243.51,-0.2780212,0.09580307,-2.902007,0.003707805,0.04369586,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13006",216.0732,0.315093,0.1085826,2.901874,0.003709376,0.04370642,180,21224,"sp|Q3B7M6|NEDD1_BOVIN","Q3B7M6","NEDD1",1.79e-06,"Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1)","cell cycle [GO:0007049]; cell division [GO:0051301]; protein localization to centrosome [GO:0071539]","GO:0000242; GO:0000922; GO:0001650; GO:0005654; GO:0005814; GO:0005829; GO:0007049; GO:0036064; GO:0045177; GO:0051301; GO:0071539"
"g350",58.70592,-0.3837856,0.1322692,-2.901549,0.003713229,0.04374387,111534,115124,"sp|Q92618|ZN516_HUMAN","Q92618","ZN516",8.85e-10,"Zinc finger protein 516","adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]","GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162; GO:0140297"
"g52792",84.5134,-0.4273955,0.1473077,-2.901379,0.003715246,0.04375967,8505,11880,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.07e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g20199",674.9167,-0.2714624,0.09356719,-2.901256,0.003716696,0.04376879,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110496",17.62323,0.52997,0.1826762,2.901144,0.003718034,0.04377659,0,5387,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",4.83e-67,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g151075",1077.893,1.819379,0.6271566,2.900997,0.003719774,0.04378912,0,1888,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",1.09e-19,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g137906",23.29983,-0.8543742,0.2945168,-2.900935,0.003720506,0.04378978,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126961",3760.021,-1.727763,0.5956183,-2.900789,0.003722243,0.04380226,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96885",25.85338,1.027785,0.3543326,2.900622,0.003724225,0.04381763,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9196",1043.218,0.4191984,0.1445323,2.900378,0.003727125,0.04382663,59745,79694,"sp|Q9LXB8|PLPK1_ARATH","Q9LXB8","PLPK1",1.21e-10,"Protein PELPK1 (Proline-rich protein 10) (Protein Pro-Glu-Leu|Ile|Val-Pro-Lys 1)","positive regulation of seed germination [GO:0010030]; post-embryonic development [GO:0009791]; regulation of photoperiodism, flowering [GO:2000028]","GO:0005576; GO:0009505; GO:0009791; GO:0010030; GO:2000028"
"g47305",36.9382,1.975989,0.6812894,2.900367,0.003727263,0.04382663,2322,4874,"sp|Q9VZ49|ENDOU_DROME","Q9VZ49","ENDOU",8.24e-17,"Endoribonuclease CG2145 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872; GO:0090502"
"g47868",24.46253,1.164611,0.4015441,2.90033,0.003727695,0.04382663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80015",28.01455,-0.668581,0.2305179,-2.900343,0.00372755,0.04382663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46937",297.521,1.330952,0.458985,2.899773,0.003734329,0.04389665,13767,18004,"sp|Q10751|ACE_CHICK","Q10751","ACE",2.13e-19,"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (Fragment)","cell population proliferation [GO:0008283]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]","GO:0003081; GO:0003084; GO:0004180; GO:0005886; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0016021; GO:0060319"
"g161323",498.8208,1.849489,0.6378247,2.899683,0.003735401,0.04390129,559,1107,"sp|P80067|CATC_RAT","P80067","CATC",7.5e-13,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g155464",18.51308,0.4985698,0.1719454,2.899582,0.003736602,0.04390745,0,1264,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.19e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17707",131.3714,0.3365939,0.1160875,2.899484,0.003737779,0.04391331,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88104",457.8573,0.3648791,0.1258526,2.899257,0.003740486,0.04393715,0,4394,"sp|P53997|SET_DROME","P53997","SET",8.9e-21,"Protein SET","nucleosome assembly [GO:0006334]","GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393"
"g25830",294.0131,-0.2531206,0.08730893,-2.899138,0.003741902,0.04394581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77598",34.51079,1.639438,0.5655203,2.898991,0.003743661,0.0439585,0,3464,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",5.94e-22,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g89977",41.87862,0.8955523,0.308947,2.898724,0.003746842,0.04398788,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15652",1915.114,-0.3401548,0.1173618,-2.898342,0.003751409,0.04400559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23727",26.51205,-0.5610242,0.1935674,-2.89834,0.003751436,0.04400559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57566",462.5021,1.145274,0.3951458,2.898358,0.003751216,0.04400559,0,8344,"sp|P00765|TRYP_ASTAS","P00765","TRYP",1.55e-26,"Trypsin-1 (EC 3.4.21.4) (Trypsin I)","digestion [GO:0007586]","GO:0004252; GO:0005615; GO:0007586; GO:0046872"
"g68306",232.0221,-0.3118862,0.1076022,-2.898512,0.003749376,0.04400559,3872,11299,"sp|A9JTS5|STPAP_XENTR","A9JTS5","STPAP",2.1e-11,"Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52)","mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180]","GO:0003723; GO:0003730; GO:0004652; GO:0005524; GO:0005730; GO:0006378; GO:0016180; GO:0016607; GO:0016779; GO:0031123; GO:0046872; GO:0050265; GO:0098789; GO:1990817"
"g77809",20.08112,0.7966407,0.2748635,2.898314,0.003751746,0.04400559,5005,8171,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.92e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g79454",665.7147,1.733824,0.5982922,2.897955,0.003756041,0.044048,0,6827,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.13e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22733",81.71017,1.137179,0.3924221,2.897848,0.003757332,0.04405516,34156,37614,"sp|Q6PAY6|HYPDH_XENLA","Q6PAY6","HYPDH",1.26e-10,"Hydroxyproline dehydrogenase (HYPDH) (EC 1.5.5.3) (Probable proline dehydrogenase 2) (EC 1.5.5.2) (Probable proline oxidase 2)","proline catabolic process to glutamate [GO:0010133]","GO:0004657; GO:0010133; GO:0016645"
"g17511",2383.881,-0.2435778,0.0840872,-2.896729,0.003770752,0.04417521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26863",410.4603,0.4578409,0.158047,2.896865,0.00376912,0.04417521,25375,34156,"sp|P31696|AGRIN_CHICK","P31696","AGRIN",7.03e-10,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0016021; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978"
"g33527",193.3216,-0.3573183,0.123347,-2.896855,0.003769243,0.04417521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103771",213.1448,-0.2450778,0.08460323,-2.89679,0.003770022,0.04417521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104982",28.52488,0.6097772,0.2105068,2.89671,0.00377098,0.04417521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97892",62.11267,0.4355291,0.150362,2.896538,0.003773054,0.04419152,0,6739,"sp|Q4ZJI4|SL9B1_HUMAN","Q4ZJI4","SL9B1",7.14e-16,"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)","flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]","GO:0005886; GO:0007338; GO:0015385; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228"
"g72336",615.1871,0.378532,0.1306891,2.896432,0.003774323,0.0441984,7342,10417,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.2e-34,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g100722",944.3294,0.4123827,0.1423826,2.896301,0.003775906,0.04420095,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127388",146.2799,1.715036,0.5921398,2.896336,0.003775482,0.04420095,0,3075,"sp|Q99LB7|SARDH_MOUSE","Q99LB7","SARDH",1.02e-18,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053"
"g89255",222.9237,0.332854,0.1149269,2.896222,0.003776846,0.04420397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15349",448.9899,0.3514271,0.1213501,2.895976,0.003779812,0.04422197,0,14423,"sp|Q9H845|ACAD9_HUMAN","Q9H845","ACAD9",7.59e-30,"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)","long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991"
"g46187",38.28305,0.3910189,0.1350239,2.895925,0.003780431,0.04422197,13285,16075,"sp|O00370|LORF2_HUMAN","O00370","LORF2",7.82e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g95380",37.33393,-0.4437752,0.1532396,-2.895957,0.003780046,0.04422197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89096",180.2501,-0.4082425,0.1409949,-2.895441,0.003786258,0.04428214,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104804",29.03138,-0.3856283,0.1331921,-2.89528,0.003788209,0.04429695,0,4244,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.08e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85339",35.15417,-0.5899982,0.203792,-2.8951,0.003790378,0.04430633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125445",154.1839,0.4152555,0.143433,2.895117,0.003790171,0.04430633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124189",195.1419,0.8939822,0.3087979,2.895039,0.003791109,0.04430688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126984",41.40226,0.6611883,0.2284181,2.894641,0.003795923,0.04435513,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138677",99.31554,-0.6794673,0.2347408,-2.894543,0.00379711,0.04436101,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90982",21.74919,0.7027131,0.2428135,2.894044,0.003803144,0.04442071,0,7565,"sp|Q1LW01|HE12_DANRE","Q1LW01","HE12",7.11e-15,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188"
"g142066",169.405,0.7749061,0.2677661,2.893967,0.003804082,0.04442071,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156999",23.08497,0.515628,0.1781744,2.893951,0.003804277,0.04442071,0,1094,"sp|Q5U2W9|RNLS_RAT","Q5U2W9","RNLS",8.49e-07,"Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) (alpha-NAD(P)H oxidase/anomerase)","negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; response to catecholamine [GO:0071869]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]","GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0045776; GO:0051379; GO:0070404; GO:0071869; GO:0071871; GO:0097621; GO:1902074"
"g140393",27.67916,0.7328094,0.2532317,2.89383,0.003805745,0.04442985,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18392",3664.854,0.3304481,0.1142045,2.893476,0.00381003,0.04445584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69337",1036.178,-0.3701707,0.127931,-2.893518,0.003809528,0.04445584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101760",53.02979,1.955204,0.6757211,2.893508,0.003809644,0.04445584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26637",2180.78,-0.2338763,0.08084026,-2.893067,0.003814995,0.04450575,2498,33724,"sp|Q9VGI8|BLM_DROME","Q9VGI8","BLM",2.34e-17,"Bloom syndrome protein homolog (Dmblm) (EC 3.6.4.12) (Bloom syndrome helicase ortholog) (Mutagen-sensitive protein 309) (RecQ helicase homolog)","cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; reciprocal meiotic recombination [GO:0007131]; strand displacement [GO:0000732]","GO:0000403; GO:0000724; GO:0000731; GO:0000732; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007131; GO:0009378; GO:0016887; GO:0032508; GO:0043138; GO:0045003; GO:0046872; GO:1901291; GO:1990814; GO:1990918"
"g58687",49.17087,0.4865772,0.1681942,2.892949,0.003816428,0.04451446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122268",30.84801,0.7862415,0.2717859,2.892871,0.003817385,0.04451761,0,3274,"sp|P10394|POL4_DROME","P10394","POL4",6.99e-27,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g142226",34.16634,0.7989452,0.2761843,2.892798,0.003818272,0.04451993,0,2620,"sp|P79401|CP3AT_PIG","P79401","CP3AT",4.07e-15,"Cytochrome P450 3A29 (EC 1.14.14.1) (CYPIIIA29)","cellular response to type I interferon [GO:0071357]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989; GO:0071357"
"g120969",20.35302,0.4820962,0.1666609,2.892678,0.003819729,0.04452892,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68625",95.48621,2.785824,0.9631476,2.892417,0.003822902,0.04455789,3367,7754,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.6e-07,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g41331",1484.798,-0.2620518,0.09060605,-2.89221,0.003825416,0.04457115,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45052",18.08421,-0.4664272,0.1612686,-2.892238,0.003825076,0.04457115,0,2350,"sp|P04323|POL3_DROME","P04323","POL3",1.36e-54,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g13025",31.24487,0.3927416,0.1358011,2.892035,0.003827557,0.04458006,52620,59344,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.57e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g119886",640.8511,-1.165281,0.4029273,-2.892039,0.00382751,0.04458006,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30391",2564.336,-0.2974741,0.1028764,-2.891569,0.003833236,0.04463665,24456,33764,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.67e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g135877",25.82647,-0.7682397,0.2656868,-2.891523,0.003833793,0.04463665,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3350",34.3648,0.4343379,0.1502221,2.891306,0.003836449,0.04465637,135395,142226,"sp|Q5ZMA6|NADE_CHICK","Q5ZMA6","NADE",2.06e-14,"Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)","'de novo' NAD biosynthetic process [GO:0034627]; NAD biosynthetic process [GO:0009435]","GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0009435; GO:0034627"
"g93369",80.16962,0.3680951,0.1273125,2.891271,0.003836865,0.04465637,9,6922,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.7e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g101209",422537.4,0.5618012,0.1943283,2.890989,0.003840311,0.04468844,0,5870,"sp|P05661|MYSA_DROME","P05661","MYSA",1.83e-144,"Myosin heavy chain, muscle","adult somatic muscle development [GO:0007527]; border follicle cell migration [GO:0007298]; epithelial cell migration, open tracheal system [GO:0007427]; flight [GO:0060361]; locomotion [GO:0040011]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; muscle thin filament assembly [GO:0071689]; myofibril assembly [GO:0030239]; myosin filament organization [GO:0031033]; protein stabilization [GO:0050821]; regulation of myosin II filament assembly [GO:0043520]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]","GO:0000146; GO:0005516; GO:0005524; GO:0005703; GO:0005863; GO:0006936; GO:0007298; GO:0007427; GO:0007517; GO:0007527; GO:0008307; GO:0016459; GO:0030017; GO:0030239; GO:0030241; GO:0031033; GO:0031672; GO:0040011; GO:0042692; GO:0042803; GO:0043520; GO:0045214; GO:0050821; GO:0051015; GO:0060361; GO:0071689"
"g944",20.82471,0.7282525,0.2519118,2.890902,0.003841373,0.04469278,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3087",18.66395,0.5240861,0.1812958,2.890779,0.003842884,0.04469525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32046",511.8372,-0.264715,0.09157241,-2.890772,0.003842965,0.04469525,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27527",338.6156,-0.4104108,0.1419761,-2.890703,0.003843806,0.04469701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4195",77.62334,0.3594302,0.1243548,2.890362,0.003847987,0.04471633,1815,14560,"sp|Q6DGG0|PPID_RAT","Q6DGG0","PPID",2.4e-35,"Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D)","apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein-containing complex assembly [GO:0065003]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979]","GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006457; GO:0006915; GO:0006979; GO:0008134; GO:0015031; GO:0016018; GO:0019899; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0043066; GO:0045070; GO:0050714; GO:0051879; GO:0051881; GO:0061077; GO:0065003; GO:0071492"
"g7142",39.29865,0.5023706,0.1738135,2.890286,0.003848918,0.04471633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8489",692.5513,-0.2740847,0.09482932,-2.890295,0.0038488,0.04471633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73716",249.8333,0.3476605,0.1202826,2.890365,0.003847945,0.04471633,0,2724,"sp|Q14974|IMB1_HUMAN","Q14974","IMB1",1.82e-18,"Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)","astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404]","GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0010494; GO:0016020; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0042564; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0090307; GO:1904813"
"g112704",45.46802,0.4254176,0.1471787,2.890483,0.0038465,0.04471633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46418",73.73624,0.8038593,0.278166,2.889854,0.003854206,0.04476973,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111129",238.2776,0.3417042,0.1182506,2.889661,0.003856574,0.04478921,1475,5331,"sp|Q0MQI5|NDUV1_GORGO","Q0MQI5","NDUV1",1.61e-27,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005743; GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0010181; GO:0046872; GO:0051287; GO:0051539"
"g142922",43.34635,1.122099,0.3883335,2.889525,0.00385824,0.04480052,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44885",141.9977,-0.384381,0.1330349,-2.889325,0.003860704,0.04480248,0,12500,"sp|P21328|RTJK_DROME","P21328","RTJK",2.25e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68998",139.2564,0.3535897,0.1223739,2.889421,0.003859521,0.04480248,0,6137,"sp|P21328|RTJK_DROME","P21328","RTJK",1.85e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g73683",1750.527,0.2451692,0.08485169,2.889385,0.003859964,0.04480248,0,6399,"sp|A7RWP6|EIF3E_NEMVE","A7RWP6","EIF3E",4.7e-33,"Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6)","formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540"
"g80297",180.1375,0.5047834,0.1747087,2.889286,0.003861174,0.04480248,0,9073,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.7e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g59567",53.42573,-0.3213592,0.1112365,-2.888974,0.003865011,0.04483897,817,3634,"sp|Q8IYN0|ZN100_HUMAN","Q8IYN0","ZN100",8.91e-78,"Zinc finger protein 100","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g50087",79.48261,1.248368,0.432123,2.888917,0.003865712,0.04483907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34488",39.60744,-0.8145696,0.2819869,-2.888679,0.003868634,0.04485427,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54565",610.3732,0.3084199,0.1067699,2.888642,0.003869099,0.04485427,0,9174,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g74399",1412.456,-0.3467278,0.1200301,-2.888673,0.003868706,0.04485427,0,4663,"sp|O95835|LATS1_HUMAN","O95835","LATS1",2.14e-29,"Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)","cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]","GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:0106310; GO:1900181; GO:2000058"
"g119586",23.46742,-0.4361438,0.1509903,-2.888555,0.003870166,0.04485861,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18467",264.6023,0.1947325,0.0674283,2.887993,0.00387708,0.04492269,12242,16384,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.28e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g148232",7203.359,0.1937131,0.06707474,2.888019,0.003876769,0.04492269,0,308,"sp|P31009|RS2_DROME","P31009","RS2",9.82e-13,"40S ribosomal protein S2 (Protein strings of pearls)","cytoplasmic translation [GO:0002181]; oogenesis [GO:0048477]; translation [GO:0006412]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0006412; GO:0022626; GO:0022627; GO:0048477"
"g60444",363.8279,-0.2992282,0.1036156,-2.887868,0.003878624,0.0449245,9307,12984,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.08e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g159830",244.9147,0.3558219,0.1232126,2.887869,0.003878616,0.0449245,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12908",283.6063,-0.3743891,0.1296531,-2.887621,0.003881669,0.04493787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15227",449.9007,-0.4816014,0.1667772,-2.887694,0.003880769,0.04493787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47754",98.31333,0.311978,0.1080438,2.887514,0.003882989,0.04493787,0,4714,"sp|P54359|SEPT2_DROME","P54359","SEPT2",5.61e-19,"Septin-2","cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; regulation of cell cycle [GO:0051726]","GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042803; GO:0051726; GO:0060090; GO:0061640"
"g103114",25.83536,-0.3925355,0.135943,-2.8875,0.00388316,0.04493787,0,3394,"sp|P21328|RTJK_DROME","P21328","RTJK",1.12e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g114410",95.53067,-0.4486028,0.1553606,-2.887494,0.003883246,0.04493787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3107",3938.04,-0.2895324,0.1002754,-2.887372,0.00388475,0.04494188,58557,82814,"sp|Q9NTZ6|RBM12_HUMAN","Q9NTZ6","RBM12",7.83e-10,"RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus) (SWAN)","regulation of RNA splicing [GO:0043484]","GO:0003723; GO:0005654; GO:0043484; GO:1990904"
"g101177",16172.53,0.2661777,0.09218924,2.887297,0.003885673,0.04494188,2825,6210,"sp|P29691|EF2_CAEEL","P29691","EF2",5.23e-32,"Elongation factor 2 (EF-2)","defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0006414; GO:0010629; GO:0043022; GO:0050829; GO:1990904"
"g107911",18.50171,0.505397,0.1750393,2.887334,0.00388522,0.04494188,0,4624,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",6.06e-65,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g11301",325.282,0.6917759,0.2396218,2.886949,0.003889972,0.04498118,20475,27213,"sp|P09327|VILI_HUMAN","P09327","VILI",1.66e-08,"Villin-1","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]","GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0065003; GO:0070062; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394"
"g24260",456.3421,-0.2038659,0.07062097,-2.886762,0.003892289,0.04498118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34810",372.2119,-0.1806047,0.06256229,-2.886798,0.003891845,0.04498118,14275,19187,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.01e-43,"PiggyBac transposable element-derived protein 4",NA,NA
"g38897",99.91041,0.7169299,0.2483393,2.886897,0.00389062,0.04498118,8569,15194,"sp|P21328|RTJK_DROME","P21328","RTJK",4.77e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g41735",75.75612,1.161146,0.4022444,2.886669,0.003893433,0.04498118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65662",1386.268,-0.3156562,0.1093473,-2.88673,0.003892685,0.04498118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86973",1462.818,-0.3435237,0.1190051,-2.886629,0.00389393,0.04498118,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70693",51.07454,1.660961,0.5754187,2.886527,0.003895196,0.04498777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16310",95.66691,0.3647112,0.1263661,2.886148,0.003899888,0.04503218,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34892",23.17171,0.561541,0.1945671,2.886104,0.003900431,0.04503218,26743,29313,"sp|Q9VM51|MME1_DROME","Q9VM51","MME1",8.3e-07,"Mitochondrial magnesium exporter 1","cellular magnesium ion homeostasis [GO:0010961]; magnesium ion export from mitochondrion [GO:1990616]; magnesium ion transmembrane transport [GO:1903830]","GO:0010961; GO:0015095; GO:0016021; GO:0031966; GO:1903830; GO:1990616"
"g11300",297.3559,0.7286764,0.2525058,2.885781,0.003904437,0.04506868,13852,23131,"sp|Q27319|GELS_HOMAM","Q27319","GELS",9.47e-14,"Gelsolin, cytoplasmic (Actin-depolymerizing factor) (ADF)","actin filament capping [GO:0051693]","GO:0005737; GO:0005856; GO:0046872; GO:0051015; GO:0051693"
"g107204",73.03284,1.470389,0.5095368,2.885737,0.003904983,0.04506868,175,3899,"sp|P21328|RTJK_DROME","P21328","RTJK",2.16e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52546",59.72245,-0.4461132,0.1545975,-2.885643,0.003906147,0.04507408,13122,15034,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.24e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g18067",20.88148,-0.4565611,0.1582265,-2.885492,0.003908027,0.04507797,23240,31740,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.89e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g44291",29.88115,1.039474,0.3602443,2.885469,0.003908306,0.04507797,10812,19294,"sp|A7RX26|HUTI_NEMVE","A7RX26","HUTI",8.3e-23,"Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog)","histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]","GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480"
"g149280",910.7521,0.6001941,0.2080073,2.885448,0.003908571,0.04507797,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78675",32.47817,0.4046771,0.1402505,2.885388,0.003909312,0.0450785,0,2145,"sp|Q8BRK8|AAPK2_MOUSE","Q8BRK8","AAPK2",4.78e-13,"5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31)","autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of lipid metabolic process [GO:0019216]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]","GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014823; GO:0014850; GO:0016055; GO:0016241; GO:0016324; GO:0016607; GO:0019216; GO:0030424; GO:0030425; GO:0030674; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0032991; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:1903829; GO:1904428; GO:1905691; GO:1990044; GO:2000758"
"g126424",136.9301,0.3930559,0.1362281,2.885278,0.003910683,0.04508628,0,3694,"sp|P48765|NAC1_BOVIN","P48765","NAC1",1.84e-18,"Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)","calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of calcium ion transport [GO:0051924]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]","GO:0002026; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005886; GO:0005901; GO:0006814; GO:0006816; GO:0006874; GO:0007154; GO:0007204; GO:0016021; GO:0031226; GO:0035725; GO:0042383; GO:0051924; GO:0070588"
"g35279",1921.099,0.2518856,0.08731085,2.884929,0.003915014,0.04512819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28886",1400.151,-0.266837,0.09250178,-2.884669,0.003918259,0.04514952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91225",36.76909,0.599779,0.2079176,2.884696,0.00391792,0.04514952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61254",531.7908,-0.3290304,0.1140747,-2.884341,0.003922332,0.04518842,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5353",257.2713,-0.4190091,0.1452763,-2.884222,0.003923826,0.04519172,116793,122134,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.89e-07,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55249",51.90961,0.3503118,0.1214586,2.884207,0.003924013,0.04519172,0,9574,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.26e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g142955",18.87137,-0.9279764,0.3217787,-2.883896,0.003927883,0.04522825,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157142",37.42784,1.092716,0.3789407,2.883606,0.003931509,0.04526195,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105263",36.15649,-0.3486721,0.120919,-2.883519,0.003932589,0.04526634,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40858",701.3538,0.4375926,0.1517638,2.883379,0.003934332,0.04527836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7226",146.2285,0.4821377,0.1672411,2.882889,0.003940458,0.04532322,42336,59224,"sp|P24635|TBA_OCTVU","P24635","TBA",1.55e-28,"Tubulin alpha chain (Fragment)","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g53535",29.09715,0.3904432,0.135444,2.88269,0.003942947,0.04532322,6528,9080,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.47e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g59852",40.44535,-0.594221,0.2061259,-2.882807,0.003941493,0.04532322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84921",224.7844,-0.2962364,0.1027623,-2.882733,0.003942414,0.04532322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99807",74.52079,0.69536,0.241225,2.88262,0.003943826,0.04532322,0,6526,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.37e-07,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g123459",29.41118,0.6298582,0.2184797,2.882913,0.003940157,0.04532322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126979",43.23967,0.4905221,0.1701519,2.882849,0.003940965,0.04532322,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140757",38.82676,1.180933,0.4096676,2.882661,0.003943319,0.04532322,0,2191,"sp|Q7T2D1|RD10B_DANRE","Q7T2D1","RD10B",4.81e-06,"Retinol dehydrogenase 10-B (EC 1.1.1.300)","retinoic acid biosynthetic process [GO:0002138]","GO:0002138; GO:0005789; GO:0005811; GO:0016021; GO:0016616; GO:0052650"
"g158625",23.76836,0.548243,0.1901996,2.882461,0.003945816,0.04533805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g595",137.136,-0.2979828,0.103388,-2.882181,0.003949322,0.0453662,49015,53210,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.72e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g28804",162.2814,0.4073536,0.1413365,2.882154,0.003949667,0.0453662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94361",27.5873,0.8995775,0.3121504,2.881872,0.003953204,0.04539878,0,730,"sp|P48321|DCE2_PIG","P48321","DCE2",3.18e-06,"Glutamate decarboxylase 2 (EC 4.1.1.15) (65 kDa glutamic acid decarboxylase) (GAD-65) (Glutamate decarboxylase 65 kDa isoform)","carboxylic acid metabolic process [GO:0019752]; neurotransmitter biosynthetic process [GO:0042136]","GO:0000139; GO:0004351; GO:0005829; GO:0019752; GO:0030170; GO:0031410; GO:0042136; GO:0042734; GO:0042995"
"g65784",459.5218,-0.3338798,0.1158643,-2.881644,0.003956059,0.04542352,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26825",2562.857,-0.4454985,0.1546029,-2.881567,0.003957034,0.04542667,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109351",209.1787,0.3114494,0.1080878,2.881448,0.003958525,0.04543573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16595",630.9669,-0.3016126,0.1046913,-2.880971,0.003964526,0.04544822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20619",476.2596,-0.2638015,0.09156613,-2.880995,0.003964225,0.04544822,8069,10794,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.24e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g26262",69.13074,-0.3931928,0.1364773,-2.881013,0.003963991,0.04544822,14665,18485,"sp|P21328|RTJK_DROME","P21328","RTJK",4.84e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g33996",568.1163,-0.2491123,0.08646198,-2.881177,0.003961933,0.04544822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74532",611.5993,0.2779348,0.09646865,2.881089,0.003963037,0.04544822,0,7991,"sp|P57721|PCBP3_HUMAN","P57721","PCBP3",1.91e-29,"Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)","mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]","GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062"
"g78379",36.76923,0.3674499,0.1275351,2.881166,0.003962065,0.04544822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80174",384.249,0.3887025,0.1349233,2.880915,0.003965225,0.04544822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82082",927.5759,-0.2787073,0.09673568,-2.881122,0.003962625,0.04544822,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28586",403.1551,0.7896992,0.2741891,2.880126,0.003975158,0.04555402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129629",60.05248,-0.4084681,0.1418293,-2.879998,0.003976773,0.04556447,0,3659,"sp|P53405|ISL1_DANRE","P53405","ISL1",5.92e-23,"Insulin gene enhancer protein isl-1 (Islet-1)","atrial cardiac muscle cell differentiation [GO:0055011]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; endocrine pancreas development [GO:0031018]; exocrine pancreas development [GO:0031017]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; pancreatic A cell development [GO:0003322]; pancreatic D cell development [GO:0003324]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; type B pancreatic cell development [GO:0003323]","GO:0000981; GO:0000987; GO:0003322; GO:0003323; GO:0003324; GO:0005634; GO:0006357; GO:0007409; GO:0007507; GO:0008016; GO:0021522; GO:0021527; GO:0031017; GO:0031018; GO:0045944; GO:0046872; GO:0048665; GO:0048666; GO:0048675; GO:0048936; GO:0055011; GO:0060931; GO:0097154"
"g140106",179.3537,-0.3403944,0.1181967,-2.879898,0.003978041,0.04557093,120,2835,"sp|Q9W138|SAMTR_DROME","Q9W138","SAMTR",1.46e-24,"S-adenosylmethionine sensor upstream of mTORC1 (dSamtor) (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-)","methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]","GO:0008168; GO:0032259; GO:1904262"
"g9714",36.52321,0.4100987,0.1424133,2.879638,0.003981317,0.0456004,68345,84456,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.6e-27,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34996",1118.586,-0.3099417,0.1076434,-2.879339,0.003985098,0.04563564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26564",159.6144,0.3767742,0.1308585,2.879249,0.003986232,0.04563789,22466,32874,"sp|P21328|RTJK_DROME","P21328","RTJK",8.02e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g145852",127.1217,-0.3727742,0.1294709,-2.879212,0.003986703,0.04563789,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140586",19.74016,0.7513781,0.2609755,2.879114,0.003987943,0.04564402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20551",607.323,-0.411973,0.1430942,-2.879034,0.003988948,0.04564746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37152",76.32403,-0.3781197,0.1313403,-2.87893,0.003990268,0.0456545,14085,26037,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.14e-51,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g44584",618.7032,-0.2302882,0.07999398,-2.878819,0.003991677,0.0456584,0,16131,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.32e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g63705",55.73754,-0.3872549,0.13452,-2.878792,0.003992018,0.0456584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69567",731.2777,-0.3943206,0.1369897,-2.878468,0.003996117,0.04568915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81823",230.2522,0.293085,0.1018192,2.878483,0.003995927,0.04568915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91618",55.44852,0.9449214,0.328285,2.878357,0.003997529,0.04569723,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97269",84.4962,-0.3195228,0.1110168,-2.878149,0.004000166,0.04571931,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23469",12684.14,0.4161355,0.1445944,2.87795,0.004002689,0.04572769,16555,44290,"sp|A2V735|TPM_CHIOP","A2V735","TPM",1.75e-15,"Tropomyosin (Tropomyosin, slow-tonic isoform) (Tm-Chio-tonic)",NA,"GO:0042803"
"g124828",1169.923,0.9279401,0.3224258,2.877995,0.00400211,0.04572769,0,4004,"sp|P08171|EST6_DROME","P08171","EST6",9.56e-15,"Esterase-6 (Est-6) (EC 3.1.1.1) (Carboxylic-ester hydrolase 6) (Carboxylesterase-6)","courtship behavior [GO:0007619]; mating [GO:0007618]; multicellular organism reproduction [GO:0032504]; organic substance catabolic process [GO:1901575]; ovulation [GO:0030728]; pheromone biosynthetic process [GO:0042811]; regulation of female receptivity, post-mating [GO:0046008]; regulation of oviposition [GO:0046662]; sperm storage [GO:0046693]","GO:0005576; GO:0005615; GO:0007618; GO:0007619; GO:0017171; GO:0030728; GO:0032504; GO:0034338; GO:0042811; GO:0046008; GO:0046662; GO:0046693; GO:0052689; GO:0080030; GO:1901575"
"g148880",30.36838,-0.9563,0.3322881,-2.877924,0.004003016,0.04572769,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76725",139.4764,0.3364382,0.1169136,2.877665,0.0040063,0.04575713,0,5382,"sp|P54279|PMS2_MOUSE","P54279","PMS2",2.26e-76,"Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]","GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006298; GO:0006974; GO:0016446; GO:0016447; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0048298; GO:0048304; GO:0051321"
"g26320",3344.273,0.2806253,0.09752523,2.877464,0.004008862,0.04577832,0,8164,"sp|Q17Q06|EIF3C_AEDAE","Q17Q06","EIF3C",1.07e-31,"Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003743; GO:0005852; GO:0016282; GO:0031369; GO:0033290"
"g25861",1745.133,0.3471602,0.1206631,2.877104,0.004013438,0.0458225,31195,34840,"sp|Q0P5L8|KBL_BOVIN","Q0P5L8","KBL",1.49e-13,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)","biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518]","GO:0005634; GO:0005739; GO:0008890; GO:0009058; GO:0019518; GO:0030170"
"g48124",26.37801,-0.4737772,0.1646816,-2.87693,0.004015652,0.04583971,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114785",5066.858,0.5781712,0.2009833,2.876712,0.004018423,0.04586325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98113",68.1668,-0.5029518,0.174856,-2.876378,0.004022681,0.04590376,0,2224,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.65e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g38899",27.89594,0.7151506,0.2486448,2.876194,0.004025029,0.04592247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12601",48.22587,-0.3336834,0.1160219,-2.876038,0.004027007,0.04592886,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15413",160.5548,-0.2788175,0.09694359,-2.87608,0.004026477,0.04592886,47084,51764,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.27e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g14185",1435.921,-0.3797945,0.1320727,-2.875647,0.004032001,0.04594539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27348",60.92538,-0.5215656,0.1813688,-2.875718,0.004031097,0.04594539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31690",96.46404,0.9269706,0.3223324,2.875823,0.004029762,0.04594539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31755",478.9316,0.4491929,0.156205,2.875662,0.004031811,0.04594539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126545",914.4318,0.3002966,0.1044219,2.875802,0.004030025,0.04594539,0,3908,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.16e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g154078",122.4656,-0.2747897,0.09556439,-2.87544,0.004034645,0.04596743,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37897",93.91117,-0.6299686,0.2191166,-2.875039,0.004039776,0.0460097,0,26330,"sp|O60658|PDE8A_HUMAN","O60658","PDE8A",6.8e-27,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.53)","cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]","GO:0001934; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0006355; GO:0007165; GO:0019900; GO:0046872; GO:0047555; GO:0060548; GO:0070062; GO:0070374; GO:0071364; GO:1903206"
"g88067",23.36123,-0.9780121,0.3401719,-2.875052,0.004039605,0.0460097,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21922",105.4201,-0.2664628,0.09268522,-2.874923,0.004041267,0.04601388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98721",29.97959,0.3832884,0.1333224,2.874899,0.004041563,0.04601388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7154",1364.845,-0.2420789,0.08420746,-2.874792,0.004042942,0.04601767,18715,22930,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.91e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g79572",372.8097,2.026359,0.7048788,2.874762,0.004043316,0.04601767,1165,9193,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",7.47e-25,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g16778",250.7568,0.8254481,0.2871835,2.874288,0.004049399,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17756",2393.811,0.6770529,0.2355346,2.874537,0.004046197,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38670",697.45,-0.5222364,0.1816804,-2.874479,0.00404695,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46192",50.90182,0.4228803,0.1471219,2.874353,0.004048561,0.04603381,0,5934,"sp|P08548|LIN1_NYCCO","P08548","LIN1",2.1e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g58955",23.03403,1.655651,0.5759662,2.874562,0.004045877,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66310",180.817,0.3400886,0.1183275,2.874129,0.004051431,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70476",3263.468,-0.3230763,0.1124029,-2.874269,0.004049639,0.04603381,5694,9784,"sp|P21328|RTJK_DROME","P21328","RTJK",9.04e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g70622",20.13609,0.4555592,0.1585051,2.874097,0.004051839,0.04603381,0,694,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.19e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g76030",860.8792,0.2544065,0.08851436,2.874184,0.004050733,0.04603381,0,7581,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.75e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g157064",16894.9,0.9829447,0.3419899,2.874192,0.004050628,0.04603381,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3294",134.1651,0.269061,0.09362019,2.873964,0.004053555,0.04604523,98405,114995,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.05e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g13055",236.2458,-0.2668247,0.09284678,-2.873818,0.004055428,0.04605843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8565",96.79775,0.2948766,0.1026126,2.873687,0.004057109,0.04606944,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88267",18.27832,-0.4817423,0.1676461,-2.873567,0.004058652,0.04607889,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109939",25.61019,-0.4308181,0.1499283,-2.873493,0.004059599,0.04608157,0,1974,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",5.88e-13,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g135242",838.3724,-0.2780227,0.09676071,-2.873302,0.004062061,0.04610144,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126927",204.2216,0.7968936,0.2773665,2.873071,0.004065028,0.04612704,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17246",118.6693,0.3725964,0.1296969,2.872826,0.004068186,0.04614511,53645,57992,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.61e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g21025",26.72299,-0.482794,0.1680575,-2.872791,0.004068635,0.04614511,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92933",48.88007,-0.35032,0.1219445,-2.872781,0.004068758,0.04614511,0,3454,"sp|P21328|RTJK_DROME","P21328","RTJK",1.25e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g102849",1413.001,-0.2737965,0.09531157,-2.872647,0.004070489,0.04615667,0,6146,"sp|O00370|LORF2_HUMAN","O00370","LORF2",4.14e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g149919",55.69934,-0.5868475,0.2043093,-2.872348,0.004074342,0.04619228,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9607",561.7847,-0.2111399,0.07351015,-2.872254,0.004075548,0.04619786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99820",125.644,0.476588,0.1659316,2.872195,0.004076311,0.04619843,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29056",28.87586,0.4451925,0.1550058,2.872103,0.004077507,0.0462039,15147,16214,"sp|Q6P4Y0|CDKAL_XENTR","Q6P4Y0","CDKAL",6.34e-10,"Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)","tRNA methylthiolation [GO:0035600]","GO:0005783; GO:0005789; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712"
"g42341",80.0761,0.4650854,0.1619539,2.871715,0.004082505,0.04625245,15115,18540,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.37e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g22977",1057.079,-0.3564304,0.1241234,-2.871581,0.004084241,0.04625891,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117910",41.81433,-0.3480093,0.1211917,-2.871561,0.004084503,0.04625891,0,4681,"sp|Q8BRH0|TMTC3_MOUSE","Q8BRH0","TMTC3",1.22e-16,"Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 3)","bud outgrowth involved in lung branching [GO:0060447]; cell differentiation [GO:0030154]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; muscle cell development [GO:0055001]; positive regulation of proteasomal protein catabolic process [GO:1901800]; post-embryonic development [GO:0009791]; protein O-linked mannosylation [GO:0035269]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000030; GO:0004169; GO:0005783; GO:0009791; GO:0010468; GO:0016021; GO:0030154; GO:0030324; GO:0034976; GO:0035269; GO:0048286; GO:0055001; GO:0060447; GO:1901800"
"g70866",1061.287,-0.3522675,0.1226964,-2.87105,0.004091103,0.04632556,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142852",315.6951,0.2914556,0.1015205,2.870905,0.004092983,0.04633875,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83262",236.6679,0.5165026,0.1799214,2.870712,0.004095486,0.04635899,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118622",4381.868,-0.3633626,0.1265939,-2.8703,0.004100825,0.04641131,0,4613,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.52e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g9785",205.4146,0.3762402,0.1310858,2.870184,0.004102336,0.04642031,38914,63954,"sp|Q9GKK4|GALK1_CANLF","Q9GKK4","GALK1",3.07e-13,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0019402; GO:0061623"
"g119191",66.45743,-0.5013572,0.1746856,-2.870055,0.004104,0.04643102,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5047",1313.445,0.2646675,0.09222039,2.869945,0.00410543,0.0464391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130927",53.47782,0.8462693,0.2948884,2.869795,0.004107374,0.04645298,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98311",90.47539,0.4644705,0.1618576,2.869625,0.004109587,0.04646989,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22578",256.3209,0.9659652,0.3366394,2.869436,0.004112043,0.04648955,17786,22314,"sp|Q4G0S4|C27C1_HUMAN","Q4G0S4","C27C1",3.47e-10,"Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase)","retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]","GO:0001972; GO:0004497; GO:0005502; GO:0005503; GO:0005506; GO:0005739; GO:0020037; GO:0031966; GO:0042572; GO:0042573; GO:0042574; GO:0043231; GO:0061896; GO:0061897; GO:0061898; GO:0061899; GO:1904768"
"g36142",805.5172,0.4075425,0.1420321,2.869369,0.004112921,0.04649136,284,1482,"sp|P49055|ACTS_CARAU","P49055","ACTS",0,"Actin, alpha skeletal muscle (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form]",NA,"GO:0005524; GO:0005737; GO:0005856"
"g40076",35.66317,0.9481032,0.3304436,2.869183,0.004115336,0.04651054,0,21574,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.31e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29575",111.7214,0.422928,0.1474129,2.869001,0.004117699,0.04652913,1181,12314,"sp|Q10570|CPSF1_HUMAN","Q10570","CPSF1",7.51e-16,"Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit)","mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]","GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0019899; GO:0035925; GO:0098789"
"g43953",613.8059,0.2679419,0.09340317,2.86866,0.004122147,0.04656315,6145,16385,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.6e-18,"PiggyBac transposable element-derived protein 4",NA,NA
"g155139",367.9596,0.4082006,0.142295,2.868693,0.004121722,0.04656315,0,1544,"sp|O73672|PSA2_CARAU","O73672","PSA2",8.25e-13,"Proteasome subunit alpha type-2","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005737; GO:0005839; GO:0006511; GO:0019773"
"g1818",1822.59,-0.2183383,0.07612692,-2.868082,0.004129681,0.04663368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16768",1327.191,-0.4473888,0.1559895,-2.86807,0.004129839,0.04663368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67857",498.7062,-0.2471201,0.08616412,-2.868016,0.004130549,0.04663368,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37876",110.3867,0.2478825,0.0864394,2.867702,0.004134643,0.04667177,6526,20354,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.7e-57,"PiggyBac transposable element-derived protein 4",NA,NA
"g57170",27.23079,-0.4129508,0.1440059,-2.867597,0.004136019,0.04667917,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27005",27.95441,1.259562,0.439249,2.867536,0.004136812,0.04667998,18615,20554,"sp|P40939|ECHA_HUMAN","P40939","ECHA",8.49e-154,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403"
"g29672",46.13635,0.8927103,0.3113256,2.867449,0.004137949,0.04668468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87236",55.58363,-0.4751631,0.1657372,-2.866968,0.004144253,0.04674767,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16981",1888.335,-0.4376628,0.1526629,-2.866857,0.004145707,0.04674779,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17917",911.2496,0.7537577,0.2629192,2.866879,0.00414541,0.04674779,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60225",2000.809,0.3115876,0.1086907,2.866736,0.004147284,0.04675743,0,10561,"sp|Q01484|ANK2_HUMAN","Q01484","ANK2",7.33e-38,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"g33457",1062.555,0.8654334,0.3019309,2.866329,0.00415262,0.04680945,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13547",43.46308,0.354931,0.1238416,2.866009,0.004156822,0.04683237,61841,68501,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.47e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g118119",24.29286,-0.6026698,0.210275,-2.866103,0.004155595,0.04683237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158932",234.6493,0.3091583,0.1078695,2.86604,0.004156419,0.04683237,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12195",307.3642,-0.4324987,0.1509178,-2.865789,0.00415971,0.04684862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147732",41.98548,0.3664317,0.1278629,2.865817,0.00415934,0.04684862,0,1359,"sp|Q5F3N1|PIMT_CHICK","Q5F3N1","PIMT",2.73e-10,"Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)","protein methylation [GO:0006479]","GO:0004719; GO:0005737; GO:0005829; GO:0006479"
"g123822",51.71739,-0.7931139,0.2767601,-2.865708,0.004160772,0.04685244,0,3494,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.01e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g156083",70.35847,0.484594,0.1691568,2.864762,0.004173233,0.04698459,0,1304,"sp|O75923|DYSF_HUMAN","O75923","DYSF",7.22e-12,"Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)","macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]","GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006906; GO:0007009; GO:0016021; GO:0030139; GO:0030315; GO:0030659; GO:0031410; GO:0033292; GO:0034451; GO:0042383; GO:0050765; GO:0061025; GO:0070062"
"g39711",694.6011,-0.3246604,0.113334,-2.864634,0.004174909,0.04699528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28880",765.2182,-0.3792074,0.1323859,-2.864409,0.004177888,0.04702065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55668",146.1684,0.3087662,0.1077999,2.864252,0.004179951,0.0470357,2086,14916,"sp|Q91W96|APC4_MOUSE","Q91W96","APC4",1.27e-64,"Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]","GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979"
"g29682",392.8948,-0.4339957,0.1515298,-2.864094,0.00418204,0.04704306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48703",3351.187,-0.288236,0.1006378,-2.864093,0.004182057,0.04704306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4285",214.3898,-0.5137082,0.17938,-2.863798,0.004185944,0.04705411,129035,134483,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.67e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g4989",105.6437,-0.4106611,0.1433971,-2.863804,0.004185867,0.04705411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48653",81.47506,-0.3556823,0.1241961,-2.863875,0.004184925,0.04705411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147698",65.69227,0.2857525,0.09977605,2.863939,0.004184089,0.04705411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37783",1920.116,-0.2814672,0.09828721,-2.863721,0.004186964,0.04705459,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105842",43.41732,0.4236871,0.1479517,2.863685,0.004187439,0.04705459,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5290",772.7293,-0.3556505,0.1241982,-2.863571,0.004188951,0.04706341,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55245",21.39862,-0.4705831,0.1643658,-2.863023,0.004196202,0.04712828,0,4769,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.04e-36,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g123526",293.6169,-0.311877,0.1089348,-2.86297,0.004196907,0.04712828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160384",82.37155,-0.6103448,0.2131786,-2.863068,0.004195606,0.04712828,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42769",77.20593,0.350073,0.1222912,2.862619,0.004201556,0.04716655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104022",57.49902,-0.4475303,0.1563368,-2.862603,0.004201771,0.04716655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18105",348.5453,-0.3533201,0.1234309,-2.862494,0.004203208,0.04717254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48146",860.8443,1.716881,0.5997938,2.862453,0.00420376,0.04717254,15250,18064,"sp|P55115|NAS15_CAEEL","P55115","NAS15",1.27e-13,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)",NA,"GO:0004222; GO:0005576; GO:0008270"
"g97510",146.4073,-0.7693476,0.2687845,-2.862321,0.004205502,0.04718391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32908",801.5492,-0.3897081,0.1361539,-2.862263,0.00420628,0.04718447,0,19481,"sp|Q9CXP4|RHG08_MOUSE","Q9CXP4","RHG08",2.56e-23,"Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)","positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165]","GO:0005096; GO:0007165; GO:0070374"
"g41607",104.6986,0.9693792,0.338694,2.862109,0.004208321,0.0471992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141689",60.56736,0.9098958,0.3179223,2.862007,0.004209677,0.04720623,0,2711,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",3.91e-20,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g40230",55.19874,0.471094,0.1646261,2.8616,0.00421509,0.04725637,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62561",150.767,0.5521072,0.1929429,2.861506,0.004216336,0.04725637,1996,12661,"sp|Q9W3C7|PPT1_DROME","Q9W3C7","PPT1",7.67e-15,"Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)","determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; macromolecule depalmitoylation [GO:0098734]; neuron fate specification [GO:0048665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein depalmitoylation [GO:0002084]; receptor-mediated endocytosis [GO:0006898]; regulation of axon guidance [GO:1902667]","GO:0002084; GO:0005764; GO:0006897; GO:0006898; GO:0008340; GO:0008474; GO:0016790; GO:0017171; GO:0043231; GO:0048665; GO:0098599; GO:0098734; GO:1900244; GO:1902667"
"g106468",13941.05,0.4538694,0.1586099,2.861545,0.004215817,0.04725637,4075,5800,"sp|Q9I7U4|TITIN_DROME","Q9I7U4","TITIN",9.78e-95,"Titin (D-Titin) (Kettin)","cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]","GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301"
"g127427",2467.283,0.2036915,0.07118684,2.861364,0.004218227,0.04726939,0,3436,"sp|G5ECU1|SKR1_CAEEL","G5ECU1","SKR1",1.31e-35,"Skp1-related protein","female sex differentiation [GO:0046660]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005737; GO:0006511; GO:0007399; GO:0010629; GO:0010826; GO:0019005; GO:0031146; GO:0031647; GO:0043065; GO:0043518; GO:0046660; GO:0090128; GO:0097602; GO:1902230"
"g20889",121.2928,-0.4750234,0.1660204,-2.861235,0.004219938,0.04728038,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10301",698.0194,-0.2383971,0.08333012,-2.860876,0.004224722,0.04730442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23795",618.2742,-0.3234799,0.113071,-2.860857,0.004224978,0.04730442,9865,37250,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",8.12e-28,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g34089",242.1802,0.2640533,0.09229874,2.860855,0.004225004,0.04730442,25866,30024,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.98e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g109479",1255.569,-0.293457,0.1025766,-2.860857,0.004224972,0.04730442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4295",30.11552,0.6075383,0.2123699,2.860755,0.004226337,0.04731117,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88527",95.92444,0.3889538,0.1359713,2.860558,0.004228957,0.04731597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118831",1375.11,-0.4628122,0.1617902,-2.86057,0.004228799,0.04731597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147524",77.92611,0.3887338,0.1358923,2.860601,0.004228383,0.04731597,0,2204,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.4e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g276",242.6865,0.3202664,0.1119707,2.860271,0.004232793,0.04734856,86406,93514,"sp|E9PVA8|GCN1_MOUSE","E9PVA8","GCN1",7.2e-40,"eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0005829; GO:0005844; GO:0006417; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:1990253"
"g45478",45.46422,0.7071679,0.2472416,2.860231,0.004233331,0.04734856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58042",68.83138,0.6058532,0.2118266,2.860137,0.004234578,0.04735034,9576,14074,"sp|Q96RW7|HMCN1_HUMAN","Q96RW7","HMCN1",2.43e-10,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"g67016",510.1335,-0.3190423,0.111549,-2.860109,0.004234952,0.04735034,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13222",150.1549,0.4334259,0.1515569,2.859823,0.004238776,0.04738355,0,10176,"sp|Q86WA9|S2611_HUMAN","Q86WA9","S2611",1.46e-12,"Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11)","ion transport [GO:0006811]; sulfate transport [GO:0008272]","GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062"
"g56964",95.29056,-0.3877329,0.1355815,-2.859777,0.004239385,0.04738355,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67948",32.57134,0.7190128,0.2514468,2.859503,0.004243056,0.04741641,0,11384,"sp|P10090|WHITE_DROME","P10090","WHITE",3.41e-12,"Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white)","aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906]","GO:0005275; GO:0005524; GO:0005886; GO:0006727; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090740; GO:0098793; GO:1905948"
"g74342",587.0415,-0.2550968,0.08921544,-2.859334,0.004245315,0.04743347,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g996",187.4488,0.2849767,0.09967038,2.859191,0.004247226,0.04744664,4605,36133,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.18e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29239",3473.323,-0.3842923,0.1344115,-2.859073,0.004248805,0.04745472,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32583",397.2655,-0.2976829,0.1041223,-2.858973,0.004250147,0.04745472,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86027",174.6769,0.3363537,0.1176478,2.858988,0.00424995,0.04745472,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1578",19.06223,-0.5859185,0.2049584,-2.85872,0.004253541,0.04747481,100906,104284,"sp|Q03720|SLO_DROME","Q03720","SLO",1.93e-08,"Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK)","circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to xenobiotic stimulus [GO:0009410]","GO:0005244; GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0009410; GO:0015269; GO:0016020; GO:0016021; GO:0034765; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074"
"g67401",43.45084,0.3831525,0.1340321,2.858663,0.004254309,0.04747481,5518,11505,"sp|Q7PRB5|OPI10_ANOGA","Q7PRB5","OPI10",2.79e-11,"Protein OPI10 homolog","protein import into nucleus [GO:0006606]","GO:0005634; GO:0005829; GO:0006606; GO:0030544; GO:0061608"
"g74316",946.2796,-0.1125724,0.03937907,-2.858685,0.004254011,0.04747481,5660,9874,"sp|P16423|POLR_DROME","P16423","POLR",1.87e-06,"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]",NA,"GO:0003964; GO:0004190; GO:0004519; GO:0046872"
"g111840",79.73101,0.3435536,0.1201816,2.85862,0.004254877,0.04747481,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93207",27.04358,-0.3966619,0.1387711,-2.85839,0.004257964,0.04748472,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99174",252.3404,-0.5012228,0.1753504,-2.858407,0.004257734,0.04748472,0,6416,"sp|Q96SE7|ZN347_HUMAN","Q96SE7","ZN347",2.4e-62,"Zinc finger protein 347 (Zinc finger protein 1111)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g117875",65.41878,0.6087673,0.2129734,2.858419,0.004257578,0.04748472,0,4574,"sp|E2RK30|PKHD1_CANLF","E2RK30","PKHD1",3.74e-06,"Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin)","branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell junction organization [GO:0045216]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of epithelial cell apoptotic process [GO:1904036]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of establishment of planar polarity [GO:0090175]","GO:0000132; GO:0000775; GO:0001952; GO:0003382; GO:0005634; GO:0005783; GO:0005794; GO:0005819; GO:0005929; GO:0010824; GO:0016021; GO:0016324; GO:0022407; GO:0030155; GO:0045216; GO:0048754; GO:0050679; GO:0051660; GO:0070062; GO:0090175; GO:1904036; GO:1904054"
"g10890",743.3135,-0.2501997,0.0875373,-2.858207,0.004260425,0.04750328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53200",1612.029,0.3022023,0.1057333,2.858157,0.004261094,0.04750328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128927",352.3529,1.488482,0.5207958,2.858091,0.004261975,0.04750493,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79833",367.3523,0.5365197,0.1877393,2.857791,0.004266009,0.04753429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161453",17.48876,1.252467,0.4382648,2.857786,0.004266077,0.04753429,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131796",53.2089,0.6251549,0.2187602,2.857718,0.004266989,0.04753628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9133",1118.096,-0.2011693,0.07039715,-2.857635,0.004268115,0.04754065,2315,24396,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.08e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g108775",129.6063,0.2556209,0.08945643,2.85749,0.004270058,0.04755412,0,3914,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.98e-35,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g58079",41.85647,0.4213329,0.1474555,2.857356,0.004271865,0.04755521,0,8310,"sp|O75600|KBL_HUMAN","O75600","KBL",5.23e-07,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)","biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; L-threonine catabolic process to glycine [GO:0019518]","GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006520; GO:0008890; GO:0009058; GO:0016607; GO:0019518; GO:0030170"
"g107335",3235.701,-0.5754094,0.2013808,-2.857319,0.004272358,0.04755521,3282,5715,"sp|Q9BYV7|BCDO2_HUMAN","Q9BYV7","BCDO2",2.33e-11,"Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2)","carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826]","GO:0003834; GO:0005739; GO:0005759; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377"
"g118462",375.6104,0.8575019,0.3001066,2.857325,0.004272288,0.04755521,385,4627,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",9.81e-32,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g108887",37.80608,-0.3054979,0.1069242,-2.857143,0.004274731,0.04757346,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7877",3768.32,-0.4577187,0.1602153,-2.856897,0.004278045,0.04758581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17290",45.39168,0.6105838,0.2137223,2.856903,0.004277971,0.04758581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29717",1133.458,-0.3383883,0.1184458,-2.856904,0.004277948,0.04758581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28296",1951.077,-0.3625163,0.1268997,-2.856714,0.004280509,0.04759845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88955",21.226,-0.5111666,0.1789392,-2.856649,0.004281385,0.04759845,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91939",278.7467,0.3160876,0.1106488,2.856674,0.004281055,0.04759845,0,7453,"sp|Q93353|IDH3B_CAEEL","Q93353","IDH3B",1.29e-21,"Probable isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)","isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004449; GO:0005739; GO:0006099; GO:0006102; GO:0051287"
"g53114",51.139,0.3667358,0.1283905,2.856409,0.004284624,0.04762629,14746,15824,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.71e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g37751",113.4592,-0.3150505,0.1103019,-2.856255,0.004286701,0.04763303,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68980",746.7118,-0.2231082,0.07811213,-2.856256,0.004286691,0.04763303,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138691",296.1185,1.105031,0.3869452,2.855783,0.004293091,0.04769585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128181",292.9466,0.7487715,0.2622016,2.855709,0.004294079,0.04769865,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22846",66.45986,-0.3538874,0.1239415,-2.855278,0.004299917,0.04774686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97411",18.14849,0.6524746,0.2285163,2.855266,0.004300085,0.04774686,666,6714,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.89e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g124266",596.9902,0.4136554,0.1448766,2.855225,0.004300629,0.04774686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129444",103.5307,0.3903828,0.1367306,2.855125,0.004301993,0.04775382,0,3673,"sp|Q45FY6|HPRT_PIG","Q45FY6","HPRT",3.04e-22,"Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)","GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]","GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0006164; GO:0006166; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657"
"g33004",2634.265,0.235436,0.08247001,2.854807,0.004306302,0.04779346,0,25844,"sp|P23403|RS20_XENLA","P23403","RS20",6.43e-42,"40S ribosomal protein S20 (S22)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005737; GO:0006412; GO:0015935"
"g52260",52.11837,0.7609051,0.2665481,2.854664,0.004308244,0.04779441,0,13820,"sp|Q9SF85|ADK1_ARATH","Q9SF85","ADK1",1.28e-17,"Adenosine kinase 1 (AK 1) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase 1)","adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to trehalose-6-phosphate [GO:0080094]","GO:0004001; GO:0005507; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006169; GO:0009506; GO:0044209; GO:0048046; GO:0080094"
"g58516",31.42831,0.704949,0.2469487,2.854637,0.0043086,0.04779441,0,6185,"sp|Q9JJ66|CDC20_MOUSE","Q9JJ66","CDC20",2.56e-12,"Cell division cycle protein 20 homolog (mmCdc20) (p55CDC)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0007094; GO:0007399; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0030154; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"g66161",43.24826,-0.6147476,0.2153428,-2.854739,0.004307221,0.04779441,3855,8140,"sp|P0CT40|TF29_SCHPO","P0CT40","TF29",1.52e-40,"Transposon Tf2-9 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005737; GO:0006310; GO:0015074; GO:0046872"
"g8347",791.8866,0.4634517,0.1623657,2.854369,0.004312235,0.04782654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2451",232.2649,-0.3794463,0.1329422,-2.85422,0.004314265,0.04784086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10954",432.0362,-0.3117425,0.1092237,-2.854165,0.004315009,0.04784093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46580",20.87492,-0.4848809,0.1698938,-2.854024,0.004316924,0.04785397,11005,13529,"sp|P21328|RTJK_DROME","P21328","RTJK",8.54e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g29486",2774.528,-0.344178,0.1205979,-2.853931,0.004318187,0.04785979,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14473",198.5139,0.2795114,0.09794463,2.853769,0.004320389,0.047876,39196,65451,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.85e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g3522",129.3784,0.404459,0.1417368,2.853593,0.004322793,0.0478805,637,29480,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.41e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g94172",449.0132,0.8116824,0.2844419,2.853597,0.004322736,0.0478805,18,6874,"sp|Q29504|UBA1_RABIT","Q29504","UBA1",1.12e-106,"Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1)",NA,"GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739"
"g106493",195.2256,0.2768391,0.09701478,2.853576,0.004323012,0.0478805,0,4294,"sp|Q9UNS1|TIM_HUMAN","Q9UNS1","TIM",0,"Protein timeless homolog (hTIM)","branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]","GO:0000076; GO:0000122; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0009582; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781"
"g88408",280.1246,0.40245,0.1410364,2.853519,0.004323789,0.04788092,3303,7465,"sp|Q8AY73|XPO2_ORENI","Q8AY73","XPO2",3.51e-130,"Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)","intracellular protein transport [GO:0006886]","GO:0005634; GO:0005737; GO:0006886; GO:0031267"
"g1848",547.4537,-0.2569523,0.09006077,-2.853099,0.004329511,0.0479279,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13422",1886.36,0.2993231,0.1049112,2.853108,0.004329389,0.0479279,21165,30500,"sp|P35129|UBC2_CAEEL","P35129","UBC2",2.96e-32,"Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2)","programmed cell death involved in cell development [GO:0010623]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006511; GO:0010623; GO:0016567; GO:0031625; GO:0061631"
"g6102",133.7515,0.3218985,0.1128329,2.852878,0.004332528,0.04794491,98725,102312,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.1e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g92139",37.02419,0.4549557,0.15947,2.852923,0.004331912,0.04794491,1931,6564,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",6.04e-13,"PiggyBac transposable element-derived protein 4",NA,NA
"g27029",40.19053,1.293224,0.4533954,2.852309,0.004340283,0.04799079,22861,28014,"sp|P40939|ECHA_HUMAN","P40939","ECHA",1.9e-143,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]","cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403"
"g40114",118.1913,0.4350018,0.1524983,2.852502,0.004337653,0.04799079,13791,22564,"sp|Q0V8R6|HEXA_BOVIN","Q0V8R6","HEXA",1.03e-13,"Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)","adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]","GO:0001501; GO:0004563; GO:0005764; GO:0005975; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0048667; GO:0050884; GO:0050885; GO:0060395; GO:0102148"
"g49929",20.39939,0.5211505,0.1827114,2.852315,0.004340204,0.04799079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92252",27.61647,-0.4267335,0.149613,-2.852248,0.004341117,0.04799079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95753",3731.613,-0.3641636,0.1276754,-2.852263,0.004340922,0.04799079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111970",17.74426,1.182894,0.4147052,2.852373,0.004339411,0.04799079,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33735",293.7427,-0.3151174,0.1104861,-2.852101,0.004343137,0.04799678,11103,23344,"sp|P34457|YMD3_CAEEL","P34457","YMD3",3.41e-21,"Putative uncharacterized transposon-derived protein F54H12.3","DNA integration [GO:0015074]","GO:0003676; GO:0015074"
"g65769",27.63234,0.5016158,0.175876,2.8521,0.004343141,0.04799678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34082",1237.174,0.4911272,0.1722194,2.851753,0.004347885,0.04800827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39654",320.5467,-0.236731,0.0830097,-2.851848,0.004346592,0.04800827,1562,4384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.11e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g51148",41.29152,-0.3938653,0.1381132,-2.851757,0.004347827,0.04800827,7765,12580,"sp|Q6ZNA1|ZN836_HUMAN","Q6ZNA1","ZN836",3.22e-65,"Zinc finger protein 836","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g57290",90.28642,-0.2462662,0.08635431,-2.851811,0.00434709,0.04800827,1556,9184,"sp|P21330|GAGJ_DROME","P21330","GAGJ",2.24e-07,"Nucleic-acid-binding protein from mobile element jockey (ORF1)",NA,"GO:0046872"
"g114067",420.6042,-0.4748111,0.1664855,-2.851967,0.004344965,0.04800827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82886",934.8028,-0.469836,0.1647573,-2.851686,0.004348809,0.04801029,0,5381,"sp|P28191|PTP1_CAEEL","P28191","PTP1",5e-21,"Tyrosine-protein phosphatase 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1)",NA,"GO:0004725; GO:0005856; GO:0008092; GO:0016529"
"g928",156.4651,-0.2744903,0.09626728,-2.851335,0.004353602,0.04804735,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53489",862.6061,-0.3729629,0.130803,-2.851332,0.004353649,0.04804735,4877,8054,"sp|P50579|MAP2_HUMAN","P50579","MAP2",3.2e-17,"Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]","GO:0003723; GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084"
"g83321",20.4118,0.9937039,0.3485464,2.850995,0.004358265,0.04808191,0,8234,"sp|P10394|POL4_DROME","P10394","POL4",2.31e-38,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g116613",52.73185,0.3552824,0.1246155,2.851029,0.004357794,0.04808191,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88697",70.00885,0.3125202,0.1096223,2.850882,0.004359817,0.0480908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110814",35.96999,1.806987,0.6338465,2.850828,0.004360555,0.0480908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54637",1719.713,0.5330964,0.1870114,2.850609,0.004363556,0.0481157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12839",1832.531,-0.2526332,0.08862769,-2.8505,0.004365052,0.04812402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99720",573.6694,-0.2849917,0.09999761,-2.849985,0.004372126,0.0481938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106274",40.26333,0.4107144,0.1441153,2.849902,0.004373275,0.04819827,0,5824,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.42e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g9503",839.904,-0.3935406,0.1381146,-2.849378,0.004380475,0.04820383,9655,16880,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.82e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g24280",133.2566,0.2588395,0.09083845,2.849448,0.004379512,0.04820383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24455",19.06705,0.7047032,0.2473091,2.849484,0.004379022,0.04820383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30811",504.624,-0.2376334,0.08339716,-2.849418,0.004379928,0.04820383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34037",26.8161,0.4760939,0.1670839,2.84943,0.00437976,0.04820383,21442,25514,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.76e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g43073",1089.703,-0.2730635,0.09582371,-2.849644,0.004376814,0.04820383,0,8490,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.66e-34,"PiggyBac transposable element-derived protein 4",NA,NA
"g91815",767.9735,-0.3544819,0.1244065,-2.849383,0.004380409,0.04820383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123285",83718.52,-0.7586342,0.2662339,-2.849503,0.004378762,0.04820383,0,4193,"sp|P49096|CYB5_MUSDO","P49096","CYB5",2.93e-11,"Cytochrome b5 (CYTB5)",NA,"GO:0005789; GO:0016021; GO:0020037; GO:0046872"
"g124529",18.80762,-0.5520116,0.193716,-2.849592,0.004377533,0.04820383,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18651",586.2886,0.4166638,0.1462509,2.848966,0.004386161,0.04825819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54004",123.8813,-0.3389193,0.1189773,-2.848606,0.004391126,0.04830462,3705,7760,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.48e-18,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g96391",45.266,0.4966243,0.1743522,2.848398,0.004393999,0.04832802,0,4354,"sp|P24043|LAMA2_HUMAN","P24043","LAMA2",4.5e-09,"Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]","GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0045785; GO:0045995; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046"
"g1889",98.838,-0.495994,0.1741445,-2.848174,0.004397086,0.04834876,101495,104515,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.33e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g28591",26.3437,0.4082728,0.143352,2.848045,0.004398869,0.04834876,0,8174,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.11e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g65650",19.33503,-0.4739107,0.1663937,-2.848129,0.004397708,0.04834876,0,6524,"sp|Q74120|POL_HV2KR","Q74120","POL",1.08e-09,"Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.47) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; suppression by virus of host gene expression [GO:0039657]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004533; GO:0005198; GO:0006310; GO:0008270; GO:0008289; GO:0015074; GO:0016020; GO:0019013; GO:0020002; GO:0039657; GO:0042025; GO:0044826; GO:0046718; GO:0055036; GO:0072494; GO:0075713; GO:0075732"
"g138354",55.69181,0.558697,0.196168,2.848054,0.004398747,0.04834876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18777",60.49132,-0.3882953,0.1363428,-2.847935,0.004400391,0.04834908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62840",149.5818,0.8974771,0.3151307,2.847952,0.00440016,0.04834908,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124224",299.1868,-0.3825574,0.1343507,-2.847454,0.004407053,0.04841407,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128180",444.1936,0.7589616,0.2665649,2.847193,0.004410665,0.04844554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7470",348.1072,0.3268443,0.1148201,2.846578,0.004419193,0.04844953,11042,15354,"sp|Q5M939|HAT1_RAT","Q5M939","HAT1",4.42e-14,"Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)","DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; response to nutrient [GO:0007584]; subtelomeric heterochromatin assembly [GO:0031509]","GO:0000781; GO:0000785; GO:0005739; GO:0006335; GO:0006336; GO:0007584; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043967"
"g13436",408.8491,-0.2871057,0.1008601,-2.846575,0.004419232,0.04844953,32985,58475,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.09e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19809",676.5,-0.3121235,0.1096489,-2.846573,0.004419254,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24804",1476.226,-0.2033812,0.0714386,-2.846936,0.004414217,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38489",162.9033,0.3185736,0.1119088,2.846725,0.004417155,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53599",8829.287,-0.2149737,0.07551141,-2.846903,0.004414684,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77008",69.17641,-0.4695502,0.1649484,-2.846648,0.004418217,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100849",75.34604,-0.4239049,0.148905,-2.846815,0.004415908,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111335",205.4697,0.6044451,0.2123301,2.846723,0.004417182,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136366",59.60367,1.446661,0.5081176,2.847099,0.004411957,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156145",1256.727,1.063505,0.3735516,2.847009,0.00441321,0.04844953,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16143",6652.709,-0.2855226,0.1003076,-2.846472,0.00442066,0.04845513,0,52912,"sp|Q9Z2W1|STK25_MOUSE","Q9Z2W1","STK25",6.65e-28,"Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1)","establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]","GO:0000139; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007163; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168; GO:0106310"
"g144004",308.7003,0.5940813,0.2087111,2.846429,0.004421261,0.04845513,0,1744,"sp|O14832|PAHX_HUMAN","O14832","PAHX",4.18e-20,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)","2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]","GO:0001561; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731"
"g81489",52.80212,1.252227,0.4399602,2.846228,0.004424047,0.04847747,0,2458,"sp|Q5ARL6|XYL2_EMENI","Q5ARL6","XYL2",3.85e-06,"Probable D-xylulose reductase A (EC 1.1.1.9) (Xylitol dehydrogenase A)","D-xylose metabolic process [GO:0042732]; L-arabinose catabolic process to xylulose 5-phosphate [GO:0019569]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006062; GO:0008270; GO:0019569; GO:0042732; GO:0046526"
"g9145",204.7024,-0.2303471,0.08094235,-2.845816,0.004429772,0.04853199,13455,17377,"sp|P08548|LIN1_NYCCO","P08548","LIN1",7.06e-10,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g82584",150.5455,0.4000996,0.1405953,2.845753,0.00443065,0.04853341,0,2364,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.22e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g325",115,-0.3150428,0.1107183,-2.845446,0.004434928,0.04856283,27545,29984,"sp|O15090|ZN536_HUMAN","O15090","ZN536",2.82e-11,"Zinc finger protein 536","negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387"
"g20530",192.2193,0.3424711,0.1203618,2.845348,0.004436295,0.04856283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43412",113.6602,1.862663,0.6546353,2.845345,0.004436334,0.04856283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109389",30.7577,0.8710329,0.3061126,2.845465,0.004434659,0.04856283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17292",88.84863,0.5126138,0.1801731,2.845118,0.004439496,0.04858923,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99171",109.36,0.4080927,0.1434441,2.844959,0.004441708,0.04860523,0,4214,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.01e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g68362",58.56217,0.4578977,0.1609572,2.844841,0.004443353,0.04861503,3126,8804,"sp|Q5PRA2|DHTK1_DANRE","Q5PRA2","DHTK1",9.92e-17,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g123493",26.19653,1.200029,0.4218397,2.844751,0.004444611,0.04862058,0,3254,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",5.35e-39,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g117948",54.7407,0.3535258,0.1242799,2.844594,0.004446807,0.04863639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10972",34.8799,0.3445045,0.121116,2.844418,0.004449263,0.04865504,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25584",3994.816,-0.3476124,0.1222182,-2.844194,0.004452387,0.04866456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29254",567.4526,0.6065238,0.2132497,2.844195,0.004452374,0.04866456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89752",339.6279,0.6050736,0.2127363,2.844242,0.004451718,0.04866456,0,3990,"sp|P21328|RTJK_DROME","P21328","RTJK",1.25e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g57287",79.15241,0.7664838,0.2695093,2.843998,0.004455138,0.04868283,0,14244,"sp|Q8WWT9|S13A3_HUMAN","Q8WWT9","S13A3",2.86e-10,"Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)","anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104]","GO:0005310; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0070062; GO:0071422; GO:0098656; GO:0150104"
"g65302",361.3475,1.311477,0.4611433,2.843967,0.004455561,0.04868283,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25983",147.9113,0.2092323,0.07357519,2.843788,0.004458065,0.04870198,35585,41056,"sp|Q8IH24|MED31_DROME","Q8IH24","MED31",7.25e-21,"Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Protein SOH1) (dSOH1)","anterior/posterior axis specification, embryo [GO:0008595]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0005634; GO:0006357; GO:0008595; GO:0016592; GO:0045893; GO:0070847"
"g43798",162.5813,0.5851822,0.2057824,2.843694,0.004459389,0.04870593,11589,19434,"sp|Q10469|MGAT2_HUMAN","Q10469","MGAT2",1.07e-06,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]","GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0042803"
"g87722",1149.498,0.3000142,0.105503,2.843655,0.00445993,0.04870593,0,7154,"sp|P54385|DHE3_DROME","P54385","DHE3",6.49e-29,"Glutamate dehydrogenase, mitochondrial (GDH) (EC 1.4.1.3)","glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536]; NADH oxidation [GO:0006116]","GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006116; GO:0006536; GO:0006538; GO:0042802"
"g74015",33.15788,0.4866197,0.1711481,2.843267,0.00446537,0.04875711,2810,9254,"sp|Q7ZVB2|A9A1A_DANRE","Q7ZVB2","A9A1A",2.82e-08,"4-trimethylaminobutyraldehyde dehydrogenase A (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1-A) (EC 1.2.1.3)","carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]","GO:0004029; GO:0005829; GO:0006081; GO:0019145; GO:0043878; GO:0045329; GO:0047105; GO:0051289"
"g39235",18.71732,1.209285,0.4253418,2.84309,0.004467851,0.04876777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128596",21.11205,0.4946837,0.1739944,2.843102,0.004467679,0.04876777,16,2134,"sp|O75564|JERKY_HUMAN","O75564","JERKY",2.04e-115,"Jerky protein homolog","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g130800",116.2444,0.2999445,0.1055141,2.842695,0.00447338,0.0488199,0,3567,"sp|Q92878|RAD50_HUMAN","Q92878","RAD50",4.95e-63,"DNA repair protein RAD50 (hRAD50) (EC 3.6.-.-)","cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]","GO:0000019; GO:0000722; GO:0000723; GO:0000729; GO:0000781; GO:0000794; GO:0003677; GO:0003691; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007131; GO:0016020; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042802; GO:0043047; GO:0044818; GO:0046872; GO:0051880; GO:0070192; GO:0070533; GO:0090305; GO:0098687; GO:0110025; GO:1904354"
"g18344",41.33605,0.9519983,0.3349199,2.842465,0.004476609,0.04884691,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50054",99.55125,-0.3443235,0.1211423,-2.842307,0.004478838,0.048863,0,16586,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.19e-21,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5381",390.0147,-0.3592005,0.1263962,-2.841861,0.00448511,0.04887084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20186",22.78412,0.4739852,0.1667919,2.841776,0.004486305,0.04887084,49186,51134,"sp|A0PV27|SYC_MYCUA","A0PV27","SYC",1.29e-17,"Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)","cysteinyl-tRNA aminoacylation [GO:0006423]","GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0008270"
"g28038",2501.009,0.1835776,0.06459272,2.842079,0.004482034,0.04887084,0,3470,"sp|P31410|VATB_HELVI","P31410","VATB",4.19e-85,"V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:0046961"
"g46124",1489.842,-0.282213,0.09930471,-2.84189,0.0044847,0.04887084,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55332",21.83947,-1.229796,0.4327296,-2.84195,0.00448385,0.04887084,0,12016,"sp|P10401|POLY_DROME","P10401","POLY",3.6e-24,"Retrovirus-related Pol polyprotein from transposon gypsy [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004519; GO:0015074"
"g67054",39.12256,-0.3632841,0.1278324,-2.841878,0.004484859,0.04887084,0,7974,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.63e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87739",414.1051,0.6317833,0.2223201,2.841773,0.004486345,0.04887084,5325,7994,"sp|Q9VAS7|INX3_DROME","Q9VAS7","INX3",8.22e-07,"Innexin inx3 (Innexin-3)","dorsal closure [GO:0007391]; intercellular transport [GO:0010496]; ion transport [GO:0006811]; phototransduction [GO:0007602]; phototransduction, visible light [GO:0007603]","GO:0005243; GO:0005737; GO:0005886; GO:0005921; GO:0006811; GO:0007391; GO:0007602; GO:0007603; GO:0010496; GO:0016021; GO:0016327; GO:0016328"
"g118650",106.8191,2.126586,0.748266,2.842018,0.004482897,0.04887084,745,4050,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.33e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g134349",24.94529,1.298031,0.4567538,2.841861,0.004485103,0.04887084,0,3283,"sp|Q2M2H8|MGAL_HUMAN","Q2M2H8","MGAL",1.19e-14,"Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]","carbohydrate metabolic process [GO:0005975]","GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246"
"g67413",275.9667,0.636179,0.2239079,2.841253,0.004493666,0.04894236,0,7879,"sp|Q9DCU9|HOGA1_MOUSE","Q9DCU9","HOGA1",8.35e-10,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)","4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866]","GO:0005739; GO:0008700; GO:0009436; GO:0019470; GO:0033609; GO:0042803; GO:0042866; GO:0046487"
"g143595",53.50442,0.363789,0.128043,2.841147,0.004495163,0.04895044,0,1444,"sp|Q17GZ9|ARP5_AEDAE","Q17GZ9","ARP5",5.1e-21,"Actin-related protein 5","chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006355"
"g66595",2050.939,-0.389782,0.1371952,-2.841077,0.00449615,0.04895296,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4359",83.46202,-0.7623619,0.2683501,-2.840923,0.004498318,0.04895882,0,17794,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.26e-32,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g24926",117.3767,-0.5946203,0.2093019,-2.84097,0.004497657,0.04895882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72876",26.13454,-0.9054695,0.3187288,-2.840878,0.004498955,0.04895882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18464",992.1067,0.1714488,0.06035512,2.840666,0.004501939,0.04897751,6345,9224,"sp|Q6GLM9|CSN5_XENLA","Q6GLM9","CSN5",1.12e-23,"COP9 signalosome complex subunit 5 (Signalosome subunit 5) (EC 3.4.-.-)","negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]","GO:0004222; GO:0005634; GO:0005829; GO:0008021; GO:0008180; GO:0043066; GO:0046872; GO:0048471; GO:0051091; GO:0070122; GO:0140492"
"g60195",85.26501,0.3000091,0.1056129,2.840649,0.004502185,0.04897751,0,4244,"sp|Q8QZT1|THIL_MOUSE","Q8QZT1","THIL",4.08e-08,"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)","acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]","GO:0001889; GO:0003985; GO:0005739; GO:0005743; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0072229; GO:0120225; GO:1902860"
"g72141",712.2565,-0.2960119,0.1042079,-2.840589,0.004503038,0.04897856,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2843",1927.075,-0.2572144,0.09055694,-2.840361,0.004506244,0.04900344,134505,139044,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.59e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g110191",214.5393,-0.3393479,0.1194753,-2.84032,0.004506837,0.04900344,315,5420,"sp|P21414|POL_GALV","P21414","POL",2e-09,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g87079",206.9187,-0.3526011,0.1241472,-2.840186,0.004508722,0.04901415,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140615",34.86471,0.382155,0.1345549,2.840143,0.004509335,0.04901415,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53711",108.7751,0.3271136,0.1151796,2.840029,0.004510939,0.04901514,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150129",741.3969,0.401562,0.1413913,2.840075,0.004510292,0.04901514,0,1974,"sp|Q21313|EPI1_CAEEL","Q21313","EPI1",5.66e-12,"Laminin-like protein epi-1","animal organ morphogenesis [GO:0009887]; axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproduction [GO:0000003]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888]","GO:0000003; GO:0001764; GO:0005201; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0010950; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711"
"g111233",143.405,0.7100305,0.2500183,2.839914,0.004512565,0.04902039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122239",5337.593,-0.7458228,0.262624,-2.839888,0.004512935,0.04902039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127855",19.49927,1.372207,0.4832139,2.839751,0.004514879,0.04903328,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20908",627.8999,0.1822302,0.0641743,2.839613,0.00451683,0.04903803,2394,43534,"sp|O88480|CABIN_RAT","O88480","CABIN",6.49e-54,"Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN)","DNA replication-independent chromatin assembly [GO:0006336]; negative regulation of cell death [GO:0060548]; response to activity [GO:0014823]","GO:0004864; GO:0005634; GO:0005737; GO:0006336; GO:0014823; GO:0019904; GO:0030346; GO:0060548"
"g46990",22.26828,0.5847418,0.2059198,2.839658,0.004516197,0.04903803,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20030",690.2046,0.3543903,0.1248076,2.839493,0.004518528,0.04904825,1105,14262,"sp|Q5RCU5|CBR1_PONAB","Q5RCU5","CBR1",2.45e-08,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)","lipid metabolic process [GO:0006629]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]","GO:0004090; GO:0005737; GO:0006629; GO:0006805; GO:0042373; GO:0047020; GO:0047021; GO:0050221"
"g8615",29.9195,-0.4337953,0.1528063,-2.838856,0.004527552,0.04913797,44467,48944,"sp|P21328|RTJK_DROME","P21328","RTJK",7.29e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g19306",2762.57,-0.3150986,0.1109992,-2.838746,0.004529116,0.0491387,39112,41464,"sp|P21328|RTJK_DROME","P21328","RTJK",4.75e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g27979",18.55207,0.8391127,0.2955929,2.838745,0.004529136,0.0491387,1645,13574,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",1.38e-07,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g99091",21.38581,-0.4421806,0.1557787,-2.838517,0.004532366,0.04916551,2335,6608,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.82e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g114107",84.66524,-0.3526631,0.124245,-2.838449,0.00453333,0.04916774,1375,5051,"sp|P21328|RTJK_DROME","P21328","RTJK",2.84e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g99623",112.6584,0.2701391,0.09517628,2.838303,0.004535414,0.0491821,0,6007,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.63e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g54795",289.6666,-0.5351325,0.188546,-2.838207,0.004536781,0.04918869,1575,5320,"sp|P60517|GBRAP_RAT","P60517","GBRAP",7.31e-07,"Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein)","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of Rac protein signal transduction [GO:0035020]","GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005794; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225; GO:1902524"
"g63789",30.7029,1.331086,0.4690168,2.838035,0.004539225,0.04920696,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57007",154.3288,-0.3466158,0.1221362,-2.837945,0.004540503,0.04921258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57223",74.70677,-0.3499752,0.1233295,-2.837726,0.004543623,0.04923816,4675,7456,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.21e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g143680",20.28767,0.5773709,0.2034777,2.837515,0.004546618,0.04926238,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20898",449.748,-0.3224449,0.1136387,-2.837457,0.004547452,0.04926317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38704",27.41391,-0.3500632,0.1233801,-2.837273,0.004550064,0.049275,12796,16574,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.51e-39,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g45345",204.329,0.3390133,0.1194852,2.837282,0.004549942,0.049275,0,20091,"sp|Q99MR8|MCCA_MOUSE","Q99MR8","MCCA",3.47e-26,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)","leucine catabolic process [GO:0006552]","GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006552; GO:0046872; GO:1905202"
"g101899",1781.322,-0.2675845,0.09431425,-2.837159,0.0045517,0.04928448,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29367",152.7099,0.4887777,0.1722952,2.836861,0.004555941,0.0493042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32879",3068.8,-0.2989935,0.1053935,-2.836925,0.004555024,0.0493042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85874",106.7144,-0.2932017,0.1033551,-2.836838,0.004556268,0.0493042,4963,7784,"sp|P11369|LORF2_MOUSE","P11369","LORF2",9.17e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g116852",50.4381,0.8453802,0.298003,2.836817,0.004556565,0.0493042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25179",1749.082,-0.2563407,0.09036931,-2.83659,0.004559815,0.04933112,19235,38050,"sp|Q9QYS1|WNT16_MOUSE","Q9QYS1","WNT16",7.11e-15,"Protein Wnt-16","bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]","GO:0005109; GO:0005125; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060070; GO:0060317; GO:0060548; GO:0090399; GO:0090403"
"g162626",71.70036,0.3130659,0.1103809,2.836233,0.004564911,0.04937801,0,364,"sp|Q8WTC1|RT15_DROME","Q8WTC1","RT15",3.46e-11,"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (DmMRPS15) (Protein bonsai)","mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]","GO:0003735; GO:0005739; GO:0005763; GO:0032543; GO:0040008"
"g42571",4366.772,-0.2023946,0.07136989,-2.835854,0.00457033,0.04942837,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51219",7831.228,-0.4757119,0.1677581,-2.835701,0.004572521,0.04944382,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58066",144.3666,0.7444224,0.2625372,2.835493,0.004575499,0.04946776,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127729",44.15254,1.14981,0.4055337,2.835302,0.004578244,0.04948919,0,3811,"sp|Q9FR44|PEAM1_ARATH","Q9FR44","PEAM1",2.48e-09,"Phosphoethanolamine N-methyltransferase 1 (AtNMT1) (PEAMT 1) (EC 2.1.1.103) (Protein XIPOTL 1)","choline biosynthetic process [GO:0042425]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; pollen development [GO:0009555]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; post-embryonic root development [GO:0048528]; unidimensional cell growth [GO:0009826]","GO:0000234; GO:0005737; GO:0006656; GO:0008168; GO:0009555; GO:0009826; GO:0009860; GO:0010183; GO:0032259; GO:0042425; GO:0048528; GO:0052667"
"g67706",302.7572,0.4785278,0.1688007,2.834869,0.00458445,0.049548,10245,11378,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5e-38,"PiggyBac transposable element-derived protein 4",NA,NA
"g70122",70.84209,0.2897107,0.1022141,2.834352,0.004591879,0.04962001,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53363",114.1798,-0.2647586,0.09341444,-2.834236,0.004593536,0.04962964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32475",19.76553,0.4528872,0.1597978,2.834127,0.004595104,0.04963003,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88158",122.2356,0.4529618,0.1598224,2.834158,0.004594667,0.04963003,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17422",495.4198,-0.263852,0.09310423,-2.833942,0.004597763,0.04963762,20285,37580,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.79e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g124824",38.62664,-0.3320282,0.1171639,-2.833879,0.004598672,0.04963762,0,4056,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.06e-32,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g130469",89.83443,-0.3337399,0.1177685,-2.833865,0.004598871,0.04963762,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159365",89.32327,1.634281,0.5766687,2.834003,0.004596894,0.04963762,0,1242,"sp|Q6P8K8|CBPA4_MOUSE","Q6P8K8","CBPA4",6.12e-13,"Carboxypeptidase A4 (EC 3.4.17.-)","proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0008270"
"g2147",535.6943,-0.2122278,0.07489483,-2.833678,0.004601568,0.04965019,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119887",469.2647,-1.182483,0.4172903,-2.833717,0.004601009,0.04965019,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12727",58.61394,-0.2858037,0.1008712,-2.833354,0.004606229,0.04968311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31458",895.2926,-0.3851769,0.135941,-2.833412,0.004605404,0.04968311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76131",366.4136,0.7138139,0.2519367,2.833306,0.004606919,0.04968311,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103626",448.4901,-0.2322858,0.08198977,-2.833107,0.00460979,0.0497058,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g326",39.09736,-0.4232113,0.1493905,-2.83292,0.004612499,0.04972673,30026,32734,"sp|O15090|ZN536_HUMAN","O15090","ZN536",6.01e-11,"Zinc finger protein 536","negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387"
"g138482",153.0886,1.792052,0.6326065,2.832807,0.004614121,0.04973594,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122654",279.2194,0.2120931,0.07487638,2.832578,0.004617435,0.04975852,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129882",85.09036,0.853514,0.3013229,2.832556,0.004617752,0.04975852,0,3639,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",6.7e-18,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g2025",768.1543,-0.2631745,0.09291424,-2.832445,0.004619353,0.0497675,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8717",218.317,-0.3083343,0.1088736,-2.83204,0.004625202,0.04982223,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39232",98.94288,1.296381,0.4577834,2.831864,0.004627747,0.04983717,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65909",443.0253,0.5914544,0.2088588,2.831838,0.004628127,0.04983717,8119,11602,"sp|P46978|STT3A_MOUSE","P46978","STT3A",7.08e-37,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"g42031",23.08053,-0.7155115,0.2526749,-2.831748,0.004629433,0.04984295,0,22493,"sp|P21328|RTJK_DROME","P21328","RTJK",8.89e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g35884",31.22074,-0.4040497,0.142707,-2.831323,0.004635585,0.04987603,12044,22454,"sp|P08548|LIN1_NYCCO","P08548","LIN1",5.39e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g41343",32.22287,1.122119,0.3963154,2.831379,0.004634783,0.04987603,13805,16795,"sp|Q9FY48|KEG_ARATH","Q9FY48","KEG",1.22e-06,"E3 ubiquitin-protein ligase KEG (EC 2.3.2.27) (EC 2.7.11.1) (Protein KEEP ON GOING) (RING finger protein KEG) (RING-type E3 ubiquitin transferase KEG)","abscisic acid-activated signaling pathway [GO:0009738]; defense response [GO:0006952]; developmental growth [GO:0048589]; endosomal transport [GO:0016197]; late endosome to vacuole transport [GO:0045324]; negative regulation of abscisic acid-activated signaling pathway [GO:0009788]; positive regulation of histone ubiquitination [GO:0033184]; protein ubiquitination [GO:0016567]; response to abscisic acid [GO:0009737]; secretion by cell [GO:0032940]","GO:0004672; GO:0004674; GO:0004712; GO:0004842; GO:0005524; GO:0005769; GO:0005802; GO:0006952; GO:0009737; GO:0009738; GO:0009788; GO:0016197; GO:0016567; GO:0032940; GO:0033184; GO:0043621; GO:0045324; GO:0046872; GO:0048589; GO:0106310"
"g114303",137.1954,-0.6053626,0.213803,-2.831404,0.004634413,0.04987603,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142925",68.55819,0.3376916,0.1192681,2.831367,0.004634956,0.04987603,1195,2301,"sp|Q60649|CLPB_MOUSE","Q60649","CLPB",4.2e-56,"Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)","antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; RIG-I signaling pathway [GO:0039529]","GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605; GO:0039529; GO:0140374"
"g157953",62.00052,0.3491592,0.1233294,2.831109,0.004638685,0.0499011,0,1341,"sp|Q3TIX9|SNUT2_MOUSE","Q3TIX9","SNUT2",2.43e-13,"U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39)","cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245]","GO:0000245; GO:0000398; GO:0004843; GO:0005634; GO:0005654; GO:0005681; GO:0007049; GO:0008270; GO:0016579; GO:0046540; GO:0051301"
"g112135",118.7756,0.3166126,0.1118416,2.830902,0.004641701,0.04992525,2957,5237,"sp|Q66I67|IFT20_DANRE","Q66I67","IFT20",1.39e-08,"Intraflagellar transport protein 20 homolog","cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283]","GO:0001669; GO:0005794; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0030154; GO:0030992; GO:0036064; GO:0042073; GO:0051642; GO:0061512; GO:2000583"
"g18617",3916.517,-0.3268762,0.1154715,-2.830795,0.004643251,0.04992535,26575,35330,"sp|P11369|LORF2_MOUSE","P11369","LORF2",8.68e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g24918",753.655,-0.4048502,0.1430151,-2.830822,0.004642857,0.04992535,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157874",139.5773,0.3592818,0.1269216,2.830738,0.004644074,0.04992592,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160521",32.91851,0.6359568,0.2246985,2.830267,0.004650913,0.04999115,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9416",1064.912,-0.2885559,0.1019588,-2.830123,0.004653007,0.04999926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37652",77.18791,0.2565732,0.0906584,2.830109,0.004653212,0.04999926,10815,15451,"sp|P54359|SEPT2_DROME","P54359","SEPT2",1.4e-26,"Septin-2","cellularization [GO:0007349]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; regulation of cell cycle [GO:0051726]","GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007295; GO:0007349; GO:0007444; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042803; GO:0051726; GO:0060090; GO:0061640"
